Citrus Sinensis ID: 005909
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | 2.2.26 [Sep-21-2011] | |||||||
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.843 | 0.633 | 0.357 | 5e-93 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.514 | 0.428 | 0.465 | 2e-83 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.437 | 0.360 | 0.508 | 1e-81 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.408 | 0.333 | 0.436 | 1e-59 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.450 | 0.364 | 0.410 | 7e-58 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.423 | 0.325 | 0.428 | 2e-57 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.419 | 0.352 | 0.439 | 3e-57 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.441 | 0.357 | 0.4 | 9e-57 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.501 | 0.325 | 0.360 | 5e-52 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.452 | 0.492 | 0.386 | 5e-52 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 342 bits (877), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 233/651 (35%), Positives = 338/651 (51%), Gaps = 86/651 (13%)
Query: 35 QSQNDTSYEDCSP-FKCGNLT-FSFPFSSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLY 92
Q D Y CS F CG+ ++P CG PN+++ C S ++ ++ +
Sbjct: 244 QHSADEVYRRCSESFSCGSQRDLNYPLWKPGREE-CGHPNFKLNC-SGGFAEINIASVKF 301
Query: 93 QVRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLT-F 151
++ + + S LI + + I DL + L+ + L L LT +
Sbjct: 302 RILDSYRS----LIRLARSDYIGDLCPAN-----PLTAPFIEKFLPVLELTGETELLTLY 352
Query: 152 FKCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRN----------------RTQSGRPSFD 195
+ C R + S + V + C++G Y+ RN R R
Sbjct: 353 YGC--RFNSSDIPANIYVGELGCDEGRSYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSV 410
Query: 196 PVSAPSGCDSVVVPVSSVTSLYLGADVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGS 255
P S P+ D P + L QGF + DCE+C+ G CGYN +
Sbjct: 411 PASGPALFDLQTRPNQDNLKM--------ALDQGFRMLITS--DCERCRGSGGACGYNQT 460
Query: 256 LKKITCFCKGGRC-----DSVKRRKSRLP--------LIIGATAGSCCMVLVAVALLVFR 302
C+CK G+C D RR R + +GA G +V+V + LL
Sbjct: 461 SSGFGCYCKDGKCGYEYDDGFFRRHRRFIATLVRYTFIALGALTG---VVIVFLVLLCPC 517
Query: 303 KRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSAL-LSNYSYNDIKKMTNGFKEKLGTGG 361
R+ F K+ S+E + ++ ++ + L +Y+Y ++KKMT F E +G GG
Sbjct: 518 FRVQIFRKRKTSDEVR-----------LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGG 566
Query: 362 YGNVYKGKFPDGRLVAVKVLEKTSNF-SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420
+G VY G D +VAVKVL+ + ++FINEVA++ + HVNI+ LLGFCC+GS RA
Sbjct: 567 FGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRA 626
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480
+IYE++ NGSL +S +K +++L L IALGVA +EYLH GC+ RI+H DIKPQN
Sbjct: 627 IIYEFLGNGSLDKFIS-DKSSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQN 685
Query: 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSY 540
VLLD + PKVSDFGLAK + S++++ RGTIGYIAPE+ R G+ S KSDVYSY
Sbjct: 686 VLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSY 745
Query: 541 GMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF------------VE 588
GML+LEMI +K R + S S+ + YFP+WIY L + +D +
Sbjct: 746 GMLVLEMIGARKKER-FDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGIS 804
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLF 639
E++ IARKM +VGLWCIQ +P DRP M +VVEM+ S +A+E+PP+P+
Sbjct: 805 SEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMM-EGSLDALEVPPRPVL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 174/374 (46%), Positives = 235/374 (62%), Gaps = 29/374 (7%)
Query: 271 VKRRKSRL--PLIIGATAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQ 328
+K + S L + I G+ V V +L R+ +K EER V
Sbjct: 433 IKGKSSHLLVKIFIAVGPGTGLATFVVVLMLWMRQ----MKRKNRKEER--------VVM 480
Query: 329 FIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS 388
F K LL+ Y+Y ++KK+T F +G GG+G VY G +GR VAVKVL+ +
Sbjct: 481 FKK-----LLNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSA 535
Query: 389 DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 448
++FINEVA++ + HVNI+ LLGFC +GS RA++YE++ NGSL +SR K +L+
Sbjct: 536 EDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK-SLTQDVTT 594
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
L IALG+A +EYLH GC+ RI+H DIKPQN+LLD + PKVSDFGLAK + SV++
Sbjct: 595 LYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLS 654
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTE 567
+ RGTIGYIAPE+F R G S KSDVYS+GML+++MI + K + T ++ S+T
Sbjct: 655 LMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASST-- 712
Query: 568 AYFPDWIYDKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
YFPDWIY L E+ D + +E+ IA+KMI+VGLWCIQ P DRPSM RVVEM+
Sbjct: 713 -YFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMM 771
Query: 624 SSASAEAIEMPPKP 637
S +A+E+PPKP
Sbjct: 772 -EGSLDALEIPPKP 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 156/307 (50%), Positives = 206/307 (67%), Gaps = 14/307 (4%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 396
LL Y Y ++KK+T F +G GG+G VY+G +GR VAVKVL+ D+FINEV
Sbjct: 482 LLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVT 541
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKP--ARLLEIAL 454
++ + HVNI+ LLGFC +GS RA+I E++ +GSL +SR K SL P L IAL
Sbjct: 542 SMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNK---SLTPNVTTLYGIAL 598
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514
G+A +EYLH GC+ RI+H DIKPQN+LLD +F PKV+DFGLAK + S++++ RG
Sbjct: 599 GIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRG 658
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574
TIGYIAPE+ R G S KSDVYSYGML+L+MI + + ETT+ N + AYFPDWI
Sbjct: 659 TIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKV---ETTT-CNGSTAYFPDWI 714
Query: 575 YDKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630
Y L ++ D + EED+ I +KMI+V LWCI+ P DRP M +VVEM+ S +A
Sbjct: 715 YKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMI-EGSLDA 773
Query: 631 IEMPPKP 637
+E+PPKP
Sbjct: 774 LELPPKP 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 127/291 (43%), Positives = 182/291 (62%), Gaps = 17/291 (5%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR 400
++Y D++ TN F KLG GG+G+VY+G PDG +AVK LE F EV+ IG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGS 542
Query: 401 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHA 459
IHH++++ L GFC +G+ R L YE++ GSL + R+K+ ++ L IALG A
Sbjct: 543 IHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKG 602
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
+ YLH C+ RI+H DIKP+N+LLD +F KVSDFGLAK +R +S V T RGT GY+
Sbjct: 603 LAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYL 661
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579
APE ++ N S KSDVYSYGM+LLE+I +K+ P+ET+ + +FP + + K+
Sbjct: 662 APE-WITNYA-ISEKSDVYSYGMVLLELIGGRKNYDPSETSE-----KCHFPSFAFKKME 714
Query: 580 QPEKEDFVEEE-------DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + D V+ + D+ + R M LWCIQ + + RPSM++VV+ML
Sbjct: 715 EGKLMDIVDGKMKNVDVTDERVQRAM-KTALWCIQEDMQTRPSMSKVVQML 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 135/329 (41%), Positives = 189/329 (57%), Gaps = 27/329 (8%)
Query: 338 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVAT 397
LS +SY +++ T F +KLG GG+G+V+KG PD +AVK LE S F EV T
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVT 539
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD--LLSREKENLSLKPARLLEIALG 455
IG I HVN++ L GFC +GS + L+Y+YMPNGSL L++ +E + L +IALG
Sbjct: 540 IGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALG 599
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
A + YLH+ C I+H DIKP+N+LLD F PKV+DFGLAK R+ S V +T RGT
Sbjct: 600 TARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGT 658
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW-- 573
GY+APE ++ + + K+DVYSYGM+L E++ +++ +E N +FP W
Sbjct: 659 RGYLAPE-WISGVA-ITAKADVYSYGMMLFELVSGRRNTEQSE-----NEKVRFFPSWAA 711
Query: 574 -IYDK------LIQPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
I K L+ P E D V+ E+ A K V WCIQ RP+M++VV++L
Sbjct: 712 TILTKDGDIRSLVDPRLEGDAVDIEEVTRACK---VACWCIQDEESHRPAMSQVVQILEG 768
Query: 626 ASAEAIEMPPKPLFPSPPQLQTQNEIISF 654
+E+ P P S L +E + F
Sbjct: 769 ----VLEVNPPPFPRSIQALVVSDEDVVF 793
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 132/308 (42%), Positives = 183/308 (59%), Gaps = 24/308 (7%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT-SNFSDNFINEVATIG 399
++Y D++ TN F + LG+GG+G VYKG LVAVK L++ S+ FI EV TIG
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIG 579
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARL-LEIALGVAH 458
+HH+N++ L G+C + S R L+YEYM NGSL + ++ +L R EIA+ A
Sbjct: 580 SMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQ 639
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS-VVTMTGPRGTIG 517
I Y H C RI+H DIKP+N+LLD +F PKVSDFGLAK R S VVTM RGT G
Sbjct: 640 GIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMI--RGTRG 697
Query: 518 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
Y+APE ++ N P + K+DVYSYGMLLLE++ +++L + + + ++P W Y
Sbjct: 698 YLAPE-WVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMS-----YDAEDFFYPGWAYK 749
Query: 577 KLIQ-------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629
+L ++ V EE++ + K + V WCIQ RPSM VV++L S E
Sbjct: 750 ELTNGTSLKAVDKRLQGVAEEEEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDE 807
Query: 630 AIEMPPKP 637
I +PP P
Sbjct: 808 -INLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 130/296 (43%), Positives = 171/296 (57%), Gaps = 15/296 (5%)
Query: 338 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVA 396
L +S+ +++ TNGF +K+G GG+G V+KG P VAVK LE+ + F EV
Sbjct: 448 LKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVC 507
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 456
TIG I HVN++ L GFC + R L+Y+YMP GSL LSR L R IALG
Sbjct: 508 TIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRF-RIALGT 566
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
A I YLH GC I+H DIKP+N+LLD D+ KVSDFGLAK R+ S V T RGT
Sbjct: 567 AKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT-MRGTW 625
Query: 517 GYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFPD 572
GY+APE G P + K+DVYS+GM LLE+I ++++ T G TE +FP
Sbjct: 626 GYVAPEWIS---GLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPP 682
Query: 573 WIYDKLIQPEKEDFVE-----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
W ++IQ + V+ E + +M V +WCIQ N + RP+M VV+ML
Sbjct: 683 WAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKML 738
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 126/315 (40%), Positives = 172/315 (54%), Gaps = 19/315 (6%)
Query: 333 YRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFI 392
Y S ++Y ++++ T FKEKLG GG+G VY+G + +VAVK LE F
Sbjct: 466 YASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFR 525
Query: 393 NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEI 452
EVATI HH+N++ L+GFC G R L+YE+M NGSL + L L I
Sbjct: 526 MEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNI 585
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
ALG A I YLH C I+H DIKP+N+L+D +F KVSDFGLAK + + M+
Sbjct: 586 ALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSV 645
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572
RGT GY+APE ++ NL S KSDVYSYGM+LLE++ K++ +E T F
Sbjct: 646 RGTRGYLAPE-WLANLPITS-KSDVYSYGMVLLELVSGKRNFDVSE-----KTNHKKFSI 698
Query: 573 WIYDKLIQPEKEDFVE---EEDDCI----ARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
W Y++ + + ++ ED + +M+ WCIQ P RP+M +VV+ML
Sbjct: 699 WAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML-- 756
Query: 626 ASAEAIEMPPKPLFP 640
E I PL P
Sbjct: 757 ---EGITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 138/383 (36%), Positives = 207/383 (54%), Gaps = 47/383 (12%)
Query: 273 RRKSRLPLIIGATAGSCCM-VLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIK 331
+ K+R I+G G + +L V + RKR +K ++++ + +G ++VK +I
Sbjct: 630 KGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKR-----RKRYTDDEELLG--MDVKPYI- 681
Query: 332 TYRSALLSNYSYNDIKKMTNGF--KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFS 388
++Y+++K T F KLG GG+G VYKG DGR+VAVK+L S
Sbjct: 682 ---------FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGK 732
Query: 389 DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 448
F+ E+ I + H N++ L G C +G R L+YEY+PNGSL L +K L L +
Sbjct: 733 GQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDK-TLHLDWST 791
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
EI LGVA + YLH +RI+H D+K N+LLD P++SDFGLAK + ++ ++
Sbjct: 792 RYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS 851
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE- 567
T GTIGY+APE MR G+ + K+DVY++G++ LE++ RP S N E
Sbjct: 852 -TRVAGTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSG----RP---NSDENLEEE 901
Query: 568 -AYFPDWIYD--------KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
Y +W ++ +LI + DF EE A++MI + L C Q + RP M+R
Sbjct: 902 KKYLLEWAWNLHEKSRDIELIDDKLTDFNMEE----AKRMIGIALLCTQTSHALRPPMSR 957
Query: 619 VVEMLSSASAEAIEMPPKPLFPS 641
VV ML S E ++ KP + S
Sbjct: 958 VVAML-SGDVEIGDVTSKPGYVS 979
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 122/316 (38%), Positives = 186/316 (58%), Gaps = 13/316 (4%)
Query: 340 NYSYNDIKKMTNGFKE--KLGTGGYGNVYKGKFPDGRLVAVKVLE-KTSNFSDNFINEVA 396
N+ Y ++K T F + KLG GG G+VYKG PDGR+VAVK L T ++D F NEV
Sbjct: 305 NFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREWADQFFNEVN 364
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 456
I + H N++ LLG +G L+YEY+ N SL +L + L + I +G+
Sbjct: 365 LISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWKQRFNIIIGI 424
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
+ +EYLH G E++I+H DIK N+LLD + +PK++DFGL ++ +++ T TG GT+
Sbjct: 425 SEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKT-QTNTGIAGTL 483
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-NTTEAYFPDWIY 575
GY+APE ++ G + K+DVY++G+L++E++ KK+ T+ TS + +F
Sbjct: 484 GYLAPEYLIK--GQLTEKADVYAFGVLIIEIVTGKKNNAFTQGTSSVLYSVWEHFKANTL 541
Query: 576 DKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 634
D+ I P K FVEEE A K++ +GL C+Q + + RPSM+ +V ML + ++ E P
Sbjct: 542 DRSIDPRLKGSFVEEE----ALKVLQIGLLCVQSSVELRPSMSEIVFMLQNKDSK-FEYP 596
Query: 635 PKPLFPSPPQLQTQNE 650
+P F S L E
Sbjct: 597 KQPPFLSASVLMPDEE 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | ||||||
| 359472680 | 689 | PREDICTED: probable receptor-like protei | 0.953 | 0.927 | 0.533 | 0.0 | |
| 147769069 | 689 | hypothetical protein VITISV_027278 [Viti | 0.953 | 0.927 | 0.532 | 0.0 | |
| 255572126 | 597 | serine/threonine kinase, putative [Ricin | 0.862 | 0.968 | 0.560 | 1e-176 | |
| 147769070 | 941 | hypothetical protein VITISV_027279 [Viti | 0.564 | 0.401 | 0.591 | 1e-124 | |
| 255551426 | 638 | serine/threonine kinase, putative [Ricin | 0.892 | 0.937 | 0.393 | 1e-108 | |
| 54290824 | 629 | putative receptor serine/threonine kinas | 0.849 | 0.904 | 0.389 | 1e-108 | |
| 357133266 | 629 | PREDICTED: probable receptor-like protei | 0.874 | 0.931 | 0.377 | 1e-107 | |
| 224127698 | 580 | predicted protein [Populus trichocarpa] | 0.826 | 0.955 | 0.390 | 1e-106 | |
| 145839451 | 627 | receptor-like protein kinase [Capsicum a | 0.874 | 0.934 | 0.382 | 1e-105 | |
| 62857020 | 691 | Ser/Thr protein kinase [Lotus japonicus] | 0.907 | 0.879 | 0.373 | 1e-105 |
| >gi|359472680|ref|XP_002279518.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/695 (53%), Positives = 472/695 (67%), Gaps = 56/695 (8%)
Query: 17 SLMIIAMGMATFPDFIHSQSQNDTSYED-CSPFKCGNLTFSFPFSSSSTSGY----CGLP 71
SL + ++TF IHSQS DTSY + C PF CGN+TFSFPFS + G+ CGLP
Sbjct: 5 SLPFLIFFISTFLTLIHSQS--DTSYYNLCKPFDCGNITFSFPFSLGADFGFGPRDCGLP 62
Query: 72 NYQITCDSSSVPKLLLSGRLYQVRNFFSS-----QDDRLITVVDTQLIKDLSSGSCESLY 126
YQI C+SSS P+L+LS R YQV+ + S Q ITVVD LI DLSSGSC SL
Sbjct: 63 GYQIFCESSSNPRLMLSDRFYQVKQLYLSPHHEQQSSNFITVVDHPLINDLSSGSCVSLG 122
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVS--CNDGHVLYLWR 184
NLS+ N+ + L LPS ++LTFF+C RL L Q+F D V+N + C +G+ L+L R
Sbjct: 123 NLSIPTNA--VAPLKLPSWGVDLTFFQCSTRLPLPQDFLDTLVNNFTYNCQEGYALHLLR 180
Query: 185 ----NRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLG-------------------AD 221
N ++ P PV PSGC V +PVS + G
Sbjct: 181 EVRGNESRLDSPPLSPVLIPSGCGLVSLPVSRASLTRYGLLNSSDGENRMVLKAHMELEQ 240
Query: 222 VFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLI 281
+ LR GFPL+W CE C+N+ GRCGY+ L K+ CFC+ G C ++ ++S+ LI
Sbjct: 241 LLHVLRDGFPLQWSSFGVCESCKNKGGRCGYDSILGKVDCFCEAGHCQQLRHQQSQRKLI 300
Query: 282 IGATAGSCCMVLVAVALLVF--RKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLS 339
+G AG +V+ AV L +F +KRI KK +S + Q +G G N +QFIK Y+SA+L+
Sbjct: 301 VGVAAGGSFIVVAAVVLSIFEFKKRI----KKSYSRKTQTVGGGRNAEQFIKEYQSAVLT 356
Query: 340 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATI 398
NYSYND+KKM++GFK+KLG GG+GNVY GK DGRL+A+K+LEK+++ S +F+NEVA+I
Sbjct: 357 NYSYNDMKKMSSGFKDKLGQGGFGNVYLGKMLDGRLIAMKMLEKSNHEISHDFVNEVASI 416
Query: 399 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 458
GRIHHVN+I LLGFC DGS +ALIYEYMPNGSLGDL+S+E LSL ARLLEIA+GVAH
Sbjct: 417 GRIHHVNVIRLLGFCWDGSKQALIYEYMPNGSLGDLMSKEGARLSLGLARLLEIAIGVAH 476
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
IEYLHNGCE RILHLDIKPQN+LLD + PK+SDFGLAK +SR+RS V++T RGTIGY
Sbjct: 477 GIEYLHNGCESRILHLDIKPQNILLDHNLNPKISDFGLAKVYSRDRSAVSVTCARGTIGY 536
Query: 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578
IAPEIFMRN+G+PS KSDVYSYGMLLL+M+ KKH+ S +E+YFPDWI+DK+
Sbjct: 537 IAPEIFMRNVGSPSHKSDVYSYGMLLLDMVGGKKHVVSKMMAS----SESYFPDWIHDKV 592
Query: 579 IQPEKED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 634
++ E + V EE+ IA+KMI+VG WCIQ++P+DRPSM RVVEML + SAEAI+MP
Sbjct: 593 MEEEGMEEPIFSVAEEEVGIAKKMIMVGSWCIQMDPRDRPSMARVVEML-NGSAEAIQMP 651
Query: 635 PKPLFPSPPQLQTQNEIISFDSIT-SELPLQHDSQ 668
PKP F S + EI +S T + LPL SQ
Sbjct: 652 PKPFFSSSSPAHFEQEITYSESDTGASLPLFESSQ 686
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769069|emb|CAN72504.1| hypothetical protein VITISV_027278 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/695 (53%), Positives = 470/695 (67%), Gaps = 56/695 (8%)
Query: 17 SLMIIAMGMATFPDFIHSQSQNDTSYED-CSPFKCGNLTFSFPFSSSSTSGY----CGLP 71
SL + ++T IHSQS DTSY + C PF CGN+TFSFPFS + G+ CGLP
Sbjct: 5 SLPFLIFFISTXLTLIHSQS--DTSYYNLCKPFDCGNITFSFPFSLGADFGFGPRDCGLP 62
Query: 72 NYQITCDSSSVPKLLLSGRLYQVRNFFSS-----QDDRLITVVDTQLIKDLSSGSCESLY 126
YQI C+SSS P+L+LS R YQV+ + S Q ITVVD LI DLSSGSC SL
Sbjct: 63 GYQIFCESSSNPRLMLSDRFYQVKQLYLSPHHEQQSSNFITVVDHPLINDLSSGSCVSLG 122
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVS--CNDGHVLYLWR 184
NLS+ N+ + L LPS ++LTFF+C RL L Q F D V+N + C +G+ L+L R
Sbjct: 123 NLSIPTNA--VAPLKLPSWGVDLTFFQCSTRLPLPQXFLDTLVNNFTYNCQEGYALHLXR 180
Query: 185 ----NRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLG-------------------AD 221
N ++ P PV PSGC V +PVS + G
Sbjct: 181 EVRGNESRLDSPPLSPVLIPSGCGLVSLPVSRASLTRYGLLNSSDGENRMVLKAHMELEQ 240
Query: 222 VFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLI 281
+ LR GFPL+W CE C+N+ GRCGY+ L K+ CFC+ G C ++ ++S+ LI
Sbjct: 241 LLHVLRDGFPLQWSSFGVCESCKNKGGRCGYDSILGKVDCFCEAGHCQQLRHQQSQRKLI 300
Query: 282 IGATAGSCCMVLVAVALLVF--RKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLS 339
+G AG +V+ AV L +F +KRI KK +S + Q +G G N +QFIK Y+SA+L+
Sbjct: 301 VGVAAGGSFIVVAAVVLSIFEFKKRI----KKSYSRKTQTVGGGRNAEQFIKEYQSAVLT 356
Query: 340 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATI 398
NYSYND+KKM++GFK+KLG GG+GNVY GK DGRL+A+K+LEK+++ S +F+NEVA+I
Sbjct: 357 NYSYNDMKKMSSGFKDKLGQGGFGNVYLGKMLDGRLIAMKMLEKSNHEISHDFVNEVASI 416
Query: 399 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 458
GRIHHVN+I LLGFC DGS +ALIYEYMPNGSLGDL+S+E LSL ARLLEIA+GVAH
Sbjct: 417 GRIHHVNVIRLLGFCWDGSKQALIYEYMPNGSLGDLMSKEGARLSLGLARLLEIAIGVAH 476
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
IEYLHNGCE RILHLDIKPQN+LLD + PK+SDFGLAK +SR+RS V++T RGTIGY
Sbjct: 477 GIEYLHNGCESRILHLDIKPQNILLDHNLNPKISDFGLAKVYSRDRSAVSVTCARGTIGY 536
Query: 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578
IAPEIFMRN+G+PS KSDVYSYGMLLL+M+ KKH+ S +E+YFPDWI+DK+
Sbjct: 537 IAPEIFMRNVGSPSHKSDVYSYGMLLLDMVGGKKHVVSKMMAS----SESYFPDWIHDKV 592
Query: 579 IQPEKED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 634
++ E + V EE+ IA+KMI+VG WCIQ++P+DRPSM RVVEML + SAEAI+MP
Sbjct: 593 MEEEGMEEPIFSVAEEEVGIAKKMIMVGSWCIQMDPRDRPSMARVVEML-NGSAEAIQMP 651
Query: 635 PKPLFPSPPQLQTQNEIISFDSIT-SELPLQHDSQ 668
PKP F S + EI +S T + LPL SQ
Sbjct: 652 PKPFFSSSSPAHFEQEITYSESDTGASLPLFESSQ 686
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572126|ref|XP_002527003.1| serine/threonine kinase, putative [Ricinus communis] gi|223533638|gb|EEF35375.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1608), Expect = e-176, Method: Compositional matrix adjust.
Identities = 343/612 (56%), Positives = 427/612 (69%), Gaps = 34/612 (5%)
Query: 8 PAP-SSIISVSLMIIAMGMAT-FPDFIHSQSQNDTS-YEDCSPFKCGNLTFSFPFSS--- 61
PAP SS++S ++ +++ ++T FP H +SQN TS Y+ C+PFKCGN+TFSFPFSS
Sbjct: 5 PAPVSSVLSSFIITLSLIISTTFP--THIKSQNSTSDYDLCTPFKCGNITFSFPFSSLTF 62
Query: 62 SSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLSSGS 121
S CGLP+YQITCD S ++LSGR +QV++ + S DRLIT VD QLIKDL++GS
Sbjct: 63 GSGPKTCGLPSYQITCDDLS-SGIILSGRFFQVKDLYLS--DRLITAVDIQLIKDLTAGS 119
Query: 122 CESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVSCNDGHVLY 181
C SL N +V+ SL+LP G LN T CP L LS++F +KG + +C +G LY
Sbjct: 120 CSSLRNFTVSSTYNPSLSLSLPPGTLNFTLLMCPAELELSKDFLEKGSYSFTCMEGDKLY 179
Query: 182 LWRNRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLGA------DVFDTLRQGFPLEWP 235
+W +Q P+ APS C V VP +S ++ G + L GF L WP
Sbjct: 180 VWDPPSQ---LKLSPLLAPSECSVVTVPSNSFLNISNGTSDDHRIQLAHILVDGFALTWP 236
Query: 236 KLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLIIGATAGSCCMVLVA 295
+C C + GRCG++GSL +I CF K G S K+ + LIIG GSC L+
Sbjct: 237 DFKECTNCSSIGGRCGFDGSLGRIVCFHKPG---SSKKNPKKGELIIGIATGSC-FTLLL 292
Query: 296 VALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKE 355
V LLV + R+P+ +K + QN + NV+QF+KTY+SALLSNYSY DI+KMTNGF+E
Sbjct: 293 VVLLVLKGRVPALKRK----KNQNTENRKNVEQFVKTYQSALLSNYSYRDIRKMTNGFRE 348
Query: 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
KLG GGYGNVYKG+ DGRLVA+K+LEK S+ +F+NEVATIG IHH N+I LLGF +
Sbjct: 349 KLGEGGYGNVYKGRLSDGRLVAIKLLEKLSSNGRDFVNEVATIGTIHHFNVIRLLGFSWN 408
Query: 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 475
GS +ALIYEYMPNGSL DLLS + +LSL+ +R+LEIA+G+AH IEYLHNGCE RILHLD
Sbjct: 409 GSKQALIYEYMPNGSLADLLSNGEFSLSLRLSRMLEIAIGIAHGIEYLHNGCESRILHLD 468
Query: 476 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS 535
IKPQNVLLD + PK+SDFGLAK +SRNRSVVTMT RGTIGYIAPEIFMRNLGNPS KS
Sbjct: 469 IKPQNVLLDQNLNPKISDFGLAKIYSRNRSVVTMTDARGTIGYIAPEIFMRNLGNPSHKS 528
Query: 536 DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP---EKEDFVEEEDD 592
DVYSYGMLLLEM+ +K + E S ++EAYFPDWIYDKLI+ E D + EEDD
Sbjct: 529 DVYSYGMLLLEMVGGRKQV---ERNILSTSSEAYFPDWIYDKLIEEKNIEIADSIAEEDD 585
Query: 593 CIARKMIIVGLW 604
I+RKMI VGLW
Sbjct: 586 DISRKMITVGLW 597
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769070|emb|CAN72505.1| hypothetical protein VITISV_027279 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1167), Expect = e-124, Method: Compositional matrix adjust.
Identities = 232/392 (59%), Positives = 299/392 (76%), Gaps = 14/392 (3%)
Query: 284 ATAGSCCMVLVAVALLVFRKRI---PSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSN 340
+GS +++ + L+F+ + P F F + R++ DG N +QFIK Y+S +L+
Sbjct: 551 VASGSSVILVTVIFFLIFKYKKGTSPFFRAFNFRKNRRSTEDGRNAQQFIKEYQSTILTK 610
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIG 399
YSY+D+KKM+ GFK+KLG GG+GNVYKGK PDGRL+A+K+LE++ + + NF+NEV TIG
Sbjct: 611 YSYHDLKKMSGGFKDKLGEGGFGNVYKGKMPDGRLIAIKILERSXHDMNQNFVNEVVTIG 670
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
RIHH+N+I LLGFC DG +AL+YEYMPNGSLGD LS+ +LSL ARLLEIA+GVAH
Sbjct: 671 RIHHLNVIRLLGFCWDGGKQALVYEYMPNGSLGDFLSQXGXSLSLGLARLLEIAIGVAHG 730
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
IEYLH GCE RILHLDIKPQNVLLD + PK+SDFGLAK +SR+RS ++MT RGTIGYI
Sbjct: 731 IEYLHFGCESRILHLDIKPQNVLLDQNLNPKISDFGLAKLYSRDRSAISMTNARGTIGYI 790
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579
APEIFMRNJGNPS KSDVYSYGMLLL+M+ KKH+ P +TS +E YFPDWIYDKL+
Sbjct: 791 APEIFMRNJGNPSHKSDVYSYGMLLLDMVGGKKHVPPEMSTS----SEKYFPDWIYDKLM 846
Query: 580 QPEKEDFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPK 636
+ E+ + ++ EE+ IA+KM++VGLWCIQ++P+DRPSMTRVVEML + S EAI+ PPK
Sbjct: 847 EEEEMEAIDSIVEEEVGIAKKMVVVGLWCIQVDPRDRPSMTRVVEML-NGSVEAIKTPPK 905
Query: 637 PLFPSPPQLQTQNEII--SFDSITSELPLQHD 666
P F SPP+ + EI DS ++ L +Q D
Sbjct: 906 PFFFSPPREDFEQEITYSKSDSDSTSLVIQED 937
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-108, Method: Compositional matrix adjust.
Identities = 259/659 (39%), Positives = 365/659 (55%), Gaps = 61/659 (9%)
Query: 10 PSSIISVSLMIIAMGMATFPDFIHSQSQNDTSYEDCS-PFKCGNL-TFSFPFSSSSTSGY 67
P S S+SL + + + PD +Q D +CS FKCGN+ +PF S+ Y
Sbjct: 3 PHSPQSMSLFFLFIAIILVPDSTPVYAQIDM---NCSQKFKCGNIPDIGYPFWGSNRPQY 59
Query: 68 CGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLS-SGSCESLY 126
CG P +++ C + + + YQV S +++ + V T I ++ S +
Sbjct: 60 CGHPEFELNC-TGQTAVITVEELTYQVLEINS--EEKTLKVARTDYIDNICPSNPVSTTL 116
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRR--LSLSQNFTDKGVSNVSCNDGHVLYLWR 184
N + + I +TL ++ CP+ + Q+FT++ SCND + ++ R
Sbjct: 117 NFNYFSYTSDIQIITL--------YYGCPQSNPMPTLQDFTNQ----FSCNDSNGFFVTR 164
Query: 185 NRTQSGRPSFDPVSAPSGCD-SVVVPV--SSVTSLYL---GADVFDTLRQGFPLEWPKLD 238
N + + ++ CD V+VP S+V SL ++ L QGF LEW +
Sbjct: 165 NLSNL---TAALMTYFRTCDVEVIVPANQSAVQSLENRPNQENLVIALEQGFGLEWRENS 221
Query: 239 DCEKCQNRSGRCGYNGSLKKI-TCFCKGGRCD-SVKRRKSRLPLIIGATAGSCCMVLVAV 296
CE C G+CG N + + C+C G S R +S G A + + +
Sbjct: 222 TCETCNMSGGQCGSNSTDPSLFACYCTNGPDPFSCGRSQSS-----GLGAAAAVLTICLG 276
Query: 297 ALLVFRKRIPSFFKKPFSEER-QNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKE 355
F +R+ + S+ R +N+ ++ FI Y+S + YSY+DI++MTN F
Sbjct: 277 IYYCFTRRV-----RFLSDTRWKNVKKDEKIENFILNYQSFMPKRYSYSDIQRMTNSFNH 331
Query: 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
KLG GG+G VYKGK DGR+VAVKVL K++ + FINEVA+I R H+N++ LLGFC +
Sbjct: 332 KLGQGGFGGVYKGKLLDGRVVAVKVLSKSTGDGEEFINEVASISRTSHINVVTLLGFCYE 391
Query: 416 GSTRALIYEYMPNGSLGDLL---SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
S RALIYEYMPNGSL + + N L L +I +G+A +EYLH GC RI+
Sbjct: 392 RSKRALIYEYMPNGSLDKFIYDQGSQGVNKHLDWKTLYDITVGIARGLEYLHRGCNTRIV 451
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H DIKP N+LLD DF PKVSDFGLAK S++TM G RGTIGYIAPEIF+RN G S
Sbjct: 452 HFDIKPHNILLDKDFCPKVSDFGLAKLCKGKESIITMLGARGTIGYIAPEIFIRNFGGVS 511
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK-----EDFV 587
KSDVYSYGM++LE+ R S++ E YFP+ IY K I+ E+ E
Sbjct: 512 YKSDVYSYGMMILEICGG----RNKSDVGVSHSGEVYFPECIY-KYIESEQVSTLHEKIT 566
Query: 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKP-LF-PSPPQ 644
+EE + + R++ IVGLWCIQ NP DRPSMT+VVEML +S E++++PPKP LF P+ PQ
Sbjct: 567 DEEGE-MVRRLTIVGLWCIQTNPSDRPSMTKVVEMLEGSSLESLQIPPKPSLFAPTTPQ 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|54290824|dbj|BAD61463.1| putative receptor serine/threonine kinase PR5K [Oryza sativa Japonica Group] gi|125568940|gb|EAZ10455.1| hypothetical protein OsJ_00288 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 237/609 (38%), Positives = 334/609 (54%), Gaps = 40/609 (6%)
Query: 45 CSPFKCGNLTFSFPFS-SSSTSGYCGLPNYQITC-DSSSVPKLLLSGRLYQVRNFFSSQD 102
C P CGNLT ++PF S CG P++Q+TC D +S P L +V F
Sbjct: 30 CPPATCGNLTITYPFWLGSQNQSSCGPPSFQLTCNDRASGP--FLRNSYIKVLGF--DYG 85
Query: 103 DRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQ 162
R + V L D +C ++N+S A S++ + L +C RL
Sbjct: 86 RRSLVAVHALLAAD---AACTVMFNVSSAFAITDRFSISQSNREL-YVLSRCRERLPPPD 141
Query: 163 NFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPV--SSVTSLYLGA 220
V+N N + +G+ PV+ GC+ V V SS + A
Sbjct: 142 AVP---VTNCRANSSGMYAYLGGSYGTGQ---TPVNN-GGCELSVFLVLGSSNAADMTAA 194
Query: 221 DVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGR-----CDSVKRRK 275
+ + GF LEW + DC C GRC Y+ S C C G CD R K
Sbjct: 195 NYRQLIAGGFLLEWEPVGDCNACTASGGRCRYDASTSAFACLCSDGGMRPSICDGKNRGK 254
Query: 276 SRLPLIIGATAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNI--GDGLNVKQFIKTY 333
L + + A AG +V +A L++R+R + F + G+ N ++ +K
Sbjct: 255 LALIVSLSAAAG---LVFAFLAWLMYRQR------QKFRSAICGVYSGNTKNEEEMLKKC 305
Query: 334 RSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFIN 393
S L Y Y+++KK+T F++ LG GGYG V+KG+ +GR+VAVK+L + ++F+N
Sbjct: 306 ESLALKRYKYSELKKITKSFEDNLGEGGYGVVFKGRLQNGRMVAVKILTVSKGNGEDFLN 365
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 453
EV +I R HVNI+ LLGFC +G RAL+YEYMPNGSL + + E NL+ LL+I
Sbjct: 366 EVMSISRTSHVNIVTLLGFCLEGPKRALVYEYMPNGSLKNYIHSESSNLATGWEMLLKIV 425
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
+G+A +EYLH GC RI+H DIKP+N+LLD +F PK++DFGLAK N S+++M R
Sbjct: 426 IGIARGLEYLHQGCNTRIIHFDIKPRNILLDHEFCPKIADFGLAKLCHLNESILSMAEAR 485
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
GTIG+IAPE+F R G S KSDVYSYGMLLLE+++ +K+++ N +E +FP W
Sbjct: 486 GTIGFIAPEVFSRGFGVVSTKSDVYSYGMLLLEIVKVRKNIKGI----ADNFSETFFPHW 541
Query: 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 633
+YD L+ + + IARKM IVGLWCIQ+ P+ RPSM+RV+EML + +E +EM
Sbjct: 542 VYDSLVSEMQCCETAYGTEEIARKMTIVGLWCIQMTPETRPSMSRVIEMLERSISE-LEM 600
Query: 634 PPKPLFPSP 642
PPKP SP
Sbjct: 601 PPKPFLCSP 609
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357133266|ref|XP_003568247.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1013), Expect = e-107, Method: Compositional matrix adjust.
Identities = 241/638 (37%), Positives = 348/638 (54%), Gaps = 52/638 (8%)
Query: 40 TSYEDCSPFKCGNLTFSFPF----SSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVR 95
T+ C P CGNLT ++PF CG P +Q+TC ++ L R ++
Sbjct: 25 TNDAGCPPATCGNLTLAYPFWLAGGQEDQQPSCGPPAFQLTCHNNGSAFL----RTSYMK 80
Query: 96 NFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAI---NSYSIGSLTLPSGNLNLTFF 152
R + V L D +C ++N+S A + Y I S
Sbjct: 81 VLNVDYGSRSLVAVHALLAAD---AACTVMFNVSSAFAITDRYRISR----SNRELYVLS 133
Query: 153 KCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPVSS 212
+C R V+N S + R + +P + S C+ + PV
Sbjct: 134 RCRERRPPPGAVP---VANCSATSSGMYAYLGGRYGTAQPPANEGS----CEISMFPV-- 184
Query: 213 VTSLYLGADVFDTL-RQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGG----- 266
+ S A+ + L + GF LEW + DC+ C GRC Y+ S C C G
Sbjct: 185 IASEATTAENYRRLIKGGFLLEWEPVGDCKACTASGGRCRYDSSTAAFVCLCSDGGLRAS 244
Query: 267 RCDSVKRRKSRLPLIIGATAGSCCMVLVAVALLVFRKR--IPSFFKKPFSEERQNIGDGL 324
CD +RK+ L LI+ + + + L +A LV+R+R I S K +S N
Sbjct: 245 TCDGKHKRKT-LTLIVSLSVAAV-LSLACLAWLVYRRRRKIRSTISKIYSSNTSN----- 297
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT 384
V++ ++ S L Y Y+++KK+T F+++LG GGYG VYKG DGR+VAVK+L+ +
Sbjct: 298 -VEEMLRKCGSLSLKKYKYSELKKITRSFEDELGEGGYGVVYKGSLKDGRMVAVKLLKGS 356
Query: 385 SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSL 444
++F+NEV +IG+ HVNI+ LLGFC +GS RALIYEYM NGSL + E L++
Sbjct: 357 KGNGEDFLNEVMSIGQTSHVNIVSLLGFCLEGSQRALIYEYMSNGSLQKHIYSESSKLAI 416
Query: 445 KPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504
L+IA+G+A +EYLH GC RI+H DIKP N+LLD +F+PK++DFGLAK
Sbjct: 417 GWEMFLKIAIGIARGLEYLHQGCNTRIIHFDIKPNNILLDHEFSPKIADFGLAKLFHLKD 476
Query: 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564
SV++M RGTIG+IAPE+F R G S KSDVYSYGMLLLEM++ KK L+ +S
Sbjct: 477 SVLSMAEARGTIGFIAPEVFSRGFGVVSTKSDVYSYGMLLLEMVQGKKDLKRNVGSS--- 533
Query: 565 TTEAYFPDWIYDKLIQPEKEDF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+E +FP W++D+L++ + V + + I RKM ++GLWCIQ+ P++RPSM+RV+EML
Sbjct: 534 -SETFFPHWVHDRLVRDLQGSCEVTQGTEEIVRKMTMIGLWCIQMTPENRPSMSRVIEML 592
Query: 624 SSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSEL 661
+ E +EMPPKP SP L + N + S+ S+ E+
Sbjct: 593 ERSINE-LEMPPKPFLCSP--LHSTN-VSSYASVQIEM 626
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1004), Expect = e-106, Method: Compositional matrix adjust.
Identities = 245/627 (39%), Positives = 337/627 (53%), Gaps = 73/627 (11%)
Query: 39 DTSYEDCSP-FKCGNL-TFSFPFSSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVRN 96
D Y CS F+CGN+ ++PF + YCG P + + C S P + +S YQV
Sbjct: 1 DERYLSCSKSFECGNIQNITYPFWGVNRPQYCGYPGFHLDC-SGDAPVIKISEVAYQVLE 59
Query: 97 FFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPR 156
S LI+ T I + N + + +S S T N+ L ++ CP
Sbjct: 60 IKSMSRVHLISTEYTDNICSIPP------VNSTFDSDRFSYASNT---KNIML-YYGCPT 109
Query: 157 -------RLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSF--DPVSAPSGCD-SV 206
L LS F+ N+S D YL RN + S SF + S C+ SV
Sbjct: 110 IPSQFLPTLGLSYQFS----CNISRTDMVGYYLTRNLSMSATGSFAANISSYLESCNHSV 165
Query: 207 VVP-----VSSVTSLYLGADVFDTLRQGFPLEWPKLDD-CEKCQNRSGRCGYNGSLKKIT 260
++P V S+ S A++ + L +GF L+W D C KC+ G+CGYN K T
Sbjct: 166 LIPAYESAVRSIESHPTAANLTNALHRGFWLQWTANDSLCNKCKFSGGQCGYNTDTSKFT 225
Query: 261 CFCKGGRCDSVKRRKSRLPLIIGATAGSCCMVLVAVALLVFRK-----RIPSFFKKPFSE 315
C+ T M+ V + +L R+ R+ SF+
Sbjct: 226 CYF--------------------VTLAMYTMIAVTIIVLCSRRGLSRGRMTSFW------ 259
Query: 316 ERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL 375
RQN LN++ I S Y+Y++IKKMTN F +KLG GG+G VYKG+ PDGR
Sbjct: 260 -RQNAQHNLNIETIIMNSHSLTPKRYTYSEIKKMTNSFVDKLGQGGFGGVYKGELPDGRP 318
Query: 376 VAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL 435
VAVKVL+ + + F+NEV +I R HVNI+ LLGFC + + RALIYEYMPNGSL +
Sbjct: 319 VAVKVLKNSKGDGEEFVNEVVSISRTSHVNIVTLLGFCFERTKRALIYEYMPNGSLDKFI 378
Query: 436 SREKE---NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492
R+ +L+ +L EIA+G+ +EYLH GC RI+H DIKP N+LLD DF PK+S
Sbjct: 379 YRQTSLHGKYNLQWEKLYEIAVGIGRGLEYLHRGCNTRIVHFDIKPHNILLDTDFCPKIS 438
Query: 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 552
DFGLAK R S+V+MTG RGT GYIAPE+F +N G S KSDVYSYGM++LEM+ K+
Sbjct: 439 DFGLAKLCKREESMVSMTGARGTAGYIAPEVFCKNFGGVSYKSDVYSYGMMVLEMVGGKR 498
Query: 553 HLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKD 612
++ E S ++E + P+ +Y+ + +E + +KM+ VGLWC+Q NP D
Sbjct: 499 NIDIGE----SQSSEIFLPNCMYESEEVSSLHGVITDETEETIKKMVTVGLWCVQTNPLD 554
Query: 613 RPSMTRVVEMLSSASAEAIEMPPKPLF 639
RPSMT+VVEML S + ++ PPKP
Sbjct: 555 RPSMTKVVEML-EGSLQFLQTPPKPFL 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1001), Expect = e-105, Method: Compositional matrix adjust.
Identities = 239/625 (38%), Positives = 339/625 (54%), Gaps = 39/625 (6%)
Query: 32 IHSQSQNDTSYEDC-SPFKCGNLT-FSFPFSSSSTSGYCGLPNYQITCDSSSVPKL-LLS 88
+ ++ +ND++ C F CGN T SFPFS S+ CG+ CD PK+ LL
Sbjct: 18 VQAKGRNDST---CPKSFSCGNFTNLSFPFSLSAQPE-CGILRMS-GCDDKPFPKIRLLP 72
Query: 89 GRLYQVRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLN 148
GR + + Q D + + D +L L+ C++ NS SI + N+N
Sbjct: 73 GRDWY---YALQQHDSSVWLGDQKLQTTLTQHKCQAFNKNFSLPNSPSISFNMI---NIN 126
Query: 149 LTFFKCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVV 208
F KC + F + N C + Y T+ + + + P+ C + +
Sbjct: 127 -NFIKCSSTQKKNDRFAGYNMYN-GCEGFSIYY---KLTRDDDKNIEAHNLPTNCSLIKL 181
Query: 209 PVSSVTSLYLGADVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRC 268
P+ D+F+ L F +EW DDC +C + GRC + + K C
Sbjct: 182 PIHKND-----GDLFNRLGPEFLVEWKLSDDCSECHHYGGRCQTDKT-NKFYCLKDVAEV 235
Query: 269 DSVKRRKSRLPLIIGATAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQ 328
+ S+ + AT S V + V L FR ++ + K + D N+++
Sbjct: 236 SKLPAGISKRFWFLAATGASLFTVGLLVLLFFFRNKV--LWYKYIRLWGSKVEDHRNIEE 293
Query: 329 FIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS 388
F+K Y S Y+Y DIK++T+ FK KL GG+G VY+G +G VAVKVL +
Sbjct: 294 FLKNYGSYAPKRYNYTDIKRITSRFKNKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGSG 353
Query: 389 DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL--SLKP 446
+NFINEVA+I R HVN++ L+GFC +G RAL+YE+MPNGSL + E+ + L
Sbjct: 354 ENFINEVASISRTSHVNVVSLVGFCFEGRKRALVYEFMPNGSLEKFIYEERSDTVRQLGW 413
Query: 447 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506
L +IALG+A +EYLH GC RILH DIKP N+LLD DF PK+SDFGLAK +N S+
Sbjct: 414 PTLYKIALGIARGLEYLHRGCTTRILHFDIKPHNILLDEDFCPKISDFGLAKLCMKNESI 473
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 566
V+M G RGTIGYIAPEI RNLG S KSD YSYGM++LEMI +K++ T+
Sbjct: 474 VSMLGARGTIGYIAPEIVCRNLGGVSHKSDAYSYGMMVLEMIGGRKNV----DAGADRTS 529
Query: 567 EAYFPDWIYDKLIQPEKEDFV----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
E YFP W+Y ++ E V EEE++C ARKM+I LWCIQ +P +RPSM++VVEM
Sbjct: 530 EIYFPHWLYQRIELDEDLQLVGIMNEEENEC-ARKMVIASLWCIQTDPSNRPSMSKVVEM 588
Query: 623 LSSASAEAIEMPPKPLFPSPPQLQT 647
L +++++PPKP SP +++
Sbjct: 589 L-EGKLDSLQIPPKPYLYSPSRIEV 612
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857020|dbj|BAD95895.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 387 bits (995), Expect = e-105, Method: Compositional matrix adjust.
Identities = 260/696 (37%), Positives = 372/696 (53%), Gaps = 88/696 (12%)
Query: 10 PSSIISV--SLMIIAMGMATFPDFIHSQSQNDTS-YE--DCSPFKCGNLTFSFPFSSSST 64
PSSI++ +L II++ + T P + S+ T+ YE C GNL +PF +
Sbjct: 23 PSSILTFWFTLFIISINIQT-PLCADNDSKYYTNCYEAFSCDGSSVGNL--KYPFWGGNR 79
Query: 65 SGYCGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSS-------QDDRLITVVDTQLIKDL 117
+ YCG ++ C+ + K+ ++ Y+V + S +DD V ++
Sbjct: 80 TEYCGQSQLELVCEDRAA-KITINSITYRVVKWEDSTQKLTVARDDFWGGVCAVSDYQNS 138
Query: 118 SSGSCESLYNLSVAINS---YSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVSC 174
S + Y+ S N Y+ GS+ PSG F++ SC
Sbjct: 139 SFDNSPFQYDFSGDNNVTLLYNCGSIDPPSG-----FYRS------------------SC 175
Query: 175 NDGH--VLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPV--SSVTSLYLGA-DVFDTLRQG 229
+ G V Y+ P+S S C SVVVPV S V++L A ++ + L +G
Sbjct: 176 DGGSRVVYYI---------VGVGPLSFASACTSVVVPVLASQVSALASTAGNIDEVLNEG 226
Query: 230 FPLEWP-KLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSV----------KRRKSRL 278
F L W +C C + G CG++G K CFC+ G S KRR S
Sbjct: 227 FGLRWSGNYQECTGCLDTRGACGFDG---KFRCFCEDGPHQSSCISDRAPAPDKRRGSTT 283
Query: 279 PLIIGATAGSCCMVLVAVA--LLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSA 336
I+ A SC LVA+ + R++ S + +++ +V+ F+++Y S
Sbjct: 284 RNIVIGVAASCVGGLVAIISIAIYIRRKFKSLSGQTMISRKRSTFVEHDVEAFMQSYGSL 343
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 396
YSY+++K++TN F KLG GGYG VYK PDGRLVAVKV+ ++ ++FINEV+
Sbjct: 344 APRRYSYSEVKRITNSFVHKLGQGGYGVVYKATLPDGRLVAVKVISESGGSGEDFINEVS 403
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS---REKENLSLKPARLLEIA 453
+I R HVNI+ LLGFC D + R LIYE+MPNGSL + ++ L ++A
Sbjct: 404 SISRTSHVNIVSLLGFCYDKNRRVLIYEFMPNGSLDNFINGMGSPNAICCFDWNTLYKVA 463
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
+G+A +EYLH GC RILHLDIKPQN+LLD D PK++DFGLAK R S+V+M G R
Sbjct: 464 IGIARGLEYLHQGCNTRILHLDIKPQNILLDEDLCPKIADFGLAKICKRKESIVSMLGTR 523
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
GT GYIAPE+F R G S KSDVYS+GML+LEM+ +K+ ++ GS ++E +FPDW
Sbjct: 524 GTPGYIAPEVFSRAFGGVSHKSDVYSFGMLILEMVGGRKNY---DSGGGSQSSEMFFPDW 580
Query: 574 IYDKLIQPEKED---FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630
IY L Q + + EE+ +ARKMI+V LWCIQ +RPSM +VVEML + E+
Sbjct: 581 IYKDLEQGDVHTNFLVITEEEHEMARKMILVSLWCIQTRSSERPSMNKVVEML-EGTLES 639
Query: 631 IEMPPKPLFPSPPQLQTQN------EIISFDSITSE 660
+ PPKP+ SP +L QN + DS+T+E
Sbjct: 640 VPYPPKPILHSPEKLLLQNSDLTSGNTLETDSMTTE 675
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 670 | ||||||
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.862 | 0.647 | 0.354 | 3.1e-83 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.841 | 0.846 | 0.364 | 4.5e-82 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.435 | 0.433 | 0.511 | 1.2e-81 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.434 | 0.364 | 0.524 | 2.6e-79 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.435 | 0.342 | 0.504 | 6.8e-79 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.435 | 0.457 | 0.516 | 1.6e-77 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.383 | 0.437 | 0.528 | 2.9e-76 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.435 | 0.439 | 0.501 | 6.3e-76 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.465 | 0.387 | 0.484 | 4.5e-75 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.434 | 0.357 | 0.498 | 2.2e-73 |
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 222/626 (35%), Positives = 326/626 (52%)
Query: 35 QSQNDTSYEDCSP-FKCGNLXXXXXXXXXXXXGYCGLPNYQITCDSSSVPKLLLSGRLYQ 93
Q D Y CS F CG+ CG PN+++ C S ++ ++ ++
Sbjct: 244 QHSADEVYRRCSESFSCGSQRDLNYPLWKPGREECGHPNFKLNC-SGGFAEINIASVKFR 302
Query: 94 VRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSY-SIGSLTLPSGNLNLTFF 152
+ + + S LI + + I DL C + + I + + LT + L L ++
Sbjct: 303 ILDSYRS----LIRLARSDYIGDL----CPANPLTAPFIEKFLPVLELTGETELLTL-YY 353
Query: 153 KCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPV--SAPSGCDXXXXXX 210
C R + S + V + C++G Y+ RN + S V + C
Sbjct: 354 GC--RFNSSDIPANIYVGELGCDEGRSYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSVP 411
Query: 211 XXXXXLY--LGADVFDTLRQGFPLEWPKL--DDCEKCQNRSGRCGYNGSLKKITCFCKGG 266
L+ D L+ + L DCE+C+ G CGYN + C+CK G
Sbjct: 412 ASGPALFDLQTRPNQDNLKMALDQGFRMLITSDCERCRGSGGACGYNQTSSGFGCYCKDG 471
Query: 267 RC-----DSVKRRKSR-LPLIIGATAGSCCMXXXXXXXXXFRKRIPSFFKKPFSEERQNI 320
+C D RR R + ++ T + F + F+ +R+
Sbjct: 472 KCGYEYDDGFFRRHRRFIATLVRYTF--IALGALTGVVIVFLVLLCPCFRVQIFRKRKT- 528
Query: 321 GDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKV 380
D + +++ +K L +Y+Y ++KKMT F E +G GG+G VY G D +VAVKV
Sbjct: 529 SDEVRLQK-LKALIP--LKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKV 585
Query: 381 LEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK 439
L+ + ++FINEVA++ + HVNI+ LLGFCC+GS RA+IYE++ NGSL +S +K
Sbjct: 586 LKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFIS-DK 644
Query: 440 ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499
+++L L IALGVA +EYLH GC+ RI+H DIKPQNVLLD + PKVSDFGLAK
Sbjct: 645 SSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKL 704
Query: 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 559
+ S++++ RGTIGYIAPE+ R G+ S KSDVYSYGML+LEMI +K R +
Sbjct: 705 CEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKER-FDQ 763
Query: 560 TSGSNTTEAYFPDWIYDKLIQP-----EK-------EDFVEEEDDCIARKMIIVGLWCIQ 607
S S+ + YFP+WIY L + EK E+ + E++ IARKM +VGLWCIQ
Sbjct: 764 NSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQ 823
Query: 608 INPKDRPSMTRVVEMLSSASAEAIEM 633
+P DRP M +VVEM+ S +A+E+
Sbjct: 824 SSPSDRPPMNKVVEMMEG-SLDALEV 848
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 225/618 (36%), Positives = 316/618 (51%)
Query: 45 CSP-FKCGNLXXXXXXXXXXXXGYCGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDD 103
CSP F CGN CG P++++ C++ VP+L +S +++ + D
Sbjct: 38 CSPSFTCGNQRGLLYPFWIAGRKECGHPDFELDCNAG-VPELSISSVKFRILG--ADYDS 94
Query: 104 RLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLT-FFKCPRRLSLSQ 162
+IT+ + I D C L N S++ L L S LT ++ C R +S
Sbjct: 95 GIITLARSDNIDD----PC--LPNSFTT--SFNETVLPLASTTDLLTIYYDCNRNVS--- 143
Query: 163 NFTDKGVSNVSC-NDG----HVLYLWRNRT------QSGRPSFDPVSAPSGCDXXXXXXX 211
+F V + C +DG YL RN T + SF C
Sbjct: 144 SFVSTFVKELDCPDDGTDDRRNYYLTRNLTFLPPSLKLEGNSFLLNDFGGSCSRNVSNPA 203
Query: 212 XXXXLYLGADVFDT------LRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKG 265
L T L GF LE DC C + G CG++ + + C+ +
Sbjct: 204 SRTALNTLESTPSTDNLKIALEDGFALEVNS--DCRTCIDSKGACGFSQTSSRFVCYYRQ 261
Query: 266 GRCDSVKRRKSRLPL------IIGATAGSCCMXXXXXXXXXFRKRIPSFFKKPFSEERQN 319
+ R K L L ++G A S M I +K ++ R
Sbjct: 262 -EPQNPTRNKVILKLFFIVIYVLGIGAASFAMMGVILVVTCLNCLIRRQ-RKTLNDPRMR 319
Query: 320 IGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVK 379
D +Q +K L +YSY + +T F E +G GG+G VY+G DGR VAVK
Sbjct: 320 TSDDSR-QQNLKALIP--LKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVK 376
Query: 380 VLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK 439
VL+++ ++FINEVA++ + HVNI+ LLGFC +G RA+IYE+M NGSL +S +K
Sbjct: 377 VLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKK 436
Query: 440 ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499
+ ++ L IALGVA +EYLH+GC RI+H DIKPQNVLLD + +PKVSDFGLAK
Sbjct: 437 SS-TMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKL 495
Query: 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 559
R S++++ RGTIGYIAPE+F R G S KSDVYSYGML+L++I + +T
Sbjct: 496 CERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDT 555
Query: 560 TSGSNTTEAYFPDWIYDKLIQPEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
TS +T+ YFP+WIY L + E + E+D IA+KM +VGLWCIQ P DRP+
Sbjct: 556 TS--STSSMYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPA 613
Query: 616 MTRVVEMLSSASAEAIEM 633
M RVVEM+ + +A+E+
Sbjct: 614 MNRVVEMMEG-NLDALEV 630
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 155/303 (51%), Positives = 208/303 (68%)
Query: 338 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTSNFSDNFINEVA 396
L +Y+Y +K+MT F E +G GG+G VY+G DGR+VAVKVL E N S++FINEV+
Sbjct: 333 LKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVS 392
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 456
++ + HVNI+ LLGFC +GS RA+IYE++ NGSL +S EK ++ L L IALGV
Sbjct: 393 SMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFIS-EKTSVILDLTALYGIALGV 451
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
A +EYLH GC+ RI+H DIKPQNVLLD + +PKVSDFGLAK + SV+++ RGTI
Sbjct: 452 ARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTI 511
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
GYIAPE+ R G+ S KSDVYSYGML+ EMI +K R + ++ N + YFP+WIY
Sbjct: 512 GYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSA--NGSSMYFPEWIYK 569
Query: 577 KLIQPEKEDF------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630
L + + D + E++ IA+KM +VGLWCIQ +P DRP M +VVEM+ S +A
Sbjct: 570 DLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEG-SLDA 628
Query: 631 IEM 633
+E+
Sbjct: 629 LEV 631
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 160/305 (52%), Positives = 211/305 (69%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDG-RLVAVKVLEKTSNFSDNFINEV 395
+L +SY +KKMT F+ LG GG+G VYKGK PDG R VAVK+L++++ ++FINE+
Sbjct: 445 MLKRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEI 504
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEIA 453
A++ R H NI+ LLGFC +G +A+IYE MPNGSL +S+ N+S K L IA
Sbjct: 505 ASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISK---NMSAKMEWKTLYNIA 561
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
+GV+H +EYLH+ C RI+H DIKPQN+L+D D PK+SDFGLAK N S+++M R
Sbjct: 562 VGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHAR 621
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
GTIGYIAPE+F +N G S KSDVYSYGM++LEMI + R +GS+ T YFPDW
Sbjct: 622 GTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQN--AGSSNTSMYFPDW 679
Query: 574 IYDKLIQPEKEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628
IY L + E F+ EEED+ I +KM++VGLWCIQ NP DRP M++VVEML S
Sbjct: 680 IYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEG-SL 738
Query: 629 EAIEM 633
EA+++
Sbjct: 739 EALQI 743
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
Identities = 155/307 (50%), Positives = 209/307 (68%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTSNFSDNFINE 394
+L YS+ +KKMTN F +G GG+G VYKGK PD GR +A+K+L+++ + FINE
Sbjct: 505 MLKRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINE 564
Query: 395 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEI 452
+ ++ R HVNI+ L GFC +GS RA+IYE+MPNGSL +S EN+S K L I
Sbjct: 565 LVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFIS---ENMSTKIEWKTLYNI 621
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
A+GVA +EYLHN C +I+H DIKPQN+L+D D PK+SDFGLAK + S+++M
Sbjct: 622 AVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDA 681
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572
RGT+GYIAPE+F +N G S KSDVYSYGM++LEMI K R TS ++ + YFPD
Sbjct: 682 RGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATK--REEVETSATDKSSMYFPD 739
Query: 573 WIYDKLIQPEK----EDFV--EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
W+Y+ L + E ED + EEE++ I ++M +VGLWCIQ NP DRP M +VVEML +
Sbjct: 740 WVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGS 799
Query: 627 SAEAIEM 633
EA+++
Sbjct: 800 RLEALQV 806
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
Identities = 155/300 (51%), Positives = 206/300 (68%)
Query: 338 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVAT 397
L YSY +++K+T F LG GG+G VY G DGR VAVK+L+ + ++FINEVA+
Sbjct: 308 LKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVAS 367
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
+ + HVNI+ LLGFC +GS RA++YE++ NGSL LS EK++L+L + L IALGVA
Sbjct: 368 MSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLS-EKKSLNLDVSTLYRIALGVA 426
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
++YLH+GC+ RI+H DIKPQN+LLD F PKVSDFGLAK + S++++ RGTIG
Sbjct: 427 RGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIG 486
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
YIAPE+F G S KSDVYSYGML+LEMI K + E T+ SN++ AYFPDWIY
Sbjct: 487 YIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKN--KEIEETAASNSSSAYFPDWIYKN 544
Query: 578 LIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 633
L E D + ED +A+KM +VGLWCIQ +P +RP M R+VEM+ S + +E+
Sbjct: 545 LENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEG-SLDVLEV 603
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 2.9e-76, Sum P(2) = 2.9e-76
Identities = 147/278 (52%), Positives = 189/278 (67%)
Query: 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
+E +G GG+G VYKG DGR VAVK+L+ ++ ++FINEVA+I + HVNI+ LLGFC
Sbjct: 284 QEVVGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFC 343
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
+ S RA++YE++ NGSL + NL + + L IALGVA IEYLH GC+ RI+H
Sbjct: 344 FEKSKRAIVYEFLENGSLD-----QSSNLDV--STLYGIALGVARGIEYLHFGCKKRIVH 396
Query: 474 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 533
DIKPQNVLLD + PKV+DFGLAK + S++++ RGTIGYIAPE+F R GN S
Sbjct: 397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456
Query: 534 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE----- 588
KSDVYSYGML+LEM + R + SN + AYFPDWI+ L E D+V+
Sbjct: 457 KSDVYSYGMLVLEMTGARNKERVQN--ADSNNSSAYFPDWIFKDL---ENGDYVKLLADG 511
Query: 589 ---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
EE+D IA+KMI+VGLWCIQ P DRPSM +VV M+
Sbjct: 512 LTREEED-IAKKMILVGLWCIQFRPSDRPSMNKVVGMM 548
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 153/305 (50%), Positives = 207/305 (67%)
Query: 336 ALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINE 394
A+L YSY +KKMTN F LG GG+G VYKGK D GR VAVK+L+ + + FINE
Sbjct: 316 AMLKRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINE 375
Query: 395 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEI 452
VA++ R HVNI+ LLGFC + + RA+IYE+MPNGSL +S N+S K RL ++
Sbjct: 376 VASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISA---NMSTKMEWERLYDV 432
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
A+G++ +EYLHN C RI+H DIKPQN+L+D + PK+SDFGLAK S+++M
Sbjct: 433 AVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHM 492
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572
RGT GYIAPE+F +N G S KSDVYSYGM++LEMI K ++ E SGSN YFP+
Sbjct: 493 RGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAK-NIEKVEY-SGSNNGSMYFPE 550
Query: 573 WIYDKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628
W+Y + E D + +E++ IA+K+++V LWCIQ+NP DRP M +V+EML +
Sbjct: 551 WVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEG-NL 609
Query: 629 EAIEM 633
EA+++
Sbjct: 610 EALQV 614
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
Identities = 156/322 (48%), Positives = 215/322 (66%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 396
LL+ Y+Y ++KK+T F +G GG+G VY G +GR VAVKVL+ +++FINEVA
Sbjct: 484 LLNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVA 543
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 456
++ + HVNI+ LLGFC +GS RA++YE++ NGSL +SR K +L+ L IALG+
Sbjct: 544 SMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK-SLTQDVTTLYGIALGI 602
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
A +EYLH GC+ RI+H DIKPQN+LLD + PKVSDFGLAK + SV+++ RGTI
Sbjct: 603 ARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTI 662
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIY 575
GYIAPE+F R G S KSDVYS+GML+++MI + K + T ++ S+T YFPDWIY
Sbjct: 663 GYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASST---YFPDWIY 719
Query: 576 DKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAI 631
L E+ D + +E+ IA+KMI+VGLWCIQ P DRPSM RVVEM+ S +A+
Sbjct: 720 KDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEG-SLDAL 778
Query: 632 EMXXXXXXXXXXQLQTQNEIIS 653
E+ ++ T++ +S
Sbjct: 779 EIPPKPSMHISTEVITESSSLS 800
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 150/301 (49%), Positives = 203/301 (67%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 396
LL Y Y ++KK+T F +G GG+G VY+G +GR VAVKVL+ D+FINEV
Sbjct: 482 LLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVT 541
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 456
++ + HVNI+ LLGFC +GS RA+I E++ +GSL +SR K +L+ L IALG+
Sbjct: 542 SMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNK-SLTPNVTTLYGIALGI 600
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
A +EYLH GC+ RI+H DIKPQN+LLD +F PKV+DFGLAK + S++++ RGTI
Sbjct: 601 ARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTI 660
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
GYIAPE+ R G S KSDVYSYGML+L+MI + + ETT+ + +T AYFPDWIY
Sbjct: 661 GYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKV---ETTTCNGST-AYFPDWIYK 716
Query: 577 KLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 632
L ++ D + EED+ I +KMI+V LWCI+ P DRP M +VVEM+ S +A+E
Sbjct: 717 DLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEG-SLDALE 775
Query: 633 M 633
+
Sbjct: 776 L 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030371001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (686 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 670 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| pfam14380 | 94 | pfam14380, WAK_assoc, Wall-associated receptor kin | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-51
Identities = 87/273 (31%), Positives = 135/273 (49%), Gaps = 23/273 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFI---NEVATIGRIHHVNIIH 408
KLG+G +G VYK K G++VAVK+L+K S S E+ + R+ H NI+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L+ D L+ EY G L D LSR LS A+ IAL + +EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKK--IALQILRGLEYLH---S 116
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+H D+KP+N+LLD + K++DFGLAK ++ S +T GT Y+APE+ +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGN 174
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
G K DV+S G++L E++ SG N + + +++ P E F E
Sbjct: 175 GYGP-KVDVWSLGVILYELLT--GKPPF----SGENILDQLQ---LIRRILGPPLE-FDE 223
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ + + + C+ +P RP+ +++
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 60/271 (22%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
LG GG+G VY + G+ VA+K++ E +S+ + + E+ + +++H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
D + L+ EY GSL DLL + LS +L I L + +EYLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSED--EILRILLQILEGLEYLH---SNGIIH 115
Query: 474 LDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
D+KP+N+LLD + K++DFGL+K + ++S + GT Y+APE+ G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVL-LGKGYYS 172
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSD++S G++L E+ + D LI+
Sbjct: 173 EKSDIWSLGVILYEL------------------------PELKD-LIR------------ 195
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+Q +P+ RPS ++E L
Sbjct: 196 -----------KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-----FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 405
+KLG G +G VYKGK VAVK L++ ++ F+ E + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
++ LLG C + ++ EYM G L L + + LSL LL AL +A +EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLS--DLLSFALQIARGMEYLE- 119
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+H D+ +N L+ + K+SDFGL++ + G + I ++APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLK 176
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 581
KSDV+S+G+LL E+ T G E +P + + L
Sbjct: 177 EGKFTS--KSDVWSFGVLLWEIF-----------TLG----EQPYPGMSNEEVLEYLKNG 219
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + M L C +P+DRP+ + +VE+L
Sbjct: 220 YRLPQPPNCPPELYDLM----LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-----FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 405
+KLG G +G VYKG VAVK L++ ++ F+ E + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
I+ LLG C + ++ EYMP G L D L R+ L + LL AL +A +EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+H D+ +N L+ + K+SDFGL++ + + G + I ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLK 177
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 581
KSDV+S+G+LL E+ T G E +P + + L +
Sbjct: 178 EGKFTS--KSDVWSFGVLLWEIF-----------TLG----EEPYPGMSNAEVLEYLKKG 220
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + + M L C +P+DRP+ + +VE+L
Sbjct: 221 YRLPKPPNCPPELYKLM----LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 3e-47
Identities = 75/266 (28%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHL 409
EKLG G +G VY + G+LVA+KV++K + + E+ + ++ H NI+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
D L+ EY G L DLL + L + A+EYLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLH---SK 116
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP+N+LLD D K++DFGLA+ +T GT Y+APE+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK-- 171
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
D++S G++L E++ K P G + F K P E +
Sbjct: 172 GYGKAVDIWSLGVILYELL-TGKPPFP-----GDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPS 615
E A+ +I + +P+ R +
Sbjct: 226 E----AKDLI---RKLLVKDPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 47/287 (16%)
Query: 353 FKEKLGTGGYGNVYKG-----KFPDGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 405
+KLG G +G VYKG VAVK L++ + + F+ E + + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
I+ LLG C G ++ EYMP G L D L + E L+LK LL++AL +A +EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLK--DLLQMALQIAKGMEYLE- 119
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+H D+ +N L+ + K+SDFGL++ + G + I ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
+ KSDV+S+G+LL E+ T P Y + E +
Sbjct: 178 DGKF--TSKSDVWSFGVLLWEIF-----------------TLGEQP---YPGMSNEEVLE 215
Query: 586 FVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+E+ ++C + M L C +P+DRP+ + +VE L
Sbjct: 216 LLEDGYRLPRPENCPDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 5e-41
Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 38/284 (13%)
Query: 355 EKLGTGGYGNVYKGKFPDG----RLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 408
+KLG G +G VYKGK VAVK L++ ++ + +F+ E + ++ H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL------SLKPARLLEIALGVAHAIEY 462
LLG C + L+ EYM G L D L + + +L LL A+ +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
L + +H D+ +N L+ D K+SDFGL++ + TG + I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI--- 579
+ KSDV+S+G+LL E+ T G+ + + + L
Sbjct: 178 SLKDGIFTS--KSDVWSFGVLLWEIF-----------TLGATPYPGLSNEEVLEYLRKGY 224
Query: 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ K ++ +E + M L C Q++P+DRP+ + +VE L
Sbjct: 225 RLPKPEYCPDE---LYELM----LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 138 bits (347), Expect = 1e-35
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 20/318 (6%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK----TSNFSDNFINEVATIGRI-HHVNII 407
KLG G +G VY + D +LVA+KVL K S + F+ E+ + + H NI+
Sbjct: 4 ILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
L F D + L+ EY+ GSL DLL + L + L I + A+EYLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--- 118
Query: 468 ELRILHLDIKPQNVLLDPD-FTPKVSDFGLAK----AHSRNRSVVTMTGPRGTIGYIAPE 522
I+H DIKP+N+LLD D K+ DFGLAK S + + GT GY+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 523 IFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
+ + +L S SD++S G+ L E++ + +S ++ T + L P
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 641
E + ++ + +PK+R S + + A + E L
Sbjct: 239 LSPSNPELISKAASD--LLKK--LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 642 PPQLQTQNEIISFDSITS 659
+ +
Sbjct: 295 DDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIHLL 410
E LG G +G+VY D G L+AVK +E + + + E+ + + H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 411 GFCCDGSTRAL-IY-EYMPNGSLGDLLSREK---ENLSLKPAR-LLEIALGVAHAIEYLH 464
G D L I+ EY+ GSL LL + E + K R +LE + YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLH 118
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
I+H DIK N+L+D D K++DFG AK + RGT ++APE+
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMI------EEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578
+D++S G ++EM E + GS+ P+ + ++
Sbjct: 176 RG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
DF+ + C++ +PK RP+
Sbjct: 234 K-----DFLRK---------------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 42/272 (15%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EK+G GG+G VYK + G+ VA+KV+ ++ + INE+ + + H NI+ G
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
++ E+ GSL DLL + N +L +++ + + +EYLH+ I
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H DIK N+LL D K+ DFGL+ S ++ TM GT ++APE+ N
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI--NGKPY 174
Query: 532 SGKSDVYSYGMLLLEMIEEK---KHLRPTET-----TSGSNTTEAYFPDWIYDKLIQPEK 583
K+D++S G+ +E+ E K L P + T+G P + E
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-------PPGLRNPEKWSDEF 227
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+DF+++ C+Q NP+ RP+
Sbjct: 228 KDFLKK---------------CLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 69/196 (35%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+G G +G+V G + G+ VAVK L+ S + F+ E + + + H N++ LLG
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 413 CCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
G+ ++ EYM GSL D L SR + ++L A+ L AL V +EYL E
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLE---EKNF 123
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +NVL+ D KVSDFGLAK S+ + + + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAPEAL--REKKF 176
Query: 532 SGKSDVYSYGMLLLEM 547
S KSDV+S+G+LL E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 353 FKEKLGTGGYGNVYKGK--FPD---GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVN 405
F ++LG G +G V + G VAVK L + +F E+ + + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 406 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
I+ G C R+ LI EY+P+GSL D L R ++ ++LK RLL + + ++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYL 125
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 522
+ R +H D+ +N+L++ + K+SDFGLAK ++ + P + I + APE
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ S SDV+S+G+ L E+ + P+++ F I Q
Sbjct: 183 CLRTS--KFSSASDVWSFGVTLYELF---TYGDPSQSPPAE------FLRMIGIAQGQMI 231
Query: 583 KEDFVE--EEDDCIARK--------MIIVGLWCIQINPKDRPS 615
+E +E + + R ++ W + P+DRPS
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCW--EAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 346 IKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN 405
I F ++LG+G +G V+ GK+ VA+K++ + + D+FI E + ++ H N
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
++ L G C ++ EYM NG L + L K L LL++ V A+EYL +
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES 118
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+H D+ +N L+ D KVSDFGLA+ + + + G + + + PE+F
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
+ S KSDV+S+G+L+ E+ E K P E S S E+ + + E
Sbjct: 175 YS--RFSSKSDVWSFGVLMWEVFSEGK--MPYERFSNSEVVESVSAGYRLYRPKLAPTEV 230
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ I+ C P+DRP+ +++ L
Sbjct: 231 YT------------IMYS-CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-28
Identities = 72/273 (26%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+++G+G +G V+ G + + R VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C + S L++E+M +G L D L ++ S + LL + L V + YL + ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQET--LLGMCLDVCEGMAYLESSN---VI 122
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+ +N L+ + KVSDFG+ + + + TG + + + +PE+F + S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVF--SFSKYS 179
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSDV+S+G+L+ E+ E K P E S S E + +L +P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK--TPYENRSNSEVVETINAGF---RLYKPR---------- 224
Query: 593 CIARKMII-VGLWCIQINPKDRPSMTRVVEMLS 624
+A + + + C + P+DRPS + ++ L+
Sbjct: 225 -LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 76/285 (26%), Positives = 118/285 (41%), Gaps = 51/285 (17%)
Query: 356 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF------INEVATIGRIHHVNIIH 408
LG G G VYK + P G++ A+K + + + + E+ T+ ++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI----HVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
G +++ EYM GSL DLL K+ + L IA + ++YLH +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--K 118
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+H DIKP N+L++ K++DFG++K N T GT+ Y++PE R
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK-VLENTLDQCNTF-VGTVTYMSPE---RIQ 173
Query: 529 GNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI-------YDKLIQ 580
G S +D++S G+ LLE K P P +
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----------PSFFELMQAICDGPPPS 222
Query: 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
E+F E D I+ C+Q +PK RPS E+L
Sbjct: 223 LPAEEFSPEFRDFISA--------CLQKDPKKRPS---AAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 85/270 (31%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 354 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 529
H D+ +N L+ + KV+DFGL++ + + T T G I + APE N
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYN-- 180
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S KSDV+++G+LL E+ T G + +Y+ L EK +E
Sbjct: 181 KFSIKSDVWAFGVLLWEI-----------ATYGMSPYPGIDLSQVYELL---EKGYRMER 226
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRV 619
+ C K+ + C Q NP DRPS +
Sbjct: 227 PEGC-PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 85/275 (30%), Positives = 126/275 (45%), Gaps = 30/275 (10%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFC 413
KLG+G +G V++G + + VA+K+L+ +F EV + R+ H ++I L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
G +I E M GSL L R E L A L+++A VA + YL E +H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 474 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 533
D+ +N+L+ D KV+DFGLA+ V + + + APE + G S
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAA--SHGTFST 183
Query: 534 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD--KLIQPEKEDFVEEED 591
KSDV+S+G+LL EM + P G N E Y D I ++ P K
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYP-----GMNNHEVY--DQITAGYRMPCPAK-------- 228
Query: 592 DCIAR-KMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
C I++ W P+DRPS + E L +
Sbjct: 229 -CPQEIYKIMLECWA--AEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 82/286 (28%), Positives = 125/286 (43%), Gaps = 51/286 (17%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EK+G G G VYK G+ VA+K + + INE+ + H NI+
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
G ++ EYM GSL D++ + + + ++ + V +EYLH+ +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHS---QNV 137
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+H DIK N+LL D + K++DFG A K S+ SVV GT ++APE+ R
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPEVIKRK 191
Query: 528 LGNPSGKSDVYSYGMLLLEMIE-EKKHLR--PTE-----TTSGSNTTEAYFPDWIYDKLI 579
P K D++S G++ +EM E E +LR P TT G P +
Sbjct: 192 DYGP--KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-------PPLKNPEKW 242
Query: 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
PE +DF+ C+ +P+ RPS E+L
Sbjct: 243 SPEFKDFLN---------------KCLVKDPEKRPS---AEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 34/281 (12%)
Query: 355 EKLGTGGYGNVYKGKF--PDGRL--VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 408
+KLG G +G V +G++ G++ VAVK L +K S+ D+F+ E A + + H N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L G ++ E P GSL D L ++ L L + A+ +A+ + YL +
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLIS-TLCDYAVQIANGMRYLESK-- 116
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMRN 527
R +H D+ +N+LL D K+ DFGL +A +N M + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL--R 173
Query: 528 LGNPSGKSDVYSYGMLLLEMI---EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
S SDV+ +G+ L EM EE P SGS + D ++L +PE
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE-----PWAGLSGSQILKKI--DKEGERLERPE-- 224
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
C + + V L C NP DRP+ + E L
Sbjct: 225 -------AC-PQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 355 EKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 408
+ +G G +G V +G K P + VA+K L+ S+ +F+ E + +G+ H NII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L G +I EYM NGSL L RE + +L+ + G+A ++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL-RENDG-KFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRN 527
+H D+ +N+L++ + KVSDFGL++ + + T G + I + APE I R
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
+ SDV+S+G+++ E++ + RP S + +A + +L P
Sbjct: 185 F---TSASDVWSFGIVMWEVMSYGE--RPYWDMSNQDVIKAVEDGY---RLPPPM----- 231
Query: 588 EEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
DC + + M L C Q + +RP+ +++V L
Sbjct: 232 ----DCPSALYQLM----LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIH 408
+++G G +G VY + DG+L +K + SN S+ +NEV + +++H NII
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ ++ EY G L + ++KE ++L+ + + A++YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGTIGYIAPEIFMR 526
+ILH DIKPQN+ L + K+ DFG++K S + T+ GT Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQ- 176
Query: 527 NLGNP-SGKSDVYSYGMLLLEM 547
P + KSD++S G +L E+
Sbjct: 177 --NKPYNYKSDIWSLGCVLYEL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 89/292 (30%), Positives = 140/292 (47%), Gaps = 41/292 (14%)
Query: 346 IKKMTNGFKEK-LGTGGYGNVYKGKF-PDGRL----VAVKVLEKTSNFSDN--FINEVAT 397
I K T K K LG+G +G VYKG + P+G VA+KVL + ++ N ++E
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
+ + H +++ LLG C S LI + MP G L D + K+N+ LL + +A
Sbjct: 63 MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIG--SQYLLNWCVQIA 119
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTP---KVSDFGLAKAHSRNRSVVTMTGPRG 514
+ YL E R++H D+ +NVL+ TP K++DFGLAK + G +
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 515 TIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
I ++A E I R + KSDV+SYG+ + E++ +P E G E PD
Sbjct: 174 PIKWMALESILHRIY---THKSDVWSYGVTVWELMTFGA--KPYE---GIPAVE--IPDL 223
Query: 574 IYDKLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+ EK + + + C I M++V W I+ + RP+ ++ S
Sbjct: 224 L-------EKGERLPQPPICTIDVYMVLVKCW--MIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 69/223 (30%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 404
D K +T F ++LGTG +G V GK+ VA+K++++ S D FI E + ++ H
Sbjct: 2 DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
++ L G C ++ EYM NG L + L RE +P++LLE+ V + YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGK-RFQPSQLLEMCKDVCEGMAYLE 117
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ + +H D+ +N L+D KVSDFGL++ + + + G + + + PE+
Sbjct: 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 567
+ S KSDV+++G+L+ E+ K P E + S T E
Sbjct: 174 L--YSKFSSKSDVWAFGVLMWEVYSLGK--MPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 82/280 (29%), Positives = 135/280 (48%), Gaps = 31/280 (11%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 404
+++K+T G E +G G +G V +G++ G+ VAVK + K + F+ E A + ++HH
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQAFLEETAVMTKLHHK 59
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N++ LLG ++ E M G+L + L R + + +LL+ +L VA +EYL
Sbjct: 60 NLVRLLGVILHNGLY-IVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ +++H D+ +N+L+ D KVSDFGLA+ S + + + + APE
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEAL 169
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
S KSDV+SYG+LL E+ + P S E EK
Sbjct: 170 KHK--KFSSKSDVWSYGVLLWEVFSYGR--APYPKMSLKEVKECV------------EKG 213
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+E + C A +++ C + PK RPS ++ E L
Sbjct: 214 YRMEPPEGCPADVYVLMTS-CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 75/202 (37%), Positives = 105/202 (51%), Gaps = 25/202 (12%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 411
LG G +G V + D G+L A+KVL+K ++ + E + RI+H I+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 412 FCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGC 467
+ L + EY P G L LS+E S + AR EI L A+EYLH+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVL----ALEYLHS-- 111
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
L I++ D+KP+N+LLD D K++DFGLAK S S GT Y+APE+
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVL--- 165
Query: 528 LGNPSGKS-DVYSYGMLLLEMI 548
LG GK+ D +S G+LL EM+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 86/293 (29%), Positives = 124/293 (42%), Gaps = 55/293 (18%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSN-FSDNFINEVATIGRIHHVNIIHL 409
EKLG G YG VYK + G +VA+K L+ + E++ + + H NI+ L
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
L L++EY L L + LS P + I + + Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS--PNLIKSIMYQLLRGLAYCHSH--- 117
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-----RSVVTMTGPRGTIGYIAPEIF 524
RILH D+KPQN+L++ D K++DFGLA+A VVT+ Y APEI
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-------YRAPEIL 170
Query: 525 MRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTET----------TSGSNTTEAY--- 569
LG+ S D++S G + EMI K L P ++ G+ T E++
Sbjct: 171 ---LGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226
Query: 570 --FPDWIYDKLIQPEK--EDFVEEEDD---CIARKMIIVGLWCIQINPKDRPS 615
PD+ P K E + D + KM +Q NP R S
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKM-------LQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
+ KLG G +G V+ G + VAVK L+ + + F+ E + ++ H ++ L C
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
+ ++ EYM GSL D L + E L+ +L+++A +A + YL +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 474 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 533
D+ +N+L+ + K++DFGLA+ + G + I + APE N G +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTI 183
Query: 534 KSDVYSYGMLLLEMI 548
KSDV+S+G+LL E++
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 48/276 (17%)
Query: 353 FKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIH 408
+ +G G +G VYKG G VA+K + + + E+ + + H NI+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+G + +I EY NGSL ++ + SL + ++ G + YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLH--- 116
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEI 523
E ++H DIK N+L D K++DFG+A + SVV GT ++APE+
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMAPEV 170
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKK---HLRPTETTSG-SNTTEAYFPDWIYDKLI 579
+ S SD++S G ++E++ L P P + I
Sbjct: 171 I--EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP-----EGI 223
Query: 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
PE +DF+ + C Q +P RP+
Sbjct: 224 SPELKDFLMQ---------------CFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
EK+G G +G+VYKG VAVK + F+ E + + H NI+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C ++ E +P GSL L ++K L++K +LL+++L A +EYL + +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CI 115
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI--GYIAPEIFMRNLGN 530
H D+ +N L+ + K+SDFG+++ + T++ I + APE N G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEAL--NYGR 171
Query: 531 PSGKSDVYSYGMLLLE 546
+ +SDV+SYG+LL E
Sbjct: 172 YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 39/271 (14%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EKLG G YG+VYK G++VA+KV+ + + I E++ + + I+ G
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-IIKEISILKQCDSPYIVKYYG 65
Query: 412 FCCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
+ ++ EY GS+ D++ K +L + I +EYLH+ +
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS---NK 119
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+H DIK N+LL+ + K++DFG++ + T+ GT ++APE+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGY 176
Query: 530 NPSGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYF--PDWIYDKLIQPEKE 584
N K+D++S G+ +EM E K + P A F P+ L PEK
Sbjct: 177 N--NKADIWSLGITAIEMAEGKPPYSDIHP---------MRAIFMIPNKPPPTLSDPEK- 224
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+ E +D + + C+ +P++RPS
Sbjct: 225 -WSPEFNDFVKK--------CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 404
+I + + KLG G +G V++G + + VAVK L+ + +F+ E + ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL- 463
+I L C ++ E M GSL + L +LK +L+++A VA + YL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLE 120
Query: 464 -HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
N +H D+ +NVL+ + KV+DFGLA+ + G + I + APE
Sbjct: 121 AQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPE 174
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ N S KSDV+S+G+LL E++
Sbjct: 175 AALYN--RFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 355 EKLGTGGYGNVYKGKF--PDGRL--VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 408
++LG G +G+V KG + G+ VAVK L E + F+ E + + ++ H I+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L+G C G L+ E P G L L K+ + + L E+A VA + YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLE---S 113
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRN 527
+H D+ +NVLL K+SDFG+++A T R + + APE N
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI--N 171
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
G S KSDV+SYG+ L E +P G+ E + +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGA--KPYGEMKGAEVIA------------MLESGERL 217
Query: 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
++C +++ + L C + P+DRP+ + +
Sbjct: 218 PRPEEC-PQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 355 EKLGTGGYGNVYKGKFPDG--RLVAVKVL------------EKTSNFSDNFINEVATIG- 399
E LG+G +G VYK + + L+A+K + E+ + + ++EV I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI-GDIVSEVTIIKE 64
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAH 458
++ H NI+ + ++ + + LG+ + KE R+ I + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
A+ YLH E RI+H D+ P N++L D ++DFGLAK +T GTI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILY 179
Query: 519 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
PEI ++N P G K+DV+++G +L +M L+P ++ + + +Y+
Sbjct: 180 SCPEI-VKNE--PYGEKADVWAFGCILYQMCT----LQPPFYSTNMLSLATKIVEAVYEP 232
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
L + + + V C+ + + RP + +V M+S
Sbjct: 233 L-----------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 25/273 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
F ++LG+G +G V+ GK+ VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C ++ E+M NG L + L + + LS LL + V +EYL +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDVCEGMEYLERN---SFI 122
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+ +N L+ KVSDFG+ + + + + +G + + + PE+F N S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVF--NFSKYS 179
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSDV+S+G+L+ E+ E K P E S E +L +P+
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK--MPFEKKSNYEVVEMISRG---FRLYRPK---------- 224
Query: 593 CIARKMII-VGLWCIQINPKDRPSMTRVVEMLS 624
+A + V C P+ RP+ ++ ++
Sbjct: 225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 353 FKEKLGTGGYGNVYKGKF--PDGRL----VAVKVLEKTSN--FSDNFINEVATIGRIHHV 404
F E+LG G +G VYKG+ P+ RL VA+K L++ + F E + + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-------------LSLKPARLLE 451
NI+ LLG C +++EY+ +G L + L R + SL + L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 452 IALGVAHAIEYL--HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSV 506
IA+ +A +EYL H+ +H D+ +N L+ T K+SDFGL++ + R
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
P + ++ PE + G + +SD++S+G++L E+
Sbjct: 184 SKSLLP---VRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLE--KTSNFSDN---------FINEVATIGRIH 402
E +G G YG VY G ++AVK +E T + +E+ T+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIE 461
H+NI+ LGF ++ EY+P GS+G L + L ++ G+A
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA---- 122
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGTIGYI 519
YLH+ ILH D+K N+L+D D K+SDFG++K S + + M+ +G++ ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMS-MQGSVFWM 177
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDWI 574
APE+ S K D++S G ++LEM ++ E + G+ + P +
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237
Query: 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ P DF+ C INP +RP+ +++
Sbjct: 238 SMN-LSPVALDFLNA---------------CFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 72/207 (34%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 353 FKEKLGTGGYGNV----YKGKFPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHV 404
F + LGTG +G V +KG G+ A+K+L K ++ +NE + I H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEY 462
+++L G D S L+ EY+P G L L R+ AR ++ L A+EY
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVL----ALEY 116
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
LH+ L I++ D+KP+N+LLD D K++DFG AK + R T T GT Y+APE
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGR---TYT-LCGTPEYLAPE 168
Query: 523 IFMRNLGNPSGKS-DVYSYGMLLLEMI 548
I L GK+ D ++ G+L+ EM+
Sbjct: 169 II---LSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 414
+KLG G +G V+ G + VA+K L++ S + F+ E + ++ H ++ L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70
Query: 415 DGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
T+ IY EYM NGSL D L + E + L +L+++A +A + ++
Sbjct: 71 ---TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNY 123
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D++ N+L+ K++DFGLA+ N G + I + APE N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTF 180
Query: 532 SGKSDVYSYGMLLLEMI 548
+ KSDV+S+G+LL E++
Sbjct: 181 TIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVL--------EKTSNFSDNFINEVATIGRIHHVN 405
E +G G +G V K + DG+++ K + EK ++EV + + H N
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPN 60
Query: 406 IIHLLGFCCDGSTRAL--IYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEY 462
I+ D S + L + EY G L L+ + +KE ++ + I + A+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 463 LHNGCEL--RILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSRNRSVVTMTGPRGTI 516
HN + +LH D+KP N+ LD + K+ DFGLAK S ++ V GT
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV------GTP 174
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
Y++PE + KSD++S G L+ E+
Sbjct: 175 YYMSPEQLNHMSYDE--KSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 357 LGTGGYGNVYKGKF--PDGRL--VAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIH 408
LG G +G+V +G+ DG VAVK + K + + F++E A + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 409 LLGFCCDGSTRA------LIYEYMPNGSLGDLL--SREKENLSLKPAR-LLEIALGVAHA 459
L+G C + S+ +I +M +G L L SR P + LL+ + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRG 514
+EYL N +H D+ +N +L D T V+DFGL+K + R + M
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM----- 177
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574
+ +IA E + KSDV+++G+ + E+ + P G E I
Sbjct: 178 PVKWIAIESLADRVYTS--KSDVWAFGVTMWEIATRGQTPYP-----GVENHE------I 224
Query: 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
YD L + +++ +DC+ ++ C + +PKDRP+ T++ E+L
Sbjct: 225 YDYLRHGNR---LKQPEDCLDELYDLM-YSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 346 IKKMTNGFKEKLGTGGYGNVYKGK----FPDG--RLVAVKVLEKTSNFS--DNFINEVAT 397
+++ T K +LG G +G V+ G+ P+ LVAVK L++T++ +F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-----------LKP 446
+ H NI+ G C +G +++EYM +G L L + + L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 447 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506
++LL+IA+ +A + YL +H D+ +N L+ D K+ DFG++ R V
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RDV 172
Query: 507 VTMTGPR--GT----IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
T R G I ++ PE M + +SDV+S+G++L E+
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 59/279 (21%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
E +G G +G VYK ++VA+KV LE+ + ++ E+ + + I G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 466
GS +I EY GS DLL KP +L E I V +EYLH
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL---------KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+H DIK N+LL + K++DFG L S+ + V GT ++APE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPE 168
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF------PDWIYD 576
+ + K+D++S G+ +E+ + + L S + F P +
Sbjct: 169 VIKQ--SGYDEKADIWSLGITAIELAKGEPPL------SDLHPMRVLFLIPKNNPPSLEG 220
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+DFV C+ +PK+RPS
Sbjct: 221 NKFSKPFKDFVSL---------------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 62/294 (21%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHVNI 406
++LGTG + + Y+ + G L+AVK + N S + E+ + R++H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYL 463
I +LG C+ S L E+M GS+ LLS+ KE + + ++ G++ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLS----YL 119
Query: 464 HNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGP-----RGTIG 517
H E +I+H D+K N+L+D +++DFG A +R + T G GTI
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA---ARLAAKGTGAGEFQGQLLGTIA 173
Query: 518 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF------ 570
++APE+ G G+S DV+S G +++EM K P SN F
Sbjct: 174 FMAPEVLR---GEQYGRSCDVWSVGCVIIEMATAKP---PWNAEKHSNHLALIFKIASAT 227
Query: 571 -PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
I + L P D L C+++ P+DRP E+L
Sbjct: 228 TAPSIPEHL-SPGLRDVT---------------LRCLELQPEDRPP---SRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 352 GFK--EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHV 404
FK +KLG G YG+VYK K D + A+K + + S + +NE+ + ++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYL 463
NII DG+ ++ EY P G L +S+ K+ L P + + I + + ++ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
H E +ILH D+K N+LL + K+ D G++K + T GT Y+APE+
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQI---GTPHYMAPEV 172
Query: 524 FMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKL 578
+ G P S KSD++S G LL EM P E S + +P
Sbjct: 173 WK---GRPYSYKSDIWSLGCLLYEMATFAP---PFEARSMQDLRYKVQRGKYP------- 219
Query: 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628
P + ++ + +Q+ PK RP+ ++L+S +
Sbjct: 220 --PIPPIY--------SQDLQNFIRSMLQVKPKLRPNCD---KILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 414
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 12 QTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 415 -DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
+ ++ EYM GSL D L R + L LL+ +L V A+EYL +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 474 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 533
D+ +NVL+ D KVSDFGL K S + + + + APE S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF--ST 178
Query: 534 KSDVYSYGMLLLEM 547
KSDV+S+G+LL E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 63/184 (34%), Positives = 92/184 (50%), Gaps = 23/184 (12%)
Query: 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD-----NF--INEVATIGRIHHV 404
+KLG G Y VYK + GR+VA+K + K + NF + E+ + + H
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDL--LSREKENLSLKPARLLEIALGVAHAIEY 462
NII LL S L++E+M DL + ++K ++ L PA + L +EY
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEY 117
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 521
LH+ ILH D+KP N+L+ D K++DFGLA++ S NR MT T Y AP
Sbjct: 118 LHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK---MTHQVVTRWYRAP 171
Query: 522 EIFM 525
E+
Sbjct: 172 ELLF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGR---LVAVKVLEK--TSNFSDNFINEVATIGRIHHVNII 407
+E +G G +G V +G+ G+ VA+K L+ T +F++E + +G+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
HL G +I E+M NG+L L R+ + +L+ + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL-RQNDG-QFTVIQLVGMLRGIAAGMKYL---S 123
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG---TIGYIAPE-I 523
E+ +H D+ +N+L++ + KVSDFGL++ + S T T G I + APE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMI 548
R + SDV+SYG+++ E++
Sbjct: 184 AYRKF---TSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 72/212 (33%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD-------NFINEVATIGRIHHVNII 407
E LG G YG VY G G+L+AVK +E ++ EV + + HVNI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIALGVAHAIEYLH 464
LG C D +T ++ E++P GS+ +L+R E + K + +I GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK--QILDGVA----YLH 119
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK------AHSRNRSVVTMTGPRGTIGY 518
N C ++H DIK NV+L P+ K+ DFG A+ H + ++ + GT +
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPYW 174
Query: 519 IAPEIFMRNLGNPSG---KSDVYSYGMLLLEM 547
+APE+ N SG KSD++S G + EM
Sbjct: 175 MAPEVI-----NESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 48/282 (17%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVNII 407
E LG+G +G+VY+G DG AVK + + E+A + ++ H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 464
LG + + E +P GSL LL + E + R +I LG +EYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR--QILLG----LEYLH 119
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ +H DIK N+L+D + K++DFG+AK + +G+ ++APE+
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVI 173
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDWIYDKLI 579
+ G +D++S G +LEM K E + G + PD +
Sbjct: 174 AQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD-----HL 227
Query: 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
E +DF+ L C+Q +P RP+ ++E
Sbjct: 228 SDEAKDFI---------------LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNI 406
F + +G G + V K + A+K+L+K E + R+ H I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 407 IHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
I L + D + EY PNG L + R+ +L K R A + A+EYLH
Sbjct: 65 IKL--YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRF--YAAEILLALEYLH 119
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA------------------------H 500
+ I+H D+KP+N+LLD D K++DFG AK
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK-SDVYSYGMLLLEMI 548
R S V GT Y++PE+ P+GK SD+++ G ++ +M+
Sbjct: 177 RRFASFV------GTAEYVSPELL---NEKPAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 351 NGFKEKLGTGGYGNVYKGKFPDGRL-VAVK-VLEKTSNFSDNFINEVATIGRIHHVNIIH 408
NG + LG G YG VY + ++ +A+K + E+ S + E+A + H NI+
Sbjct: 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
LG + + E +P GSL LL + L ++ + ++YLH +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---D 126
Query: 469 LRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSR-NRSVVTMTGPRGTIGYIAPEIF-- 524
+I+H DIK NVL++ K+SDFG +K + N T T GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDK 183
Query: 525 -MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
R G P +D++S G ++EM K P G A F ++ I PE
Sbjct: 184 GPRGYGAP---ADIWSLGCTIVEMATGK----PPFIELG-EPQAAMFKVGMFK--IHPE- 232
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ E A+ I L C + +P R S +++
Sbjct: 233 ---IPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGF 412
E LG G +G V+KG D VAVK ++ F++E + + H NI+ L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C ++ E +P G L ++K+ L K +L++ AL A + YL + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTK--QLVKFALDAAAGMAYLESK---NCI 115
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMRNLGNP 531
H D+ +N L+ + K+SDFG+++ + + + +G + I + APE N G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGRY 171
Query: 532 SGKSDVYSYGMLLLE 546
S +SDV+SYG+LL E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNI 406
F ++LG G +G+V ++ G +VAVK L+ ++ +F E+ + + H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 407 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
+ G C R L+ EY+P GSL D L + +E L + +LL A + +EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR--KLLLYASQICKGMEYLG 125
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP-RGTIGYIAPEI 523
R +H D+ +N+L++ + K+ DFGL K +++ + P I + APE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEM 547
+ S SDV+S+G++L E+
Sbjct: 183 LTESKF--SVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 357 LGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLL 410
LGTG +G + +G K P R VA+ L + F+ E T+G+ H NI+ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G G+T ++ EYM NG+L L + + L +L+ + G+A ++YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYL---SEMG 127
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+H + VL++ D K+S F + ++ ++ T + + + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAI--QYHH 184
Query: 531 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590
S SDV+S+G+++ E++ + RP SG + +A + D P
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGE--RPYWDMSGQDVIKA-----VEDGFRLPAPR------ 231
Query: 591 DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+C + + M L C Q +RP +++ +LS
Sbjct: 232 -NCPNLLHQLM----LDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 357 LGTGGYGNVYKG--KFPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHVNIIHLL 410
+G G +G V G K P R + V + + +++ +F++E + +G+ H NIIHL
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G ++ EYM NGSL L + ++ +L+ + G+A ++YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMG 126
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-RSVVTMTGPRGTIGYIAPE-IFMRNL 528
+H D+ +N+L++ + KVSDFGL++ + + T G + I + APE I R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 529 GNPSGKSDVYSYGMLLLEMI 548
+ SDV+SYG+++ E++
Sbjct: 187 ---TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 75/232 (32%), Positives = 114/232 (49%), Gaps = 53/232 (22%)
Query: 353 FKEKLGTGGYGNV----------YKGKFP---DGR--LVAVKVL--EKTSNFSDNFINEV 395
KEKLG G +G V + G+ DG+ LVAVK+L + T ++F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS-REKENL--------SLKP 446
+ R+ + NII LLG C +I EYM NG L LS RE E+ S+
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 447 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--- 503
A LL +A+ +A ++YL L +H D+ +N L+ +T K++DFG+ SRN
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM----SRNLYS 181
Query: 504 --------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
R+V+ I ++A E + LG + SDV+++G+ L EM
Sbjct: 182 GDYYRIQGRAVL-------PIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 57/295 (19%)
Query: 357 LGTGGYGNVYKG-------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 407
LG G +G VY+G P+ R VA+K + + ++ + F+NE + + + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENLSLKPA-----RLLEIALGVAHAI 460
LLG G ++ E M G L L R + + + +++A +A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGT-- 515
YL + +H D+ +N ++ D T K+ DFG+ + R G +G
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-----GGKGLLP 184
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575
+ ++APE G + KSDV+S+G++L EM T A P Y
Sbjct: 185 VRWMAPESLKD--GVFTTKSDVWSFGVVLWEM-----------------ATLAEQP---Y 222
Query: 576 DKLIQPEKEDFVEEED-----DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
L E FV + + K++ + C Q NPK RP+ +V L
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 40/266 (15%)
Query: 357 LGTGGYGNVYKGKF-PDGRL----VAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIH 408
LG+G +G V+KG + P+G VA+K ++ S F + + + +G + H I+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE-ITDHMLAMGSLDHAYIVR 73
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
LLG C G++ L+ + P GSL D + + +++L P RLL + +A + YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQIAKGMYYLE---E 127
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
R++H ++ +N+LL D +++DFG+A + + + I ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL--F 185
Query: 529 GNPSGKSDVYSYGMLLLEMI----EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
G + +SDV+SYG+ + EM+ E +RP E PD + EK
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----------PDLL-------EKG 227
Query: 585 DFVEEEDDC-IARKMIIVGLWCIQIN 609
+ + + C I M++V W I N
Sbjct: 228 ERLAQPQICTIDVYMVMVKCWMIDEN 253
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
++G G +G V+K K G VA+K + + + E+ + H ++ LL
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
GS L+ EYMP L ++L E+ L + L + Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANG 119
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I+H D+KP N+L+ D K++DFGLA+ S + T Y APE+ G
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELL---YGA 175
Query: 531 P--SGKSDVYSYGMLLLEMI 548
D+++ G + E++
Sbjct: 176 RKYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 7/207 (3%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 414
+KLG G +G V+ G + + VAVK L+ + F+ E + + H ++ L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 415 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHL 474
+I EYM GSL D L ++ L P +L++ + +A + Y+ +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 475 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK 534
D++ NVL+ K++DFGLA+ N G + I + APE N G+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIK 184
Query: 535 SDVYSYGMLLLEMIEEKKHLRPTETTS 561
SDV+S+G+LL E++ K P + S
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 354 KEK-LGTGGYGNVYKG--KFPDGR---LVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 405
K+K +G G +G V++G K P GR VA+K L+ T +F++E + +G+ H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMP-GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
II L G +I EYM NG+L L R+ + +L+ + G+A ++YL +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDG-EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-RSVVTMTGPRGTIGYIAPE-I 523
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE I
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMI 548
R + SDV+S+G+++ E++
Sbjct: 183 AYRKF---TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 356 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLLGF 412
+LG G G V K P G+++AVK + N + + E+ + + + I+ G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGCELRI 471
+ ++ EYM GSL +L + + P R+L +IA+ V + YLH + +I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRI---PERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+H D+KP N+L++ K+ DFG++ +S ++ V GT Y+APE R G
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPE---RIQG 173
Query: 530 NPSG-KSDVYSYGMLLLEM 547
N KSD++S G+ L+E+
Sbjct: 174 NDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 414
+KLG G +G V+ G + VAVK L+ + ++F+ E + ++ H ++ L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 415 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHL 474
+ ++ EYM GSL D L ++ E +LK L+++A VA + Y+ + +H
Sbjct: 72 EEPIY-IVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 475 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK 534
D++ N+L+ K++DFGLA+ N G + I + APE + G + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAAL--YGRFTIK 183
Query: 535 SDVYSYGMLLLEMI 548
SDV+S+G+LL E++
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
++G G YG VYK + G LVA+K + + N + F I E+ + ++ H NI+ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 410 LGFCCD---GSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIE 461
GS +++EYM + L LL + + + LLE ++
Sbjct: 64 KEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQ 114
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
YLH+ ILH DIK N+L++ D K++DFGLA+ +++ S T T+ Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPP 170
Query: 522 EIFMRNLG--NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----------GSNTTEAY 569
E+ LG + D++S G +L E+ K + T GS T E +
Sbjct: 171 ELL---LGATRYGPEVDMWSVGCILAELF-LGKPIFQGSTELEQLEKIFELCGSPTDENW 226
Query: 570 -----FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
P + K +P K E I + + + ++PK R S
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 356 KLGTGGYGNVYKG-KFPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
K+G G +G VY G L+AVK + +E+ + + H N++
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNLVKYY 65
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G + EY G+L +LL L R+ + L + YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEG--LAYLH---SHG 119
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRNL 528
I+H DIKP N+ LD + K+ DFG A N + + + GT Y+APE+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 529 GNPSGKS-DVYSYGMLLLEMIEEKK 552
G G++ D++S G ++LEM K+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 63/282 (22%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 404
+I + + ++KLG G +G V+ + VAVK ++ S + F+ E + + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 405 NIIHLLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
++ L T+ IY E+M GSL D L ++ + P +L++ + +A +
Sbjct: 62 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP-KLIDFSAQIAEGMA 116
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
++ + +H D++ N+L+ K++DFGLA+ N G + I + AP
Sbjct: 117 FIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
E N G+ + KSDV+S+G+LL+E++ + P + ++I+
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---------------EVIRA 215
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + + ++ + + C + P++RP+ + +L
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 71/227 (31%), Positives = 115/227 (50%), Gaps = 36/227 (15%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL---VAVKVLEKTSNFSD--NFINEVAT 397
+NDIK F++ +G G +G V K + L A+K +++ ++ D +F E+
Sbjct: 6 WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 398 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------- 447
+ ++ HH NII+LLG C L EY P+G+L D L R+ L PA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTAS 119
Query: 448 -----RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502
+LL A VA ++YL + + +H D+ +N+L+ ++ K++DFGL SR
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SR 172
Query: 503 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ V V T R + ++A E N + SDV+SYG+LL E++
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLG 411
E++G G +G V+ G+ D VAVK +T + F+ E + + H NI+ L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
C ++ E + G L E L +K L+++ A +EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLESKH---C 115
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +N L+ K+SDFG+++ T + + + APE N G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGRY 173
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591
S +SDV+S+G+LL E P S T EA E+ + +
Sbjct: 174 SSESDVWSFGILLWEAFSLGA--VPYANLSNQQTREAI------------EQGVRLPCPE 219
Query: 592 DC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
C + R M C + +P RPS + V + L S
Sbjct: 220 LCPDAVYRLM----ERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 357 LGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 408
LG G +G VY+G + VAVK L ++ + D +F+ E + + +H NI+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL----SLKPARLLEIALGVAHAIEYLH 464
L+G + R ++ E M G L L + SL LL A VA +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 465 NGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYI 519
E +H DI +N LL P K++DFG+A+ R+ G R I ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRAMLPIKWM 188
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEM 547
PE F+ G + K+DV+S+G+LL E+
Sbjct: 189 PPEAFLD--GIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 38/276 (13%)
Query: 357 LGTGGYGN--VYKGKFPDGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
LG G +G +Y+ + D LV K + + + +NE+ + + H NII
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
D +T + EY G+L D + R+K L + +L + A+ Y+H + I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKA----HSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
LH DIK N+ L K+ DFG++K +S +VV GT Y++PE+
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV------GTPYYMSPELCQGV 176
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
N KSD+++ G +L E++ K+ T +N + K++Q
Sbjct: 177 KYN--FKSDIWALGCVLYELLTLKR------TFDATNPLN------LVVKIVQGNYTP-- 220
Query: 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ ++I + +Q +P+ RP+ V++
Sbjct: 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 85/307 (27%), Positives = 144/307 (46%), Gaps = 73/307 (23%)
Query: 353 FKEKLGTGGYGNVY----KG--KFPDGR-----------LVAVKVL--EKTSNFSDNFIN 393
FKEKLG G +G V+ +G KF D LVAVK+L + N ++F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK--------ENLSLK 445
E+ + R+ NII LL C +I EYM NG L LSR + + +++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 446 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-- 503
+ L+ +A +A ++YL + L +H D+ +N L+ ++T K++DFG+ SRN
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGM----SRNLY 181
Query: 504 ---------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---EEK 551
R+V+ I +++ E + LG + SDV+++G+ L E++ +E+
Sbjct: 182 SGDYYRIQGRAVL-------PIRWMSWESIL--LGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 552 KHLRPTETTSGSNTTEAYFPD---WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI 608
+ + ++ NT E +F D +Y L +P + + L C +
Sbjct: 233 PYSQLSDEQVIENTGE-FFRDQGRQVY--LPKPA----------LCPDSLYKLMLSCWRR 279
Query: 609 NPKDRPS 615
N K+RPS
Sbjct: 280 NAKERPS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 360 GGYGNVYKG-KFPDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLL-GFC 413
G YG V+ K G + A+KV++K N D + E + + ++ L F
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRI 471
L+ EY+P G L LL +L AR + EI L A+EYLH+ I
Sbjct: 64 GK-KNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVL----ALEYLHS---NGI 114
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR------GTIGYIAPEIFM 525
+H D+KP N+L+D + K++DFGL+K R + + GT YIAPE+
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI- 173
Query: 526 RNLGNPSGKS-DVYSYGMLLLEMI 548
LG K+ D +S G +L E +
Sbjct: 174 --LGQGHSKTVDWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 85/291 (29%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 357 LGTGGYGNV----YKGKFPD-GRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G V Y G +VAVK L E + + E+ + ++H NI+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 410 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
G C + + LI EY+P GSL D L + K NL A+LL A + + YLH+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL----AQLLLFAQQICEGMAYLHSQ- 126
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA----HSRNRSVVTMTGPRGTIGYIAPEI 523
+H D+ +NVLLD D K+ DFGLAKA H R V G Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWY-AVEC 181
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEE--------KKHLRPTETTSGSNTTEAYFPDWIY 575
N S SDV+S+G+ L E++ KK G T
Sbjct: 182 LKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV-------- 231
Query: 576 DKLIQ-PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+LI+ E+ + +C I++ C + K RP+ ++ +L
Sbjct: 232 -RLIELLERGMRLPCPKNCPQEVYILMKN-CWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 357 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN----------FINEVATIGRIHHVN 405
+G+G +G+VY G G L+AVK +E S + + E+A + + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
I+ LG D + EY+P GS+ LL+ + + + + + YLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN 124
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR----GTIGYIAP 521
I+H DIK N+L+D K+SDFG++K N G R G++ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
E+ + K+D++S G L++EM+ K
Sbjct: 182 EVVKQTSYTR--KADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 357 LGTGGYGNVYKGKF-PDGRLV----AVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHL 409
LG+G +G VYKG + P+G V A+K+L +T+ N F++E + + H +++ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
LG C T L+ + MP+G L D + K+N+ + LL + +A + YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQ--LLLNWCVQIAKGMMYLE---ER 128
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRNL 528
R++H D+ +NVL+ K++DFGLA+ + G + I ++A E I R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 529 GNPSGKSDVYSYGMLLLEMI 548
+ +SDV+SYG+ + E++
Sbjct: 189 ---THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 357 LGTGGYGNVYKGKF-PDG----RLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G V ++ P+G VAVK L E N + E+ + ++H NI+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 410 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
G C + LI E++P+GSL + L R K ++LK + L+ A+ + ++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDYLGS-- 127
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMR 526
+ +H D+ +NVL++ + K+ DFGL KA ++ T+ + + + APE ++
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 527 NLGNPSGKSDVYSYGMLLLEMI 548
+ + SDV+S+G+ L E++
Sbjct: 187 SKFYIA--SDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 32/277 (11%)
Query: 357 LGTGGYGNVYKGKF-PDGR----LVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHL 409
LG+G +G VYKG + PDG VA+KVL + ++ N ++E + + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
LG C ST L+ + MP G L D + K+ + + LL + +A + YL E+
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQ--DLLNWCVQIAKGMSYLE---EV 128
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
R++H D+ +NVL+ K++DFGLA+ + + G + I ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-- 186
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
+ +SDV+SYG+ + E++ T G+ + I D L EK + + +
Sbjct: 187 RFTHQSDVWSYGVTVWELM-----------TFGAKPYDGIPAREIPDLL---EKGERLPQ 232
Query: 590 EDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
C I MI+V W I+ + RP +V+ S
Sbjct: 233 PPICTIDVYMIMVKCW--MIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 30/273 (10%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
E +G G VY P+ VA+K LEK D EV + + +H N++
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCE 468
G L+ Y+ GSL D++ L A + + V +EYLH NG
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG-- 122
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+H DIK N+LL D + K++DFG++ A +R+ GT ++APE+ M
Sbjct: 123 --QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV-ME 179
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
+ K+D++S+G+ +E+ T S Y P + +Q +
Sbjct: 180 QVHGYDFKADIWSFGITAIELA--------TGAAPYSK----YPPMKVLMLTLQNDPPSL 227
Query: 587 VEEEDDC----IARKMIIVGLWCIQINPKDRPS 615
D RKMI + C+Q +P RP+
Sbjct: 228 ETGADYKKYSKSFRKMISL---CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G VY D GR +AVK + +T + E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNG 466
G D T ++ EYMP GS+ D L E ++ K R + +EYLH+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------QILEGVEYLHSN 123
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT-MTGPRGTIGYIAPEIFM 525
I+H DIK N+L D K+ DFG +K S T M GT +++PE+
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI- 179
Query: 526 RNLGNPSG-KSDVYSYGMLLLEMIEEK 551
G G K+DV+S G ++EM+ EK
Sbjct: 180 --SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 77/242 (31%), Positives = 116/242 (47%), Gaps = 62/242 (25%)
Query: 353 FKEKLGTGGYGNVY-----------KGKFP----DGR--LVAVKVL--EKTSNFSDNFIN 393
FKEKLG G +G V+ +FP GR LVAVK+L + N ++F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-------EKENLSLKP 446
EV + R+ NII LLG C D +I EYM NG L LS E N ++ P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 447 A---------RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497
A LL +AL +A ++YL + L +H D+ +N L+ + T K++DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM- 184
Query: 498 KAHSRN-----------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 546
SRN R+V+ I ++A E + +G + SDV+++G+ L E
Sbjct: 185 ---SRNLYAGDYYRIQGRAVL-------PIRWMAWECIL--MGKFTTASDVWAFGVTLWE 232
Query: 547 MI 548
++
Sbjct: 233 IL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 72/284 (25%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVL-EKTSNFSD-NFINEVATIGRI-HHVNIIHLL 410
++LG G +G+VY + + G LVA+K + +K ++ + + EV ++ ++ H NI+ L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCEL 469
+ ++EYM G+L L+ K + + I + + ++H +G
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
H D+KP+N+L+ K++DFGLA+ R+R T T Y APEI +R+
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRP--PYTDYVSTRWYRAPEILLRS-T 174
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
+ S D+++ G ++ E+ LRP GS+ + + I L P K+D+ E
Sbjct: 175 SYSSPVDIWALGCIMAELYT----LRP--LFPGSSEIDQLYK--ICSVLGTPTKQDWPEG 226
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 633
+A K+ + ++ +AS EAI++
Sbjct: 227 YK--LASKLGFRFPQFAPTSLHQ---------LIPNASPEAIDL 259
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLE---KTSNFSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG VYK + G +VA+K + +T I E++ + ++H NI+ LL
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 411 GFCCDGSTRALIYEYMPNGSLG---DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ L++E++ + L D L L + L ++ G+A + H+
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCHSH- 119
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
R+LH D+KPQN+L++ + K++DFGLA+A V T T T+ Y APEI
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL--- 172
Query: 528 LGNP--SGKSDVYSYGMLLLEMIEEK 551
LG S D++S G + EM+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 52/292 (17%)
Query: 350 TNGFK--EKLGTGGYGNVYKGK-FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIH 402
FK +K+G G + VYK DGR+VA+K ++ + + + E+ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIE 461
H N+I L + + ++ E G L ++ K+ L P R + + + + A+E
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN----RSVVTMTGPRGTIG 517
++H RI+H DIKP NV + K+ D GL + S S+V GT
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV------GTPY 171
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD- 576
Y++PE N N KSD++S G LL EM L+ N +Y
Sbjct: 172 YMSPERIHENGYN--FKSDIWSLGCLLYEMAA----LQSPFYGDKMN---------LYSL 216
Query: 577 --KLIQPE-----KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
K+ + + + + EE D ++R CI +P+ RP ++ V++
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSR--------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 357 LGTGGYGNVYKGKFP------DGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIH 408
LG G +G V+ K LV VK L+KT N F E+ ++ H N++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENLS----LKPARLLEIALGVAHAIEY 462
LLG C + +I EY G L L ++ K+ L + + + +A +++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-------HSRNRSVVTMTGPRGT 515
L N R +H D+ +N L+ KVS L+K RN +
Sbjct: 133 LSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--------P 181
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575
+ ++APE + + S KSDV+S+G+L+ E+ E F
Sbjct: 182 LRWLAPEAVQED--DFSTKSDVWSFGVLMWEVF---------------TQGELPFYGLSD 224
Query: 576 DKLIQPEKEDFVE--EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
++++ + +E + C +R ++ C +NPKDRPS + +V L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLM-TRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 355 EKLGTGGYGNVYKGKF-----PDGRL-VAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 405
+ LG G +G V K + P+ VAVK+L+ + D + ++E+ + I H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 450
II+LLG C ++ EY +G+L D L + E L+ K L+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK--DLV 135
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 509
A VA +E+L + + +H D+ +NVL+ D K++DFGLA+ H + T
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
G R + ++APE + + +SDV+S+G+LL E+
Sbjct: 193 NG-RLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 8/192 (4%)
Query: 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 475
++ EYM GSL D L E L+ +L+++A +A + Y+ + +H D
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 476 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS 535
++ N+L+ + KV+DFGLA+ N G + I + APE + G + KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKS 184
Query: 536 DVYSYGMLLLEM 547
DV+S+G+LL E+
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 346 IKKMTNGFKEK-LGTGGYGNVYKGKF-PDGR----LVAVKVLEKTSNFSDN--FINEVAT 397
I K T K K LG+G +G VYKG + P+G VA+K L + ++ N ++E
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
+ + + ++ LLG C ST LI + MP G L D + K+N+ + LL + +A
Sbjct: 63 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIA 119
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+ YL E R++H D+ +NVL+ K++DFGLAK + G + I
Sbjct: 120 KGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 518 YIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
++A E I R + +SDV+SYG+ + E++ T GS + I
Sbjct: 177 WMALESILHRIY---THQSDVWSYGVTVWELM-----------TFGSKPYDGIPASEISS 222
Query: 577 KLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVV 620
L EK + + + C I MI+V W I+ RP ++
Sbjct: 223 IL---EKGERLPQPPICTIDVYMIMVKCW--MIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 93/381 (24%), Positives = 159/381 (41%), Gaps = 38/381 (9%)
Query: 268 CDSVKRRKSRLPLIIGATAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVK 327
C V++ S I + LVA + R R K+ +E DG
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE------DGTWEL 672
Query: 328 QFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL-VAVKVLEKTSN 386
QF + S + + + NDI + + G G YKGK + VK + ++
Sbjct: 673 QF---FDSKVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 387 FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKP 446
+ I + +G++ H NI+ L+G C LI+EY+ +L ++L NLS +
Sbjct: 729 IPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWE- 780
Query: 447 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506
R +IA+G+A A+ +LH C ++ ++ P+ +++D P + L +
Sbjct: 781 -RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG------LL 832
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 566
T T + Y+APE R + + KSD+Y +G++L+E++ K P + G + +
Sbjct: 833 CTDTKCFISSAYVAPE--TRETKDITEKSDIYGFGLILIELLTGKS---PADAEFGVHGS 887
Query: 567 EAYFPDWIY-----DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ + Y D I P V + I M + L C +P RP V++
Sbjct: 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLK 946
Query: 622 MLSSASAEAIEMPPKPLFPSP 642
L SAS + F S
Sbjct: 947 TLESASRSSSSCVTGLKFSSL 967
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 358 GTGGYGNVYKGKFPDGRLV-------AVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 410
G G +G V + D + + K +EK S N +NE + ++H +++L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS--VRNVLNERRILQELNHPFLVNLW 66
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 468
D L+ + + G L LS+ K S + + EI L A+EYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVL----ALEYLH---S 118
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+H DIKP N+LLD ++DF +A + + + + GT GY+APE+ R
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQ- 174
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 567
S D +S G+ E + K RP S + +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGK---RPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 475
++ E+M GSL D L +E + LK +L+++A +A + Y+ + +H D
Sbjct: 73 EPIY-IVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 476 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS 535
++ N+L+ + K++DFGLA+ N G + I + APE + G + KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKS 184
Query: 536 DVYSYGMLLLEMIEEKK 552
DV+S+G+LL E++ + +
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
+G G YG V K + G +VA+K E + + EV + ++ H NI++L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
L++EY+ +L +LL L R L AI Y H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCH---SHN 120
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H DIKP+N+L+ K+ DFG A+A +R S +T T Y APE+ +G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELL---VG 175
Query: 530 NPS-GKS-DVYSYGMLLLEMI 548
+ + GK DV++ G ++ E++
Sbjct: 176 DTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 342 SYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN-----FINEV 395
S D KK F EK+G G G VY G+ VA+K + N INE+
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEI 67
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 455
+ H NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRE 123
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRG 514
A+E+LH+ +++H DIK N+LL D + K++DFG A+ TM G
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---G 177
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549
T ++APE+ R P K D++S G++ +EM+E
Sbjct: 178 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 357 LGTGGYGNVYKGKFPD------GRL-VAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 407
LG+G +G VY+G D G + VAVK L K + + F+ E + +H NI+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLS--REKENLSLKPA-----RLLEIALGVAHAI 460
LLG C + +I E M GDLLS R+ P LL+I L VA
Sbjct: 63 KLLGVCLLNEPQYIIMELMEG---GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 461 EYLHNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
YL ++ +H D+ +N L+ D D K+ DFGLA+ ++
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ ++APE + +SDV+S+G+L+ E++
Sbjct: 177 VRWMAPESLLDGKFT--TQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LE-KTSNFSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG VYK + G +VA+K LE + I E++ + ++H NI+ LL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
+ L++E++ + L + L P + + I Y H+ R
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+LH D+KPQN+L+D + K++DFGLA+A V T T T+ Y APEI LG+
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL---LGS 174
Query: 531 P--SGKSDVYSYGMLLLEMIEEK 551
S D++S G + EM+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 42/227 (18%)
Query: 353 FKEKLGTGGYGNVY------------KGKFPDG-----RLVAVKVLEK--TSNFSDNFIN 393
F EKLG G +G V+ K + LVAVKVL + N ++F+
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-EKEN-------LSLK 445
EV + R+ NI LLG C +I EYM NG L L + E SL
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 446 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNR 504
+ LL +A +A + YL L +H D+ +N L+ ++T K++DFG+++ +S +
Sbjct: 129 FSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 505 SVVTMTGPRGT----IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
V +G I ++A E + LG + KSDV+++G+ L E+
Sbjct: 186 YRV-----QGRAPLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 355 EKLGTGGYGNVYKGKF--PDGRLV--AVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 408
+G G +G VY G DG+ + AVK L + ++ + F+ E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 409 LLGFCCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
LLG C L+ YM +G L + + E N ++K L+ L VA +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYL---A 115
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFM 525
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 526 RNLGNPSGKSDVYSYGMLLLEMI 548
+ KSDV+S+G+LL E++
Sbjct: 176 TQ--KFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS----DNFINEV 395
+S +D +K+ +E +G G +G VY + +VA+K + + S + I EV
Sbjct: 8 FSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA-- 453
+ ++ H N I G T L+ EY GS D+L K KP + +EIA
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-----KPLQEVEIAAI 120
Query: 454 -LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
G + YLH+ +H DIK N+LL T K++DFG A S S V
Sbjct: 121 CHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV----- 172
Query: 513 RGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
GT ++APE I + G GK DV+S G+ +E+ E K
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLG 411
+LG G G+V K + + G + A+K + N + E+ I+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 412 FCCD--GSTRALIYEYMPNGSLGDLLSREKEN---LSLKPARLLEIALGVAHAIEYLHNG 466
D S+ + EY GSL + + K+ + K L +IA V + YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV--LGKIAESVLKGLSYLH-- 122
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+I+H DIKP N+LL K+ DFG++ N T T GT Y+APE R
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGTFT---GTSFYMAPE---R 174
Query: 527 NLGNP-SGKSDVYSYGMLLLEM 547
G P S SDV+S G+ LLE+
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVA---VKVLEKTSNF--SDNFINEVATIGRIHHVNIIHL 409
+++G G +G V G+ G A VK L ++ F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGC 467
LG C + L+ E+ P G L + L + ++ + L +A VA + +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE---IF 524
+ +H D+ +N L D + K+ D+GLA +T + ++APE I
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 525 MRNL--GNPSGKSDVYSYGMLLLEMIE 549
++L + + KS+++S G+ + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 354 KEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 407
+G G +G+VY+G + + VAVK + ++ S F+ E + + H +I+
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
L+G + ++ E P G L L K +L L A L+ + ++ A+ YL +
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLES-- 125
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMR 526
R +H DI +NVL+ K+ DFGL++ + S + + I ++APE I R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 527 NLGNPSGKSDVYSYGMLLLEMI 548
+ SDV+ +G+ + E++
Sbjct: 184 RF---TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 72/227 (31%), Positives = 117/227 (51%), Gaps = 36/227 (15%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLV--AVKVLEKTSNFSD--NFINEVAT 397
+ DIK F++ +G G +G V + DG + A+K+L++ ++ +D +F E+
Sbjct: 1 WEDIK-----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV 55
Query: 398 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------- 447
+ ++ HH NII+LLG C + + EY P G+L D L R+ L PA
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTAS 114
Query: 448 -----RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502
+LL+ A VA ++YL E + +H D+ +NVL+ + K++DFGL SR
Sbjct: 115 TLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL----SR 167
Query: 503 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
V V T R + ++A E N + KSDV+S+G+LL E++
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 353 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 403
F + LG G +G V + K VAVK+L+ T++ S+ ++E+ + + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
NI++LLG C G +I EY G L + L R++E+ L LL + VA + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL 157
Query: 464 HN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+ C +H D+ +NVLL K+ DFGLA+ + + V R + ++APE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD-KLIQP 581
+ + +SDV+SYG+LL E+ + GSN +P D K +
Sbjct: 214 SIFNCV--YTFESDVWSYGILLWEIF-----------SLGSNP----YPGMPVDSKFYKL 256
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
KE + + + ++ + C +P RP+ ++V+++
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
+++G+G YG+VYK + G LVA+KV LE +F E++ + H NI+
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPNIVAY 65
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNG 466
G ++ EY GSL D+ + LS L+IA + YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----LQIAYVCRETLKGLAYLH-- 118
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPE 522
E +H DIK N+LL D K++DFG++ ++ +S + GT ++APE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPE 171
Query: 523 IFMRNLGNP-SGKSDVYSYGMLLLEMIE 549
+ GK D+++ G+ +E+ E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EKLG G Y VYKG+ G +VA+K L+ I E++ + + H NI+ L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ L++EYM + L + +L P + + I + H E R+
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
LH D+KPQN+L++ K++DFGLA+A V T + T+ Y AP++ LG+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFG--IPVNTFSNEVVTLWYRAPDVL---LGSR 176
Query: 532 --SGKSDVYSYGMLLLEMI 548
S D++S G ++ EMI
Sbjct: 177 TYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG VYKG+ G++VA+K + S I E++ + + H NI+ L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
S LI+E++ + L L + + + + I + H R
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+LH D+KPQN+L+D K++DFGLA+A V T T+ Y APE+ LG+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFG--IPVRVYTHEVVTLWYRAPEVL---LGS 176
Query: 531 P--SGKSDVYSYGMLLLEMIEEK 551
P S D++S G + EM +K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 65/201 (32%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLLG 411
LG GG+G V K R A+K ++K +E + +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 412 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
D + IY EY G L +L R++ AR IA V A EYLHN
Sbjct: 61 TFKD---KKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFY-IA-CVVLAFEYLHN--- 111
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I++ D+KP+N+LLD + K+ DFG AK + T GT Y+APEI L
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEII---L 165
Query: 529 GNPSGKS-DVYSYGMLLLEMI 548
S D +S G+LL E++
Sbjct: 166 NKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVK-VLEKTSNFSDNFIN--EVATIGRIHHVNIIHLL 410
K+G G YG VYK + G +VA+K + + + E+ + ++H NII LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
L++E+M + L L+ L + + + + + H+
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
ILH D+KP+N+L++ + K++DFGLA+ S R T T Y APE+ + + G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGDKG 175
Query: 530 NPSGKSDVYSYGMLLLEMI 548
+ D++S G + E++
Sbjct: 176 YSTP-VDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 49/288 (17%)
Query: 357 LGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 408
LG G +G V K VAVK+L++ ++ S+ + ++E + +++H ++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 409 LLGFCCDGSTRALIYEYMPNGSL---------------GDLLSREKENL------SLKPA 447
L G C LI EY GSL G +R L +L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 448 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507
L+ A ++ ++YL E++++H D+ +NVL+ K+SDFGL++ S V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 567
+ R + ++A E ++ + +SDV+S+G+LL E++ T G N
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV-----------TLGGNPYP 231
Query: 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
P+ +++ L K + E + + +M + L C + P RP+
Sbjct: 232 GIAPERLFNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 41/212 (19%)
Query: 357 LGTGGYGNVYKGKFPDG----RLVAVKVLEKTS---NFSD--------NFINEVATIGRI 401
LG GGYG V++ + G ++ A+KVL+K + N D N + V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV------ 57
Query: 402 HHVNIIHLL-GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR---LLEIALGVA 457
H I+ L+ F G LI EY+ G L + E+E + ++ L EI+L
Sbjct: 58 KHPFIVDLIYAFQTGGKLY-LILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISL--- 111
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
A+E+LH + I++ D+KP+N+LLD K++DFGL K + VT T GTI
Sbjct: 112 -ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFC-GTIE 165
Query: 518 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
Y+APEI MR+ G+ GK+ D +S G L+ +M+
Sbjct: 166 YMAPEILMRS-GH--GKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 32/274 (11%)
Query: 356 KLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHL 409
+LG+G +G V KG + + VAVK+L+ +N D + E + ++ + I+ +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G C + + L+ E G L L + K + + E+ V+ ++YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLE---ET 114
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNL 528
+H D+ +NVLL K+SDFGL+KA + + T + + + APE N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM--NY 172
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
S KSDV+S+G+L+ E +P + G+ T+ E + +E
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYG--QKPYKGMKGNEVTQMI------------ESGERME 218
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
C +M + C +RP VVE+
Sbjct: 219 CPQRC-PPEMYDLMKLCWTYGVDERPGFA-VVEL 250
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD----NFINEVATIGRI---HHVNIIH 408
+G G YG VYK + GR VA+K + + + + + E+A + ++ H NI+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 409 LLGFC--CDGSTR---ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
LL C L++E++ + L LS+ + L P + ++ + +++L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFL 123
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS----VVTMTGPRGTIGYI 519
H+ RI+H D+KPQN+L+ D K++DFGLA+ +S + VVT+ Y
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW-------YR 173
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEM 547
APE+ +++ D++S G + E+
Sbjct: 174 APEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 412
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 413 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
+ L+ E+ GS+ DL+ K N +LK + I + + +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLH-- 128
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+ +++H DIK QNVLL + K+ DFG++ +R+V GT ++APE+
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 527 NLGNPSG----KSDVYSYGMLLLEMIE 549
+ NP KSD++S G+ +EM E
Sbjct: 186 D-ENPDATYDFKSDLWSLGITAIEMAE 211
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 356 KLGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLG-F 412
+LG G +G VYK K + G L A KV+E K+ ++++ E+ + +H I+ LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
DG +I E+ P G++ D + E + L ++ I + A++YLH+ ++I+
Sbjct: 79 YWDGKLWIMI-EFCPGGAV-DAIMLELDR-GLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
H D+K NVLL D K++DFG++ K R S + GT ++APE+ M
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCET 186
Query: 529 GNPSG---KSDVYSYGMLLLEM--IEEKKH-LRP 556
+ K+D++S G+ L+EM IE H L P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 31/213 (14%)
Query: 357 LGTGGYGNVYKGKFPDGRL---VAVKVLEKTSNFSD--NFINEVATIGRI-HHVNIIHLL 410
+G G +G V K + L A+K +++ ++ D +F E+ + ++ HH NII+LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------------RLLEIALGV 456
G C L EY P+G+L D L R+ L PA +LL A V
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGT 515
A ++YL + + +H D+ +N+L+ ++ K++DFGL SR + V V T R
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLP 174
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ ++A E N + SDV+SYG+LL E++
Sbjct: 175 VRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 44/226 (19%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
+G G +G V+ + D G++ A+KVL K+ N + E + I+ L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCEL 469
D L+ EYMP G L +LL R K+ + AR E+ L A++ +H L
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVL----ALDSVHK---L 120
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSR--------NRSVVTMTGPR---- 513
+H DIKP N+L+D D K++DFGL K A R N R
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 514 -----------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
GT YIAPE+ + D +S G++L EM+
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 412
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 413 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
S L+ E+ GS+ DL+ K N +LK + I + + +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAH 140
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+++H DIK QNVLL + K+ DFG++ +R+V GT ++APE+
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 527 NLGNPSG----KSDVYSYGMLLLEMIE 549
+ NP +SD++S G+ +EM E
Sbjct: 196 D-ENPDATYDYRSDIWSLGITAIEMAE 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 67/298 (22%)
Query: 354 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 411
E +G G YG VYK + G+LVA+K+++ + + E + + +H NI G
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 412 F------CCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLH 464
+ L+ E GS+ DL+ K+ LK + I + YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA-----KAHSRNRSVVTMTGPRGTIGYI 519
+++H DIK QN+LL + K+ DFG++ RN + GT ++
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-------GTPYWM 180
Query: 520 APEIFMRNLGNPS----GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF----- 570
APE+ + P +SDV+S G+ +E+ + K L + A F
Sbjct: 181 APEVIACDE-QPDASYDARSDVWSLGITAIELADGKPPL------CDMHPMRALFKIPRN 233
Query: 571 --PDWIYDKLIQPEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
P L PE DF+ C+ N + RP M ++E
Sbjct: 234 PPP-----TLKSPENWSKKFNDFIS---------------ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 28/199 (14%)
Query: 360 GGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV-----NIIHLLGFC 413
G +G+VY K G A+KVL+K+ + N + V I + + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLH-NGCELR 470
L+ EY+ G L+ + L A+ + E+ LGV E LH G
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGV----EDLHQRG---- 117
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I+H DIKP+N+L+D K++DFGL++ N+ V GT Y+APE + G
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETIL---GV 168
Query: 531 PSGK-SDVYSYGMLLLEMI 548
K SD +S G ++ E +
Sbjct: 169 GDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 353 FKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 405
F E+LG +G +YKG +LVA+K L+ +N F E + + +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL------------SREKENL--SLKPARLLE 451
I+ LLG +++EY+ G L + L S E + SL L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511
IA+ +A +EYL + +H D+ +N+L+ K+SD GL++
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
I ++ PE M G S SD++S+G++L E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 357 LGTGGYGNVYKGKF--PDGRL-VAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
LG G +G+V +G+ D L VAVK ++ T + ++F++E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 411 GFCCDGSTR------ALIYEYMPNGSLGDLL--SREKENLSLKPARLL-EIALGVAHAIE 461
G C +I +M +G L L SR + P ++L + +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTI 516
YL + +H D+ +N +L+ + V+DFGL+K + R + M I
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
+A ++ + KSDV+S+G+ + E+ + P G +E IYD
Sbjct: 184 ESLADRVY-------TTKSDVWSFGVTMWEIATRGQTPYP-----GVENSE------IYD 225
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLW-----CIQINPKDRPSMTRVVEMLSSAS 627
L Q + +++ DC+ GL+ C +NPKDRPS + L A
Sbjct: 226 YLRQGNR---LKQPPDCLD------GLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 333 YRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDN 390
+R+AL D + + F K+G G G V GR VAVK ++ + +
Sbjct: 4 FRAALQLVVDPGDPRSYLDNFV-KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL 62
Query: 391 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL 450
NEV + H NI+ + G ++ E++ G+L D+++ + + ++
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIA 118
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSV 506
+ L V A+ +LH ++H DIK ++LL D K+SDFG ++K R +S+
Sbjct: 119 TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIE 549
V GT ++APE+ R P G + D++S G++++EM++
Sbjct: 176 V------GTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVD 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 35/208 (16%)
Query: 357 LGTGGYGNVY---KGKFPD-GRLVAVKVLEK-TSNFSDNF--INEVATIGRIHHVNIIHL 409
LG G +G V+ K PD G+L A+KVL+K T D E + ++H I+ L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 410 -LGFCCDGSTRALIYEYMPNGSLGDLLSRE----KENLSLKPARLLEIALGVAHAIEYLH 464
F +G LI +++ G L LS+E +E++ A E+AL + H LH
Sbjct: 64 HYAFQTEGKLY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDH----LH 115
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSRNRSVVTMTGPRGTIGYIA 520
+ L I++ D+KP+N+LLD + K++DFGL+K + S GT+ Y+A
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
PE+ R + +D +S+G+L+ EM+
Sbjct: 167 PEVVNRR--GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDNFINE 394
L S S D KK F EK+G G G VY G+ VA+K + + + INE
Sbjct: 8 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 395 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 454
+ + + NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 122
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPR 513
A+++LH+ +++H DIK N+LL D + K++DFG A+ TM
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 176
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549
GT ++APE+ R P K D++S G++ +EM+E
Sbjct: 177 GTPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDNFINE 394
L S S D KK F EK+G G G VY G+ VA++ + + + INE
Sbjct: 9 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 395 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 454
+ + + NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMT 510
A+E+LH+ +++H DIK N+LL D + K++DFG + S+ ++V
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 177
Query: 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549
GT ++APE+ R P K D++S G++ +EMIE
Sbjct: 178 ---GTPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMIE 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 49/240 (20%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVL--EKTSNFSDNFI 392
Y N+I+ + +G G +G V++ + P +VAVK+L E +++ +F
Sbjct: 2 YPRNNIE-----YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 56
Query: 393 NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPAR 448
E A + H NI+ LLG C G L++EYM G L + L R + +LS +
Sbjct: 57 REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 449 ---------------LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493
L IA VA + YL E + +H D+ +N L+ + K++D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 494 FGLAKAHSRNRSVVTMTGPRGT------IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
FGL+ R++ + + + I ++ PE N + +SDV++YG++L E+
Sbjct: 174 FGLS------RNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNF--INEVATIGRIHHVNIIHLLG 411
EKLG G Y VYKGK +G+LVA+KV+ F I E + + + H NI+ L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T L++EY+ DL +K L P + + + Y+H +
Sbjct: 71 IIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRY 123
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIGYIAPEIFM 525
ILH D+KPQN+L+ K++DFGLA+A H+ + VVT+ Y P++
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW-------YRPPDVL- 175
Query: 526 RNLGNPSGKS--DVYSYGMLLLEMIE 549
LG+ + D++ G + +EMI+
Sbjct: 176 --LGSTEYSTCLDMWGVGCIFVEMIQ 199
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 356 KLGTGGYGNVY-KGKFPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
++G G +G VY +VAVK + ++T+ + I EV + ++ H N I
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGC 467
G T L+ EY GS DLL K KP + +EIA G + YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM-R 526
++H DIK N+LL K++DFG A S S V GT ++APE+ +
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAM 192
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHL 554
+ G GK DV+S G+ +E+ E K L
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 354 KEKLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN----II 407
K +G G +G V + K G + A+KV++K+ + ++ I ++ I
Sbjct: 6 KSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHN 465
L D L+ EY P G L LL+R ++ A+ L E+ L AI +H
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL----AIHSVH- 119
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
++ +H DIKP+NVL+D K++DFG A + N+ V + P GT YIAPE+
Sbjct: 120 --QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLT 176
Query: 526 RNLGNPSGKSDV----YSYGMLLLEMI 548
G+ G V +S G++ EMI
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 58/295 (19%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNF--INEVATIGRIHHVNIIHLLG 411
EKLG G Y VYKG +G+LVA+KV+ + F I E + + + H NI+ L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
T ++EYM + L + + L RL L + Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIHGQ---HI 124
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
LH D+KPQN+L+ K++DFGLA+A S T + T+ Y P++ + +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLL-GATDY 181
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLR------------------PTETT-SGSNTTEAYFPD 572
S D++ G + +EM++ + PTE T G + Y P+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241
Query: 573 W-----------IYDKLIQ-PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
W ++ +L + P+ ED +A +M + + PKDR S
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAED--------LASQM-------LMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 342 SYNDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLE-KTSNFSDNFINEVATIG 399
S D KK + EK+G G G V+ G+ VA+K + + + INE+ +
Sbjct: 13 SIGDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
+ + NI++ L G ++ EY+ GSL D+++ + A++ + A
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQA 127
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRGTIGY 518
+E+LH +++H DIK NVLL D + K++DFG A+ TM GT +
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYW 181
Query: 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549
+APE+ R P K D++S G++ +EM+E
Sbjct: 182 MAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 346 IKKMTNGFKEKLGTGGYGNVYKGK----FP--DGRLVAVKVL-EKTSNFSDNFINEVATI 398
IK+ K +LG G +G V+ + P D LVAVK L E + + +F E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 399 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS---------REKENLSLKP--- 446
+ H +I+ G C +G +++EYM +G L L E+++
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 447 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRS 505
++L IA +A + YL L +H D+ +N L+ K+ DFG+++ +S +
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 506 VV---TMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEM 547
V TM I ++ PE I R + +SD++S+G++L E+
Sbjct: 179 RVGGRTML----PIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 73/222 (32%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 344 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGR---LVAVKVLEKTSNFSD----NFINEVA 396
D +K+ +E +G G +G VY + D R +VA+K + + S+ + I EV
Sbjct: 21 EDPEKLFTDLRE-IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL-- 454
+ RI H N I G T L+ EY GS DLL K KP + +EIA
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAIT 131
Query: 455 -GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
G + YLH+ ++H DIK N+LL K++DFG A S S V
Sbjct: 132 HGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------ 182
Query: 514 GTIGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554
GT ++APE+ + + G GK DV+S G+ +E+ E K L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 356 KLGTGGYGNVYKGKFPDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
+LG+G +G V KG + + VA+KVL E + D + E + ++ + I+ ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G C + L+ E G L LS +K+ +++ + ++E+ V+ ++YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLE---GKN 115
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRNLG 529
+H D+ +NVLL K+SDFGL+KA + S + + + + APE N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFR 173
Query: 530 NPSGKSDVYSYGMLLLE 546
S +SDV+SYG+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 354 KEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 409
K+G G +G V+K + D R+ A+K ++ + + I+E + ++ II
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLL-----SREKENLSLKPARLLEIALGVAHAIEYLH 464
D ++ EY NG L LL E+ + ++I LG+AH LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR--FFIQILLGLAH----LH 118
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEI 523
+ +ILH DIK N+ LD K+ D G+AK S N + T+ GT Y++PE+
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPEL 172
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEM 547
N KSDV++ G++L E
Sbjct: 173 CEDKPYNE--KSDVWALGVVLYEC 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHL 409
++G GGYG V+ K D G +VA+K ++K+ F N + V T I ++ L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
L D L EY+P G LL+ LS AR + A ++ LH EL
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEA--VDALH---EL 120
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
+H D+KP+N L+D K++DFGL+K + SVV G+ Y+APE+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL--RG 172
Query: 529 GNPSGKSDVYSYGMLLLEMI 548
D +S G +L E +
Sbjct: 173 KGYDFTVDYWSLGCMLYEFL 192
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V + GRL AVKVL+K D+ + T RI +H + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL- 61
Query: 411 GFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
+CC + L + E++ NG GDL+ +++ AR A + A+ +LH +
Sbjct: 62 -YCCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---D 114
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I++ D+K NVLLD + K++DFG+ K N T + GT YIAPEI L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172
Query: 529 GNPSGKSDVYSYGMLLLEMI 548
PS D ++ G+LL EM+
Sbjct: 173 YGPS--VDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 355 EKLGTGGYGNVYKGKF---PDGRL--------VAVKVLEKTSNFSDNFINEVATIGRIHH 403
E LG G + N+YKG D + V +KVL S F + + ++ H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 404 VNIIHLLGFC-CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
+++ L G C D + ++ EY+ G L L REK N+SL L++A +A A+ Y
Sbjct: 61 KHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSL--HWKLDVAKQLASALHY 116
Query: 463 LHNGCELRILHLDIKPQNVLL---DPDFTP----KVSDFGLAKAHSRNRSVVTMTGPRGT 515
L + +++H ++ +N+L+ + K+SD G+ +V++
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP------ITVLSREERVER 167
Query: 516 IGYIAPEIFMRNLG-NPSGKSDVYSYGMLLLEM 547
I +IAPE +RN + + +D +S+G LLE+
Sbjct: 168 IPWIAPE-CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKV-LEKTSNFSDNFI--NEVATIGRIHHVNIIHLL 410
+G G YG V K K + G++VA+K LE + I E+ + ++ H N+++L+
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
L++E++ + L DL EK L +R+ + + IE+ H+
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-------GTIGYIAPEI 523
I+H DIKP+N+L+ K+ DFG A+ T+ P T Y APE+
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR---------TLAAPGEVYTDYVATRWYRAPEL 171
Query: 524 FMRNLGNPS-GKS-DVYSYGMLLLEMI 548
+G+ G++ D+++ G L+ EM+
Sbjct: 172 L---VGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 357 LGTGGYGNVY--KGKFPDGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+G G +G V+ + K D +LV +K V + T + NE + + H NII
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ ++ EY P G+L + + + +L L +L + + A+ ++H I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK---LI 122
Query: 472 LHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
LH D+K QN+LLD K+ DFG++K S T+ GT YI+PE+ G
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCE---GK 176
Query: 531 P-SGKSDVYSYGMLLLEMIEEKK 552
P + KSD+++ G +L E+ K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 357 LGTGGYGNVY----KGKFPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 407
LGTG YG V+ G G+L A+KVL+K + +++ E + + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 408 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 464
L + T+ LI +Y+ G L L ++E+ + R+ EI L A+++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVL----ALDHLH 122
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-----GTIGYI 519
+L I++ DIK +N+LLD + ++DFGL+K + R GTI Y+
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK------EFLAEEEERAYSFCGTIEYM 173
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
APE+ G D +S G+L E++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 89/319 (27%), Positives = 147/319 (46%), Gaps = 58/319 (18%)
Query: 357 LGTGGYGNVYKGK-------FPDGRL-VAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 405
LG G +G V + + PD + VAVK+L+ + D + I+E+ + I H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 450
II+LLG C +I EY G+L + L + E LS K L+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD--LV 137
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 509
A VA +EYL + R +H D+ +NVL+ D K++DFGLA+ H + T
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 510 TGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568
G R + ++APE +F R + +SDV+S+G+L+ E+ T GS
Sbjct: 195 NG-RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEIF----------TLGGSP---- 236
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE----MLS 624
+P ++L + +E ++ ++ ++ C P RP+ ++VE +L+
Sbjct: 237 -YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 625 SASAEAIE--MPPKPLFPS 641
+ S E ++ MP + PS
Sbjct: 296 AVSEEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 344 NDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATI 398
+D +K+ + +E +G G +G VY + + +VA+K + + S+ + I EV +
Sbjct: 11 DDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 399 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---G 455
++ H N I G T L+ EY GS DLL K KP + +EIA G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHG 123
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
+ YLH+ ++H D+K N+LL K+ DFG A + V GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GT 174
Query: 516 IGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554
++APE+ + + G GK DV+S G+ +E+ E K L
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 57/294 (19%)
Query: 356 KLGTGGYGNVYKGKF-------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRI--HHV 404
+LG G +G VY+G + R VAVK + ++++ + F+NE + + HHV
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPA----RLLEIALGVA 457
+ LLG G ++ E M +G L L E EN +P ++++A +A
Sbjct: 72 --VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--T 515
+ YL+ + +H D+ +N ++ DFT K+ DFG+ + + G +G
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 184
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575
+ ++APE + S SD++S+G++L E+ T+ A P Y
Sbjct: 185 VRWMAPESLKDGVFTTS--SDMWSFGVVLWEI-----------------TSLAEQP---Y 222
Query: 576 DKLIQPEKEDFV------EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
L + FV ++ D+C R ++ + C Q NPK RP+ +V +L
Sbjct: 223 QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 331 KTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNV-YKGKFPDGRLVAVKVLE-KTSNFS 388
+ +R+AL S D ++ + F K+G G G V + G+ VAVK ++ +
Sbjct: 5 EQFRAALQLVVSPGDPREYLDSFI-KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR 63
Query: 389 DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 448
+ NEV + HH N++ + G ++ E++ G+L D+++ + N +
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN----EEQ 119
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNR 504
+ + L V A+ YLHN ++H DIK ++LL D K+SDFG ++K + +
Sbjct: 120 IATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176
Query: 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIE 549
S+V GT ++APE+ R P G D++S G++++EMI+
Sbjct: 177 SLV------GTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMID 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV---NIIH 408
E +G G YG VY+GK P GR+VA+K++ + D + EVA + ++ NI
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA-----HAIEYL 463
G G +I EY GS+ L+ K + E + V A++Y+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISVIIREVLVALKYI 117
Query: 464 H-NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGTIGYIAP 521
H G ++H DIK N+L+ K+ DFG+A ++N S T GT ++AP
Sbjct: 118 HKVG----VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GTPYWMAP 170
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMI 548
E+ + K+D++S G+ + EM
Sbjct: 171 EVITEGKYYDT-KADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 357 LGTGGYGNV----YKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNII 407
LG G +G V KG L AVKVL+K D+ + T R+ H +
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 408 HLLGFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
L C + L + EY+ NG GDL+ + + R A + +++LH
Sbjct: 60 QL--HSCFQTKDRLFFVMEYV-NG--GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH- 113
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
E I++ D+K NVLLD + K++DFG+ K VT + GT YIAPEI
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEIL- 168
Query: 526 RNLGNPSGKS-DVYSYGMLLLEMI 548
P G + D ++ G+LL EM+
Sbjct: 169 --SYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 355 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHL 409
+++G G +G V G+ G V VK L +++ + F+ E + H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLS--REKENLSLKPARLLEIALGVAHAIEYLHNGC 467
LG C + + L+ E+ P G L L R+ E ++ P L +A +A + +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+H D+ +N LL D T K+ D+GL+ + VT + +IAPE+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 528 LGN-----PSGKSDVYSYGMLLLEMIE 549
GN + +S+V+S G+ + E+ E
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFE 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 40/266 (15%)
Query: 376 VAVKVLEKTSNFSD--NFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432
VAVK+L+ + D + I+E+ + I H NII+LLG C +I EY G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 433 DLLSREK---------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 477
+ L + E LS K L+ A VA +EYL + + +H D+
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKD--LVSCAYQVARGMEYLASK---KCIHRDLA 167
Query: 478 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDV 537
+NVL+ D K++DFGLA+ T R + ++APE + + +SDV
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDV 225
Query: 538 YSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARK 597
+S+G+LL E+ T GS +P ++L + KE ++ +
Sbjct: 226 WSFGVLLWEIF----------TLGGSP-----YPGVPVEELFKLLKEGHRMDKPSNCTNE 270
Query: 598 MIIVGLWCIQINPKDRPSMTRVVEML 623
+ ++ C P RP+ ++VE L
Sbjct: 271 LYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFS--DNFINEVA 396
+I T F E+LG +G VYKG + VA+K L+ + + F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----------SREKENL---S 443
R+ H NI+ LLG ++I+ Y + L + L S + + +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L+PA + I +A +E+L + ++H D+ +NVL+ K+SD GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
M I +++PE M G S SD++SYG++L E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG VYK + +A+K + ++ I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 411 GFCCDGSTRALIYEYMPNGSLGDL-LSRE-------KENLSLKPARLLEIALGVAHAIEY 462
L++EY+ DL L + +N L L +I G+A Y
Sbjct: 68 DVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----Y 117
Query: 463 LHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
H+ R+LH D+KPQN+L+D K++DFGLA+A V T T T+ Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWYRAP 172
Query: 522 EIFM--RNLGNPSGKSDVYSYGMLLLEMIEEK 551
EI + R+ P D++S G + EM+ +K
Sbjct: 173 EILLGSRHYSTP---VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLL-GFC 413
LG G +G VYK + + G A K+++ ++ ++F+ E+ + H NI+ L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
+ LI E+ G+L ++ + L ++ + + A+ +LH+ +++H
Sbjct: 73 YENKLWILI-EFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 474 LDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRGTIGYIAPEIFM--RNLGN 530
D+K N+LL D K++DFG+ AK S + T GT ++APE+ N
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDN 183
Query: 531 P-SGKSDVYSYGMLLLEMIE 549
P K+D++S G+ L+E+ +
Sbjct: 184 PYDYKADIWSLGITLIELAQ 203
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 356 KLGTGGYGNVYKGKFP-DGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K+G G +G V+K + ++VA+K + + F + E+ + + H N+++L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 412 FCCDGST-----RALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
C +T + Y L LLS +N+ + + ++ + + + Y+H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS--NKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS------RNRSVVTMTGPRGTIGY 518
+ILH D+K N+L+ D K++DFGLA+A S NR T T+ Y
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR----YTNRVVTLWY 189
Query: 519 IAPEIFM--RNLGNPSGKSDVYSYGMLLLEM 547
PE+ + R+ G P D++ G ++ EM
Sbjct: 190 RPPELLLGERDYGPP---IDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 373 GRLVAVKVL-----EKTSNFSDNFINEVATIGRIHHVNIIHLL--GFCCDGSTRALIYEY 425
G VA+K+L E+ + F E A R++H NI+ LL G G A ++EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRA-RFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60
Query: 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD- 484
+P +L ++L+ + +L + L V A+ HN I+H D+KPQN+++
Sbjct: 61 VPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 485 PDFTP--KVSDFG----LAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMRNLGNPSGKSDV 537
P KV DFG L + + +T T GT Y APE +R + SD+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ-LRG-EPVTPNSDL 172
Query: 538 YSYGMLLLE 546
Y++G++ LE
Sbjct: 173 YAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 50/292 (17%)
Query: 357 LGTGGYGNVY--------KGKFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 405
LG G +G V K K VAVK+L+ + D + ++E+ + I H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 450
II+LLG C ++ EY G+L + L + E L+ K L+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD--LV 137
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 509
A VA +EYL + + +H D+ +NVL+ D K++DFGLA+ H+ + T
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 569
G R + ++APE + + +SDV+S+G+LL E+ T GS
Sbjct: 195 NG-RLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIF----------TLGGSP----- 236
Query: 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+P ++L + KE ++ ++ ++ C P RP+ ++VE
Sbjct: 237 YPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 85/314 (27%), Positives = 138/314 (43%), Gaps = 85/314 (27%)
Query: 354 KEKLGTGGYGNVYKGKFPD---GRLVAVK-VLEKTSNFSDN--------FINEVATIGRI 401
+KLG G YG V+K D +VA+K + + N +D F+ E+
Sbjct: 12 LQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----- 64
Query: 402 HHVNIIHLLGFCCDGSTRA-------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 454
H NI+ LL +A L++EYM DL + + N+ L+ I
Sbjct: 65 DHPNIVKLLNV-----IKAENDKDIYLVFEYMET----DLHAVIRANI-LEDVHKRYIMY 114
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514
+ A++Y+H+G ++H D+KP N+LL+ D K++DFGLA RS+ +
Sbjct: 115 QLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA------RSLSELEENPE 165
Query: 515 ---------TIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMIEEKKHLRPTETTSGS 563
T Y APEI LG+ K D++S G +L EM+ K L P G+
Sbjct: 166 NPVLTDYVATRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGKP-LFP-----GT 216
Query: 564 NTTEAYFPDWIYDKLIQ----PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 619
+T + + +K+I+ P ED +E A M+ + + R +
Sbjct: 217 STL-----NQL-EKIIEVIGPPSAED-IESIKSPFAATML------DSLPSRPRKPLD-- 261
Query: 620 VEMLSSASAEAIEM 633
E+L AS +A+++
Sbjct: 262 -ELLPKASDDALDL 274
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 356 KLGTGGYGNVYKGK---FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 408
+G G YG VYK K DG+ A+K + + + S + E+A + + H N++
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 409 LLGFCCDGSTRA--LIYEYMPNGSLGDLLS-----REKENLSLKPARLLEIALGVAHAIE 461
L+ + + ++ L+++Y + DL R+ + +S+ P+ + + + + +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 462 YLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTI 516
YLH +LH D+KP N+L+ K+ D GLA ++ + + + TI
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 517 GYIAPEIFM 525
Y APE+ +
Sbjct: 180 WYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 356 KLGTGGYGNVYKG-------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 406
+LG G +G VY+G P+ R VA+K + + ++ + F+NE + + + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKP---ARLLEIALGVAHA 459
+ LLG G +I E M G L L + N P +++++A +A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIG 517
+ YL+ + +H D+ +N ++ DFT K+ DFG+ + + G +G +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
+++PE G + SDV+S+G++L E+ + +P + S + DK
Sbjct: 187 WMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVMEGGLLDK 242
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620
D+C ++ + C Q NPK RPS ++
Sbjct: 243 ------------PDNCPDMLFELMRM-CWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 353 FKEKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
++E LG G G VYK R++AVKV L+ T ++E+ + + II
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G + ++ E+M GSL D+ + E++ L IA+ V + YL + L
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVYRKIPEHV------LGRIAVAVVKGLTYLWS---L 114
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+ILH D+KP N+L++ K+ DFG++ +S ++ V GT Y+APE R
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------GTNAYMAPE---RI 165
Query: 528 LGNPSG-KSDVYSYGMLLLEM 547
G G SDV+S G+ +E+
Sbjct: 166 SGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 356 KLGTGGYGNVYKGKF-PDGRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
K+G G G V G+LVAVK ++ + + NEV + H N++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
G ++ E++ G+L D+++ + N ++ + L V A+ LH ++H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMN----EEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 474 LDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
DIK ++LL D K+SDFG ++K R +S+V GT ++APE+ R
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISRLPY 193
Query: 530 NPSGKSDVYSYGMLLLEMIE 549
P + D++S G++++EM++
Sbjct: 194 GP--EVDIWSLGIMVIEMVD 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 356 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN---FSDNFINEVATIGRIH---HVNIIH 408
++G G YG VYK + P G VA+K + +N + + EVA + R+ H NI+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 409 LLGFCCDGSTR-----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
L+ C T L++E++ L L + + ++ +++L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
H C I+H D+KP+N+L+ K++DFGLA+ +S + +T T+ Y APE+
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEV 178
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
+++ + D++S G + EM K
Sbjct: 179 LLQS--TYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 344 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL--VAVKVLEKTSNFS----DNFINEVAT 397
N +K F LGTG +G V + + VA+K EK+ D+ +E
Sbjct: 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS----LKPARLLEIA 453
+ I+H ++L G D S L+ E++ G L R K + A+++ I
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI- 143
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGP 512
EYL + L I++ D+KP+N+LLD D K++DFG AK +R ++
Sbjct: 144 ------FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----- 189
Query: 513 RGTIGYIAPEIFMRNLGNPSGK-SDVYSYGMLLLEMI 548
GT YIAPEI + N+G+ GK +D ++ G+ + E++
Sbjct: 190 -GTPEYIAPEILL-NVGH--GKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 346 IKKMTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS-NFSDNFINEVATI 398
IK+ K +LG G +G V+ + D LVAVK L+ S N +F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 399 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD----------LLSREKENLSLKPAR 448
+ H +I+ G C +G +++EYM +G L L++ L ++
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVV 507
+L IA +A + YL +H D+ +N L+ + K+ DFG+++ +S + V
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 508 ---TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 553
TM I ++ PE M + +SDV+S G++L E+ K
Sbjct: 179 GGHTML----PIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 356 KLGTGGYGNVYKGKFP-DGRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
K+G G G V + GR VAVK+++ + + NEV + H N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
G ++ E++ G+L D++S+ + L ++ + V A+ YLH+ ++H
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 474 LDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
DIK ++LL D K+SDFG ++K + +S+V GT ++APE+ R
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP- 193
Query: 530 NPSGKSDVYSYGMLLLEMIE 549
+ D++S G++++EM++
Sbjct: 194 -YGTEVDIWSLGIMVIEMVD 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 41/243 (16%)
Query: 346 IKKMTNGFKEKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFS--DNFINEVAT 397
IK+ K +LG G +G V+ + D LVAVK L K + +F E
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAEL 60
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE-------------KENLSL 444
+ + H +I+ G C DG +++EYM +G L L + L
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 445 KPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRN 503
+++L IA +A + YL +H D+ +N L+ + K+ DFG+++ +S +
Sbjct: 121 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 504 RSVV---TMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKK----HLR 555
V TM I ++ PE I R + +SDV+S+G++L E+ K L
Sbjct: 178 YYRVGGHTML----PIRWMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLS 230
Query: 556 PTE 558
TE
Sbjct: 231 NTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 356 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVNIIH 408
+G GG G VY P R VA+K + + + S+N F+ E + H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIRE--DLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 409 LLGFCCDGSTRALIYEYMP---NGSLGDLLS--REKENLSLKP-------ARLLEIALGV 456
+ C DG +Y MP +L LL +KE+LS K L I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIFHKI 122
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA-------------KAHSRN 503
IEY+H+ +LH D+KP N+LL + D+G A RN
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 504 RSVVTMTGPR---GTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMI 548
+MT P GT Y+APE R LG P S +D+Y+ G++L +M+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 36/283 (12%)
Query: 357 LGTGGYGNVYKG--KFPDGRL--VAVKVLEKTSNFS---DNFINEVATIGRIHHVNIIHL 409
LG G +G+V + K DG VAVK+L+ S + F+ E A + H N+I L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 410 LGFCCDGSTRA------LIYEYMPNGSLGD--LLSREKEN-LSLKPARLLEIALGVAHAI 460
+G + +I +M +G L L+SR E +L L+ + +A +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
EYL + +H D+ +N +L+ + T V+DFGL+K + + ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580
E N+ + SDV+++G+ + E++ R +G +E IY+ LI+
Sbjct: 184 LESLADNV--YTTHSDVWAFGVTMWEIMT-----RGQTPYAGVENSE------IYNYLIK 230
Query: 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ +++ DC+ ++ C PK RPS + + L
Sbjct: 231 GNR---LKQPPDCLEDVYELM-CQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 355 EKLGTGGYGNVY----KGKFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNI 406
+ LG G G V+ KG G+L A+KVL+K N + V T + + H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPAR--LLEIALGVAHAIEYL 463
L + L+ +Y P G L LL R+ LS + AR E+ L A+EYL
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL----ALEYL 119
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----------AHSRNRS-------- 505
H L I++ D+KP+N+LL +SDF L+K R S
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 506 ----VVTMTGPR-----GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
R GT YIAPE+ + G+ S D ++ G+LL EM+
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSA-VDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
KLG G +G VYK + GR+VA+K + N D F + E+ + ++ H N++ L
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 410 LGFCCDGS-----TRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
+ + R +Y P + L LL E ++ L +++ L + I Y
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL--ENPSVKLTESQIKCYMLQLLEGINY 130
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI--- 519
LH E ILH DIK N+L+D K++DFGLA+ + G GT Y
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 520 ------APEIFM--RNLGNPSGKSDVYSYGMLLLEMIEEK 551
PE+ + R D++ G + EM +
Sbjct: 188 VTRWYRPPELLLGERRYTTA---VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 357 LGTGGYGNVYKGKFPDGR-LVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHLLG 411
+GTG +G V+ + A+KV+ + NE + + H II L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
D ++ EY+P G L L R S A + A+EYLH+ I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFY--ASEIVCALEYLHS---KEI 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
++ D+KP+N+LLD + K++DFG AK R+R+ T+ GT Y+APE+ N
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRT-WTLC---GTPEYLAPEVIQSKGHNK 177
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579
+ D ++ G+L+ EM+ N P IY+K++
Sbjct: 178 A--VDWWALGILIYEMLVGYPPFF------DDN------PFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 348 KMTNGFKEKLGTGGYGNVY--------KGKFPDGRLVAVKVLEKTSNFSD--NFINEVAT 397
K+T G + LG G +G V K K + VAVK+L+ + D + ++E+
Sbjct: 16 KLTLG--KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 398 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------EN 441
+ I H NII+LLG C +I EY G+L + L + E
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 442 LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501
++ K L+ VA +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 134 MTFKD--LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 561
T R + ++APE + + +SDV+S+G+L+ E+ T
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIF----------TLG 236
Query: 562 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
GS +P ++L + KE ++ ++ ++ C P RP+ ++VE
Sbjct: 237 GSP-----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 622 ML 623
L
Sbjct: 292 DL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+KLG G Y VYKG+ G+LVA+K LE I E + + + H NI+ L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL--GVAHAIEYLHNGCEL 469
T L++EY+ + L + LS+ RL L G+A Y H +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCH---QR 122
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMRN 527
R+LH D+KPQN+L+ K++DFGLA+A +SV + T T+ Y P++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVL--- 175
Query: 528 LG--NPSGKSDVYSYGMLLLEMI 548
LG S D++ G + EM
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/247 (25%), Positives = 118/247 (47%), Gaps = 31/247 (12%)
Query: 356 KLGTGGYGNVYKGK--FPDGRLVA---VKVLEKTSNFSDNFINEVATIGRIH---HVNII 407
++G G YG V+K + GR VA V+V + I EVA + + H N++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 408 HLLGFCC----DGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
L C D T+ L++E++ + L L + E + + ++ + +++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 125
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
LH+ R++H D+KPQN+L+ K++DFGLA+ +S ++ ++ T+ Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPE 179
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ +++ + + D++S G + EM K R GS+ + I D + P
Sbjct: 180 VLLQS--SYATPVDLWSVGCIFAEMFRRKPLFR------GSSDVDQLGK--ILDVIGLPG 229
Query: 583 KEDFVEE 589
+ED+ +
Sbjct: 230 EEDWPRD 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|222721 pfam14380, WAK_assoc, Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-12
Identities = 30/76 (39%), Positives = 37/76 (48%), Gaps = 11/76 (14%)
Query: 200 PSGCD-SVVVPVSSVTSLYLGADVFDT------LRQGFPLEWPKLD-DCEKCQNRSGRCG 251
GC SVVVPV LGAD+ LR+GF LEW DC +C+ GRCG
Sbjct: 22 SGGCSRSVVVPVLGSA---LGADLGSGDGYEEVLREGFELEWNVDPGDCSECEASGGRCG 78
Query: 252 YNGSLKKITCFCKGGR 267
Y+ + + C C G
Sbjct: 79 YDQTSEFFGCLCPDGP 94
|
This WAK_assoc domain is cysteine-rich and lies C-terminal to the binding domain, GUB_WAK_bind, pfam13947. Length = 94 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 355 EKLGTGGYGNVYKG--KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLL 410
+KLG G Y VYKG K D LVA+K LE I EV+ + + H NI+ L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
+ L++EY+ + L L ++++ +L L + Y H +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCH---RRK 124
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+LH D+KPQN+L++ K++DFGLA+A S T + T+ Y P+I + + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYSNEVVTLWYRPPDILLGST-D 181
Query: 531 PSGKSDVYSYGMLLLEM-----------IEEKKHL------RPTETTSGSNTTEAYFPDW 573
S + D++ G + EM +EE+ H PTE T + F +
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241
Query: 574 IYDK 577
Y K
Sbjct: 242 NYPK 245
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 408
++K+G G + VY+ DG VA+K ++ + + I E+ + +++H N+I
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGC 467
+ + ++ E G L ++ K+ L P + + + + + A+E++H+
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-- 124
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
R++H DIKP NV + K+ D GL + S + GT Y++PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHEN 181
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQPEKED 585
N KSD++S G LL EM + ++ D +Y + E+ D
Sbjct: 182 GYN--FKSDIWSLGCLLYEM---------------AALQSPFYGDKMNLYSLCKKIEQCD 224
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
+ D + ++ + CI +P+ RP +T V ++
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 34/205 (16%)
Query: 356 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLL 410
++G+G G VYK P GRL A+KV+ N D E+ + ++H N++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 411 GFCCDGSTRALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
++ E+M GSL G ++ E+ L ++A + I YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQF--------LADVARQILSGIAYLH---RR 187
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR-----NRSVVTMTGPRGTIGYIAPEIF 524
I+H DIKP N+L++ K++DFG+++ ++ N SV GTI Y++PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-------GTIAYMSPERI 240
Query: 525 MRNL--GNPSGKS-DVYSYGMLLLE 546
+L G G + D++S G+ +LE
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
+G G +G V K DG+ AVKVL+K + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 414 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T +Y +Y+ G L L RE+ S R A +A A+ YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLN 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
I++ D+KP+N+LLD ++DFGL K HS+ S GT Y+APE+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-----GTPEYLAPEVLRK- 170
Query: 528 LGNPSGKS-DVYSYGMLLLEMI 548
P ++ D + G +L EM+
Sbjct: 171 --QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
++LG G YG+VYK P G +A+K LE + + I E+ + + I+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 410 LG-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
G F +G+ + EYM GSL L + + L I V +++L E
Sbjct: 65 YGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+H D+KP NVL++ + K+ DFG+ S N G Y+APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERI--KS 175
Query: 529 GNPSG------KSDVYSYGMLLLEM 547
G P+ +SDV+S G+ +LEM
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 356 KLGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLL-GF 412
+LG G +G VYK + + G L A KV++ K+ ++++ E+ + H NI+ LL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+ + LI E+ G++ D + E E L ++ + A+ YLH E +I+
Sbjct: 72 YYENNLWILI-EFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLH---ENKII 125
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+K N+L D K++DFG++ ++ R++ GT ++APE+ M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 533 G---KSDVYSYGMLLLEM--IEEKKH 553
K+DV+S G+ L+EM IE H
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 76/257 (29%), Positives = 115/257 (44%), Gaps = 39/257 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVL------EKTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G VY D GR +AVK + ++TS + E+ + + H I+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 410 LGFCCDGSTRAL--IYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 464
G D + L EYMP GS+ D L EN++ + R +I GV+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--QILQGVS----YLH 123
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP-----RGTIGYI 519
+ I+H DIK N+L D K+ DFG S+ + M+G GT ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGA----SKRIQTICMSGTGIKSVTGTPYWM 176
Query: 520 APEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDW 573
+PE+ G G K+DV+S ++EM+ EK E + + T+ PD
Sbjct: 177 SPEVIS---GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 574 IYDKLIQPEKEDFVEEE 590
+ D K+ FVEE+
Sbjct: 234 VSDACRDFLKQIFVEEK 250
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLG 411
LG GG+G V + G++ A K L+K +NE + ++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L+ M G L + E AR + A + +E+LH RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
++ D+KP+NVLLD ++SD GLA + + G GT GY+APE+ + +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 532 SGKSDVYSYGMLLLEMI 548
S D ++ G L EMI
Sbjct: 174 S--VDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 42/254 (16%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+KLG G Y V+KG+ LVA+K LE I EV+ + + H NI+ L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L++EY+ + L L +S+ ++ L + Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCH---KRKI 124
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMRNLG 529
LH D+KPQN+L++ K++DFGLA+A +SV T T T+ Y P++ LG
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVL---LG 177
Query: 530 NP--SGKSDVYSYGMLLLEM-----------IEEKKHL------RPTETT-SGSNTTEAY 569
+ S D++ G +L EM ++E+ HL PTE T G + E +
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237
Query: 570 ----FPDWIYDKLI 579
FP + LI
Sbjct: 238 RSYLFPQYRAQPLI 251
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G VY D GR +AVK ++ +TS + E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 410 LGFCCDGSTRAL--IYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 464
G D R L E+MP GS+ D L EN++ K R +I GV+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--QILEGVS----YLH 123
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEI 523
+ I+H DIK N+L D K+ DFG +K + S M GT +++PE+
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 524 FMRNLGNPSG-KSDVYSYGMLLLEMIEEK 551
G G K+D++S G ++EM+ EK
Sbjct: 181 IS---GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 408
++K+G G + VY+ D + VA+K ++ + + + E+ + +++H N+I
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGC 467
L + + ++ E G L ++ K+ L P R + + + + A+E++H+
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
R++H DIKP NV + K+ D GL + S + GT Y++PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHEN 181
Query: 528 LGNPSGKSDVYSYGMLLLEM 547
N KSD++S G LL EM
Sbjct: 182 GYN--FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 60/172 (34%)
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKP 478
LI EY+P G + LL + K+ + + R + E L AI+ +H +L +H DIKP
Sbjct: 78 LIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETIL----AIDSIH---KLGYIHRDIKP 129
Query: 479 QNVLLDPDFTPKVSDFGL-----------------------------------AKAHS-- 501
N+LLD K+SDFGL KA +
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189
Query: 502 RNR-----SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
RNR S V GT YIAPE+F++ N D +S G+++ EM+
Sbjct: 190 RNRRALAYSTV------GTPDYIAPEVFLQTGYNKE--CDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 49/227 (21%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
E +G+G YG V G+ VA+K K + D E+ + H NII
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIK---KIPHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLG-------DLLS-------REKENLSLKPAR--LLE 451
+ P G+ DL+ + L+ + R L +
Sbjct: 68 AIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--M 509
+ G ++Y+H+ ++H D+KP N+L++ D ++ DFG+A+ S + + M
Sbjct: 116 LLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556
T T Y APE+ + +L + D++S G + EM+ ++ L P
Sbjct: 169 TEYVATRWYRAPEL-LLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 355 EKLGTGGYGNVYKG--KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLL 410
EKLG G Y V+KG K + LVA+K LE I EV+ + + H NI+ L
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCE 468
+ L++EY+ + L + +S+ + L +I G+A Y H
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCH---R 122
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMR 526
++LH D+KPQN+L++ K++DFGLA+A +SV T T T+ Y P++ +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 527 NLGNPSGKSDVYSYGMLLLEM 547
+ S + D++ G + EM
Sbjct: 179 S-SEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
E++G G +G VYKG +VA+K+ LE+ + ++ E+ + + I G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
G+ +I EY+ GS DLL L+ + I + ++YLH+ R
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RK 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-----RNRSVVTMTGPRGTIGYIAPEIFMR 526
+H DIK NVLL K++DFG+A + RN V GT ++APE+ +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAPEVIKQ 175
Query: 527 NLGNPSGKSDVYSYGMLLLEM 547
+ + K+D++S G+ +E+
Sbjct: 176 SAYD--FKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 354 KEKLGTGGYGNV----YKGKFPDGRLVAVKVLEKTSNFS----DNFINEVATIGRIHHVN 405
E LGTG +G V +KG G A+K L+K + E + + + H
Sbjct: 23 GETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYL 463
I++++ D + + E++ G L L R+ A+ E+ L A EYL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVL----AFEYL 134
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
H+ I++ D+KP+N+LLD KV+DFG AK +R+ GT Y+APE+
Sbjct: 135 HS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTPEYLAPEV 186
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
+++ G+ GK+ D ++ G+LL E I
Sbjct: 187 -IQSKGH--GKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 80/338 (23%), Positives = 132/338 (39%), Gaps = 83/338 (24%)
Query: 353 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEK--TSNFSDNFINEVATIGRI-HH 403
+ LG G +G V + K R VAVK+L++ T++ + E+ + I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 404 VNIIHLLGFCC-DGSTRALIYEYMPNGSLGDLLSREKENLSL------------------ 444
+N+++LLG C G +I EY G+L + L ++E S
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 445 ------------------------------KPARLLEIALGVAHAIEY---LHNGCEL-- 469
+ L + L + I Y + G E
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 470 --RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMR 526
+ +H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE IF +
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
+SDV+S+G+LL E+ P G E + +L + +
Sbjct: 251 VYTT---QSDVWSFGVLLWEIFSLGASPYP-----GVQIDEEFC-----RRLKEGTRMRA 297
Query: 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
E I M L C NP+DRP+ + +VE+L
Sbjct: 298 PEYATPEIYSIM----LDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 357 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 407
LGTG YG V+ K D G+L A+KVL+K + ++ E + + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 408 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 464
L + + LI +Y+ G + L +++N S R EI L A+E+LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIIL----ALEHLH 122
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+L I++ DIK +N+LLD + ++DFGL+K T + GTI Y+APEI
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEI- 177
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMI 548
+R G D +S G+L+ E++
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 410
E+LG G YG V K + P G ++AVK + T N + + ++ R + +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G + E M + SL + + L++ L +IA+ + A+EYLH+ +L
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KL 123
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
++H D+KP NVL++ + K+ DFG++ + + T+ G Y+APE +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDA--GCKPYMAPE-RINPEL 179
Query: 530 NPSG---KSDVYSYGMLLLEM 547
N G KSDV+S G+ ++E+
Sbjct: 180 NQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 29/205 (14%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG------RIHHVNIIH 408
+G G +G VY+ + D R+ A+KVL K + EVA TIG R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGERNILVRTLLDESPF 57
Query: 409 LLGFCCDGSTRA---LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYL 463
++G T + L+ +YM G L L +E S A+ + E+ L A+E+L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVL----ALEHL 112
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPE 522
H + I++ D+KP+N+LLD + DFGL+KA+ + N++ T GT Y+APE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPE 166
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEM 547
+ + G + D +S G+L+ EM
Sbjct: 167 VLLDEKGY-TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 356 KLGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLG 411
K+G G + V K + G+ A+K ++K S N + E+ + R+ H NI+ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 412 FCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCE 468
D T AL++E M + +L +L+ K L R+ + +++++H NG
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP--EKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
I H DIKP+N+L+ D K++DFG + +S+ T T Y APE + +
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYTEYISTRWYRAPECLLTD 173
Query: 528 LGNPSGKSDVYSYGMLLLEMI 548
G K D+++ G + E++
Sbjct: 174 -GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 40/273 (14%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
LG G G+V K K P G ++A KV + S+ + E + +H +++ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE---LQIMHECRSPYIVSFY 69
Query: 414 CDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
G+ + E+M GSL + K+ + L +IA+ V + YL+N
Sbjct: 70 --GAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--V 122
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMR 526
RI+H DIKP N+L++ K+ DFG++ +S + V GT Y++PE
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG 176
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---- 582
G + KSDV+S G+ ++E+ K + D + + +P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234
Query: 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
DF E+ D + C+ +P +RP+
Sbjct: 235 SSDFPEDLRDFVDA--------CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 355 EKLGTGGYGNVYK-GKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 412
E +G G YG VYK DG L AVK+L+ S+ + E + + +H N++ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 413 C-----CDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNG 466
G L+ E GS+ +L+ L A + I G +++LHN
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-----RNRSVVTMTGPRGTIGYIAP 521
RI+H D+K N+LL + K+ DFG++ + RN SV GT ++AP
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-------GTPFWMAP 197
Query: 522 EIF---MRNLGNPSGKSDVYSYGMLLLEM 547
E+ + + + DV+S G+ +E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 357 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-------HHVNIIH 408
LG G +G V + L A+K+L+K D+ + R+ + +H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 409 LLGFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
C + L + EY+ NG GDL+ ++ K + A +A + +LH+
Sbjct: 68 ----SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
I++ D+K NV+LD + K++DFG+ K + T T GT YIAPEI
Sbjct: 121 ---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI-FGGKTTRTFC-GTPDYIAPEII-- 173
Query: 527 NLGNPSGKS-DVYSYGMLLLEMI 548
P GKS D +++G+LL EM+
Sbjct: 174 -AYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 409
LG G +G VY D GR +A K ++ +TS E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 410 LGFCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
G D + + L EYMP GS+ D L K +L + + + + YLH+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPR---GTIGYIAPEI 523
I+H DIK N+L D K+ DFG +K R +++ ++ TG R GT +++PE+
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 524 FMRNLGNPSG-KSDVYSYGMLLLEMIEEK 551
G G K+DV+S G ++EM+ EK
Sbjct: 181 IS---GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 357 LGTGGYGNVYKGK----FPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 407
LGTG YG V+ + G+L A+KVL+K + +++ E + I +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 408 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 464
L + T+ LI +Y+ G L LS ++E + ++ EI L A+E+LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVL----ALEHLH 122
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-----GTIGYI 519
+L I++ DIK +N+LLD + ++DFGL+K R GTI Y+
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFHEDEVERAYSFCGTIEYM 173
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
AP+I G D +S G+L+ E++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 357 LGTGGYGNVY----KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LL 410
LG G +G V KG + A+KVL+K D+ ++ T RI + H L
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCEL 469
C T+ ++ M + GDL+ + + + R A V A+ +LH +G
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+++ D+K N+LLD + K++DFG+ K N VT T GT YIAPEI
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173
Query: 530 NPSGKSDVYSYGMLLLEMI 548
PS D ++ G+L+ EM+
Sbjct: 174 GPS--VDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFI-------NEVATIGRIHHVNII 407
+K+G G +G +Y K + + + K + + + EV + ++ H NI+
Sbjct: 6 KKIGEGSFGKIYLAK---AKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARL---LEIALGVAHAIEYLH 464
+ ++ EY G L ++R++ L + L ++I+LG+ H +H
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH----IH 118
Query: 465 NGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
+ +ILH DIK QN+ L + K+ DFG+A+ N S+ GT Y++PEI
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEI 173
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
N K+D++S G +L E+ K P E G+N + I P
Sbjct: 174 CQNRPYN--NKTDIWSLGCVLYELCTLK---HPFE---GNNLHQLVLK--ICQGYFAPIS 223
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+F + + +I L+ +++P+DRPS+T +++
Sbjct: 224 PNFSRD------LRSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 355 EKLGTGGYGNVYKGKFPDGR---LVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
EK+G G +G V+KG D R +VA+K+ LE+ + ++ E+ + + +
Sbjct: 10 EKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G + +I EY+ GS DLL E L ++ I + ++YLH+
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE--- 120
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+ +H DIK NVLL K++DFG+A + + + GT ++APE+ ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178
Query: 530 NPSGKSDVYSYGMLLLEM 547
+ K+D++S G+ +E+
Sbjct: 179 D--SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 29/202 (14%)
Query: 360 GGYGNVYKGKFPD---GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
G YG VY+ + D G +VA+K L ++ F + E+ + ++ H NI+ +
Sbjct: 16 GTYGVVYRAR--DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 414 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCE 468
GS IY EY+ + L L+ K+ + +L++ GVAH LH +
Sbjct: 74 V-GSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH----LH---D 124
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
ILH D+K N+LL+ K+ DFGLA+ + T T+ Y APE+ L
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELL---L 179
Query: 529 GNP--SGKSDVYSYGMLLLEMI 548
G S D++S G + E++
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V+ + + A+K L+K D+ + R+ H + HL
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 411 GFCCDGSTRALIY--EYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAIEYLH 464
+C + L + EY+ NG GDL+ S K +L EI G +++LH
Sbjct: 62 -YCTFQTKENLFFVMEYL-NG--GDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ I++ D+K N+LLD D K++DFG+ K + + GT YIAPEI
Sbjct: 114 SK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEIL 168
Query: 525 MRNLGNPSGKS-DVYSYGMLLLEMI 548
LG S D +S+G+LL EM+
Sbjct: 169 ---LGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 357 LGTGGYGNVY------KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 410
LG GG+G V GK + + K L+K + + E + ++H I+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 411 GFCCDGSTRA---LIYEYMPNGSLG-DLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
T+ L+ M G L + + ++EN R + +E+LH
Sbjct: 59 --AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-- 114
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+ RI++ D+KP+NVLLD D ++SD GLA +S G GT G++APE+
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELL-- 169
Query: 527 NLGNPSGKS-DVYSYGMLLLEMIEEKKHLR 555
G S D ++ G+ L EMI + R
Sbjct: 170 -QGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 360 GGYGNVYKGKFPDG-----RLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHLLGF 412
G +G ++ G D V VK ++ ++ + E + + H NI+ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 413 CCDGSTRALI-YEYMPNGSLGDLLSREKE-----NLSLKPARLLEIALGVAHAIEYLHNG 466
C + + Y YM G+L L + + +L +L+ +A+ +A + YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----------AHSRNRSVVTMTGPRGTI 516
++H DI +N ++D + K++D L++ + NR V M
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM------- 186
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
A E + + + SDV+S+G+LL E++
Sbjct: 187 ---ALESLVNKEYSSA--SDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 355 EKLGTGGYGNVYKGKFPDGR---LVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 409
E++G G +G V+KG D R +VA+K+ LE+ + ++ E+ + + +
Sbjct: 10 ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G G+ +I EY+ GS DLL + L EI G ++YLH+ E
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKG----LDYLHS--EK 121
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+I H DIK NVLL K++DFG+A + + + GT ++APE+ ++
Sbjct: 122 KI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAY 178
Query: 530 NPSGKSDVYSYGMLLLEM 547
+ K+D++S G+ +E+
Sbjct: 179 D--SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
+G G +G V K DG AVKVL+K + N + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 414 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T +Y +Y+ G L L RE+ L + AR A VA AI YLH+ L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFY--AAEVASAIGYLHS---LN 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I++ D+KP+N+LLD ++DFGL K T + GT Y+APE+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRK---E 171
Query: 531 PSGKS-DVYSYGMLLLEMI 548
P ++ D + G +L EM+
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+++G+G YG+VYK G L AVK+ LE +FS E+ + H NI+ G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-LIQQEIFMVKECKHCNIVAYFG 73
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ EY GSL D+ L+ A + L + YLH+ ++
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKGKM-- 128
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG---YIAPEI-FMRN 527
H DIK N+LL + K++DFG+A + T+ + IG ++APE+ +
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 528 LGNPSGKSDVYSYGMLLLEMIE 549
G + D+++ G+ +E+ E
Sbjct: 183 NGGYNQLCDIWAVGITAIELAE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIHLL 410
+G+G YG V GR VA+K + F D + E+ + + H NII LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV--FDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 411 GFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPAR--LLEIALGVAHAIE 461
S ++ E M DL + + + L+ + L +I G+
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQPLTDDHIQYFLYQILRGLK---- 117
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 520
YLH+ ++H D+KP N+L++ + K+ DFGLA+ +T T Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 521 PEIFMRNLGNPSGKS---DVYSYGMLLLEMIEEK 551
PE+ L + S + D++S G + E++ K
Sbjct: 175 PEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 355 EKLGTGGYGNV-YKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
+++G+G YG V G VA+K L + + F+ E+ + + H N+I LL
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 411 G-FCCDGSTRAL--IYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
F D S Y MP LG L+ EK L R+ + + ++Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIHA 136
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H D+KP N+ ++ D K+ DFGLA+ ++ MTG T Y APE+ +
Sbjct: 137 A---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEK 551
N + + D++S G ++ EM+ K
Sbjct: 189 -NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V + A+K L+K D+ + R+ H + HL
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 411 GFCCDGSTRALIY--EYMPNGSLGDLLS--REKENLSLKPARLL--EIALGVAHAIEYLH 464
FC + L + EY+ NG GDL+ + AR EI G +++LH
Sbjct: 62 -FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICG----LQFLH 113
Query: 465 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR------GTIG 517
G I++ D+K NVLLD D K++DFG+ K + M G GT
Sbjct: 114 KKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKEN--------MNGEGKASTFCGTPD 161
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
YIAPEI N S D +S+G+LL EM+
Sbjct: 162 YIAPEILKGQKYNES--VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 36/290 (12%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 411
LG GG+G V + G++ A K LEK +NE + +++ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L+ M G L + E + R + A + +E LH + RI
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
++ D+KP+N+LLD ++SD GLA + T+ G GT+GY+APE+ ++N
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEV-VKN-ERY 178
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591
+ D ++ G LL EMI + + + E +L++ +E++ E+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---------RLVKEVQEEYSEKFS 229
Query: 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 641
AR + C + KD P E L A E+ PLF
Sbjct: 230 PD-ARSL------CKMLLCKD-PK-----ERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 39/220 (17%)
Query: 344 NDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR 400
ND++ + ++G+G G VYK +F G ++AVK + +T N +N + ++ + +
Sbjct: 15 NDLENL-----GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 401 IHHV-NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAH 458
H I+ G+ S + E M L LL R + + P +L ++ + +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPI---PEDILGKMTVAIVK 125
Query: 459 AIEYL---HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA------KAHSRNRSVVTM 509
A+ YL H ++H D+KP N+LLD K+ DFG++ KA +R+
Sbjct: 126 ALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS------ 174
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSG--KSDVYSYGMLLLEM 547
G Y+APE NP ++DV+S G+ L+E+
Sbjct: 175 ---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL-- 409
+G G YG VYK + D G LVA+K + + N + F I E+ + +++H NI++L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 410 --------LGFCCDGSTRALIYEYMPNGSLGDLLSR----EKENLSLKPARLLEIALGVA 457
L F D L++EYM + +G L S ++++ +LLE
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE------ 127
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+ Y H LH DIK N+LL+ K++DFGLA+ ++ S T T+
Sbjct: 128 -GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLW 182
Query: 518 YIAPEIFMRNLGN----PSGKSDVYSYGMLLLEMIEEK 551
Y PE+ LG P+ DV+S G +L E+ +K
Sbjct: 183 YRPPELL---LGEERYGPA--IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 34/180 (18%)
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
++YLH+ ILH DIKP N+L++ + K+ DFGLA+ + S MT T Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYR 171
Query: 520 APEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP----DW 573
APEI M G+ + D++S G + E++ +A P D
Sbjct: 172 APEILM---GSRHYTSAVDIWSVGCIFAELL------------GRRILFQAQSPIQQLDL 216
Query: 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 633
I D L P E + AR I+ G P PS+ + + S A+ EA+ +
Sbjct: 217 ITDLLGTPSLEAMRSACEG--ARAHILRG-------PHKPPSLPVLYTLSSQATHEAVHL 267
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHV 404
F LG G +G V + L A+K+L+K D+ + E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 405 NIIHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+ L C R + EY+ NG GDL+ ++ K + + A ++ + +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
H I++ D+K NV+LD + K++DFG+ K H + V T T GT YIAPEI
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFC-GTPDYIAPEI 172
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
P GKS D ++YG+LL EM+
Sbjct: 173 IAY---QPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 421 LIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 478
L+Y M GDL + KE L +++E + +A A++YLH E ILH D+K
Sbjct: 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKT 130
Query: 479 QNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDV 537
QNV L KV D G+A+ ++ T+ GT Y++PE+F N KSDV
Sbjct: 131 QNVFLTRTNIIKVGDLGIARVLENQCDMASTLI---GTPYYMSPELFSNKPYNY--KSDV 185
Query: 538 YSYGMLLLEM 547
++ G + EM
Sbjct: 186 WALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 355 EKLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHL 409
+++G G +G V + V VK L+ ++ + F+ + + H NI+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-----EIALGVAHAIEYLH 464
LG C + L++EY G L LS+E+ + LL EIA GV H +H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH----MH 116
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ LH D+ +N L D T KV D+G+ + + + T + ++APE+
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 525 MRNLG-----NPSGKSDVYSYGMLLLEMIE 549
G + S+V++ G+ L E+ E
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFE 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG V+K K + +VA+K + + + + E+ + + H NI+ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR------LLEIALGVAHAIEYLH 464
L++EY L + ++ + + ++ G+A H
Sbjct: 66 DVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS--H 118
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-----SRNRSVVTMTGPRGTIGYI 519
N +LH D+KPQN+L++ + K++DFGLA+A + VVT+ Y
Sbjct: 119 N-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-------YR 166
Query: 520 APEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556
P++ L + S D++S G + E+ + L P
Sbjct: 167 PPDVLFGAKLYSTS--IDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSD--NFINEVAT 397
++ D+K + ++G G +G V K G ++AVK + T + + + ++
Sbjct: 1 FTAEDLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 398 IGRIHH-VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIA 453
+ R I+ G + E M + SL D + E + L +IA
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELM-DISL-DKFYKYVYEVLKSVIPEEILGKIA 113
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
+ A+ YL EL+I+H D+KP N+LLD + K+ DFG++ + + T
Sbjct: 114 VATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDS--IAKTRDA 168
Query: 514 GTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEM 547
G Y+APE + + +SDV+S G+ L E+
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 53/225 (23%)
Query: 412 FCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGC 467
FC + R L + EY+ G LL + L + AR+ E L A+EYLHN
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL----ALEYLHN-- 119
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-------------G 514
I+H D+KP N+L+ K++DFGL+K + + G G
Sbjct: 120 -YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 515 TIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-----SNTTEA 568
T YIAPE+ +R G P D ++ G++L E + G +T E
Sbjct: 179 TPEYIAPEVILRQGYGKP---VDWWAMGIILYEFL------------VGCVPFFGDTPEE 223
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613
F I D + PE ++ + + + ++ ++ NP +R
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRL-------LRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 355 EKL---GTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNI 406
EKL G G YG VY+ + G +VA+K + + N D + E+ + + H NI
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 407 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEY 462
+ L + L+ EY L LL +N+ +++ + L + ++Y
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLL----DNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-----AHSRNRSVVTMTGPRGTIG 517
LH I+H D+K N+LL K++DFGLA+ A VVT+
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW------- 173
Query: 518 YIAPEIFMRNLG--NPSGKSDVYSYGMLLLEMIEEK 551
Y APE+ LG + D+++ G +L E++ K
Sbjct: 174 YRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 411
LG GG+G V + G++ A K LEK +NE + +++ +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L+ M G L N + R L A + +E LH
Sbjct: 68 AYETKDALCLVLTIMNGGDL-KFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENT 123
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
++ D+KP+N+LLD ++SD GLA S+ G GT+GY+APE+
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTL 180
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLR 555
S D + G L+ EMIE + R
Sbjct: 181 S--PDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
+G G +G V + + + AVKVL+K + + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 414 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T +Y +Y+ G L L RE+ L+P R A +A A+ YLH+ L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRER--CFLEP-RARFYAAEIASALGYLHS---LN 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I++ D+KP+N+LLD ++DFGL K + + T + GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHK---Q 171
Query: 531 PSGKS-DVYSYGMLLLEMI 548
P ++ D + G +L EM+
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 34/204 (16%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG-- 411
LG G G V K P G ++A K+ LE + I E+ + H N +++G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGFY 65
Query: 412 --FCCDGSTRALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNG 466
F DG ++ E+M GSL +L + EN+ L +I++ V + YL
Sbjct: 66 GAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPENI------LGKISIAVLRGLTYLRE- 117
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIF 524
+ +I+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE-- 168
Query: 525 MRNLGNP-SGKSDVYSYGMLLLEM 547
R G + +SD++S G+ L+EM
Sbjct: 169 -RLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 355 EKLGTGGYGNVYKGKFPD----GRL----VAVKVLEKT-SNFSDNFINEVATIGRIHHVN 405
E LG G + ++KG + G L V +KVL+K+ N+S++F + + ++ H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYL 463
++ G C G ++ EY+ GSL L + K N+S K LE+A +A A+ +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK----LEVAKQLAWALHFL 116
Query: 464 HNGCELRILHLDIKPQNVLL---------DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514
+ + H ++ +NVLL +P F K+SD G++ V+
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISIT------VLPKEILLE 166
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
I ++ PE + N N S +D +S+G L E+
Sbjct: 167 RIPWVPPEC-IENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 26/112 (23%)
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510
EI G+ LH RI++ D+KP+N+LLD ++SD GLA T+
Sbjct: 110 EITCGLED----LHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIR 159
Query: 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSY-------GMLLLEMIEEKKHLR 555
G GT+GY+APE+ K++ Y++ G L+ EMIE K R
Sbjct: 160 GRVGTVGYMAPEVV---------KNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 71/305 (23%), Positives = 111/305 (36%), Gaps = 78/305 (25%)
Query: 360 GGYGNVYKGKFPDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIHLLGFCCDG 416
++ K K P LVAVK L+ S + E+ T ++ H NI+ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 417 STRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIAL---GVAHAIEYLH-NGCELRI 471
S ++ M GS DLL E L L IA V +A++Y+H G
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPE-----LAIAFILKDVLNALDYIHSKGF---- 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS----RNRSVVTMTGPRGTIG---YIAPEIF 524
+H +K ++LL D +S GL + S R V P+ ++ +++PE+
Sbjct: 123 IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 525 MRNLGNPSGKSDVYSYG---------------MLLLEMIEEKKHLR-------------- 555
+NL + KSD+YS G M +M+ EK +R
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPL 238
Query: 556 -----PTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINP 610
+S + D Y + FVE C+Q +P
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---------------CLQRDP 283
Query: 611 KDRPS 615
+ RPS
Sbjct: 284 ESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 48/239 (20%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 352 GFK--EKLGTGGYGNVYKGKFPDGR--LVAVKVLEKTSNFSDNFINEVATIGRIHHVNII 407
G+ + L G G V+ G+ V +K+ +K + + E + ++H ++I
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT-----LIEAMLLQNVNHPSVI 120
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ G+ ++ + + L L++ L + A ++E + + YLH
Sbjct: 121 RMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ--ILEGLRYLH--- 174
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
RI+H D+K +N+ ++ + D G A+ G GT+ APE+ R+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARD 231
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---SNTTEAYFPDWIYDKLIQPEK 583
N K+D++S G++L EM+ + ++ + ++ I + PE+
Sbjct: 232 KYN--SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+++G+G YG+VYK + G L A+KV LE +F E+ + H NI+ G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ E+ GSL D+ L +++ ++ + YLH+ ++
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKM-- 128
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS----RNRSVVTMTGPRGTIGYIAPEI-FMR 526
H DIK N+LL + K++DFG++ + + +S + GT ++APE+ +
Sbjct: 129 -HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVAAVE 181
Query: 527 NLGNPSGKSDVYSYGMLLLEMIE 549
G + D+++ G+ +E+ E
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 357 LGTGGYGNVYKGKFPDGRL---VAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
+G+G YG V D + VA+K L + ++ + E+ + + H N+I LL
Sbjct: 23 VGSGAYGQVCSAF--DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 411 G-FCCDGSTRAL--IYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
F S +Y L +++ +K L + + + ++Y+H+
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----LSDDHIQFLVYQILRGLKYIHS 136
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y APEI M
Sbjct: 137 A---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI-M 187
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEK 551
N + + D++S G ++ E++ K
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+G G +G V + G+ VA+K + K T + E+ + + H NII L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL--- 74
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
D L Y LG L R + L+ + + ++Y+H+ ++
Sbjct: 75 -SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVV 130
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+KP N+L++ + K+ DFGLA+ MTG T Y APEI M
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEI-MLTWQKYD 184
Query: 533 GKSDVYSYGMLLLEMIEEK 551
+ D++S G + EM+E K
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 12/132 (9%)
Query: 421 LIYEYMPNGSLGDL----LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 476
LI EY GS GDL R KE+L + + + + A++ +H+ ++H D+
Sbjct: 142 LIMEY---GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDL 195
Query: 477 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSD 536
K N+ L P K+ DFG +K +S + S+ + GT Y+APE++ R S K+D
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKAD 253
Query: 537 VYSYGMLLLEMI 548
++S G++L E++
Sbjct: 254 MWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 48/231 (20%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHLLG 411
+G G +G V + D G + A+K+L K + + I + ++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
D LI E++P G + LL + K+ L+ + IA V AI+ +H +L
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLT-EEETQFYIAETVL-AIDSIH---QLGF 122
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLA----KAH--------------------------- 500
+H DIKP N+LLD K+SDFGL KAH
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 501 ---SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
RNR + + GT YIAPE+FM+ N D +S G+++ EM+
Sbjct: 183 ETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNK--LCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEK---------TSNFSDNFINEVATIGRIHHVNI 406
+G GG+G VY + D G++ A+K L+K T ++ + + + G +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 464
+ D I + M G L LS+ S K R EI LG +E++H
Sbjct: 62 MTYAFHTPD--KLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILG----LEHMH 114
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
N +++ D+KP N+LLD ++SD GLA S+ + ++ GT GY+APE+
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 167
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 559
+ S +D +S G +L +++ R +T
Sbjct: 168 QKGTAYDS-SADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 25/235 (10%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGF- 412
+G G Y V + R+ A+KV++K D I+ V T + H L+G
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 413 -CCDGSTRAL-IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 468
C +R + EY+ G L + R+++ L + AR EI+L A+ YLH E
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH---E 114
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I++ D+K NVLLD + K++D+G+ K R T + GT YIAPEI
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILR--- 169
Query: 529 GNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
G G S D ++ G+L+ EM+ + P + S+ + D+++ +++ +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRS---PFDIVGSSDNPDQNTEDYLFQVILEKQ 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPARL--LEIALGVAHAIEYLHNGCELRILHLDIKP 478
++ EYMP G L +L+S ++ K AR E+ L A++ +H+ + +H D+KP
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVL----ALDAIHS---MGFIHRDVKP 170
Query: 479 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-D 536
N+LLD K++DFG N V T GT YI+PE+ G+ G+ D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 537 VYSYGMLLLEMI 548
+S G+ L EM+
Sbjct: 230 WWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN-I 406
EK+G G YG VYK + G+LVA+K KT D + E++ + + I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 407 IHLLGF--CCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL-----EIALGV 456
+ LL + + + +Y EY+ + + S + PA+ + ++ GV
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGT 515
AH H + ++H D+KPQN+L+D K++D GL +A S V + T T
Sbjct: 124 AH----CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIVT 174
Query: 516 IGYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMI 548
+ Y APE+ LG+ S D++S G + EM
Sbjct: 175 LWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNII 407
+G G YG V P G VA+K K S F + E+ + R H NII
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 408 HLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 460
+L S + ++ E M L L+ ++LS + L +I G+
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGL---- 119
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYI 519
+Y+H+ +LH D+KP N+LL+ + K+ DFGLA+ +T T Y
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
APEI M N + D++S G +L EM+
Sbjct: 177 APEI-MLNSKGYTKAIDIWSVGCILAEML 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
+G G +G VY+ D VA+K + + + + E+ + ++H+NII L +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYT 130
Query: 416 GSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPARLLEI-ALGVAHAIEYLHNG 466
+ ++ E++P + + N +L P L+++ + + A+ Y+H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL-PLFLVKLYSYQLCRALAYIHSK 189
Query: 467 CELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I H D+KPQN+L+DP+ T K+ DFG AK + V+ R Y APE+ M
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPEL-M 242
Query: 526 RNLGNPSGKSDVYSYGMLLLEMI 548
N + D++S G ++ EMI
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 15/134 (11%)
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKP 478
L+ +Y G L LLS+ ++ L AR L E+ L AI+ +H +L +H DIKP
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL----AIDSVH---QLGYVHRDIKP 130
Query: 479 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK---- 534
NVLLD + +++DFG + +V + GT YI+PEI ++ + + G+
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEI-LQAMEDGKGRYGPE 188
Query: 535 SDVYSYGMLLLEMI 548
D +S G+ + EM+
Sbjct: 189 CDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 420 ALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 478
AL+ +Y G L ++ SR K N + + + + V A+ ++H+ ++H DIK
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKS 171
Query: 479 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDV 537
N+LL + K+ DFG +K ++ S GT Y+APEI+ R P S K+D+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR---KPYSKKADM 228
Query: 538 YSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI--YDKL---IQPEKEDFVEEEDD 592
+S G+LL E++ K RP + G N E YD L I PE ++ V
Sbjct: 229 FSLGVLLYELLTLK---RPFD---GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTA--- 279
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
+ +PK RPS ++++ M
Sbjct: 280 ------------LLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 453
EVA + + H NI+ + ++ +Y G L ++ ++ L ++L+
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWF 107
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
+ + A++++H + +ILH DIK QN+ L D T K+ DFG+A+ + T+ R
Sbjct: 108 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELAR 159
Query: 514 GTIG---YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
IG Y++PEI N KSD+++ G +L EM K
Sbjct: 160 TCIGTPYYLSPEICENRPYN--NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHLLG 411
LG G +G V + G+ A+K+L+K + + + T R+ H + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ EY+ G L LSRE+ R + A++YLH+G +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
++ D+K +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLE---DND 171
Query: 532 SGKS-DVYSYGMLLLEMI 548
G++ D + G+++ EM+
Sbjct: 172 YGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 357 LGTGGYGNVYKGKFPDGR-LVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+G G YG V K + + + +VA+K E+ + + E+ + + NI+ L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
L++EY+ L +LL E+ + P ++ + AI + H I+
Sbjct: 69 FRRRGKLYLVFEYVEKNML-ELL--EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIV 122
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H DIKP+N+L+ + K+ DFG A+ S S T T Y +PE+ LG P
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELL---LGAPY 178
Query: 533 GKS-DVYSYGMLLLEMIEEKKHLRPTET 559
GK+ D++S G +L E+ + + L P E+
Sbjct: 179 GKAVDMWSVGCILGEL-SDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
LG G +G V K GR A+K+L+K + + + T R+ N H L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALK 61
Query: 414 CDGSTR---ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T + EY G L LSRE+ S AR + A++YLH+ E
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFY--GAEIVSALDYLHS--EKN 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+++ D+K +N++LD D K++DFGL K ++ + TM GT Y+APE+ N
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLE---DN 171
Query: 531 PSGKS-DVYSYGMLLLEMI 548
G++ D + G+++ EM+
Sbjct: 172 DYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 356 KLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG- 411
+LG G G V K + P G ++A K+ LE + I E+ + + I+ G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
F DG ++ E+M GSL +L KE + L ++++ V + YL + +I
Sbjct: 72 FYSDGEI-SICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQI 125
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT-- 177
Query: 530 NPSGKSDVYSYGMLLLEM 547
+ S +SD++S G+ L+E+
Sbjct: 178 HYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTI 516
++Y+H+ +LH D+KP N+L++ D K+ DFGLA+ S N MT T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
Y APEI M + + + DV+S G +L E++ K
Sbjct: 174 WYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 357 LGTGGYGNVYKGKFPDG-RLVAVKVLEK--------TSNFSDNFINEVATIGRIHHVNII 407
+G G +G V K R+ A+K+L K T+ F + V G + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--RNVLVNGDCQWITTL 66
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
H F D + L+ +Y G L LLS+ ++ L AR +A + +H+
Sbjct: 67 HY-AFQ-DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIH 119
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR- 526
+L +H DIKP NVLLD + +++DFG +++ +V + GT YI+PEI
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAM 178
Query: 527 --NLGNPSGKSDVYSYGMLLLEMI 548
+G + D +S G+ + EM+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH----LLG 411
LG G +G V + GR A+K+L K + + + T R+ N H L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALK 61
Query: 412 FCCDGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
+ R + EY G L LSRE+ + + AR + A+EYLH+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFY--GAEIVSALEYLHSR---D 115
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+++ DIK +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE---DN 170
Query: 531 PSGKS-DVYSYGMLLLEMI 548
G++ D + G+++ EM+
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 55/161 (34%), Positives = 75/161 (46%), Gaps = 41/161 (25%)
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480
LI E++P G + LL + K+ LS + + IA V AI+ +H +L +H DIKP N
Sbjct: 78 LIMEFLPGGDMMTLLMK-KDTLSEEATQFY-IAETVL-AIDAIH---QLGFIHRDIKPDN 131
Query: 481 VLLDPDFTPKVSDFGLA----KAHS----RNR--------SVVTMTGPR----------- 513
+LLD K+SDFGL KAH RN S M R
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 514 ------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
GT YIAPE+FM+ N D +S G+++ EM+
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKL--CDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 33/207 (15%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIHHVNI 406
LG G +G V ++ G L A+K L+K S + I E A H +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSERHPFL 64
Query: 407 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
++L C + EY G L ++ + S A A V ++YLH
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFY--AACVVLGLQYLH- 118
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTIGYIAPE 522
E +I++ D+K N+LLD + K++DFGL K S GT ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEFLAPE 171
Query: 523 IFMRNLGNPSGKS-DVYSYGMLLLEMI 548
+ ++ D + G+L+ EM+
Sbjct: 172 VL---TETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 438 EKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496
E++ L+L LL + VA + +L + C +H D+ +N+LL K+ DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556
A+ + + V R + ++APE + + +SDV+SYG+LL E+
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIF-------- 310
Query: 557 TETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616
+ GS+ D + K+I KE + +C +M + C +P RP+
Sbjct: 311 ---SLGSSPYPGMPVDSKFYKMI---KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364
Query: 617 TRVVEML 623
++V+++
Sbjct: 365 KQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
+G G +G V K DG+ AVKVL+K + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 414 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
T +Y +++ G L L RE+ S R A +A A+ YLH+ +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---IN 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I++ D+KP+N+LLD ++DFGL K T T GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRK---Q 171
Query: 531 PSGKS-DVYSYGMLLLEMI 548
P + D + G +L EM+
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF- 412
+G G Y V + R+ A+KV++K D I+ V T + N L+G
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 413 -CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 468
C +R + E++ G L + R+++ L + AR EI+L A+ +LH E
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISL----ALNFLH---E 114
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I++ D+K NVLLD + K++D+G+ K R T + GT YIAPEI
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILR--- 169
Query: 529 GNPSGKS-DVYSYGMLLLEMI 548
G G S D ++ G+L+ EM+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 365 VYKGKFPDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGF---CCDGS 417
+YKG F + + V ++ +K D NE+ + RI NI+ + GF D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 418 TR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 476
R +LI EY G L ++L +EK +LS K L++A+ + L+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK-DLSFKTK--LDMAIDCCKGLYNLYK--YTNKPYKNL 149
Query: 477 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR----GTIGYIAPEIFMRNLGNPS 532
+ L+ ++ K+ GL K ++ P + Y + ++ +
Sbjct: 150 TSVSFLVTENYKLKIICHGLEK---------ILSSPPFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
K D+YS G++L E+ K T IYD +I + +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKE------------IYDLIINKNNSLKLPLDCP 248
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+ ++ C + RP++ ++ LS
Sbjct: 249 LEIKCIVEA---CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 356 KLGTGGYGNVYK-GKFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG- 411
+LG G G V+K P G ++A K+ LE + I E+ + + I+ G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGCELR 470
F DG ++ E+M GSL +L + P ++L ++++ V + YL + +
Sbjct: 72 FYSDGEI-SICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE--KHK 124
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT- 177
Query: 529 GNPSGKSDVYSYGMLLLEM 547
+ S +SD++S G+ L+EM
Sbjct: 178 -HYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 59/248 (23%), Positives = 88/248 (35%), Gaps = 74/248 (29%)
Query: 357 LGTGGYGNVYKGKFPDGR-LVAVKVLEKTSNFSDNFINEVATIGRIHHVN---------- 405
+G G +G V + D L A+K L K N + A HV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRN---QAA------HVKAERDILAEAD 59
Query: 406 ---IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIE 461
++ L D + +Y+P G + LL R L + L + + AIE
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIE 115
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--------------HSRNRSV- 506
+H + +H DIKP N+L+D D K++DFGL H R S+
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 507 ----VTMTGPR----------------------GTIGYIAPEIFMRNLGNPSGKSDVYSY 540
+ GT YIAPE+ +R D +S
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL--CDWWSV 230
Query: 541 GMLLLEMI 548
G++L EM+
Sbjct: 231 GVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEI---ALGVAHAIEYLHNGCELRIL 472
G L + P+ S +E ++L P + ++ + VA +E+L + +
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRNLGNP 531
H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE IF +
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY--- 253
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591
+ +SDV+S+G+LL E+ S Y I ++ Q K+
Sbjct: 254 TTQSDVWSFGVLLWEIF--------------SLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ ++ + L C Q +PK+RP+ + +VE+L
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFIN-----EVATIGRIHHVNIIH 408
K+G G YG V+K + + G++VA+K ++ + D I E+ + ++ H N+++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVN 64
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGC 467
L+ L++EY + L +L EK + + +I A+ + H + C
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG-------TIGYIA 520
+H D+KP+N+L+ K+ DFG A+ +TGP T Y A
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFAR---------ILTGPGDDYTDYVATRWYRA 168
Query: 521 PEIFMRNL--GNPSGKSDVYSYGMLLLEMI 548
PE+ + + G P DV++ G + E++
Sbjct: 169 PELLVGDTQYGPP---VDVWAIGCVFAELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGF- 412
+G G Y V + + ++ A+KV++K D I+ V T + + L+G
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 413 -CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
C ++R L+ EY+ G L + R+++ L + AR A + A+ +LH E
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFY--AAEICIALNFLH---ERG 116
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
I++ D+K NVLLD D K++D+G+ K T + GT YIAPEI G
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILR---GE 171
Query: 531 PSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF 570
G S D ++ G+L+ EM+ + NT + F
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480
++ EYMP G L +L+S ++ K AR V A++ +H+ + +H D+KP N
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHS---MGFIHRDVKPDN 172
Query: 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP--SGKSDVY 538
+LLD K++DFG ++ V T GT YI+PE+ G+ + D +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 539 SYGMLLLEMI 548
S G+ L EM+
Sbjct: 232 SVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 357 LGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 414
LG G +G V + K G+ A+K+L+K + + EVA H + +L
Sbjct: 3 LGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKD---EVA-----HTLTESRVLQNTR 53
Query: 415 DGSTRALIY------------EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAI 460
AL Y EY G L LSRE+ S AR EI A+
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVS----AL 108
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
YLH+ +++ D+K +N++LD D K++DFGL K + + TM GT Y+A
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 163
Query: 521 PEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
PE+ N G++ D + G+++ EM+
Sbjct: 164 PEVLE---DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 376 VAVKVLEKT-SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 434
V +KVL+ + + + F + + ++ H+++ + G C GS ++ E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 435 LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL-----LDPDFTP 489
L +EK + A + +A +A A+ YL + ++H ++ +N+L L +P
Sbjct: 107 LRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSP 161
Query: 490 --KVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 546
K+SD G++ A SR V I +IAPE + + S +D +S+G LLE
Sbjct: 162 FIKLSDPGVSFTALSREERV-------ERIPWIAPEC-VPGGNSLSTAADKWSFGTTLLE 213
Query: 547 M 547
+
Sbjct: 214 I 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 353 FKEKLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN----I 406
F LG G +G V + K D L A+K+L+K D+ + R+ ++
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTD-ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 407 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ L C R + EY+ NG GDL+ + ++ K + A +A + +LH+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I++ D+K NV+LD + K++DFG+ K + + VT GT YIAPEI
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174
Query: 526 RNLGNPSGKS-DVYSYGMLLLEMI 548
P GKS D +++G+LL EM+
Sbjct: 175 Y---QPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 28/247 (11%)
Query: 312 PFSEERQNIGDGLN-VKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF 370
P + +NI + LN ++ ++ R + Y+ +K +G G +G V +
Sbjct: 13 PALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKV--------IGRGAFGEVQLVRH 64
Query: 371 PDGRLV-AVKVLEKTSNF--SDN--FINEVATIGRIHHVNIIHLLGFCC--DGSTRALIY 423
+ V A+K+L K SD+ F E + + ++ L FC D ++
Sbjct: 65 KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVM 122
Query: 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483
EYMP G L +L+S E+ L A++ +H+ + ++H D+KP N+LL
Sbjct: 123 EYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL----ALDAIHS---MGLIHRDVKPDNMLL 175
Query: 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP--SGKSDVYSYG 541
D K++DFG V T GT YI+PE+ G+ + D +S G
Sbjct: 176 DKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 542 MLLLEMI 548
+ L EM+
Sbjct: 235 VFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 355 EKLGTGGYGNVYK-GKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGF 412
E +G G YG V+K +G AVK+L+ + + E + + H N++ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 413 -----CCDGSTRALIYEYMPNGSLGDL----LSR-EKENLSLKPARLLEIALGVAHAIEY 462
+G L+ E GS+ DL L R E+ + L E +G+ H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH---- 139
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIG 517
LH + +H D+K N+LL + K+ DFG++ RN SV GT
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-------GTPF 189
Query: 518 YIAPEIFM--RNLGNP-SGKSDVYSYGMLLLEM 547
++APE+ + L + + DV+S G+ +E+
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 361 GYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420
G + +GK RL+A K ++ S + NE+ +GR++H NI+ + +
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239
Query: 421 LI--------YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+I Y +M + + K+ LK R I + A+EY+H+ +++
Sbjct: 240 MITQKYDFDLYSFMYDEAF-----DWKDRPLLKQTR--AIMKQLLCAVEYIHDK---KLI 289
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H DIK +N+ L+ D + DFG A + R G GT+ +PEI +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGD--GYC 346
Query: 533 GKSDVYSYGMLLLEMI 548
+D++S G++LL+M+
Sbjct: 347 EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510
+I G+ H LH + I++ D+KP+NVLLD ++SD GLA +++ T
Sbjct: 103 QITCGILH----LH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---T 152
Query: 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
GT GY+APEI S D ++ G + EM+
Sbjct: 153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 360 GGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLGFCC 414
G +G VY G K + +L AVKV++K + N +++V + I+HL
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 415 DGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ L+ EY+ G + LL E +++K + E+AL A++YLH I
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK--YISEVAL----ALDYLH---RHGI 125
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAK 498
+H D+KP N+L+ + K++DFGL+K
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 38/224 (16%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLE--KTSNFSDNFINEVATIG-------------R 400
LG G YG V K G++VA+K ++ + SN V G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 401 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460
I H NI+ L+ +G L+ + M DL + L +++ I L + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT------------ 508
LH +H D+ P N+ ++ K++DFGLA+ + T
Sbjct: 133 NVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 551
MT T+ Y APE+ M + D++S G + E++ K
Sbjct: 190 MTSKVVTLWYRAPELLMG--AEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIG 517
I++LH+ I+H D+KP N+++ D T K+ DFGLA R M P T
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRY 182
Query: 518 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK 551
Y APE+ LG D++S G ++ EMI
Sbjct: 183 YRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 5/86 (5%)
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
RI++ D+KP+N+LLD ++SD GLA T+ G GT+GY+APE+ N
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI--NNE 176
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLR 555
+ D + G L+ EMI+ + R
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIH------HVNIIHL 409
+G G YG V K + VA+K K +N DN I+ T+ I H N+I +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK---KIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 410 LGFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPAR--LLEIALGVAHAI 460
A ++YE M DL + R + LS + L ++ G +
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRG----L 121
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
+Y+H+ +LH D+KP N+LL+ + K+ DFGLA+ S MT T Y A
Sbjct: 122 KYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRA 176
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
PE+ + N + DV+S G + E++ K
Sbjct: 177 PELLL-NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 12/98 (12%)
Query: 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510
EI LG +E++HN +++ D+KP N+LLD ++SD GLA S+ + ++
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
GT GY+APE+ + + S +D +S G +L +++
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 357 LGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+G+G YG+V G VA+K L + + F+ E+ + + H N+I LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 413 CCDGSTRALIYEYMPNGSL------GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
D T A+ + + L DL LS + L + ++Y+H+
Sbjct: 81 --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--VYQMLCGLKYIHSA 136
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
I+H D+KP N+ ++ D K+ DFGLA+ + MTG T Y APE+ +
Sbjct: 137 ---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVIL- 187
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK--- 583
N + + D++S G ++ EM+ K + D++ D+L Q K
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------------DYL-DQLTQILKVTG 232
Query: 584 ---EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLSSASAEAIEMPPKPL 638
+FV++ +D A+ I K P R + AS +A+++ K L
Sbjct: 233 VPGPEFVQKLEDKAAKSYI-----------KSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 61/257 (23%)
Query: 357 LGTGGYGNV-YKGKFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLG 411
LG G +G V K L A+K L K + N + V + + ++ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIEYLHNGCELR 470
D + +Y+P G + LL R + + P L + + AIE +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVH---KMG 121
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAK--------------AHSRNRSVV--------- 507
+H DIKP N+L+D D K++DFGL +H R S+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 508 -TMTGPR---------------------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 545
G R GT YIAPE+ +R + D +S G++L
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILF 239
Query: 546 EM-IEEKKHLRPTETTS 561
EM + + L PT T +
Sbjct: 240 EMLVGQPPFLAPTPTET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 381 LEKTSNFSDNFINEVATIGRIHHVNIIHLL-GFCCDGSTRALIYEYMPNGSLGDLLSREK 439
L K+S+ ++ E + ++ H NI+ F DG ++ EY G L + ++
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY-IVMEYCDGGDLMQKIKLQR 93
Query: 440 ENLSLKPARL---LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496
L + L +++ LGV H +H E R+LH DIK +N+ L + K+ DFG
Sbjct: 94 GKLFPEDTILQWFVQMCLGVQH----IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
A+ + + GT Y+ PEI+ N KSD++S G +L E+
Sbjct: 147 ARLLTSPGAYACTY--VGTPYYVPPEIWENMPYN--NKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 354 KEKLGTGGYGNVYKGKFPDGRLVA---VKVLEKTS------NFSDNFINEVATIGRIHHV 404
+++LG G +G VY K D + VA +KVL++ N + E + ++ H
Sbjct: 5 QQRLGKGSFGTVYLVK--DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHA 459
I+ + +I EY L L K +++ LGV
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV--- 119
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
Y+H + RILH D+K +N+ L + K+ DFG+++ + + T GT Y+
Sbjct: 120 -HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF--TGTPYYM 172
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEM 547
+PE +++ G S KSD++S G +L EM
Sbjct: 173 SPEA-LKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 357 LGTGGYGNVYKGKFPDGRL---VAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 410
+G+G YG+V D RL VAVK L + + E+ + + H N+I LL
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 411 G-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
F S Y+ +G L+ + L + + + ++Y+H+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA--- 137
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP NV ++ D ++ DFGLA+ MTG T Y APEI M N
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEI-MLNWM 191
Query: 530 NPSGKSDVYSYGMLLLEMIEEK 551
+ + D++S G ++ E+++ K
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 81/317 (25%), Positives = 134/317 (42%), Gaps = 55/317 (17%)
Query: 357 LGTGGYGNVY----KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNII 407
LG G +G V KGK G AVK L+K D+ + R+ + +
Sbjct: 3 LGKGSFGKVLLAELKGK---GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
HL C T+ ++ M + GDL+ ++ R A + +++LH+
Sbjct: 60 HLY---CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SRNRSVVTMTGPRGTIGYIAPEIFM 525
I++ D+K NV+LD D K++DFG+ K + NR+ GT YIAPEI
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTPDYIAPEIL- 168
Query: 526 RNLGNPSGKS-DVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPDWIYDKLIQP 581
G S D +S+G+LL EM+ + E ++P W I
Sbjct: 169 --QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW-----ITK 221
Query: 582 EKEDFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPL 638
E +D +E E D R++ +VG N + P + ++ + E E+ P
Sbjct: 222 ESKDILEKLFERDP--TRRLGVVG------NIRGHP----FFKTINWTALEKRELDP--- 266
Query: 639 FPSPPQLQTQNEIISFD 655
P P++++ ++ +FD
Sbjct: 267 -PFKPKVKSPSDYSNFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 396 ATIGR-IHHVNIIHLLG-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 453
A I R I+H +II L G F + T ++ Y DL ++ +L I
Sbjct: 134 AHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-----DLYCYLAAKRNIAICDILAIE 188
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513
V AI+YLH RI+H DIK +N+ ++ + DFG A + + G
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
GTI APE+ R+ P+ D++S G++L EM
Sbjct: 245 GTIATNAPELLARDPYGPA--VDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 357 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLG- 411
+G+G YG+V G VAVK L + + E+ + + H N+I LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
F S Y+ +G L+ + L + + + ++Y+H+ I
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DI 141
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+KP N+ ++ D K+ DFGLA+ H+ + MTG T Y APEI M N +
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE----MTGYVATRWYRAPEI-MLNWMHY 195
Query: 532 SGKSDVYSYGMLLLEMI 548
+ D++S G ++ E++
Sbjct: 196 NQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 356 KLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
K+G G YG+VYK K DG R A+K +E T S + E+A + + H N+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKV 66
Query: 413 CCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARL-----LEIALGVAHAIEYLHN 465
+ R L+++Y + + + KP +L + + I YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 466 GCELRILHLDIKPQNVLL---DPDF-TPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 520
+LH D+KP N+L+ P+ K++D G A+ +S + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK--HLRPTETTSGSNTTEAYFPDWIYDKL 578
PE+ + + + D+++ G + E++ + H R E SN D I++ +
Sbjct: 184 PELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCR-QEDIKTSNPYHHDQLDRIFNVM 241
Query: 579 IQPEKEDF 586
P +D+
Sbjct: 242 GFPADKDW 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 357 LGTGGYGNVYKGKFPDG-RLVAVKVLEK--------TSNFSDNFINEVATIGRIHHVNII 407
+G G +G V K + ++ A+K+L K T+ F + +V G + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE--RDVLVNGDNQWITTL 66
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHN 465
H D + L+ +Y G L LLS+ ++ L AR L E+ + AI+ +H
Sbjct: 67 HYA--FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI----AIDSVH- 119
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+L +H DIKP N+L+D + +++DFG + +V + GT YI+PEI
Sbjct: 120 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176
Query: 526 R---NLGNPSGKSDVYSYGMLLLEMI 548
G + D +S G+ + EM+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 80/342 (23%), Positives = 135/342 (39%), Gaps = 95/342 (27%)
Query: 357 LGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HHVNII 407
LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH+N++
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 408 HLLG--------------FCCDGSTRALIY----EYMP--------------NGSLGDLL 435
+LLG FC G+ + E++P G + + L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 436 SR------------------------------EKENLSLKPARLLEI---ALGVAHAIEY 462
R E+E+L K L ++ + VA +E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
L + +H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 523 -IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
IF R + +SDV+S+G+LL E+ S Y I ++ +
Sbjct: 252 TIFDRVY---TIQSDVWSFGVLLWEIF--------------SLGASPYPGVKIDEEFCRR 294
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
KE D +M L C P RP+ + +VE L
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 423 YEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481
Y+ + + +LLS + E L+ LL VA +E+L + +H D+ +NV
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLD--LLSFTYQVARGMEFLASK---NCVHRDLAARNV 268
Query: 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 541
LL K+ DFGLA+ + + V+ + ++APE NL + SDV+SYG
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYG 326
Query: 542 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIV 601
+LL E+ P + Y+K+ K + + D +++ +
Sbjct: 327 ILLWEIFSLGGTPYPGMIVDST----------FYNKI----KSGYRMAKPDHATQEVYDI 372
Query: 602 GLWCIQINPKDRPSMTRVVEMLSS 625
+ C P+ RPS + +++ S
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 356 KLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
K+G G YG+VYK K DG + A+K +E T S + E+A + + H N+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKV 66
Query: 413 CCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARL-----LEIALGVAHAIEYLHN 465
S R L+++Y + + + KP +L + + I YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 466 GCELRILHLDIKPQNVLL---DPDF-TPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 520
+LH D+KP N+L+ P+ K++D G A+ +S + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
PE+ + + + D+++ G + E++
Sbjct: 184 PELLL-GARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFCC 414
LG G G V+ D + VAVK + T S + + E+ I R+ H NI+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 415 DGSTR-----------ALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460
+ +Y EYM L ++L E+ LS + ARL L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARLFMYQL--LRGL 127
Query: 461 EYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTI 516
+Y+H+ +LH D+KP NV ++ D K+ DFGLA+ H ++ ++ T
Sbjct: 128 KYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG--LVTK 182
Query: 517 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
Y +P + + N + D+++ G + EM+ K
Sbjct: 183 WYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 75/299 (25%), Positives = 112/299 (37%), Gaps = 92/299 (30%)
Query: 357 LGTGGYGNV-YKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN---------- 405
+G G +G V K G++ A+K L K+ F + ++ HV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD---------QLAHVKAERDVLAESD 59
Query: 406 ---IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 460
++ L D LI E++P G L +L + + S R + E L AI
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVL----AI 114
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRN------------- 503
E +H +L +H DIKP N+L+D K+SDFGL+ K H
Sbjct: 115 EAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 504 -----RSVV------TMTGPR-----------------GTIGYIAPEIFMRNLGNPSGKS 535
SV TM+ GT YIAPEIF++ +
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQEC 229
Query: 536 DVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
D +S G ++ E + E H + + T YFPD I+ + E ED +
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL--YFPDDIH---LSVEAEDLI 283
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 58/244 (23%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 343 YNDIKKMTNGFK--EKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSDNFINE 394
Y+D + N ++ +K+G G +G V+ K F + ++ + L++ + E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK--SQLVIE 62
Query: 395 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL-----SLKPARL 449
V + + H NI+ + + + + L Y M GDL SR + ++ +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKL-YILMEFCDAGDL-SRNIQKCYKMFGKIEEHAI 120
Query: 450 LEIALGVAHAIEYLHNGCE----LRILHLDIKPQNVLLDPDF-----------------T 488
++I + HA+ Y HN + R+LH D+KPQN+ L
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 489 PKVSDFGLAKAHSRNRSVVTMTGP-RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
K+ DFGL S+N + +M GT Y +PE+ + + KSD+++ G ++ E+
Sbjct: 181 AKIGDFGL----SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 548 IEEK 551
K
Sbjct: 237 CSGK 240
|
Length = 1021 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 357 LGTGGYGNVYKGKFPDG-RLVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHL-L 410
+G G +G V + + D R+ A+K + K S + + E + +++ I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
F L+ ++ G L L RE L AR L A +E LH +
Sbjct: 61 SFQSPEKLY-LVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCA--LENLH---KFN 113
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+++ D+KP+N+LLD + DFGL K + ++ GT Y+APE+ LG+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELL---LGH 168
Query: 531 PSGKS-DVYSYGMLLLEMI 548
K+ D ++ G+LL EM+
Sbjct: 169 GYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 374 RLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA------LIYE 424
R VA+K L + + E+ + ++H NII LL + L+ E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484
M + +L ++ E L R+ + + I++LH+ I+H D+KP N+++
Sbjct: 103 LM-DANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 153
Query: 485 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 544
D T K+ DFGLA+ + MT T Y APE+ + +G D++S G ++
Sbjct: 154 SDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVIL-GMGYKE-NVDIWSVGCIM 208
Query: 545 LEMIEEK 551
EM+ K
Sbjct: 209 GEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 356 KLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINE--VATIGRIHHVNIIHLLG 411
KL G +G V K K P +L K++ K NF N I E V + + + N I L
Sbjct: 23 KLIDGKFGKVSVLKHK-PTQKLFVQKII-KAKNF--NAI-EPMVHQLMK-DNPNFIKLYY 76
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
LI +Y+ +G L DLL +E + LS + I + A+ LH I
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKK--IIRQLVEALNDLHKH---NI 130
Query: 472 LHLDIKPQNVLLDPDFTPKV--SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+H DIK +NVL D ++ D+GL K + T + GT+ Y +PE
Sbjct: 131 IHNDIKLENVLYD-RAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLG 411
LG G +G V + D L A+K L K N + V + + ++ L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIEYLHNGCELR 470
D + +Y+P G + LL R + + P L + + A+E +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH---KMG 121
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA--------------HSRNRSV---------- 506
+H DIKP N+L+D D K++DFGL H R S+
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 507 VTMTGPR---------------------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 545
G R GT YIAPE+ +R + D +S G++L
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILY 239
Query: 546 EMI 548
EM+
Sbjct: 240 EML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
I++LH+ I+H D+KP N+++ D T K+ DFGLA+ N MT T Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188
Query: 519 IAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIE 549
APE+ LG ++ D++S G ++ E+++
Sbjct: 189 RAPEVI---LGMGYKENVDIWSVGCIMGELVK 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 449 LLEIALGVAHAIEYL-HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507
LL + VA +++L C +H D+ +NVLL K+ DFGLA+ + + V
Sbjct: 214 LLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269
Query: 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
R + ++APE + + +SDV+SYG+LL E+
Sbjct: 270 VKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVK----VLEKTSNFSDNFINEVATIGRIHHVNIIHL 409
E +G G YG V G VA+K V E S+ + + E+ + + H +I+ +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD-ATRILREIKLLRLLRHPDIVEI 64
Query: 410 LGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
S R +++E M + DL K N L P + A++Y+H
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
+ H D+KP+N+L + D K+ DFGLA+ + + + T T Y APE+
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
+ D++S G + E++ K
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 14/151 (9%)
Query: 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNII--HLLG 411
+ L G VY D V +K+ + EVA + + + +L
Sbjct: 3 IKLLKGGLTNRVYLLGTKDEDYV-LKINPSRE-KGADREREVAILQLLARKGLPVPKVLA 60
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L+ E++ +L ++ EKE+++ + A LL LH L +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAK----------LHQLPLLVL 110
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502
H D+ P N+L+D + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
I++LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
APE+ + +G D++S G ++ EMI+
Sbjct: 192 RAPEVIL-GMGYKE-NVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 18/64 (28%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 49 KCGNLTFSFPFSSSSTSGYCGL-PNYQITCDSSSV-PKLLLSGRLYQVRNFFSSQDDRLI 106
+CGN++ +PF C P +++TC++++ P+LLL Y+V + S + +
Sbjct: 7 RCGNVSIPYPF---GIGPGCARDPGFELTCNNTTSPPRLLLGNGNYEVLSI--SLANGTV 61
Query: 107 TVVD 110
V+D
Sbjct: 62 RVLD 65
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 18/188 (9%)
Query: 371 PDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427
P G LV V++ LE + + NEV H NI+ GS +I +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDIKPQNVLLDPD 486
GS LL + + A + I G + YLH NG +H +IK ++L+ D
Sbjct: 83 YGSANSLL-KTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGD 137
Query: 487 FTPKVSDFGLAKAHS--RN--RSVVTMTGPR---GTIGYIAPEIFMRNLGNPSGKSDVYS 539
+S GL+ +S RN ++ V P+ + +++PE+ ++L + KSD+YS
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 540 YGMLLLEM 547
G+ E+
Sbjct: 196 VGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
L G G V++ PD + V VK S+ ++E + R+ H ++ LL
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASS-----VHEARLLRRLSHPAVLALLDVRVV 231
Query: 416 GSTRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 473
G L+ +P L L L L A++ +A + AI+Y+H E I+H
Sbjct: 232 GGLTCLV---LPKYRSDLYTYLGARLRPLGL--AQVTAVARQLLSAIDYIH--GE-GIIH 283
Query: 474 LDIKPQNVLLDPDFTPK---VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
DIK +NVL++ P+ + DFG A + S G GT+ APE+ G+
Sbjct: 284 RDIKTENVLVN---GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA---GD 337
Query: 531 PSGKS-DVYSYGMLLLE 546
P S D++S G+++ E
Sbjct: 338 PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 371 PDGRLVAVKV--LEKTSNFSDNFIN-EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427
P G V V+ LE +N F+ E+ +H NI+ + ++ +M
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 487
GS DL+ + + + I GV A++Y+H+ + +H +K ++L+ D
Sbjct: 83 YGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVD- 137
Query: 488 TPKVSDFGLAKAHSR----NRSVVTMTGPRGTIG---YIAPEIFMRNLGNPSGKSDVYSY 540
KV GL S R V P+ ++ +++PE+ +NL KSD+YS
Sbjct: 138 -GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 541 GMLLLEM 547
G+ E+
Sbjct: 197 GITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDP 485
P + D L E LS L+ + VA+ +E+L + C +H D+ +NVL+
Sbjct: 221 PERTRRDTLINESPALSYMD--LVGFSYQVANGMEFLASKNC----VHRDLAARNVLICE 274
Query: 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 545
K+ DFGLA+ R+ + ++ + ++APE NL + SDV+S+G+LL
Sbjct: 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLW 332
Query: 546 EM 547
E+
Sbjct: 333 EI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 355 EKLGTGGYGNVYKGKFPDGR-------------LVAVKVLEKT-SNFSDNFINEVATIGR 400
E LG G +Y G V +KVL+ + + S F + + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 401 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460
+ H +I+ L G C ++ E++ G L DL K ++ P + ++A +A A+
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWK-FKVAKQLASAL 118
Query: 461 EYLHNGCELRILHLDIKPQNVLL-----DPDFTP--KVSDFGLA-KAHSRNRSVVTMTGP 512
YL + ++H ++ +N+LL D + P K+SD G+ SR V
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV------ 169
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 547
I +IAPE + + N S +D +S+G L E+
Sbjct: 170 -ERIPWIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 15/138 (10%)
Query: 353 FKEKLGTGGYGNV-----YKGKFPDGRL-VAVKVLEKTSNFSDN--FINEVATIGRI-HH 403
F + LG G +G V Y D + VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIAL--GVAHAI 460
+NI++LLG C G +I EY G L + L R++++ + K E AL + H
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR 158
Query: 461 EYLHNGCELRILHLDIKP 478
E C+ ++D+KP
Sbjct: 159 E---MSCDSLNEYMDMKP 173
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 353 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEKTSNFSDN---FINEVATIGRI-H 402
F + LG G +G V + GK + VAVK+L K S +D ++E+ + +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSHLGQ 100
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL 442
H NI++LLG C G +I EY G L + L ++ E
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 33/164 (20%)
Query: 357 LGTGGYGNVY----KGKFPDGRLVAVKV--LEKTSNFSDNF-------INEVATIGRIHH 403
+G GG+G VY K+ LE + + I+++A IH
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH- 78
Query: 404 VNIIHL---LGFCCDGSTRALIY------EYMPNGSLGDLLSREKENLSLKPARLLE-IA 453
NI HL + C R +Y E + + ++ R K K +L++ I
Sbjct: 79 -NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIM 132
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497
+ +EY+H E I H DIKP+N+++D + + D+G+A
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.03 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.8 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.68 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.46 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.29 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.8 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.57 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.54 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.01 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.95 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.21 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.13 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.11 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.99 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=438.01 Aligned_cols=280 Identities=43% Similarity=0.740 Sum_probs=236.2
Q ss_pred ccCCCCHHHHHHHHHhhh--ccccccCceEEEEEEeCCCcEEEEEEcccCCcc-hHHHHHHHHHhcccccccccccccee
Q 005909 337 LLSNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF-SDNFINEVATIGRIHHVNIIHLLGFC 413 (670)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~ 413 (670)
....|++.+++++|++|. ..||+|+||.||+|.+++++.||||++...... .++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 466799999999999998 589999999999999999999999988776654 67799999999999999999999999
Q ss_pred eeCC-eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 414 CDGS-TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 414 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
.+.+ ..+||||||++|+|.++|+..... .++|.++++||.++|+||+|||..+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999886554 78999999999999999999999988899999999999999999999999
Q ss_pred ecCCccccCC-CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSR-NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 571 (670)
|||+|+.... ........ .||.+|+|||++.. +..+.|+|||||||+|+||++|+++.+.... ..+..+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~-----~~~~~l~ 290 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV--MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRP-----RGELSLV 290 (361)
T ss_pred CccCcccCCccccceeeec--CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCC-----cccccHH
Confidence 9999977654 33322211 68999999999975 6899999999999999999999998876442 1222366
Q ss_pred HHHHHHhcCCccc-----ccc-chhhH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 572 DWIYDKLIQPEKE-----DFV-EEEDD-CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 572 ~~~~~~~~~~~~~-----~~~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+|++..+.+.... ... ..... +...++..++.+|++.+|++||+|.||+++|+..
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 7765554443221 111 12221 5677899999999999999999999999999744
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=390.80 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=209.6
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCcc---hHHHHHHHHHhccccccccccccceeeeCC-eeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF---SDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~e~~~~ 428 (670)
+.+.||+|+||+||+|.+.+...||||++...... .++|.+|+.+|.+++|||||+|+|+|.+.. ...+||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999976666999999875422 568999999999999999999999999888 79999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCcEEECCCC-CeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR-ILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~~ 506 (670)
|+|.++++.. .+..+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999874 334699999999999999999999998 6 99999999999999997 99999999998765432
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
..++...||+.|||||++.+....++.|+|||||||++|||+||+.||..... .+.+.........+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQVASAVVVGGLRPPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhcCCCCCC
Confidence 23344679999999999984223689999999999999999999999975332 1111222222222221
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
. ......+..++.+||+.||+.||++.+++..|+.....
T Consensus 268 p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 268 P----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred C----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1 22566788899999999999999999999999865443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=369.27 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred CCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEccc--CCcchHHHHHHHHHhccccccccccccceeeeCC
Q 005909 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS 417 (670)
Q Consensus 341 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 417 (670)
.+..|+++ .+.||+|..|+|||++++ +++.+|+|++.. .....+++.+|++++++.+||+||+++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44455553 378999999999999996 689999999943 3456789999999999999999999999999888
Q ss_pred -eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 418 -TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 418 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
...++||||.+|||++++...+ .+++..+-+|+.++++||.|||.. .+||||||||+|||++..|++||+|||.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 5999999999999999997653 599999999999999999999962 3999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
++.+... .....+||..|||||.+.+. .++.++||||||+.++|+++|+.|+.+.... .....+ ...
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------~~~~~~-Ll~ 292 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------YLDIFE-LLC 292 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCC------CCCHHH-HHH
Confidence 9887654 22456799999999999875 7888999999999999999999999764110 011111 122
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+..+..+.+... ..+.++..++..||++||.+||+++|++++
T Consensus 293 ~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2333222222222 467789999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=387.65 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=217.1
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
++.+....+.++||+|.||.||.|+++....||+|.++......++|.+|+++|++|+|+|||+++|+|..++..+||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 34444455778999999999999999888899999999887778999999999999999999999999999889999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
||+.|+|.++|.... +..+...+++.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+...++.
T Consensus 282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999998732 33688999999999999999999998 99999999999999999999999999999655544
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ...+..-+..|.|||.+.. +.++.|||||||||+||||+| |+.|+..... ..+.+.+.+
T Consensus 358 Y~-~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------~ev~~~le~--- 419 (468)
T KOG0197|consen 358 YT-ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------EEVLELLER--- 419 (468)
T ss_pred ee-ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCH------------HHHHHHHhc---
Confidence 43 3455566889999999975 589999999999999999998 5555543221 122233332
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+.+...+..++..+.+++..||..+|++|||+..+...|+...
T Consensus 420 -GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 420 -GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2333344456778999999999999999999999999988543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=383.75 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=209.6
Q ss_pred HHHhhhccccccCceEEEEEEe-CCCcEEEEEEccc----CCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+|...+.||+|||+++|+++. ..|+.||+|++.+ .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3455567899999999999998 7899999999987 4456788999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|.|++++|.+++++.+ .+++.+++.+..||+.||.|||++ +|+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999997543 699999999999999999999998 9999999999999999999999999999988754
Q ss_pred -CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 -RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
....+ ..|||.|+|||++.+. .++..+||||+|||+|.||.|++||+.... ...+.++....
T Consensus 172 ~Erk~T---lCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------------kety~~Ik~~~ 234 (592)
T KOG0575|consen 172 GERKKT---LCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV------------KETYNKIKLNE 234 (592)
T ss_pred ccccce---ecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH------------HHHHHHHHhcC
Confidence 33333 3489999999999864 788899999999999999999999975322 12233333221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. ..+...+.+..++|.++|+.||.+|||+++|+.+=
T Consensus 235 Y-----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 Y-----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred c-----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1 11123456778899999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=366.26 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=208.2
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--------chHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
.|-+.+.||+|+||.|-+|..+ +|+.||||++.+... ......+|+++|++|+|||||++++++...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3445689999999999999875 799999999976431 2234679999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC---CCeEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~---~~~ki~DfGla 497 (670)
+|+||+++|.|.+.+..++ .+.+..-.-++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|
T Consensus 253 mVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999997665 577888899999999999999998 99999999999999665 78999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
+....... +....||+.|.|||++.......+ .+.|+||+|||||-+++|.+||..... +.-..+
T Consensus 327 K~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-----------~~sl~e 392 (475)
T KOG0615|consen 327 KVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-----------DPSLKE 392 (475)
T ss_pred hcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-----------CccHHH
Confidence 98875443 444568999999999976533333 488999999999999999999975322 111234
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+..+.. .+.+..+.++..+..+++.|||..||++|||+.|++++
T Consensus 393 QI~~G~y-~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 QILKGRY-AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHhcCcc-cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 4444443 23345677889999999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=354.43 Aligned_cols=244 Identities=27% Similarity=0.437 Sum_probs=195.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.++||+|+||+||+|+++ ++..||||.+.+.. ...+.+..|+.+|+.++|||||+|++++..++..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 4467999999999999986 57999999997653 4567789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC------CCeEEeecCCccccCC
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD------FTPKVSDFGLAKAHSR 502 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~------~~~ki~DfGla~~~~~ 502 (670)
|+|.++|++.+ .+++..++.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+..
T Consensus 94 GDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 94 GDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999998765 599999999999999999999998 99999999999999764 4689999999999886
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..-.. ...|++-|||||+++. .+++.|+|+||+|+|+|++++|+.||+.... ......+.++
T Consensus 168 ~~~a~---tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~------------~eL~~~~~k~- 229 (429)
T KOG0595|consen 168 GSMAE---TLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETP------------KELLLYIKKG- 229 (429)
T ss_pred hhHHH---HhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCH------------HHHHHHHhcc-
Confidence 54332 3458999999999975 5899999999999999999999999974322 0111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
..............+.+++...++.+|.+|-+..+-..
T Consensus 230 -~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 230 -NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred -ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 12223333334444556666677777777766655443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=392.55 Aligned_cols=261 Identities=27% Similarity=0.467 Sum_probs=216.4
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeC
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG 416 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 416 (670)
++.+....+.++||+|+||.||+|+.. +.+.||||.++...+ ..++|.+|++++..++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444456789999999999999853 356899999987664 468999999999999999999999999999
Q ss_pred CeeEEEEEecCCCCcccccccccC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 417 STRALIYEYMPNGSLGDLLSREKE-----------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
+.+++|+|||..|+|.++|..... +.+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 999999999999999999965432 22388999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005909 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSN 564 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~ 564 (670)
+..|||+||||+|..-..++........-+++||+||.+.- +++|.+||||||||||||+++ |+.|+.....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccch-----
Confidence 99999999999997655544432223345789999999975 699999999999999999998 7778765332
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+.+.+.+..+.. .+.++..+.++.+|+..||+.+|++||+++||...|+..
T Consensus 712 -------~EVIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 712 -------QEVIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -------HHHHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 234444444332 344555678899999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=337.47 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=208.5
Q ss_pred HHHhhhccccccCceEEEEEEe-CCCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccc-eeeeC-CeeEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLG-FCCDG-STRALI 422 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~-~~~~lv 422 (670)
..+.+.++||.|.||+|||+.. .+|..+|.|.+.-. ....++...|+.+|++|+|||||++++ -+.+. +..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3455678999999999999975 58999999998733 245678999999999999999999999 34444 448999
Q ss_pred EEecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 423 YEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
||++.+|+|..+++..+ .+..+++..+++++.|++.||..+|++ .++ |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999997643 345799999999999999999999984 224 99999999999999999999999999999
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
+...... ....+|||.||+||.+.++ .++.||||||+||++|||..-+.||.+..- .....++.
T Consensus 178 l~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------------~~L~~KI~ 241 (375)
T KOG0591|consen 178 LSSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL------------LSLCKKIE 241 (375)
T ss_pred hcchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH------------HHHHHHHH
Confidence 8765543 2456899999999999875 788999999999999999999999975421 12344555
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.+.. .+-...-++..+..++..|+..||+.||+.-.++..+.
T Consensus 242 qgd~---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 242 QGDY---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cCCC---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 4432 22233567888999999999999999998655555554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.12 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=205.2
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||+|.||+||+|+|.+ .||||+++... +..+.|.+|+..+++.+|.||+-|.|+|..... .+|+.+|++
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 356899999999999999943 58999998654 456789999999999999999999999998877 999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
.+|+.+||-... .++..+.+.||.|++.||.|||.+ +|||||||+.||+|.+++.|||+||||+.....-.....
T Consensus 472 sSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 472 SSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred chhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 999999987664 489999999999999999999998 999999999999999999999999999976544333333
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
...+.|...|||||++... ...+++.+||||||+|+|||++|..|+..... .. .++. +.++......
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq----------Iifm-VGrG~l~pd~ 614 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ----------IIFM-VGRGYLMPDL 614 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh----------eEEE-ecccccCccc
Confidence 3456689999999999642 24679999999999999999999999972211 10 0111 1111111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
........++|.+|+..||..++++||.+.+|+..|+...
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1112234568889999999999999999999999888543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=372.89 Aligned_cols=270 Identities=25% Similarity=0.445 Sum_probs=224.7
Q ss_pred cCCCCHHHHHHHHHhhh-----------ccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhcc
Q 005909 338 LSNYSYNDIKKMTNGFK-----------EKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGR 400 (670)
Q Consensus 338 ~~~~~~~~l~~~~~~~~-----------~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~ 400 (670)
...++|+|.-++..+|. +.||.|.||.|++|+++ ....||||.++... +...+|+.|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 45678888777777664 46999999999999985 24689999998754 556799999999999
Q ss_pred ccccccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCc
Q 005909 401 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480 (670)
Q Consensus 401 l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 480 (670)
+.||||++|.|+........+|.|||+||+|+.+|+.+.+ .+.+.++.-++++||.||.||-+. +.|||||..+|
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARN 761 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARN 761 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhh
Confidence 9999999999999999999999999999999999987664 489999999999999999999975 99999999999
Q ss_pred EEECCCCCeEEeecCCccccCCCC-ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTE 558 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~ 558 (670)
||++.+..+|++||||+|.+.++. ...+..+.+-+++|.|||.+.- .+++.+|||||||+|+||.++ |.+|+-...
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999886554 3333445566889999999975 489999999999999999986 777764322
Q ss_pred CCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccccc
Q 005909 559 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630 (670)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 630 (670)
. ++++.....+.....+.+.+..|.+|++.|||+|..+||.+.+|+..|..+..++
T Consensus 840 N----------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 840 N----------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred h----------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 1 2222222233444455567888999999999999999999999999998765443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=346.07 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=208.6
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHH--HHHHHHHhcccc-ccccccccceeeeCC-eeEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDN--FINEVATIGRIH-HVNIIHLLGFCCDGS-TRALIY 423 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lv~ 423 (670)
.+|...++||.|.||.||+|+.. ++..||||.+++.-...++ -++|+..|++|+ ||||++|.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 45667899999999999999865 6899999999876544444 367999999998 999999999999888 899999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||| ..+|.++++++ +..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+||||||.....
T Consensus 90 E~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 999 67999999876 34799999999999999999999998 9999999999999998889999999999988655
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchH-HH
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPD-WI 574 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~-~~ 574 (670)
.. .+.-+.|.+|+|||++.+. +.++.+.|+|++|||++|+.+-++.|.+..+.+.. ......++. .-
T Consensus 164 pP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 PP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 3445679999999999876 78899999999999999999999988765442100 001111111 11
Q ss_pred HHHhcCCcc----ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 575 YDKLIQPEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 575 ~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......-.. ...........+.+.++++.+|+++||++|||+.|.+++-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111 1111111122566788999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.62 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=213.1
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
|++.+.||.|..++||+|+. +.+..||||++...+ ...+.+.+|+..|+.++||||++.+..|..+..+|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 45678999999999999986 468999999997655 346789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC-CCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR-NRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~-~~~~ 506 (670)
+||+.++++..-.. .+++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.+-.+.. +...
T Consensus 108 ~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 99999999765433 499999999999999999999998 999999999999999999999999998765432 2221
Q ss_pred -eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC----
Q 005909 507 -VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP---- 581 (670)
Q Consensus 507 -~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 581 (670)
..+...+||+.|||||+++.....++.|+||||||+...||.+|..||...... .....++...
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----------kvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----------KVLLLTLQNDPPTL 252 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----------HHHHHHhcCCCCCc
Confidence 222567899999999998777778899999999999999999999999754331 1111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.......+..+.....+.+++..||+.||++|||+++++++=
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 111344555667777899999999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.45 Aligned_cols=260 Identities=21% Similarity=0.344 Sum_probs=199.7
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
-..++|+|+||.|||.+++ +|+.||||++..+++ ..+-.++|+++|++++|+|+|.++.+|.....++||+||++.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3468999999999999987 599999999987664 346789999999999999999999999999999999999976
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC-CCcee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR-NRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~-~~~~~ 507 (670)
.-|.++= +... .++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 86 TvL~eLe-~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--- 156 (396)
T KOG0593|consen 86 TVLHELE-RYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--- 156 (396)
T ss_pred HHHHHHH-hccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc---
Confidence 5555443 3222 489999999999999999999998 999999999999999999999999999998873 32
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc---ccchHHHHHHhc-----
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFPDWIYDKLI----- 579 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~----- 579 (670)
..+..+.|.+|+|||++.+. ..+....||||+||++.||++|.+.|.+..+.+.-.... ..+...-.+-..
T Consensus 157 ~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 23455679999999999875 477889999999999999999999886543311000000 000000000000
Q ss_pred ------CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 ------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........+..-......+++++..||+.||++|++-++++.+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0001111111223345578999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=338.78 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=202.5
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHh--ccccccccccccceeeeCC----eeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATI--GRIHHVNIIHLLGFCCDGS----TRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l--~~l~H~nIv~l~g~~~~~~----~~~lv~e~~ 426 (670)
+.+.||+|.||.||||.+ +++.||||++..... +.|++|-++. -.++|+||+++++.-..+. .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 457899999999999999 459999999986554 4555555544 4568999999999877655 789999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
++|+|.++|+.+ .++|....+|+..+++||+|||... +++|+|||||++||||.+|++..|+|||||..+
T Consensus 291 ~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 291 PKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred cCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999876 5999999999999999999999653 568999999999999999999999999999998
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCC-----ccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc-----ccc
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-----GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE-----AYF 570 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~-----~~~ 570 (670)
..........+.+||.+|||||++.+.. ++. .+.||||+|.|||||+++-..+++.....-+...+ -.-
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 8776666667789999999999998752 333 35799999999999998876654321111000000 011
Q ss_pred hHHHHHHhcCCccccccchhh--HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 571 PDWIYDKLIQPEKEDFVEEED--DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+.+++.+...+......... .....-+.+.+.-||..|++.|.|+.=+.+++.++
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 112233333332222222111 13355688899999999999999999988888754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=352.11 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=204.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcccc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 434 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 434 (670)
+.||.|+.|.||.|++ .++.||||+++.-++ .+|+-|++|+|+||+.|.|+|.....++||||||..|-|..+
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~elkE------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVRELKE------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhhhh------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 6799999999999999 577899998765433 689999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCC
Q 005909 435 LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514 (670)
Q Consensus 435 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~g 514 (670)
|+..+ .+.+..+..|..+||.||.|||.+ .|||||||+-||||+.+..+||+|||.++...... ++..+.|
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaG 273 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAG 273 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhh
Confidence 97665 689999999999999999999998 99999999999999999999999999998876553 2345679
Q ss_pred CccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHH
Q 005909 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCI 594 (670)
Q Consensus 515 t~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (670)
|..|||||++... ..++|.|||||||||||||||..|+...+.. ..||.. .. ..+-...+...
T Consensus 274 TVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----------AIIwGV-Gs---NsL~LpvPstc 336 (904)
T KOG4721|consen 274 TVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----------AIIWGV-GS---NSLHLPVPSTC 336 (904)
T ss_pred hHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchh-----------eeEEec-cC---CcccccCcccC
Confidence 9999999999764 7899999999999999999999998754321 011111 00 01111122234
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccccccCCC
Q 005909 595 ARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPP 635 (670)
Q Consensus 595 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 635 (670)
+.-+.-|+++||+..|..||++++|+.+|.=+..+.++++.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~te 377 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTE 377 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccH
Confidence 55677789999999999999999999999855555555543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=342.90 Aligned_cols=261 Identities=27% Similarity=0.410 Sum_probs=205.9
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e 424 (670)
++-.++||+|.||.||||+. .+|+.||+|+++.+. ....-..+||.+|++|+||||++|.+...+. ...|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 34457899999999999987 479999999997654 4456788999999999999999999998876 68999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
||++ +|.-++.... ..+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+.+....
T Consensus 199 YMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 199 YMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9964 7877776543 3599999999999999999999998 99999999999999999999999999999876554
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccccchHHHHH
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDWIYD 576 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~ 576 (670)
.. .++..+-|.+|+|||++.+. ..++.+.|+||.||||.||+.|+..+.+..+... ....+.+++ ..
T Consensus 273 ~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~---~~ 347 (560)
T KOG0600|consen 273 SA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP---VS 347 (560)
T ss_pred Cc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc---cc
Confidence 33 35677789999999999987 5889999999999999999999999876543110 011111211 11
Q ss_pred Hhc-----CCcc--ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLI-----QPEK--EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~-----~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
++. .... .....+.....+...++|+..+|..||++|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 1111 112223334456677889999999999999999998853
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.81 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=203.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|.-.++||+|.||.||+|++. +|+.||||+++..+ ......++|++.|+.++|+||+.+++++...+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 444578999999999999874 79999999998654 23567899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
..+|+.+|+... ..+.+..+..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 84 -~tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 84 -PTDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred -cccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 568999997654 3699999999999999999999998 9999999999999999999999999999988755433
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--------CCCCcc------ccchH
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS--------GSNTTE------AYFPD 572 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~--------~~~~~~------~~~~~ 572 (670)
. +..+-|.+|+|||++.+. ..++...||||.|||+.||+-|.+-|.+..+.+ ...... ..+++
T Consensus 158 ~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred c--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 2 223578999999999986 578889999999999999998877665433311 001111 12222
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
++.-+ ....+... ..-......+.+++..|+..||.+|++++|++++=
T Consensus 235 Y~~~~--~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 235 YVKIQ--QFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HHHHh--cCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 22111 10000000 01112345568899999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.70 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||+|+||+||.++.+ +++.+|+|++++.. ...+...+|..+|.+++||.||+++-.|.+.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 5589999999999999875 68999999998754 346778999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
||.|..+|.+++ .+++..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++..-.....
T Consensus 109 GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~- 181 (357)
T KOG0598|consen 109 GGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA- 181 (357)
T ss_pred CccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc-
Confidence 999999998765 589999999999999999999998 9999999999999999999999999999854333221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|||||++.+. .++..+|.||+|+++|||++|.+||..... ..+.+++.......
T Consensus 182 -t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~------------~~~~~~I~~~k~~~-- 244 (357)
T KOG0598|consen 182 -TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDV------------KKMYDKILKGKLPL-- 244 (357)
T ss_pred -cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccH------------HHHHHHHhcCcCCC--
Confidence 1235699999999999875 788999999999999999999999975432 22344444433111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRP----SMTRVVE 621 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~ 621 (670)
.+.-.+.+..+++...|+.||++|. .+.+|-+
T Consensus 245 --~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 245 --PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1111345677888999999999995 4555444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=340.04 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=201.9
Q ss_pred hhccccccCceEEEEEEeCC-CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCC--eeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~e~~~~ 428 (670)
..+.||+|+||+||++...+ |...|||.+.... ...+.+.+|+.+|.+++|||||+.+|.....+ ..++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 45789999999999999864 8999999987653 22567899999999999999999999855444 68899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCC-CCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSR-NRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~-~~~~ 506 (670)
|+|.+++.+.++ .+++..+.++++|+++||+|||++ +|||+||||+|||++. ++.+||+|||+++.... ....
T Consensus 101 GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 101 GSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999988765 599999999999999999999998 9999999999999999 79999999999987763 1111
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......+||+.|||||++... .....++|||||||++.||+||+.||... .....++.........+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEALLLIGREDSLP-- 242 (313)
T ss_pred cccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHHHHHhccCCCC--
Confidence 122346799999999999751 23345899999999999999999998642 11122222222222112
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..+..++.+..+++..|++.||++||||.+++++.-
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 223335667888999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.39 Aligned_cols=244 Identities=25% Similarity=0.420 Sum_probs=205.4
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
++||+|+.|.||.++. .+++.||||++..... ..+-+.+|+.+|+..+|+|||++++.+..++.+|+|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 6899999999999976 4788999999987664 3456889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++... .+++.++..|.++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....... ...
T Consensus 359 DvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--~Tm 429 (550)
T KOG0578|consen 359 DVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--STM 429 (550)
T ss_pred hhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--ccc
Confidence 999665 489999999999999999999998 99999999999999999999999999998887665432 346
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
+||+.|||||++.++ .++.|.||||||++++||+.|.+||-.... +.+ ++ .+.. .........+
T Consensus 430 VGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----------lrA-ly-LIa~--ng~P~lk~~~ 493 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------LRA-LY-LIAT--NGTPKLKNPE 493 (550)
T ss_pred cCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCCh----------HHH-HH-HHhh--cCCCCcCCcc
Confidence 799999999999875 788899999999999999999999854222 111 00 1111 1112223345
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.++..+.+++.+||+.|+++|++++|+|++=
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 6788899999999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.95 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=200.3
Q ss_pred HHHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCC-e
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-T 418 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~ 418 (670)
..+.+.++||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3455678999999999999974 235689999987543 2346789999999999 8999999999887644 5
Q ss_pred eEEEEEecCCCCcccccccccC----------------------------------------------------------
Q 005909 419 RALIYEYMPNGSLGDLLSREKE---------------------------------------------------------- 440 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 440 (670)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999998864321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCcccc
Q 005909 441 -NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519 (670)
Q Consensus 441 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~ 519 (670)
...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12478889999999999999999998 99999999999999999999999999998664332222222334678899
Q ss_pred chhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHH
Q 005909 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKM 598 (670)
Q Consensus 520 aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (670)
|||++.+. .++.++||||||+++|||++ |+.||..... .......+..+..... ....+..+
T Consensus 244 aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~----~~~~~~~l 306 (338)
T cd05102 244 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----------NEEFCQRLKDGTRMRA----PENATPEI 306 (338)
T ss_pred CcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-----------cHHHHHHHhcCCCCCC----CCCCCHHH
Confidence 99999753 67889999999999999997 9998864321 0111122222111111 12234568
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 599 IIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 599 ~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+++.+||+.||++||++.||++.|+.+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.13 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=205.7
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|.+.||+|+|++|++|+.. .++.+|||++.+.. ...+-...|-.+|.+| .||.|++|+-.|.+...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 6789999999999999875 68999999997643 3445677888999999 8999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.++|++.+ .+++...+.++.+|+.||+|||+. |||||||||+|||||+++++||+|||.|+.+......
T Consensus 157 ~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred CCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999998775 599999999999999999999998 9999999999999999999999999999987532211
Q ss_pred ---------ee--ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 507 ---------VT--MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 507 ---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
.. ...++||..|++||++... ..+..+|+|+|||+||+|+.|++||....+ -.++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------------yliF 296 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE------------YLIF 296 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH------------HHHH
Confidence 11 1457899999999999864 778899999999999999999999976543 1234
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
+++..-.. +.+...++.+.+|+.+.|..||.+|++.++|.++.-
T Consensus 297 qkI~~l~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 297 QKIQALDY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHHhcc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 44433222 111122345677888899999999999999998874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=371.29 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=209.2
Q ss_pred HHHHhhhccccccCceEEEEEEeCC--Cc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCee
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPD--GR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 419 (670)
.....+.+.||+|+||.||+|...+ +. .||||.+++.. ....+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3344456789999999999998743 43 48999998764 4567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 420 ALIYEYMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
++++|||++|+|..+|++.+. ...+....++.++.|||+|+.||+++ +.|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987632 23689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
||+.+...+.........-+..|||||.+.. +.++.|+|||||||++||++| |..|+..... ..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n------------~~v 913 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------------FEV 913 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch------------HHH
Confidence 9996654444332222345679999999986 689999999999999999999 5566643222 112
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
...+..+. +...+..++..+.+|+.+||+.+|++||++..|++.+......
T Consensus 914 ~~~~~~gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 914 LLDVLEGG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHhCC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22122211 2222333466788999999999999999999999998865443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=349.09 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=203.5
Q ss_pred hhccccccCceEEEEEEeCC--C--cE-EEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFPD--G--RL-VAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.++||+|+||.||+|++.. + .. ||||..+.+ .....+|.+|+++|++++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45899999999999998753 2 23 899998852 245678999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|+|+||+|.++|+.... .++..+.++++.+.|.||+|||++ ++|||||.++|+|++.++.+||+||||++.....
T Consensus 241 El~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999987654 589999999999999999999998 9999999999999999999999999998765411
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
. .......-+..|+|||.+.. +.++.++|||||||++||+++ |..|+.+... ..+..++....
T Consensus 316 ~--~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------------~~v~~kI~~~~ 379 (474)
T KOG0194|consen 316 V--MKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------------YEVKAKIVKNG 379 (474)
T ss_pred e--eccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCH------------HHHHHHHHhcC
Confidence 1 11112245789999999975 488999999999999999998 6777765332 13334442221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... .+...+..+..++.+||+.||++||+|.++.+.|+....
T Consensus 380 ~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 380 YRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred ccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1111 111345677788889999999999999999999985543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=337.18 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=200.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----C--cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----S--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||+|+.|++. +++.||+|++.+. . ...+.+.+|+.++++++ ||||++++.++......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 445688999999999999875 6899999987664 1 23456678999999998 99999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHS 501 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~ 501 (670)
|||+.+|+|.+++.+.+ .+.+..+.+++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999998732 588899999999999999999998 99999999999999999 999999999999873
Q ss_pred -CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 502 -RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 502 -~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
.+.. .....||+.|+|||++.+.......++||||+||+||.|++|+.||+.... .....++..
T Consensus 173 ~~~~~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------------~~l~~ki~~ 237 (370)
T KOG0583|consen 173 GEDGL---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------------PNLYRKIRK 237 (370)
T ss_pred CCCCc---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------------HHHHHHHhc
Confidence 3322 344669999999999987621336799999999999999999999986322 112233333
Q ss_pred CccccccchhhHHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 581 PEKEDFVEEEDDCI-ARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 581 ~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+... .+..+ +..+..++.+||+.||.+|+++.+|++
T Consensus 238 ~~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCcc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 2221 11111 567788999999999999999999994
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.19 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcc----hHHHHHHHHHhccccccccccccceeee----CCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF----SDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e~~ 426 (670)
..||+|++|.||+|++ +|+.||||+++..... .+.+.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999998 7889999999765432 4677899999999999999999999877 34678999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.... .+++...++++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997643 588999999999999999999973 278899999999999999999999999998654322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC-cccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP-EKED 585 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 585 (670)
....|+..|+|||++.+....++.++|||||||++|||++|+.||..... ..+...+... ....
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------------~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------------KEIYDLIINKNNSLK 242 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhcCCCCC
Confidence 12347899999999976445788999999999999999999999964321 1111222111 1111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
. +...+..+.+++.+||+.||++|||++|+++.|++.
T Consensus 243 ~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 L----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 112355788999999999999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=342.25 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=208.5
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||.|+-|.|-.|++. +|+.+|||++.+.. .....+.+|+.+|+.|+||||+++++++++...+|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 4578999999999999985 79999999997653 334568899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|-|.+++.+.+ .+++.++.+++.||+.|+.|+|+. +|+||||||+|+|||..+++||+|||+|..-..+.-..
T Consensus 96 gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 96 GGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred CchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999999997665 699999999999999999999998 99999999999999999999999999998766555433
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
+ ..|++.|.|||++++. .....++||||.|||||.||+|+.||++... ..+..++..+..
T Consensus 170 T---SCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------------r~LLlKV~~G~f---- 229 (786)
T KOG0588|consen 170 T---SCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI------------RVLLLKVQRGVF---- 229 (786)
T ss_pred c---cCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH------------HHHHHHHHcCcc----
Confidence 3 4589999999999986 3557899999999999999999999985432 223344444433
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
+.+..++.+..+|+.+||..||+.|.|++||+++--
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 222445667888999999999999999999999753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.28 Aligned_cols=243 Identities=29% Similarity=0.424 Sum_probs=205.1
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|.||.||||+-+ +.+.||+|.+.+.. ...+.+.+|++++++++||||+.++++|+.....++|.||+.+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 4577999999999999876 68999999997654 3456789999999999999999999999999999999999965
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
+|..+|.... .++++.+..++.++..||.|||+. +|+|||+||.|||++.++.+|++|||+|+.+..+.. .
T Consensus 86 -~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--v 156 (808)
T KOG0597|consen 86 -DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--V 156 (808)
T ss_pred -hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce--e
Confidence 9999997654 599999999999999999999998 999999999999999999999999999999876544 3
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.+..+|||-|||||++.+ +.++..+|.||+|||+||+.+|++||..... .+.+..-+.++..
T Consensus 157 ltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------~~Lv~~I~~d~v~----- 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------TQLVKSILKDPVK----- 218 (808)
T ss_pred eeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------HHHHHHHhcCCCC-----
Confidence 466789999999999986 4788899999999999999999999964322 1122111222111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+...+..+..++...|++||.+|.+-.+++.+-
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1124567888999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=334.61 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=197.5
Q ss_pred HHhhhccccccCceEEEEEEeCC-----------------CcEEEEEEcccCC--cchHHHHHHHHHhcccccccccccc
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD-----------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLL 410 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~ 410 (670)
.+.+.++||+|+||.||++.+++ +..||+|++.... ....++.+|+.++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 34567899999999999997532 3469999987643 2346799999999999999999999
Q ss_pred ceeeeCCeeEEEEEecCCCCcccccccccC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 005909 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKE----------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHL 474 (670)
Q Consensus 411 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 474 (670)
+++.+.+..++||||+++|+|.+++..... ...+++..+++++.|++.||.|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 999999999999999999999998854321 12467888999999999999999998 99999
Q ss_pred CCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhC--CC
Q 005909 475 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE--KK 552 (670)
Q Consensus 475 dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg--~~ 552 (670)
||||+|||+++++.+||+|||+++...............++..|+|||++.. +.++.++||||||+++|||+++ ..
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999987654433222223446789999999865 4688899999999999999874 45
Q ss_pred CCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 553 HLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 553 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
|+..... ......+.......... .........+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTD--------EQVIENAGEFFRDQGRQ-VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCH--------HHHHHHHHHHhhhcccc-ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5543211 11111111111111000 000011123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.70 Aligned_cols=249 Identities=32% Similarity=0.592 Sum_probs=194.5
Q ss_pred hhccccccCceEEEEEEeC-----CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.||.|.||.||+|.+. .+..|+||+++.... ..+++.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999886 257899999965432 368899999999999999999999999988889999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.++|.... ...+++..+..|+.|+++||+|||++ +++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 23589999999999999999999998 999999999999999999999999999987743333
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
............|+|||.+... ..+.++||||||+++|||++ |+.|+..... ..+...+.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------------~~~~~~~~~~~~~ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------------EEIIEKLKQGQRL 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------------HHHHHHHHTTEET
T ss_pred cccccccccccccccccccccc--ccccccccccccccccccccccccccccccc------------ccccccccccccc
Confidence 3333445578899999999764 57899999999999999999 6677643211 1222333333222
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.. ....+..+.+++.+||+.||++||++.+|++.|
T Consensus 225 ~~----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PI----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ee----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 122355688899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=305.26 Aligned_cols=250 Identities=28% Similarity=0.385 Sum_probs=205.4
Q ss_pred HHHHhhccccCCCCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccc
Q 005909 329 FIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHH 403 (670)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H 403 (670)
+..+........+++.|.+ +.+.||.|+||.|..++.+ +|..+|+|++.+.. ...+...+|..+|+.+.|
T Consensus 29 ~~~~~~~~~~~~~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~ 103 (355)
T KOG0616|consen 29 FPKKWANTPQNPYSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH 103 (355)
T ss_pred hhhhhcCCCCCCcchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC
Confidence 3333333333336666554 4578999999999999986 68899999998755 345678899999999999
Q ss_pred cccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 404 ~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
|.++++++.+.+.+..+|||||+++|.|..+|++.+ .+++..++.+|.||+.||+|||+. +|++|||||+||||
T Consensus 104 PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLl 177 (355)
T KOG0616|consen 104 PFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLL 177 (355)
T ss_pred ceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeee
Confidence 999999999999999999999999999999998765 599999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 563 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~ 563 (670)
|.+|.+||+|||.|+...... .+ ..|||.|+|||.+... .+..++|-|||||++|||+.|..||.....
T Consensus 178 D~~G~iKitDFGFAK~v~~rT--~T---lCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~---- 246 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGRT--WT---LCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP---- 246 (355)
T ss_pred ccCCcEEEEeccceEEecCcE--EE---ecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh----
Confidence 999999999999999876542 22 3489999999999875 677899999999999999999999975433
Q ss_pred CCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCC
Q 005909 564 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613 (670)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 613 (670)
..+++++..+...- +.-....+.+++...|+.|-.+|
T Consensus 247 --------~~iY~KI~~~~v~f-----P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 --------IQIYEKILEGKVKF-----PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------HHHHHHHHhCcccC-----CcccCHHHHHHHHHHHhhhhHhh
Confidence 34677777665421 11123456677888888888888
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=343.56 Aligned_cols=256 Identities=26% Similarity=0.471 Sum_probs=199.5
Q ss_pred HHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.++||+|+||.||+|++ .++..||||+++... ...+.+.+|+.++..+ +||||+++++++.+++..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 345678999999999999964 245689999997543 2346788999999999 8999999999999999999
Q ss_pred EEEEecCCCCcccccccccC------------------------------------------------------------
Q 005909 421 LIYEYMPNGSLGDLLSREKE------------------------------------------------------------ 440 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 440 (670)
+||||+++|+|.+++.+...
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 99999999999988864321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 441 ------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 441 ------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
...+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 12478889999999999999999998 999999999999999999999999999987654332222
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||..... ...+... +........
T Consensus 273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~----~~~~~~~~~- 338 (375)
T cd05104 273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKM----IKEGYRMLS- 338 (375)
T ss_pred cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHH----HHhCccCCC-
Confidence 2223456789999999753 67889999999999999998 7777754221 1111111 111111110
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
....+.++.+++.+||+.||++||++.||++.|++
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11224578899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.24 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=218.9
Q ss_pred CHHHHHHHHHhhhccccccCceEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 342 SYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 342 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
+-.|+++.......+||.|.||.||.|.|+. .-.||||.++.+....++|++|+.+|+.++|||+|+|+|+|......|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3345555555567899999999999999974 668999999998888999999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
||+|||.+|+|.++|.+-. +..++...++.++.||+.||+||..+ ++|||||..+|.|+.++..+||+||||++++
T Consensus 340 IiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999997643 33588888999999999999999998 9999999999999999999999999999998
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
..+.... ..+..=++.|.|||-+.- ..++.|+|||+|||+|||+.| |..|+.+.+. ..++..+.
T Consensus 416 tgDTYTA-HAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------------SqVY~LLE 480 (1157)
T KOG4278|consen 416 TGDTYTA-HAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYGLLE 480 (1157)
T ss_pred cCCceec-ccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH------------HHHHHHHh
Confidence 7665433 344556789999999864 478999999999999999998 6666644321 12333332
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
. +...+.+..+++.+.+++++||+++|.+||++.|+.+.++.+.
T Consensus 481 k----gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 K----GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred c----cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 2 2333444456778999999999999999999999999887543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=328.07 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=203.5
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.||+|.||.||||.+. .++.||+|++.... ...+++++|+.+|.+.+++||.+.+|.+..+..++++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 378999999999999875 68999999997654 556889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
+.+.|+... .+++..+.-++++++.||.|||++ +.+|||||+.|||+..+|.+|++|||++..+....... .
T Consensus 98 v~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 98 VLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred hhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 999997553 357888888999999999999998 99999999999999999999999999998876554432 4
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
..+||+.|||||++... .++.|+||||||+..+||++|.+|+...... +++........+..
T Consensus 170 tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L 231 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRL 231 (467)
T ss_pred cccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCcc
Confidence 57899999999999853 7888999999999999999999998754431 00000001111122
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....++.+.+++..||+.||+.||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22456778899999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.79 Aligned_cols=249 Identities=24% Similarity=0.438 Sum_probs=201.1
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.+.||+|+||.||++.++++..+|+|.+.......+++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 35678999999999999998888999999886665667899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.++++.... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++........ ....
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 87 LNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred HHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 999875432 488999999999999999999988 9999999999999999999999999999865433222 1223
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
..++..|+|||.+... .++.++||||||+++|||++ |+.||..... .+ ....+........
T Consensus 161 ~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----------~~-~~~~i~~~~~~~~---- 222 (256)
T cd05114 161 AKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----------YE-VVEMISRGFRLYR---- 222 (256)
T ss_pred CCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----------HH-HHHHHHCCCCCCC----
Confidence 3456789999998653 67889999999999999999 8888854321 11 1111221111101
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112456889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.86 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||.||+++.+ +++.+|+|+++... .....+.+|+.++.+++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 23456788999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 9999886543 589999999999999999999998 999999999999999999999999999875422211 11
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~------------~~~~~~~~~~~~-~---- 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEI-R---- 213 (323)
T ss_pred cceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCH------------HHHHHHHHcCCC-C----
Confidence 234589999999999753 678899999999999999999999864221 111111111111 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
....+...+.+++.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1122456788899999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.46 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=199.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+...+.||+|+||+||+|++. +++ .||+|+++... ...+++.+|+.+++.++||||++++|++... ..++++
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 445678999999999999864 333 48999987543 3456889999999999999999999998765 567999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++..... .+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 88 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999976432 488899999999999999999998 9999999999999999999999999999877654
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.......+..++..|+|||++.+ ..++.++||||||+++|||++ |+.|+..... ..+...+....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------SEISSILEKGE 228 (316)
T ss_pred CcceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHhCCC
Confidence 44333333445778999999975 367889999999999999998 8888854211 00111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
..... ......+.+++.+||+.+|++||++.+++..|.....+
T Consensus 229 ~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 RLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111 11234678899999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.86 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=200.2
Q ss_pred HHHhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
..+.+.+.||+|+||.||+|.++ .+..||+|+++... ...+.+.+|+..+.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34456789999999999999763 35689999988653 3346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 2588999999999999999999988 999999999999999999999999998765432
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... ......++..|+|||.+.+ ..++.++||||||+++||+++ |+.||..... ..+...+.+.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------------~~~~~~~~~~ 224 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------------QDVIKAVEDG 224 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHHCC
Confidence 2111 1112335678999999865 477889999999999999875 9998864321 1111222221
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.... .....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 ~~~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 FRLP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1111 122345678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.96 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=205.6
Q ss_pred HHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+..+.+.+.||+|++|.||+|.+.+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++|+||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34456678999999999999998888899999998766667789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 999999986543 23589999999999999999999987 9999999999999999999999999999876533211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
...+...+..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~~- 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------------AEVLQQVDQGYRMP- 224 (261)
T ss_pred ccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCCC-
Confidence 11223345689999998653 67889999999999999999 8888754211 11112221111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111234678899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=330.85 Aligned_cols=266 Identities=25% Similarity=0.415 Sum_probs=215.2
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
|.-+....|.++||+|-||.|.......+..||||+++... ....+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 33444445678999999999999999888999999998765 3457999999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+|||++|+|.++|.++... .+......+|+.||+.||+||.+- ++|||||.++|+|+|.++++||+|||++|-+-.
T Consensus 614 ~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999877533 245566778999999999999987 999999999999999999999999999997766
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..........+-+++|||+|.+.. ++++.+||||+||+.+||+++ ...|+....... ..+. ...+..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------vven-~~~~~~ 758 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------VVEN-AGEFFR 758 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------HHHh-hhhhcC
Confidence 666554445567899999999975 599999999999999999864 667775432210 0000 111222
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
..........+.-.+..+.+++.+||..|.++||+++++...|++
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 222233333444556788899999999999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.42 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=199.6
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.+.||+|+||.||+++.. ++..||+|+++... ...+.+.+|+.+++.+ +|+||+++++++.+....+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4456789999999999998742 34589999997543 2345788999999999 8999999999999999999
Q ss_pred EEEEecCCCCcccccccccC------------------------------------------------------------
Q 005909 421 LIYEYMPNGSLGDLLSREKE------------------------------------------------------------ 440 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 440 (670)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999988854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCC
Q 005909 441 -------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 513 (670)
Q Consensus 441 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~ 513 (670)
...+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...............
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 12478889999999999999999998 99999999999999999999999999998664433222222234
Q ss_pred CCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 514 gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
++..|+|||++.+ ..++.++||||||+++|||++ |+.||..... .. .....+....... ...
T Consensus 276 ~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~----~~~~~~~~~~~~~----~~~ 338 (374)
T cd05106 276 LPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NS----KFYKMVKRGYQMS----RPD 338 (374)
T ss_pred CccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cH----HHHHHHHcccCcc----CCC
Confidence 5678999999865 367889999999999999997 9999864321 00 0111111110000 111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..+..+.+++.+||+.||++||++.+|++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.30 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=197.9
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
..+.||+|+||.||++.+. +++.||+|.+.... .....+.+|+.++.+++|+||+++++.+.+.+..++|+||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999874 78999999986533 223467899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 84 ~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 84 GGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred CCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 999988875432 22589999999999999999999998 999999999999999999999999999987543322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+.....
T Consensus 158 -~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~---- 222 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRRVKEDQE---- 222 (285)
T ss_pred -ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHHhhcccc----
Confidence 2345689999999999753 6788999999999999999999999753221 011111222211111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
......+..+.+++.+||+.||++||+ +.+++++
T Consensus 223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 112234567888999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.35 Aligned_cols=242 Identities=25% Similarity=0.306 Sum_probs=197.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 45688999999999999986 68999999986532 23456889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 84 PGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 9999999986543 588999999999999999999998 99999999999999999999999999998764322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....|++.|+|||++.+. ..+.++|||||||++|||++|+.||..... ..+.+.+...... .
T Consensus 156 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------------~~~~~~i~~~~~~-~ 217 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP------------FGIYEKILAGKLE-F 217 (291)
T ss_pred ---ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCcC-C
Confidence 123589999999998764 578899999999999999999999864321 1122222222111 1
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 623 (670)
+......+.+++.+||+.||.+||+ +++++++-
T Consensus 218 ----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 218 ----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1122456788999999999999995 88888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.03 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||.||+++.. +|+.||+|+++... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 23456788999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 9998886543 589999999999999999999998 999999999999999999999999999875432221 12
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------------~~~~~~~~~~~~-~~--- 214 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEI-RF--- 214 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCC-CC---
Confidence 33458999999999975 3678899999999999999999999864321 111111111111 01
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
+..++..+.+++.+||+.||++|| ++.+++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 112355778899999999999998 88888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.53 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=203.0
Q ss_pred HHHhhhccccccCceEEEEEEeCC------CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
..+.+.+.||+|+||.||+|+..+ ++.+|+|.++.... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445677899999999999998643 47899999876543 3578999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCe
Q 005909 421 LIYEYMPNGSLGDLLSREKE-----------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 489 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ 489 (670)
+||||+++++|.+++..... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999965421 23578999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccc
Q 005909 490 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEA 568 (670)
Q Consensus 490 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 568 (670)
||+|||+++...............+++.|+|||++.. +.++.++||||||+++|||++ |+.||.....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------- 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------- 230 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 9999999976543322211223345788999999975 467889999999999999998 9988854321
Q ss_pred cchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
......+..+.... .....+..+.+++.+||+.||++||++.||++.|+
T Consensus 231 ---~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 ---EEVIECITQGRLLQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 01111112211111 11234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=320.91 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=203.7
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..++++||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 44568999999999999998888899999987666567789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.++++.... ..+++.+++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++........ ...
T Consensus 88 L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 162 (261)
T cd05072 88 LLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-ARE 162 (261)
T ss_pred HHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccC
Confidence 9999875432 2588899999999999999999987 9999999999999999999999999999876543221 122
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||++.. +..+.++||||||+++|||++ |+.||..... ......+.......
T Consensus 163 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~---- 224 (261)
T cd05072 163 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------------SDVMSALQRGYRMP---- 224 (261)
T ss_pred CCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------------HHHHHHHHcCCCCC----
Confidence 3346778999999865 367889999999999999998 8888853211 11111111111111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.....+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111234568889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.63 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=202.0
Q ss_pred hhhccccccCceEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.||+|+||.||+|.... ...+++|.+.... .....+.+|+..+.+++||||+++++++......++++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 456889999999999998643 2579999987543 23467899999999999999999999999988999999
Q ss_pred EecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeE
Q 005909 424 EYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 490 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~k 490 (670)
||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++|+||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999865321 13588899999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCcccc
Q 005909 491 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAY 569 (670)
Q Consensus 491 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 569 (670)
|+|||+++...............+++.|+|||.+.. +.++.++|||||||++|||++ |+.||.....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---------- 232 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---------- 232 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 999999986543332222233446788999999865 367889999999999999998 9888864321
Q ss_pred chHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
..+...+....... .....+.++.+++.+||+.||++||+++||+++|+.
T Consensus 233 --~~~~~~i~~~~~~~----~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 --QEVIEMIRSRQLLP----CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcCC----CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11222222221111 123346788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=320.14 Aligned_cols=252 Identities=30% Similarity=0.477 Sum_probs=202.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.++||+|+||.||+|.+. .++.+++|++.......+++.+|++++++++|+||+++++++......+++|||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 35678999999999999875 58899999988766566789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++.... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||+++......... ..
T Consensus 89 L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~ 163 (263)
T cd05052 89 LLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HA 163 (263)
T ss_pred HHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cC
Confidence 999986543 23589999999999999999999988 99999999999999999999999999998765432211 11
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||.+.+. .++.++||||||+++|||++ |..|+..... ......+...... .
T Consensus 164 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~----~ 225 (263)
T cd05052 164 GAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYELLEKGYRM----E 225 (263)
T ss_pred CCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHHCCCCC----C
Confidence 22346789999998653 67889999999999999998 8888753211 1112222221111 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.....+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.42 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=200.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccc-cccccceeeeCC------eeE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVN-IIHLLGFCCDGS------TRA 420 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------~~~ 420 (670)
...++||+|+||+||+|+.+ +|+.||+|+++...+ ......+|+.+|++++|+| |+++++++...+ ..+
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 34467999999999999875 789999999986643 4567889999999999999 999999998877 788
Q ss_pred EEEEecCCCCcccccccccCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 421 LIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
+|+||+ .-+|..++...... ..++...+..++.|+++||+|||++ +|+||||||.||||+++|.+||+|||+|+.
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 999999 67899998765432 3577789999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
..-... ..+..++|..|.|||++.+. ..++...||||+|||++||++++..|.+..+. .....+.+.+.
T Consensus 170 ~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--------~ql~~If~~lG 238 (323)
T KOG0594|consen 170 FSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--------DQLFRIFRLLG 238 (323)
T ss_pred hcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--------HHHHHHHHHcC
Confidence 653322 23455689999999999986 36888999999999999999999888764431 11111122211
Q ss_pred CCcc---------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEK---------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~---------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+.. ................+++.+||+.+|.+|.|++.++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 000011111112467889999999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.97 Aligned_cols=242 Identities=25% Similarity=0.330 Sum_probs=197.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||++++. +++.+|+|++.... ...+.+.+|+.++++++||||+++++.+.+++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345688999999999999986 68999999987532 3346788999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 100 VVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999986543 588899999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
...|++.|+|||++.+. ..+.++|||||||++|||++|+.||..... ......+......
T Consensus 174 -----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~------------~~~~~~i~~~~~~- 233 (329)
T PTZ00263 174 -----TLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------------FRIYEKILAGRLK- 233 (329)
T ss_pred -----eecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH------------HHHHHHHhcCCcC-
Confidence 23589999999999764 568899999999999999999999864221 1122233222111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
. +..+...+.+++.+||+.||++||+ +++++++
T Consensus 234 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 F----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1113456788999999999999996 6887765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.78 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=192.0
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.++||+|+||+||++++. +++.||||++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999875 68999999986543 23467899999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+.. ...+..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 158 ~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 225 (353)
T PLN00034 158 SLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PC 225 (353)
T ss_pred cccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cc
Confidence 986543 356778889999999999999998 999999999999999999999999999987643221 11
Q ss_pred cCCCCCccccchhhccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~---~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....|+..|+|||++.... ...+.++|||||||++|||++|+.||..... ..+...+.. ......
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--------~~~~~~~~~-~~~~~~--- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--------GDWASLMCA-ICMSQP--- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHH-HhccCC---
Confidence 2346899999999885321 1235689999999999999999999963211 111111111 111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..........+.+++.+||+.||++||++.|++++-
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111123456788999999999999999999999863
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.56 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=201.9
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.+.||+|+||+||+|++.++..+|+|.++......+++.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 45688999999999999988777899999886655567899999999999999999999999988889999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++..... .+++..+++++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ...+
T Consensus 87 ~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05113 87 LNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVG 160 (256)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCC
Confidence 999865432 589999999999999999999988 9999999999999999999999999998866443221 2223
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
..++..|+|||.+.. ..++.++||||||+++|||++ |+.||..... ..+...+.........
T Consensus 161 ~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~~--- 223 (256)
T cd05113 161 SKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------------SETVEKVSQGLRLYRP--- 223 (256)
T ss_pred CccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHhcCCCCCCC---
Confidence 446678999999965 367889999999999999998 8888753221 1112222222111111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
......+.+++.+||+.+|++||++.+|++.|+
T Consensus 224 -~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 -HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=317.49 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---------------chHHHHHHHHHhccccccccccccceee
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------------FSDNFINEVATIGRIHHVNIIHLLGFCC 414 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 414 (670)
|.+.+.||+|.||.|-+|+.. +++.||||++.+.+. ..+...+|+.+|++++|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 445688999999999999875 799999999965331 1257889999999999999999999987
Q ss_pred eC--CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 415 DG--STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 415 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
+. +..|||+|||..|.+...=.. +..+.+.+++++++++..||+|||.+ +||||||||+|+||+++|++||+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 54 578999999998877554321 22389999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccCCC---CceeeecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc
Q 005909 493 DFGLAKAHSRN---RSVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 567 (670)
Q Consensus 493 DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~ 567 (670)
|||.+...... ..........|||.|+|||+..+.. ...+.+.||||+||.||-|+.|+.||-....
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------- 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------- 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------
Confidence 99998766222 1111223467999999999987621 2336788999999999999999999964321
Q ss_pred ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
-..++++..... ......++...+.+++.++|.+||+.|.+..+|..+.-
T Consensus 325 ----~~l~~KIvn~pL---~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 ----LELFDKIVNDPL---EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----HHHHHHHhcCcc---cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 122333332211 11112245667889999999999999999999998874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.81 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=191.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||.||+++.. +++.+|+|++... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999986 5789999998653 23346788999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 99986543 589999999999999999999998 999999999999999999999999999976432221 1223
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..+
T Consensus 153 ~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~------------~~~~~~~~~~~~-----~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV------------NEMYRKILQEPL-----RFP 213 (312)
T ss_pred ccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH------------HHHHHHHHcCCC-----CCC
Confidence 4589999999999763 678899999999999999999999964221 111222222111 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPS---MTRVVEM 622 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 622 (670)
......+.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 224557788999999999999985 5555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.01 Aligned_cols=241 Identities=23% Similarity=0.355 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||.||+++.. +++.+|+|++.... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999997532 33467889999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 9998886543 589999999999999999999998 999999999999999999999999999875432221 12
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~------------~~~~~~~~~~~~-~~--- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEDI-KF--- 214 (328)
T ss_pred ccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCH------------HHHHHHhccCCc-cC---
Confidence 234589999999999753 678899999999999999999999964221 011111111111 11
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
+......+.+++.+||+.||++|| ++.+++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 122355788899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=311.38 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=208.9
Q ss_pred HHHHHHHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCee
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 419 (670)
--.+.+|++.+.||+|.||.|-+|.. ..|+.||||.++++.- ..-.+.+|+++|+.|+||||+.++.+|++.+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 33456778889999999999999976 5799999999987652 223578999999999999999999999999999
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
.|||||..+|.|.+++.+.+ .+++.+.+++++||..|+.|+|.+ +++|||||.+|||||+++++||+||||+..
T Consensus 129 vivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999997765 599999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
+..+... +.+.|++-|.+||.+.+. ..-.+..|-|||||+||.|+.|.-||++.+. . .+...+.
T Consensus 203 y~~~kfL---qTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------k-~lvrQIs 266 (668)
T KOG0611|consen 203 YADKKFL---QTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------K-RLVRQIS 266 (668)
T ss_pred hccccHH---HHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchH-----------H-HHHHHhh
Confidence 8766544 345589999999999875 2446789999999999999999999986433 1 1112222
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+...+.. .+....-+|.|||..+|++|.|+.+|..+-
T Consensus 267 ~GaYrEP~------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 RGAYREPE------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccccCCC------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22221111 122345589999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=323.17 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=195.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
|.+.++||+|+||.||+|+.+ +++.||+|+++... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 345688999999999999876 68899999987543 334578899999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 -~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 87 -SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred -cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 589888864432 478899999999999999999998 999999999999999999999999999876543221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHH----H
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWI----Y 575 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~----~ 575 (670)
......+++.|+|||++.+. ..++.++||||+||++|||++|+.||......... ......++... +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12234578999999998653 35788999999999999999999998653221000 00000000000 0
Q ss_pred HHhcCCcc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQPEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+.. .............++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000000011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.47 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~~~~ 428 (670)
.+|++|.||.||+|+++ +++.||+|+++...+ ..-..++|+.+|.+++|||||.+-.+.... +..|+||||++
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E- 160 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE- 160 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-
Confidence 68999999999999986 689999999987653 223568999999999999999999887643 57899999995
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
-+|..+++.-+ .++...++..+..|+++|++|||.+ -|+|||||++|+|++..|.+||+||||||.+..... .
T Consensus 161 hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~ 233 (419)
T KOG0663|consen 161 HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--P 233 (419)
T ss_pred hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc--c
Confidence 58888887654 3588889999999999999999998 999999999999999999999999999999876532 3
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHH----HHH
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDW----IYD 576 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~----~~~ 576 (670)
++..+-|.+|+|||++.+. ..++...|+||+|||+.||+++++.|.+..+.... ...+..++.. .++
T Consensus 234 ~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred CcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 4556679999999999986 57889999999999999999999988654331100 0001111110 000
Q ss_pred HhcCCccc--cccchhhH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEKE--DFVEEEDD-CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~~--~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
++.....+ .+...... .+...-.+++...|..||.+|.|++|.+++=
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 11111110 01111111 1345667888899999999999999988753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.86 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=198.1
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||+|+||.||.++-+ +|..+|+|+++++. ...+....|-.+|...++|+||+|+-.|.+.+.+||||||+|
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3478999999999999875 69999999999865 445678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC-----
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR----- 502 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~----- 502 (670)
||++..+|.+.. .|++..+..++.+++-|++-||+. |+|||||||+|+|||..|++||+||||+..+..
T Consensus 225 GGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 225 GGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred CccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999997654 699999999999999999999998 999999999999999999999999999853211
Q ss_pred ------------------CCc----eee------------------ecCCCCCccccchhhcccccCCCCccchhHHHHH
Q 005909 503 ------------------NRS----VVT------------------MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 542 (670)
Q Consensus 503 ------------------~~~----~~~------------------~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGv 542 (670)
+.. ... ....+|||.|||||++.+. .++..+|.|||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGC 376 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHH
Confidence 000 000 0123699999999999986 5788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCC---CHHHH
Q 005909 543 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP---SMTRV 619 (670)
Q Consensus 543 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~ev 619 (670)
|+||||.|-+||..... ...+.++..-... +........+.+..++|.+||. ||++|- .++||
T Consensus 377 ImyEmLvGyPPF~s~tp------------~~T~rkI~nwr~~-l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETP------------QETYRKIVNWRET-LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHhCCCCCCCCCH------------HHHHHHHHHHhhh-ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999976433 2233333322110 0011111223677889999998 999996 46666
Q ss_pred HHHH
Q 005909 620 VEML 623 (670)
Q Consensus 620 l~~L 623 (670)
.++-
T Consensus 443 K~HP 446 (550)
T KOG0605|consen 443 KKHP 446 (550)
T ss_pred hcCC
Confidence 6543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.70 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=199.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+++.++||+|+||.||++++. ++..+|+|++.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 445678999999999999986 68899999987543 334679999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 87 GGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999986543 588999999999999999999974 269999999999999999999999999987654322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC-----CCc--ccc-----------
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-----NTT--EAY----------- 569 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~-----~~~--~~~----------- 569 (670)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||......... ... ...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 1234589999999999754 6788999999999999999999999643210000 000 000
Q ss_pred ------------ch----HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 570 ------------FP----DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 570 ------------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+ ......+..... ...........+.+++.+||+.||++|||++|++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPP---PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCC---cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 000000000000 0001113456789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.63 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=205.2
Q ss_pred HHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.++||.|+||.||+|.+.+++.+++|++..... ...++.+|+.++++++|+||+++++++.+....++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 3556789999999999999998899999999987654 567899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... ..+++..+++++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-- 160 (261)
T cd05148 87 GSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-- 160 (261)
T ss_pred CCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--
Confidence 999999976433 3589999999999999999999988 9999999999999999999999999999876443222
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |+.||..... ..+...+......
T Consensus 161 ~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~--- 223 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------------HEVYDQITAGYRM--- 223 (261)
T ss_pred ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------------HHHHHHHHhCCcC---
Confidence 123446778999999865 367889999999999999998 7888854221 1111111111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.||++|||++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112334578899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=335.47 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=200.3
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.++||+|+||.||+|++. .+..||||+++... ...+.+.+|+.++.++. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445689999999999999863 23479999997543 23467999999999995 999999999999999999
Q ss_pred EEEEecCCCCcccccccccC------------------------------------------------------------
Q 005909 421 LIYEYMPNGSLGDLLSREKE------------------------------------------------------------ 440 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 440 (670)
+||||+++|+|.++|+....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 99999999999988864211
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC
Q 005909 441 ---------------------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 487 (670)
Q Consensus 441 ---------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~ 487 (670)
...+++..+++++.|+++||+|||+. +|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 12478888999999999999999987 999999999999999999
Q ss_pred CeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 005909 488 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 566 (670)
Q Consensus 488 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~ 566 (670)
.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~------- 345 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIV------- 345 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccch-------
Confidence 9999999999866433322222234467889999998753 67889999999999999997 8888754211
Q ss_pred cccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.......+...... ......+..+.+++.+||+.||++||++.+|+++|+++
T Consensus 346 ----~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 346 ----DSTFYNKIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ----hHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 01111222221111 11123456788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.42 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=200.6
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.+.||+|+||.||+++++++..+|+|++.......+++.+|+.++++++|+||+++++++.+.+..++|+||+++++|
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 46688999999999999988888899999876655567899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........ ...+
T Consensus 87 ~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 160 (256)
T cd05059 87 LNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG 160 (256)
T ss_pred HHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence 999875433 589999999999999999999998 9999999999999999999999999998765432211 1122
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
..++..|+|||.+.+. .++.++||||||+++|||++ |+.||..... ......+..... ...
T Consensus 161 ~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~----~~~ 222 (256)
T cd05059 161 TKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------------SEVVESVSAGYR----LYR 222 (256)
T ss_pred CCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCH------------HHHHHHHHcCCc----CCC
Confidence 2345689999998753 67889999999999999998 7888754221 011112211111 111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
....+.++.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1224567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.10 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=201.6
Q ss_pred HhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|.++. ...||+|+++... ....+|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 3456889999999999998752 4589999987543 334678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++..... .+++..+++++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 86 YMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred cCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999976443 589999999999999999999987 99999999999999999999999999998775322
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.........++..|+|||.+... .++.++||||||+++|||++ |+.|+..... ..+...+.....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~ 226 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSN------------QDVIKAVEDGYR 226 (266)
T ss_pred cceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 22222233456789999998753 67889999999999999998 8888743211 111222222111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
... ....+..+.+++.+||+.+|++||+++||+++|+++
T Consensus 227 ~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 112355788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.31 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=201.2
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.++||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4556789999999999999864 257899999976543 24678899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC
Q 005909 422 IYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 488 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~ 488 (670)
++||+++++|.+++.... .+..+++..+++++.|++.||+|||++ +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 123588889999999999999999988 9999999999999999999
Q ss_pred eEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCcc
Q 005909 489 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 567 (670)
Q Consensus 489 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 567 (670)
+||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 99999999887654333222233446789999999865 467889999999999999998 7777653211
Q ss_pred ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
..+.+.+........ ....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 233 ----~~~~~~i~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ----QDVIEMIRNRQVLPC----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 112222222221111 12245568899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=330.67 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=199.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||.||+|++. +++.||+|+++... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 35688999999999999986 58999999997542 33467889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~--- 154 (333)
T cd05600 84 PGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--- 154 (333)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence 9999999996543 588999999999999999999998 9999999999999999999999999999765431
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc---c
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---K 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 583 (670)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... .
T Consensus 155 --~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~~~ 218 (333)
T cd05600 155 --ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP------------NETWENLKYWKETLQ 218 (333)
T ss_pred --cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCH------------HHHHHHHHhcccccc
Confidence 2334589999999999764 778899999999999999999999964321 00111111100 0
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...........+..+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0000000123456788899999999999999999999873
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.29 Aligned_cols=255 Identities=22% Similarity=0.389 Sum_probs=198.4
Q ss_pred HHHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
..+.+.++||+|+||.||+|.+. .+..+|+|++.... ....++.+|+.++++++|+||+++++++.++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 34556789999999999999763 24679999986543 23457889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 421 LIYEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
+|+||+++++|.+++.+... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 99999999999999865322 12467888999999999999999987 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |..||..... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------------~ 228 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------------E 228 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------H
Confidence 999986544332222222345788999999875 367889999999999999999 6777753211 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.............. ....+..+.+++.+||+.||++||++.|+++.|+
T Consensus 229 ~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 QVLRFVMEGGLLDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111111111111 1123456889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.71 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=199.2
Q ss_pred HhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
..+.++||+|+||+||+|++ .+++.+++|.+..... ...++.+|+.++++++||||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 34668899999999999985 2467899999875432 3357889999999999999999999999999999999
Q ss_pred EecCCCCcccccccccC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCe
Q 005909 424 EYMPNGSLGDLLSREKE--------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 489 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ 489 (670)
||+++++|.+++..... +..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 99999999999853221 23578999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccc
Q 005909 490 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEA 568 (670)
Q Consensus 490 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 568 (670)
||+|||+++...............++..|+|||++.+ +..+.++||||||+++|||++ |..||.....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------- 232 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 9999999987644332222233345778999999865 367889999999999999998 8888753211
Q ss_pred cchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..+.+.+........ ....+..+.+++.+||+.||++||++.+|+++|+
T Consensus 233 ---~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 233 ---QEVIEMVRKRQLLPC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 112222222111111 1123457888999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.15 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=199.7
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeC-Cee
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-STR 419 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~ 419 (670)
.+++.+.||+|+||.||+|... .++.||+|+++... ...+.+..|+.++.++ +|+||+++++++... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4567789999999999999642 24789999987543 2345678899999999 899999999988654 567
Q ss_pred EEEEEecCCCCcccccccccC----------------------------------------------------------C
Q 005909 420 ALIYEYMPNGSLGDLLSREKE----------------------------------------------------------N 441 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------~ 441 (670)
++++||+++++|.+++..... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 899999999999988854221 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccch
Q 005909 442 LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521 (670)
Q Consensus 442 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 521 (670)
..+++..+.+++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2588999999999999999999988 9999999999999999999999999999876543332222334567889999
Q ss_pred hhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHH
Q 005909 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMII 600 (670)
Q Consensus 522 E~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 600 (670)
|++.+. .++.++|||||||++|||++ |+.||..... ...+. ..+...... ........++.+
T Consensus 245 E~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~----~~~~~~~~~----~~~~~~~~~~~~ 307 (337)
T cd05054 245 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFC----RRLKEGTRM----RAPEYATPEIYS 307 (337)
T ss_pred HHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHH----HHHhccCCC----CCCccCCHHHHH
Confidence 998764 68889999999999999998 8888854221 01111 111111111 111223457889
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 601 VGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 601 l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
++.+||+.+|++||++.||+++|+++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.52 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=202.2
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
.+.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|+.++.+++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3445688999999999999752 34578999987654 3456799999999999999999999999999999999
Q ss_pred EEecCCCCccccccccc----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 423 YEYMPNGSLGDLLSREK----------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
+||+++++|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999986432 122489999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 571 (670)
|||+++...............++..|+|||.+.. ..++.++||||||+++|||++ |+.||.....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------------ 228 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------ 228 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 9999986644332222222345778999999865 367889999999999999998 8888753221
Q ss_pred HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 572 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
......+..+..... ....+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 229 ~~~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 229 NEVIECITQGRVLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111222222221111 1123456899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.68 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=194.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.||+|+||.||+|++. +++.+|+|.+.... .....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999885 68999999876543 3356799999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99986543 2588999999999999999999988 999999999999999999999999999876543221111111
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...+..|+|||.+.+ +..+.++||||||+++|||++ |..|+..... ......+...... ..
T Consensus 156 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------------~~~~~~~~~~~~~----~~ 217 (252)
T cd05084 156 KQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSN------------QQTREAIEQGVRL----PC 217 (252)
T ss_pred CCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCH------------HHHHHHHHcCCCC----CC
Confidence 123567999999865 367889999999999999998 7777753211 0111111111111 11
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
....+..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=323.84 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=210.0
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCC---C--cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPD---G--RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS 417 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 417 (670)
++.+....+.++||+|.||.||+|.+.+ | -.||||.-+.+. +..+.|+.|..+|++++||||++|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 4555555667899999999999998743 3 358889887643 5578999999999999999999999999765
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++|||.++.|.|.++|+.++. .++...+..++.||..+|+|||+. +.|||||..+|||+.....+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 67899999999999999987654 588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
|.+..+..... ....-++.|||||.+. +..++.+||||.|||.+||++. |.+||.+....+ +..
T Consensus 539 R~~ed~~yYka-S~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------VI~ 603 (974)
T KOG4257|consen 539 RYLEDDAYYKA-SRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------VIG 603 (974)
T ss_pred hhccccchhhc-cccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------eEE
Confidence 99876654432 2344578999999995 4589999999999999999986 899997644311 011
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
++.. +.....++.+++.|..++.+||+.||.+||.++|+...|+..
T Consensus 604 ~iEn----GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 604 HIEN----GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred EecC----CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1111 222233445677888999999999999999999999888644
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=331.79 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=200.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.. +++.||+|++.... .....+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 45688999999999999986 68999999987532 34567889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC--
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-- 504 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~-- 504 (670)
++++|.+++.+. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 84 PGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999765 2589999999999999999999997 99999999999999999999999999998664432
Q ss_pred -------------------------ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 005909 505 -------------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 559 (670)
Q Consensus 505 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~ 559 (670)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112234689999999999764 778899999999999999999999964321
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHH
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-MTRVVEML 623 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L 623 (670)
.....++...... ........++..+.+++.+||+ ||++||+ +++++++.
T Consensus 236 ------------~~~~~~i~~~~~~-~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 ------------QETYNKIINWKES-LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred ------------HHHHHHHhccCCc-ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1112222221000 0000011145678889999997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.30 Aligned_cols=241 Identities=28% Similarity=0.394 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.||+|+||.||+++. ..++.+|+|+++... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999986 357899999987532 2335678899999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.+.. .+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986543 478888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....|++.|+|||++.+. ..+.++||||||+++|||++|+.||..... ......+..... .
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~------------~~~~~~~~~~~~-~ 218 (323)
T cd05584 156 V--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENR------------KKTIDKILKGKL-N 218 (323)
T ss_pred c--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC-C
Confidence 1 1234589999999999764 568899999999999999999999964321 111122222211 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
. +......+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 112345678899999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=310.14 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=201.4
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEccc---CCcchHHHHHHHHHhccccccccccccceeee-----CCeeEEEEE
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-----GSTRALIYE 424 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~lv~e 424 (670)
.+.||+|+||.|+++..+ +|+.||||++.. .....++..+|+.+|+.++|+||+.+++.+.- -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 367999999999999885 789999999873 23456788999999999999999999998765 346799999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+| ..+|..+++... .++...+..+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||+......
T Consensus 107 lM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 789999997654 489999999999999999999998 99999999999999999999999999999886543
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---cccchHHHHHHhc--
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLI-- 579 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~-- 579 (670)
....++.-+.|.+|.|||++.. ...++.+.||||.|||+.||++|+..|.+.+........ -..-.+.....+.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred cccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 3344567778999999999964 468899999999999999999999988764431100000 0000001111111
Q ss_pred ------C--Ccccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 580 ------Q--PEKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 580 ------~--~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. +..+. .....-....+..++++.+||..||.+|+|++|.+++-
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0 00000 00111123355678899999999999999999998754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.97 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=193.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||+||+|+.. +++.+|+|++.... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 445689999999999999986 68999999987543 234567899999999999999999999999999999999995
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 87 -TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred -cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 67877775443 2488899999999999999999998 999999999999999999999999999875432221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc-----
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE----- 582 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 582 (670)
......+++.|+|||++.+. ..++.++|||||||++|||++|+.||....... ..+ ..+...+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~-~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ------DQL-ERIFLVLGTPNEDTWP 230 (303)
T ss_pred cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH------HHH-HHHHHHhCCCChhhcc
Confidence 12334578999999998653 356789999999999999999999997532100 000 00000000000
Q ss_pred ------------cccccchhh------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 ------------KEDFVEEED------DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ------------~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......... ......+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000 0123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.99 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=197.1
Q ss_pred HhhhccccccCceEEEEEEeCC--CcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|++++ +..||+|++.... ...+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4466899999999999998653 3689999986532 345678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 112 y~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999997543 588999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 186 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 246 (340)
T PTZ00426 186 -----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP------------LLIYQKILEGIIY 246 (340)
T ss_pred -----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH------------HHHHHHHhcCCCC
Confidence 223589999999999753 578899999999999999999999964321 1222333322211
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
. +......+.+++.+||+.||++|+ ++++++++
T Consensus 247 -~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 -F----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -C----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 112344577899999999999995 89998876
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.60 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=202.2
Q ss_pred HHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..+.+.++||+|+||.||+|++.+...||+|+++......+++.+|+.++++++|+||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 345677899999999999999877778999999876655678999999999999999999999874 4567899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~- 159 (262)
T cd05071 85 GSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA- 159 (262)
T ss_pred CcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc-
Confidence 999999975432 2578999999999999999999998 99999999999999999999999999998665433211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||+..+ ..++.++||||||+++|||++ |+.||..... ..+..........
T Consensus 160 ~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------------~~~~~~~~~~~~~--- 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRM--- 222 (262)
T ss_pred ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------------HHHHHHHhcCCCC---
Confidence 123346778999998865 367889999999999999999 7777753211 1112222111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
......+..+.+++.+|++.||++||++.++++.|+..
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.63 Aligned_cols=251 Identities=23% Similarity=0.270 Sum_probs=191.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+|+.. +++.+|+|++.... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34578999999999999875 68899999997543 23457889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 84 PGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999986543 588999999999999999999998 9999999999999999999999999997643210000
Q ss_pred ---------------------------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHH
Q 005909 507 ---------------------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 541 (670)
Q Consensus 507 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlG 541 (670)
.......||+.|+|||++.+. .++.++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG 235 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehh
Confidence 001124589999999999753 678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHh--ccccCCCCCCCHHHH
Q 005909 542 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW--CIQINPKDRPSMTRV 619 (670)
Q Consensus 542 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~ev 619 (670)
|++|||++|+.||..... ......+...... ........+..++.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP------------TETQLKVINWENT-LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCH------------HHHHHHHHccccc-cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999964322 0011111110000 0000011134456667766 556667779999999
Q ss_pred HHHH
Q 005909 620 VEML 623 (670)
Q Consensus 620 l~~L 623 (670)
+++-
T Consensus 303 l~hp 306 (381)
T cd05626 303 KAHP 306 (381)
T ss_pred hcCc
Confidence 9863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.97 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+++.+ +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999986 5889999998753 23446677888888877 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 99998886543 589999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~------------~~~~~~i~~~~~~---- 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENE------------DDLFEAILNDEVV---- 214 (320)
T ss_pred ccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHhcCCCC----
Confidence 2234589999999999753 678899999999999999999999964321 1122222221111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 622 (670)
........+.+++.+||+.||++||++ ++++++
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011234567889999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=313.42 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=205.3
Q ss_pred HHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.++++.++||+|+||.||+|..++++.+|+|.+.......+++.+|+.++++++|+||+++++++. .+..++++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 345566778999999999999999988999999999877766788999999999999999999999864 4568999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999865432 3589999999999999999999987 999999999999999999999999999977653222
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......++..|+|||++.. ...+.++||||||+++|||++ |+.||..... ..+...+......
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~ 222 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------------PEVIQNLERGYRM 222 (260)
T ss_pred c-cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------------HHHHHHHHcCCCC
Confidence 1 1123345778999999865 367889999999999999998 9988864321 1111122111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
. .....+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 P----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 111234578899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.62 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=202.0
Q ss_pred hhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.+.||+|+||.||+++.. ++..+++|.+..... ..+.+.+|+..+++++|+||+++++++......++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 35578999999999999752 355788998876543 34678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEE
Q 005909 425 YMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 491 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki 491 (670)
|+++++|.+++..... ...+++..+++++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 9999999999865421 23488999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccc
Q 005909 492 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYF 570 (670)
Q Consensus 492 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 570 (670)
+|||+++...............++..|+|||.+... .++.++||||||+++|||++ |+.||.....
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~----------- 231 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------- 231 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 999999766443322222334467889999998753 67889999999999999999 8888754321
Q ss_pred hHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
....+.+..+.... .....+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 232 -~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 232 -TEVIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -HHHHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11112222211111 11223557889999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=366.13 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=199.2
Q ss_pred CCHHHHHHHHHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCee
Q 005909 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 341 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 419 (670)
++++++.+.. ...+.||+|+||.||+|+. .+++.||||++....... ..|++.+++++||||++++|+|.+....
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 4444544332 2346799999999999997 478999999987544322 3568899999999999999999999999
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++||||+++|+|.++++ .++|.++.+++.|+++||+|||..+..+|+||||||+||+++.++..++. ||....
T Consensus 759 ~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 99999999999999995 27899999999999999999997666799999999999999999988876 666544
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
.... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.|++.... .......|......
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~------~~~~~~~~~~~~~~ 897 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFG------VHGSIVEWARYCYS 897 (968)
T ss_pred cccC------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccC------CCCcHHHHHHHhcC
Confidence 3221 12247899999999875 3688999999999999999999999854321 11222333322111
Q ss_pred --------CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 580 --------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 580 --------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
++.... ......+...++.+++.+||+.||++||+|+||++.|++.
T Consensus 898 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 898 DCHLDMWIDPSIRG-DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred ccchhheeCccccC-CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 111111 1112234456788999999999999999999999999954
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.91 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=199.0
Q ss_pred HhhhccccccCceEEEEEEeC-C-CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.+.||+|+||.||+|... + ++.||+|.+.... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 456688999999999999764 3 6788888775544 334567889999999999999999999999999999999999
Q ss_pred CCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+|+|.+++.+. .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 2234688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------------~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ------------REIMQQVLYGKYDPF 291 (478)
T ss_pred ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCCCC
Confidence 222344589999999999753 678899999999999999999999864221 111222222111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...++..+.+++.+||+.||++||++.+++.+
T Consensus 292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11234578899999999999999999998753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.01 Aligned_cols=198 Identities=24% Similarity=0.383 Sum_probs=170.4
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
...+++.++||+|+||.||++.+. ++..+|+|++.... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 345566789999999999999986 68889999887543 234678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++.... .+++..+..++.|+++||.|||+. .+|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999996543 588999999999999999999974 279999999999999999999999999987653321
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234589999999999753 678899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.49 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=194.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
|.+.++||+|+||.||++.+. +++.||+|... .+.+.+|+.++++++||||+++++++......++|+|++ .+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~ 167 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT 167 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence 556689999999999999875 68899999754 245679999999999999999999999999999999999 57
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 168 ~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~ 240 (391)
T PHA03212 168 DLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KY 240 (391)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-cc
Confidence 8888875543 588999999999999999999998 9999999999999999999999999999754322111 12
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHH----------------
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW---------------- 573 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------- 573 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.|+.......+.......+...
T Consensus 241 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 241 YGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 335689999999999753 67889999999999999999998875432211110000000000
Q ss_pred -----HHHHhcCC-c-ccc--ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 574 -----IYDKLIQP-E-KED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 574 -----~~~~~~~~-~-~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+...... . ... .........+..+.+++.+||+.||++|||++|++++-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00000000 0 000 01111223466788999999999999999999998643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.14 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||.||+++.. +++.+|+|++.... .....+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 23456788999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
+|..++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9998886543 58999999999999999999997 5 8999999999999999999999999998754322211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~------------~~~~~~i~~~~~-~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEI-RF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCH------------HHHHHHHhcCCC-CC--
Confidence 1234589999999999753 678899999999999999999999964221 111111111111 01
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
+......+.+++.+||+.||++|+ ++.+++++-
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 112345678899999999999996 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=317.14 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=196.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.+.||+|+||+||+++++ +++.+|+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 345688999999999999986 57899999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++++..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 887776554322 2588999999999999999999987 9999999999999999999999999999876433221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---CccccchHHHHHH-hcCCc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---TTEAYFPDWIYDK-LIQPE 582 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~ 582 (670)
......|++.|+|||++.+. .++.++|||||||++|||++|+.||.......... .....++...... .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 157 -NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 12234579999999999764 57889999999999999999999986532100000 0000000000000 00000
Q ss_pred c-----cc------ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 K-----ED------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~-----~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. +. .........+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 00 0000112245678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=325.37 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=209.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCe-eEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-RALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lv~e~ 425 (670)
|.+.+++|+|+||.++..+++ +++.+++|.++... ...+...+|+.++++++|||||.+.+.|.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 456689999999999999886 57789999987544 445678999999999999999999999998887 8999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++||+|.+.|.+.+ ...+++.++.+|+.|++.|+.|||++ .|+|||||+.||+++.++.+||+|||+|+.+.....
T Consensus 86 ~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred cCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999998766 34699999999999999999999987 999999999999999999999999999999877652
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....||+.||.||.+.+. .+..|+|||||||++|||++-+++|...+- .. ...++.....
T Consensus 162 ~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------~~-Li~ki~~~~~-- 223 (426)
T KOG0589|consen 162 L--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------SE-LILKINRGLY-- 223 (426)
T ss_pred h--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-----------HH-HHHHHhhccC--
Confidence 2 2335699999999999875 788899999999999999999999975432 11 2223333221
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+..++.++..++..|++.+|+.||++.+++.+-
T Consensus 224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 222334567889999999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=290.55 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=202.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
++.+.||+|-||.||.|+.+ ++-.||+|++.+++ ....++.+|+++-+.|+||||+++++++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 35688999999999999986 67899999998765 34578999999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|...|...... .+++.....++.|+|.||.|+|.+ +||||||||+|+|++..+.+||+|||-+..-..+..
T Consensus 105 ~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR- 179 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR- 179 (281)
T ss_pred CCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCc-
Confidence 999999999754332 588888899999999999999988 999999999999999999999999999876553322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.++ .||..|.+||...+. ..+...|+|++|++.||++.|.+||.... ....+.++..-..
T Consensus 180 ~tl---cgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~------------~~etYkrI~k~~~--- 239 (281)
T KOG0580|consen 180 KTL---CGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQS------------HSETYKRIRKVDL--- 239 (281)
T ss_pred eee---ecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhh------------hHHHHHHHHHccc---
Confidence 223 379999999999875 77889999999999999999999996422 1223333332211
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+..++....+++.+|+..+|.+|.+..|++++
T Consensus 240 --~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 --KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1113345677889999999999999999999875
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.88 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=204.1
Q ss_pred HHHHhhhccccccCceEEEEEEeCC-----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeee-CCee
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTR 419 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 419 (670)
+..+.+.+.||+|+||.||+|.+.+ +..|++|++.... ...+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3445567899999999999999865 7889999987543 335678899999999999999999998776 4678
Q ss_pred EEEEEecCCCCcccccccccCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeec
Q 005909 420 ALIYEYMPNGSLGDLLSREKEN-----LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~Df 494 (670)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654322 3689999999999999999999987 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+++.+.............++..|+|||++... .++.++||||||+++||+++ |+.||..... ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~ 227 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDP------------FE 227 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------------HH
Confidence 999876544333222334467789999998653 67889999999999999999 9998864321 01
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+...+....... .....+..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 228 MAAYLKDGYRLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHHcCCCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111121111111 11123457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.65 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=201.1
Q ss_pred HHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.++||+|+||.||++..+++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 45567899999999999999888889999999876666678999999999999999999999875 45678999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......... .
T Consensus 86 ~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~ 160 (260)
T cd05070 86 SLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-R 160 (260)
T ss_pred cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-c
Confidence 99999875432 2589999999999999999999998 99999999999999999999999999998764432211 1
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....++..|+|||.+.+ ..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 161 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~---- 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------------REVLEQVERGYRM---- 222 (260)
T ss_pred cCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 22335678999999865 367889999999999999999 8888853211 0111112111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112335578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.05 Aligned_cols=265 Identities=19% Similarity=0.291 Sum_probs=193.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC-----eeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~l 421 (670)
|.+.++||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 345688999999999999875 68999999987432 23456889999999999999999999886432 4799
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+ +++|.+++.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELM-ESDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecC-CCCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99999 478888886543 589999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHH
Q 005909 502 RNRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDK 577 (670)
Q Consensus 502 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 577 (670)
.... ........|++.|+|||++.+....++.++|||||||++|||++|+.||........... .....+......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 112233568999999999865334678899999999999999999999864321000000 000000000000
Q ss_pred hcCC-----------ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQP-----------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+... ................+.+++.+||+.||++||++.|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00000000011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.98 Aligned_cols=249 Identities=28% Similarity=0.475 Sum_probs=208.8
Q ss_pred hccccccCceEEEEEEe-CCC----cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 354 KEKLGTGGYGNVYKGKF-PDG----RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.++||+|+||+||||.+ +.| -+||+|++.... +...+++.|+-+|.+++|||+++|+|+|.... ..||++|+
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47899999999999986 333 479999997755 45789999999999999999999999998766 78999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+.|+|.++++.++. .+..+..+.|..|||+||.|||.+ +++||||..+|||+..-.++||.|||+++....+...
T Consensus 780 P~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999988765 488889999999999999999988 9999999999999999999999999999999887776
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....+..-.+.|||=|.+.. ..++.++|||||||.+||++| |.+|++.... +.|.+.+..+..
T Consensus 855 y~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------~eI~dlle~geR-- 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------EEIPDLLEKGER-- 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------HHhhHHHhcccc--
Confidence 66666677899999999975 488999999999999999998 7788765433 223333333322
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...+.-....+..++.+||..|++.||+++++...+.+.
T Consensus 919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 222333455678889999999999999999999888654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.23 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=206.7
Q ss_pred HHHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCC-----eeEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRAL 421 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~l 421 (670)
.+|.+.+.||+|||+.||.++. .+++.+|+|++.-.. +..+..++|++..++++||||++++++...+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 3456778999999999999984 578899999887655 66788999999999999999999999876443 4899
Q ss_pred EEEecCCCCcccccccccCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 422 IYEYMPNGSLGDLLSREKENL-SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++|+..|||.+.+.+...+. .+++.++++|+.++++||.+||.. .++.+||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999997655433 799999999999999999999987 456999999999999999999999999998754
Q ss_pred CCCCc-------eeeecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 501 SRNRS-------VVTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 501 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
..... .........|..|+|||++.-.. ...++++|||||||+||+|+.|..||+......++......-++
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 32100 00112335789999999985432 35588999999999999999999999864442222111111000
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
........++..+.+++.+||+.||.+||++.+++.++..
T Consensus 260 -------------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 260 -------------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -------------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 0111112267789999999999999999999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.46 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=194.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.. +++.||||++.... .....+.+|+.++..++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34588999999999999986 68999999997532 33456788999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 84 PGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999986543 589999999999999999999998 9999999999999999999999999998754321100
Q ss_pred e------------------------------------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhC
Q 005909 507 V------------------------------------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE 550 (670)
Q Consensus 507 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg 550 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcC
Confidence 0 00123589999999998753 678899999999999999999
Q ss_pred CCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 005909 551 KKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEM 622 (670)
Q Consensus 551 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 622 (670)
+.||..... ......+...... .........+..+.+++.+|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~~~~------------~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP------------QETYRKIINWKET-LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH------------HHHHHHHHcCCCc-cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999964321 0111111111110 0000011234567788888886 9999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=310.14 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=200.6
Q ss_pred HHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.++||+|++|.||++.++.+..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 35567889999999999999887778999998776666678999999999999999999998875 45678999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 86 ~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05069 86 SLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-cc
Confidence 99999975432 2578999999999999999999987 9999999999999999999999999999766433221 11
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....++..|+|||.+.+ ...+.++||||||+++|||++ |+.|+..... ......+......
T Consensus 161 ~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~---- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------------REVLEQVERGYRM---- 222 (260)
T ss_pred CCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 22345778999998865 367889999999999999999 8888754221 1111111111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.||++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112345678899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=316.60 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=199.9
Q ss_pred hhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.||+|+||.||+|... ....+++|.+..... ..+++.+|+.++.+++||||+++++.+...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999863 235788998875442 34678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 425 YMPNGSLGDLLSREK---------------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
|+++++|.+++.... ....+++..++.++.|++.||.|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999875421 112578999999999999999999987 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSG 562 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~ 562 (670)
++++.+||+|||+++...............++..|+|||.+.+. ..+.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~---- 234 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---- 234 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC----
Confidence 99999999999999865433322222333457789999998653 67889999999999999998 888885321
Q ss_pred CCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+..+++.+....... .....+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 235 --------~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 --------PERLFNLLKTGYRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --------HHHHHHHHhCCCCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112222222211111 11233557889999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=314.74 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=194.5
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||+||++... +++.+|+|.+.... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 68899999986533 1235678899999999999999999999999999999999999999
Q ss_pred cccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 432 GDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 432 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875422 234689999999999999999999998 9999999999999999999999999999766443321 23
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...|++.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+...+..... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~-----~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEK--------VENKELKQRILNDSV-----TY 220 (280)
T ss_pred ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHhhcccCC-----CC
Confidence 34689999999999763 6788999999999999999999999643220 001111112211110 11
Q ss_pred hHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
...++..+.+++.+||+.||++|| ++++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 123456788999999999999999 77888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.01 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=194.3
Q ss_pred hhccccccCceEEEEEEeCCC-c--EEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 353 FKEKLGTGGYGNVYKGKFPDG-R--LVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
+.++||+|+||.||+|.+.+. + .+|+|.++... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999998643 3 68999887542 3456788999999999999999999987532 2468
Q ss_pred EEEEecCCCCccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
+++||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874321 223589999999999999999999997 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
+...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~~~ 225 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYD 225 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHH
Confidence 876543322111223457789999998753 67889999999999999999 7777753211 11222
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.+........ .......+.+++.+||+.||++|||+.+|++.|++
T Consensus 226 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 226 YLRQGNRLKQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHcCCCCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 2222211111 11234568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.71 Aligned_cols=240 Identities=22% Similarity=0.312 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+++++ +++.||+|+++... ...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 68899999987532 3345667788888765 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 99998886542 588999999999999999999998 999999999999999999999999999875322221 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~------------~~~~~~~~~~~~-~~-- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------------DELFESIRVDTP-HY-- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC--
Confidence 2334589999999999764 678899999999999999999999964321 111222211111 11
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 621 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 621 (670)
.......+.+++.+||+.||++||++. ++++
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112345678899999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.40 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=195.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||++++. +++.||+|+++... ...+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999886 68899999997532 2345678899999988 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 99998886543 589999999999999999999998 999999999999999999999999999875322111 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||+...... .......++..+.+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD---NPDQNTEDYLFQVILEKQIR-I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccc---cccccchHHHHHHHHcCCCC-C--
Confidence 1234589999999999763 67889999999999999999999997432211 01111223333333322111 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPS------MTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 622 (670)
+..++..+.+++.+||+.||++||+ +.+++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1123456788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.50 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=196.1
Q ss_pred hhhccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.++||+|+||.||+++. .+++.+|+|++.... ...+.+..|+.++.++ +|+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4568899999999999876 357899999986432 2345688899999999 59999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999986543 589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
...... .....||+.|+|||++.+. ...+.++|||||||++|||++|+.||...... .....+...+...
T Consensus 157 ~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~~~~~~~~~ 226 (332)
T cd05614 157 SEEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGER--------NTQSEVSRRILKC 226 (332)
T ss_pred ccCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCC--------CCHHHHHHHHhcC
Confidence 322211 1234589999999998753 34678999999999999999999999643221 1111222222221
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
.. . ....+...+.+++.+||+.||++|| ++++++++
T Consensus 227 ~~-~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DP-P----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC-C----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 1 1112355678899999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.82 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+++.. +++.+|+|+++... ...+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999986 57899999997532 2345677888888877 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 99988876543 589999999999999999999998 999999999999999999999999999875322211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ........++.+.+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~~-~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQIR-I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcC---CcccccHHHHHHHHhcCCCC-C--
Confidence 1234589999999999764 67889999999999999999999996422211 11112223333333322211 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPS------MTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 622 (670)
+......+.+++.+||+.||++||+ +.+++++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1223456788999999999999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.89 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=191.2
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||.||+|+..+ +..+++|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998876542 3357889999999999999999999999988999999999999
Q ss_pred CcccccccccC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 430 SLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 430 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|.+++..... ....++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965432 22467788889999999999999998 99999999999999999999999999997654333222
Q ss_pred eecCCCCCccccchhhcccccC-----CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLG-----NPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
......++..|+|||++.+..+ .++.++||||||+++|||++ |+.||...... . .... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-------~-~~~~---~~~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-------Q-VLTY---TVREQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-------H-HHHH---Hhhcc
Confidence 2233456788999999864311 34779999999999999996 99898543210 0 0000 01110
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
................+.+++.+|+ .+|++|||++||++.|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000000101112345677888898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.78 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=203.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+|+.. +++.+|||.+.... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45688999999999999875 68999999875422 23457889999999999999999999999999999999999
Q ss_pred CCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++++|.+++..... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999988854322 23588999999999999999999988 999999999999999999999999999887654322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....+++.|+|||.+.+. ..+.++||||||+++|||++|+.|+..... .... +...+......
T Consensus 162 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~---------~~~~-~~~~~~~~~~~- 226 (267)
T cd08228 162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLFS-LCQKIEQCDYP- 226 (267)
T ss_pred H--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccc---------cHHH-HHHHHhcCCCC-
Confidence 1 1234578899999998754 678899999999999999999999854221 0111 11222211111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223456788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=329.03 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=201.1
Q ss_pred HHHHHHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeC
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDG 416 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~ 416 (670)
+....+.+.++||+|+||.||+|++. .++.||+|+++... ...+.+.+|+.++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33334445689999999999999863 34689999997643 23457889999999997 99999999999998
Q ss_pred CeeEEEEEecCCCCcccccccccC--------------------------------------------------------
Q 005909 417 STRALIYEYMPNGSLGDLLSREKE-------------------------------------------------------- 440 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 440 (670)
...++|+||+++|+|.+++++.+.
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 899999999999999999865321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 441 ---------------------------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 441 ---------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
...+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 12367788899999999999999987 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 560 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~ 560 (670)
|+++++.+||+|||+++...............++..|+|||.+.. ..++.++||||||+++|||++ |+.|+.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 999999999999999986543322212223346788999999975 367889999999999999998 8888753211
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+.....+..+.... .+...+..+.+++.+||+.+|++||+++||++.|+.+
T Consensus 348 ----------~~~~~~~~~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 ----------NEQFYNAIKRGYRMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----------hHHHHHHHHcCCCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111112222111111 1112356788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=314.16 Aligned_cols=251 Identities=26% Similarity=0.454 Sum_probs=193.8
Q ss_pred hhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.||+|+||+||+|++. +++ .+++|.+.... ....++..|+..+.+++||||+++++++. +...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 4578999999999999874 344 47788875433 23357788888999999999999999875 4457889999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 90 SPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999975432 589999999999999999999988 999999999999999999999999999987644332
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
........++..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ....+.+ ......
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~----~~~~~~ 230 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLL----EKGERL 230 (279)
T ss_pred ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH----HCCCcC
Confidence 222333457789999999865 367889999999999999998 8888854321 1111111 111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... .....+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 231 ~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1101 12345677899999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=317.21 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=197.2
Q ss_pred HHHHhhhccccccCceEEEEEEeCC---------------CcEEEEEEcccCC--cchHHHHHHHHHhcccccccccccc
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPD---------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLL 410 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~ 410 (670)
+..+++.++||+|+||.||+++..+ ...||+|++.... ...+.+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3445677899999999999987632 2358999987543 3346789999999999999999999
Q ss_pred ceeeeCCeeEEEEEecCCCCcccccccccC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKE---------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 411 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
+++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999854321 12478899999999999999999998 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTET 559 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt--g~~p~~~~~~ 559 (670)
++++++.+||+|||+++...............++..|+|||.+.. +.++.++||||||++++||++ +..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999976543332222223345778999999865 467899999999999999998 4455543211
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
......+.+.... .............+..+.+++.+||+.||++||++.+|++.|+
T Consensus 239 --------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --------EQVIENTGEFFRN-QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --------HHHHHHHHHhhhh-ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000001010000 0000000111123457899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.08 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=189.3
Q ss_pred HhhhccccccCceEEEEEEeC--CCcEEEEEEcccCC---cchHHHHHHHHHhccc---cccccccccceeee-----CC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GS 417 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~ 417 (670)
|.+.+.||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 445688999999999999873 46889999986533 2334566777776665 69999999998852 34
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++|+||++ ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 6789999995 689888865432 2589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+...... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||....... .+ ..+.+.
T Consensus 158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-------~~-~~i~~~ 224 (290)
T cd07862 158 RIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-------QL-GKILDV 224 (290)
T ss_pred EeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-------HH-HHHHHH
Confidence 8664332 12334589999999999653 67889999999999999999999987532200 00 001000
Q ss_pred hcC------------------CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQ------------------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... .................+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000000001111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.41 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=198.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
++..+.||+|+||+||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345578999999999999875 68999999987533 2234578899999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999998886532 23589999999999999999999998 999999999999999999999999999987543322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+...+....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~--- 221 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--------VKREEVERRVKEDQ--- 221 (285)
T ss_pred ---cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchh--------hHHHHHHHHhhhcc---
Confidence 123458999999999975 36788999999999999999999999643220 00011111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
......++..+.+++.+||+.||++|| ++.+++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111223466788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.38 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
++||+|+||.||+|...+ ...+++|.+.... .....+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997643 3578888876543 23457889999999999999999999999999999999999999
Q ss_pred CcccccccccCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 430 SLGDLLSREKEN--LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 430 sL~~~l~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|.+++...... ...++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765431 2356788899999999999999998 99999999999999999999999999987644332222
Q ss_pred eecCCCCCccccchhhcccc-----cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 508 TMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
......++..|+|||++... ....+.++||||||+++|||++ |+.||..... .+.........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~~~~~~~~~~ 226 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----------EQVLKQVVREQ 226 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HHHHHHHhhcc
Confidence 22334467789999997532 1245789999999999999999 6677643211 01111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
...-............+.+++..|+ .||++||++++|++.|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111112234455667778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=312.80 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=197.0
Q ss_pred hhccccccCceEEEEEEeCC----CcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCe------e
Q 005909 353 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------R 419 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~ 419 (670)
+.+.||+|+||.||+|++.. +..||+|+++... ...+.+.+|+..++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998742 3689999987543 234578999999999999999999998876554 6
Q ss_pred EEEEEecCCCCccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 420 ALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
++++||+++++|..++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999885432 223689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
++...............++..|+|||.+.. ..++.++||||||+++|||++ |..||..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------------~~~~ 225 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------------HEIY 225 (273)
T ss_pred eeeccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------------HHHH
Confidence 987644332211122335678999999865 367889999999999999999 7787753221 1112
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+.+..+..... .......+.+++.+||+.||++||++.|+++.|+++
T Consensus 226 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 DYLRHGNRLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHcCCCCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222211111 123456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.82 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=198.4
Q ss_pred hhhccccccCceEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.++||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++.+.+..++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 35689999999999999642 35688999887544 345689999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 425 YMPNGSLGDLLSREKE------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
|+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 9999999999875432 12488999999999999999999988 99999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 571 (670)
|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... .
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~ 231 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-----------T 231 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----------H
Confidence 99999765433222222223357889999998753 67889999999999999998 8888753221 0
Q ss_pred HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 572 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
+ ............. ...++..+.+++.+||+.||++||++.||++.|+
T Consensus 232 ~-~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 E-AIECITQGRELER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHHHHHcCccCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 1111111111111 1123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.83 Aligned_cols=245 Identities=25% Similarity=0.427 Sum_probs=194.2
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 356 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+||+|+||.||+|.++ ++..+|+|+++... ...+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57899999987543 23467899999999999999999999875 45678999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee-
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT- 508 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~- 508 (670)
+|.+++.... .+++..+.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999986543 588999999999999999999988 999999999999999999999999999987654432211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.. ...+.++||||||+++|||++ |+.||..... . .+...+.........
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~----~~~~~i~~~~~~~~~ 220 (257)
T cd05116 155 KTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------N----EVTQMIESGERMECP 220 (257)
T ss_pred cCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------H----HHHHHHHCCCCCCCC
Confidence 122334678999999864 367889999999999999998 8888864321 1 111222222111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 221 ----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 ----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1245678899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.20 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=200.2
Q ss_pred HhhhccccccCceEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.+.||+|+||.||++...+ ...+|+|.+.... ....++.+|+.++.++ +|+||+++++++..++..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3456789999999999998642 3689999987543 2345688999999999 89999999999999999999
Q ss_pred EEEecCCCCccccccccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC
Q 005909 422 IYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 488 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~ 488 (670)
+|||+++|+|.+++.+.. ....+++..+++++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 999999999999986431 223688999999999999999999987 9999999999999999999
Q ss_pred eEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCcc
Q 005909 489 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 567 (670)
Q Consensus 489 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 567 (670)
+||+|||+++...............++..|+|||++.+ ..++.++||||||+++|||++ |..|+.....
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 240 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------- 240 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCH--------
Confidence 99999999987654333222233345678999999865 367889999999999999997 8887753211
Q ss_pred ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..+...+........ .......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 241 ----~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 ----EELFKLLKEGYRMEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111222222211111 112345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.46 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=197.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC--------e
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------T 418 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~ 418 (670)
|.+.+.||+|+||+||+++.. +++.||||++.... .....+.+|+..+..++|+||+++++.+.... .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 445688999999999999864 78999999986543 33456889999999999999999988765332 3
Q ss_pred eEEEEEecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 419 RALIYEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
.++||||+++|+|.++++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 679999999999999986532 234689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+...............||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------------~~~~~~ 256 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM------------EEVMHK 256 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH
Confidence 876433222222334689999999999753 678899999999999999999999864221 112222
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......... ....+..+.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDPL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222211111 12245678899999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.27 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=198.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.. +++.+|+|+++... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45688999999999999875 68999999997543 24466888999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 84 PGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999976532 589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhcccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
......||+.|+|||++... ...++.++|||||||++|||++|+.||..... ......+....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------------~~~~~~i~~~~ 225 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------------AKTYNNIMNFQ 225 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------------HHHHHHHHcCC
Confidence 22334689999999998632 23567899999999999999999999964321 01112221111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ........++..+.+++..||+ +|++||++.+++++
T Consensus 226 ~~-~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RF-LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred Cc-cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 10 0000111235567889999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=313.83 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=196.8
Q ss_pred hhhccccccCceEEEEEEeCC------CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.||+|++|.||+|.+.+ +..|++|.+..... ....+.+|+.++++++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 345789999999999998853 56889998875432 3457899999999999999999999999998999999
Q ss_pred EecCCCCcccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeecCC
Q 005909 424 EYMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGL 496 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~DfGl 496 (670)
||+++++|.+++.+.+. ...+++..+++++.|++.||+|||++ +++||||||+||+++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence 99999999999876432 12589999999999999999999998 999999999999998754 599999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
++................+..|+|||++.+ ..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------------~~~~ 231 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------------QEVM 231 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHH
Confidence 987643322221122234568999999965 368899999999999999997 8888864221 0111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..+........ ....+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 232 ~~~~~~~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRLDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111111 1223567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=306.50 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=197.6
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcc--ccccccccccceeeeCC----eeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCDGS----TRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~lv~e~ 425 (670)
.+.+.||+|.||.||+|++ .|+.||||++...++ +.+.+|.++.+. |+|+||+.+++.-..++ +++||.+|
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 3568899999999999999 688899999986654 445667666665 49999999998765433 67899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG-----CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
.++|||.|+|.+. .++....++++..+|.||++||.. .++.|.|||||++|||+..++...|+|+|||...
T Consensus 291 He~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 291 HEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred ccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999999774 599999999999999999999953 4678999999999999999999999999999887
Q ss_pred CCCCcee--eecCCCCCccccchhhcccccC--CC--CccchhHHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 005909 501 SRNRSVV--TMTGPRGTIGYIAPEIFMRNLG--NP--SGKSDVYSYGMLLLEMIEE----------KKHLRPTETTSGSN 564 (670)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~~--s~~sDV~SlGvvl~elltg----------~~p~~~~~~~~~~~ 564 (670)
..+.... .....+||.+|||||++..... .+ -..+||||||+|+||+.-+ +.||.+...
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp----- 441 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP----- 441 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-----
Confidence 6554332 2344679999999999975321 11 2368999999999999732 234443222
Q ss_pred CccccchHHHHHHhcCCcccc--ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 565 TTEAYFPDWIYDKLIQPEKED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+..+.++ .+.+-..+... ...-........|.+++..||..+|..|-|+=.|-+.|.++.
T Consensus 442 -~DPs~eeM-rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 -SDPSFEEM-RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred -CCCCHHHH-hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11222222 12111111111 112224456778999999999999999999999999988654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.20 Aligned_cols=254 Identities=24% Similarity=0.441 Sum_probs=204.2
Q ss_pred HHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..+.+.++||+|+||.||+|.+++++.+++|.+.......+++.+|+.++++++|+||+++++++......++|+||+++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 34456789999999999999988888999999987766678899999999999999999999999988899999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... ..+++..+..++.+++.||.|||++ +++|+||||+||++++++.+||+|||+++........ .
T Consensus 86 ~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~ 160 (261)
T cd05034 86 GSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-A 160 (261)
T ss_pred CCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh-h
Confidence 999999976432 2589999999999999999999988 9999999999999999999999999998876532211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.+. ..+.++||||||++++||++ |+.||..... ......+......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~--- 223 (261)
T cd05034 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------------REVLEQVERGYRM--- 223 (261)
T ss_pred hhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC---
Confidence 1223346789999998753 67889999999999999998 8888853211 1111122111110
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011124578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=313.39 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=197.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
..+.++||+|+||+||+|++. +++ .||+|+++... ...+++.+|+.++.+++|+||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence 345688999999999999863 444 48999987543 3356788999999999999999999998754 567999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 88 QLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999875432 589999999999999999999998 9999999999999999999999999999877544
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..........++..|+|||.+.+ ..++.++||||||+++|||++ |..|+..... .....+ +....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~----~~~~~ 228 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDL----LEKGE 228 (279)
T ss_pred cceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH----HHCCC
Confidence 33322233345778999999865 367889999999999999998 8888754221 111111 11111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... ....+..+.+++.+||+.||++||++.++++.|++..
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 RLPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred cCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 1123456888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.46 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=190.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHH---hccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVAT---IGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.||+|+||.||++.+. +++.||||+++... ...+.+.+|+++ +++++||||+++++++.+++..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 34678999999999999875 68999999997532 233456666654 46778999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999998887543 489999999999999999999998 9999999999999999999999999998754322
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~------------~~~~~~i~~~~~ 218 (324)
T cd05589 155 GD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDE------------EEVFDSIVNDEV 218 (324)
T ss_pred CC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC
Confidence 11 11234589999999999753 678899999999999999999999864321 111112211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
. .+..++..+.+++.+||+.||++|| ++.+++++-
T Consensus 219 ~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 R-----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred C-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 0 1112355678899999999999999 577776653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=318.12 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=203.0
Q ss_pred HHHHHHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceee
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCC 414 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 414 (670)
+....+.+.+.||+|+||.||+++.. ++..+|+|.+.... ...+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33444556789999999999999741 24579999987543 3346789999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 415 DGSTRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 415 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
.....++||||+++++|.+++.+... ...+++..++.++.|+++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999875421 12578889999999999999999998 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 560 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~ 560 (670)
++++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 9999999999999999876543322222334467789999998653 67889999999999999998 6777643211
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+.+.+........ ....+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 246 -----------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 -----------EELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred -----------HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 112222222211111 1233567888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.44 Aligned_cols=249 Identities=31% Similarity=0.534 Sum_probs=203.2
Q ss_pred ccccccCceEEEEEEeCC----CcEEEEEEcccCCcc--hHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||++.... +..+++|++...... .+.+.+|++.+.+++|+||+++++++.+....++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998864 789999999876543 57899999999999999999999999999999999999999
Q ss_pred CCcccccccccC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 429 GSLGDLLSREKE------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 429 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
++|.+++..... ...+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976521 24689999999999999999999998 999999999999999999999999999987765
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
...........++..|+|||.+... ..+.++||||||++++||++ |+.||..... ..+.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~ 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------EEVLEYLRKG 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcC
Confidence 4322223345578899999998754 67889999999999999999 5888864311 1222233222
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
... .....++..+.+++.+||+.+|++||++.|++++|+
T Consensus 224 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRL----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.40 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=193.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||+||+++.+ +|+.+|+|.+.... .....+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 58999999986432 1234556799999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 988865432 3588999999999999999999988 999999999999999999999999999877654322 223
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..|+..|+|||++.+. .++.++|||||||++|||++|+.||...... . -...+.......... ...
T Consensus 154 ~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~----~~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-------V-AKEELKRRTLEDEVK----FEH 219 (277)
T ss_pred cCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcch-------h-hHHHHHHHhhccccc----ccc
Confidence 4589999999999764 5888999999999999999999998643210 0 011111221111111 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..++.++.+++.+||+.||++||+++|+++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 234557889999999999999999977765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=328.67 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=190.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+|+.. +++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 34678999999999999875 68899999987543 23467889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc-
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS- 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~- 505 (670)
++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 84 PGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999986543 588899999999999999999998 999999999999999999999999999753211000
Q ss_pred --------------------------------------------eeeecCCCCCccccchhhcccccCCCCccchhHHHH
Q 005909 506 --------------------------------------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 541 (670)
Q Consensus 506 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlG 541 (670)
........||+.|+|||++.+. .++.++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG 235 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEech
Confidence 0001123589999999999764 678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCC---HHH
Q 005909 542 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTR 618 (670)
Q Consensus 542 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~e 618 (670)
|++|||++|+.||..... ......+...... ........+...+.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP------------LETQMKVINWQTS-LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCH------------HHHHHHHHccCCC-cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999964321 0111111111000 000011123445666676665 59999987 888
Q ss_pred HHHH
Q 005909 619 VVEM 622 (670)
Q Consensus 619 vl~~ 622 (670)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.07 Aligned_cols=241 Identities=23% Similarity=0.325 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+|+.. +++.+|+|++.... ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999886 57899999987532 3345677888888866 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|...+.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99998886543 588999999999999999999998 999999999999999999999999999875432221 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~------------~~~~~~i~~~~~~---- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNE------------DDLFESILHDDVL---- 214 (321)
T ss_pred ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 2334589999999998753 678899999999999999999999964321 1112222221110
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRP-------SMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 622 (670)
.+......+.+++.+||+.||++|| ++.+++++
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111345678899999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.20 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=196.4
Q ss_pred hhhccccccCceEEEEEEeC-----CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeee--CCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~ 423 (670)
.+.+.||+|+||+||++..+ +++.||+|.+.... ...+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 35678999999999999752 57899999987654 335678999999999999999999998754 34678999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++.+... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 87 EYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999865432 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cceeee-cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc----ccchHHHHHHh
Q 005909 504 RSVVTM-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE----AYFPDWIYDKL 578 (670)
Q Consensus 504 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~ 578 (670)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|..++............. ........+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 322111 11223456999999865 367889999999999999999877653321100000000 00011111111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...... ......+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 240 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRL----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111110 11122345788999999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.34 Aligned_cols=236 Identities=22% Similarity=0.366 Sum_probs=195.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|.||+|+++.++ +++.+|||++++.. +..+..+.|-+++... +||.+++++.+|...+..++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 35689999999999999986 57899999999865 4567788888888877 599999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC-CCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-RNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~-~~~ 504 (670)
+.+|++..+.+.. .+++.++..++..++.||.|||++ +||+||||.+|||||.+|++||+||||++..- .+.
T Consensus 451 ~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred cCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9999966655433 499999999999999999999998 99999999999999999999999999998653 222
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ....-||+.|||||++.+. .++...|-|||||+|||||.|..||.+.++ +.+.+.+.....
T Consensus 524 ~---TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------ee~FdsI~~d~~- 585 (694)
T KOG0694|consen 524 R---TSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------EEVFDSIVNDEV- 585 (694)
T ss_pred c---cccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHhcCCC-
Confidence 2 2335689999999999874 889999999999999999999999986544 223333332221
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 616 (670)
..+..++.+.+.++.++|..+|++|--+
T Consensus 586 ----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122345678889999999999999755
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.89 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=200.4
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.+.||+|+||.||++... .+..+|+|+++... ...+.+.+|+.+++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 3446689999999999999752 34579999987643 3346789999999999 7999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+|+||+++|+|.+++++... ..+++.++..++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||+++..
T Consensus 116 lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999975432 2489999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
.............++..|+|||.+.+. ..+.++||||||+++|||++ |+.|+..... .+.......
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----------~~~~~~~~~ 258 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----------DSKFYKLIK 258 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----------hHHHHHHHH
Confidence 543322222233467889999998653 67889999999999999998 8888754321 011111111
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.+.... .....+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 259 ~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EGYRMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cCCcCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 111111 111224578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.93 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.||+|+||.||+|...+++.+|+|++..... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999876432 2456889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++..... .+++..++.++.|++.+|.|||++ +++||||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 98865432 478999999999999999999987 99999999999999999999999999987644322111 1112
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
.++..|+|||++.. +.++.++||||||+++|||++ |..||..... ......+....... ..
T Consensus 155 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------------~~~~~~~~~~~~~~----~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTN------------QQAREQVEKGYRMS----CP 216 (250)
T ss_pred CCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHHcCCCCC----CC
Confidence 34678999999865 467889999999999999998 8888854221 11111221111111 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.41 Aligned_cols=236 Identities=26% Similarity=0.356 Sum_probs=186.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+|+.. +++.||+|++.... ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999986 68999999987532 22344555555 56788999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 99999886543 588999999999999999999998 999999999999999999999999999875422211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.+..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~-~~~- 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------------AEMYDNILNKPL-RLK- 216 (323)
T ss_pred cccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH------------HHHHHHHHcCCC-CCC-
Confidence 2234589999999998753 678899999999999999999999864321 111222222111 111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMT 617 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 617 (670)
...+..+.+++.+||+.||++||++.
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 ---PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11255678899999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.43 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=192.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.. +++.+|+|++.... ...+.+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45688999999999999976 58999999987522 23456889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 84 VGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999965322 488999999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
. .....||+.|+|||++... .+.++.++|||||||++|||++|+.||..... .+ ....+.....
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----------~~-~~~~i~~~~~ 225 (331)
T cd05597 159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VE-TYGKIMNHKE 225 (331)
T ss_pred c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----------HH-HHHHHHcCCC
Confidence 1 1223589999999998632 23567899999999999999999999864221 01 1111211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINP--KDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~evl~~ 622 (670)
...........+..+.+++.+|+..++ ..||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000111111245566777777775433 347899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.49 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+|++. +++.||+|+++... ...+.+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999985 57899999987532 2344566677777654 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 99999886543 589999999999999999999998 999999999999999999999999999976433221 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~-~~--- 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDE------------DELFDSILNDR-PH--- 214 (316)
T ss_pred cccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCC-CC---
Confidence 2234589999999999754 678899999999999999999999964321 11122222111 11
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 621 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 621 (670)
.+......+.+++.+||+.||++||++. ++++
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1112345677899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.69 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=200.9
Q ss_pred HHHHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeC
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG 416 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 416 (670)
...+.+.+.||+|+||.||+++.. +...+|+|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 344566789999999999999753 23579999997543 3345788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 417 STRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
...++|+||+++|+|.+++..... ...+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975432 12488999999999999999999987 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSG 562 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~ 562 (670)
+.++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence 99999999999998765432211111222345789999998653 67889999999999999998 7777743211
Q ss_pred CCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+...+...... .........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 249 ---------~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 ---------EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---------HHHHHHHHcCCCC----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1112222221111 111223567888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.01 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=197.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.++||+|+||.||+|+.. +++.+|+|++.... .....+.+|+.++++++||||+++++.+..++..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 456689999999999999974 68899999987543 3345688999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.++++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 91 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd06646 91 GSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-- 162 (267)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence 99999886543 588999999999999999999988 9999999999999999999999999999866432211
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+... ...++.++||||||+++|||++|+.|+......... ..+.........
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------------FLMSKSNFQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------------eeeecCCCCCCC
Confidence 1234578899999988532 235678999999999999999999998543211000 000000000000
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......++..+.+++.+||+.+|++||++++++++|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011122456788999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.08 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=198.8
Q ss_pred HhhhccccccCceEEEEEEeCC-----------------CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccc
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD-----------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 411 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g 411 (670)
+.+.++||+|+||.||++++.+ +..||+|.+.... ...+++.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4567899999999999987642 2468999987654 34567899999999999999999999
Q ss_pred eeeeCCeeEEEEEecCCCCcccccccccC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 412 FCCDGSTRALIYEYMPNGSLGDLLSREKE--------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 412 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
++..+...++++||+++++|.+++.+... ...+++..++.++.|++.||+|||++ +++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence 99999999999999999999999865431 12589999999999999999999988 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTS 561 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt--g~~p~~~~~~~~ 561 (670)
++++.+||+|||+++...............++..|+|||.+.+ +..+.++||||||+++|||++ +..|+.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 9999999999999986544332222233456789999999875 367889999999999999998 5556542211
Q ss_pred CCCCccccchHHHHHHhcCC---ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 562 GSNTTEAYFPDWIYDKLIQP---EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..+....... .............+.++.+++.+||+.||++||++.||++.|+
T Consensus 240 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ----------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111 0000001111223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.81 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||++++. +++.+|+|+++... ...+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999886 57899999997542 3345677888888888 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|..++.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 99998886543 589999999999999999999988 9999999999999999999999999998753222111
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~------------~~~~~~i~~~~~-~--- 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDE------------DELFQSILEDEV-R--- 214 (318)
T ss_pred ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCH------------HHHHHHHHcCCC-C---
Confidence 1223579999999999763 678899999999999999999999964321 111122221111 0
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
.+...+..+.+++.+||+.||++||++ .+++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111235578899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=313.52 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=200.0
Q ss_pred HHHhhhccccccCceEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
..+.+.+.||+|+||.||+|..++ +..+|+|.+.... .....+.+|+.++.+++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 344456889999999999998742 3689999987554 23457889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 421 LIYEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
+|+||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 99999999999999865332 12478899999999999999999987 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++...............++..|+|||.+.. +..+.++||||||+++|||++ |+.|+..... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------------~ 228 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------------E 228 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCH------------H
Confidence 999986544322211223346789999999865 367889999999999999998 8888753211 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.....+......... ...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 EVLKFVIDGGHLDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111122221111111 112567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.04 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=200.1
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|++|.||+++.+ +++.+++|.+... ....+.+.+|++++++++||||+++++++.+....++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4578999999999999885 6889999998643 23457789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 84 GDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred CcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999997642 23689999999999999999999987 9999999999999999999999999998876543221
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ..............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~--- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ------------GALILKIIRGVFPP--- 220 (256)
T ss_pred hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCCC---
Confidence 1233578899999999753 678899999999999999999999864321 11122222221111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....+...+.+++.+||+.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.08 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=197.0
Q ss_pred hhhccccccCceEEEEEEe-----CCCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeC--CeeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 422 (670)
.+.+.||+|+||+||++.. .+++.||+|+++.... ....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4568899999999988653 3578999999876432 456788999999999999999999988654 357899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998653 489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--CCCcc-ccchHHHHHHh
Q 005909 503 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--SNTTE-AYFPDWIYDKL 578 (670)
Q Consensus 503 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~ 578 (670)
...... .....++..|+|||.+.. ...+.++||||||+++|||++|+.|+........ ..... ........+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 322111 112235667999999865 3678899999999999999999998754321000 00000 00000001111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..... .......+..+.+++.+||+.||++||++++|++.|+.+
T Consensus 238 ~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMR----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCC----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11100 011122356788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.65 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=202.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||++... +++.++||.+.... ...+++.+|+.++++++|+||+++++++.+++..++++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 345678999999999999964 78999999876532 2346788999999999999999999999999999999999
Q ss_pred cCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++++|.+++.... ....+++..++.++.|+++||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999999886422 233689999999999999999999988 99999999999999999999999999987664432
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.. .....++..|+|||++.+. ..+.++||||||+++|||++|..||...... ... ....+......
T Consensus 161 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~~~-~~~~~~~~~~~ 226 (267)
T cd08229 161 TA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYS-LCKKIEQCDYP 226 (267)
T ss_pred cc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccch---------HHH-HhhhhhcCCCC
Confidence 21 1234578899999999654 6788999999999999999999998542210 000 11111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..........+.+++.+||+.||++||||.+|++.++++
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123456788999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.56 Aligned_cols=249 Identities=25% Similarity=0.488 Sum_probs=200.1
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.+.||+|+||.||++.+.+++.+|+|.+........++.+|++++++++||||+++++++......++|+||+++++|
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 35688999999999999987788999999887665667899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++..... .+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ ....
T Consensus 87 ~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05112 87 SDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG 160 (256)
T ss_pred HHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence 999865432 478999999999999999999988 9999999999999999999999999998765432211 1122
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
..++.+|+|||.+.+ +.++.++||||||+++|||++ |+.||..... ....+.+....... .
T Consensus 161 ~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~----~ 222 (256)
T cd05112 161 TKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------------SEVVETINAGFRLY----K 222 (256)
T ss_pred CccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------------HHHHHHHhCCCCCC----C
Confidence 335678999999875 367889999999999999998 8888753221 11112221111100 0
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
....+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.90 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=198.7
Q ss_pred HHHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
..+.+.++||+|+||.||+|..+ .+..||+|.+..... ....+.+|+..+++++|+||+++++++.+....+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34556789999999999999753 245899999875542 2346889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 421 LIYEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
+||||+++|+|.+++..... .....+..+++++.|++.||.|||++ +|+||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999965321 12456778899999999999999988 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++...............++..|+|||.+.+ +..+.++||||||+++|||++ |+.|+..... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------------~ 228 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------------E 228 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------------H
Confidence 999986543322211122235678999999875 367889999999999999998 6777753211 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+...+......... ...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 229 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 QVLKFVMDGGYLDQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111222221111111 12245788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.14 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=204.0
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-ccccccccccee
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFC 413 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 413 (670)
++.+.++.+.+.||+|+||.||++... .+..+|+|+++... ...+++.+|+.++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444556677899999999999999752 12378999887543 3356889999999999 799999999999
Q ss_pred eeCCeeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCc
Q 005909 414 CDGSTRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480 (670)
Q Consensus 414 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 480 (670)
......++++||+++|+|.+++.+... ...+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 999999999999999999999865321 22478899999999999999999988 99999999999
Q ss_pred EEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTET 559 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~ 559 (670)
|++++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999866443222222233346789999999753 67889999999999999998 7777753211
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.+ ....+........ ....+..+.+++.+||+.+|++||++.|+++.|+....
T Consensus 243 -----------~~-~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 -----------EE-LFKLLKEGHRMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -----------HH-HHHHHHcCCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 1122222111111 11234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.47 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=191.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.+.||+|+||.||++.+. .++.||||... ...+.+|++++++++|+||+++++++..++..++|+|++ .++
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~ 245 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD 245 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence 34578999999999999986 47889999632 234678999999999999999999999999999999999 578
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... .+++..++.|+.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++............
T Consensus 246 L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 246 LYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 8888754322 589999999999999999999998 99999999999999999999999999998764332221223
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC-Cc-------
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ-PE------- 582 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------- 582 (670)
...||..|+|||++.+. .++.++|||||||++|||++|..++...............+...+...... ..
T Consensus 321 ~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 45689999999999764 678899999999999999998876543221110011111111111110000 00
Q ss_pred --------------cccccc---hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 --------------KEDFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 --------------~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... .........+.+++.+||+.||++|||+.|++++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 0001223467889999999999999999999976
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.74 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=197.1
Q ss_pred HHHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeC-Ce
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-ST 418 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~ 418 (670)
..+.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3456789999999999999974 347899999997643 2345788999999999 789999999988654 46
Q ss_pred eEEEEEecCCCCcccccccccC----------------------------------------------------------
Q 005909 419 RALIYEYMPNGSLGDLLSREKE---------------------------------------------------------- 440 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 440 (670)
.++|+||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998864221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCC
Q 005909 441 ------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514 (670)
Q Consensus 441 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~g 514 (670)
...+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999998 999999999999999999999999999986543322222222345
Q ss_pred CccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHH
Q 005909 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDC 593 (670)
Q Consensus 515 t~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (670)
+..|+|||.+.+. .++.++||||||+++|||++ |..|+..... . ......+......... ..
T Consensus 244 ~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~----~~~~~~~~~~~~~~~~----~~ 306 (343)
T cd05103 244 PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------D----EEFCRRLKEGTRMRAP----DY 306 (343)
T ss_pred CcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------c----HHHHHHHhccCCCCCC----CC
Confidence 6789999998653 67889999999999999997 8888753211 0 1111111111111111 11
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 594 IARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 594 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
....+.+++.+||+.||++||++.||+++|+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.16 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=191.6
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC-----eeEEEEEecC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALIYEYMP 427 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv~e~~~ 427 (670)
.+.+|.|+||.||+|+.. +++.||||++-.+.... -+|+.+|+++.|||||++.-++.... ...+|+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 368999999999999985 57899999886655422 27999999999999999998876432 2348999996
Q ss_pred CCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCCCc
Q 005909 428 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 428 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~~~ 505 (670)
. +|.++++.. ..+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+..+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 4 888888742 1233577788888999999999999997 99999999999999976 9999999999998876655
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC----
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP---- 581 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 581 (670)
....- .|..|+|||++.+. ..++.+.||||.|||+.||+-|+..|.+.... ..+ ..+.+.+..+
T Consensus 182 niSYi---cSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-------dQL-~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 182 NISYI---CSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-------DQL-VEIIKVLGTPTRED 249 (364)
T ss_pred ceeEE---EeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHH-------HHH-HHHHHHhCCCCHHH
Confidence 44332 47899999999986 58899999999999999999999988763321 011 1111111111
Q ss_pred -----------cccccc-----chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 -----------EKEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 -----------~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+... .........+..+++.++|+.+|.+|.++.|++.+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 001100 11233456688999999999999999999999864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.44 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=191.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 45688999999999999875 58999999986532 23466889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc-
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS- 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~- 505 (670)
++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 84 PGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999996543 588899999999999999999998 999999999999999999999999999753210000
Q ss_pred ----------------------------------------eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHH
Q 005909 506 ----------------------------------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 545 (670)
Q Consensus 506 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ 545 (670)
........||+.|+|||++.+. .++.++|||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvily 235 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceee
Confidence 0001124689999999999764 6788999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 005909 546 EMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP---SMTRVVEM 622 (670)
Q Consensus 546 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~~ 622 (670)
||++|+.||...... .....+..... .........++..+.+++.+|+ .+|++|+ ++.|++++
T Consensus 236 ell~G~~Pf~~~~~~------------~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPA------------ETQLKVINWET-TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHH------------HHHHHHhccCc-cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999653220 01111111000 0000001123445667777765 5999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.24 Aligned_cols=237 Identities=24% Similarity=0.335 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEe----CCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 355 EKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.||+|+||.||+++. .+|+.+|+|++.... .....+..|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999997543 234567789999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 999999886543 589999999999999999999998 9999999999999999999999999998765433211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|++.|+|||.+.+. ..+.++||||||+++|||++|+.||..... ......+..... .
T Consensus 155 -~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~------------~~~~~~i~~~~~-~-- 216 (318)
T cd05582 155 -AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDR------------KETMTMILKAKL-G-- 216 (318)
T ss_pred -eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCH------------HHHHHHHHcCCC-C--
Confidence 1234589999999999753 568899999999999999999999864321 111112211111 0
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 618 (670)
.+......+.+++.+||+.||++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11123456788999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.18 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=193.5
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 356 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876542 3467899999999999999999999875 457789999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce-eee
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTM 509 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~-~~~ 509 (670)
|.+++.... ..+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........ ...
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999986433 2589999999999999999999998 9999999999999999999999999999865443221 112
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....++..|+|||.+.. ..++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-- 219 (257)
T cd05115 156 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------------PEVMSFIEQGKRLDC-- 219 (257)
T ss_pred CCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHHCCCCCCC--
Confidence 22334678999999865 367889999999999999996 9988864321 111222222211111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
+...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 220 --~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 --PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11234578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.73 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=197.5
Q ss_pred HhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||.||+++++ ++..+|+|++.... ...+++.+|+.++.+++||||+++++++.++...++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 345678999999999999864 46789999987543 2346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 423 YEYMPNGSLGDLLSREKE-------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
+||+++++|.+++..... ...+++..++.++.|++.||+|||++ +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 999999999999864321 12478889999999999999999988 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSG 562 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~ 562 (670)
++++.+||+|||+++................+..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--- 238 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999876543322111122234678999999865 367889999999999999997 7777743211
Q ss_pred CCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..+...+........ ....+..+.+++.+||+.||++||++.|+++.|+
T Consensus 239 ---------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 ---------EEVIYYVRDGNVLSC----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ---------HHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111122222211111 1123467889999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.97 Aligned_cols=244 Identities=22% Similarity=0.314 Sum_probs=192.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+|+.. +++.+|+|++.... ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 35678999999999999886 57899999987542 2334567788888777 689999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 83 VNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999998886543 588999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~------------~~~~~~i~~~~~-~ 219 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNV-A 219 (323)
T ss_pred --ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-C
Confidence 12234589999999999753 678999999999999999999999964321 111122221111 0
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
.+...+.++.+++.+||+.||++|++. .++.++
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111235577889999999999999974 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.65 Aligned_cols=247 Identities=30% Similarity=0.482 Sum_probs=201.1
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.+.||.|+||.||++... ++.||+|.+.......+++.+|+.++++++|+||+++++++.+....++|+||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 345688999999999999874 7889999998766556789999999999999999999999998889999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 87 L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 87 LVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred HHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 9999865432 2589999999999999999999998 999999999999999999999999999987643221
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....+..|+|||.+.. +..+.++||||||+++|||++ |+.||..... ..+...+..... ..
T Consensus 158 ~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~----~~ 219 (256)
T cd05039 158 SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPHVEKGYR----ME 219 (256)
T ss_pred cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHhcCCC----CC
Confidence 2335678999999865 367889999999999999997 8888753211 111122111111 11
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.....+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112335678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.61 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=168.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
++.+.||+|+||+||+++.. +++.+|+|++.... .....+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 34678999999999999875 58999999997532 23456788999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 84 PGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999997543 589999999999999999999998 9999999999999999999999999998754321100
Q ss_pred ---------------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCC
Q 005909 507 ---------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 553 (670)
Q Consensus 507 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p 553 (670)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCC
Confidence 001234689999999999753 678899999999999999999999
Q ss_pred CCC
Q 005909 554 LRP 556 (670)
Q Consensus 554 ~~~ 556 (670)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=319.06 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=202.4
Q ss_pred cccccCceEEEEEEeCC-CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCccc
Q 005909 356 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD 433 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~ 433 (670)
.||+|.||+||.|++.+ ...+|||-+.... ...+-+..|+.+.++++|.|||+.+|.+.+++..-+.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999865 5678999987544 456778899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeecCCccccCCCCceeeecCC
Q 005909 434 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 434 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+|....+...-.+.+.-.+.+||++||.|||.+ .|||||||-+|+|++ -.|.+||+|||.++.+..-... ....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc--cccc
Confidence 998766543447888899999999999999998 999999999999995 5799999999999877533221 1234
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.||..|||||++......+..++|||||||.+.||.|||+||.....+ .+.+ .+-..-..-+..+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------qAAM-----FkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------QAAM-----FKVGMYKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------hHhh-----hhhcceecCCCCcH
Confidence 589999999999876678899999999999999999999999643221 1111 11111112233445
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+++.+...++++|+..||.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 67788889999999999999999999985
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.14 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=193.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+++.. +++.+|+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999875 57899999997642 2345688899999888 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|..++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 99998886543 589999999999999999999998 999999999999999999999999999875322111 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .....+++...+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~-~-- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-----DMNTEDYLFQVILEKPIR-I-- 222 (327)
T ss_pred eecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-----ccccHHHHHHHHHhCCCC-C--
Confidence 1234589999999999753 67889999999999999999999996432211 111222333333222111 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 622 (670)
+...+..+.+++.+||+.||++|+++ .+++++
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11234567789999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.31 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=196.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeC------CeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG------STRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~~~~lv 422 (670)
+.+.+.||+|+||.||+|... +++.+|+|++.........+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 345678999999999999875 588999999987666667889999999999 799999999998753 357899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++++|.+++..... ..+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999999876432 3588999999999999999999998 999999999999999999999999999976543
Q ss_pred CCceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
... ......|+..|+|||++... ...++.++|||||||++|||++|+.|+...... .......
T Consensus 164 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------------~~~~~~~ 229 (272)
T cd06637 164 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------------RALFLIP 229 (272)
T ss_pred ccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------------HHHHHHh
Confidence 221 12234578999999998632 235677999999999999999999998542210 0001111
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... .....+..+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111111 111234568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.46 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=199.9
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
..+.+.++||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34456689999999999999886 68899999986532 23355788999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 123 EYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998653 478888899999999999999998 9999999999999999999999999999866433
Q ss_pred CceeeecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 196 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~ 262 (370)
T cd05596 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMDH 262 (370)
T ss_pred Ccc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------------HHHHHHHHcC
Confidence 211 122356899999999986531 2468899999999999999999999964321 1112222221
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEML 623 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 623 (670)
... ........++..+.+++.+||+.+|++ |+++.|++++-
T Consensus 263 ~~~-~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 263 KNS-LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCc-CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 110 011111124567888999999999988 99999998774
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=305.24 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEeCC----CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++||+|+||.||+|++.. +..+|+|.+..... ..+++.+|+.+++++.|+||+++++++. .+..++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997642 26899999886654 4568999999999999999999999875 4567999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 507 (670)
++|.+++.... .+++..++.++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997653 589999999999999999999988 99999999999999999999999999998764433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......++..|+|||.+.. ..++.++||||||+++|||++ |+.||..... .. +...+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~----~~~~~~~~~~~-- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AE----VIAMLESGERL-- 217 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HH----HHHHHHcCCcC--
Confidence 1122234568999999865 367889999999999999998 8988854321 11 11111111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=314.68 Aligned_cols=240 Identities=22% Similarity=0.338 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+|++. +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999986 5789999998754 23345667788888765 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 99999986532 588999999999999999999998 9999999999999999999999999998753222111
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~------------~~~~~~i~~~~-~~~-- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------------EELFQSIRMDN-PCY-- 215 (316)
T ss_pred eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC-CCC--
Confidence 1234589999999999753 678899999999999999999999864321 11111111111 001
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 621 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 621 (670)
+......+.+++.+||+.||++||++. ++.+
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112345678899999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.44 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=196.4
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.+.+.||+|+||.||++++. +++.+|+|++.+.. ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4556688999999999999986 58899999986422 234567899999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 124 y~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 124 YMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999998643 478899999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
. .......||+.|+|||++.+.. +.++.++|||||||++|||++|+.||..... ......+....
T Consensus 197 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------~~~~~~i~~~~ 263 (370)
T cd05621 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------VGTYSKIMDHK 263 (370)
T ss_pred c-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 2 1223456899999999996532 2367899999999999999999999964321 01112222111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 622 (670)
. .........++..+.+++.+||+.++.+ |+++.|++++
T Consensus 264 ~-~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 N-SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c-ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1 0111111234556778888899755543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.79 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=196.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4578999999999999985 68999999986532 234678899999999999999999999999999999999996
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++........+++..++.++.|+++||+|||++ +++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--V 157 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--c
Confidence 68888886544444689999999999999999999988 999999999999999999999999999876543221 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccccchHH----HHH
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDW----IYD 576 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~----~~~ 576 (670)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........ .......++.+ .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234568899999998653 3567899999999999999999999864321000 00000000000 000
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.................++.++.+++.+||+.||++|||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000111112245677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.38 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=198.0
Q ss_pred hhhccccccCceEEEEEEeC-CC---cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DG---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
...+.||+|+||.||+|+.+ ++ ..+++|.+.... ...+++.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999875 23 379999987653 3356789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 88 MENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 99999999986543 2589999999999999999999988 999999999999999999999999999986643322
Q ss_pred ee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 506 VV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 506 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. .......+..|+|||++.. ..++.++||||||+++|||++ |+.||..... .+ ....+.....
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----------~~-~~~~i~~~~~ 228 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------HE-VMKAINDGFR 228 (268)
T ss_pred cceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HH-HHHHHhcCCC
Confidence 11 1112223567999999865 367889999999999999997 9999853211 11 1111211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
... ....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 112345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.46 Aligned_cols=254 Identities=23% Similarity=0.440 Sum_probs=202.4
Q ss_pred HHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+..+.+.++||+|+||.||++.+.++..+++|.+.......+.+.+|+.++++++|+||+++++.+.+ ...++++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 34455678999999999999998888889999988766556789999999999999999999999877 67899999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 9999999966432 3578899999999999999999987 9999999999999999999999999999766433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......++..|+|||++.. +..+.++||||||+++|||++ |+.||..... .+ +...+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~~-~~~~~~~~~~~-- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PE-VIRALERGYRM-- 222 (260)
T ss_pred cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----------HH-HHHHHhCCCCC--
Confidence 1223345678999999865 367889999999999999998 8888854221 00 11111111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112345578899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.66 Aligned_cols=249 Identities=29% Similarity=0.447 Sum_probs=206.6
Q ss_pred hhccccccCceEEEEEEeC--CC--cEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP--DG--RLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.|+||+|.||.|++|.|+ +| -.||||.++.... ...+|++|+.+|.+|+|+|+++|||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 5588999999999999985 34 3689999987663 56899999999999999999999999987 6778999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+.|+|.+.|++ ..+..+....+..++.|||+||.||.++ +.|||||..+|+||-..-.+||+||||.+.+..+...
T Consensus 193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999987 3344688888999999999999999998 9999999999999998889999999999998776666
Q ss_pred eeecCC-CCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 VTMTGP-RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 ~~~~~~-~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
..+... .-...|.|||.+.. ..++.+||||+|||.+|||++ |..||.+... ..|.+++.+
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------~qIL~~iD~---- 330 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------IQILKNIDA---- 330 (1039)
T ss_pred eEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH------------HHHHHhccc----
Confidence 555543 35778999999975 589999999999999999998 5677765332 123333332
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
......++..++.+++++++||..+|++||++..|.+.+-
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2223334456788999999999999999999999985543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=304.08 Aligned_cols=240 Identities=22% Similarity=0.376 Sum_probs=186.1
Q ss_pred ccccccCceEEEEEEeCC-------------CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 355 EKLGTGGYGNVYKGKFPD-------------GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
+.||+|+||.||+|++.+ ...|++|++.... .....+.+|+.++.+++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358889876544 33457888999999999999999999999998999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC-------eEEee
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-------PKVSD 493 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~-------~ki~D 493 (670)
+|+||+++++|..++..... .+++..+++++.|+++||+|||++ +|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988865432 488999999999999999999988 9999999999999987654 89999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI-EEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||++...... ....++..|+|||.+... ..++.++||||||+++|||+ +|+.|+..... .+
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~ 217 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----------AE 217 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----------hH
Confidence 9998765322 123468889999988633 46788999999999999998 57777643211 00
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
. ......... ... .....+.+++.+||+.||++||++++|++.|+
T Consensus 218 -~-~~~~~~~~~-~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 -K-ERFYEGQCM-LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -H-HHHHhcCcc-CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 011111110 011 11346788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.94 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=191.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccc-cccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+..|..++..++| ++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999876 5789999998753 2345678889999999965 5688899999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 83 VNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999999886543 488999999999999999999998 999999999999999999999999999875322111
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~------------~~~~~~i~~~~~-~ 219 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------DELFQSIMEHNV-S 219 (324)
T ss_pred --ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCC-C
Confidence 11234589999999999753 678899999999999999999999964321 111122221111 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
. +......+.+++.+||+.||++|++. .+++++
T Consensus 220 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 Y----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 11235567889999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.39 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=206.2
Q ss_pred hhccccccCceEEEEEEeC-CCcEEE---EEE--cccCCcchHHHHHHHHHhccccccccccccceeeeCCe--eEEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVA---VKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST--RALIYE 424 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~va---vK~--~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lv~e 424 (670)
|.++||+|+|-+||||.+. +|..|| ||. +.++....+.|..|+.+|+.|+|+||++++..|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999885 466665 332 23344556899999999999999999999999987665 678999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~ 503 (670)
.+..|+|..|+++.+ .++...+.+|++||++||.|||++ .++|||||||-+||+|+.+ |.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998876 488889999999999999999998 8899999999999999764 89999999999988765
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
... ...|||.|||||++.. .+.+..||||||+.++||+|+..|+.. -.-+..|+.++..+.+
T Consensus 200 ~ak----svIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsE-----------C~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSE-----------CTNPAQIYKKVTSGIK 261 (632)
T ss_pred ccc----eeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhh-----------hCCHHHHHHHHHcCCC
Confidence 443 2469999999999974 688899999999999999999999853 3346778999999888
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+....... -+++.++|.+||.. .++|||+.|+|+.=
T Consensus 262 P~sl~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 262 PAALSKVK---DPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred HHHhhccC---CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 66444333 34677899999999 99999999999753
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.44 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEeCC--C--cEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD--G--RLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ..+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3689999987554 45689999999999999999999999888 888999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 507 (670)
++|.+++.+... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976542 3589999999999999999999998 99999999999999999999999999998765432221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhc-CCcccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLI-QPEKED 585 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 585 (670)
......++..|+|||.+... .++.++||||||+++|||++ |+.|+..... .+ +...+. .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~-~~~~~~~~~~~~- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----------SQ-ILKKIDKEGERL- 220 (257)
T ss_pred cccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-HHHHHHhcCCcC-
Confidence 11234567899999998653 67889999999999999998 9998853211 01 111111 11110
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
......+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111223567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=314.76 Aligned_cols=197 Identities=25% Similarity=0.398 Sum_probs=160.5
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee--CCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e~~~~g 429 (670)
++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 57999999999999865 46789999987543 34567899999999999999999998864 346789999984 5
Q ss_pred Cccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE----CCCCCeEEeecCCccc
Q 005909 430 SLGDLLSREK------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKA 499 (670)
Q Consensus 430 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll----~~~~~~ki~DfGla~~ 499 (670)
+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7877764321 122588999999999999999999998 99999999999999 4568999999999987
Q ss_pred cCCCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 500 HSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 500 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
....... .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 6533211 122345689999999998753 35788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=303.57 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=203.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||+|... +++.+++|.++... ...+.+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 345688999999999999987 78999999886422 2356789999999999999999999999999999999999
Q ss_pred cCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++++|.+++.... ....+++.+++.++.+++.||+|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999886532 233589999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ..... .+........
T Consensus 161 ~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~-~~~~~~~~~~ 226 (267)
T cd08224 161 TA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSL-CKKIEKCDYP 226 (267)
T ss_pred cc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCc---------cHHHH-HhhhhcCCCC
Confidence 21 1223478899999998653 678899999999999999999999854321 01111 1111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
. .........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 P---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 11123456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=298.59 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=207.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.++||+|+||.|||+.++ .|+.+|||.+.... ..+++.+|+.++++.+.|+||++||.+.....+++|||||..|+
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 34589999999999999886 69999999987655 46889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
..++++.++ .++.++++..+++..++||+|||.- .-||||||..||||+.+|++||+|||.|..+...-.. ..
T Consensus 115 iSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK--RN 187 (502)
T KOG0574|consen 115 ISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK--RN 187 (502)
T ss_pred HHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--hC
Confidence 999997543 3799999999999999999999986 8899999999999999999999999999876543222 23
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...||+.|||||++..- .+..++||||||+...||..|++|+....... .-..-+..+......
T Consensus 188 TVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIFMIPTKPPPTFKK 251 (502)
T ss_pred ccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeEeccCCCCCCCCC
Confidence 35699999999999864 56779999999999999999999987543311 001112222222333
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+...+.++.+++++||-.+|++|-|+.+++++-
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 556788899999999999999999999998865
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.91 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=196.2
Q ss_pred HhhhccccccCceEEEEEEeC-----------------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccc
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-----------------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 411 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g 411 (670)
+.+.++||+|+||.||++... +...+|+|++.... ...+++.+|+.++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456788999999999998542 23468999987543 23467999999999999999999999
Q ss_pred eeeeCCeeEEEEEecCCCCcccccccccC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 412 FCCDGSTRALIYEYMPNGSLGDLLSREKE--------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 412 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
++...+..++|+||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 99999999999999999999999865431 12477889999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTS 561 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt--g~~p~~~~~~~~ 561 (670)
++++.+||+|||+++.+.............++..|+|||.... +.++.++||||||+++|||++ |..|+......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 9999999999999986644332221222334678999998765 468889999999999999998 56676532210
Q ss_pred CCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 562 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
. .................. ......+..+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ------~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ------Q-VIENTGEFFRDQGRQVYL-PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ------H-HHHHHHHHHhhccccccC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 000000000000000000 011123467889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.02 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=195.1
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceee-eCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lv~e~~~~g 429 (670)
+.+.+.||+|+||.||++..+ +..+++|.++... ..+.+.+|+.++++++|+||+++++++. +++..++++||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 345688999999999999874 7789999986543 3567999999999999999999999765 456789999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 86 SLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99999875432 2588999999999999999999998 99999999999999999999999999987654322
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....++..|+|||++.+ ..++.++||||||+++|||++ |+.|+..... .. +...+......
T Consensus 157 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------~~-~~~~~~~~~~~---- 218 (256)
T cd05082 157 DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KD-VVPRVEKGYKM---- 218 (256)
T ss_pred CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-HHHHHhcCCCC----
Confidence 12234678999999865 367889999999999999997 8888753211 11 11111111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112345678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.61 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=200.0
Q ss_pred HHhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeC--CeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 420 (670)
++.+.++||+|+||.||++++ .++..||+|.++... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 445668899999999999974 257889999987543 3346789999999999999999999998775 5678
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+++++|.+++.+... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999865432 589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----CCCCccccchHHHH
Q 005909 501 SRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIY 575 (670)
Q Consensus 501 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~ 575 (670)
....... ......++..|+|||++.+. .++.++||||||+++|||++++.|........ +........... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-V 236 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-H
Confidence 5433221 11234567789999998653 67889999999999999999876543211100 000011111111 1
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..+....... .....+..+.+++.+||+.||++||+++++++.|+.+
T Consensus 237 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111111 1122456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.66 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=193.9
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC-----eeEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALIY 423 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv~ 423 (670)
+.++||+|+||.||++... +++.||+|++.... ...+.+.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4578999999999999874 78999999986532 23467889999999999999999999998776 789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+. ++|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 84 ELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9995 67777775432 589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-----CccccchH------
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-----TTEAYFPD------ 572 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~-----~~~~~~~~------ 572 (670)
... ......++..|+|||++.+. ..++.++|||||||++|||++|+.||.......... ........
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 22334578999999998754 356889999999999999999999996533210000 00000000
Q ss_pred HHHHHhcC-Cccccc---cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 573 WIYDKLIQ-PEKEDF---VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 573 ~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+.. ...... ...........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000100 000000 000111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.44 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=199.1
Q ss_pred HHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 418 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 418 (670)
.+.+.++||+|+||.||+++.. ....+|+|.++... ....++.+|+.++.++ +||||+++++++.+...
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3446689999999999999752 24579999987543 2346788999999999 69999999999999889
Q ss_pred eEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 419 RALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
.++++||+++|+|.+++..... ...+++.++++++.|++.||.|||++ +++||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence 9999999999999999865321 13588999999999999999999988 9999999999999999
Q ss_pred CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005909 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSN 564 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~ 564 (670)
++.+||+|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.||.....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 99999999999986643222111112234568999999865 367889999999999999999 7877753211
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+...+........ ....+..+.+++.+||+.+|++||++.|+++.|++..
T Consensus 243 -------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 -------EELFKLLREGHRMDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -------HHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 112222222211111 1123456788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.56 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=195.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||+||+|+.+ +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 345678999999999999876 67889999987543 234567899999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........
T Consensus 88 -~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 88 -KDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred -CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 478877755432 478899999999999999999998 9999999999999999999999999998765432221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc---ccchHHHHHHhcC----
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFPDWIYDKLIQ---- 580 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~---- 580 (670)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||............. .......+..+..
T Consensus 161 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1234578999999998653 457889999999999999999999996532210000000 0000000000000
Q ss_pred -----Ccc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 581 -----PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 581 -----~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
... ..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000 0000011122455678999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=311.89 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=195.3
Q ss_pred hhhccccccCceEEEEEEeCC-C--cEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD-G--RLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+|..++ + ..+++|.++... ...+.+.+|+.++.++ +||||+++++++.+....++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 356789999999999998753 3 347888887432 3346789999999999 799999999999999999999999
Q ss_pred cCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 426 MPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
+++++|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 999999999865321 12588999999999999999999988 99999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 571 (670)
|||++....... .......+..|+|||++... .++.++|||||||++|||++ |+.||.....
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------------ 224 (297)
T cd05089 162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------------ 224 (297)
T ss_pred CcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999986432211 11112235679999998653 67889999999999999997 9888854321
Q ss_pred HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 572 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+........... ....++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 AELYEKLPQGYRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHHHHHhcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112222211111 11123457889999999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.56 Aligned_cols=236 Identities=25% Similarity=0.348 Sum_probs=184.7
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+|+.. +++.+|+|++.... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999985 68899999986532 22345555654 57888999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|...+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 99988886432 588889999999999999999988 999999999999999999999999999875322211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~~~-~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------------SQMYDNILHKPL-QL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH------------HHHHHHHhcCCC-CC--
Confidence 2234589999999998753 678899999999999999999999964321 111222222111 11
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMT 617 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 617 (670)
+......+.+++.+||+.||++||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111244678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=291.68 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=205.2
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC---------cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEE
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 422 (670)
++.||.|..++|-+..++ +|+..|+|++.... ...+.-.+|+.+|+++ .||||+.+.++++.....++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 356899999999887765 67888998885322 1234567899999999 699999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+|.|+.|.|.++|...- .+++.+.++|++|+.+|+.|||.+ +||||||||+|||+|++.++||+|||.+..+..
T Consensus 102 Fdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999996543 699999999999999999999998 999999999999999999999999999999887
Q ss_pred CCceeeecCCCCCccccchhhcccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
+..... ..|||+|+|||.+.-+ ...++...|+|++||++|.|+.|-.||.... +++.-++
T Consensus 176 GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------------QmlMLR~ 239 (411)
T KOG0599|consen 176 GEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------------QMLMLRM 239 (411)
T ss_pred chhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------------HHHHHHH
Confidence 765443 4489999999998532 2356778999999999999999999985321 1222222
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.....-.+...++..++....+++.+||+.||.+|.|++|++++-
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 222233456677788889999999999999999999999998754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.10 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=195.3
Q ss_pred cccccCceEEEEEEeCC-------CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 356 KLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.||+|+||.||+|+..+ ++.+++|.+.... .....+.+|+.++++++||||+++++++......++|+||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998743 2579999886543 34568899999999999999999999999999999999999
Q ss_pred CCCCccccccccc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-----CeEEeecCCc
Q 005909 427 PNGSLGDLLSREK----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-----TPKVSDFGLA 497 (670)
Q Consensus 427 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-----~~ki~DfGla 497 (670)
++++|.+++.+.. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999996532 123478899999999999999999987 999999999999999877 8999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
+...............++..|+|||.+.+ +..+.++||||||+++|||++ |+.||..... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------------~~~~~ 224 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------------QEVLQ 224 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCH------------HHHHH
Confidence 76543322221222345788999999975 467899999999999999998 8888753211 00111
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.+..... .......+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 225 ~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 HVTAGGR----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHhcCCc----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111 1112234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=305.51 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=193.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
..||+|+||.||+|++. ++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999875 57889999887654 34567899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCCCceeeecC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
+++.........++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++......... ...
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--ccc
Confidence 9997543322237888899999999999999988 9999999999999976 679999999998765432211 122
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..++..|+|||++.+.....+.++||||||+++|||++|+.|+....... ...+......... ..+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----------~~~~~~~~~~~~~----~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----------AAMFKVGMFKIHP----EIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----------hhHhhhhhhccCC----CCC
Confidence 34789999999986543347789999999999999999999985422100 0000100000001 111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 2244568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.38 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=199.5
Q ss_pred HhhhccccccCceEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.++||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 3456789999999999999875 78999999876544 678999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++.... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++......... .
T Consensus 84 ~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~ 156 (256)
T cd06612 84 SVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--R 156 (256)
T ss_pred cHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--c
Confidence 9999986433 2589999999999999999999988 9999999999999999999999999998876543221 1
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....++..|+|||.+.+. ..+.++||||||+++|||++|+.|+....... .. ..... .......
T Consensus 157 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----------~~--~~~~~--~~~~~~~ 220 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------AI--FMIPN--KPPPTLS 220 (256)
T ss_pred ccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----------hh--hhhcc--CCCCCCC
Confidence 223478899999998764 67889999999999999999999986432210 00 00000 0000111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....+...+.+++.+||+.||++||+++||+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122345678899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.93 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=197.4
Q ss_pred HhhhccccccCceEEEEEEeCC-C---cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD-G---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|.+.. + ..||+|++.... ...++|..|+.++++++||||+++++++.++...++|+|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 3466889999999999998753 3 369999987643 345689999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 86 FMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred cCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999865432 588999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeeecC---CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 505 SVVTMTG---PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 505 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
....... ...+..|+|||.+.. ..++.++||||||+++|||++ |+.||..... . .+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~----~~~~~i~~ 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------Q----DVINAIEQ 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------H----HHHHHHHc
Confidence 2111111 112457999999865 367889999999999999886 8888854321 0 11112211
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
...... ....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 227 DYRLPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CCcCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111011 11234567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.98 Aligned_cols=247 Identities=28% Similarity=0.360 Sum_probs=195.9
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4578999999999999875 689999999865321 235688899999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 86 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 86 MPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred CCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999886543 588899999999999999999988 999999999999999999999999999876543221
Q ss_pred eee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
... .....++..|+|||++.+. ..+.++||||||+++|||++|+.||..... . ..+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~-~~~~~~~~~~~~- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEA----------M-AAIFKIATQPTN- 225 (263)
T ss_pred ccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccch----------H-HHHHHHhccCCC-
Confidence 111 1223478899999999764 578899999999999999999999854221 0 111111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..........+.+++.+||+.+|++||++.+++++
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112345567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.26 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=186.8
Q ss_pred ccccccCceEEEEEEeCCC---cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
++||+|+||.||++...++ ..+++|.+.... ...+.+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999976433 356677665443 34568999999999999999999999999999999999999999
Q ss_pred CcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 430 SLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 430 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
+|.+++.+... ....++..++.++.|+++||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 23467778889999999999999987 999999999999999999999999999864322221111
Q ss_pred ecCCCCCccccchhhccccc-----CCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 509 MTGPRGTIGYIAPEIFMRNL-----GNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDV~SlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.....++..|+|||++.... ...+.++||||||+++|||+++ ..|+..... .+ ....+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~-~~~~~~~~~ 225 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----------RE-VLNHVIKDQ 225 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-HHHHHHhhc
Confidence 22345788999999985321 2346789999999999999975 556643211 11 111111111
Q ss_pred ccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 583 KED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 583 ~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
... ............+.+++..|| .+|++||++++|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 100 001111123456777888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.95 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=191.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4588999999999999875 68999999986532 234678889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce-
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~- 506 (670)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 85 GGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999986543 588999999999999999999998 9999999999999999999999999999643211000
Q ss_pred --------------------------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHH
Q 005909 507 --------------------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 542 (670)
Q Consensus 507 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGv 542 (670)
.......||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv 236 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence 000123589999999999754 6788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCC---CCHHHH
Q 005909 543 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR---PSMTRV 619 (670)
Q Consensus 543 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ev 619 (670)
++|||++|+.||..... ......+...... ........+...+.+++.+||+ +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENS------------HETYRKIINWRET-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCH------------HHHHHHHHccCCc-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999964321 1111111111000 0000111234567788999997 67665 599998
Q ss_pred HHHH
Q 005909 620 VEML 623 (670)
Q Consensus 620 l~~L 623 (670)
+++-
T Consensus 303 l~hp 306 (377)
T cd05629 303 KSHP 306 (377)
T ss_pred hcCC
Confidence 8764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=314.59 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=186.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||++++. +++.+|+|++.... .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999986 57889999987532 22234444544 56788999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... .+.+..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 99999886543 478888899999999999999998 999999999999999999999999999875432221 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~~~-~~-- 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------------AEMYDNILNKPL-QL-- 215 (325)
T ss_pred cccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCH------------HHHHHHHHhCCc-CC--
Confidence 2234589999999999763 678899999999999999999999964321 111112211111 01
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 620 (670)
...+...+.+++.+||+.||++||++.+.+
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 --KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112355678899999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.13 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=197.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+...+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++..+...++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445578999999999999875 57899999987443 344678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... .+++..+..++.|+++||.|||++ +++|+||+|+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06642 86 GGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence 99999988542 588999999999999999999987 9999999999999999999999999999766533211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+.....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~~~~~~~---- 218 (277)
T cd06642 158 -RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPM------------RVLFLIPKNSP---- 218 (277)
T ss_pred -hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchh------------hHHhhhhcCCC----
Confidence 1223578899999998754 6788999999999999999999998643210 00001111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.......+..+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 111123456788999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=305.65 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEeCC-Cc--EEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD-GR--LVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+|++++ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999854 33 57888887532 3456788999999999 899999999999999999999999999
Q ss_pred CCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 429 GSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 429 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 12478999999999999999999987 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
++........ ......+..|+|||++... .++.++||||||+++|||++ |+.||..... .+ .
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----------~~-~ 220 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AE-L 220 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCH-----------HH-H
Confidence 9864321111 1112245679999998653 67889999999999999997 8888854211 11 1
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...+........ .......+.+++.+||+.||.+||++.++++.|+++
T Consensus 221 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 221 YEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHhCCCCCCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 122211111111 112345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=314.86 Aligned_cols=253 Identities=23% Similarity=0.248 Sum_probs=193.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+++.. +++.+|+|++.... .....+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45688999999999999986 67899999986532 23455788999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 84 VGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999976332 588999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
......|++.|+|||++.+. .+.++.++||||||+++|||++|+.||..... ......+.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------------~~~~~~i~~~~~ 225 (331)
T cd05624 159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHEE 225 (331)
T ss_pred -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------------HHHHHHHHcCCC
Confidence 11234589999999998642 13567899999999999999999999964321 011122211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 622 (670)
..........++..+.+++.+|+..++++ |+++++++++
T Consensus 226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00011111223556778888888865544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.52 Aligned_cols=247 Identities=28% Similarity=0.478 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
++||+|+||.||++.+.+++.|++|.+..... ..+.+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999876543 4568999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++..... .+++..++.++.+++.||+|||++ +++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99865432 578999999999999999999988 9999999999999999999999999999865432222111122
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..+..|+|||.+.+ +.++.++||||||+++|||++ |..|+..... ......+..... ....
T Consensus 156 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------------~~~~~~~~~~~~----~~~~ 217 (251)
T cd05041 156 QIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSN------------QQTRERIESGYR----MPAP 217 (251)
T ss_pred cceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCH------------HHHHHHHhcCCC----CCCC
Confidence 34667999999865 367889999999999999999 7777753221 011111111100 0111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 223557889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.84 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=202.4
Q ss_pred HhhhccccccCceEEEEEEeC-----CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeee--CCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l 421 (670)
+.+.+.||+|+||.||++++. ++..+|+|++..... ..+++.+|++.+++++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999864 368999999986655 36789999999999999999999999887 557899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999976543 489999999999999999999987 99999999999999999999999999998776
Q ss_pred CCCceee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC----CCccccchHHHHH
Q 005909 502 RNRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----NTTEAYFPDWIYD 576 (670)
Q Consensus 502 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~ 576 (670)
....... .....++..|+|||.+... .++.++||||||+++|||++|+.|+......... .........+ .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-LE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH-HH
Confidence 3322211 1123356679999998653 6788999999999999999999887643221100 0000011111 11
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+..... .......+.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus 238 ~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 111122346788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=313.49 Aligned_cols=266 Identities=18% Similarity=0.263 Sum_probs=194.5
Q ss_pred hhcccccc--CceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.++||+| +|++||+++.+ +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999875 78999999987543 23456778999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998654322 488999999999999999999988 9999999999999999999999999865433211100
Q ss_pred e-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC-CCcccc---------ch
Q 005909 507 V-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-NTTEAY---------FP 571 (670)
Q Consensus 507 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~-~~~~~~---------~~ 571 (670)
. ......++..|+|||++.+....++.++|||||||++|||++|+.||......... ...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0 00112467789999999764345788999999999999999999999643211000 000000 00
Q ss_pred -HHHHHH---------hcCC---------ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 572 -DWIYDK---------LIQP---------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 572 -~~~~~~---------~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... .... ................+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000000 0000 00000011122345678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=304.88 Aligned_cols=252 Identities=25% Similarity=0.444 Sum_probs=198.7
Q ss_pred HhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|.+. .+..+|+|.++... ...+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 345688999999999999864 23479999987543 234688999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 86 YMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999975432 478999999999999999999988 99999999999999999999999999998765433
Q ss_pred cee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 505 SVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 505 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... ......++..|+|||++... .++.++||||||+++||+++ |+.||..... . .....+.+..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~----~~~~~~~~~~ 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------Q----DVIKAIEEGY 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------H----HHHHHHhCCC
Confidence 221 11222345689999999753 67889999999999999886 9988854321 0 0111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.. ......+..+.+++.+||+.+|++||+|.++++.|++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 10 1111234577899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.01 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=193.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+++++ +++.+|+|++.+.. ...+.+.+|+.++..++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 35688999999999999986 47889999986422 23345888999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 84 VGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999999976432 588999999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
......||+.|+|||++... ...++.++|||||||++|||++|+.||..... ......+.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------------~~~~~~i~~~~~ 225 (332)
T cd05623 159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHKE 225 (332)
T ss_pred -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------------HHHHHHHhCCCc
Confidence 12234689999999998631 23568899999999999999999999964321 111122221111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 622 (670)
..........++..+.+++.+|+..++++ |+++.|++++
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111111234556777888887654444 6899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=303.30 Aligned_cols=247 Identities=20% Similarity=0.289 Sum_probs=198.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||.||++... +++.+++|.++... ...+.+.+|+.++++++|+||+++++.+.++...++++||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 35688999999999999876 68899999886433 3456788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... ..+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 156 (255)
T cd08219 83 GDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-- 156 (255)
T ss_pred CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc--
Confidence 999998865332 2578999999999999999999998 9999999999999999999999999998766432221
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....+++.|+|||++.+. ..+.++||||||+++|+|++|+.||..... ... ...+.......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------~~~-~~~~~~~~~~~--- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW-----------KNL-ILKVCQGSYKP--- 219 (255)
T ss_pred cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH-----------HHH-HHHHhcCCCCC---
Confidence 1234578899999998653 678899999999999999999999864221 111 11121111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....++..+.+++.+||+.||++||++.+++..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112244568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.27 Aligned_cols=257 Identities=22% Similarity=0.275 Sum_probs=201.0
Q ss_pred hhhccccccCceEEEEEEeCCC-cEEEEEEccc-CCcchHHHHHHHHHhcccc-ccccccccce-eee------CCeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDG-RLVAVKVLEK-TSNFSDNFINEVATIGRIH-HVNIIHLLGF-CCD------GSTRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~------~~~~~l 421 (670)
.+.+.|.+|||+.||.|.+..+ ..+|+|++-. ++...+...+|+++|++|+ |+|||.+++. ... .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 4567899999999999998766 9999988754 4456688999999999996 9999999993 221 125679
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
.||||.+|.|-+++...... .|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.+....
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred ehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999999765444 399999999999999999999986 7789999999999999999999999999986432
Q ss_pred CCC-ceeee------cCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHH
Q 005909 502 RNR-SVVTM------TGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 502 ~~~-~~~~~------~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
... ..... -...-|+.|+|||++.-- ....++|+|||+|||+||-|+....||+.....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------- 264 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------- 264 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------------
Confidence 211 10000 011248999999998531 135689999999999999999999999764221
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
.+..+.. .......++..|.+||..||+.||++||++.+|++++.++...
T Consensus 265 ---aIlng~Y---~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ---AILNGNY---SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---eEEeccc---cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 0111111 1111245688899999999999999999999999998766543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=337.53 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=197.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||.||+|.+. +++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 45688999999999999986 58999999987542 23467899999999999999999999999999999999999
Q ss_pred CCCCcccccccccC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 427 PNGSLGDLLSREKE--------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 427 ~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
++++|.+++..... ...+++..+++++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999864211 12456778899999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce----------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005909 499 AHSRNRSV----------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562 (670)
Q Consensus 499 ~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~ 562 (670)
........ .......||+.|+|||++.+. ..+.++|||||||++|||++|+.||......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 65211100 001123589999999998754 6788999999999999999999998642210
Q ss_pred CCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhhc
Q 005909 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 626 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 626 (670)
... ....+..+.. ......++..+.+++.+||+.||++|| +++++++.|+..
T Consensus 238 ----ki~----~~~~i~~P~~----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 ----KIS----YRDVILSPIE----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhh----hhhhccChhh----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0011111100 011123456788899999999999995 677787877754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.96 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=200.3
Q ss_pred HhhhccccccCceEEEEEEeCC-C----cEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD-G----RLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.+.||+|+||+||+|.+++ + ..+|+|.+..... ...++.+|+.++.+++|+||+++++++.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3456889999999999998742 3 2689998876543 34678899999999999999999999887 7889999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 88 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred ecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999976533 489999999999999999999997 9999999999999999999999999999876544
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..........++..|+|||.+.. ..++.++||||||+++|||++ |+.||..... ..+...+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------------VEIPDLLEKGE 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHhCCC
Confidence 33332233334678999998864 467889999999999999998 9998864221 11222222221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
...... .....+.+++.+||..||++||++.++++.|+++..
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 RLPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111 123457789999999999999999999999996543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.30 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=194.9
Q ss_pred hhhccccccCceEEEEEEeC-CCc--EEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGR--LVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+|.++ ++. .+++|.+.... ...+++.+|++++.++ +|+||+++++++.+.+..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 45688999999999999875 344 45777765432 3446788999999999 899999999999999999999999
Q ss_pred cCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 426 MPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
+++++|.++++.... ...+++.+++.++.|++.||+|||++ +++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 999999999865421 22578999999999999999999988 99999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 571 (670)
|||+++....... .....++..|+|||++... .++.++||||||+++|||++ |..||.....
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------ 229 (303)
T cd05088 167 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------------ 229 (303)
T ss_pred ccccCcccchhhh---cccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCCh------------
Confidence 9999864321111 1112346789999988653 57889999999999999998 8988854221
Q ss_pred HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 572 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
....+.+....... .....+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 230 AELYEKLPQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHHHHHhcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111221111111 11123456788999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.63 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=202.7
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
...+++.++||+|+||+||++... +++.+|+|++.... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345567789999999999999875 68899999876543 345788999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++...+ .+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999886533 589999999999999999999963 279999999999999999999999999986543221
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ....|+..|+|||++.+ +.++.++|||||||++|||++|+.||...............+..+... .......
T Consensus 159 ~----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQEPPP 231 (284)
T ss_pred c----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-HhhccCC
Confidence 1 22457899999999865 377889999999999999999999997543211100011111111111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.. .....+..+.+++.+||+.||++||++.|++++.-
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11 11124567889999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=289.56 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=204.8
Q ss_pred HHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.+.||+|.|+.||+..+ ++|+..|+|+++... ...+++.+|+.+-+.|+||||++|.....+....+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 455678899999999999865 478999999886533 4567889999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCccccCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla~~~~~ 502 (670)
|.+++|..-|... ...++..+-..++||+++|.|.|.+ +|||||+||.|+++. ..--+||+|||+|..+..
T Consensus 92 m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 92 VTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 9999997655433 2578888999999999999999998 999999999999994 345699999999998873
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.. ...+..|||+|||||++.+. .++..+|||+.|||||-|+.|..||.+... ..+++.+..+.
T Consensus 166 g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~------------~rlye~I~~g~ 228 (355)
T KOG0033|consen 166 GE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYEQIKAGA 228 (355)
T ss_pred cc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccH------------HHHHHHHhccc
Confidence 32 23678899999999999864 788899999999999999999999976322 23455555544
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ....+++.+.++..+++.+||..||.+|.|+.|.+.+
T Consensus 229 yd-~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 YD-YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cC-CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 32 2233445567778899999999999999999988754
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.32 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=197.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+++.++||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++|+||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345688999999999999986 47788999886544 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|..++.+.. ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 99998876432 2589999999999999999999998 999999999999999999999999999876543221 1
Q ss_pred ecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....++..|+|||++... ...++.++|||||||++|||++|+.||..... ..............
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------------HHHHHHHhhcCCCC
Confidence 2234578999999998521 23467899999999999999999998854221 00111111111110
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......++..+.+++.+||+.||++||++.+++++-
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 --LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 011223456788999999999999999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.30 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=190.6
Q ss_pred ccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceee-eCCeeEEEEEecC
Q 005909 355 EKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIYEYMP 427 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lv~e~~~ 427 (670)
+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999863 24579999886433 33567889999999999999999999876 4556789999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce-
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~- 506 (670)
+++|.+++.+... .+.+..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999865432 367788899999999999999987 9999999999999999999999999999765432211
Q ss_pred -eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCC-CCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 -VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH-LRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 -~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.| +..... .+ ....+......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----------~~-~~~~~~~~~~~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----------FD-ITVYLLQGRRL 221 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------HH-HHHHHhcCCCC
Confidence 11123345778999999865 3678899999999999999996554 432111 01 11122221111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.. ....+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 222 ~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11 1122456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.70 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=194.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||+|+||.||+|.+. +++.+|+|++.... ...+.+.+|+.++.+++||||+++++.+...+..++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 35678999999999999874 68899999986543 3346788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 84 GSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 9986542 367888999999999999999988 99999999999999999999999999997654322
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......... ..+................
T Consensus 150 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-----LMPLQLLQCIVDEDPPVLP- 221 (279)
T ss_pred ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-----cchHHHHHHHhccCCCCCC-
Confidence 2234688999999999764 6788999999999999999999998653221100 0111111111111111110
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......++.+++.+||+.+|++||+++|++++-
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 112345688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.59 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=185.3
Q ss_pred cccccCceEEEEEEeCC-------------------------CcEEEEEEcccCCc-chHHHHHHHHHhccccccccccc
Q 005909 356 KLGTGGYGNVYKGKFPD-------------------------GRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHL 409 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l 409 (670)
.||+|+||.||+|++.. ...|++|++..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13588998865442 34578889999999999999999
Q ss_pred cceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC--
Q 005909 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-- 487 (670)
Q Consensus 410 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-- 487 (670)
++++.+....++||||+++|+|..++.+... .+++..++.++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998865432 588899999999999999999988 999999999999997643
Q ss_pred -----CeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCC
Q 005909 488 -----TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI-EEKKHLRPTETTS 561 (670)
Q Consensus 488 -----~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ell-tg~~p~~~~~~~~ 561 (670)
.+|++|||++....... ...++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred cCccceeeecCCcccccccccc------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 48999999876543221 12367889999988653 46788999999999999995 688887543210
Q ss_pred CCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 562 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.... ...... .... .....+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 -------~~~~-~~~~~~-----~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -------EKER-FYEKKH-----RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -------HHHH-HHHhcc-----CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0001 111100 0000 11246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=308.68 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=197.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.+.||+|+||.||+|+.. +++.+++|.+.... ...+.+.+|+.++++++|+||+++++.+..+...++|+||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 445678999999999999874 68899999887544 3456788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 9999998543 478999999999999999999998 9999999999999999999999999998765433221
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....+++.|+|||.+.+. ..+.++|||||||++|||++|+.||...... ........... . ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~-~--~~ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLIATNGT-P--EL 236 (296)
T ss_pred cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----------HhHHHHhcCCC-C--CC
Confidence 1223578899999998753 6788999999999999999999999643220 00011111110 0 00
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+...+.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122345678889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.12 Aligned_cols=238 Identities=22% Similarity=0.326 Sum_probs=188.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
++.+.||+|+||+||+++.. +++.||+|++.... ...+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45688999999999999875 68999999987532 33456778888888885 67888899999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 83 VNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999999886543 589999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~------------~~~~~~i~~~~~~- 219 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------------DELFQSIMEHNVS- 219 (323)
T ss_pred --cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 11234589999999999753 678899999999999999999999864321 1112222221110
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 616 (670)
.+...+..+.+++.+||+.+|++|++.
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111234567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.68 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=196.8
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.++||+|+||.||+|+.. +++.+|+|+++... .....+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 3456688999999999999875 68899999987654 234567889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06645 90 GGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-- 161 (267)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--
Confidence 999999986543 589999999999999999999998 999999999999999999999999999876543221
Q ss_pred eecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......|+..|+|||++.. ..+.++.++|||||||++|||++|+.|+...... ..+............
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----------~~~~~~~~~~~~~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----------RALFLMTKSNFQPPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----------hhHHhhhccCCCCCc
Confidence 1233458999999999742 1245788999999999999999999988532210 000000000000000
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......++..+.+++.+||+.+|++||++.+|+++
T Consensus 231 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 -LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00011234567889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.87 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=203.8
Q ss_pred HHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
++...|++.++||.||.+.||++...+.+.+|+|.+.... ...+-|.+|+..|.+| .|.+|++|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4455566778999999999999999888888888765432 4567899999999999 59999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||= .-+|..+|.+.... ++...++.+..||+.++.++|.+ +|||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99986 67999999776543 33237788999999999999998 999999999999996 4699999999999999
Q ss_pred CCCceeeecCCCCCccccchhhcccccC---------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLG---------NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
.+...+......||+.||+||.+..... +.+.+|||||+|||||+|+.|+.||..... .
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------~ 578 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------Q 578 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------H
Confidence 8888877788899999999999954321 267899999999999999999999964321 1
Q ss_pred HHH-HHhcCCccc-cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 573 WIY-DKLIQPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 573 ~~~-~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
|.. ..+.++... .+..... ..+++++++.||++||++||+..|++++-
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~---~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPE---NDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHHHHhhcCCCccccccCCCC---chHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 111 112222110 1111100 12388999999999999999999998764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=303.59 Aligned_cols=252 Identities=31% Similarity=0.496 Sum_probs=196.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchH---HHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD---NFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
++.+.||+|+||+||+++.. +++.+|+|++........ ...+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 45689999999999999987 467899999987764333 34569999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..++.++.|+++||++||++ +++|+||||+||++++++.++|+|||.+....... .
T Consensus 82 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~ 153 (260)
T PF00069_consen 82 GGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--E 153 (260)
T ss_dssp TEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--S
T ss_pred cccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--c
Confidence 999999997322 589999999999999999999998 99999999999999999999999999997642211 1
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
......++..|+|||++... ...+.++||||+|+++|+|++|+.|+..... ......+.............
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNS--------DDQLEIIEKILKRPLPSSSQ 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--------HHHHHHHHHHHHTHHHHHTT
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccc--------hhhhhhhhhccccccccccc
Confidence 23445689999999998722 4778899999999999999999999864310 00011111111110000000
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .......+.+++.+||+.||++||++.+++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00112678999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.04 Aligned_cols=239 Identities=24% Similarity=0.312 Sum_probs=186.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+++.. +|+.+|+|++.... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 68999999986532 23345556655 46778999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 99998886533 589999999999999999999988 999999999999999999999999999875422211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~------------~~~~~~~~~~~~~-~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------------AEMYDNILHKPLV-LRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCH------------HHHHHHHHcCCcc-CCC
Confidence 2234589999999999753 678899999999999999999999864321 1112222221110 111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 620 (670)
.....+.+++.+||+.+|++||++++.+
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1345677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.99 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=188.9
Q ss_pred ccccccCceEEEEEEeCCCc-----------EEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPDGR-----------LVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.||+|+||.||+|.+.+.. .+++|++.........+.+|+.++++++|+||+++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999986432 57888877655447789999999999999999999999988 7789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-------CeEEeecCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-------TPKVSDFGL 496 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-------~~ki~DfGl 496 (670)
||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999976543 588999999999999999999987 999999999999999887 799999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCccccchHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
+...... ....++..|+|||++......++.++||||||+++|||++| ..|+..... . .+.
T Consensus 155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-------~----~~~- 216 (259)
T cd05037 155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-------S----EKE- 216 (259)
T ss_pred ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-------h----hHH-
Confidence 8865431 12335778999999875433678899999999999999995 555543211 0 000
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.......... ... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 217 ~~~~~~~~~~-~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 217 RFYQDQHRLP-MPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHHhcCCCCC-CCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000100000 000 157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.95 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=187.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC--------CeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG--------STRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~l 421 (670)
+.+.++||+|+||.||+|... +++.||||++..... ...+|+.++++++||||+++++++... ...++
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 445688999999999999885 688999998865432 345799999999999999999876432 24568
Q ss_pred EEEecCCCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccc
Q 005909 422 IYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKA 499 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~ 499 (670)
||||++ ++|.+++... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 999996 5676666432 2234689999999999999999999998 999999999999998664 799999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
....... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... ..+.. +...+.
T Consensus 221 ~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-------~~~~~-i~~~~~ 288 (440)
T PTZ00036 221 LLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-------DQLVR-IIQVLG 288 (440)
T ss_pred ccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHH-HHHHhC
Confidence 6543322 234579999999998653 35788999999999999999999999653220 00000 000000
Q ss_pred CC---------------cccc-----ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QP---------------EKED-----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~---------------~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+ ..+. .....+...+.++.+++.+||+.||++|||+.|++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0000 0000111234578899999999999999999999865
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.12 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=195.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceee-----eCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCC-----DGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-----~~~~~~lv~e 424 (670)
.+.+.||+|+||.||+++.. +++.+|+|++........++.+|+.+++++ +|+||+++++++. .+...++|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 45578999999999999875 578999999876555567788999999999 6999999999874 3456899999
Q ss_pred ecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|+++++|.+++.... ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 999999999876422 223588999999999999999999988 9999999999999999999999999998766432
Q ss_pred CceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
... .....|+..|+|||++... ...++.++|||||||++|||++|+.|+...... .. + .....
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----------~~-~-~~~~~ 243 (286)
T cd06638 178 RLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----------RA-L-FKIPR 243 (286)
T ss_pred CCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----------HH-H-hhccc
Confidence 211 1234589999999998532 134678999999999999999999998643220 00 0 00111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...... .........+.+++.+||+.||++||++.||++++
T Consensus 244 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000 01111244688899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.81 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=194.8
Q ss_pred HHHhhhccccccCceEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+.+.++||+|+||.||++... .++.|++|.+... +...+|++++++++||||+++++++......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 34567789999999999999753 3578999988653 2356899999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 168 ~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 168 YK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred cC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 94 6888887432 3589999999999999999999998 999999999999999999999999999976654333
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH-----------
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI----------- 574 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 574 (670)
........||+.|+|||++... .++.++|||||||++|||++|+.||....... ....+...+
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS----SSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC----cHHHHHHHHHHhccCccccC
Confidence 2222345689999999999753 67889999999999999999999996543211 000000000
Q ss_pred ----------HHHhcCCccccc-cchh--hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 575 ----------YDKLIQPEKEDF-VEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 575 ----------~~~~~~~~~~~~-~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
............ .... .......+.+++.+||+.||++||++.|++.+=
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000 0000 011234677899999999999999999999764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=307.51 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=195.7
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
..+.||+|+||+||++... +++.+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4578999999999999876 68899999986543 123457789999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 84 g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 84 GGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 9999998865332 3589999999999999999999987 999999999999999999999999999876543322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... .. .. ............
T Consensus 158 -~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~----~~-~~~~~~~~~~~~-- 223 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IK----RE-EVERLVKEVQEE-- 223 (285)
T ss_pred -ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----ch----HH-HHHhhhhhhhhh--
Confidence 123458999999999975 36788999999999999999999999653210 00 00 001111100000
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
........+.+++.+||+.||++||+ ++|++++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11123456788999999999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.94 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=198.4
Q ss_pred HHHhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
..+.+.+.||+|+||.||+|.+.+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 344567899999999999998743 3468999887554 345689999999999999999999998875 457899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999965432 489999999999999999999987 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
..... .....++..|+|||.+... .++.++||||||+++|||++ |+.||...... + ....+...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------~-~~~~~~~~ 224 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----------D-VIGRIENG 224 (270)
T ss_pred cccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----------H-HHHHHHcC
Confidence 42221 1223345789999998653 67889999999999999996 99998643220 0 01111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..... ....+..+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 225 ~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 225 ERLPM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1223557888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.70 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=195.6
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
..+.||+|+||+||++.+. +++.+|+|.+.... .....+.+|++++++++|+||+++.+.+..++..++|+||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3478999999999999885 68899999986543 223457889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 84 GGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred CccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 999998886543 23589999999999999999999987 999999999999999999999999999876543221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+...+.....
T Consensus 158 -~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--------~~~~~~~~~~~~~~~~---- 222 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--------KVKREEVDRRVLETEE---- 222 (285)
T ss_pred -ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhhhcccc----
Confidence 123458999999999965 3678899999999999999999999864321 0001111122211111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
.........+.+++.+||+.||++||+ +.+++.+
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111223456788999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.65 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=197.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-----------chHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-----------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
..+.||+|+||.||+|... +++.+|+|.++.... ..+.+.+|+.++++++|+||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3478999999999999875 688999998753210 1246788999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+|+||+++++|.+++.+.. .+++..+..++.|++.||.|||++ +++||||+|+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999987652 588999999999999999999987 9999999999999999999999999999765
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
.............++..|+|||.+......++.++||||||+++|||++|+.|+..... . ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------~-~~~~~~~~~ 227 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----------I-AAMFKLGNK 227 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----------H-HHHHHhhcc
Confidence 43222222233457899999999875423478899999999999999999999853221 0 011111111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.............++..+.+++.+||+.+|++||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111122223346678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.29 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=196.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||.||++++. ++..+|+|.+.... ....++.+|++++++++||||+++++++.+++..++|+||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 35578999999999999875 57889999886542 2345788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.++++... .+++..+..++.|+++||.|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 84 GSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 99999997542 588999999999999999999973 289999999999999999999999999987653321
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcccc---ch--------------
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY---FP-------------- 571 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~---~~-------------- 571 (670)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+............... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 1234578999999998653 5788999999999999999999998643211000000000 00
Q ss_pred -------HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 572 -------DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 572 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
....+.+.....+.. ....+...+.+++.+||+.||++||++.+|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKL---PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccC---cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000000 0112455688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.53 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=195.2
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCc-------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+.||+|+||+||+|...+++.+|+|.+..... ..+.+.+|++++++++|+||+++++++.+....++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4578999999999999988899999998864321 235688999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 84 VPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999996543 478999999999999999999987 999999999999999999999999999876432111
Q ss_pred ----eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 506 ----VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 506 ----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
........++..|+|||++.+. ..+.++||||||+++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----------~~~~~~~~~~~~ 225 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDR----------LAAMFYIGAHRG 225 (265)
T ss_pred cccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCCh----------HHHHHHhhhccC
Confidence 1111234578999999998753 578899999999999999999999864321 001000000000
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
........+...+.+++.+||+.+|++||++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111112234567888999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.63 Aligned_cols=242 Identities=27% Similarity=0.401 Sum_probs=198.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||.|+||.||-|++. +.+.||||++.-+. +..+++++|+..|.+++|||++.+-|++....+.||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 56999999999999875 67899999986432 44578999999999999999999999999999999999999 67
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
|-.++|.-++ .++.+..+..|..+.+.||+|||++ +.||||||..||||++.|.|||+|||.|....+..
T Consensus 111 SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----- 180 (948)
T KOG0577|consen 111 SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----- 180 (948)
T ss_pred cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----
Confidence 8888885443 3699999999999999999999998 99999999999999999999999999998776543
Q ss_pred cCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.++|||.|||||++.. ..|.++-|+||||||+...||...++|+-.... .... -.+.....+-+
T Consensus 181 -sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSAL-YHIAQNesPtL-- 245 (948)
T KOG0577|consen 181 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSAL-YHIAQNESPTL-- 245 (948)
T ss_pred -cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHHH-HHHHhcCCCCC--
Confidence 3569999999999853 337889999999999999999999988754322 0001 11111111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+++..+..++..||++-|.+|||..+++++-
T Consensus 246 -qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 -QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 2345677889999999999999999999988753
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.48 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=197.0
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
..+.+.+.||+|+||.||++++. +++.+|+|++.... ...+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 44556789999999999999986 68899999986422 23456788999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 123 EYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999998643 378888999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeeecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||..... ......+...
T Consensus 196 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~ 262 (371)
T cd05622 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMNH 262 (371)
T ss_pred Ccc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------------HHHHHHHHcC
Confidence 211 123456899999999996532 2367899999999999999999999964321 1112222221
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEML 623 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 623 (670)
... ........++..+.+++.+||+.++.+ |+++.|++++.
T Consensus 263 ~~~-~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNS-LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCc-ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 110 001111234566788999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.43 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=195.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||.||+|+.+ +++.||+|.++... .....+.+|+.++++++|+||+++++++......++|+||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 345678999999999999886 57899999986543 334567899999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++..... .+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++.........
T Consensus 88 -~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 88 -KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred -cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 688888865432 588999999999999999999998 9999999999999999999999999998765432211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHHHHH-h
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIYDK-L 578 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~-~ 578 (670)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......++.+.... .
T Consensus 161 -~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1233468899999998653 35678999999999999999999998643220000 00000001000000 0
Q ss_pred cCCccccc----cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPEKEDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+.. .......+...+.+++.+||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 001112235567899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.62 Aligned_cols=197 Identities=24% Similarity=0.397 Sum_probs=159.7
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee--CCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e~~~~g 429 (670)
.+||+|+||+||+|+.. ++..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 57999999999999875 35789999887543 34567899999999999999999998854 456789999985 5
Q ss_pred Cccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE----CCCCCeEEeecCCccc
Q 005909 430 SLGDLLSREK------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKA 499 (670)
Q Consensus 430 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll----~~~~~~ki~DfGla~~ 499 (670)
+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 7777664221 123588999999999999999999998 99999999999999 5668999999999987
Q ss_pred cCCCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 500 HSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 500 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
....... .......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6543221 122334578999999998653 35788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.81 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=196.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+++.++||+|+||.||+|+.. +++.+++|++.... ...+.+.+|+.++++++|+||+++++.+......++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 456688999999999999986 58899999987654 3457788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|..++.+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 94 ~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-- 166 (292)
T cd06644 94 GAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-- 166 (292)
T ss_pred CcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc--
Confidence 999888754332 589999999999999999999987 9999999999999999999999999998754322111
Q ss_pred ecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....++..|+|||++... ...++.++|||||||++|||++|+.|+..... ..............
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------------HHHHHHHhcCCCcc
Confidence 1223478899999998532 13457789999999999999999998854211 11111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .....+...+.+++.+||+.||++||++.+++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 1122344568889999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.28 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=194.5
Q ss_pred hhccccccCceEEEEEEeC-CCc----EEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+.||+|+||.||+|.+. ++. .+|+|.+..... ...++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3478999999999999864 343 578898875442 234788999999999999999999998754 46789999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 90 MPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999999875432 488999999999999999999998 999999999999999999999999999987654333
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
........++..|+|||.+.+ ...+.++||||||+++|||++ |+.|+..... ....+++ ......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~----~~~~~~ 230 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLL----EKGERL 230 (303)
T ss_pred ccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----HCCCCC
Confidence 222233445778999999865 367889999999999999997 8888853211 1111111 111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.. .......+.+++.+||..+|++||++.++++.|+.+.
T Consensus 231 ~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 PQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1112346788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.66 Aligned_cols=241 Identities=26% Similarity=0.327 Sum_probs=186.7
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc---cccccccccceeeeCCeeEEEEEecCC
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI---HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
||+|+||+||+|+.. +++.||+|++.... .....+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 58999999986532 2233455676766655 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 99998886543 589999999999999999999998 9999999999999999999999999998754322211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------------QQMYRNIAFGKVR-FP- 217 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH------------HHHHHHHHcCCCC-CC-
Confidence 1234589999999998653 3468899999999999999999999864321 1112222221111 10
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRP----SMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~~ 622 (670)
.......+.+++.+||+.||++|| ++.+++++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 012345677899999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=299.48 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=198.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+...++||+|+||.||+|.+. +++.+|+|++.... ...+.+.+|+.++++++|+||+++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 344578999999999999875 58899999987543 345678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 86 GGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 99999988643 488899999999999999999987 9999999999999999999999999999766433211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+...... .....+... ..
T Consensus 158 -~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~~~~~----~~ 218 (277)
T cd06640 158 -RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPM------------RVLFLIPKN----NP 218 (277)
T ss_pred -cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChH------------hHhhhhhcC----CC
Confidence 1223578899999998753 6788999999999999999999998643210 000111111 11
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.......+..+.+++.+||+.+|++||++.+++++-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 122234566788999999999999999999998763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=336.94 Aligned_cols=254 Identities=21% Similarity=0.354 Sum_probs=195.9
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--CCeeEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALI 422 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv 422 (670)
..|.+.++||+|+||+||++++. .++.+|+|++.... .....+..|+.++.+++||||+++++++.+ ....+||
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 34556789999999999999986 57789999887532 335678999999999999999999998864 3568999
Q ss_pred EEecCCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEecCCCCCcEEECC------------
Q 005909 423 YEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCE----LRILHLDIKPQNVLLDP------------ 485 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~dlkp~NIll~~------------ 485 (670)
|||+++++|.++|..... ...+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999999865322 2369999999999999999999998421 25999999999999964
Q ss_pred -----CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005909 486 -----DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 560 (670)
Q Consensus 486 -----~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~ 560 (670)
.+.+||+|||+++....... .....||+.|+|||++.+....++.++|||||||+||||++|+.||.....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred cccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 34589999999987643322 123458999999999875444678899999999999999999999964221
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+... ...+..... .. ....+..+.+++.+||+.+|++||++.|++.
T Consensus 249 ---------~~ql-i~~lk~~p~--lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 ---------FSQL-ISELKRGPD--LP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ---------HHHH-HHHHhcCCC--CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1111 111111111 00 0112457889999999999999999999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.09 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=190.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||+|+||+||+++.. +++.+|+|+++.. ......+.+|+.++.+++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999886 6899999998743 2344678889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce-
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~- 506 (670)
+|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 85 GGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999986543 589999999999999999999998 9999999999999999999999999998754321100
Q ss_pred --------------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 005909 507 --------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554 (670)
Q Consensus 507 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~ 554 (670)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCC
Confidence 001124689999999999764 6788999999999999999999999
Q ss_pred CCCCCCCCCCCccccchHHHHHHhcCCcc-ccccchhhHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 005909 555 RPTETTSGSNTTEAYFPDWIYDKLIQPEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEM 622 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 622 (670)
..... .....++..... ...... ......+.+++.+++ .||++|++ +.|++++
T Consensus 237 ~~~~~------------~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETP------------QETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCH------------HHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 64322 111222221110 001000 112445667777766 49999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.20 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=201.1
Q ss_pred hhccccccCceEEEEEEeCC-CcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||.|.-|+||++++.+ +...|+|++.+.. ....+.+.|-++|+.+.||.++.||+.++.....+++||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45789999999999999974 5899999998754 344577889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC-----
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR----- 502 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~----- 502 (670)
||+|..+++++..+ .+++..++.++.+++-||+|||-. |||.|||||+||||.++|++.|+||.|+.....
T Consensus 161 GGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 161 GGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 99999998776544 699999999999999999999976 999999999999999999999999999854311
Q ss_pred ----------------------------CCce---------------------eeecCCCCCccccchhhcccccCCCCc
Q 005909 503 ----------------------------NRSV---------------------VTMTGPRGTIGYIAPEIFMRNLGNPSG 533 (670)
Q Consensus 503 ----------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~ 533 (670)
.... ......+||-.|+|||++.+. .++.
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHgs 314 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHGS 314 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CCCc
Confidence 0000 011234699999999999886 6788
Q ss_pred cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCC
Q 005909 534 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613 (670)
Q Consensus 534 ~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 613 (670)
+.|-|+|||++|||+.|+.||.+... +..+... +.++.. +. ....++..+.+||.+.|.+||++|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~-------~~Tl~NI----v~~~l~--Fp--~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN-------KETLRNI----VGQPLK--FP--EEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc-------hhhHHHH----hcCCCc--CC--CCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999986533 1122222 122111 11 111456778899999999999999
Q ss_pred CC----HHHHHHHH
Q 005909 614 PS----MTRVVEML 623 (670)
Q Consensus 614 Ps----~~evl~~L 623 (670)
.. +.||-++=
T Consensus 380 lg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 380 LGSKRGAAEIKRHP 393 (459)
T ss_pred hccccchHHhhcCc
Confidence 87 77777654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=296.95 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=200.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.+.||+|+||.||++... +++.+++|++.... ...+.+.+|+.++++++||||+++++++.++...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 345688999999999999885 57889999987644 3457899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||++.........
T Consensus 85 ~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-- 157 (262)
T cd06613 85 GSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-- 157 (262)
T ss_pred CcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc--
Confidence 99999886542 2588999999999999999999988 9999999999999999999999999998765432211
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+... ....+.++||||||+++|||++|+.|+...... .. +. ...........
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----------~~-~~-~~~~~~~~~~~ 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----------RA-LF-LISKSNFPPPK 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----------HH-HH-HHHhccCCCcc
Confidence 1234578899999998642 125678999999999999999999998643210 00 00 01111001111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......+..+.+++.+||+.+|++||++.+|+.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12233456778999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.18 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=209.3
Q ss_pred HHhhhccccccCceEEEEEEeCC-CcEEEEEEcccCCc----chHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN----FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.|.+.+.||+|.||.||+++.+. |+.+|+|++.+... ..+.+.+|+.+|+++. |||||.+.+.+++....++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 35566889999999999999875 99999999976552 3468999999999998 999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC----CCeEEeecCCccc
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKA 499 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~----~~~ki~DfGla~~ 499 (670)
|++.+|.|.+.|... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++..
T Consensus 116 EL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999765 289999999999999999999997 99999999999999543 5799999999998
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
..... ......||+.|+|||++... .++..+||||+||++|.|++|..||...... .....+.
T Consensus 189 ~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~------------~~~~~i~ 251 (382)
T KOG0032|consen 189 IKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEF------------EIFLAIL 251 (382)
T ss_pred ccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChh------------HHHHHHH
Confidence 87622 34557799999999999753 7888999999999999999999999764320 1112233
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+.. .+..+..+.++..+.+++..++..||.+|+++.+++++
T Consensus 252 ~~~~-~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RGDF-DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCC-CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 3222 34455566678889999999999999999999999986
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.55 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=200.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||.++.. +++.+++|.+.... ...+++.+|+.++++++|+||+++++++.+....++++||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 45688999999999998865 68899999876532 345678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.+.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 83 GGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 999999997653 23589999999999999999999987 999999999999999999999999999987644332
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
......+++.|+|||.+.+. ..+.++||||||+++|||++|+.||..... ......+..+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------------~~~~~~~~~~~~~~-- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP------------LNLVVKIVQGNYTP-- 220 (256)
T ss_pred cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCCCC--
Confidence 12234578999999998754 577899999999999999999999854221 11111122211111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
........+.+++.+||+.+|++||+++++++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1133456788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.13 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=198.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+++.+.||+|+||.||+++.. +++.+|+|.+.... ...+.+.+|+.++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456788999999999999986 68999999886532 334678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|..++........+++..+..++.|++.||.|||++ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 999999887643334689999999999999999999963 2899999999999999999999999999876533221
Q ss_pred eecCCCCCccccchhhccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNL----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
....++..|+|||.+.+.. ..++.++|||||||++|||++|+.||..... .. ... ....+.....
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~-~~~-~~~~~~~~~~ 227 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-------AN-IFA-QLSAIVDGDP 227 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-------hh-HHH-HHHHHhhcCC
Confidence 2234788999999985421 1347899999999999999999999864221 00 000 0111111111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .....+...+.+++.+||+.+|++||++.+++++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 1122356678889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.48 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=186.5
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.||+|+||+||+|.... ...+++|.+.... ...+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 2348888876543 3346788999999999999999999999998999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC--------eEEeecCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--------PKVSDFGLA 497 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~--------~ki~DfGla 497 (670)
+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999976543 588999999999999999999998 9999999999999987765 699999988
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
....... ...++..|+|||++.+. ...+.++||||||+++|||++|.. |+..... . ... .
T Consensus 156 ~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----------~-~~~-~ 216 (258)
T cd05078 156 ITVLPKE------ILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----------Q-KKL-Q 216 (258)
T ss_pred cccCCch------hccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccH----------H-HHH-H
Confidence 6554321 23468899999999753 356889999999999999999954 4432111 0 000 0
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
..... ..... ....++.+++.+||+.||++|||++++++.|+
T Consensus 217 ~~~~~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYEDR--HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHcc--ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00111 12346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.03 Aligned_cols=188 Identities=23% Similarity=0.377 Sum_probs=159.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+|++ .+
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~ 141 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS 141 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence 456689999999999999986 5678999975433 2356999999999999999999999999999999999 56
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 142 ~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~ 213 (357)
T PHA03209 142 DLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---F 213 (357)
T ss_pred cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---c
Confidence 8888876533 2589999999999999999999998 999999999999999999999999999875432221 2
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~ 554 (670)
.+..||..|+|||++.+. .++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence 234589999999999764 6788999999999999999876654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.37 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=197.7
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3445688999999999999874 78999999987544 344678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 100 GGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 99999998543 478999999999999999999987 9999999999999999999999999998765433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ... ..... . ..
T Consensus 172 -~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~-----~~~~~-~--~~ 234 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYL-----IATNG-T--PE 234 (297)
T ss_pred -cCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eee-----eccCC-C--CC
Confidence 122347889999999975 3678899999999999999999999965322100 000 00000 0 00
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..........+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.16 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=189.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 420 (670)
|.+.+.||+|+||.||+++.. +++.+|+|++.... .....+.+|+.+++.++||||+++++++.... ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 345688999999999999875 68999999986532 33567889999999999999999999886443 468
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 103 LVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 99999964 56655532 378888999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCcccc---
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAY--- 569 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~--- 569 (670)
..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ......
T Consensus 174 ~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 174 CTNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccCcc---CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 33221 2334579999999999753 6788999999999999999999999754220000 000000
Q ss_pred chHHHHHHhcC-Cccccc-------------cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 570 FPDWIYDKLIQ-PEKEDF-------------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 570 ~~~~~~~~~~~-~~~~~~-------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
....+...... +..... ...........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000 000000 0001112245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.20 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=197.1
Q ss_pred hhhccccccCceEEEEEEeCC--CcEEEEEEcccCC-----------cchHHHHHHHHHhcc-ccccccccccceeeeCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTS-----------NFSDNFINEVATIGR-IHHVNIIHLLGFCCDGS 417 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~ 417 (670)
.+.+.||+|+||.||+|.+.. ++.+|+|.+.... ....++.+|+.++.+ ++||||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 355789999999999999865 6889999875321 223567788888875 79999999999999999
Q ss_pred eeEEEEEecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 418 TRALIYEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
..++++||+++++|.+++.... ....+++..+++++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999885422 233689999999999999999999963 2899999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
+....... ......++..|+|||.+.+ +.++.++||||||+++|||++|+.|+..... .. ...
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----------~~-~~~ 223 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----------LS-LAT 223 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCH-----------HH-HHH
Confidence 98765433 2234557899999999975 3678899999999999999999999854321 01 111
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.+....... .........+.+++.+||+.||++||++.|+.++++
T Consensus 224 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhccCCc---CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111 111123567889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.26 Aligned_cols=258 Identities=23% Similarity=0.283 Sum_probs=189.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
+.+.+.||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 345688999999999999875 68899999987532 3346788999999999999999999987543 3568
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 106 IVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 9999995 567666632 378889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC----CccccchHH---
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDW--- 573 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~--- 573 (670)
..... .....++..|+|||++.+. .++.++|||||||++|||++|+.||.......... ......+.+
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 177 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 43321 2334589999999999753 67889999999999999999999996532200000 000000000
Q ss_pred ----HHHHhc-CCccc-------------cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 574 ----IYDKLI-QPEKE-------------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 574 ----~~~~~~-~~~~~-------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... .+... .............+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000 00001111123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.54 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=198.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.+.||.|++|.||+|+.. +++.+++|++.... .....+.+|+.++++++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345678999999999999976 68899999987543 334678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 99999998654 589999999999999999999987 999999999999999999999999999987754321
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+.........
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~------------~~~~~~~~~~~~~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHP------------MRVLFLIPKNNPPSLE 219 (274)
T ss_pred ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCch------------HHHHHHhhhcCCCCCc
Confidence 12234578899999999764 588999999999999999999999864321 0011111111111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ..+..+.+++.+||+.+|++||++++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 145568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.40 Aligned_cols=197 Identities=25% Similarity=0.373 Sum_probs=172.8
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-c-----cccccccceeeeCCeeEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H-----VNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~lv 422 (670)
+|.+.+.||+|.||+|.|+.+. +++.||||++++......+...|+.+|..|+ | -|+|++++++...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 5667799999999999999875 6999999999999988899999999999997 4 4899999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC--CCeEEeecCCcccc
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD--FTPKVSDFGLAKAH 500 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~--~~~ki~DfGla~~~ 500 (670)
+|.+ ..+|.++|+.++-. .++...++.|+.||+.||..||.. +|||+||||+||||.+. ..+||+|||.|...
T Consensus 267 fELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999 67999999887654 599999999999999999999987 99999999999999653 47999999999877
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE 558 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~ 558 (670)
...... ..-+..|+|||++.+. .++.+.||||||||++||++|.+.|.+..
T Consensus 342 ~q~vyt-----YiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 342 SQRVYT-----YIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred CCccee-----eeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence 654431 1237789999999974 88999999999999999999977765443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=298.22 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=196.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee-CCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~e~ 425 (670)
|.+.+.||+|++|.||+++.+ +++.+++|.+.... ...+.+.+|++++++++|+|++++++.+.. ....++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 346688999999999999875 57889999986533 334578899999999999999999988764 4467899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++..... ..+++.+++.++.+++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999876432 3589999999999999999999988 999999999999999999999999999976643222
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....+++.|+|||++.+. .++.++||||||++++||++|+.||..... ..... .+.......
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----------~~~~~-~~~~~~~~~ 221 (257)
T cd08223 158 M--ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-----------NSLVY-RIIEGKLPP 221 (257)
T ss_pred c--cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHH-HHHhcCCCC
Confidence 1 1234578999999998753 678899999999999999999998863221 11111 111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........+.+++.+||+.||++||++.+++++
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.51 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=196.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
++.+.||+|+||.||+|+++ +++.+|+|++.... ...+.+.+|+.++++++|+||+++++++......++|+||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 45678999999999999986 58999999886543 234568899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 84 HTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred ccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 988887765432 489999999999999999999997 9999999999999999999999999999876543321
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH--HHhc------
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY--DKLI------ 579 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~------ 579 (670)
.....++..|+|||.+.+. ..++.++||||||+++|||++|+.||...............+..++. ....
T Consensus 157 -~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223468899999998653 35678999999999999999999998643221000000000000000 0000
Q ss_pred ----CCccc--cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 ----QPEKE--DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ----~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... .........++..+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 00001112335678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=294.87 Aligned_cols=248 Identities=30% Similarity=0.541 Sum_probs=198.7
Q ss_pred hhccccccCceEEEEEEeCC-----CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.||+|+||.||++++.+ +..+|+|++..... ..+.+.+|+..+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998864 48899999976654 467899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999998754321 289999999999999999999998 999999999999999999999999999987654422
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
... ....++..|+|||.+.. ...+.++||||||++++||++ |+.|+..... ..+.+.+......
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~ 223 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------------EEVLEYLKKGYRL 223 (258)
T ss_pred ccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHhcCCCC
Confidence 211 12346789999999854 467889999999999999998 6777653211 1111222221111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.. ....+.++.+++.+||+.||++|||+.|+++.|
T Consensus 224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 112466788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.58 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=188.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccc---cccccccccceeee-----CCee
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GSTR 419 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~~~ 419 (670)
.+.+.||+|+||+||+|+.. +++.||+|.++... .....+.+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 45678999999999999886 68999999987532 2234566777777665 69999999998764 2357
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++|+||++ ++|.+++..... ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 89999996 588888765432 2489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. +.....
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-------~~~~~-~~~~~~ 224 (288)
T cd07863 158 YSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-------DQLGK-IFDLIG 224 (288)
T ss_pred ccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-------HHHHH-HHHHhC
Confidence 643321 1234578999999999753 6788999999999999999999998643210 00000 000000
Q ss_pred C--------------C----ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 Q--------------P----EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~--------------~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. . ............+...+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0 00000011112345567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=301.05 Aligned_cols=251 Identities=21% Similarity=0.360 Sum_probs=198.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.++||+|+||.||++.+. +++.+|+|++.... ...+.+.+|++++++++|+||+++++.+..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 456788999999999999885 68899999987654 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.+... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 159 (280)
T cd06611 87 GALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-- 159 (280)
T ss_pred CcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence 999999865432 589999999999999999999998 9999999999999999999999999998765432221
Q ss_pred ecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....+++.|+|||.+... ...++.++||||||+++|||++|+.||..... ......+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------------MRVLLKILKSEPPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------------HHHHHHHhcCCCCC
Confidence 1223478999999998532 13467799999999999999999999864321 00111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1112345578889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=297.42 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=201.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||.|+||+||+|... ++..+++|++.... ...+.+.+|+..++.++|+||+++++.+..++..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45688999999999999875 67899999986543 3457899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 507 (670)
++|.+++........+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..........
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999997643333689999999999999999999988 99999999999999999999999999987665432221
Q ss_pred -eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 -TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 -~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......|+..|+|||.+... ...+.++||||||+++|||++|+.||...... .. ..+.........
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~-----~~~~~~~~~~~~ 227 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KV-----LMLTLQNDPPSL 227 (267)
T ss_pred cccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChh-------hh-----HHHHhcCCCCCc
Confidence 11223578999999998754 36788999999999999999999998643220 01 111111111111
Q ss_pred cc-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ......+..+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 1112445678899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.70 Aligned_cols=258 Identities=24% Similarity=0.283 Sum_probs=189.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
+.+.+.||+|+||.||++... .++.+|+|++.... ...+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 344578999999999999875 68899999987532 2346788899999999999999999987643 3468
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||++ ++|.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 99 LVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred EEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 9999995 466666532 378889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC----ccccchH----
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPD---- 572 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~---- 572 (670)
..... .....||..|+|||++.+. .++.++|||||||++|||++|+.||........... .....+.
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 170 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred CCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 43321 2234579999999999753 678899999999999999999999965321000000 0000000
Q ss_pred ---HHHHHhcC-Ccc-------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 573 ---WIYDKLIQ-PEK-------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 573 ---~~~~~~~~-~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+...... +.. ..............+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000 000001112234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.93 Aligned_cols=251 Identities=27% Similarity=0.376 Sum_probs=195.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeee------CCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD------GSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~lv 422 (670)
+.+.+.||+|+||.||+|++. +++.+|+|++........++..|+.++.++ +|+||+++++++.. ....+++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 345678999999999999985 688999999877665667788999999999 79999999998853 4577999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++|+|.+++..... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 999999999999865432 2578888999999999999999998 999999999999999999999999999876532
Q ss_pred CCceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
... ......|+..|+|||.+... ...++.++||||||+++|||++|+.||...... .. + ..+.
T Consensus 174 ~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~-----~-~~~~ 239 (282)
T cd06636 174 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------RA-----L-FLIP 239 (282)
T ss_pred ccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------hh-----h-hhHh
Confidence 211 11234578999999998531 235677999999999999999999998643210 00 0 0011
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... .....++..+.+++.+||+.||++||++.||+++
T Consensus 240 ~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 111111 1112345678899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=300.08 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=194.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----------chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.||+|++|.||+|... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4578999999999999875 578999998865331 12468889999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999996543 588899999999999999999987 99999999999999999999999999998765
Q ss_pred CCCcee----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 502 RNRSVV----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 502 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
...... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~-~ 223 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----------LQAIF-K 223 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccH-----------HHHHH-H
Confidence 321111 11123478899999998753 678899999999999999999999864321 01111 1
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... .........+.+++.+||+.||++||++.||+++
T Consensus 224 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 IGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111 1112345678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.50 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=196.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.++||.|++|.||+|... +++.|++|.+.... ...+.+.+|+.+++.++|+||+++++++......++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 35578999999999999864 78999999886543 34567889999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... .
T Consensus 102 ~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 172 (296)
T cd06655 102 SLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--R 172 (296)
T ss_pred cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--C
Confidence 999988543 489999999999999999999998 9999999999999999999999999998765443221 1
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .... . .+....... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~----------~~~~-~-~~~~~~~~~--~~ 236 (296)
T cd06655 173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------LRAL-Y-LIATNGTPE--LQ 236 (296)
T ss_pred CCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------HHHH-H-HHHhcCCcc--cC
Confidence 223578899999998753 678899999999999999999999864322 0000 0 010000000 01
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....+...+.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 112345568889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.56 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=196.5
Q ss_pred hhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
..+.||+|+||.||+|+.+ +.+.+++|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4578999999999999864 346799998876543 35789999999999999999999999999899999999
Q ss_pred ecCCCCcccccccccCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 425 YMPNGSLGDLLSREKEN------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
|+++++|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999999765422 1589999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
....... .......++..|+|||.+.+. ..+.++||||||+++|||++ |..||..... .. +...
T Consensus 166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----------~~-~~~~ 230 (275)
T cd05046 166 DVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----------EE-VLNR 230 (275)
T ss_pred ccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccch-----------HH-HHHH
Confidence 5432221 122233457789999998653 57789999999999999998 6777743211 01 1111
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
........ ......+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 231 ~~~~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLEL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111100 011123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.15 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=196.5
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|+.++++++|+||+++++++.++...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4578999999999999986 78999999986533 2346789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999986543 488999999999999999999988 99999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......++..|+|||.+... ..++.++|+||||+++|||++|+.||..... ..............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~- 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----------VAAVFKIGRSKELP- 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----------HHHHHHHHhcccCC-
Confidence 12334578999999998654 2378899999999999999999999864321 01111111101111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+...+.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1112235667889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=297.78 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=188.9
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIY 423 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 423 (670)
..+.||+|+||.||+|... +++.+++|++.... ...+.+.+|+.++++++||||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4578999999999999875 58899999886432 2235688899999999999999999988753 5678999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 86 EYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999986543 478899999999999999999987 9999999999999999999999999998765422
Q ss_pred Cc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.. ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------~~~~~~~~~~~~ 226 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------MAAIFKIATQPT 226 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccch-----------HHHHHHHhcCCC
Confidence 11 111123457889999999875 3678899999999999999999999864211 111111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .........+..++ +||..+|++||+++||+++
T Consensus 227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11 11122334455555 6888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.91 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=193.8
Q ss_pred hhccccccCceEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------ee
Q 005909 353 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TR 419 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~ 419 (670)
+.+.||+|+||.||+|.+. +++.+|||++.... ...+++.+|+.++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999863 36889999987643 23567889999999999999999999886542 24
Q ss_pred EEEEEecCCCCccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 420 ALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
++++||+++|+|.+++.... ....+++..+++++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 68899999999988875322 122578899999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
++...............++..|++||.+... ..+.++||||||+++|||++ |+.|+..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~------------~~~~ 225 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------------SEIY 225 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------------HHHH
Confidence 9876543322222233456789999998653 67889999999999999999 7777753211 0111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
............ ......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 NYLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111111 12345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=297.22 Aligned_cols=244 Identities=29% Similarity=0.488 Sum_probs=194.2
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++++++||||+++++++... ..++||||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 34568899999999999975 67789999986543 356789999999999999999999998654 4789999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 85 L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~ 155 (254)
T cd05083 85 LVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----D 155 (254)
T ss_pred HHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----C
Confidence 9999875432 3588999999999999999999987 99999999999999999999999999987643221 1
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....+..|+|||.+.+ +.++.++||||||+++|||++ |+.||..... .. ....+...... .
T Consensus 156 ~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~-~~~~~~~~~~~----~ 217 (254)
T cd05083 156 NSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----------KE-VKECVEKGYRM----E 217 (254)
T ss_pred CCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----------HH-HHHHHhCCCCC----C
Confidence 2234678999999865 467889999999999999997 8888754321 01 11122111111 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
....++..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 11234567889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.78 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=195.6
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||+|++|+||++... +++.+|+|.+..... ..+.+.+|++++.+++|+||+++++.+.+....++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4578999999999999986 489999999876442 34578899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 85 ~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 85 GGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999986542 23589999999999999999999987 99999999999999999999999999987543221100
Q ss_pred ---------------------------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005909 508 ---------------------------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 560 (670)
Q Consensus 508 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~ 560 (670)
......|+..|+|||++.+. ..+.++||||||+++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~- 237 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSNR- 237 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCch-
Confidence 01123578899999999754 678899999999999999999999864322
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS----MTRVVEM 622 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~~ 622 (670)
.. ....+..... ........+..+.+++.+||+.||++||+ +.|++.+
T Consensus 238 ------~~-----~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 ------DE-----TFSNILKKEV---TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ------HH-----HHHHHhcCCc---cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 00 1111111110 00111124667899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=295.84 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=199.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++.+.||+|++|.||++.++ +++.+++|.+.... ...+++.+|++++++++||||+++++.+......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 35678999999999999986 68999999987653 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+..........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 84 GSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 99999997643 368899999999999999999998 6 99999999999999999999999999987654322111
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
..++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... . ....+. .+...........
T Consensus 159 ----~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~-~~~~~~-~~~~~~~~~~~~~ 225 (265)
T cd06605 159 ----FVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDP-----P-DGIFEL-LQYIVNEPPPRLP 225 (265)
T ss_pred ----ccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccc-----c-ccHHHH-HHHHhcCCCCCCC
Confidence 4578899999998764 6788999999999999999999998653220 0 011111 1112221111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. ..+...+.+++.+||..||++||++.+++++
T Consensus 226 ~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 S---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 1156678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.99 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999875 68999999986533 34567889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ....
T Consensus 107 ~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 177 (297)
T cd06659 107 DIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL 177 (297)
T ss_pred HHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence 887542 488999999999999999999988 9999999999999999999999999998765433221 1234
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.++..|+|||++.+. .++.++||||||+++|||++|+.||...... . ....+...... ......
T Consensus 178 ~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------~-~~~~~~~~~~~--~~~~~~ 241 (297)
T cd06659 178 VGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----------Q-AMKRLRDSPPP--KLKNAH 241 (297)
T ss_pred ecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------H-HHHHHhccCCC--CccccC
Confidence 578999999999753 6788999999999999999999998642210 0 00111111000 011111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+.+++.+||+.+|++||++++++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 234567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.82 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=194.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||+|+.. +|+.+++|++.... .....+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 45678999999999999986 68999999986532 233567889999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 83 -QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred -CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 57877775433 2589999999999999999999998 999999999999999999999999999986543221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh---------
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL--------- 578 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 578 (670)
......++..|+|||++.+. ..++.++||||||+++|||++|+.|+....... .. ...+...+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~------~~-~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD------DQ-LKRIFRLLGTPTEESWP 226 (284)
T ss_pred CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH------HH-HHHHHHHhCCCChHHhH
Confidence 12234578899999998653 346889999999999999999999865432200 00 00000000
Q ss_pred -----cCCc-ccccc-----chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 -----IQPE-KEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 -----~~~~-~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ..... .......+..+.+++.+||+.||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 00000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.25 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=196.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
++.++||+|+||.||++.++ +++.+|+|++..... ..+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 45688999999999999986 589999999865432 34678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.++..... .+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 84 HTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred ccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 988888765432 489999999999999999999998 9999999999999999999999999998865433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHH-------
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDK------- 577 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~------- 577 (670)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||........... ....+.......
T Consensus 157 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2234578899999998753 3567899999999999999999988853221000000 000000000000
Q ss_pred --hcCCccc--cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 --LIQPEKE--DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 --~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... .........++..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 00000112345678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=297.41 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=198.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCC------eeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS------TRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------~~~lv 422 (670)
+.+.+.||+|++|.||+|..+ +++.+++|++.......+++.+|+.+++++ +|+||+++++++.+.. ..++|
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 445688999999999999985 578999999987776678899999999999 7999999999987644 48999
Q ss_pred EEecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 423 YEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|||+++++|.+++.... .+..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999886533 133689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
..... .....++..|+|||.+... ...++.++||||||++++||++|+.||...... ... ..+
T Consensus 165 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~-~~~ 230 (275)
T cd06608 165 STLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----------RAL-FKI 230 (275)
T ss_pred cchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----------HHH-HHh
Confidence 32221 1234578899999988532 134577899999999999999999998642210 001 111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ..........+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 11122356678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.82 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=189.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
+.+.+.||+|+||+||++... +++.||||++.... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 445678999999999999875 67899999987543 2345678999999999999999999987543 3468
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 97 ~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 97 LVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 999988 78898877532 489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHH
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDK 577 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 577 (670)
... .....|+..|+|||++.+. ..++.++|||||||++|||++|+.||........... ............
T Consensus 169 ~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 169 DDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 432 2234589999999998653 3578899999999999999999999864321000000 000000000000
Q ss_pred hcCC-------ccccccc----hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQP-------EKEDFVE----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~-------~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+... ....... .........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000 0001123457789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.94 Aligned_cols=259 Identities=15% Similarity=0.229 Sum_probs=185.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccccc------ccccccceeeeC-CeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV------NIIHLLGFCCDG-STRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~g~~~~~-~~~~lv 422 (670)
+.+.++||+|+||+||+|.+. .++.||||+++......+++..|+.++.+++|. +++++++++... ...++|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 445688999999999999875 578999999976554455667788777777554 588888888755 467899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---------------
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF--------------- 487 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~--------------- 487 (670)
||++ +++|.+++.+.. .+++..+..|+.|++.||+|||++ .+||||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9988 778888886543 589999999999999999999972 2899999999999998765
Q ss_pred -CeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC-
Q 005909 488 -TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT- 565 (670)
Q Consensus 488 -~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~- 565 (670)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 285 ~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred ceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643222 2334689999999999764 678899999999999999999999975332000000
Q ss_pred --ccccchHHHHH--------HhcCCc---cccc-----------cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 566 --TEAYFPDWIYD--------KLIQPE---KEDF-----------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 566 --~~~~~~~~~~~--------~~~~~~---~~~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
....++..... .+.... .... ...........+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00000100000 000000 0000 00000011345779999999999999999999997
Q ss_pred H
Q 005909 622 M 622 (670)
Q Consensus 622 ~ 622 (670)
+
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 4
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.17 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=198.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||.||+++.. +++.+++|.+.... ...+++.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 45688999999999999875 68899999986432 334678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++..... ..+++..+++++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 83 GGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 9999998865432 2478999999999999999999987 9999999999999999999999999999765433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|++.|+|||++.+. ..+.++||||||++++||++|+.|+..... .+.+ .....+...
T Consensus 158 -~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~~-~~~~~~~~~--- 219 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------KNLV-LKIIRGSYP--- 219 (256)
T ss_pred -hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-----------HHHH-HHHhcCCCC---
Confidence 1123478899999998753 678899999999999999999999853211 1111 122222111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.87 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=196.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhcccc---ccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+|.+. +++.+++|.+.... ...+++.+|+.++++++ |||++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 44578999999999999974 68999999986542 34567889999999996 99999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++... .+++..++.++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 84 AEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999988543 589999999999999999999988 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....|+..|+|||.+.+. ..++.++||||||+++|||++|+.||...... ..+ ..+.......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----------~~~-~~~~~~~~~~ 221 (277)
T cd06917 157 K--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----------RAM-MLIPKSKPPR 221 (277)
T ss_pred c--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChh-----------hhh-hccccCCCCC
Confidence 1 1234578899999998643 34688999999999999999999998643221 000 0011111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ......+.+++.+||+.||++||++.+++++
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111 1145578899999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=301.39 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=195.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.+.||+|++|.||+|... +++.|++|.++.... ....+..|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34578999999999999975 689999999976532 23457789999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+ +++|.+++.... ..+++..++.++.|+++||+|||++ +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 83 FM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred cc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 99 999999996543 2589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHHHH
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIYD 576 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 576 (670)
.. .....++..|+|||.+.+. ..++.++||||||+++|||++|..+|......... ......++.+ .
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV--T 231 (298)
T ss_pred cc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc--c
Confidence 21 1223467889999998643 35688999999999999999997776532210000 0000000000 0
Q ss_pred HhcCCcc-----ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+..... ..............+.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 000011112335678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=295.13 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=196.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++.+..++..++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 45678999999999999875 68899999986543 345678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~~~~ 506 (670)
+++|.+++.... ...+++..+..++.+++.||+|||++ +++|+||+|+||+++++ +.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 83 GGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 999999997643 23589999999999999999999998 99999999999999865 46899999999876543221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....++..|+|||.+.+. ..+.++||||||+++|+|++|+.|+..... ..... .........
T Consensus 159 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----------~~~~~-~~~~~~~~~- 220 (256)
T cd08220 159 ---YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-----------PALVL-KIMSGTFAP- 220 (256)
T ss_pred ---cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-----------HHHHH-HHHhcCCCC-
Confidence 123478899999998753 678899999999999999999999864321 11111 111111111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+..+.+++.+||+.+|++||++.|++++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=300.63 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
..||+|+||.||++... ++..||||.+.... ...+.+.+|+..+++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999875 68899999986543 34567889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++......... ....
T Consensus 108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 108 DIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 988543 488999999999999999999998 9999999999999999999999999998765432221 1223
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.++..|+|||.+.+. .++.++||||||+++|||++|+.||..... . .....+........ ....
T Consensus 179 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~----------~--~~~~~~~~~~~~~~--~~~~ 242 (292)
T cd06658 179 VGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----------L--QAMRRIRDNLPPRV--KDSH 242 (292)
T ss_pred ecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------H--HHHHHHHhcCCCcc--cccc
Confidence 478999999998653 678899999999999999999999864221 0 00011111000000 0111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 234567789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.29 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=194.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeC-----CeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-----STRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-----~~~~lv~e~ 425 (670)
+.+.||+|+||.||++... +++.+|+|++.........+.+|+.++.++ +||||+++++++... ...++|+||
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 4578999999999999885 688999999977655567788999999999 899999999998754 357899999
Q ss_pred cCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++++|.++++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99999999886432 223589999999999999999999988 99999999999999999999999999988654322
Q ss_pred ceeeecCCCCCccccchhhccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. .....++..|+|||.+.... ...+.++|||||||++|||++|+.|+...... ..+. .....
T Consensus 183 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----------~~~~-~~~~~ 248 (291)
T cd06639 183 LR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----------KTLF-KIPRN 248 (291)
T ss_pred cc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----------HHHH-HHhcC
Confidence 11 12245788999999985431 13578999999999999999999998643210 0011 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... .........+.+++.+||+.+|++||++.|++++
T Consensus 249 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 1112234568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.20 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=197.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--CCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e~ 425 (670)
++.+.||.|+||.||++... +++.+++|++.... ...+.+.+|+.++++++|+||+++++++.. +...++++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 35578999999999999875 67899999986533 334578899999999999999999997764 4567899999
Q ss_pred cCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 426 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 426 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+++++|.+++.... ....+++..++.++.|++.||+|||... +.+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999986542 2346899999999999999999999221 23999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.... .....++..|+|||.+... ..+.++||||||+++|+|++|+.|+..... ..+.+.+....
T Consensus 163 ~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~ 226 (265)
T cd08217 163 DSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ------------LQLASKIKEGK 226 (265)
T ss_pred Cccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH------------HHHHHHHhcCC
Confidence 4321 1234578999999998753 578899999999999999999999864321 11112222221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... .....+..+.+++.+||+.+|++||++.+|+++
T Consensus 227 ~~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FRR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=295.66 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=196.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||.||+|... +++.+|+|++.... ...+.+.+|+..+.+++||||+++++++.++...++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 445678999999999999875 68899999976543 334678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 99999988643 488999999999999999999998 9999999999999999999999999998765432211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.. ..++.++||||||+++|||++|+.|+..... ......+......
T Consensus 158 -~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~--- 219 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHP------------MKVLFLIPKNNPP--- 219 (277)
T ss_pred -hccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccch------------HHHHHHHhcCCCC---
Confidence 122357889999999865 3678899999999999999999999853211 0111111111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....++..+.+++.+||+.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112345668889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=292.82 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=198.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
...+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+.+.+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999875 689999999876553 46789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 83 GGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999986542 478899999999999999999998 99999999999999999999999999998765433221
Q ss_pred e--ecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 508 T--MTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 508 ~--~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. .....++..|+|||++.+.. ...+.++||||||+++|||++|+.||...... . ..... +......
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------~-~~~~~-~~~~~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------F-QIMFH-VGAGHKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------H-HHHHH-HhcCCCC
Confidence 1 12345788999999997542 23788999999999999999999998643210 0 01111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
... ....+...+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 11123556778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.44 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=193.3
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..+.||.|++|.||+|+.. +++.++||++.... ...+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 4578999999999999875 68899999886543 233578899999999999999999999999999999999995
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 83 QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 68888876543 23589999999999999999999987 9999999999999999999999999998765432211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHH-----H
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWI-----Y 575 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~-----~ 575 (670)
.....++..|+|||.+.+. ...+.++||||||+++|||++|+.||......... .......+... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 1223468899999988653 34578999999999999999999998643220000 00000000000 0
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... ...............+.+++.+||+.||++||++++++++
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKW-ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccc-cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000 0000001111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.83 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=198.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.+.||+|+||.||+|++. +++.+++|++.... ...+.+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 345688999999999999975 68999999987543 33567999999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 999999986543 3589999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh--------
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL-------- 578 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 578 (670)
.......++..|+|||.+.+. ...+.++||||+|++++||++|+.++...... .....+...+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--------EQLAIVFRTLGTPNEETW 225 (286)
T ss_pred CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--------HHHHHHHHHcCCCChHHH
Confidence 112234578999999998653 35688999999999999999997777532210 0000000000
Q ss_pred ------------cCCcccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 ------------IQPEKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ------------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ............+.+++.+||+.||++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0001111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.09 Aligned_cols=246 Identities=28% Similarity=0.401 Sum_probs=194.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+...+.||+|+||+||+|+.. +++.||+|.+.... ...+++.+|++++++++||||+++++++.+....++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 455688999999999999875 68999999886432 2235788999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++ |+|.+++..... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 97 ~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 97 CL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred hC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 96 677776654332 589999999999999999999987 99999999999999999999999999987654322
Q ss_pred eeeecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
...++..|+|||++.+ ..+.++.++||||||+++|||++|+.|+..... ...... +......
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----------~~~~~~-~~~~~~~ 232 (307)
T cd06607 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYH-IAQNDSP 232 (307)
T ss_pred -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----------HHHHHH-HhcCCCC
Confidence 2346889999998853 124678899999999999999999999854321 001111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.. .....+..+.+++.+||+.||++||++.+|+++.
T Consensus 233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 233 TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 11 1123456788999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.96 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=192.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||+|++|.||+|+.+ +++.||+|.+.... .....+.+|++++++++|+||+++++++.++...++|+||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD- 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence 35678999999999999986 68999999986543 233567889999999999999999999999999999999997
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.+... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 159 (291)
T cd07844 87 TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T 159 (291)
T ss_pred CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence 589888865432 588999999999999999999988 999999999999999999999999999875432211 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------CCccccchHHHHH-Hh
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTTEAYFPDWIYD-KL 578 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~-~~ 578 (670)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||......... ......++..... ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1223467899999998653 35688999999999999999999998643210000 0000000000000 00
Q ss_pred cCCccc----cccchhhHHH--HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPEKE----DFVEEEDDCI--ARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~~~----~~~~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... .......... ...+.+++.+||+.+|++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 0000000011 2567789999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.23 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=196.2
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~~~ 427 (670)
+.++||.|++|.||++.+. +++.+|+|.+..... ...++.+|++++++++||||+++++++.+. ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4578999999999999985 588999999875443 456789999999999999999999988654 46899999999
Q ss_pred CCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 999998875432 223588999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ........+ +........
T Consensus 161 ---~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~----~~~~~~~~~ 228 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSY----IVNMPNPEL 228 (287)
T ss_pred ---ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHH----HhcCCchhh
Confidence 12346889999999865 367889999999999999999999987542210 011111111 111111111
Q ss_pred --cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 --VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 --~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...........+.+++.+||+.+|++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 1111122456788999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=292.84 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=189.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIY 423 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~ 423 (670)
+.+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++.+. ...++++
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4578999999999999875 58999999875322 1235788899999999999999999988764 4678999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++.+.. .+++...++++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 86 EHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999986543 478888999999999999999998 9999999999999999999999999998765422
Q ss_pred Cc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.. ........++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~ 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPT 226 (265)
T ss_pred cccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccch-----------HHHHHHHhcCCC
Confidence 11 1112234578899999998753 678899999999999999999999853211 011111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. ...+......+.+++.+|+. +|++||+++||+++
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 11123345567778888884 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.90 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=199.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.+.||+|++|.||+|.++ +++.+++|++.......+.+.+|++.+++++|+||+++++.+......++|+||+++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 34578999999999999987 68899999998765556788999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 102 L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 174 (286)
T cd06614 102 LTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RN 174 (286)
T ss_pred HHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--hc
Confidence 999997654 2589999999999999999999987 9999999999999999999999999998765433211 12
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... . .... ......... ...
T Consensus 175 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----------~-~~~~-~~~~~~~~~--~~~ 238 (286)
T cd06614 175 SVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPP----------L-RALF-LITTKGIPP--LKN 238 (286)
T ss_pred cccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCH----------H-HHHH-HHHhcCCCC--Ccc
Confidence 23468899999998653 678899999999999999999999853221 0 0000 111110111 111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+...+.+++.+||+.+|.+||++.+++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 222456788999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.17 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=202.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|.+.+.||+|.|+.|-.|++- +|..||||++.+.+ -....+.+|++.|+.+.|||||+||.+......+|||.|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 344578999999999999875 89999999998765 23457889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla~~~~~~~~ 505 (670)
.+|+|+++|-++.. .+.+....+++.||+.|+.|.|+. .+|||||||+|+.+- .-|-+||+|||++..+..+..
T Consensus 100 D~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred CCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999976654 489999999999999999999987 999999999998874 568999999999988877665
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.. ...|+..|-|||.+.+. ....++.||||||||||.|++|+.||+...+. ..+ ..+.+-+
T Consensus 175 L~---TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------ETL-----TmImDCK--- 235 (864)
T KOG4717|consen 175 LT---TSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------ETL-----TMIMDCK--- 235 (864)
T ss_pred hh---cccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccch-------hhh-----hhhhccc---
Confidence 43 34589999999999875 23356899999999999999999999754331 111 1122211
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+.-++.+-.++|..||..||++|.+.+||+..
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 12233456677889999999999999999999853
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.79 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=195.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||++... .++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34578999999999999986 57899999987543 23457889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc-
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS- 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~- 505 (670)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 84 EGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999996543 588999999999999999999988 999999999999999999999999999874211100
Q ss_pred ------------eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHH
Q 005909 506 ------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 506 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
........++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------------~~ 223 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------------EE 223 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HH
Confidence 001112346889999999865 3678899999999999999999999853211 11
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
+........... .......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVISDDIEW--PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHhcccCC--CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111111000 00111345668899999999999999997667666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.14 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=197.7
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.+.||+|+||.||++... +++.+++|.+.... ...+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 3445688999999999999864 67899999986543 345678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 100 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999998653 478899999999999999999988 9999999999999999999999999998765433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. . . +.......
T Consensus 172 -~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~-~----~-~~~~~~~~-- 234 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------AL-Y----L-IATNGTPE-- 234 (293)
T ss_pred -cccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------he-e----e-hhcCCCCC--
Confidence 122357889999999865 367889999999999999999999996432210 00 0 0 00000000
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......+...+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345578889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.97 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=196.1
Q ss_pred hhccccccCceEEEEEEe-CCCcEEEEEEcccCC-------cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
..+.||+|++|.||+++. .+++.+|+|++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346799999999999987 468999999987533 124678999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~ 503 (670)
|+++++|.+++.+.. .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 84 WMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred ccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999986543 588999999999999999999998 999999999999998775 5999999998776533
Q ss_pred Ccee--eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 504 RSVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 504 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... ......++..|+|||.+.+. .++.++||||+|++++||++|+.||..... ......+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKH--------SNHLALIFKIASAT 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCC--------cchHHHHHHHhccC
Confidence 1111 01123478899999998653 678899999999999999999999853221 01111111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
............+.+++.+||+.+|++||++.+++++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1112233456678899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=294.68 Aligned_cols=241 Identities=28% Similarity=0.403 Sum_probs=196.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||++.+. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 45688999999999999886 58999999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-- 155 (290)
T cd05580 84 PGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-- 155 (290)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence 9999999986653 589999999999999999999997 99999999999999999999999999998765431
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....+++.|+|||.+... ..+.++||||||+++|||++|+.||..... ......+..... ..
T Consensus 156 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~~ 217 (290)
T cd05580 156 ---YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP------------IQIYEKILEGKV-RF 217 (290)
T ss_pred ---CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCc-cC
Confidence 223478999999998653 677899999999999999999999864321 112222222111 11
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
+......+.+++.+||+.||++|+ +++|++++
T Consensus 218 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 ----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111245778899999999999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.75 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=196.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|++|.||+|+.. +++.||+|+++... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD- 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-
Confidence 34678999999999999986 68899999987643 335677899999999999999999999999999999999997
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++........+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (284)
T cd07836 82 KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-- 156 (284)
T ss_pred ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--
Confidence 58888886554444689999999999999999999987 9999999999999999999999999999765432211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHHHHHhcC
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 580 (670)
.....++..|++||.+.+. ..++.++||||||+++|||++|+.||......... ......+..+.......
T Consensus 157 ~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223468899999998653 35678999999999999999999998653221000 00000000000000000
Q ss_pred Cccccc----cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... ........+..+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 001112235678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.26 Aligned_cols=247 Identities=22% Similarity=0.381 Sum_probs=196.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||++..+ ++..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 34578999999999999986 57899999986542 345678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~~ 506 (670)
+++|.+++.+... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+.........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 83 GGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999999865432 2579999999999999999999988 999999999999998885 4699999998776543221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....|++.|+|||++.+. .++.++||||||+++|||++|+.|+..... ..++..... ....
T Consensus 159 --~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~-~~~~-- 220 (257)
T cd08225 159 --AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------HQLVLKICQ-GYFA-- 220 (257)
T ss_pred --ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHhc-ccCC--
Confidence 1223578899999998653 678899999999999999999999853221 122222111 1111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........+.+++.+||+.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.84 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=194.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+...+.||+|+||.||+++.. +++.+|+|++.... ....++.+|++++++++|+|++++++++.++...++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 345578999999999999875 68899999986532 2335788999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++ |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 57777775433 2589999999999999999999988 9999999999999999999999999998754432
Q ss_pred eeeecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
....++..|+|||++.. ..+..+.++||||||+++|||++|+.|+..... .... ..+......
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~-~~~~~~~~~ 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSAL-YHIAQNESP 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----------HHHH-HHHHhccCC
Confidence 12347889999999753 224678899999999999999999999854211 0011 111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
. .........+.+++.+||+.+|++||++.+|++++-
T Consensus 243 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1 111234556888999999999999999999998775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.63 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=191.2
Q ss_pred HHHHhhh--ccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeee-------
Q 005909 348 KMTNGFK--EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD------- 415 (670)
Q Consensus 348 ~~~~~~~--~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------- 415 (670)
+..++|. +.||+||||.|||++.+ ||+.+|||++.... .....+.+|+.+|.+|+|||||+++..|.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3444454 57999999999999987 89999999997653 445678899999999999999998622210
Q ss_pred --------------------------------------------------------------------------------
Q 005909 416 -------------------------------------------------------------------------------- 415 (670)
Q Consensus 416 -------------------------------------------------------------------------------- 415 (670)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 005909 416 ------------------------G--------STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463 (670)
Q Consensus 416 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 463 (670)
. ..+||-||||+..+|.++++++.-. -.....++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 0 2346778999888888888765421 14678899999999999999
Q ss_pred HcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC----------------CCCceeeecCCCCCccccchhhcccc
Q 005909 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS----------------RNRSVVTMTGPRGTIGYIAPEIFMRN 527 (670)
Q Consensus 464 H~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 527 (670)
|+. +||||||||.||+||++..|||+|||+|.... ........++.+||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 998 99999999999999999999999999998621 11122245677899999999999765
Q ss_pred cC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhcc
Q 005909 528 LG-NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCI 606 (670)
Q Consensus 528 ~~-~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 606 (670)
.. .++.|+|+||+||||+||+. ||....+ ...+...+.++..+.. ..........-++++.|++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-----------Ra~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-----------RASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH-----------HHHHHHhcccCCCCCC-cccccccchHHHHHHHHHh
Confidence 22 68999999999999999984 4543211 1123334444433322 1223333445667999999
Q ss_pred ccCCCCCCCHHHHHH
Q 005909 607 QINPKDRPSMTRVVE 621 (670)
Q Consensus 607 ~~dP~~RPs~~evl~ 621 (670)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=294.35 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=194.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.++||.|++|.||+|.+. +|+.|++|++.... ...+.+.+|++.+++++|+|++++++++.+++..++++||+ +
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-D 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-C
Confidence 4578999999999999875 78999999987543 23367889999999999999999999999999999999999 4
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 155 (283)
T cd07835 82 LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-- 155 (283)
T ss_pred cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence 789988865432 3589999999999999999999987 9999999999999999999999999999765432211
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccc------cchHHH
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEA------YFPDWI 574 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~------~~~~~~ 574 (670)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||........ ...... ..++..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223468899999988653 3468899999999999999999999864321000 000000 000000
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ..........+...+.+++.+||+.||++||+++|++++
T Consensus 235 -~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 -PTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred -hhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 000011112234578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.83 Aligned_cols=244 Identities=24% Similarity=0.317 Sum_probs=198.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||.|+||.||+++.. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.++...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45688999999999999986 58999999987543 34578999999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 83 LGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred CCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 999999998654 2589999999999999999999987 999999999999999999999999999887654321
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....|+..|+|||.+... ..+.++||||||+++|+|++|+.|+...... ...+........
T Consensus 156 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~----- 217 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------IRDQIRAKQETA----- 217 (258)
T ss_pred --ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------HHHHHHHHhccc-----
Confidence 2334578899999998764 5788999999999999999999998753320 112222222211
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSM--TRVV 620 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 620 (670)
....+...+..+.+++.+||+.||++||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111112235678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=282.13 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=201.0
Q ss_pred HhhhccccccCceEEEEEEeC---C--CcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee-CCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP---D--GRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l 421 (670)
|+..++||+|.||.||||.-+ + .+.+|+|.++..+ .......+|+.+++.++||||+.|..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 455688999999999999543 2 2378999998764 345778999999999999999999999887 678899
Q ss_pred EEEecCCCCcccccccccC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC----CCeEEeecC
Q 005909 422 IYEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFG 495 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~----~~~ki~DfG 495 (670)
++||.+. +|.++|+.++. ...++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999964 78888864432 34689999999999999999999998 89999999999999777 999999999
Q ss_pred CccccCCCCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-CccccchHH
Q 005909 496 LAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-TTEAYFPDW 573 (670)
Q Consensus 496 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~ 573 (670)
++|.+...-... .....+-|+.|+|||++.+. ..++.+.|||+.|||+.||++-++.|...++..... .......+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999875432221 23344569999999999986 588999999999999999999998887654422111 111111222
Q ss_pred HHHHhcCCcccc----------------ccchh-----hHH-------HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 574 IYDKLIQPEKED----------------FVEEE-----DDC-------IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 574 ~~~~~~~~~~~~----------------~~~~~-----~~~-------~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
|.+.+..+...+ +.... ... -.+...+++..+|+.||-+|.|+++.+++.=
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 333322221110 00000 000 1123678899999999999999999998764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=293.56 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=187.0
Q ss_pred cccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhc---cccccccccccceeeeCCeeEEEEEecC
Q 005909 356 KLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIG---RIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~---~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.||+|+||.||+++.. +++.+|+|.+..... ....+.+|..+++ ..+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999885 588999998865431 1223444544333 3479999999999999899999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999886543 589999999999999999999998 999999999999999999999999999875543221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
....|+..|+|||.+.+. ..++.++||||||+++|||++|+.||...... ....+...... ..
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~~~~-----~~ 215 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLT-----VN 215 (279)
T ss_pred --cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc---------CHHHHHHHhhc-----CC
Confidence 223589999999998642 35688999999999999999999999643221 01111111110 00
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
.......+..+.+++.+||+.||++|| +++|++++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 111223456788999999999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.38 Aligned_cols=265 Identities=20% Similarity=0.347 Sum_probs=194.2
Q ss_pred hhhccccccCceEEEEEEeCC---CcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeC--CeeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 422 (670)
.+.++||+|+||.||+|+... ++.+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 456789999999999999854 7899999987632 3346788999999999999999999999988 789999
Q ss_pred EEecCCCCcccccccccC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC----CCCeEEeecCC
Q 005909 423 YEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP----DFTPKVSDFGL 496 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~----~~~~ki~DfGl 496 (670)
+||++ ++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99996 467666643322 23688999999999999999999988 9999999999999999 99999999999
Q ss_pred ccccCCCCc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC--ccccchHH
Q 005909 497 AKAHSRNRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT--TEAYFPDW 573 (670)
Q Consensus 497 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~ 573 (670)
++....... ........++..|+|||.+.+. ..++.++||||||++++||++|+.||........... ....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE-R 236 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH-H
Confidence 987643322 1122234578899999988653 3568899999999999999999999975433210000 000000 0
Q ss_pred HHHHhcC--------------------C-cccccc-chhhH------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 574 IYDKLIQ--------------------P-EKEDFV-EEEDD------CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 574 ~~~~~~~--------------------~-~~~~~~-~~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+...+.. . ...... ..... ....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0 000000 00000 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.39 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=200.9
Q ss_pred hhhccccccCceEEEEEEeCC-CcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
++...||.|+||.||||..++ +-..|-|++.... ...++++-|+++|....||+||+|++.|...+.++++.|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 345789999999999998875 4456678887544 56789999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
-...++..... .+++.++.-+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+........ ..
T Consensus 115 AVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q--kR 187 (1187)
T KOG0579|consen 115 AVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ--KR 187 (1187)
T ss_pred hHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh--hh
Confidence 99988866543 699999999999999999999998 999999999999999999999999999864432211 12
Q ss_pred cCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 510 TGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
..+.|||.|||||+.+-. ...++.++||||||+.|.||..+.+|...... -.+.-++.....+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------------MRVllKiaKSePPTL 255 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPTL 255 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------------HHHHHHHhhcCCCcc
Confidence 346799999999998532 13567899999999999999999988643222 122223322222222
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+..+...+.+++.+||..||+.||++.+++++-
T Consensus 256 --lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 --LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred --cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 22345677899999999999999999999998753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.79 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=196.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+++.++||+|+||.||+|.++ +++.|++|+++... ...+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345688999999999999986 58899999987542 34578899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++.+..++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 887776655432 2489999999999999999999998 9999999999999999999999999999876544321
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---cccchHHHHHHhc-CCc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLI-QPE 582 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~ 582 (670)
......++..|+|||++.+. ...+.++||||||+++|||++|+.||............ ...++........ ...
T Consensus 157 -~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 -PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 11234578899999999753 26788999999999999999999988643210000000 0000000000000 000
Q ss_pred -----cccc------cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 -----KEDF------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 -----~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... .......++..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000111236778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.69 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=194.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|+++ +++.+++|.++... .....+.+|+.++++++||||+++++++... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 345688999999999999986 58899999987543 2334677899999999999999999998877 78999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|++ ++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 87 YVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 996 589888865432 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---cccchHHHHHH---h
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDK---L 578 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~---~ 578 (670)
. ......++..|+|||.+.+. ...+.++|+||||+++|||++|+.||............ .....+..+.. +
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 1 11234468899999998653 34678999999999999999999998643210000000 00000000000 0
Q ss_pred cCCc--------cccccchhhHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPE--------KEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~--------~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ........... +...+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00000000111 35668889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=294.75 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=191.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHH-hccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVAT-IGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||++++. +|+.||+|+++.... ...++..|+.. ++.++||||+++++++..+...++++||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34578999999999999986 689999999876532 33456667765 556689999999999999999999999995
Q ss_pred CCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|.+++.... ....+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 78888775432 234689999999999999999999974 3899999999999999999999999999886543221
Q ss_pred eeecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.....++..|+|||.+.+.. ...+.++|+||||+++|||++|+.|+..... .+.. +... ......
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~-~~~~-~~~~~~ 226 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---------PFQQ-LKQV-VEEPSP 226 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---------CHHH-HHHH-HhcCCC
Confidence 12245788999999886421 2457899999999999999999999853211 0111 1111 111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ....++..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 112345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=290.13 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=201.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++.+.||+|++|.||+++.. +++.+++|++.... ...+.+.+|+..+.+++|+||+++++++......++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 34578999999999999987 48999999987654 3467899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++..........
T Consensus 84 ~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 84 GSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999754 358999999999999999999998 7 99999999999999999999999999998765433221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
....++..|+|||.+.+. ..+.++||||||+++|||++|+.|+..... ..+.+.. ..+.........
T Consensus 158 --~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~-~~~~~~~~~~~~ 224 (264)
T cd06623 158 --NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFELM-QAICDGPPPSLP 224 (264)
T ss_pred --cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccc--------cCHHHHH-HHHhcCCCCCCC
Confidence 123478899999998653 678899999999999999999999865432 0111111 111111111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....+..+.+++.+||+.+|++||++.+++++
T Consensus 225 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 ---AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11145678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.66 Aligned_cols=243 Identities=22% Similarity=0.352 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
++||+|++|.||++... +++.+++|++.... ...+.+.+|+.++++++|+||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 68999999999999874 68899999886543 33456889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++......... ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 175 (285)
T cd06648 105 DIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSL 175 (285)
T ss_pred HHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccc
Confidence 998662 488999999999999999999998 9999999999999999999999999988765433221 1224
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+........ ....
T Consensus 176 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------------~~~~~~~~~~~~~~~--~~~~ 239 (285)
T cd06648 176 VGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------------LQAMKRIRDNLPPKL--KNLH 239 (285)
T ss_pred cCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCH------------HHHHHHHHhcCCCCC--cccc
Confidence 578999999998653 578899999999999999999999854221 001111111111111 1111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.++..+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 245678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.99 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=193.3
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+.+|.|+++.||+++. +++.+|+|++... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34556666666666655 7899999998754 2345689999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc-----
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS----- 505 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~----- 505 (670)
|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999976432 2588999999999999999999998 999999999999999999999999998865432111
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------C-CccccchHHHH
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------N-TTEAYFPDWIY 575 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~---------~-~~~~~~~~~~~ 575 (670)
........++..|+|||++......++.++||||||+++|||++|+.||......... . ......+.. .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY-E 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh-c
Confidence 0011223467889999999764345788999999999999999999999753221000 0 000000000 0
Q ss_pred HHhcC-------Cc-cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 576 DKLIQ-------PE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 576 ~~~~~-------~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+.. .. ...............+.+++.+||+.||++|||+++++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000 00 00011112234456788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=293.57 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=192.0
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.++||+|+||.||++++. +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++......++++||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 3468999999999999875 58999999987543 34567889999999996 9999999999998889999999985
Q ss_pred CCccccccc--ccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|.++... ......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 455554321 11123689999999999999999999963 38999999999999999999999999999765433221
Q ss_pred eeecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....|+..|+|||++.+.. ..++.++||||||+++|||++|+.||..... ....+. .........
T Consensus 165 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~-~~~~~~~~~ 230 (288)
T cd06616 165 ---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLT-QVVKGDPPI 230 (288)
T ss_pred ---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHh-hhcCCCCCc
Confidence 2234788999999986531 2578899999999999999999999864211 001111 111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........++..+.+++.+||+.||++||++++|+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111123356678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=286.69 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=200.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~~ 426 (670)
..+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+..+++++|+||+++++.+.+. ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3478999999999999987 68999999987655 3467899999999999999999999999988 8899999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.........
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 84 SGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999987653 689999999999999999999997 9999999999999999999999999999876554321
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.......++..|+|||.+... ..+.++||||||+++++|++|+.||..... ....+. .+.... .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~-~~~~~~---~ 221 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGN----------PMAALY-KIGSSG---E 221 (260)
T ss_pred ccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------hHHHHH-hccccC---C
Confidence 112234578999999998754 578899999999999999999999865431 111111 111101 1
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...........+.+++.+|++.||++||++.+++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111122236678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=285.62 Aligned_cols=246 Identities=27% Similarity=0.451 Sum_probs=199.1
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++.+++++|+||+++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4578999999999999986 688999999977653 56789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++.... ..+++..+..++.|+++||.|||.. +++||||+|+||++++++.++|+|||.+........ ..
T Consensus 84 L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 84 LKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred HHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 999986643 3589999999999999999999997 999999999999999999999999999987655432 12
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...++..|+|||.+... ..+.++||||||+++++|++|+.|+..... ...+.. .......... .
T Consensus 156 ~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~~~~~~--~ 219 (253)
T cd05122 156 TMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALFK-IATNGPPGLR--N 219 (253)
T ss_pred ceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHHH-HHhcCCCCcC--c
Confidence 23478899999998754 578899999999999999999999864321 011111 1111011111 1
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+...+.+++.+||+.||++||++.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11125678899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.02 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=193.3
Q ss_pred cccccc--CceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..||+| +||+||++++. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999985 78999999987543 2346788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 507 (670)
++|.+++.+... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876432 2588999999999999999999987 99999999999999999999999998654332111100
Q ss_pred -ee---cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC----------CCccccchHH
Q 005909 508 -TM---TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----------NTTEAYFPDW 573 (670)
Q Consensus 508 -~~---~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~----------~~~~~~~~~~ 573 (670)
.. ....++..|+|||++.+....++.++||||||+++|||++|+.||......... ......++..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 00 011246679999999765445788999999999999999999998653210000 0000000000
Q ss_pred H--------------HHHhcC-----C-ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 574 I--------------YDKLIQ-----P-EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 574 ~--------------~~~~~~-----~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. .+.... . ................+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 000000 0 000111122344567889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.92 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=198.2
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+...||.|..|+||+.++. .|..+|||.+.... +..++++..+.++.+-+ .|.||+.+|+|..+...++.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 3467999999999999986 58999999998765 34466777787766654 899999999999999889999988 4
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
.-++.+|++... ++++..+-++...+.+||.||..+ .+|+|||+||+|||+|+.|++|++|||++..+-....+
T Consensus 175 ~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 TCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 456666665443 588988899999999999999986 49999999999999999999999999999877654433
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
+...|-+.|||||.+.-+ ...++.++||||||+.|+||.||+.||..... .| .+..++.....+.+.
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---------dF--e~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---------DF--EVLTKVLNEEPPLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---------cH--HHHHHHHhcCCCCCC
Confidence 234578999999999654 34677899999999999999999999975332 11 123334433222222
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.. ...+..+.++...||++|+.+||...+++++=
T Consensus 317 ~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 317 GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 22 22677899999999999999999999998764
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.81 Aligned_cols=241 Identities=26% Similarity=0.346 Sum_probs=192.8
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||.|++|.||+++.. +++.+++|++.... ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 48899999987543 3346789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++.+.. .+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 99996543 488999999999999999999997 999999999999999999999999999987654321 122
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..++..|+|||.+.+. .++.++|+||||+++|||++|+.|+..... . +..+...+........ .+
T Consensus 152 ~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~~~~~~~---~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDE---------D-PMEIYNDILKGNGKLE---FP 216 (262)
T ss_pred ccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------C-HHHHHHHHhccCCCCC---CC
Confidence 3478899999998653 678899999999999999999999865432 0 1111222221111111 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPS-----MTRVVE 621 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 621 (670)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=292.80 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=191.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeC--CeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDG--STRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~e~ 425 (670)
.+.++||+|+||.||+|+.. +++.+|+|+++... .......+|+.++.++. |+||+++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 35678999999999999875 68899999987643 22334567999999995 99999999999887 889999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++ ++|.+.+.... ..+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 96 57877775432 2589999999999999999999998 9999999999999999 9999999999987643322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC----CccccchHHHHHHhcCC
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 581 (670)
. ....++..|+|||++... +..+.++|||||||++|||++|+.||.......... ........+ .......
T Consensus 155 ~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (282)
T cd07831 155 Y---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKS 229 (282)
T ss_pred c---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccc
Confidence 1 223468899999987543 356889999999999999999999986432200000 000000111 1111111
Q ss_pred ccccc---------cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDF---------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... ........+..+.+++.+||+.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 001112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=292.03 Aligned_cols=243 Identities=26% Similarity=0.341 Sum_probs=191.2
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||+||++... +++.+++|++.... .....+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 68899999986532 2344677899999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++..... ..+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence 999865443 3589999999999999999999998 999999999999999999999999999876543221 123
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..++..|+|||.+.+. .++.++||||||+++++|++|+.||....... ....+....... .....
T Consensus 154 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~-----~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--------EKEELKRRTLEM-----AVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--------cHHHHHhccccc-----cccCC
Confidence 4578899999998754 57889999999999999999999986533210 011111111110 01111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRP-----SMTRVVE 621 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 621 (670)
......+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22356788999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=292.01 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=195.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~~ 426 (670)
+.++||+|++|.||+|+.. +++.+|+|++.... ...+.+.+|+.++++++|+|++++++++... ...++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999986 58899999998653 3446788999999999999999999999888 7899999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+ ++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 83 D-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred c-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 6 58888886542 2589999999999999999999987 9999999999999999999999999999876543321
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHH----
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWI---- 574 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~---- 574 (670)
......++..|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......++.+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 12334467889999987653 35688999999999999999999998643220000 00000000000
Q ss_pred HHHhcC-CccccccchhhHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 YDKLIQ-PEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ~~~~~~-~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... ............. ++..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 0000000011111 26678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.38 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=195.9
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||.||+++.. +++.+++|++.... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 48999999987543 2456788999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc------
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS------ 505 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~------ 505 (670)
.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997643 589999999999999999999988 999999999999999999999999999876533211
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
........++..|+|||..... ..+.++||||||+++|||++|+.||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETP------------EEIFQNILNGKIE- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCcC-
Confidence 0112234478899999998754 578899999999999999999999864321 1111222211111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.. .....+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 220 ~~--~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WP--EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CC--ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 011135678899999999999999999777777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=293.80 Aligned_cols=260 Identities=26% Similarity=0.367 Sum_probs=189.3
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.||+|+||.||+|... +++.+++|++.... .....+.+|+.++++++|+||+++++++..+...++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 4578999999999999875 68899999986543 233567899999999999999999999999999999999995 6
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+.+.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++........ .
T Consensus 88 ~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~ 160 (291)
T cd07870 88 DLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--Y 160 (291)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--C
Confidence 7766664432 2478888899999999999999998 9999999999999999999999999998764322111 1
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------CCccccc------hHHH
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTTEAYF------PDWI 574 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~------~~~~ 574 (670)
....++..|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......+ +.+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 223468899999998653 34678999999999999999999998643220000 0000000 0000
Q ss_pred HHHhcCCccccccchhh--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 YDKLIQPEKEDFVEEED--DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ............. ......+.+++.+|++.||++|||+.|++.+
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chh-ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 0000000000000 0013467789999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=293.44 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=191.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhcccc-ccccccccceeeeCCe-----eEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGST-----RAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~-----~~l 421 (670)
.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.++++++ |+||+++++++...+. .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 34578999999999999975 68999999886543 23467889999999995 6999999999887665 799
Q ss_pred EEEecCCCCcccccccccC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCcc
Q 005909 422 IYEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK 498 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~ 498 (670)
||||+++ +|.+++..... ...+++..++.++.|+++||.|||++ +|+||||||+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999975 78888764332 23689999999999999999999988 9999999999999998 8999999999987
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
........ .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||....... . +.. +...+
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~------~-~~~-~~~~~ 228 (295)
T cd07837 160 AFSIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ------Q-LLH-IFKLL 228 (295)
T ss_pred ecCCCccc--cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH------H-HHH-HHHHh
Confidence 65432211 1223467889999998653 356889999999999999999999886432100 0 000 00000
Q ss_pred cCCc-------------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPE-------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~-------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+. ...............+.+++.+||+.||++||++.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000011112345678899999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.45 Aligned_cols=199 Identities=30% Similarity=0.528 Sum_probs=174.7
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC------eeEEEEE
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRALIYE 424 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lv~e 424 (670)
.+.||+|+||.||+|+++ .|+.||||.++... ...+...+|+++|++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999975 79999999998754 45677889999999999999999999865543 5679999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC--C--CCCeEEeecCCcccc
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--P--DFTPKVSDFGLAKAH 500 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~--~--~~~~ki~DfGla~~~ 500 (670)
||.+|||..+|.+......|++.+++.+..++..||.|||.+ +|+||||||.||++- + .-.-||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999887777899999999999999999999988 999999999999993 2 235799999999998
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 559 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~ 559 (670)
..+. .++...||..|++||++.+. +.++...|.|||||++||.+||..||.+...
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 8766 35667899999999999752 5788899999999999999999999987544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.73 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=193.6
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHhccc-cccccccccceeeeC--CeeEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG--STRALI 422 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~lv 422 (670)
.+.+.+.||+|+||.||+|.+. +++.+|+|++... ......+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 3456688999999999999986 5889999988542 23345677899999999 999999999988653 367999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 88 FEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99996 6888887543 578899999999999999999987 999999999999999999999999999986643
Q ss_pred CCce---eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccc-
Q 005909 503 NRSV---VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYF- 570 (670)
Q Consensus 503 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~- 570 (670)
.... .......|+..|+|||.+.+. ...+.++||||||+++|||++|+.||......... ......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221 112234578899999988653 45678999999999999999999998643221000 0000000
Q ss_pred ------hHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 571 ------PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 571 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+...+...... .........+..+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRK-PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhccccccc-chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000100000 0011112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.10 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=199.7
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
.+||.|.||.||.+.. .+|...|+|-++-.. ...+...+|+.++..++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 4699999999999976 478999999886543 344678899999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce--ee
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV--VT 508 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~--~~ 508 (670)
|++++...+ -.++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|+.+...... ..
T Consensus 1321 La~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999996653 366666778899999999999998 9999999999999999999999999999887654211 11
Q ss_pred ecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|||||++.+.. .....+.||||+|||++||+||++||...+. .+. |.-++..+..+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~a--IMy~V~~gh~P--- 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWA--IMYHVAAGHKP--- 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhH--HHhHHhccCCC---
Confidence 23456999999999998753 2345689999999999999999999965433 111 11222222222
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+..++.+-.+++.+||+.||++|+++.|++++=
T Consensus 1461 -q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 -QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 22333677788899999999999999999888764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.66 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=193.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+...+.||+|+||.||+|+.. +++.+++|.+.... ...+++.+|++++++++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 334578999999999999975 57899999886422 2345788999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 95 68877775433 2488999999999999999999988 9999999999999999999999999998765432
Q ss_pred eeeecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
....++..|+|||.+.+. .+..+.++||||||+++|||++|+.|+..... ..... ........
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~-~~~~~~~~ 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALY-HIAQNESP 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------HHHHH-HHhhcCCC
Confidence 123478899999998531 23567899999999999999999998754221 00111 11111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
. .........+.+++.+||+.+|++||++.+++++..
T Consensus 233 ~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred C---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1 111234566888999999999999999999998755
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.33 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999885 68999999886433 34567889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......... ....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 987543 478999999999999999999998 9999999999999999999999999998765433211 1223
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+..... ... ....
T Consensus 177 ~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~~----~~~--~~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLP----PKL--KNLH 240 (292)
T ss_pred ccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhCC----ccc--CCcc
Confidence 47889999999864 3678899999999999999999999864221 000011111110 000 0112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+...+.+++.+||+.||.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.57 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=191.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|++|+||+|+.+ +++.+|+|.+.... ...+.+.+|++++++++|+||+++++++.++...++|+||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 35678999999999999986 68899999986543 234678899999999999999999999999999999999995
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++........
T Consensus 85 -~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 85 -LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred -ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 577777754332 2467888899999999999999998 9999999999999985 56799999999976543221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCcc------ccchH
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTE------AYFPD 572 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~------~~~~~ 572 (670)
......+++.|+|||++.+. ...+.++||||||+++|||++|+.||......... .... ..+++
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11234568899999998653 35688999999999999999999998643210000 0000 00000
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+... ...................+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSA--FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhh--cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000001112235568889999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.42 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=182.2
Q ss_pred HHhhhccccccCceEEEEEEeCC--CcEEEE------------------EEcccCCcchHHHHHHHHHhccccccccccc
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD--GRLVAV------------------KVLEKTSNFSDNFINEVATIGRIHHVNIIHL 409 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vav------------------K~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 409 (670)
.|.+.++||+|+||+||++.++. +...++ |.+.........+.+|+.+|.+++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 35567899999999999987532 222222 2222222344578899999999999999999
Q ss_pred cceeeeCCeeEEEEEecCCCCcccccccccC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC
Q 005909 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 487 (670)
Q Consensus 410 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~ 487 (670)
++++...+..++|+|++ .++|.+++..... ........++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 99999999999999998 4677776643221 11234566788999999999999998 999999999999999999
Q ss_pred CeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC-CC--
Q 005909 488 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-SN-- 564 (670)
Q Consensus 488 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~-~~-- 564 (670)
.+||+|||+++.+....... .....||..|+|||++.+. .++.++|||||||++|||++|+.++........ ..
T Consensus 305 ~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999998765432211 2234689999999999763 678899999999999999998864332111000 00
Q ss_pred -------CccccchH---HHHHHhcCCcccc---ccchh--hHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 565 -------TTEAYFPD---WIYDKLIQPEKED---FVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 565 -------~~~~~~~~---~~~~~~~~~~~~~---~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....+++ ..++.+....... ..... .......+.+++.+||+.||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 0111110000000 00000 00123456778899999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.52 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=192.2
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC--------
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-------- 417 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 417 (670)
.+.+.+.||+|+||.||+|.++ +++.||+|+++... .....+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 3445688999999999999986 58899999987543 23456788999999999999999999887654
Q ss_pred --eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 418 --TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 418 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
..++|+||+++ +|.+.+.... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999975 6766665432 2589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
++......... ......++..|+|||.+.+. ...+.++||||||+++|||++|+.||...... ..+ ..+.
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-------~~~-~~~~ 231 (302)
T cd07864 162 LARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQEL-------AQL-ELIS 231 (302)
T ss_pred ccccccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-------HHH-HHHH
Confidence 99876543221 11223457789999988643 34678999999999999999999998643210 000 0000
Q ss_pred HHhcCCc---------------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQPE---------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~~---------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ............+..+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000 0000001111235678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.73 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=199.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||.||+++.. +++.+++|.+.... .....+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 35678999999999999865 67899999987543 334578899999999999999999999999999999999999
Q ss_pred CCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++|.+++.+... +..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 158 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA- 158 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc-
Confidence 9999999865322 23689999999999999999999988 999999999999999999999999999987654421
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....++..|+|||.+.+. .++.++|+||||+++|||++|+.||..... ..............
T Consensus 159 ---~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~- 220 (256)
T cd08530 159 ---KTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSM------------QDLRYKVQRGKYPP- 220 (256)
T ss_pred ---ccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCCCC-
Confidence 224478899999998753 678899999999999999999999864321 01111222211111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122456678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.36 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=191.8
Q ss_pred hhhccccccCceEEEEEEeCC-CcEEEEEEcccCC--cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||+|++++ ++.+|||.++... ....++..|+.++.+.. |+||+++++++.+....++++||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456899999999999999874 8999999997643 23456777887777774 9999999999999999999999984
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++..... .+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 98 -~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 98 -TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred -cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 567776654322 689999999999999999999963 28999999999999999999999999998765433221
Q ss_pred eecCCCCCccccchhhccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....++..|+|||.+.+.. +..+.++||||||+++|||++|+.||..... .+ + ............
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~-~-~~~~~~~~~~~~ 238 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---------EF-E-VLTKILQEEPPS 238 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---------HH-H-HHHHHhcCCCCC
Confidence 2234788999999986542 3468899999999999999999999854211 00 1 111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
... ......++.+++.+||+.||++||++.+++++-
T Consensus 239 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 100 112355788999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.20 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=192.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC-----eeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv 422 (670)
+.+.++||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++|+||+++++++.... ..++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 345688999999999999875 68999999986432 34467889999999999999999999876443 47899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+. ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 87 QELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 99995 5777776442 589999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC----ccccchHHHHHH
Q 005909 503 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWIYDK 577 (670)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~ 577 (670)
..... ......|+..|+|||.+.+. ..++.++||||||+++|||++|+.||........... ......+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED-LNC 236 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH-HHH
Confidence 22111 11234578999999987543 3578899999999999999999999854321000000 00000000 000
Q ss_pred hcCCc----------ccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhh
Q 005909 578 LIQPE----------KED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSS 625 (670)
Q Consensus 578 ~~~~~----------~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~ 625 (670)
+.... ... ............+.+++.+||+.||++||++.|++++ ++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00000 000 0000011235678899999999999999999999987 553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.20 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=192.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~ 425 (670)
++.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.++++++|+||+++++++.+. +..++|+||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34578999999999999985 68999999986543 2234567899999999999999999998755 468999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 90 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 90 CE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred CC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 95 57888876533 3589999999999999999999998 999999999999999999999999999987654321
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccchHHHH--
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIY-- 575 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~-- 575 (670)
. .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......++....
T Consensus 164 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 164 P--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1 1223457889999998653 35688999999999999999999998643220000 000000000000
Q ss_pred --HHhcCCcc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 576 --DKLIQPEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 576 --~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
........ ..............+.+++.+||+.||++|||++|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00000000 0000001112356778899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=318.05 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=203.0
Q ss_pred hhhccccccCceEEEEEEeC----C----CcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP----D----GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.||+|.||+|++|... . ...||||.++... ...+.+..|+++|+.+ +|+||+.++|+|.+.+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45569999999999999753 1 4579999998655 3467899999999999 6999999999999989999
Q ss_pred EEEEecCCCCccccccccc---------C--C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC
Q 005909 421 LIYEYMPNGSLGDLLSREK---------E--N--LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 487 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~ 487 (670)
+|+||+..|+|.++|+..+ . . ..+....++.++.|||.||+||++. ++|||||..+|||++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999998765 0 0 1388899999999999999999998 999999999999999999
Q ss_pred CeEEeecCCccccCCCCceeee-cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005909 488 TPKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 565 (670)
Q Consensus 488 ~~ki~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~ 565 (670)
.+||+|||+++........... ....-+..|||||.+.. ..++.|||||||||+||||++ |..|+...
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-------- 525 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGI-------- 525 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCC--------
Confidence 9999999999976655444321 11113567999999986 488999999999999999998 55565321
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.....+.+.+.++.. .+.+.....++.++++.||+.+|++||++.++.+.++..
T Consensus 526 ---~~~~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 ---PPTEELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---CcHHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111122333333322 222223356788999999999999999999999999863
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.41 Aligned_cols=263 Identities=20% Similarity=0.336 Sum_probs=189.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC--------e
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------T 418 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~ 418 (670)
+.+.++||+|+||.||+|+.. +++.||+|.+.... .....+.+|+.++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 345688999999999999886 68999999886432 22345678999999999999999999887654 3
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.++|+||+. ++|.+.+.... ..+++..++.++.|+++||+|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 489999995 57877775432 2589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHH
Q 005909 499 AHSRNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDW 573 (670)
Q Consensus 499 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~ 573 (670)
........ .......++..|+|||.+.+. ...+.++||||||+++|||++|+.|+........... ....++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 66432211 112234578899999988653 3467899999999999999999998864321000000 00000000
Q ss_pred HH---------HHhcCCccccccchhhH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 574 IY---------DKLIQPEKEDFVEEEDD-----CIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 574 ~~---------~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
++ ..+..... ....... .....+.+++.+||+.||++||++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQG--QKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCc--cchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000000 0000000 012456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=288.38 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=198.1
Q ss_pred hhhccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.||+|++|.||+++. .+++.+|||+++... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3467899999999999875 357889999987532 2345788999999999 69999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999886532 588999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
...... .....|+..|+|||.+.+.....+.++||||||+++|||++|+.|+..... ......+.......
T Consensus 157 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~ 227 (288)
T cd05583 157 AEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--------QNSQSEISRRILKS 227 (288)
T ss_pred cccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--------cchHHHHHHHHHcc
Confidence 332211 122457899999999875433468899999999999999999999853211 00111111222111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.. . ........+.+++.+||+.||++|||++++.+.|+..
T Consensus 228 ~~-~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 KP-P----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CC-C----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11 1 1112345678899999999999999999988888743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=284.96 Aligned_cols=243 Identities=24% Similarity=0.334 Sum_probs=188.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHH-hccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVAT-IGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||+|... +++.||+|++..... ....+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 689999999875431 12334455544 4455899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999986543 588999999999999999999998 9999999999999999999999999998764331
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....++..|+|||.+.+. ..+.++||||||+++|||++|..||..... ..+...+..... ....
T Consensus 151 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~~~~ 214 (260)
T cd05611 151 -KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETP------------DAVFDNILSRRI-NWPE 214 (260)
T ss_pred -ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhccc-CCCC
Confidence 223478899999998764 478899999999999999999999864221 111111111110 0111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.....++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111234567889999999999999998876666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=289.34 Aligned_cols=257 Identities=18% Similarity=0.231 Sum_probs=180.2
Q ss_pred HHhhhccccccCceEEEEEEeCC----CcEEEEEEcccCCcch------------HHHHHHHHHhcccccccccccccee
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNFS------------DNFINEVATIGRIHHVNIIHLLGFC 413 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~H~nIv~l~g~~ 413 (670)
.+.+.++||+|+||+||+|...+ +..+++|+........ .....+...+..+.|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 34567899999999999998754 3566677643322111 1223344566777899999999976
Q ss_pred eeCC----eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCe
Q 005909 414 CDGS----TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 489 (670)
Q Consensus 414 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ 489 (670)
.... ..++++|++ ..++.+.+.... ..++..+..++.|+++||+|||++ +|+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 93 SFKRCRMYYRFILLEKL-VENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eEecCCceEEEEEEehh-ccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 6543 346777776 345655554332 357788899999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCce-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 490 KVSDFGLAKAHSRNRSV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 490 ki~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 99999999866432211 111234589999999998754 67899999999999999999999997542200 0
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.......++ ...+..+... ....+..+.+++..|++.+|++||++.++++.|.
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDF-IKRLHEGKIK------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHH-HHHhhhhhhc------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000011 1122211110 1112466888999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.56 Aligned_cols=258 Identities=24% Similarity=0.293 Sum_probs=190.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
+...+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 334578999999999999875 68999999986432 3345778899999999999999999987643 3468
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 98 LVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 9999995 578777743 278889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC----CccccchHH---
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDW--- 573 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~--- 573 (670)
..... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+...... .......++
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 169 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 44322 2234578899999999763 67889999999999999999999986432100000 000000000
Q ss_pred ----HHHHhcC-Ccc--------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 574 ----IYDKLIQ-PEK--------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 574 ----~~~~~~~-~~~--------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ... ...........+..+.+++.+||+.||++||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000 000001122345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=289.70 Aligned_cols=242 Identities=28% Similarity=0.420 Sum_probs=189.8
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.++||+|+||+||+|+.. +++.+++|++.... ...+.+.+|++++++++|+|++++++++.+....++|+||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 467999999999999875 68899999986432 233568899999999999999999999999999999999995
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 105 ~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 105 GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 67777775433 2589999999999999999999988 9999999999999999999999999998643221
Q ss_pred ecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
....|+..|+|||++.. ..+.++.++||||||+++|||++|+.|+..... ...+...... ....
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~-~~~~-- 239 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQN-DSPT-- 239 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhc-CCCC--
Confidence 22457889999999853 124578899999999999999999999854321 0111111111 1111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........+.+++.+||+.+|++||++.+++.+
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234567889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.78 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=193.6
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|++|+||+|+.. +++.|++|.+..... ......+|+..+.+++ |+||+++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4678999999999999986 578999999876433 2234567999999998 999999999999999999999999 8
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.... ...+++..+..++.|++++|.|||++ +++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 82 GNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 89988886543 23589999999999999999999998 9999999999999999999999999999866433221
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccccchHHHH-HHhc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDWIY-DKLI 579 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~-~~~~ 579 (670)
....++..|+|||++.+. ..++.++||||||++++||++|+.||........ .......+..... ....
T Consensus 156 -~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223468899999988654 3578899999999999999999988854322000 0000000000000 0000
Q ss_pred CCccccc----cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEKEDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ...........+.+++.+||+.||++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 000001114578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.12 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=206.7
Q ss_pred hhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeC-CeeEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIY 423 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~ 423 (670)
....+-+|.||.||+|.+. +.+.|.+|.++.... ....++.|...+..+.|||++.+.+++.+. ...+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456899999999999653 456788888876554 346789999999999999999999988754 5778999
Q ss_pred EecCCCCcccccc-----cccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 424 EYMPNGSLGDLLS-----REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 424 e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.++.-|+|..+|. +......+...++..++.|++.|++|||++ +|||.||..+|.+||+..++||+|=.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999997 333345688889999999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
.+...+.+........+..||+||.+..+ .++.++|||||||+||||+| |+.|+...++ ..+...
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDP------------fEm~~y 510 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDP------------FEMEHY 510 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCH------------HHHHHH
Confidence 88777766555555678899999999875 88999999999999999998 7777643222 222233
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+.++. +...+...+.++..++.-||+.+|++||++++++.-|.+...
T Consensus 511 lkdGy----RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 511 LKDGY----RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred Hhccc----eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 33322 222333456788999999999999999999999999986644
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=285.47 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=197.2
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..+.||+|++|.||++..+ +++.+++|.+..... ....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD- 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-
Confidence 4578999999999999885 688999999875442 35678899999999999999999999999999999999996
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ..+++..++.++.|+++||.|||+. +|+|+||||+||++++++.+||+|||.+........ .
T Consensus 82 ~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 82 TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 48888776543 2589999999999999999999998 999999999999999999999999999987654431 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC-----------CCCccccchHHHHHH
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-----------SNTTEAYFPDWIYDK 577 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~ 577 (670)
.....++..|+|||.+.+. ...+.++||||||+++|+|++|+.||........ .......+..+....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234478889999998653 3678899999999999999999998854321000 000000000000000
Q ss_pred hcC-Ccc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQ-PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~-~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ... .............++.+++.+||+.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 000 001112233456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=282.27 Aligned_cols=244 Identities=23% Similarity=0.406 Sum_probs=197.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|++|.||+++.. +++.+++|.+.... ...+.+.+|++++++++|+|++++++++.+++..++++||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 35688999999999999876 67899999997665 345689999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 83 NGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999998655 2589999999999999999999988 9999999999999999999999999999876543321
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....++..|+|||.+.+. ..+.++||||+|+++|+|++|+.|+..... ... ... ........
T Consensus 156 -~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----------~~~-~~~-~~~~~~~~-- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNP----------MAA-LFR-IVQDDHPP-- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccH----------HHH-HHH-HhccCCCC--
Confidence 1234578899999998654 478899999999999999999999864221 111 111 11111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
........+.+++.+||+.+|++||++.+++.
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11223557888999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=283.31 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=192.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhccccccccccccceeeeC--CeeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 422 (670)
.+.+.||+|+||.||+|... +++.+++|.+.... .....+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 35678999999999999875 58999999875321 2345788999999999999999999998764 457899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+++++|.+++.... .+++..+.+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999886532 478899999999999999999988 999999999999999999999999999986532
Q ss_pred CCc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
... ........++..|+|||.+.+. ..+.++||||||+++|||++|+.||..... ...+.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~ 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEA-----------MAAIFKIATQP 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCH-----------HHHHHHHHcCC
Confidence 111 1111234578999999999753 678899999999999999999999864211 11111211111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ...+......+.+++.+||+ +|..||++.+++.+
T Consensus 226 ~~----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TK----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CC----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11 11223345678889999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=285.90 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=194.6
Q ss_pred hhhccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.||+|+||.||+++. .+|+.+|+|++.... ...+.+.+|+.++.++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 3457899999999999986 368899999987532 2346788899999999 59999999999999889999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+|||+++++.+||+|||+++...
T Consensus 83 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 83 ILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999986543 588999999999999999999987 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
..... ......|+..|+|||.+.......+.++||||||+++|||++|+.|+..... ...... +...+...
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~-~~~~~~~~ 227 (290)
T cd05613 157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-------KNSQAE-ISRRILKS 227 (290)
T ss_pred ccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-------cccHHH-HHHHhhcc
Confidence 33211 1123457889999999875434567899999999999999999999853211 011111 11111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
.. . ........+.+++.+||+.||++|| ++.+++++
T Consensus 228 ~~-~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 EP-P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC-C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 0 1122455778899999999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=294.72 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=192.2
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCCcc---------------hHHHHHHHHHhccccccccccccceeeeCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF---------------SDNFINEVATIGRIHHVNIIHLLGFCCDGS 417 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 417 (670)
.+.||+|+||+||+|... +++.||+|+++..... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999875 6899999998654321 125789999999999999999999999999
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++||||+. ++|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 9999999996 68988886432 588999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCC------------ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005909 498 KAHSRNR------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 565 (670)
Q Consensus 498 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~ 565 (670)
+...... .........++..|+|||.+.+. ...+.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~----- 240 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI----- 240 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 7654111 01111223467889999998653 34688999999999999999999998643220
Q ss_pred ccccchHHHHHHhcCCcc-------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 566 TEAYFPDWIYDKLIQPEK-------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.....+...+..+.. ..............+.+++.+||+.+|++||++.|++.+-
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 000011111100000 0000011112345688999999999999999999999754
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.47 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=193.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeC-----CeeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lv 422 (670)
.+.+.||+|+||+||+++.. +++.||||.+... ......+.+|+.++++++|+||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 34578999999999999875 6899999998653 23345678899999999999999999987654 247999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 88 YELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99995 78888876432 589999999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC---------CCCCcc--ccch
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTE--AYFP 571 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~---------~~~~~~--~~~~ 571 (670)
... ......++..|+|||.+... ...+.++||||||+++|||++|+.||....... +....+ ....
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 161 KGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred Ccc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 321 12233578899999998643 357889999999999999999999986432100 000000 0000
Q ss_pred H-HHHHHhcC-Ccccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhh
Q 005909 572 D-WIYDKLIQ-PEKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSS 625 (670)
Q Consensus 572 ~-~~~~~~~~-~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~ 625 (670)
. .....+.. ..... .........+..+.+++.+||+.+|++||+++|++++ ++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 00000000 00000 0011112346678899999999999999999999987 553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.66 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=200.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.++||.|.|+.|..|++. ++..||||.+.++.. ..+.+.+|+++|..++|||||+++++......+|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345688999999999999986 689999999987652 3355889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
.+|.++++|.++.. ..+..+..++.|+.++++|+|++ .|+|||||.+||||+.+.++||+|||++..+......
T Consensus 138 ~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 138 SGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred cCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccccc
Confidence 99999999987753 56688889999999999999998 9999999999999999999999999999887754332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....|++.|.|||++.+. ....+.+|+||+|++||.|+.|..||++..... ...+...++..-.
T Consensus 212 ---qt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------Lr~rvl~gk~rIp 275 (596)
T KOG0586|consen 212 ---QTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------LRPRVLRGKYRIP 275 (596)
T ss_pred ---cccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccc------------ccchheeeeeccc
Confidence 335589999999999886 466889999999999999999999998643311 1112222221110
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. -+..+..++++++|-.+|.+|++++++.++-
T Consensus 276 ~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 276 F-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred c-----eeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 0 0122345678889999999999999998753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=283.99 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=186.5
Q ss_pred cccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHH---HhccccccccccccceeeeCCeeEEEEEecC
Q 005909 356 KLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVA---TIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.||+|+||.||+++.. +++.||+|.+..... ....+..|.. .++...||||+++++.+...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999875 588999999875431 1122444443 3444579999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999998886432 589999999999999999999987 999999999999999999999999999876543221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
....|+..|+|||.+.+. ..++.++||||+|+++|||++|+.||....... . ......... ....
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~----~~~~~~~~~-~~~~-- 217 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K----HEIDRMTLT-MAVE-- 217 (278)
T ss_pred --cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----h----HHHHHHhhc-cCCC--
Confidence 223589999999998643 257889999999999999999999996532210 0 011111111 0011
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
.....+..+.+++.+||+.+|++|| ++.+++++-
T Consensus 218 --~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 218 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred --CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 1112356788899999999999999 999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=281.49 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=199.4
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||.|+||.||++.+. +++.+++|++.... ...+.+.+|++++++++|+|++++++.+..+...++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4578999999999999986 58899999987643 3456788999999999999999999999999999999999999
Q ss_pred CCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 429 GSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
++|.+++.+.. ....+++..+..++.+++.||+|||++ +++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL- 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcce-
Confidence 99999997643 123689999999999999999999998 9999999999999999999999999999876544311
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....|++.|+|||.+.+. ..+.++||||+|+++++|++|+.|+..... . .+.............
T Consensus 160 -~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~-~~~~~~~~~~~~~~~ 224 (258)
T cd08215 160 -AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL-----------L-ELALKILKGQYPPIP 224 (258)
T ss_pred -ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH-----------H-HHHHHHhcCCCCCCC
Confidence 1223578899999998653 578899999999999999999999854321 1 112222221111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......+.+++.+||+.+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 ----SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1234578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=292.73 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=187.3
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRALI 422 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lv 422 (670)
..+.||+|+||.||+|+.. +++.+|+|++.... .....+.+|+.++++++|+||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 3478999999999999875 68999999986532 23456889999999999999999999886542 45899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+. .+|..++. ..+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 99 ~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 99 MPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 99985 46665542 1488999999999999999999998 999999999999999999999999999876533
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC----ccccchHHHHHHh
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWIYDKL 578 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 578 (670)
.. ....++..|+|||.+.+. ...+.++||||||+++|||++|+.||........... .....+.+ .+..
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 242 (342)
T cd07879 170 EM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-VQKL 242 (342)
T ss_pred CC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-HHHh
Confidence 21 233468899999998653 3578899999999999999999999965321000000 00000000 0000
Q ss_pred cCCc-------cccccc----hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhhc
Q 005909 579 IQPE-------KEDFVE----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSA 626 (670)
Q Consensus 579 ~~~~-------~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 626 (670)
.... .+.... .........+.+++.+||+.||++||++.+++++ ++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 000000 0001234567899999999999999999999965 5543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.73 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=190.7
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccc---cccccccccceeeeCCe-----eE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRI---HHVNIIHLLGFCCDGST-----RA 420 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----~~ 420 (670)
+.+.||+|+||.||+|+++ +++.+|+|+++.... ....+.+|+.++.++ +|+||+++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999987 489999999974332 234566787776665 69999999999987776 89
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++||++ ++|.+++..... ..+++..++.++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 83 l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999996 588888865432 2589999999999999999999998 9999999999999999999999999999776
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
...... ....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+.. +.+....
T Consensus 158 ~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-------~~~~~-~~~~~~~ 224 (287)
T cd07838 158 SFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEA-------DQLDK-IFDVIGL 224 (287)
T ss_pred cCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChH-------HHHHH-HHHHcCC
Confidence 543221 223468899999999764 6788999999999999999999888643210 00000 0000000
Q ss_pred ------------------CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 ------------------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.................+.+++.+||+.||++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000001111123445678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=293.55 Aligned_cols=264 Identities=19% Similarity=0.313 Sum_probs=194.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee----CCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ 423 (670)
.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 34578999999999999875 68999999987543 334677889999999999999999998753 34678999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 88 e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 88 DLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9995 68888886443 489999999999999999999988 9999999999999999999999999999765432
Q ss_pred Cce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC---------CCCc---ccc
Q 005909 504 RSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---------SNTT---EAY 569 (670)
Q Consensus 504 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~---------~~~~---~~~ 569 (670)
... .......++..|+|||.+.+. ...+.++||||||+++|||++|+.||........ .... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 211 111234678899999998653 3578899999999999999999999965322100 0000 000
Q ss_pred chHHHHHHhcC-Cccccc-cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 570 FPDWIYDKLIQ-PEKEDF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 570 ~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+.+...... +..... ........+..+.+++.+||+.+|++||++.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000 000000 0111123467789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=282.69 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=190.9
Q ss_pred HhhhccccccCceEEEEEEeCC-CcEEEEEEcccC------CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
|.+.++||+|+||.||++++.. +..+++|+++.. .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 3456889999999999998753 444555555431 123346778999999999999999999999999999999
Q ss_pred EecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 424 EYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
||+++++|.+++.... ....+++..++.++.|+++||.|||+. +++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886422 223689999999999999999999987 9999999999999975 5699999999876543
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+..... .. .........
T Consensus 158 ~~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----------~~-~~~~~~~~~ 221 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----------LS-VVLRIVEGP 221 (260)
T ss_pred Cccc--ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HH-HHHHHHcCC
Confidence 3221 123457889999999864 3567899999999999999999998853211 11 111221111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .....+...+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 1223456678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=285.42 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=196.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+++.. +++.+++|++.... ...+.+.+|+.++.+++ |+||+++++++..++..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 35578999999999999886 68999999987632 33467889999999998 99999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.+.. .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 84 APNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999997643 599999999999999999999988 999999999999999999999999999886543221
Q ss_pred e------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc
Q 005909 506 V------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 567 (670)
Q Consensus 506 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~ 567 (670)
. .......++..|+|||.+... ..+.++||||||++++|+++|+.|+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 227 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------- 227 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence 1 111223578899999998753 678899999999999999999999864321
Q ss_pred ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 005909 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM----TRVVEM 622 (670)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~~ 622 (670)
............ ......+..+.+++.+||+.+|++||++ ++++++
T Consensus 228 ----~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 ----YLTFQKILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HHHHHHHHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 011111111110 1112235678899999999999999999 776643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.58 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=188.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC--------ee
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------TR 419 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~~ 419 (670)
.+.++||+|+||.||+|... +++.+++|++.... .....+.+|++++++++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 45678999999999999976 68899999886433 22346789999999999999999999875433 46
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++|+||+. ++|...+.... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 91 ~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 91 YMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 89999995 46766665432 2589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcee---------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------
Q 005909 500 HSRNRSVV---------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-------- 562 (670)
Q Consensus 500 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~-------- 562 (670)
........ ..+...+++.|+|||.+.+. ...+.++||||||+++|||++|+.||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 11223467889999998653 3568899999999999999999999864322100
Q ss_pred CCCccccchHHHHHHhcCC-------ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 563 SNTTEAYFPDWIYDKLIQP-------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++.| ..+... ................+.+++.+||+.||++|||+.|++.+
T Consensus 244 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGW--RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhh--hhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000000 000000 00000001111223568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=266.78 Aligned_cols=269 Identities=24% Similarity=0.364 Sum_probs=209.8
Q ss_pred HHHHHHHHhhhccccccCceEEEEEE-eCCCcEEEEEEcccCCc-chHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 344 NDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSN-FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 344 ~~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
+|+-+.| .+.||+|+++.|--.+ +.+|..+|||++.+... ......+|++++.+- .|+||+.|++||+++...|
T Consensus 76 ~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 76 EDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 3444444 3679999999998875 56899999999988764 457889999999998 5999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~DfGla 497 (670)
||||.|.+|+|..+|++++ .+++.++.++.++|+.||.+||.+ +|.||||||+|||-.+-. -+||+||.|.
T Consensus 153 LVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999997654 599999999999999999999998 999999999999996543 4899999987
Q ss_pred cccCCC-----CceeeecCCCCCccccchhhcc---cccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC-CCCCcc-
Q 005909 498 KAHSRN-----RSVVTMTGPRGTIGYIAPEIFM---RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-GSNTTE- 567 (670)
Q Consensus 498 ~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~---~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~-~~~~~~- 567 (670)
..+... .+......+.|+..|||||+.. +....++.+.|.||||||||-||+|..||.+.-... +....+
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 643211 1122345678999999999873 222456789999999999999999999998643311 111111
Q ss_pred -ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 568 -AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 568 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..-....++.+.++. -++.++++..++.+..+++...+..|+.+|-++.+++.+
T Consensus 307 Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111222333333332 346667777788888889999999999999999888873
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=279.49 Aligned_cols=234 Identities=24% Similarity=0.280 Sum_probs=181.4
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCCCcccc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 434 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 434 (670)
||+|+||.||++..+ +++.+|+|++........ |+.....+ +|+||+++++.+...+..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 599999999999875 678899999865432111 22222222 799999999999999999999999999999999
Q ss_pred cccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCCceeeecCCC
Q 005909 435 LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPR 513 (670)
Q Consensus 435 l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~~~~~~~~~ 513 (670)
+.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ...
T Consensus 100 l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~ 167 (267)
T PHA03390 100 LKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYD 167 (267)
T ss_pred HHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCC
Confidence 96543 689999999999999999999988 999999999999999988 99999999987654322 234
Q ss_pred CCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHH
Q 005909 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDC 593 (670)
Q Consensus 514 gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (670)
++..|+|||++.+. .++.++||||||+++|||++|+.||...... ......+... . .. .. .....
T Consensus 168 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~-~~-~~----~~~~~ 232 (267)
T PHA03390 168 GTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------ELDLESLLKR-Q-QK-KL----PFIKN 232 (267)
T ss_pred CCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc------hhhHHHHHHh-h-cc-cC----Ccccc
Confidence 78999999999753 6788999999999999999999998633211 1111112111 1 11 00 11123
Q ss_pred HHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 005909 594 IARKMIIVGLWCIQINPKDRPS-MTRVVE 621 (670)
Q Consensus 594 ~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 621 (670)
.+..+.+++.+||+.+|++||+ ++|+++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 5667889999999999999995 688875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.75 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=196.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC-----eeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lv 422 (670)
.+.+.||.|++|.||+++.. +++.+++|++.... ...+.+.+|+.++++++|+||+++++++.... ..+++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 45688999999999999986 48999999987643 34567899999999999999999999988765 78999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||++ ++|.+++.+.. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 83 TELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred ecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99996 58888886543 689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC---------CCC-------
Q 005909 503 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---------SNT------- 565 (670)
Q Consensus 503 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~---------~~~------- 565 (670)
.... .......++..|+|||.+.+. ...+.++||||||+++|+|++|+.||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 3210 112334578899999999764 2678899999999999999999999865432000 000
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++.. ... .............+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKS-LPK-KPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhh-ccc-CCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 000 00000001112245678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.91 Aligned_cols=261 Identities=28% Similarity=0.377 Sum_probs=196.0
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|++|.||+|+.. +++.+++|++.... ...+.+..|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999986 48999999988643 345678899999999999999999999999999999999997
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.+.. ..+++..++.++.|++.||+|||++ +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 82 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 82 MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 68999997653 2589999999999999999999998 999999999999999999999999999987644322 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---cccchHHHHHHhcC-----
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLIQ----- 580 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~----- 580 (670)
.....++..|+|||.+.+. ...+.++||||||+++|||++|+.||............ ........+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2223457789999998653 36788999999999999999999888543210000000 00000000100000
Q ss_pred Cccccc----cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+.. ...........+.+++.+||+.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 001111225678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=265.23 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=195.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.|.+.||+|.||.|...+-+ .++.+|+|++++.- +....-+.|-++|+..+||.+..|--.+...+.+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 35688999999999999876 78999999998754 33345667889999999999999988889999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
.+|.|.-+|.+.+ .+++...+.+..+|..||.|||++ +||.||||.+|.|+|.+|++||+||||.+.--...
T Consensus 251 nGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-- 322 (516)
T KOG0690|consen 251 NGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-- 322 (516)
T ss_pred cCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc--
Confidence 9999999997754 588899999999999999999998 99999999999999999999999999987532221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH-HHHhcCCcccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI-YDKLIQPEKED 585 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 585 (670)
..+....|||.|+|||++..+ .+..+.|-|.+|||+|||++|+.||...+. ..+-+.| .+.+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~ed~k------ 386 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILMEDLK------ 386 (516)
T ss_pred ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhhhcc------
Confidence 123456699999999999875 788899999999999999999999975322 1111111 11111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
.+..++++...++...|.+||.+|. .++||.++=
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 1223345566777888999999994 466665543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=281.60 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=201.0
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
-+.||+|+||.||-.... +|+.+|.|.+.+.. ....-.++|-.+|++++.+.||.+--.++..+.+++|+..|++
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999998765 68999999886543 2334578999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.-+|.+.+. ..+++.+++.++.+|+-||++||.. +||.|||||+|||||+.|+++|+|+|||..+......
T Consensus 270 GDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-- 343 (591)
T KOG0986|consen 270 GDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-- 343 (591)
T ss_pred CceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--
Confidence 999999987654 4699999999999999999999998 9999999999999999999999999999998877653
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
++.+||.+|||||++.+. .++...|-||+||++|||+.|+.||..... ..-.+.+..++... ..
T Consensus 344 -~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~~-----~~ 407 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLED-----PE 407 (591)
T ss_pred -ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhcc-----hh
Confidence 455799999999999875 588899999999999999999999975332 11111222222221 11
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
+..+..+++...+....|+.||++|-. +.+|.++
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 223445667778888899999999964 4455554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.01 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=202.3
Q ss_pred cCCCCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccc-ccccccccccee
Q 005909 338 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFC 413 (670)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 413 (670)
...|+-.+++.. +.||.|+||+|+|-.++ .|+..|||.++... ...++++.|.+...+- +.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 445666666544 57999999999999875 69999999997654 4567889999877666 689999999999
Q ss_pred eeCCeeEEEEEecCCCCcccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEE
Q 005909 414 CDGSTRALIYEYMPNGSLGDLLSRE--KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 491 (670)
Q Consensus 414 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki 491 (670)
...+..|+-||.| ..||..+-+.. ..+..+++.-+-+|..-...||.||... ..|||||+||+|||||..|.+||
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence 8888999999999 56776554321 1233688998889999999999999975 69999999999999999999999
Q ss_pred eecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccch
Q 005909 492 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 492 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 571 (670)
+|||++..+..... .+...|-..|||||.+......++.+|||||||+.|+|+.||+.|+..-. ..|.
T Consensus 210 CDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---------svfe 277 (361)
T KOG1006|consen 210 CDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---------SVFE 277 (361)
T ss_pred ecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---------HHHH
Confidence 99999876654322 23345778899999998765558889999999999999999999985311 1122
Q ss_pred HHHHHHhcCCcccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 572 DWIYDKLIQPEKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 572 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+. ...+ .+..+. .........+..|..++..|+.+|.++||...++.+.
T Consensus 278 ql-~~Vv-~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 278 QL-CQVV-IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HH-HHHH-cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 21 1111 111121 2223334567789999999999999999999998764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=273.53 Aligned_cols=235 Identities=31% Similarity=0.404 Sum_probs=190.3
Q ss_pred ccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 357 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
||+|+||.||++... +++.+++|++..... ..+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999986 588999999876432 345789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 99996553 589999999999999999999997 999999999999999999999999999877644321 1233
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..++..|+|||.+.+. ..+.++|+||||+++|||++|+.||..... ......+..... . .+
T Consensus 153 ~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~----~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------------KEIYEKILKDPL-R----FP 213 (250)
T ss_pred CcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHhcCCC-C----CC
Confidence 4578899999998754 578899999999999999999999854221 111222222111 1 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTR 618 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~e 618 (670)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=288.07 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=188.4
Q ss_pred hhhccccccCceEEEEEEeC-C--CcEEEEEEcccCC---cchHHHHHHHHHhccc-cccccccccceeeeC----CeeE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-D--GRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG----STRA 420 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~~~ 420 (670)
.+.+.||+|+||.||+++.. . ++.+|+|++.... ...+.+.+|+.+++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 35678999999999999975 3 7799999987532 2346788999999999 599999999875432 3567
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++||+. ++|.+.+.... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 8888884 68888885432 589999999999999999999988 9999999999999999999999999999865
Q ss_pred CCCCce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---cccchHHHH
Q 005909 501 SRNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIY 575 (670)
Q Consensus 501 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~ 575 (670)
...... .......|+..|+|||++.+. ...+.++||||||+++|+|++|+.||............ ....+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432211 112234688999999988643 35788999999999999999999998653210000000 000000000
Q ss_pred HHhcCC----------ccc-cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQP----------EKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~----------~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+... ... .............+.+++.+||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 000 00000011124578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.71 Aligned_cols=263 Identities=20% Similarity=0.264 Sum_probs=188.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeC------------
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------------ 416 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------------ 416 (670)
+.+.+.||.|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 345688999999999999875 68899999986544 3456788999999999999999999876543
Q ss_pred --CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEee
Q 005909 417 --STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSD 493 (670)
Q Consensus 417 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~D 493 (670)
...++|+||++ ++|.+++... .+++..++.++.|+++||.|||+. +|+||||||+||+++ +++.+||+|
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999996 5888777532 488999999999999999999988 999999999999997 456789999
Q ss_pred cCCccccCCCCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------C
Q 005909 494 FGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------N 564 (670)
Q Consensus 494 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~ 564 (670)
||+++......... ......++..|+|||.+... ..++.++|||||||++|||++|+.||......... .
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997654321111 11223468899999987543 35778999999999999999999999643220000 0
Q ss_pred Cc---cccchHHHHHHhcC-Cccc-cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 565 TT---EAYFPDWIYDKLIQ-PEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 565 ~~---~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ...+.......... .... ............++.+++.+||+.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00000000000000 0000 00001111234578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=287.98 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=190.7
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCe------eEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------RALI 422 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~lv 422 (670)
+.+.||+|++|.||+|+.. +++.+|+|++.... ...+.+.+|+.++++++|+||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4578999999999999986 57899999986532 234567889999999999999999998766554 8899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 99 ~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 99 THLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9998 67998888642 589999999999999999999987 999999999999999999999999999986643
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHHhc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 579 (670)
. .....++..|+|||.+.+. ...+.++||||||+++|||++|+.||........... .....++....+..
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 3 1233578899999998643 3568899999999999999999999864321000000 00000000001100
Q ss_pred CC-----------ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QP-----------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .............+..+.+++.+||+.||++|||+.+|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 00000001111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=287.56 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=189.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 421 (670)
.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 34578999999999999865 68999999986432 23456889999999999999999999887543 3589
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+||+ +++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 v~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 98 VMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 99998 77888887542 489999999999999999999988 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHHh
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKL 578 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~ 578 (670)
... ....+++.|+|||.+.+. ...+.++||||||+++|+|++|+.||........... .....+......+
T Consensus 170 ~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 170 SEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 321 234568899999998653 3578899999999999999999999864321000000 0000000000000
Q ss_pred cCCc-----------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPE-----------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ...............+.+++.+|++.||++||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000001112234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=286.27 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=187.3
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALI 422 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lv 422 (670)
+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++|+||+++++++... ...+++
T Consensus 21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 3478999999999999864 68899999987532 2345688899999999999999999987643 235778
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 101 ~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 101 THLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 8876 78998877543 488999999999999999999998 999999999999999999999999999876533
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHHhc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 579 (670)
.. ....++..|+|||.+.+. ...+.++||||||+++|||++|+.||........... .....+..+...+.
T Consensus 173 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 173 EM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 21 234578899999998642 3578899999999999999999999854221000000 00000001111110
Q ss_pred CCc----------ccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 580 QPE----------KED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 580 ~~~----------~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
... ... ............+.+++.+||+.||++||++.+++++=
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000 000 00000001245678999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=282.92 Aligned_cols=243 Identities=28% Similarity=0.363 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.||.|.||+||-|+++ +|+.||||++.+.. ....++.+|+.+|++++||.||.|.-.|+..+..++|||.+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 68999999999999985 79999999997643 445789999999999999999999999999999999999995555
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC---CCeEEeecCCccccCCCCcee
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~---~~~ki~DfGla~~~~~~~~~~ 507 (670)
|.-+|...++ .+++..-..++.||+.||.|||.+ +|+|.||||+|||+.+. -++||+|||+||.+......
T Consensus 650 LEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 650 LEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred HHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 5555554443 588888889999999999999998 99999999999999543 57999999999998766543
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
...+||+.|+|||++... .+...-|+||.|||+|--++|..||...++. .+.+++ ..-...
T Consensus 724 --rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----------ndQIQN-----AaFMyP 784 (888)
T KOG4236|consen 724 --RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----------NDQIQN-----AAFMYP 784 (888)
T ss_pred --hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccch----------hHHhhc-----cccccC
Confidence 346799999999999864 6677789999999999999999999754431 111111 111234
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+.++....+++|...||..-++|-+..+-+.+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 45566778888999999999999999998876653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=291.85 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=209.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceee-----eCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCC-----DGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-----~~~~~~lv~e 424 (670)
+|.+.||.|.+|.||+++.. +++.+|+|+.....+..+++..|.++|+.. +|||++.++|++. .++.+|||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 45689999999999999875 789999999998888889999999999999 6999999999886 3568999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
||.+||..|+++... ...+.|..+.-|+.+++.||.+||.+ .++|||||-.|||++.++.+|+.|||++..+....
T Consensus 102 fC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred ccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999999998766 44799999999999999999999998 99999999999999999999999999998775433
Q ss_pred ceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. .....||+.|||||++.-. ...++.++|+||||++..||.-|.+|+-+... +......+
T Consensus 178 gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------------mraLF~Ip 241 (953)
T KOG0587|consen 178 GR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------------MRALFLIP 241 (953)
T ss_pred cc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------------hhhhccCC
Confidence 22 2345699999999999642 23456789999999999999999998865433 11122223
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+......+....+++.++|..||..|-++||++.+++++
T Consensus 242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 33334444566788899999999999999999999998864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=273.31 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=196.4
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcc--------hHHHHHHHHHhccccccccccccceee-eCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNF--------SDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~ 420 (670)
|-+...||+|+|+.||||.+ ...+.||+|+-...+.+ .+...+|.++.+.|.||.||++|+++. +.+..+
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 33456799999999999975 46789999987544332 345778999999999999999999886 556788
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla 497 (670)
.|+|||++.+|.-+|+.++ .+++.+++.|+.||+.||.||... +++|||-||||.||||- .-|.+||+||||+
T Consensus 545 TVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 9999999999999998765 589999999999999999999986 78999999999999994 4588999999999
Q ss_pred cccCCCCce-----eeecCCCCCccccchhhcccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccc
Q 005909 498 KAHSRNRSV-----VTMTGPRGTIGYIAPEIFMRN--LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF 570 (670)
Q Consensus 498 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 570 (670)
+.+..+... .......||.+|++||.+.-. ..+.+.|.||||.|||+|..+.|++||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 988654332 112235699999999988532 3567889999999999999999999997543211
Q ss_pred hHHHHH-HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 571 PDWIYD-KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 571 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+.... .++... +........+..+...+|.+||+.--++|....++..
T Consensus 692 -dILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 -DILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -HHHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111 111100 0111112234556778999999999999998888764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=283.08 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=188.8
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee-CCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~e~~~ 427 (670)
+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++.+++||||+++++++.. ....++++||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 4578999999999999875 78999999875422 335678899999999999999999998865 55788999998
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++... .+++..+..++.|+++||+|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 93 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--- 162 (328)
T cd07856 93 GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--- 162 (328)
T ss_pred ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc---
Confidence 56888887543 478888899999999999999998 99999999999999999999999999987543321
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHHhcCCc--
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLIQPE-- 582 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-- 582 (670)
....++..|+|||.+.+. ..++.++||||||+++|||++|+.||........... .-...+....+......
T Consensus 163 --~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 --TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223468899999987542 3578899999999999999999999854321000000 00000000011000000
Q ss_pred -------c-cc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 -------K-ED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 -------~-~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .. ............+.+++.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0001111235678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=262.23 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=201.5
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeee----CCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lv~e~~~~ 428 (670)
++||-|-.|.|-...++ +++..|+|++..+.. ..+|+++.-.. .|||||.+++++.+ ...+.+|||.|++
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 68999999999998775 688999999986554 45788776666 59999999998764 3456789999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~ 505 (670)
|.|...+.+++. ..+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. +-.+||+|||+|+......
T Consensus 144 GeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 144 GELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred hHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 999999987654 3699999999999999999999987 9999999999999954 5679999999998765432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....+.-|+.|.|||++... +++...|+||+||++|-|++|.+||..... ..+..-+..++..+. -+
T Consensus 219 --~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg--------~aispgMk~rI~~gq-y~ 285 (400)
T KOG0604|consen 219 --DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHG--------LAISPGMKRRIRTGQ-YE 285 (400)
T ss_pred --cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCC--------ccCChhHHhHhhccC-cc
Confidence 34456679999999999754 678889999999999999999999975432 111222333443333 45
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+..+++.++++...++++.+|..+|.+|.|+.+++++-
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 67788899999999999999999999999999998754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=302.79 Aligned_cols=141 Identities=29% Similarity=0.445 Sum_probs=126.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+|.+. +++.||||+++... .....+..|+.++..++|+||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 35688999999999999986 68999999997543 22467889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
++++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999986543 478899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=269.65 Aligned_cols=220 Identities=19% Similarity=0.180 Sum_probs=174.4
Q ss_pred cCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcccccccc
Q 005909 360 GGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE 438 (670)
Q Consensus 360 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~ 438 (670)
|.+|.||+++++ +++.+|+|++..... +.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999885 688999999876542 334555555667999999999999999999999999999999998654
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccc
Q 005909 439 KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518 (670)
Q Consensus 439 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y 518 (670)
. .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||++....... ....++..|
T Consensus 80 ~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 80 L---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 3 489999999999999999999987 99999999999999999999999999876654321 223457789
Q ss_pred cchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHH
Q 005909 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKM 598 (670)
Q Consensus 519 ~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (670)
+|||.+.+ ...+.++||||+|+++|||++|+.++....... ..... ...+......+
T Consensus 149 ~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~ 205 (237)
T cd05576 149 CAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEA 205 (237)
T ss_pred cCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHH
Confidence 99998864 367889999999999999999998764321100 00000 00111234567
Q ss_pred HHHHHhccccCCCCCCCHH
Q 005909 599 IIVGLWCIQINPKDRPSMT 617 (670)
Q Consensus 599 ~~l~~~cl~~dP~~RPs~~ 617 (670)
.+++.+||+.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=238.04 Aligned_cols=193 Identities=25% Similarity=0.436 Sum_probs=165.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
++||+|.||+||||+.. .++.||+|.++.++ ......++|+-+++.++|+|||++++....+....+|+||| ..+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHH
Confidence 78999999999999875 58899999997654 33467899999999999999999999999999999999999 567
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|..+...-. ..++.+.++.++.|+++||.+.|++ ++.||||||.|.||+.+|++|++|||+++.+.-.... ..
T Consensus 87 lkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc--ys 159 (292)
T KOG0662|consen 87 LKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YS 159 (292)
T ss_pred HHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--ee
Confidence 777765443 3599999999999999999999998 9999999999999999999999999999987644322 22
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
..+-|..|.+|.++.+. .-++...|+||-||++.|+....+|.-+
T Consensus 160 aevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 34568999999999875 5678889999999999999986655544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=283.69 Aligned_cols=237 Identities=23% Similarity=0.341 Sum_probs=192.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+...+|.|+|+.|-.+.+. +++..++|++.+.. .+..+|+.++.+. .||||+++.+.+.++...++|||.+.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 456677999999999888764 68889999998763 2334677766666 799999999999999999999999998
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE-CCCCCeEEeecCCccccCCCCcee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll-~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+-|.+.+.... .....+..|+.+|+.++.|||.+ ++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 401 ~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 401 GELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred cHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 88777775443 23367778999999999999998 99999999999999 68999999999999887655
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
...+.-|..|.|||++.. ..+++++|+||||++|||||+|+.|+...... ..+..++..+...
T Consensus 470 -~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------IEIHTRIQMPKFS--- 532 (612)
T ss_pred -hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------HHHHHhhcCCccc---
Confidence 223345889999999984 48899999999999999999999999754321 2334444433222
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..++....+++.+||+.||.+||+|.++..+
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 4566778889999999999999999998754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=257.71 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=193.0
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEccc---CCcchHHHHHHHHHhccccccccccccceeeeC--------CeeEE
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG--------STRAL 421 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~l 421 (670)
..+||+|.||.||+|+.+ .|+.||+|++-. ........++|+++|..++|+|++.++..|... ...++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999986 577788877643 234456788999999999999999999988632 34789
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+++|+ .+|+-+|..... .++...+.+++.++.+||.|+|.. .|+|||+|+.|+||+.+|.+||+|||+++.+.
T Consensus 102 Vf~~ce-hDLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 102 VFDFCE-HDLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eHHHhh-hhHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999995 578888865433 588899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCccccch
Q 005909 502 RNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFP 571 (670)
Q Consensus 502 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~ 571 (670)
..... ...+..+-|..|++||.+.+. ..++++.|||.-|||+.||++|.+.++........ ......+|
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 43322 223445569999999999876 57889999999999999999999887654331100 00011111
Q ss_pred HH----HHHHhcCCccccccchhhHHHH------HHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 572 DW----IYDKLIQPEKEDFVEEEDDCIA------RKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 572 ~~----~~~~~~~~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.. .++.+..+..........+... .+.++++..++..||.+|+.+.+++.+--
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11 1122211100000000000111 24667888999999999999999987653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.29 Aligned_cols=237 Identities=28% Similarity=0.423 Sum_probs=191.1
Q ss_pred CceEEEEEEeC-CCcEEEEEEcccCCcc--hHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCccccccc
Q 005909 361 GYGNVYKGKFP-DGRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR 437 (670)
Q Consensus 361 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 437 (670)
+||.||+|+.. +++.+++|++...... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 4899999999765432 57899999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCcc
Q 005909 438 EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517 (670)
Q Consensus 438 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 517 (670)
.. .+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 43 288999999999999999999998 99999999999999999999999999998765432 1233457889
Q ss_pred ccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHH
Q 005909 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARK 597 (670)
Q Consensus 518 y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (670)
|++||.+.. ...+.++||||||+++++|++|+.|+..... ...+.+.+....... ......+...
T Consensus 152 ~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----------LLELFKKIGKPKPPF--PPPEWKISPE 216 (244)
T ss_pred CCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------HHHHHHHHhccCCCC--ccccccCCHH
Confidence 999999874 3678899999999999999999998854211 111222222211111 0000114567
Q ss_pred HHHHHHhccccCCCCCCCHHHHHH
Q 005909 598 MIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 598 l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=292.46 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=204.8
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
...+.+.+.||+|+||.|..++++ .++.+|+|++++.. ....-|..|-.+|..-+.+-|+.++-.|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 334556789999999999999986 68999999998733 3456788899999988999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
||||+||+|-.++.+.. .+++.-++.++..|.-||.-||+- |+|||||||+|||||..|++||+|||..-.+..
T Consensus 154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999997765 489999999999999999999986 999999999999999999999999999877765
Q ss_pred CCceeeecCCCCCccccchhhcccc--c-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRN--L-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
+... .....+|||.|++||++... . +.++...|-||+||++|||+.|..||....- -.-+.++.
T Consensus 228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------------veTY~KIm 294 (1317)
T KOG0612|consen 228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------------VETYGKIM 294 (1317)
T ss_pred CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------------HHHHHHHh
Confidence 5433 34567899999999999642 2 5678899999999999999999999975322 11234444
Q ss_pred CCccc-cccchhhHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHHh
Q 005909 580 QPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEMLS 624 (670)
Q Consensus 580 ~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~L~ 624 (670)
..... .+. ....++....++|.+.+ -+|+.|-. +.++-.|.-
T Consensus 295 ~hk~~l~FP--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 295 NHKESLSFP--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred chhhhcCCC--cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCcc
Confidence 33221 122 12236667777777644 47888887 888888764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=269.01 Aligned_cols=273 Identities=19% Similarity=0.283 Sum_probs=209.0
Q ss_pred CCCCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-c-c----ccccccc
Q 005909 339 SNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H-V----NIIHLLG 411 (670)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~g 411 (670)
..|...|....++.+.+.+|+|.||.|-+..+. .+..||||+++.-....+..+-|+++|+++. + | -+|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 456666777777778899999999999998775 4789999999988877888899999999993 3 2 2778888
Q ss_pred eeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC------
Q 005909 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP------ 485 (670)
Q Consensus 412 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~------ 485 (670)
|+...+..++|+|.+ +-|+.++|..+.- .+++...++.|+.|+++++++||+. +++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 999999999999998 7799999977543 3689999999999999999999987 9999999999999931
Q ss_pred --------------CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCC
Q 005909 486 --------------DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551 (670)
Q Consensus 486 --------------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~ 551 (670)
+..+||+|||.|+......+.. +.|..|.|||++.+- .++..+||||+||||.||.+|.
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~i-----VsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTI-----VSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCccee-----eeccccCCchheecc--CcCCccCceeeeeEEEEeeccc
Confidence 3458999999998776655433 358899999999985 7899999999999999999999
Q ss_pred CCCCCCCCCC---CCCCccccchHHHHHHh-----c-CCc--------------------cccccchhhHHHHHHHHHHH
Q 005909 552 KHLRPTETTS---GSNTTEAYFPDWIYDKL-----I-QPE--------------------KEDFVEEEDDCIARKMIIVG 602 (670)
Q Consensus 552 ~p~~~~~~~~---~~~~~~~~~~~~~~~~~-----~-~~~--------------------~~~~~~~~~~~~~~~l~~l~ 602 (670)
..|+.-+..+ +....-..+|..+..+. . .+. .........+.....|.+++
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9887543211 00000112222221111 0 000 00001112334456799999
Q ss_pred HhccccCCCCCCCHHHHHHHH
Q 005909 603 LWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 603 ~~cl~~dP~~RPs~~evl~~L 623 (670)
.+||..||.+|+|+.|++.+-
T Consensus 387 ~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHccCccccccHHHHhcCH
Confidence 999999999999999998754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=268.06 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=206.9
Q ss_pred CCHHHHHHHHHhhhccccccCceEEEEEEeCCCc-EEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeee
Q 005909 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGR-LVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCD 415 (670)
Q Consensus 341 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 415 (670)
..+.+++.. ..||-|+||.|-.++.+... ..|+|++++.. ...+....|-.+|...+.|.||++|..+.+
T Consensus 417 v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 444555433 57999999999999886544 48889887644 345678889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 416 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
....|+.||-|-+|.|...|...+ .++......++..+++|++|||++ +||.|||||+|.+||.+|-+||.|||
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999997654 588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
+|+.+..+....++ .||+.|.|||.+... .++.++|.||||++++||++|++||...+. -..+
T Consensus 566 FAKki~~g~KTwTF---cGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp------------mktY 628 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTF---CGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP------------MKTY 628 (732)
T ss_pred hHHHhccCCceeee---cCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch------------HHHH
Confidence 99999877765554 489999999999865 677899999999999999999999986544 1234
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 623 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 623 (670)
+.++.+.. ..+.+..+.+...+++++.+..+|.+|-. +.+|-++-
T Consensus 629 n~ILkGid---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 629 NLILKGID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHhhhh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 44444332 12233556677788889999999999965 66666543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=279.97 Aligned_cols=262 Identities=19% Similarity=0.220 Sum_probs=177.5
Q ss_pred hhhccccccCceEEEEEEe-----------------CCCcEEEEEEcccCCc-chHH--------------HHHHHHHhc
Q 005909 352 GFKEKLGTGGYGNVYKGKF-----------------PDGRLVAVKVLEKTSN-FSDN--------------FINEVATIG 399 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~-~~~~--------------~~~E~~~l~ 399 (670)
.+.++||+|+||+||+|.+ .+++.||||.+..... ..++ ...|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3568999999999999964 2356899999865432 1223 344677777
Q ss_pred ccccccc-----ccccceeee--------CCeeEEEEEecCCCCcccccccccC---------------------CCCCC
Q 005909 400 RIHHVNI-----IHLLGFCCD--------GSTRALIYEYMPNGSLGDLLSREKE---------------------NLSLK 445 (670)
Q Consensus 400 ~l~H~nI-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~ 445 (670)
+++|.++ ++++++|.. .+..+|||||+++++|.++++.... ...++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 7766554 677887753 3467999999999999999864321 11356
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcc
Q 005909 446 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525 (670)
Q Consensus 446 ~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 525 (670)
+..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++......... .....+++.|+|||.+.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhc
Confidence 778899999999999999988 99999999999999999999999999997654332211 11223478999999985
Q ss_pred ccc--------------------CCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCC-CCccccchHHHHHHhcCCcc
Q 005909 526 RNL--------------------GNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGS-NTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 526 ~~~--------------------~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 583 (670)
... .....+.||||+||+++||++|.. |+.....-... .........|. ......
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~- 460 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQK- 460 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccC-
Confidence 321 011235799999999999999875 55321110000 00001111111 111111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINP---KDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~ 622 (670)
......+.......+++.++|..+| .+|+|++|+++|
T Consensus 461 --~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 --YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111223345677888999999766 689999999876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=289.06 Aligned_cols=262 Identities=20% Similarity=0.247 Sum_probs=165.0
Q ss_pred hhhccccccCceEEEEEEeC-C----CcEEEEEEcccCCcchHHHHHHHHHhccccccccccccce------eeeCCeeE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-D----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF------CCDGSTRA 420 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~~~~~~~ 420 (670)
.+.++||+|+||.||+|++. + +..||+|++..... .+...+| .+.+..+.++..++.. ...+...+
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 45689999999999999985 4 68999998764332 1111111 1222223333333222 23556789
Q ss_pred EEEEecCCCCcccccccccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 421 LIYEYMPNGSLGDLLSREKEN-----------------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
+|+||+++++|.+++...... .......+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEE
Confidence 999999999999988653211 0112344568999999999999998 99999999999999
Q ss_pred CC-CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccC--------------------CCCccchhHHHHH
Q 005909 484 DP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG--------------------NPSGKSDVYSYGM 542 (670)
Q Consensus 484 ~~-~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~sDV~SlGv 542 (670)
++ ++.+||+|||+++.+....... .....+++.|+|||.+..... .++.++|||||||
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 86 5899999999998654332211 123457899999997643211 2344679999999
Q ss_pred HHHHHHhCCCCCCCCCCCCC--CCCccccchHHHHHHhcCCcc-cccc--chhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 005909 543 LLLEMIEEKKHLRPTETTSG--SNTTEAYFPDWIYDKLIQPEK-EDFV--EEEDDCIARKMIIVGLWCIQINPKDRPSMT 617 (670)
Q Consensus 543 vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 617 (670)
+||||+++..+.+....... .......+..|. ....... .+.. .+..+.......+++.+||+.||++|||++
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR--KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH--HhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999987655432100000 000000111121 1111110 0000 000011122455899999999999999999
Q ss_pred HHHHH
Q 005909 618 RVVEM 622 (670)
Q Consensus 618 evl~~ 622 (670)
|++++
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=253.51 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC-----CeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lv~e~ 425 (670)
+.||-|+||.||.+.++ +|+.|++|++..-. ...+.+.+|+++|.-++|.||+..+++..-. ++.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 56999999999999885 79999999886533 3457889999999999999999998876533 256788898
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
| ..+|..+|.... .++...+.-+..||++||.|||+. +|+||||||.|.|++.+..+||+|||+++.-..++.
T Consensus 139 m-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 M-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred H-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8 678888886543 688888999999999999999998 999999999999999999999999999997655443
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-----CccccchHH------H
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-----TTEAYFPDW------I 574 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~-----~~~~~~~~~------~ 574 (670)
. .++..+-|..|+|||.+++. ..++.+.||||.|||+.||+.++..|........-. .......++ .
T Consensus 212 ~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 L-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred h-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 34555678899999999987 578999999999999999998888776432210000 000000110 0
Q ss_pred HHHhcCCc-c-cccc----chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 575 YDKLIQPE-K-EDFV----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 575 ~~~~~~~~-~-~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
...+++.. . ++.. ....+..-.+...+.+.++..||++|.+..+.+.++-
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 1 1100 0111111234456778899999999999999988764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=256.62 Aligned_cols=242 Identities=22% Similarity=0.312 Sum_probs=190.7
Q ss_pred HHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCee
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 419 (670)
++....+|...||+|+||.|..|.-+ +.+.+|||+++++- +..+--+.|-++|..- +-|.++++..++...+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34444578899999999999999775 46789999998754 2233345666677666 578999999999999999
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
|+||||+.+|+|--++++.+ .+.+..+..+|.+||-||-+||++ +||.||||.+|||||.+|++||+|||+.+.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998887655 477888899999999999999998 999999999999999999999999999875
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
---+.. +.....||+.|+|||.+.- ..++...|-|||||+||||+.|..||++.++ +.+.+.+.
T Consensus 500 ni~~~~--TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------------~elF~aI~ 563 (683)
T KOG0696|consen 500 NIFDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------DELFQAIM 563 (683)
T ss_pred cccCCc--ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHH
Confidence 322221 2234568999999999963 4778889999999999999999999987544 12222222
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCC
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP 614 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 614 (670)
+.. ...++..+.+...+....|..+|.+|.
T Consensus 564 ehn-----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHN-----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hcc-----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 211 112334566677788888999999994
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=280.36 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=185.7
Q ss_pred ccccccCceE-EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGN-VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.+|.|..|+ ||+|.+ +|+.||||++-..- .+-..+|+..|+.- +|||||++++.-.+....|+..|.| ..+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 5689999987 699999 78899999876432 34567899999888 6999999999888889999999999 78999
Q ss_pred cccccccCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-----CCCeEEeecCCccccCCCCce
Q 005909 433 DLLSREKEN-LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 433 ~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-----~~~~ki~DfGla~~~~~~~~~ 506 (670)
+++...... ........+.+..|+++||++||+. +||||||||.||||+. ...++|+|||+++.+..+.+.
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999774111 1111144577889999999999986 9999999999999965 257999999999988766554
Q ss_pred ee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 VT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.. ..+..||-+|+|||++... ..+.++||||+|||+|+.++| +.||...-..+ ..+..+...
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------------~NIl~~~~~ 731 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------------ANILTGNYT 731 (903)
T ss_pred hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhh--------------hhhhcCccc
Confidence 32 3456799999999999864 446689999999999999987 77886532211 112222221
Q ss_pred -cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 -DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 -~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++ +..++|.+|++.||..||++.+|+.+
T Consensus 732 L~~L~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEPLPDC---EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeeccCchH---HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111222 66789999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=232.92 Aligned_cols=197 Identities=29% Similarity=0.405 Sum_probs=163.3
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
...||.|++|.|-+-++. +|+..|+|.++..- ...++.+.|+.+..+- ..|.+|+++|........++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 467999999999998874 79999999997654 3456788898876665 7999999999888888899999999 66
Q ss_pred Ccccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 430 SLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 430 sL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
||..+-.+. .....+++..+-+|+..+.+||.|||++ +.+||||+||+||||+.+|++||||||++..+.+.-..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 777665432 2234689999999999999999999997 69999999999999999999999999999877544322
Q ss_pred ecCCCCCccccchhhcccc--cCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 509 MTGPRGTIGYIAPEIFMRN--LGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~--~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
+...|-..|||||.+... ...++.||||||||+.+.||.+++.|++.
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 223467889999998653 23578899999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=241.02 Aligned_cols=242 Identities=21% Similarity=0.317 Sum_probs=189.5
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+...||+|+|+.|..++++ +.+.+|+|++++. .+..+-.+.|-.+..+. +||.+|.+..++.....+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3478999999999999986 5789999998763 23445566777777777 7999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc-CCCCc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~-~~~~~ 505 (670)
++|+|--++.+.+ .++++.++.+..+|.-||.|||++ +||.||||.+|+|||..|++||+|+|+.+.- ...+.
T Consensus 334 ~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred cCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 9999987776554 599999999999999999999998 9999999999999999999999999998753 23332
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. ....||+.|+|||.+.+. .+....|-|++||+++||+.|+.||+-... ...+..-.++.++.+++....-
T Consensus 408 t---stfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm----~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 408 T---STFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGM----DNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred c---ccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecC----CCcccchhHHHHHHHhhhcccc
Confidence 2 235589999999999875 677789999999999999999999985432 1222233333344333322211
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP 614 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 614 (670)
++..+.+...+++.-|++||.+|.
T Consensus 479 -----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 -----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----cceeehhhHHHHHHhhcCCcHHhc
Confidence 112234455677888999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=256.75 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=165.6
Q ss_pred ccccccCceEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||-|+||.|.+++- ++...+|+|.+++.+ ........|-.+|.....+-||+|+-.|.+++.+|+||||+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 5699999999999864 456789999998754 23445778999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC--------
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-------- 501 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~-------- 501 (670)
++-.+|.+.+ -+++..++.++.++..|+++.|.- |+|||||||+|||||.+|++||+||||..-+.
T Consensus 715 DmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999997654 488888899999999999999975 99999999999999999999999999975321
Q ss_pred -CCC-------------------------------ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh
Q 005909 502 -RNR-------------------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549 (670)
Q Consensus 502 -~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt 549 (670)
.+. ........+||+.|+|||++.+. .++..+|.||.|||||||+.
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHhh
Confidence 000 00011234699999999999875 77889999999999999999
Q ss_pred CCCCCCCCCC
Q 005909 550 EKKHLRPTET 559 (670)
Q Consensus 550 g~~p~~~~~~ 559 (670)
|+.||-....
T Consensus 867 g~~pf~~~tp 876 (1034)
T KOG0608|consen 867 GQPPFLADTP 876 (1034)
T ss_pred CCCCccCCCC
Confidence 9999975443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=250.50 Aligned_cols=154 Identities=24% Similarity=0.412 Sum_probs=130.5
Q ss_pred HHHHHHhhccccCCCCHHHHHH-HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc--
Q 005909 327 KQFIKTYRSALLSNYSYNDIKK-MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-- 402 (670)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-- 402 (670)
++-.+.|+...+....+.|+-. .+|-+.++||-|.|++||++.+. +.+.||+|+.+......+..+.||++|++++
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3445677777777777888776 77878899999999999999875 6789999999988877888999999999994
Q ss_pred ---c---cccccccceeee----CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 005909 403 ---H---VNIIHLLGFCCD----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472 (670)
Q Consensus 403 ---H---~nIv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 472 (670)
| ..||+|++.|.. +.+.+||+|++ +.+|..+|....- ..++...+.+|++|++.||.|||.+| +||
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gII 210 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GII 210 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--Ccc
Confidence 2 369999998864 55789999999 7788888865432 25999999999999999999999986 999
Q ss_pred ecCCCCCcEEEC
Q 005909 473 HLDIKPQNVLLD 484 (670)
Q Consensus 473 H~dlkp~NIll~ 484 (670)
|-||||+|||+.
T Consensus 211 HTDlKPENvLl~ 222 (590)
T KOG1290|consen 211 HTDLKPENVLLC 222 (590)
T ss_pred ccCCCcceeeee
Confidence 999999999993
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=231.19 Aligned_cols=211 Identities=35% Similarity=0.625 Sum_probs=182.6
Q ss_pred ccccCceEEEEEEeCC-CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCccc
Q 005909 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD 433 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~ 433 (670)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|+..+++++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 89999999987654 35789999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCCCceeeecCC
Q 005909 434 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 434 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986542 2588999999999999999999998 9999999999999999 89999999999987654321 11223
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhH
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (670)
.+...|++||.+... ...+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 468899999998653 3667899999999999999
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 593 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=225.70 Aligned_cols=253 Identities=17% Similarity=0.272 Sum_probs=189.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccce-eeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF-CCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lv~e~~~ 427 (670)
+++.+.||+|.||.+-.+.++ .++.+++|.+.......++|.+|..---.| .|.||+.-++. +...+...+++||+|
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 456788999999999999986 577899999988888889999999866666 69999998874 566777889999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE--CCCCCeEEeecCCccccCCCCc
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll--~~~~~~ki~DfGla~~~~~~~~ 505 (670)
.|+|.+-+... .+-+....+++.|+++|+.|||++ ++||||||.+|||| .+...+||+|||+.+..+.-..
T Consensus 106 ~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 106 RGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred cchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 99999988664 378888899999999999999998 99999999999999 3446899999999876543221
Q ss_pred eeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
. ..-+..|.+||+.... .....+.+|||.||++++..+||+.||+..... ...-..+..| .+.....
T Consensus 179 ~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~w--~~rk~~~ 248 (378)
T KOG1345|consen 179 Y-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQW--LKRKNPA 248 (378)
T ss_pred h-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHHH--hcccCcc
Confidence 1 2246679999987532 123466789999999999999999999742210 1111122222 2222222
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.+. .-...+..+.++..+-+..++++|-...++.++-+
T Consensus 249 ~P~----~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 249 LPK----KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred Cch----hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 222 22234556777888899999999965555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=253.07 Aligned_cols=276 Identities=19% Similarity=0.256 Sum_probs=215.6
Q ss_pred ccCCCCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc------ccccccc
Q 005909 337 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH------HVNIIHL 409 (670)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l 409 (670)
.+..+.+.|+...+|.+....|+|-|++|.+|+++ .|+.||||+|+..+-..+.=+.|+++|++|. .-|.++|
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 34556788899999988899999999999999986 4789999999998877788889999999995 3589999
Q ss_pred cceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CC
Q 005909 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FT 488 (670)
Q Consensus 410 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~ 488 (670)
+..|...++++||+|-+ ..+|.++|+..+.+..|....+..++.|+.-||..|... +|+|.||||+|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999988 678999999988888899999999999999999999987 99999999999999875 57
Q ss_pred eEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---C
Q 005909 489 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---T 565 (670)
Q Consensus 489 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~---~ 565 (670)
+||||||.|.....+.-.. .--+-.|.|||.+.+- .++...|+||.||.||||.||+..|.+.....+-. .
T Consensus 576 LKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITP----YLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred eeeccCccccccccccccH----HHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 8999999998766543221 1235689999999985 66778999999999999999999886543211000 0
Q ss_pred ccccchHHHHH---------------------Hhc-----------CC-c------c-ccccchhhHHHHHHHHHHHHhc
Q 005909 566 TEAYFPDWIYD---------------------KLI-----------QP-E------K-EDFVEEEDDCIARKMIIVGLWC 605 (670)
Q Consensus 566 ~~~~~~~~~~~---------------------~~~-----------~~-~------~-~~~~~~~~~~~~~~l~~l~~~c 605 (670)
....|+.-+.. ++. .+ . . ......+.......+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 01111111100 000 00 0 0 0012233455677899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 005909 606 IQINPKDRPSMTRVVEM 622 (670)
Q Consensus 606 l~~dP~~RPs~~evl~~ 622 (670)
+..||++|.|..+.|++
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998865
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=220.55 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=191.2
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeeeCC--eeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGS--TRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~lv~e~~ 426 (670)
+++.+++|+|-++.||.|.. .+++.++||+++... .+.+.+|+.+|..++ ||||++|++...+.. ...||+||+
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 45678999999999999975 578899999998654 467889999999997 999999999987654 568999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~~~ 505 (670)
.+.+...+-. .++...+..++.++++||.|+|+. ||.|||+||.|++||.. -.++|+|+|||........
T Consensus 118 ~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 118 NNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred ccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 8877665542 477788899999999999999987 99999999999999864 5799999999998776543
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC------ccccchHHHHH---
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYD--- 576 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~------~~~~~~~~~~~--- 576 (670)
.. ..+.+..|.-||++..- ..++..-|+|||||+|.+|+..+.||-.......+.. ....+...+..
T Consensus 189 Yn---VRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 189 YN---VRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ee---eeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 32 23356778899999753 4667788999999999999999999965433111100 00011111110
Q ss_pred -------H-hcCCcc---ccccchh-hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 -------K-LIQPEK---EDFVEEE-DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 -------~-~~~~~~---~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. +.+... ..+...+ ..-+.++.++++...|..|-++|+|++|.+.+-
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 0 000000 1111111 122346788999999999999999999988653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=247.02 Aligned_cols=191 Identities=26% Similarity=0.352 Sum_probs=163.1
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCCcchH---------HHHHHHHHhcccc---ccccccccceeeeCCeeE
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD---------NFINEVATIGRIH---HVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+|+|+||.|+.+.++ +...|+||.+.+.+-..+ ..-.|+.+|..++ |+||++++++|++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 467999999999999987 467899999987652221 2446999999997 999999999999999999
Q ss_pred EEEEec-CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 421 LIYEYM-PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 421 lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
|++|.. ++-+|.++|.... .+++.++.-|++|++.|+++||++ +|||||||-+|+.++.+|-+||+|||.+..
T Consensus 646 l~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred EEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence 999975 3568899996543 599999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 555 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~ 555 (670)
...+. +...+||..|.|||++.++ ......-|||++|++||.++....|+.
T Consensus 720 ~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65543 3346799999999999876 344667899999999999998888775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=252.15 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=199.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
++..++|.|.+|.|||+++. .++.+|+|+++... ....-..+|+-+++.-+|+||+.++|-+...+..++.||||.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 35578999999999999985 68999999998765 34456778999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|++.-+-.+ .+++.++....++.++||+|||+. +-+|||||-.|||+++.|.+|++|||.+..+..-- ...
T Consensus 98 slQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~Kr 169 (829)
T KOG0576|consen 98 SLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKR 169 (829)
T ss_pred cccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--hhh
Confidence 9999886544 699999999999999999999987 88999999999999999999999999987664322 223
Q ss_pred cCCCCCccccchhhcc-cccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~-~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....||+.|||||+.. ++.+.+..++|||+.|+...|+-.-+.|...... ..+.-.+-+........
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------------mr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------------MRALFLMTKSGFQPPTL 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------------HHHHHHhhccCCCCCcc
Confidence 4567999999999873 3346788899999999999999765555432111 11111111111222333
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+......+.+-++++.++..+|++||+++.+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 444556778889999999999999999988775
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=229.92 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=184.6
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeC------CeeEEEEE
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIYE 424 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lv~e 424 (670)
+.+|.|.- .|-.+.+. .+++||+|++... ....+...+|...+..+.|+||++++.++.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 35677776 55555443 6889999887542 23456788999999999999999999998643 35689999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+| ..+|...+.. .++-.++..|+.|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.-..+
T Consensus 102 ~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 102 LM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 99 6788888863 378889999999999999999998 9999999999999999999999999999876544
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccccc---hHH
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYF---PDW 573 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~---~~~ 573 (670)
..++..+.+..|.|||++.+. .+.+.+||||.||++.||++|+-.|.+...... ......+. ...
T Consensus 172 --~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred --cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 234555678899999999875 478899999999999999999988764322100 00000000 000
Q ss_pred HHHHhc-CCc---------ccc----ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 574 IYDKLI-QPE---------KED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 574 ~~~~~~-~~~---------~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+...+. .++ .++ ...+..+.....+.+++.+||-.||++|.++++++++=
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 000000 000 001 01111223345677899999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=224.47 Aligned_cols=197 Identities=32% Similarity=0.517 Sum_probs=168.7
Q ss_pred hhccccccCceEEEEEEeCC-CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.||+|++|+||++...+ ++.+++|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999875 88999999987553 4678999999999999999999999999989999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 83 ~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 83 DLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999876432 178999999999999999999998 9999999999999999999999999999876544200 11
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
....++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2234678899999984 224677799999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=225.87 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=190.7
Q ss_pred hhccccccCceEEEEEEeC----CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
..++||+|.|++||++.+. ..+.||+|.+..... ...+.+|+++|..+ -+.||+++.+++..++...+|+||++
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 4578999999999999764 467899999876653 45688999999999 59999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCCC--
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNR-- 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~~-- 504 (670)
.....+++.. ++...+..++..++.||.++|.+ |||||||||+|+|.+. -+.-.|.|||||.......
T Consensus 119 H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 119 HDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 9888887743 66788899999999999999998 9999999999999975 4678999999997210000
Q ss_pred ------------c----------------------------eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHH
Q 005909 505 ------------S----------------------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 544 (670)
Q Consensus 505 ------------~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl 544 (670)
. ........||++|.|||++.+- +..+.++||||-|||+
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeecccee
Confidence 0 0001123599999999999864 5778899999999999
Q ss_pred HHHHhCCCCCCCCCCCC----------------------CC--CCcccc---chHHH--HHHhc-CC----ccccccch-
Q 005909 545 LEMIEEKKHLRPTETTS----------------------GS--NTTEAY---FPDWI--YDKLI-QP----EKEDFVEE- 589 (670)
Q Consensus 545 ~elltg~~p~~~~~~~~----------------------~~--~~~~~~---~~~~~--~~~~~-~~----~~~~~~~~- 589 (670)
+-+++++.||-...... +. ...... .++.. ++.+. .. .......+
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999985432211 00 000000 00000 00110 00 00000111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+..+..+.+++.+|+..||.+|.|+++.+++-
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 1222344788999999999999999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-26 Score=214.26 Aligned_cols=264 Identities=23% Similarity=0.383 Sum_probs=197.4
Q ss_pred cccCCCCHHHHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEccc---CCcchHHHHHHHHHhccccccccccccce
Q 005909 336 ALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGF 412 (670)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 412 (670)
..+.+|+-.+... .++.-+|.+...|..|+|+++++.. ++|+++. +....++|..|.-.|+-+.||||++++|.
T Consensus 179 atlsr~~gid~~~--lnl~tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 179 ATLSRYTGIDVSS--LNLITKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred cccccccCcchhh--hhhhhhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhh
Confidence 3444454444433 2466789999999999999976554 4566543 33556789999999999999999999999
Q ss_pred eeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 413 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
|.....+.++..||+.|+|..+|+... ....+..++.+++.++|+|++|||+. ++-|...-|.++.++||++.+++|+
T Consensus 256 cnsppnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 256 CNSPPNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred ccCCCCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 999999999999999999999998754 33577888999999999999999986 4445566799999999999998885
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccch
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 571 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 571 (670)
- +-+ .......+..-.+.||+||.+++..... -.++|+|||.+++|||.|..-||......+
T Consensus 334 m-ad~------kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------- 396 (448)
T KOG0195|consen 334 M-ADT------KFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------- 396 (448)
T ss_pred c-ccc------eeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----------
Confidence 1 111 1111122333478999999998753333 246899999999999999999997543210
Q ss_pred HHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 572 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.-.+ -..+++....+..++..+.+++.-|++.||.+||.+..|+-.|+..
T Consensus 397 --cgmk---ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 397 --CGMK---IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --hhhh---hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 0000 1112333344455677888999999999999999999999998854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=263.47 Aligned_cols=197 Identities=18% Similarity=0.234 Sum_probs=137.3
Q ss_pred cccc-ccccccccee-------eeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 005909 400 RIHH-VNIIHLLGFC-------CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471 (670)
Q Consensus 400 ~l~H-~nIv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 471 (670)
+++| +||+++++++ .+....++++||+ .++|.++|.... ..+++..++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4556 6888898887 2234566788887 679999996532 3589999999999999999999998 99
Q ss_pred EecCCCCCcEEECC-------------------CCCeEEeecCCccccCCCCc--------------eeeecCCCCCccc
Q 005909 472 LHLDIKPQNVLLDP-------------------DFTPKVSDFGLAKAHSRNRS--------------VVTMTGPRGTIGY 518 (670)
Q Consensus 472 vH~dlkp~NIll~~-------------------~~~~ki~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 518 (670)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654211000 0001123578899
Q ss_pred cchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHH
Q 005909 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKM 598 (670)
Q Consensus 519 ~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 598 (670)
||||++.+. .++.++|||||||+||||++|..|+..... .+.. +...... . .........
T Consensus 182 ~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~-~~~~~~~----~----~~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSS-LRHRVLP----P----QILLNWPKE 241 (793)
T ss_pred EChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHH-HHHhhcC----h----hhhhcCHHH
Confidence 999998764 678899999999999999998776532110 0011 1111110 0 000112345
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH
Q 005909 599 IIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 599 ~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..++.+||+.+|.+||+|.||+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=205.99 Aligned_cols=167 Identities=19% Similarity=0.247 Sum_probs=124.1
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++...+ ..+++..++.++.|+++||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68889887543 2599999999999999999999987 4 999999999999999 99987654322
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
..|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.... .......... .
T Consensus 64 ---~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~------~~~~~~~~~-~~~~~~~~~~--~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERE------LSAILEILL-NGMPADDPRD--R 129 (176)
T ss_pred ---CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccch------hcHHHHHHH-HHhccCCccc--c
Confidence 2478999999999764 678899999999999999999999854221 011111111 1111110000 0
Q ss_pred hhhHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 589 EEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 589 ~~~~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
........ .+.+++.+||+.||++||++.|+++++...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11222333 689999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=212.10 Aligned_cols=172 Identities=20% Similarity=0.170 Sum_probs=129.0
Q ss_pred HhhhccccccCceEEEEEEeC--CCcEEEEEEcccC------CcchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
|.+.+.||+|+||+||+|.++ +++.+|||++... ....+.|.+|+++|++++|+|+++.+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 345688999999999999875 5788899986532 1234568999999999999999863322 2457999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCcEEECCCCCeEEeecCCccccC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI-KPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-kp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|||+++++|... .. .. ...++.+++++|.|||++ +|+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 97 mE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 97 RGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999632 11 11 146788999999999998 9999999 9999999999999999999999765
Q ss_pred CCCceee------ecCCCCCccccchhhcccccC----CCCccchhH
Q 005909 502 RNRSVVT------MTGPRGTIGYIAPEIFMRNLG----NPSGKSDVY 538 (670)
Q Consensus 502 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~s~~sDV~ 538 (670)
....... .+...++..|+|||.+..... ..+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4321111 134567888999999865321 223446776
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=203.04 Aligned_cols=260 Identities=21% Similarity=0.275 Sum_probs=189.3
Q ss_pred HHhhhccccccCceEEEEEEeCCC--cEEEEEEcccCCcc-hHHHHHHHHHhccccc----ccccccccee-eeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDG--RLVAVKVLEKTSNF-SDNFINEVATIGRIHH----VNIIHLLGFC-CDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l 421 (670)
.+.+.++||+|+||.||++..... ..+|+|+....... ...+..|..++..+.+ .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 344668999999999999997653 57888887665322 2267888888888863 5788888888 46778899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-----CCeEEeecCC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-----FTPKVSDFGL 496 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-----~~~ki~DfGl 496 (670)
||+.+ +.+|.++..... ...++..+.++|+.|++.+|.+||+. +++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 899999876554 34699999999999999999999998 99999999999999765 4699999999
Q ss_pred cc--ccCCCCc-----eee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccc
Q 005909 497 AK--AHSRNRS-----VVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568 (670)
Q Consensus 497 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~ 568 (670)
++ ....... ... ....+||..|.++++..+. ..+.+.|+||++.++.|++.|..||....... ...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~ 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKS 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHH
Confidence 98 4322211 111 1345699999999998764 78899999999999999999999986543311 011
Q ss_pred cchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.+......... .. .....+..+.++...+-..+..++|....+...|++...
T Consensus 248 ~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 248 KFEKDPRKLLT----DR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHhhhhcc----cc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11111000000 00 111123345555555556899999999999999875543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-20 Score=192.71 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=192.6
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCc----chHHHHHHHHHhcccccc-ccccccceeeeCCeeEEEEEecC
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHV-NIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+.+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4578999999999999987 8889999876542 367899999999999988 79999999977777899999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~~ 506 (670)
++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999996665432112588899999999999999999998 899999999999999988 7999999999865443322
Q ss_pred e----eecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 507 V----TMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 507 ~----~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
. ......|+..|+|||.+.... ...+...|+||+|++++++++|..|+...... .........+.......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTPS 234 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCcc
Confidence 1 234566899999999997531 36778999999999999999999996543210 00011111111111000
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
................+.+++..++..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000001223456778888999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-22 Score=219.59 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=185.1
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcc----cCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLE----KTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
...+|.|++|.|+..... .....+.|..+ .... ....+..|+.+-..++|+|++..+....+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 357899999977776543 33333333332 2111 112366788888899999999988888777766667999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++. +|..++.+.. .+....+..++.|+..|+.|||+. +|.|||+|++|++++.+|.+||+|||.+........
T Consensus 403 ~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 9999997652 478888899999999999999997 999999999999999999999999999987654443
Q ss_pred e--eeecCCCCCccccchhhcccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC-
Q 005909 506 V--VTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP- 581 (670)
Q Consensus 506 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 581 (670)
. ....+..|+..|+|||++.+. .+ ....||||.|+++..|++|+.||.......... ........
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~~ 544 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQR 544 (601)
T ss_pred hhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhcccccc
Confidence 3 445677899999999999875 34 346899999999999999999997543211110 00000110
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
............++.+...++.+||+.||.+|.|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111222334456677888999999999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=180.50 Aligned_cols=254 Identities=18% Similarity=0.268 Sum_probs=192.4
Q ss_pred HHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
-+.+.++||+|.||..+.|+. -++++||||.-... ...-++..|.+..+.| ..+.|...+-|..++..-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 345679999999999999974 48999999975433 3456788899998888 4689999888888888889999998
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-----CCCeEEeecCCccccCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-----~~~~ki~DfGla~~~~~ 502 (670)
+-||+|+..--.. .++..++.-+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+.+
T Consensus 107 GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8899998865443 488899999999999999999998 9999999999999943 35689999999998754
Q ss_pred CCce-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 503 NRSV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 503 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
.... .......||.+||+=....++ +.+.+.|+=|+|-|+++.|-|..||++..+.. ....+++
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---------nK~kYeK 250 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---------NKEKYEK 250 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcc---------hHHHHHH
Confidence 4332 123345699999998888765 67889999999999999999999998765521 1233455
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+.+.+..-.+.+.....+.++..-+.-.-..+=++-|...-+..
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~ 294 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK 294 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 55544433333333444555555555445566667777654443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=179.14 Aligned_cols=138 Identities=19% Similarity=0.247 Sum_probs=108.2
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCc---c-------hHH-----------------HHHHHHHhcccccccc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---F-------SDN-----------------FINEVATIGRIHHVNI 406 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~H~nI 406 (670)
.+.||+|+||.||+|...+|+.||||+++.... . ... ...|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999988999999999975421 1 112 2349999999988877
Q ss_pred ccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCCCcEEECC
Q 005909 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL-HNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 407 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlkp~NIll~~ 485 (670)
.....+.. ...+|||||++++++....... ..+++..+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 54433322 2348999999887776543222 2588899999999999999999 676 999999999999998
Q ss_pred CCCeEEeecCCcccc
Q 005909 486 DFTPKVSDFGLAKAH 500 (670)
Q Consensus 486 ~~~~ki~DfGla~~~ 500 (670)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=199.26 Aligned_cols=218 Identities=24% Similarity=0.411 Sum_probs=163.3
Q ss_pred hccccccccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EecCC
Q 005909 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI-LHLDI 476 (670)
Q Consensus 398 l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~dl 476 (670)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..+++.....+++++++||+|||+. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 467899999999999999999999999999999999997743 3589999999999999999999986 44 99999
Q ss_pred CCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhccccc--CC---CCccchhHHHHHHHHHHHhCC
Q 005909 477 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL--GN---PSGKSDVYSYGMLLLEMIEEK 551 (670)
Q Consensus 477 kp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~---~s~~sDV~SlGvvl~elltg~ 551 (670)
++.|.++|..+.+||+|||+.................-..-|.|||.+.... .. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987764211111111122356799999997631 11 467899999999999999999
Q ss_pred CCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch--hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 552 KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 552 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.||+...... -++.+...+.........+. ...+....+..++.+||..+|++||++++|-..++....
T Consensus 156 ~~~~~~~~~~--------~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVE--------DPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccC--------ChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9997533211 11222222332111111111 111445578899999999999999999999988875443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=172.69 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=183.1
Q ss_pred HHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccccc-cccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.++||.|+||.+|.|.. .+|..||||+-.... ...++..|..+...++| ..|..+..+..+...-.+|||.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 345668999999999999975 689999999855443 34567889999999965 67778888888888999999998
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~ 504 (670)
+-||.++..--.. .++..+++-++-|++.-++|+|.+ +.|||||||+|+|+.- ...+.++|||||+.+.+..
T Consensus 94 GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 94 GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8899998854322 478889999999999999999998 9999999999999954 3568999999998764432
Q ss_pred cee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 505 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 505 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
... ....-.||.+|.+-....+. ..+.+.|+-|+|.+|.++.-|..||++..+... ...++++.
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---------~QKyEkI~ 237 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---------KQKYEKIS 237 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhH---------HHHHHHHH
Confidence 221 11234589999987777653 567789999999999999999999987654211 11122333
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
+.+..-.........+.++.-.+..|-..-=++-|...-+-+
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHH
Confidence 222222222222333444555555566666666665544433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=174.76 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=111.0
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCcc---------------------------hHHHHHHHHHhcccccccc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF---------------------------SDNFINEVATIGRIHHVNI 406 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~H~nI 406 (670)
.+.||+|++|+||+|++.+|+.||||+++..... ...+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999888999999998764210 1123578899999999987
Q ss_pred ccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECC
Q 005909 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 407 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~ 485 (670)
.....+... ..+|||||++++++....... ..++.....+++.|++.++.+||+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 554444333 248999999887654432221 247788899999999999999999 7 999999999999999
Q ss_pred CCCeEEeecCCccccCC
Q 005909 486 DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~ 502 (670)
++.++|+|||+++....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999977653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=206.20 Aligned_cols=248 Identities=22% Similarity=0.229 Sum_probs=178.1
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHH--hccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVAT--IGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||.+.|=+|.+++++.|. |+||++-+.. -..+.|.++++- ...++|||.+++.-+-......|||-+|. .
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv-k 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV-K 104 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-h
Confidence 4578999999999999998888 8899986544 233444444433 44558999999988766677778888888 5
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc--CC---C
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SR---N 503 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~--~~---~ 503 (670)
-+|+|.|.- +..+...+.+-|+.|++.||...|.. +|.|||||.+||||+.-+-+.|+||.--+.. .. .
T Consensus 105 hnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 105 HNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 688888853 33577788888999999999999988 9999999999999999999999999866532 21 1
Q ss_pred CceeeecCCCCCccccchhhccccc---------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNL---------GNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
+....+...+.-..|+|||.+.... ...+++.||||+|||++||++ |+++|.-..-..- .....+.++.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY-r~~~~~~~e~ 257 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY-RSGNADDPEQ 257 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH-hccCccCHHH
Confidence 2222233344566899999885421 125678899999999999997 4666643211000 0000122222
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
+.+++. ...+++++..|++.||++|-++++.++.-+
T Consensus 258 ~Le~Ie---------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 258 LLEKIE---------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHhCc---------------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 222221 125678899999999999999999998854
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8e-20 Score=177.29 Aligned_cols=170 Identities=15% Similarity=0.153 Sum_probs=128.8
Q ss_pred HHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchH----------HHHHHHHHhccccccccccccceeeeC
Q 005909 347 KKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD----------NFINEVATIGRIHHVNIIHLLGFCCDG 416 (670)
Q Consensus 347 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~ 416 (670)
.+..+...+.||.|+||.||.... ++..+|+|++.......+ .+.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 344455568899999999999766 577899999975432222 267899999999999999999886643
Q ss_pred --------CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC
Q 005909 417 --------STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 488 (670)
Q Consensus 417 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~ 488 (670)
...+|||||+++.+|.++.. +++ ....+++.+|..+|.. +++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999987631 333 2456899999999998 999999999999999988
Q ss_pred eEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHH
Q 005909 489 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 548 (670)
Q Consensus 489 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ell 548 (670)
++|+|||..+....+.... .+.... .+..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~d--------------~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKD--------------RIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHH--------------HHHHHh--HhcccccccceeEeehHHH
Confidence 9999999876553222110 022222 3446899999999988764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=169.84 Aligned_cols=186 Identities=16% Similarity=0.124 Sum_probs=139.7
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchH-----HHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD-----NFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
..|+.|+||+||.+.- .+..++.+.+.......+ .+.+|+++|+++. |++|.+++++ +..+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 5799999999997766 778888887776664333 5889999999995 5889999886 446899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCcEEECCCCCeEEeecCCccccCCCCce-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI-KPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-kp~NIll~~~~~~ki~DfGla~~~~~~~~~- 506 (670)
.+|...+.. ....++.|++++|.++|++ +|+|||| ||.|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 888654311 1135778999999999998 9999999 799999999999999999999855432210
Q ss_pred ---e-------eecCCCCCccccchhhcccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCC
Q 005909 507 ---V-------TMTGPRGTIGYIAPEIFMRNLGNPS-GKSDVYSYGMLLLEMIEEKKHLRPTET 559 (670)
Q Consensus 507 ---~-------~~~~~~gt~~y~aPE~~~~~~~~~s-~~sDV~SlGvvl~elltg~~p~~~~~~ 559 (670)
. ...-...++.|++|+...-- ...+ ...+-++-|.-+|.++|++.+.-...+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 00112357888888865322 1223 456888999999999999987654433
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=155.17 Aligned_cols=101 Identities=30% Similarity=0.539 Sum_probs=79.9
Q ss_pred CCCCCCCCCCccccCCCCCCCCCCCCCC-CCceeeecCC-CCCceeecCceEEEEEEeccCCceEEEEEecccccccCCC
Q 005909 43 EDCSPFKCGNLTFSFPFSSSSTSGYCGL-PNYQITCDSS-SVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLSSG 120 (670)
Q Consensus 43 ~~C~~~~CG~~~I~yPF~~~~~~~~Cg~-~~f~l~C~~~-~~~~l~~~~~~~~V~~I~~~~~~~~~~v~~~~~~~~~~~~ 120 (670)
++|+ .+|||++|+||||++ ++|++ |+|+|+|+++ ++++|.+.++.|+|++|+|. +++++|.++....
T Consensus 2 ~~C~-~~CGnv~IpYPFgi~---~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~--~~~i~v~~~~~~~----- 70 (106)
T PF13947_consen 2 PGCP-SSCGNVSIPYPFGIG---PGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYE--NGTIRVSDPISSN----- 70 (106)
T ss_pred CCCC-CccCCEeecCCCccC---CCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecC--CCEEEEEeccccc-----
Confidence 5797 899999999999999 67999 9999999987 46688888899999999999 9999999987644
Q ss_pred CCCCCcccc--cccccccccccccCCCCcceEEEecCC
Q 005909 121 SCESLYNLS--VAINSYSIGSLTLPSGNLNLTFFKCPR 156 (670)
Q Consensus 121 ~C~~~~~~~--~~~~~~~~~~f~~~~~~~~~~~~~C~~ 156 (670)
|....... ....++. .||.+++..|.++++||++
T Consensus 71 -~~~~~~~~~~~~~~~~~-~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 71 -CYSSSSSNSSNSNLSLN-GPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred -eecCCCCcccccEEeec-CCceEccCCcEEEEECCCC
Confidence 44331111 1111233 3888888889999999984
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=171.73 Aligned_cols=230 Identities=22% Similarity=0.284 Sum_probs=146.1
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccc----------ccccccccee-----
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHH----------VNIIHLLGFC----- 413 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H----------~nIv~l~g~~----- 413 (670)
.+.||.|+++.||.+++. +++.+|||+..... ...+++.+|......+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367999999999999997 58999999985433 345677777766665432 1222222221
Q ss_pred ----eeCC--------eeEEEEEecCCCCccccccc---ccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 005909 414 ----CDGS--------TRALIYEYMPNGSLGDLLSR---EKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 477 (670)
Q Consensus 414 ----~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk 477 (670)
.... ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 1111 225677776 6788877642 111 11234455577889999999999998 99999999
Q ss_pred CCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccc------cCCCCccchhHHHHHHHHHHHhCC
Q 005909 478 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN------LGNPSGKSDVYSYGMLLLEMIEEK 551 (670)
Q Consensus 478 p~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDV~SlGvvl~elltg~ 551 (670)
|+|++++.+|.++|+||+.......... . ...+..|.+||..... .-.++.+.|.|++|+++|.|++|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999987665433211 1 2346789999987542 124578899999999999999999
Q ss_pred CCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCC
Q 005909 552 KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613 (670)
Q Consensus 552 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 613 (670)
.||....... ..++ + ..... .+++.+..++..+|+.||++|
T Consensus 248 lPf~~~~~~~--------~~~~-----------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEA--------DPEW-----------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGS--------TSGG-----------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccc--------cccc-----------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9997543311 1111 1 11112 567788899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-19 Score=186.52 Aligned_cols=232 Identities=25% Similarity=0.287 Sum_probs=179.4
Q ss_pred cccccCceEEEEEE----eCCCcEEEEEEcccCCc---chHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecC
Q 005909 356 KLGTGGYGNVYKGK----FPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+|+|.||.|+.++ .+.|...|+|++++... .......|..++..++ ||.+|++.-.+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998754 23577788888865431 1124556788888886 9999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|.|...+.... ..+......+...++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998886654 467777788889999999999987 9999999999999999999999999999876443322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.||..|||||.+. .....+|-||||++++||++|-.||.. .+...+.. ..
T Consensus 154 -----cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----------------~~~~~Il~-----~~ 203 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----------------DTMKRILK-----AE 203 (612)
T ss_pred -----ccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----------------HHHHHHhh-----hc
Confidence 4799999999996 356689999999999999999999864 11111211 11
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCH--HHHHHHHh
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSM--TRVVEMLS 624 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~~L~ 624 (670)
...+.+.......++.+++..+|..|--. ..+.+.++
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 22344456666777888888999999644 45555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.5e-18 Score=162.49 Aligned_cols=132 Identities=19% Similarity=0.301 Sum_probs=103.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHhccc-----cccccccccceeeeCC---e-eEEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRI-----HHVNIIHLLGFCCDGS---T-RALIYE 424 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~-~~lv~e 424 (670)
+.||+|+||.||. ++.....+||++.... ...+++.+|+..++++ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 5433334799886543 3457899999999999 5799999999998874 3 337899
Q ss_pred e--cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCCCCCcEEECC----CCCeEEeecCCc
Q 005909 425 Y--MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI-EYLHNGCELRILHLDIKPQNVLLDP----DFTPKVSDFGLA 497 (670)
Q Consensus 425 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dlkp~NIll~~----~~~~ki~DfGla 497 (670)
| +++++|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5579999999653 25554 35677888787 999998 9999999999999964 348999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=189.55 Aligned_cols=198 Identities=23% Similarity=0.269 Sum_probs=155.0
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc---ccccccccceeeeCCeeEE
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l 421 (670)
++....+.+.+.||+|+||+||+|...+|+.||+|+-+.... ++|.-=.+++.||+ -+-|.++.......+.-+|
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 333444456678999999999999998999999999665442 22222223333333 3446666666667778889
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-------CCCCeEEeec
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-------PDFTPKVSDF 494 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-------~~~~~ki~Df 494 (670)
|+||.+.|+|.+++.. ...++|...+.++.|+++.++.||.. +||||||||+|+||. ++..++|+||
T Consensus 772 v~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 9999999999999973 33699999999999999999999998 999999999999993 2456999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 552 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~ 552 (670)
|-+-.+..-.....+.+..+|-.+--+|+..++ .++...|.|.+.-+++-||-|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence 998755432222345667789999999999875 78999999999999999998875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=164.02 Aligned_cols=200 Identities=21% Similarity=0.223 Sum_probs=139.7
Q ss_pred cccccccccceeee---------------------------CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHH
Q 005909 402 HHVNIIHLLGFCCD---------------------------GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 454 (670)
Q Consensus 402 ~H~nIv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 454 (670)
+|||||+++++|.+ +..+|+||..+ ..+|++++-.. ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999887653 34568888887 46888888543 356667778999
Q ss_pred HHHHHHHHHHcCCCCCeEecCCCCCcEEE--CCCC--CeEEeecCCccccCCC----CceeeecCCCCCccccchhhccc
Q 005909 455 GVAHAIEYLHNGCELRILHLDIKPQNVLL--DPDF--TPKVSDFGLAKAHSRN----RSVVTMTGPRGTIGYIAPEIFMR 526 (670)
Q Consensus 455 ~ia~gL~yLH~~~~~~ivH~dlkp~NIll--~~~~--~~ki~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 526 (670)
|+++|+.|||.+ +|.|||+|++|||| |+++ .+.|+|||..-..... .........-|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999998 99999999999999 4443 5788999976322110 00011122336778999999865
Q ss_pred ccCCC----CccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHH
Q 005909 527 NLGNP----SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVG 602 (670)
Q Consensus 527 ~~~~~----s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 602 (670)
..|.. -.|+|.|+.|.+.||+++...||..... ..+...-++ ++..+..+..++..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--------m~L~~r~Yq-------e~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--------MLLDTRTYQ-------ESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--------heechhhhh-------hhhCCCCcccCChHHHHHH
Confidence 43332 3489999999999999999999975221 111111011 1112222334566778889
Q ss_pred HhccccCCCCCCCHHHHHHHHh
Q 005909 603 LWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 603 ~~cl~~dP~~RPs~~evl~~L~ 624 (670)
...|+.||++|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876666654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=161.48 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=108.3
Q ss_pred HhhhccccccCceEEEEEE--eCCCcEEEEEEcccCCc-------------------------chHHHHHHHHHhccccc
Q 005909 351 NGFKEKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSN-------------------------FSDNFINEVATIGRIHH 403 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l~~l~H 403 (670)
+.+.+.||+|++|.||+|. ..+|+.||+|+++.... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3456889999999999998 46899999999875321 01235689999999975
Q ss_pred cc--cccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCc
Q 005909 404 VN--IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR-ILHLDIKPQN 480 (670)
Q Consensus 404 ~n--Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlkp~N 480 (670)
.. +.+++++ ...++||||+++++|........ .+.......++.|++.++++||++ + ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 32 3333332 23589999999988877653221 355666789999999999999998 8 9999999999
Q ss_pred EEECCCCCeEEeecCCccccC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~ 501 (670)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999886543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=156.92 Aligned_cols=133 Identities=21% Similarity=0.303 Sum_probs=112.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc---------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.||+|++|.||+|.+ ++..+++|+...... ....+.+|+.++..++|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999988 677888997653221 124578899999999999998888787777888999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
+++++|.+++.... + .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885421 2 7789999999999999998 999999999999999 78999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=154.86 Aligned_cols=136 Identities=19% Similarity=0.196 Sum_probs=107.7
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCc-----------------------chHHHHHHHHHhccccccc--
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-----------------------FSDNFINEVATIGRIHHVN-- 405 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~H~n-- 405 (670)
+.+.+.||+|+||.||++..++|+.||||+++.... ....+..|+..+.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 445688999999999999988899999998764321 0123667888999998774
Q ss_pred cccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 406 Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
+.+.++ ....++||||+++++|..+... .....++.+++.++.++|+. +++||||||+||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence 444433 3456899999999998775421 23457889999999999997 9999999999999999
Q ss_pred CCCeEEeecCCccccCC
Q 005909 486 DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~ 502 (670)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=172.97 Aligned_cols=175 Identities=23% Similarity=0.338 Sum_probs=130.4
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
.+++.|+++...+|.++|.+.......++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999876666678888999999999999999 4 8999999999999999999999999998
Q ss_pred cccCCCC----ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 498 KAHSRNR----SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 498 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
....... .....+...||..||+||.+.+. .++.|+||||||++|+||+. =...++...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------------- 467 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERIA-------------- 467 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHHH--------------
Confidence 8765544 22345667799999999999875 88999999999999999985 111111000
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 619 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 619 (670)
....+.++..+ +....+ .+.-..++.+++.+.|.+||++.++
T Consensus 468 -t~~d~r~g~ip---~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 -TLTDIRDGIIP---PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -hhhhhhcCCCC---hHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 01111222211 011111 1223468889999999999955444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=152.98 Aligned_cols=129 Identities=22% Similarity=0.343 Sum_probs=106.4
Q ss_pred cccccCceEEEEEEeCCCcEEEEEEcccCC----c-----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTS----N-----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.||+|+||.||+|.+ ++..+++|+..... . ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999986 56789999864322 1 1255778999999999887766666666677789999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++++|.+++.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874421 0 7899999999999998 999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=174.05 Aligned_cols=132 Identities=20% Similarity=0.304 Sum_probs=108.1
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccC-C-------cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT-S-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.||+|+||+||+|.+.+...++.+.+.+. . ...+.+.+|++++.+++|++++....++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 5789999999999998865543333222221 1 1124688999999999999999888887777788999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999988874 3467899999999999998 99999999999999 6779999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-15 Score=146.36 Aligned_cols=135 Identities=20% Similarity=0.254 Sum_probs=97.4
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCcch---HHH----------------------HHHHHHhccccccc--c
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS---DNF----------------------INEVATIGRIHHVN--I 406 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~H~n--I 406 (670)
.+.||+|+||+||+|...+++.||||+++...... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998889999999987543211 111 24555555554332 3
Q ss_pred ccccceeeeCCeeEEEEEecCCCCcccc-cccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEEC
Q 005909 407 IHLLGFCCDGSTRALIYEYMPNGSLGDL-LSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 407 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~ 484 (670)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|+ . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 333332 245899999998654322 21111 11 5668899999999999998 6 999999999999999
Q ss_pred CCCCeEEeecCCccccC
Q 005909 485 PDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 485 ~~~~~ki~DfGla~~~~ 501 (670)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=134.32 Aligned_cols=133 Identities=20% Similarity=0.201 Sum_probs=113.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc--cccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.||+|.++.||+++..+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 679999999999999855 7899999876544 5678999999999976 58999988888778899999999887776
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
.+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 4556678899999999999986445799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-15 Score=167.28 Aligned_cols=203 Identities=26% Similarity=0.343 Sum_probs=136.5
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
++.|..|++|.||.++++ ..+..|+|+ ++.....+. ++.....|.+| |+=.
T Consensus 88 IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn------ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN------ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcc-cccchhhhc------cccccCCccee---------------------chhh
Confidence 478999999999999987 466777744 332211111 22222333322 3444
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce------
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV------ 506 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~------ 506 (670)
..++..+ .++.. ++.+++|||+- +|+|||+||+|.+|+.-|++|++|||+++........
T Consensus 140 tllk~~g---~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 140 TLLKNIG---PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhcccCC---CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 4444322 23322 27899999987 9999999999999999999999999998753211100
Q ss_pred -------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 507 -------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 507 -------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
..-....||+.|+|||++... .+....|.|++|+|+||.+-|..||..... +.-|...+.+.+
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtp-------eelfg~visd~i- 275 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVISDDI- 275 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCH-------HHHHhhhhhhhc-
Confidence 111234699999999999864 678889999999999999999999976432 122222222221
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCC
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP 614 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 614 (670)
...+.+.....++.+++.+.|+.+|..|-
T Consensus 276 ------~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 ------EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 12222444566788889999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5e-14 Score=140.23 Aligned_cols=133 Identities=17% Similarity=0.244 Sum_probs=103.4
Q ss_pred cccc-ccCceEEEEEEeCCCcEEEEEEcccCC--------------cchHHHHHHHHHhcccccccc--ccccceeeeCC
Q 005909 355 EKLG-TGGYGNVYKGKFPDGRLVAVKVLEKTS--------------NFSDNFINEVATIGRIHHVNI--IHLLGFCCDGS 417 (670)
Q Consensus 355 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~~~ 417 (670)
..|| .|+.|+||++... +..++||.+.... .....+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999884 6778888774311 123467889999999998775 66777644322
Q ss_pred ----eeEEEEEecCC-CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 418 ----TRALIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 418 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||++ +|+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898887542 34443 356899999999998 99999999999999998999999
Q ss_pred ecCCccc
Q 005909 493 DFGLAKA 499 (670)
Q Consensus 493 DfGla~~ 499 (670)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998755
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-15 Score=169.93 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=186.6
Q ss_pred hhccccccCceEEEEEEeC--CCcEEEEEEcccCC---cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.||+|+|+.|-..... ....+|+|.+.... ...+....|..+-..+. |+|++++++...+.+..+++.+|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 4466999999999887664 34556666665443 33345556777777776 999999999999999999999999
Q ss_pred CCCCccccc-ccccCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCC-
Q 005909 427 PNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSR- 502 (670)
Q Consensus 427 ~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~- 502 (670)
.++++.+.+ +.... ..+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 104 ~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 104 DGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999988 43321 3555666778999999999999 66 999999999999999999 999999999988776
Q ss_pred CCceeeecCCCC-CccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVVTMTGPRG-TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
...........| ++.|+|||...+. ....+..|+||.|+++.-+++|..|++...... ..+..|...+..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------~~~~~~~~~~~~-- 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------GRYSSWKSNKGR-- 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc------ccceeecccccc--
Confidence 444444455667 9999999999764 345678999999999999999999987543311 222222211100
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
..............++...++..+|+.|.+.+++..
T Consensus 250 ----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 ----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 011112233445566777888899999998887753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.1e-14 Score=136.17 Aligned_cols=207 Identities=20% Similarity=0.268 Sum_probs=141.4
Q ss_pred HHHhccccccccccccceeeeC-----CeeEEEEEecCCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 005909 395 VATIGRIHHVNIIHLLGFCCDG-----STRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCE 468 (670)
Q Consensus 395 ~~~l~~l~H~nIv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 468 (670)
..-|-++-|-|||+++.|+.+. ....++.|||..|+|..+|++-+. ...+....+.+|..||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3455666799999999998754 346789999999999999987543 23678888899999999999999985 8
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHH
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 546 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~e 546 (670)
++|+|+++.-+.|++..+|-+||.--.-.......... .......+-++|.|||.-.. .+.+..+|||+||+..+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHH
Confidence 89999999999999999999998532111111000000 00112346789999997543 356678999999999999
Q ss_pred HHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 547 MIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 547 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
|.-+...... ....+..+.-......+...+. -+.++..|++..|..||+|++++.+.
T Consensus 275 mailEiq~tn--------seS~~~~ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTN--------SESKVEVEENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCC--------CcceeehhhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 9876643211 1111222221122221111111 12355679999999999999988765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.1e-13 Score=142.60 Aligned_cols=140 Identities=21% Similarity=0.271 Sum_probs=98.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcch-----------------------------------------HHHHH
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS-----------------------------------------DNFIN 393 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~~ 393 (670)
+.||.|++|+||+|++++|+.||||+.+..-... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999999999999999985431000 02344
Q ss_pred HHHHhcccc----cccccccccee-eeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q 005909 394 EVATIGRIH----HVNIIHLLGFC-CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH-AIEYLHNGC 467 (670)
Q Consensus 394 E~~~l~~l~----H~nIv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 467 (670)
|+..+.+++ |.+-+.+-..+ ...+..+|||||+++++|.++...... ..+ ..+++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC-
Confidence 555455442 22222222222 223457899999999999987643211 122 3456666666 46788887
Q ss_pred CCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 468 ~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+++|+|+||.||++++++.+++.|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-12 Score=139.26 Aligned_cols=249 Identities=21% Similarity=0.188 Sum_probs=180.7
Q ss_pred HHHHhhhccccc--cCceEEEEEEe---CCCcEEEEEEccc--C-CcchHHHHHHHHHhccc-cccccccccceeeeCCe
Q 005909 348 KMTNGFKEKLGT--GGYGNVYKGKF---PDGRLVAVKVLEK--T-SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 418 (670)
Q Consensus 348 ~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 418 (670)
+.+..+.+.+|. |.+|.||+++. .++..+|+|.-+. . ......=.+|+...+++ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 334445677899 99999999987 3678888887322 2 12233345778888888 59999999999999999
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEee
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH----AIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSD 493 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~D 493 (670)
.++-.|.+ +.+|.++.+.... .++...++....+... ||.++|+. +++|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999998 5788887765432 4777888888888888 99999998 99999999999999998 8899999
Q ss_pred cCCccccCCCCceee---ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccc
Q 005909 494 FGLAKAHSRNRSVVT---MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF 570 (670)
Q Consensus 494 fGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 570 (670)
||+...+........ .....|...|++||++.+ ..+..+|+|++|.+.+|...+-...... +.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g-----------~~ 332 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVG-----------KN 332 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCC-----------CC
Confidence 999988765542211 122357889999999974 5778999999999999999877654332 11
Q ss_pred hHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
..|...+ ... ...+.......++..++.+|++.+|-.|++.+.+..
T Consensus 333 ~~W~~~r--~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 SSWSQLR--QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCccccc--ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1221110 000 111111122334555888899999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.9e-12 Score=118.01 Aligned_cols=130 Identities=24% Similarity=0.190 Sum_probs=97.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccccccc-ccceeeeCCeeEEEEEecCCCCccc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH-LLGFCCDGSTRALIYEYMPNGSLGD 433 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lv~e~~~~gsL~~ 433 (670)
+.|+.|.++.||+++.. ++.+++|+..........+.+|+..+..+.+.++++ ++.+ .....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 56889999999999875 778999997665433345678999999987655543 4433 3334689999999988765
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 434 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 434 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
.- ... ..++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~-------~~~----~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED-------FSD----PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-------ccC----HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 011 245678999999999872 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.1e-12 Score=136.66 Aligned_cols=138 Identities=20% Similarity=0.275 Sum_probs=87.6
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEEcccCCc-----------------------------------chHH------HH
Q 005909 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN-----------------------------------FSDN------FI 392 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----------------------------------~~~~------~~ 392 (670)
+.||.|++|+||+|++++ |+.||||+++..-. ..+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 99999999874310 0111 23
Q ss_pred HHHHHhcccc----ccccccccceeee-CCeeEEEEEecCCCCccccc--ccccC-CCCCCHHHHHHHHHHHHHHHHHHH
Q 005909 393 NEVATIGRIH----HVNIIHLLGFCCD-GSTRALIYEYMPNGSLGDLL--SREKE-NLSLKPARLLEIALGVAHAIEYLH 464 (670)
Q Consensus 393 ~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH 464 (670)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+++.++- ...+. ...+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 3333333332 2222222222221 34567999999999998742 22110 00122222333333433
Q ss_pred cCCCCCeEecCCCCCcEEECCCC----CeEEeecCCccccCC
Q 005909 465 NGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLAKAHSR 502 (670)
Q Consensus 465 ~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla~~~~~ 502 (670)
.. +++|+|+||.||+++.++ .+++.|||+...++.
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999888 999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.4e-10 Score=121.90 Aligned_cols=165 Identities=18% Similarity=0.222 Sum_probs=125.5
Q ss_pred eCCCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHH
Q 005909 370 FPDGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 448 (670)
Q Consensus 370 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 448 (670)
..++.+|.|.+.+.... ..+...+-++.|+.+|||||++++..+......|||+|.+ ..|..++++.. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHH
Confidence 34688888888776554 3455778889999999999999999999999999999987 35777775432 455
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhccccc
Q 005909 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528 (670)
Q Consensus 449 ~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 528 (670)
..-.+.||+.||.+||..+ +++|++|.-..|++++.|+.||++|.+......... ......--..|..|+.+..+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS- 180 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc-
Confidence 5667899999999999753 899999999999999999999999998754432111 00111123356777766432
Q ss_pred CCCCccchhHHHHHHHHHHHhC
Q 005909 529 GNPSGKSDVYSYGMLLLEMIEE 550 (670)
Q Consensus 529 ~~~s~~sDV~SlGvvl~elltg 550 (670)
.-..|.|-||++++|++.|
T Consensus 181 ---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 ---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---ccchhhhhHHHHHHHHhCc
Confidence 1346999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=108.66 Aligned_cols=135 Identities=16% Similarity=0.185 Sum_probs=98.9
Q ss_pred ccccccCceEEEEEEeCC-------CcEEEEEEcccCC-----------------------cchHHH----HHHHHHhcc
Q 005909 355 EKLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTS-----------------------NFSDNF----INEVATIGR 400 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~----~~E~~~l~~ 400 (670)
..||.|--+.||.|...+ +..+|||+.+.+. ...+.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 4799999974311 011222 379999999
Q ss_pred ccc--cccccccceeeeCCeeEEEEEecCCCCccc-ccccccCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCC
Q 005909 401 IHH--VNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYL-HNGCELRILHLDI 476 (670)
Q Consensus 401 l~H--~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dl 476 (670)
+.. -++.+++++ ...+|||||+.++.+.. .+++. .++..+...+..+++.+|..| |.. +++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 466666654 56789999997654432 22221 245566678889999999999 776 9999999
Q ss_pred CCCcEEECCCCCeEEeecCCccccC
Q 005909 477 KPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 477 kp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.1e-11 Score=98.22 Aligned_cols=68 Identities=37% Similarity=0.850 Sum_probs=57.6
Q ss_pred CCCCCCE-EEEeCcCcccc---cccccHHHHhhCCceeeeCC-CCcchhhhcCCCccccCCCCCeEEEecCCC
Q 005909 199 APSGCDS-VVVPVSSVTSL---YLGADVFDTLRQGFPLEWPK-LDDCEKCQNRSGRCGYNGSLKKITCFCKGG 266 (670)
Q Consensus 199 ~~~~C~~-~~vpv~~~~~~---~~~~~~~~~l~~g~~l~W~~-~~~C~~C~~~~g~C~~~~~~~~~~C~C~~g 266 (670)
....|+. +.|||...... ....+|.++|++||+|+|.. ...|.+|+.++|+|+++.+...+.|+|++|
T Consensus 21 ~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~Cgy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 21 LAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRCGYDSNSEQFTCFCSDG 93 (94)
T ss_pred cCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEeCCCCCCceEEEECCCC
Confidence 6789987 66999876431 35678999999999999984 458999999999999998888999999876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-10 Score=110.33 Aligned_cols=141 Identities=23% Similarity=0.265 Sum_probs=111.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHhccccc--cccccccceeeeCC---eeEEEEEecC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHH--VNIIHLLGFCCDGS---TRALIYEYMP 427 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lv~e~~~ 427 (670)
+.|+.|..+.||++...+|+.+++|+...... ....+.+|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778899999866443 45678899999999975 44566777766542 5689999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC---------------------------------------- 467 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 467 (670)
+.++.+.+.. ..+++.....++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988887642 14777888888999999999998531
Q ss_pred -------------CCCeEecCCCCCcEEECC--CCCeEEeecCCccc
Q 005909 468 -------------ELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKA 499 (670)
Q Consensus 468 -------------~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~ 499 (670)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-09 Score=99.14 Aligned_cols=130 Identities=19% Similarity=0.255 Sum_probs=98.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEc-ccCCc--------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTSN--------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+++|+-+.+|.+.+.+ ..+++|.- .+.-. ..+...+|+.++.+++--.|.-..=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997743 34556543 22211 124567899999998765555555566778888899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
+++..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888543 245677788888999998 999999999999998764 99999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.8e-10 Score=123.03 Aligned_cols=240 Identities=18% Similarity=0.184 Sum_probs=167.3
Q ss_pred hhccccccCceEEEEEEeC--CCcEEEEEEcccCCcc-h--HHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTSNF-S--DNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~--~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+...||.|.|+.|++...+ ++..+++|.+.+.... . ..-..|+.+...+ .|.++++.+..|......++--||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3468999999999997654 5788888887654321 1 1223455555555 5889999888888888888999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~~~ 505 (670)
.++++...+. ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||....+.....
T Consensus 349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc
Confidence 9998877662 223578888999999999999999976 99999999999999875 8899999999865322111
Q ss_pred eeeecCCCCCcccc-chhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYI-APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.....-+++ .+|.+... ..+-.+.|++|||.-+.|.+++..-...... | ..+..+...
T Consensus 423 -----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~--~~i~~~~~p 481 (524)
T KOG0601|consen 423 -----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------S--LTIRSGDTP 481 (524)
T ss_pred -----cccccccccccchhhccc-cccccccccccccccccccccCcccCccccc-------------c--eeeeccccc
Confidence 111234455 35555544 4667799999999999999987753322111 0 111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.... ....+..++..++..++..||.+.++..+.+
T Consensus 482 ~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 482 NLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111 1134455667788999999999988876655
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.5e-09 Score=96.00 Aligned_cols=140 Identities=24% Similarity=0.319 Sum_probs=103.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEc-ccCC--------cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTS--------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
..+-||+-+.|+++.+ .|+...||.- .+.- -..+...+|++.|.+.+--.|.-..-++.+.....|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999998 5666666643 2211 1235678899999998755555555567777788899999
Q ss_pred cCC-CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeecCCccc
Q 005909 426 MPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKA 499 (670)
Q Consensus 426 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~DfGla~~ 499 (670)
+++ .++.+++....... ........++..+-+.+.-||.+ +|+|+||..+||+|..++ .+-++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 965 37788876554332 33333478899999999999998 999999999999996544 358999999743
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3e-08 Score=103.84 Aligned_cols=169 Identities=18% Similarity=0.274 Sum_probs=128.7
Q ss_pred CceEEEEEEeC-CCcEEEEEEcccCCcc-hHHHHHHHHHhccccccccccccceeee----CCeeEEEEEecCC-CCccc
Q 005909 361 GYGNVYKGKFP-DGRLVAVKVLEKTSNF-SDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYEYMPN-GSLGD 433 (670)
Q Consensus 361 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e~~~~-gsL~~ 433 (670)
.-.+.||+... ||..+++|++...+.. ...-..-++.++++.|.|||+|.+++.. +..+++||+|+|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678999875 8999999999543321 2233456789999999999999998762 3467899999984 57766
Q ss_pred cccccc------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 434 LLSREK------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 434 ~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
+-.... .+...++..+|.++.|+..||.++|+. |..-+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 223578899999999999999999998 99999999999999999999999888776655
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 553 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p 553 (670)
.+.. |.+. -..+-|.=.||.+++.|.+|...
T Consensus 445 ~d~~----------------~~le-----~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLE-----SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchh-----HHhhhhHHHHHHHHHHHhhcccc
Confidence 4431 1121 12367999999999999998654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-08 Score=96.95 Aligned_cols=125 Identities=26% Similarity=0.372 Sum_probs=82.1
Q ss_pred EEEEEEeCCCcEEEEEEcccCC--------------c-------------chHHHHHHHHHhcccccc--ccccccceee
Q 005909 364 NVYKGKFPDGRLVAVKVLEKTS--------------N-------------FSDNFINEVATIGRIHHV--NIIHLLGFCC 414 (670)
Q Consensus 364 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~E~~~l~~l~H~--nIv~l~g~~~ 414 (670)
-||.|...+|..+|||+.+... . ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999974310 0 013467899999999755 56666544
Q ss_pred eCCeeEEEEEecC--CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCCCCCcEEECCCCCeEE
Q 005909 415 DGSTRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY-LHNGCELRILHLDIKPQNVLLDPDFTPKV 491 (670)
Q Consensus 415 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~dlkp~NIll~~~~~~ki 491 (670)
....|||||++ +..+..+.... +.......++.+++..+.. +|.. +|+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 24579999998 54554433221 1133446677778886665 4676 99999999999999988 9999
Q ss_pred eecCCccccC
Q 005909 492 SDFGLAKAHS 501 (670)
Q Consensus 492 ~DfGla~~~~ 501 (670)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-09 Score=123.01 Aligned_cols=241 Identities=17% Similarity=0.206 Sum_probs=159.8
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcch----HHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+-+-.|.++.++.++-. .|...+.|+........ +....+-.++-..+||-+++..--+......+|+++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 45778888888876543 34444444443332211 22222223333334566666555555667789999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC-------
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR------- 502 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~------- 502 (670)
+|...|+... ..+..-.+.....+...++|||+. .+.|+|++|.|+++..+++.+++|||+......
T Consensus 890 ~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 890 DLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred CchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 9999998765 345455566777788999999986 699999999999999999999999984432100
Q ss_pred --------------C----C----ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005909 503 --------------N----R----SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 560 (670)
Q Consensus 503 --------------~----~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~ 560 (670)
. . .........+|+.|.+||.+.+. .....+|.|++|++++|.++|..||.....
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tp- 1040 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETP- 1040 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcch-
Confidence 0 0 00112335689999999999875 556689999999999999999999875433
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMT 617 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 617 (670)
+.+.+.+...... ......+...++.+++...+..+|.+|-.|.
T Consensus 1041 -----------q~~f~ni~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 -----------QQIFENILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -----------hhhhhccccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2222333322221 1122223344566677777889999998776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-07 Score=96.07 Aligned_cols=138 Identities=20% Similarity=0.111 Sum_probs=98.5
Q ss_pred ccccCceEEEEEEeCCCcEEEEEEcccCCc--ch----------HHHHHHHHHhccccc--cccccccceeee-----CC
Q 005909 357 LGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FS----------DNFINEVATIGRIHH--VNIIHLLGFCCD-----GS 417 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~----------~~~~~E~~~l~~l~H--~nIv~l~g~~~~-----~~ 417 (670)
+-+-....|.+..+ +|+.+.||....... .. ..+.+|...+.++.. -.+.+++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667666 677899997643221 01 147889998888853 334455666543 23
Q ss_pred eeEEEEEecCCC-CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-------CCCe
Q 005909 418 TRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-------DFTP 489 (670)
Q Consensus 418 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-------~~~~ 489 (670)
..+||+|++++. +|.+++..... ...+......++.+++..+.-||.+ +|+|+|++++|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 468999999875 78888753221 2355667788999999999999998 9999999999999975 4689
Q ss_pred EEeecCCccc
Q 005909 490 KVSDFGLAKA 499 (670)
Q Consensus 490 ki~DfGla~~ 499 (670)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-07 Score=92.10 Aligned_cols=135 Identities=22% Similarity=0.237 Sum_probs=95.7
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCC-------------------c----chHHHHHHHHHhcccccc--c
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-------------------N----FSDNFINEVATIGRIHHV--N 405 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~----~~~~~~~E~~~l~~l~H~--n 405 (670)
+.+.++||.|--+.||.|..++|.++|||.-+... + ......+|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999999999999999853211 0 123467899999999644 6
Q ss_pred cccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 406 Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
|.+.+++ +...+|||++++-.|...-.. .-+... ++..|++-+.-+-.. |+||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~-----~en~~~---il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLD-----VENPDE---ILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCc-----ccCHHH---HHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6666644 567899999988666554310 122233 333333333333344 9999999999999999
Q ss_pred CCCeEEeecCCcccc
Q 005909 486 DFTPKVSDFGLAKAH 500 (670)
Q Consensus 486 ~~~~ki~DfGla~~~ 500 (670)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999765443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.6e-07 Score=91.63 Aligned_cols=263 Identities=14% Similarity=0.122 Sum_probs=154.8
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccce------eeeCC-eeEEEEEe
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF------CCDGS-TRALIYEY 425 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~------~~~~~-~~~lv~e~ 425 (670)
...||+|+.+.+|-.-.-.++ +-|+...-.-..+ .+.+..|... .||-+..=+.| .-+.+ ..-+.|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQ--VAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhch--hheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 467999999999964322222 2355443322111 1223334444 46544331111 11122 24566666
Q ss_pred cCCC-Ccccccc---cccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 426 MPNG-SLGDLLS---REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 426 ~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
+++. ....++. +.+.-....|+.+++.++.++.+.+-||.+ |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-
Confidence 6543 2233332 222223578999999999999999999998 9999999999999999999999875432222
Q ss_pred CCCceeeecCCCCCccccchhhcc-ccc--CCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCC-CCCCccccchHH--H
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFM-RNL--GNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTS-GSNTTEAYFPDW--I 574 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~~sDV~SlGvvl~elltg-~~p~~~~~~~~-~~~~~~~~~~~~--~ 574 (670)
........++|...|.+||.-. +.+ ..-+...|-|.|||++++|+.| +.||.+..... .....+.....- .
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 2223456688999999999865 221 1335678999999999999886 88887643211 111111111110 0
Q ss_pred HH-HhcCCccccccchhhHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHhhc
Q 005909 575 YD-KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI--NPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 575 ~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~~ 626 (670)
+. +...+..+........-....+..+..+|+.. ++.-||+++..+..|..+
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00 01111111111222223345666677788765 367899999988877544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-08 Score=109.12 Aligned_cols=154 Identities=14% Similarity=0.244 Sum_probs=101.0
Q ss_pred HHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce----eee---cCCCCCccccchhhccc
Q 005909 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV----VTM---TGPRGTIGYIAPEIFMR 526 (670)
Q Consensus 454 ~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~----~~~---~~~~gt~~y~aPE~~~~ 526 (670)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+........... ... ....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 69999999999999999999999999987644331110 000 01124568999999976
Q ss_pred ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhcc
Q 005909 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCI 606 (670)
Q Consensus 527 ~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 606 (670)
. ..+.++|+||+|+++|.+..|+++.-..... .. ......... ..........++.++.+-+.+++
T Consensus 184 ~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~-----~~~~~~~~~---~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 T--TNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LL-----SYSFSRNLL---NAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred c--cccccccceeeeeEEEEEecCCcchhhccCC----cc-----hhhhhhccc---ccccccccccCcHHHHHHHHHHh
Confidence 4 6678999999999999999555443221110 00 000011111 01111112445667788888899
Q ss_pred ccCCCCCCCHHHHHHHH
Q 005909 607 QINPKDRPSMTRVVEML 623 (670)
Q Consensus 607 ~~dP~~RPs~~evl~~L 623 (670)
..++..||++.++....
T Consensus 250 ~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cCCcccCcchhhhhccc
Confidence 99999999887766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.1e-07 Score=100.19 Aligned_cols=141 Identities=19% Similarity=0.253 Sum_probs=90.8
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc-------------------------------chH----------HHHH
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------------------FSD----------NFIN 393 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------------------~~~----------~~~~ 393 (670)
+.|+.++-|+||+|++++|+.||||+.+..-. ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45889999999999999999999999753210 001 1334
Q ss_pred HHHHhcccc-----ccccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 005909 394 EVATIGRIH-----HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468 (670)
Q Consensus 394 E~~~l~~l~-----H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 468 (670)
|...+.+++ .++|.=.-=++.......|+|||++|-.+.+...-... ..+...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f~~q~~~d---- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAFLRQLLRD---- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHHHHHHHhc----
Confidence 444444442 22222111123335567899999999999888532221 2443333332222222222223
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.2e-06 Score=80.88 Aligned_cols=137 Identities=16% Similarity=0.114 Sum_probs=101.5
Q ss_pred ccccCceEEEEEEeCCCcEEEEEEcccC-------CcchHHHHHHHHHhccccc--cccccccceee-eC----CeeEEE
Q 005909 357 LGTGGYGNVYKGKFPDGRLVAVKVLEKT-------SNFSDNFINEVATIGRIHH--VNIIHLLGFCC-DG----STRALI 422 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~-~~----~~~~lv 422 (670)
-|.||-+.|++..+. |+.+-+|.-... +.....|.+|+..+.++.. -.+.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366899999998774 446888876521 2245689999999999953 3355555 332 21 235799
Q ss_pred EEecCC-CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC--eEEeecCCccc
Q 005909 423 YEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKA 499 (670)
Q Consensus 423 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~--~ki~DfGla~~ 499 (670)
+|-+++ .+|.+++.+... ...+......+..+++..++-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997753 588888755322 1467777889999999999999998 9999999999999986666 99999986654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.6e-06 Score=84.53 Aligned_cols=107 Identities=25% Similarity=0.355 Sum_probs=84.1
Q ss_pred hHHHHHHHHHhcccc--ccccccccceeeeCC----eeEEEEEecCCC-CcccccccccCCCCCCHHHHHHHHHHHHHHH
Q 005909 388 SDNFINEVATIGRIH--HVNIIHLLGFCCDGS----TRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAI 460 (670)
Q Consensus 388 ~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 460 (670)
...+.+|...+.++. .-.+.+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346778888888884 344566677766532 347999999874 78888865332 55667788999999999
Q ss_pred HHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeecCCcccc
Q 005909 461 EYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKAH 500 (670)
Q Consensus 461 ~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~DfGla~~~ 500 (670)
+-||.+ +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999998 999999999999998887 8999999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.1e-06 Score=90.46 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=93.1
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCc--------------------------------chH------HHHHHHH
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--------------------------------FSD------NFINEVA 396 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------------------~~~------~~~~E~~ 396 (670)
+.||.-+.|+||+|++++|+.||||+-+..-+ ..+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46999999999999999999999999643210 001 2444554
Q ss_pred Hhccc----cccc------cccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005909 397 TIGRI----HHVN------IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466 (670)
Q Consensus 397 ~l~~l----~H~n------Iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 466 (670)
-..+. +|-+ |.+++ +.-.....|+|||++|..+.++-.-.. ..++...+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 33333 3444 22222 223446789999999998887743222 13666655555444443333333
Q ss_pred CCCCeEecCCCCCcEEECC----CCCeEEeecCCccccCC
Q 005909 467 CELRILHLDIKPQNVLLDP----DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 467 ~~~~ivH~dlkp~NIll~~----~~~~ki~DfGla~~~~~ 502 (670)
|.+|.|=+|.||+++. ++.+.+-|||+......
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 67899999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.9e-06 Score=80.00 Aligned_cols=132 Identities=21% Similarity=0.252 Sum_probs=84.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc--cccccceeeeCCeeEEEEEecCCCC-c
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGFCCDGSTRALIYEYMPNGS-L 431 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~e~~~~gs-L 431 (670)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 24456788876533 3456789999999986433 4667777777777889999998863 2
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHcC-CCCCe
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHA---------------------------------------IEYLHNG-CELRI 471 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------L~yLH~~-~~~~i 471 (670)
...+. .+......++..+++. ..+|... ....+
T Consensus 83 ~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 83 SRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 21111 0011111111112222 2222211 12357
Q ss_pred EecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 472 LHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 472 vH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
+|+|+.|.||++++++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-05 Score=77.90 Aligned_cols=136 Identities=23% Similarity=0.272 Sum_probs=92.1
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcch--------------------H-----HHHHHHHHhcccc--ccccc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS--------------------D-----NFINEVATIGRIH--HVNII 407 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~E~~~l~~l~--H~nIv 407 (670)
..|.+|--+.||+|...++..+|||+.+.....- + -..+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4678899999999998889999999986532111 0 1234555555553 33333
Q ss_pred cccceeeeCCeeEEEEEecCCCCc-ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 408 HLLGFCCDGSTRALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 408 ~l~g~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
+.+++. ...|||||+....+ +=.|+.. .+.......+..++++.+.-|-.. .++||+||..-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 343332 34599999964411 1222221 233335677788888888888873 3999999999999999 7
Q ss_pred CCeEEeecCCccccC
Q 005909 487 FTPKVSDFGLAKAHS 501 (670)
Q Consensus 487 ~~~ki~DfGla~~~~ 501 (670)
+.+.|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999886654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.4e-05 Score=77.38 Aligned_cols=139 Identities=15% Similarity=0.160 Sum_probs=84.6
Q ss_pred ccccCc-eEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCCCCcccc
Q 005909 357 LGTGGY-GNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 434 (670)
Q Consensus 357 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 434 (670)
|-.|.. ..||+.... +..+.+|+..... ..+..+|++++..+. +--+.+++++....+..++|||++++.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 789999764 4778888876543 345678998888883 44455677777666678999999998877643
Q ss_pred c-------------------ccccC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHcC----CC
Q 005909 435 L-------------------SREKE-NLSLKP--ARLLEIAL--------------------GVAHAIEYLHNG----CE 468 (670)
Q Consensus 435 l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~gL~yLH~~----~~ 468 (670)
. |.... ...... ...+.... .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11000 001110 00000000 011112222111 12
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998888999998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.9e-05 Score=73.71 Aligned_cols=128 Identities=17% Similarity=0.204 Sum_probs=80.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHH----------HHHHHHHhccccc---cccccccceee-----eC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN----------FINEVATIGRIHH---VNIIHLLGFCC-----DG 416 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~H---~nIv~l~g~~~-----~~ 416 (670)
+.+-......|.+-.. +|+..++|..+......++ ..+++..+.+++. .....++.+.. ..
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3444444445555444 5677888887654322221 2234444444432 22233333222 22
Q ss_pred CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 417 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
...+|+|||++|..|.++.. +++ .++..+.+++.-||.. |++|+|.+|.|++++++ .+++.||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcc
Confidence 34568999999988877642 333 2445677889999998 99999999999999865 599999986
Q ss_pred cc
Q 005909 497 AK 498 (670)
Q Consensus 497 a~ 498 (670)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.3e-06 Score=94.06 Aligned_cols=182 Identities=16% Similarity=0.140 Sum_probs=132.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc-cccccceeeeCCeeEEEEEecCCC-Ccc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYEYMPNG-SLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~e~~~~g-sL~ 432 (670)
..+++|+++.++|.+....+....+.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 446789999999988755555556666544 34456889999999999 777777676777888999999776 222
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
..... ....+...+...+.+.-+++++|||+. .-+|+| ||+..+ +..|..||+....+.+.. .....
T Consensus 324 ~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 324 LEMTV--SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred ccCCh--hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 21111 112355556667777888999999975 558998 777765 689999999987776543 12345
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 555 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~ 555 (670)
.+++.|+|||+...+ .+..+-|+|++|+-..+|.-|-.|..
T Consensus 391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence 689999999998764 56778999999988888877766654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.1e-05 Score=75.08 Aligned_cols=105 Identities=24% Similarity=0.216 Sum_probs=82.6
Q ss_pred HHHHHHhccccc-cccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 005909 392 INEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470 (670)
Q Consensus 392 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 470 (670)
.+|..+++.+.+ +++.+++|.| ..++|.||...+++...-..-..-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888865 6999999999 34689999987766532110001114789999999999999999999865446
Q ss_pred eEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 471 ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.03 E-value=3e-05 Score=76.89 Aligned_cols=141 Identities=21% Similarity=0.244 Sum_probs=83.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccc--ccccccceeee---CCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGFCCD---GSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~---~~~~~lv~e~~~~g 429 (670)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++..... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568899999999999977 68999987665 4567788999998888533 34566664433 23468999999988
Q ss_pred Cccc----------------cc---cccc-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHcC-
Q 005909 430 SLGD----------------LL---SREK-ENLSLKPAR---------LLEI------------ALGVAH-AIEYLHNG- 466 (670)
Q Consensus 430 sL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~~- 466 (670)
.+.. .+ +... ......... .... ...+.+ .+..+++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7777 11 1110 000111100 0000 111222 33333321
Q ss_pred ---CCCCeEecCCCCCcEEEC-CCCCeEEeecCCc
Q 005909 467 ---CELRILHLDIKPQNVLLD-PDFTPKVSDFGLA 497 (670)
Q Consensus 467 ---~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla 497 (670)
....++|+|+.|.||+++ +++.+.|.||+.+
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 234799999999999999 6666789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=85.19 Aligned_cols=145 Identities=16% Similarity=0.252 Sum_probs=91.0
Q ss_pred ccccccCceEEEEEEeCCC---cEEEEEEcccCC--cchHHHHHHHHHhcccc-cccc--ccccceeeeC---CeeEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNI--IHLLGFCCDG---STRALIY 423 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lv~ 423 (670)
+.++.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.+| .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5689999999999887654 366777764432 23457889999999995 6664 7777777654 3578999
Q ss_pred EecCCCCcccc-----------------------cccccCC--------CCCC--HHHHHHHH---------------HH
Q 005909 424 EYMPNGSLGDL-----------------------LSREKEN--------LSLK--PARLLEIA---------------LG 455 (670)
Q Consensus 424 e~~~~gsL~~~-----------------------l~~~~~~--------~~l~--~~~~~~i~---------------~~ 455 (670)
||+++..+.+. ||..... .+.. ..++..+. ..
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987654321 1110000 0000 11111111 12
Q ss_pred HHHHHHHHHcCCC--------CCeEecCCCCCcEEECCC--CCeEEeecCCccc
Q 005909 456 VAHAIEYLHNGCE--------LRILHLDIKPQNVLLDPD--FTPKVSDFGLAKA 499 (670)
Q Consensus 456 ia~gL~yLH~~~~--------~~ivH~dlkp~NIll~~~--~~~ki~DfGla~~ 499 (670)
+.+.+.+|..+.. ..++|+|+++.||+++.+ ..+-|.||+++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3344566754321 249999999999999753 3468999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00024 Score=73.26 Aligned_cols=75 Identities=12% Similarity=0.106 Sum_probs=56.0
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc---cccccccceeeeC---CeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH---VNIIHLLGFCCDG---STRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~lv~e~~~~ 428 (670)
+.||.|..+.||+....+++ +.+|..+. ......+.+|.+.|+.+.. ..|.++++++..+ +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 56999999999999876664 56676433 2234678899999988843 3677888877543 568999999988
Q ss_pred CCc
Q 005909 429 GSL 431 (670)
Q Consensus 429 gsL 431 (670)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.80 E-value=7.2e-05 Score=86.25 Aligned_cols=199 Identities=17% Similarity=0.180 Sum_probs=138.1
Q ss_pred HHHHHHHhccccccccccccceeeeCCeeE----EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005909 391 FINEVATIGRIHHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466 (670)
Q Consensus 391 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 466 (670)
..-|...+.++.|+|++.+++|..+....- +..++++.-++...+.... .++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 445777888889999999999877654332 4457787778877775543 588899999999999999999987
Q ss_pred CCCCeEecCCCCC---cEEECCCCCeEEe--ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHH
Q 005909 467 CELRILHLDIKPQ---NVLLDPDFTPKVS--DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 541 (670)
Q Consensus 467 ~~~~ivH~dlkp~---NIll~~~~~~ki~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlG 541 (670)
...|.-+..+ +...+.++..+++ ||+.++......... ...-+..|.+||....+....+...|+|.+|
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 4445444444 5556677788888 998887765433221 1223567889998877655666678999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 542 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 542 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
..+..+..|..+-..... ...+.. ... ...+.+....|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~---------------~~~~l~--------~~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV---------------PVSLLD--------VLS---TSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc---------------hhhhhc--------ccc---chhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999887654321110 000000 000 003455667899999999999999998
Q ss_pred HHh
Q 005909 622 MLS 624 (670)
Q Consensus 622 ~L~ 624 (670)
+.-
T Consensus 434 ~~f 436 (1351)
T KOG1035|consen 434 HPF 436 (1351)
T ss_pred chh
Confidence 775
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00031 Score=67.39 Aligned_cols=129 Identities=21% Similarity=0.344 Sum_probs=90.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCC-----------------cchHHHHHHHHHhcccc------ccccccccc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----------------NFSDNFINEVATIGRIH------HVNIIHLLG 411 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------H~nIv~l~g 411 (670)
..||+|+.-.||. +++.....||+..... ...++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4689999999985 5666777889887654 23466777776555555 889999999
Q ss_pred eeeeCCeeEEEEEecCC--C----CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 412 FCCDGSTRALIYEYMPN--G----SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 412 ~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
+..++....+|+|.+-+ | +|.+++.+. .+++ ...+. +-+-..||-.+ .|+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEEEe
Confidence 99999999999998743 2 566666433 3554 33333 33445566665 8999999999999943
Q ss_pred C--C--CeEEee-cCC
Q 005909 486 D--F--TPKVSD-FGL 496 (670)
Q Consensus 486 ~--~--~~ki~D-fGl 496 (670)
. + .+.|+| ||-
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 2 2 466665 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00025 Score=70.60 Aligned_cols=75 Identities=15% Similarity=0.234 Sum_probs=45.9
Q ss_pred ccccccCce-EEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccc---ccccccceeeeC---CeeEEEEEecC
Q 005909 355 EKLGTGGYG-NVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV---NIIHLLGFCCDG---STRALIYEYMP 427 (670)
Q Consensus 355 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~---~~~~lv~e~~~ 427 (670)
+.++.|+.. .||+. +..+++|.... .....++.+|.+.+..+... -+.+.++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 346666665 58875 23466776554 22355788999988877532 233344333222 23478999999
Q ss_pred CCCcccc
Q 005909 428 NGSLGDL 434 (670)
Q Consensus 428 ~gsL~~~ 434 (670)
+.++.+.
T Consensus 78 G~~l~~~ 84 (235)
T cd05155 78 GETATAA 84 (235)
T ss_pred CCCCCcc
Confidence 8877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00038 Score=69.30 Aligned_cols=74 Identities=18% Similarity=0.223 Sum_probs=49.1
Q ss_pred ccccccCceEEEEEEeCC--CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEecCCCCc
Q 005909 355 EKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.|..|-...+|+....+ ++.+++|+........-+..+|+.++..+....+ .++++... ..+++||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998764 6788899876543322233578888888854333 33433322 2489999998776
Q ss_pred c
Q 005909 432 G 432 (670)
Q Consensus 432 ~ 432 (670)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00048 Score=63.43 Aligned_cols=127 Identities=24% Similarity=0.245 Sum_probs=84.9
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccccccc-ccceeeeCCeeEEEEEecCCCCcc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH-LLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+.|++|.+|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.-.++.+ ++.+. ...+.|||+.+-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 467999999999999995 4578888765443 4678999999999887665544 33222 223559999877776
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC-CCcEEECCCCCeEEeecCCccc
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK-PQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk-p~NIll~~~~~~ki~DfGla~~ 499 (670)
+.-.. .+...+ ..+++.---|... +|-|+.|. |..++|..++.+.|+||.-|+.
T Consensus 101 ~~~~~------~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG------GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc------ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65421 122333 3344443334433 99999995 5545554555999999998763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00095 Score=67.42 Aligned_cols=137 Identities=14% Similarity=0.135 Sum_probs=78.6
Q ss_pred ccccCceEEEEEEeCCCcEEEEEEcccCCcch-HHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEecCCCCcccc
Q 005909 357 LGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSLGDL 434 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~~~gsL~~~ 434 (670)
+..|-.+.+|+... +++.+++|+........ -+..+|..+++.+....+ .+++... . ..+|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 55677889999874 56678888765433221 245788888888864333 3333332 2 3689999998776432
Q ss_pred -----------------cccccC-CCCCCHH-HHHHHHHH---------HHHHHHHHHcC-----CCCCeEecCCCCCcE
Q 005909 435 -----------------LSREKE-NLSLKPA-RLLEIALG---------VAHAIEYLHNG-----CELRILHLDIKPQNV 481 (670)
Q Consensus 435 -----------------l~~~~~-~~~l~~~-~~~~i~~~---------ia~gL~yLH~~-----~~~~ivH~dlkp~NI 481 (670)
||.... ...++.. .+..+..+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111110 1111211 11111111 11112222111 123589999999999
Q ss_pred EECCCCCeEEeecCCccc
Q 005909 482 LLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~ 499 (670)
++++++ ++|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999997743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0015 Score=62.22 Aligned_cols=123 Identities=28% Similarity=0.481 Sum_probs=86.7
Q ss_pred HHhhhccccccCc-eEEEEEEeCCCcEEEEEEccc---C---------C----------cchHHHHHHHHHhcccc---c
Q 005909 350 TNGFKEKLGTGGY-GNVYKGKFPDGRLVAVKVLEK---T---------S----------NFSDNFINEVATIGRIH---H 403 (670)
Q Consensus 350 ~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~---------~----------~~~~~~~~E~~~l~~l~---H 403 (670)
..+|.+.||.|.- |.|||++. +|+.+|+|+++. . . ...+.|..|.+...+|+ +
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 3456789999999 99999999 677999999321 0 0 11235888998888884 4
Q ss_pred ccc--ccccceeeeC------------------CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 005909 404 VNI--IHLLGFCCDG------------------STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463 (670)
Q Consensus 404 ~nI--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 463 (670)
.++ |+.+||..-. ....||-||.+... .+. .+-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 456 8888886321 01246666664332 122 33456678888999
Q ss_pred HcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 464 H~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 987 9999999999986 3489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0014 Score=67.62 Aligned_cols=141 Identities=19% Similarity=0.151 Sum_probs=84.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc--cccccce------eeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGF------CCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~e~~ 426 (670)
+.|..|....+|+....++ .+++|+... ...++...|+.++..+.+.. +.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4677788889999876544 678888765 23456777888888885332 4444432 22344568999999
Q ss_pred CCCCcccc--------------cccccCC--------CCCCHHHHH----------HHHHHHHHHHHHHHc----CCCCC
Q 005909 427 PNGSLGDL--------------LSREKEN--------LSLKPARLL----------EIALGVAHAIEYLHN----GCELR 470 (670)
Q Consensus 427 ~~gsL~~~--------------l~~~~~~--------~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~~~ 470 (670)
+|..+... +|..... ....|.... .....+...+.++.. ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 98776431 0110000 011111110 011123344445443 12347
Q ss_pred eEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 471 ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
++|+|+.|.||++++++.+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=67.22 Aligned_cols=140 Identities=24% Similarity=0.277 Sum_probs=84.1
Q ss_pred ccccccCceEEEEEEeCC-------CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+ .++++++.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345667777999988765 5789999976654444556788888888853333 344444432 3589999
Q ss_pred CCCCcccc-----------------cccccCCC------CCC--HHHHHH--------------------------HHHH
Q 005909 427 PNGSLGDL-----------------LSREKENL------SLK--PARLLE--------------------------IALG 455 (670)
Q Consensus 427 ~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~~ 455 (670)
+|.++... +|+..... ..+ +..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776431 11111100 000 111111 1122
Q ss_pred HHHHHHHHHc------CCCCCeEecCCCCCcEEECCC----CCeEEeecCCcc
Q 005909 456 VAHAIEYLHN------GCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAK 498 (670)
Q Consensus 456 ia~gL~yLH~------~~~~~ivH~dlkp~NIll~~~----~~~ki~DfGla~ 498 (670)
+..-+.+|.. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2233344432 234578999999999999985 889999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0025 Score=67.89 Aligned_cols=73 Identities=15% Similarity=0.139 Sum_probs=52.9
Q ss_pred ccccccCceEEEEEEeCCC-cEEEEEEcccC--------CcchHHHHHHHHHhcccc---ccccccccceeeeCCeeEEE
Q 005909 355 EKLGTGGYGNVYKGKFPDG-RLVAVKVLEKT--------SNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv 422 (670)
+.||.|.+..||++...+| +.++||.-... ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999999877 58999985411 123456777888888763 2456667766 44557899
Q ss_pred EEecCCC
Q 005909 423 YEYMPNG 429 (670)
Q Consensus 423 ~e~~~~g 429 (670)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0073 Score=63.15 Aligned_cols=141 Identities=13% Similarity=0.121 Sum_probs=77.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc--cccccc------eeeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLG------FCCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g------~~~~~~~~~lv~e~~ 426 (670)
+.|+.|...++|+....+| .+++|+... ...+....|+..+..|.... +.+.+. +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567787789999887665 578888762 22344445556565553211 333332 122345678999999
Q ss_pred CCCCcccc--------------cccccCC--------CCCCH-HHHHH------------HH-HHHHHHHHHHHcC----
Q 005909 427 PNGSLGDL--------------LSREKEN--------LSLKP-ARLLE------------IA-LGVAHAIEYLHNG---- 466 (670)
Q Consensus 427 ~~gsL~~~--------------l~~~~~~--------~~l~~-~~~~~------------i~-~~ia~gL~yLH~~---- 466 (670)
++..+... +|..... ..+.+ ..... .. ..+...++.+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 88754211 1111000 01111 11111 11 1111222333211
Q ss_pred CCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 467 ~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
...+++|+|+++.||+++++....|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23489999999999999977666899998763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.015 Score=60.35 Aligned_cols=141 Identities=18% Similarity=0.184 Sum_probs=81.4
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccc--ccccccce------eeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF------CCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~------~~~~~~~~lv~e~~ 426 (670)
+.++.|....+|+....++ .+++|+..... ..++...|++++..|... .+.+++.. ....+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4567777789999876555 46678765432 234556677777776422 23444332 12245578999999
Q ss_pred CCCCcccc--------------cccccCCC---------CCCHHHHH------------HHHHHHHHHHHHHHc----CC
Q 005909 427 PNGSLGDL--------------LSREKENL---------SLKPARLL------------EIALGVAHAIEYLHN----GC 467 (670)
Q Consensus 427 ~~gsL~~~--------------l~~~~~~~---------~l~~~~~~------------~i~~~ia~gL~yLH~----~~ 467 (670)
+|..+... +|...... .-.|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 88654311 11110000 00111100 011223345555542 22
Q ss_pred CCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 468 ~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..+++|+|+++.||++++++...|.||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 458999999999999998877789999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.012 Score=60.53 Aligned_cols=140 Identities=20% Similarity=0.274 Sum_probs=97.4
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCC----------------------cch-----HHHHHHHHHhcccccccc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS----------------------NFS-----DNFINEVATIGRIHHVNI 406 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~-----~~~~~E~~~l~~l~H~nI 406 (670)
-..|..|--+-||.+.-.+|..+|||+.+.+- ... --...|++-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35788999999999999999999999975421 000 113457777777765443
Q ss_pred ccccceeeeCCeeEEEEEecCCCCc-ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 407 IHLLGFCCDGSTRALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 407 v~l~g~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
.-.--+.. ....|||+|+..... +-.|+. ..++...+..+-.+++.-|.-|.+.| ++||.||.--|+|+.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 32111111 234689999953222 222222 25777788888889999999998876 899999999999996
Q ss_pred CCCeEEeecCCccccCC
Q 005909 486 DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~ 502 (670)
+|.+.|+|-+-+.....
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 56899999998765543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.017 Score=58.92 Aligned_cols=72 Identities=13% Similarity=0.135 Sum_probs=39.9
Q ss_pred cccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 358 GTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 358 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
++|--..|+.....+|+..++|.-+.. .....+.+|.++|..++..-=++.-.+.. .+...++|+++++..+
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~~~l~vpvP~~~~-~~~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRRP-DVSERAAAEKRVLALVRKHLPVQVPDWRV-HTPELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHHhcCCCCCCceee-ecCceEEEeccCCCcc
Confidence 444445666665556888888887532 23456788999998885210011111111 1123466777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=60.47 Aligned_cols=140 Identities=20% Similarity=0.224 Sum_probs=81.4
Q ss_pred ccccccCceEEEEEEeCC-----CcEEEEEEcccCCcchHHHHHHHHHhccccccccc-cccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNII-HLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+-.|-...+|+....+ ++.+++|+........-+-.+|..++..+...++. ++++.+..+ .|.||+++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 345557778899987542 36788998765443222236788888888644443 455554332 58999987
Q ss_pred CCcccc-----------------cccccC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-C
Q 005909 429 GSLGDL-----------------LSREKE---NLSLKPARLLEIALGV-----------------AHAIEYL----HN-G 466 (670)
Q Consensus 429 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~-~ 466 (670)
.+|... +|+... .....+.++.++..++ ..-+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 111110 0011123332332111 1112222 21 1
Q ss_pred CCCCeEecCCCCCcEEECC-CCCeEEeecCCcc
Q 005909 467 CELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK 498 (670)
Q Consensus 467 ~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~ 498 (670)
....++|+|+++.|||+++ ++.++++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2346899999999999986 4689999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0055 Score=61.83 Aligned_cols=133 Identities=17% Similarity=0.184 Sum_probs=90.9
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC-----------------cch------HHHHHHHHHhcccc-cc-cc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----------------NFS------DNFINEVATIGRIH-HV-NI 406 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~------~~~~~E~~~l~~l~-H~-nI 406 (670)
.+.++||-|--+-||.+...+|++.++|.-+... ... -...+|...|+.+. |- -|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4568999999999999999999999998753211 001 13456777777773 22 23
Q ss_pred ccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 407 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
.+.+ +.+..++|||++.+-.|...-+- .++.++..- +..-+--|-.+ |+||+|..-=||+++++
T Consensus 175 Pkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~---lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 175 PKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDD---LMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHH---HHHHHHHHHHc---CceecccchheeEEecC
Confidence 3333 34567899999988888765432 233333333 33334445555 99999999999999999
Q ss_pred CCeEEeecCCcccc
Q 005909 487 FTPKVSDFGLAKAH 500 (670)
Q Consensus 487 ~~~ki~DfGla~~~ 500 (670)
+.++++||--....
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999755433
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.017 Score=59.07 Aligned_cols=72 Identities=19% Similarity=0.293 Sum_probs=47.9
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc---ccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.++.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 568889999999988 578889999876 333466788888877773 445778888888777889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.055 Score=57.63 Aligned_cols=71 Identities=11% Similarity=0.080 Sum_probs=48.7
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEccc-----CC---cchHHHHHHHHHhcccc---ccccccccceeeeCCeeEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEK-----TS---NFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.||.|....||+.... ++.++||.-.. .. ........|++.|+.+. ..++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 57899999999998874 45688887651 11 12344445566666553 247778888776 4467899
Q ss_pred EecCC
Q 005909 424 EYMPN 428 (670)
Q Consensus 424 e~~~~ 428 (670)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.1 Score=54.64 Aligned_cols=72 Identities=17% Similarity=0.129 Sum_probs=47.4
Q ss_pred cCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc--ccccccc---c--eeeeCCeeEEEEEecCCCCc
Q 005909 360 GGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLL---G--FCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 360 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~---g--~~~~~~~~~lv~e~~~~gsL 431 (670)
+.-..||+....++..+++|+.+.......+...|++.+..+.. -.|+... | ....++..+.++++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34567999988888899999987554455677788887777732 1223222 2 22334567789999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.1 Score=53.73 Aligned_cols=132 Identities=20% Similarity=0.285 Sum_probs=80.9
Q ss_pred cCceEEEEEEeCCCcEEEEEEccc-C--CcchHHHHHHHHHhccccc--cccccccceeeeCC--eeEEEEEecCCCCcc
Q 005909 360 GGYGNVYKGKFPDGRLVAVKVLEK-T--SNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGS--TRALIYEYMPNGSLG 432 (670)
Q Consensus 360 G~~g~Vy~~~~~~~~~vavK~~~~-~--~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lv~e~~~~gsL~ 432 (670)
|..-.+|..... ++..+++ ... . ........+|+.++..+.- .-+.+.++.|.++. ..+.||+|+++..+.
T Consensus 36 G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 433445555443 7777777 331 1 1234556677777777742 23445567776666 678999999875444
Q ss_pred cccccccCCCCCCHHHHHHHH-HHHHHHHHHHH-----------------------------------------------
Q 005909 433 DLLSREKENLSLKPARLLEIA-LGVAHAIEYLH----------------------------------------------- 464 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~-~~ia~gL~yLH----------------------------------------------- 464 (670)
..+.... .. .+++ ..+++.|+-||
T Consensus 114 ~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 114 SALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred CcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 4332211 11 1122 24555555555
Q ss_pred ---cCC-----CCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 465 ---NGC-----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 465 ---~~~-----~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
++. ...++|+|+.+.|++++.+.-+-|.||+++..-.
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 221 1358999999999999999889999999986543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.12 Score=53.92 Aligned_cols=138 Identities=22% Similarity=0.253 Sum_probs=84.9
Q ss_pred ccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc------cccccc----eeeeCCeeEEEEEec
Q 005909 357 LGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN------IIHLLG----FCCDGSTRALIYEYM 426 (670)
Q Consensus 357 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g----~~~~~~~~~lv~e~~ 426 (670)
|.+ .-..+|+....+|+. ++|+.+.. ....++..|+..+..+.-.. |..+-| ....+...+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 556789998878877 89998887 56777888888888874221 222222 111223677899999
Q ss_pred CCCCccc-cc--------------ccccC---------CCCCCHHH-------------HHHHHHHHHHHHHHHHcCC--
Q 005909 427 PNGSLGD-LL--------------SREKE---------NLSLKPAR-------------LLEIALGVAHAIEYLHNGC-- 467 (670)
Q Consensus 427 ~~gsL~~-~l--------------~~~~~---------~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~-- 467 (670)
+|..+.. .. |.... .....|.. -.....++...+..+.+..
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9888873 11 11000 00122220 0113344445555555431
Q ss_pred --CC-C--eEecCCCCCcEEECCCCC-eEEeecCCc
Q 005909 468 --EL-R--ILHLDIKPQNVLLDPDFT-PKVSDFGLA 497 (670)
Q Consensus 468 --~~-~--ivH~dlkp~NIll~~~~~-~ki~DfGla 497 (670)
.. + +||+|+.|.||+++++.. +.+.||+-+
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 12 3 999999999999999874 899999865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.076 Score=55.72 Aligned_cols=141 Identities=15% Similarity=0.176 Sum_probs=79.2
Q ss_pred ccccccCceEEEEEEeCC----CcEEEEEEcccCCcchHHHHHHHHHhccccccccc-cccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNII-HLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.|..|-...+|+....+ +..+++|+........-+-.+|..+++.+..-++. ++++++..+ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 345557777889887543 24788998765443322345788888888655553 455554322 589999776
Q ss_pred Ccccc-----------------cccccC---CCCCCHHHHHHHHHHH----------------------HHHHHH---HH
Q 005909 430 SLGDL-----------------LSREKE---NLSLKPARLLEIALGV----------------------AHAIEY---LH 464 (670)
Q Consensus 430 sL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i----------------------a~gL~y---LH 464 (670)
+|..- +|.... +..--+..+.++..++ .+-+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 111110 0011122222222221 111111 11
Q ss_pred -c-CCCCCeEecCCCCCcEEECC-CCCeEEeecCCccc
Q 005909 465 -N-GCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKA 499 (670)
Q Consensus 465 -~-~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~ 499 (670)
+ ....-..|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11224789999999999975 57899999998754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.024 Score=55.32 Aligned_cols=122 Identities=17% Similarity=0.177 Sum_probs=60.3
Q ss_pred CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEecCCCCcccc-c---------------
Q 005909 373 GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSLGDL-L--------------- 435 (670)
Q Consensus 373 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l--------------- 435 (670)
++.|+||+........-+-..|..+++.+....+ .++++.+.++ .|++|+++.+|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678888887765555566788888888864444 4455544332 57799976665321 1
Q ss_pred -ccccC----CCCCCHHHHHHH----------------------HHHHHHHHHHHHc---C--CCCCeEecCCCCCcEEE
Q 005909 436 -SREKE----NLSLKPARLLEI----------------------ALGVAHAIEYLHN---G--CELRILHLDIKPQNVLL 483 (670)
Q Consensus 436 -~~~~~----~~~l~~~~~~~i----------------------~~~ia~gL~yLH~---~--~~~~ivH~dlkp~NIll 483 (670)
|.... ....-+..+..+ ...+.+-+..+.. . ...-+.|+|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 10000 000011111111 1111122222211 1 12357899999999999
Q ss_pred -CCCCCeEEeecCCcc
Q 005909 484 -DPDFTPKVSDFGLAK 498 (670)
Q Consensus 484 -~~~~~~ki~DfGla~ 498 (670)
+.++.++++||..+.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 888999999999774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.099 Score=54.70 Aligned_cols=71 Identities=17% Similarity=0.122 Sum_probs=46.7
Q ss_pred cccccCceEEEEEEeCCC-cEEEEEEccc-----C---CcchHHHHHHHHHhcccc--cc-ccccccceeeeCCeeEEEE
Q 005909 356 KLGTGGYGNVYKGKFPDG-RLVAVKVLEK-----T---SNFSDNFINEVATIGRIH--HV-NIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-----~---~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lv~ 423 (670)
.||.|....||++..++| +.|+||.-.. . +-..++..-|.+.|+... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998754 6889987531 1 223345566777776653 23 3444443 3555667999
Q ss_pred EecCC
Q 005909 424 EYMPN 428 (670)
Q Consensus 424 e~~~~ 428 (670)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.0025 Score=75.70 Aligned_cols=159 Identities=11% Similarity=-0.006 Sum_probs=107.0
Q ss_pred HHHHHHhccccccccccccceee--eCCeeEEEEEecCCCCcccccccccCC-CCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 005909 392 INEVATIGRIHHVNIIHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVAHAIEYLHNGCE 468 (670)
Q Consensus 392 ~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 468 (670)
..|...++...|+++.....=.. +..+.+.+++|+..|.+.+.|.+...+ ..++..-+...-.+......-.|+..+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34444555567888776544322 233567889999999999988654332 233333333333333455555554422
Q ss_pred --CCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHH
Q 005909 469 --LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 546 (670)
Q Consensus 469 --~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~e 546 (670)
.-.+|+++|+-|.+|..+..+|+.++|+.+........ .....+++-|++|+...+- ..+.++|+|..|+-+|+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHH
Confidence 24789999999999999999999999999844433221 2334578889999988653 67778999999999999
Q ss_pred HHhCCCCC
Q 005909 547 MIEEKKHL 554 (670)
Q Consensus 547 lltg~~p~ 554 (670)
+--|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 97665544
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.06 Score=51.64 Aligned_cols=152 Identities=17% Similarity=0.175 Sum_probs=94.3
Q ss_pred cCceEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCccccccc
Q 005909 360 GGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR 437 (670)
Q Consensus 360 G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 437 (670)
++-++.-+++-+-|. ..+|+++..+- ...-|.++.+++.+++ .|+++..= ++...-++.|+|..-
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 444555555543333 34565555442 3456778888888875 35665521 333456888988321
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCcc
Q 005909 438 EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517 (670)
Q Consensus 438 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 517 (670)
.... ..++.-=++.|.-.|+. +.+.+|||-.|+||+-|..|.+||.|=+.... . +..
T Consensus 140 -------~i~~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~ 196 (308)
T PF07387_consen 140 -------KINF-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVN 196 (308)
T ss_pred -------ccch-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h------------eee
Confidence 1111 12222225778888965 56899999999999999999999999874321 1 112
Q ss_pred ccchhhcccccCCCCccchhHHHHHHHHHHHhCCC
Q 005909 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 552 (670)
Q Consensus 518 y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~ 552 (670)
|.--|+ ...+.++.+-+|=.-+++++...+
T Consensus 197 ~vN~~Y-----~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 197 MVNIEY-----ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred EEeeec-----cccChHHHHHHHHHHHHHHHHHHh
Confidence 332111 245778899999888888886544
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.21 Score=51.93 Aligned_cols=31 Identities=16% Similarity=0.144 Sum_probs=27.7
Q ss_pred CCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 468 ~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
..+++|+|+.+.|+|+++++.+.|+||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3479999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.28 Score=50.90 Aligned_cols=28 Identities=29% Similarity=0.286 Sum_probs=24.8
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
.+++|+|+.+.||+++. +.+.|.||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 58999999999999987 67899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.063 Score=57.64 Aligned_cols=71 Identities=18% Similarity=0.214 Sum_probs=47.9
Q ss_pred EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC-eeEEEEEecCCCCcccccccc
Q 005909 365 VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPNGSLGDLLSRE 438 (670)
Q Consensus 365 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~ 438 (670)
++.|....|... ..-+.... ...+++.....++.+.|+|+-..+.+-.... ...+|+|++ +.||.+++..+
T Consensus 5 ~~~a~~~~~~~c-~nglplt~-~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTP-NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcCCC-cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 455555555543 22222222 2456777888999999999999888766543 456789998 78999988654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.43 Score=50.97 Aligned_cols=74 Identities=19% Similarity=0.238 Sum_probs=45.3
Q ss_pred ccccccCceEEEEEEeCCC--c-----EEEEEEcccCCcchHHHHHHHHHhcccccccccc-ccceeeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDG--R-----LVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH-LLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lv~e~~ 426 (670)
+.|..|-...+|++...++ . .|.+++........-+-.+|+.+++.+...++.+ +++.+.. .+++||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 3555688889999876543 1 2455543222222223357889999996555544 4554432 5899999
Q ss_pred CCCCcc
Q 005909 427 PNGSLG 432 (670)
Q Consensus 427 ~~gsL~ 432 (670)
++.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.19 Score=52.00 Aligned_cols=102 Identities=13% Similarity=0.225 Sum_probs=69.2
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..|+++++- +++|... + ...+.+...++.+.+..++-+..+ .+.=|||+.-.||||+ +|++.|+||-++
T Consensus 300 y~yl~~kdh-gt~is~i-k------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISII-K------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeeee-e------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 445666654 4444322 1 356788899999998888888865 6889999999999999 999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSY 540 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~Sl 540 (670)
|.-. +...... ...-.|-.+.+ .-+..-|||-+
T Consensus 369 Rl~~-~q~~isy------~rldhp~lF~G---~dd~QFeIYrl 401 (488)
T COG5072 369 RLSY-SQGIISY------NRLDHPDLFNG---VDDYQFEIYRL 401 (488)
T ss_pred eccc-CCceeec------cccCchhhhcC---ccceeeeHHHH
Confidence 8433 2222211 12234555543 33556788764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.17 Score=53.58 Aligned_cols=72 Identities=14% Similarity=0.128 Sum_probs=47.9
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEEccc----C---CcchHHHHHHHHHhcccc--cc-ccccccceeeeCCeeEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEK----T---SNFSDNFINEVATIGRIH--HV-NIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lv~ 423 (670)
+.||.|.-..||++.+++ ++.|+||.-.. . .-..++..-|.+.|+... -| .+.+++.+ +.+...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 578999999999999853 56788887431 1 123456677777777663 23 34445533 455667888
Q ss_pred EecCC
Q 005909 424 EYMPN 428 (670)
Q Consensus 424 e~~~~ 428 (670)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.63 Score=56.40 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=78.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc-------cccccccc-ce--e--ee-CC--ee
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-------HVNIIHLL-GF--C--CD-GS--TR 419 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------H~nIv~l~-g~--~--~~-~~--~~ 419 (670)
+.|+ |..-.+|+....+|+.+++|+.+... .......|...|..|. -|.+++-. |- . .. .+ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 3464 45678899988888899999998643 2334444555555442 23333322 11 1 11 12 35
Q ss_pred EEEEEecCCCCcccccc-----------------c----cc---CCCCCCHH-----------------HHHHHHHHHHH
Q 005909 420 ALIYEYMPNGSLGDLLS-----------------R----EK---ENLSLKPA-----------------RLLEIALGVAH 458 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~-----------------~----~~---~~~~l~~~-----------------~~~~i~~~ia~ 458 (670)
+-+++|+++..|.+... . .. ....+.|. ....++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 66899999887765110 0 00 00112221 11222233333
Q ss_pred HHH-----HHHcCCCCCeEecCCCCCcEEECCCC--Ce-EEeecCCccc
Q 005909 459 AIE-----YLHNGCELRILHLDIKPQNVLLDPDF--TP-KVSDFGLAKA 499 (670)
Q Consensus 459 gL~-----yLH~~~~~~ivH~dlkp~NIll~~~~--~~-ki~DfGla~~ 499 (670)
.+. .|. ....++||+|+.+.|||++.++ .+ -|+|||-+..
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 222 122 2234799999999999998875 44 4999997643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 670 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-103
Identities = 110/300 (36%), Positives = 158/300 (52%), Gaps = 26/300 (8%)
Query: 341 YSYNDIKKMTNGFKE--KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVA 396
+S +++ ++ F LG GG+G VYKG+ DG LVAVK L++ F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLK-PARLLEIAL 454
I H N++ L GFC + R L+Y YM NGS+ L R + L P R IAL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ-RIAL 138
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 514
G A + YLH+ C+ +I+H D+K N+LLD +F V DFGLAK + VT T RG
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRG 197
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574
TIG+IAPE G S K+DV+ YG++LLE+I + R + +N + DW+
Sbjct: 198 TIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQ---RAFDLARLANDDDVMLLDWV 252
Query: 575 --------YDKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ L+ + + ++ +EE ++I V L C Q +P +RP M+ VV ML
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 9e-89
Identities = 99/315 (31%), Positives = 145/315 (46%), Gaps = 44/315 (13%)
Query: 338 LSNYSYNDIKKMTNGFKE--------KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD 389
++S+ ++K +TN F E K+G GG+G VYKG + VAVK L + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 390 N-----FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSL 444
F E+ + + H N++ LLGF DG L+Y YMPNGSL D LS L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 445 K-PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSR 502
R +IA G A+ I +LH +H DIK N+LLD FT K+SDFGLA+ +
Sbjct: 131 SWHMR-CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562
++V+T + GT Y+APE +R G + KSD+YS+G++LLE+I +
Sbjct: 187 AQTVMT-SRIVGTTAYMAPE-ALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHR---- 238
Query: 563 SNTTEAYFPDWI---------YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613
D + I + D M V C+ R
Sbjct: 239 ---EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS----VEAMYSVASQCLHEKKNKR 291
Query: 614 PSMTRVVEMLSSASA 628
P + +V ++L +A
Sbjct: 292 PDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-86
Identities = 94/296 (31%), Positives = 154/296 (52%), Gaps = 21/296 (7%)
Query: 341 YSYNDIKKMTNGFKEK--LGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN-FINEVAT 397
D+++ TN F K +G G +G VYKG DG VA+K S+ F E+ T
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLK-PARLLEIALG 455
+ H +++ L+GFC + + LIY+YM NG+L L + +S+ R LEI +G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR-LEICIG 147
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRG 514
A + YLH I+H D+K N+LLD +F PK++DFG++K +++ ++ T +G
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVKG 203
Query: 515 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFP 571
T+GYI PE F++ G + KSDVYS+G++L E++ + + + N E
Sbjct: 204 TLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 572 DWIYDKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
+ ++++ P + E RK + C+ ++ +DRPSM V+ L A
Sbjct: 262 NGQLEQIVDPNLADKIRPES----LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 1e-70
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 31/311 (9%)
Query: 339 SNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 396
+ ++ + + E G +G V+K + VAVK+ S EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 397 TIGRIHHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEI 452
++ + H NI+ +G G++ LI + GSL D L + L I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHI 126
Query: 453 ALGVAHAIEYLH-------NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505
A +A + YLH +G + I H DIK +NVLL + T ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 506 VVTMTGPRGTIGYIAPEIFMRNLGNP---SGKSDVYSYGMLLLEMI--------EEKKHL 554
G GT Y+APE+ + + D+Y+ G++L E+ +++
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 555 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP 614
P E G + + + + K +P D+ ++ + C + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA--GMAMLCETIEECWDHDAEARL 304
Query: 615 SMTRVVEMLSS 625
S V E ++
Sbjct: 305 SAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 79/351 (22%), Positives = 135/351 (38%), Gaps = 80/351 (22%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH 402
Y +I+ +E +G G +G V K K+ + VA+K + ++ + FI E+ + R++
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFIVELRQLSRVN 59
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
H NI+ L G C + L+ EY GSL ++L + A + L + + Y
Sbjct: 60 HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFT-PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
LH+ ++H D+KP N+LL T K+ DFG A MT +G+ ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAP 172
Query: 522 EIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK------------------KHLRPTETTSG 562
E+F G+ S K DV+S+G++L E+I + RP
Sbjct: 173 EVFE---GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----- 224
Query: 563 SNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 619
+ + L+ C W +P RPSM +
Sbjct: 225 -------LIKNLPKPIESLMT-----------RC----------W--SKDPSQRPSMEEI 254
Query: 620 VEMLSSASAEAIEMPPKPLFPSPPQLQTQNE-----IISFDSITSELPLQH 665
V++++ +P L + + F + H
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-64
Identities = 80/316 (25%), Positives = 132/316 (41%), Gaps = 71/316 (22%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIG 399
+ D+ KEK+G G +G V++ ++ G VAVK+L + + + F+ EVA +
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
R+ H NI+ +G +++ EY+ GSL LL + L R L +A VA
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
+ YLHN I+H ++K N+L+D +T KV DFGL++ + ++ GT ++
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWM 206
Query: 520 APEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK-----------------KHLRPTETTS 561
APE+ P + KSDVYS+G++L E+ + K R
Sbjct: 207 APEVLR---DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---- 259
Query: 562 GSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
P + +I+ C P RPS
Sbjct: 260 --------IPRNLNPQVAAIIE-----------------------GCWTNEPWKRPSFAT 288
Query: 619 VVEMLSSASAEAIEMP 634
++++L A+ P
Sbjct: 289 IMDLLRPLIKSAVPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-59
Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 42/297 (14%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--------FIN 393
N+I+ +++++G GG+G V+KG+ D +VA+K L + + F
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 394 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 453
EV + ++H NI+ L G + ++ E++P G L L + + L +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWS--VKLRLM 128
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLD-----PDFTPKVSDFGLAKAHSRNRSVVT 508
L +A IEY+ N I+H D++ N+ L KV+DFGL++ +
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----S 182
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568
++G G ++APE + + K+D YS+ M+L ++ + P + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD---EYSYGKI 236
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
F + I ++ ++P E+ + + C +PK RP + +V+ LS
Sbjct: 237 KFINMIREEGLRPT---IPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKELSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 81/326 (24%), Positives = 128/326 (39%), Gaps = 44/326 (13%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINE--VATIGRIHHVNIIHLL 410
E +G G YG VYKG D R VAVKV + NFINE + + + H NI +
Sbjct: 17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFI 73
Query: 411 GFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ L+ EY PNGSL LS + +A V + YLH
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT 129
Query: 466 ------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV------VTMTGPR 513
+ I H D+ +NVL+ D T +SDFGL+ + NR V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 514 GTIGYIAPEIF-----MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS------- 561
GTI Y+APE+ +R+ + + D+Y+ G++ E+ L P E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 562 ---GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
G++ T + + +P+ + +E + R + C + + R +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV-RSLKETIEDCWDQDAEARLTAQX 308
Query: 619 VVEMLSSASAEAIEMPPKPLFPSPPQ 644
E ++ I K + P+
Sbjct: 309 AEERMA--ELMMIWERNKSVSPTAHH 332
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 64/307 (20%), Positives = 117/307 (38%), Gaps = 76/307 (24%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL---EKTSNFSDNFINEVATIG 399
+ + F KL G ++KG++ G + VKVL + ++ S +F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 400 RIHHVNIIHLLGFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
H N++ +LG C LI +MP GSL ++L E N + ++ ++ AL +A
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+ +LH E I + ++V++D D T ++S + G
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPA 173
Query: 518 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK-----------------KHLRPTET 559
++APE + + +D++S+ +LL E++ + + LRPT
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-- 231
Query: 560 TSGSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616
P I KL++ C+ +P RP
Sbjct: 232 ----------IPPGISPHVSKLMK-----------------------ICMNEDPAKRPKF 258
Query: 617 TRVVEML 623
+V +L
Sbjct: 259 DMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 77/317 (24%), Positives = 124/317 (39%), Gaps = 86/317 (27%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL-----EKTSNFSDNFINEVAT 397
+ ++ +E +G GG+G VY+ + G VAVK E S +N E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 398 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
+ H NII L G C L+ E+ G L +LS ++ + P L+ A+ +A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIA 115
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTP--------KVSDFGLAKAHSRNRSVVTM 509
+ YLH+ + I+H D+K N+L+ K++DFGLA+ R T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TK 171
Query: 510 TGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK----------------- 551
G ++APE+ + S SDV+SYG+LL E++ +
Sbjct: 172 MSAAGAYAWMAPEVIR---ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 552 KHLRPTETTSGSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI 608
L P + KL++ DC W
Sbjct: 229 NKLALP------------IPSTCPEPFAKLME-----------DC----------W--NP 253
Query: 609 NPKDRPSMTRVVEMLSS 625
+P RPS T +++ L++
Sbjct: 254 DPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 29/284 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHL 409
+++G+G +G VYKGK+ G VAVK+L T F NEV + + HVNI+
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G A++ ++ SL L + +K +L++IA A ++YLH
Sbjct: 86 MG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLHA---K 139
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+K N+ L D T K+ DFGLA SR G+I ++APE+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 530 NP-SGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
NP S +SDVY++G++L E++ + ++ + + + P+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----------VGRGSLSPDLSK 249
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629
+ R M C++ +RPS R++ + + E
Sbjct: 250 VRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIEELARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 9e-55
Identities = 63/330 (19%), Positives = 121/330 (36%), Gaps = 80/330 (24%)
Query: 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIG 399
+ ++ E +G G +G VY G++ G VA+++++ + F EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 400 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
+ H N++ +G C A+I +L ++ K L + + +IA +
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--KTRQIAQEIVKG 142
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR---NRSVVTMTGPRGTI 516
+ YLH ILH D+K +NV D + ++DFGL R + G +
Sbjct: 143 MGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 517 GYIAPEIFMRNLGNPSG-------KSDVYSYGMLLLEMIEEK----------------KH 553
++APEI + + SDV++ G + E+ +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 554 LRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 613
++P + G I D ++ +C ++R
Sbjct: 259 MKPNLSQIG-------MGKEISD-ILL-----------------------FCWAFEQEER 287
Query: 614 PSMTRVVEMLSSASAEAIEMPPKPLFPSPP 643
P+ T++++ML ++P + S P
Sbjct: 288 PTFTKLMDMLE-------KLPKRNRRLSHP 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 67/325 (20%), Positives = 115/325 (35%), Gaps = 66/325 (20%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
E LG G +G K G ++ +K L + + F+ EV + + H N++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G I EY+ G+L ++ + + A +A + YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWS--QRVSFAKDIASGMAYLH---SMN 128
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAK------------AHSRNRSVVTMTGPRGTIGY 518
I+H D+ N L+ + V+DFGLA+ + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 519 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
+APE+ G K DV+S+G++L E+I PD++
Sbjct: 189 MAPEMIN---GRSYDEKVDVFSFGIVLCEII----------------GRVNADPDYL--- 226
Query: 578 LIQPEKEDFVEEED---------DC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
P DF +C + C ++P+ RPS ++ L
Sbjct: 227 ---PRTMDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWL-- 277
Query: 626 ASAEAIEMPPKPLFPSPPQLQTQNE 650
E + M P PQL+ +
Sbjct: 278 ---ETLRMHLAGHLPLGPQLEQLDR 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 29/295 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+++G G YG V+ GK+ G VAVKV T S E+ + H NI+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 413 CCDGSTR----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 464
G+ LI +Y NGSL D L L +L++A + +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 465 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTIGYIAP 521
+ I H D+K +N+L+ + T ++D GLA + + V GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 522 EIFMRNLGNPSG----KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 570
E+ +L +D+YS+G++L E+ +++ P S+ +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ + K ++P + ++ ++ C NP R + RV + L+
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMT--ECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 65/304 (21%), Positives = 126/304 (41%), Gaps = 30/304 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+E +G G +G V++GK+ G VAVK+ S E+ + H NI+ +
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 413 CCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 464
+ L+ +Y +GSL D L+R + ++++AL A + +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 465 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTIGYIAP 521
+ I H D+K +N+L+ + T ++D GLA H + GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 522 EIFMRNLGNPSG----KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 570
E+ ++ ++D+Y+ G++ E+ + + P S+ +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS-ASAE 629
+ ++ ++P + + + I+ C N R + R+ + LS + E
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMR--ECWYANGAARLTALRIKKTLSQLSQQE 338
Query: 630 AIEM 633
I+M
Sbjct: 339 GIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 47/304 (15%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
E +G G YG V++G + G VAVK+ S E+ + H NI+ +
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 413 CCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 464
+ LI Y GSL D L L L I L +A + +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 465 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA--KAHSRNRSVVTMTGPRGTIGYIAP 521
+ I H D+K +N+L+ + ++D GLA + S N+ V GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 522 EIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
E+ + + D++++G++L E+ R + + F D +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV------ARRMVSNGIVEDYKPPFYDVVP-- 238
Query: 578 LIQPEKEDFVE---------------EEDDCIAR-KMIIVGLWCIQINPKDRPSMTRVVE 621
P ED + D + ++ W NP R + R+ +
Sbjct: 239 -NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSARLTALRIKK 295
Query: 622 MLSS 625
L+
Sbjct: 296 TLTK 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 53/292 (18%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
LG G +G V K + D R A+K + T ++EV + ++H ++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 412 FCCDGS----------TRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 458
+ ++ ++ EY NG+L DL+ ENL+ + + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQILE 127
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT---------- 508
A+ Y+H I+H D+KP N+ +D K+ DFGLAK R+ ++
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 509 --MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 566
+T GT Y+A E+ + G+ + K D+YS G++ EM + P T G
Sbjct: 185 DNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEM------IYPFST--GMERV 235
Query: 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCI---ARKMIIVGLWCIQINPKDRPS 615
I KL E F + DD +K+I I +P RP
Sbjct: 236 N------ILKKLRSVSIE-FPPDFDDNKMKVEKKII---RLLIDHDPNKRPG 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 68/317 (21%), Positives = 115/317 (36%), Gaps = 61/317 (19%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+ LG GG+G V++ K D A+K L + + EV + ++ H I+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 412 FCCDG---------STRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
+ S + +Y + +L D ++ + + L I L +A A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA----------HSRNRSVVTM 509
+E+LH ++H D+KP N+ D KV DFGL A + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 510 TGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568
TG GT Y++PE GN S K D++S G++L E+ L P T
Sbjct: 188 TGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLILFEL------LYPFSTQMERVR--- 235
Query: 569 YFPDWIYDKL----IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+ P E + + +P +RP ++
Sbjct: 236 -----TLTDVRNLKFPPLFTQKYPCEYVMVQ--------DMLSPSPMERPEAI---NIIE 279
Query: 625 SASAEAIEMPPKPLFPS 641
+A E ++ P K +
Sbjct: 280 NAVFEDLDFPGKTVLRQ 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 55/283 (19%), Positives = 112/283 (39%), Gaps = 52/283 (18%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
E +G+GG+G V+K K DG+ +K ++ + + EV + ++ HVNI+H G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 414 CDGSTRA----------------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 457
+ E+ G+L + + + L LE+ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
++Y+H ++++ D+KP N+ L K+ DFGL + + GT+
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GTLR 186
Query: 518 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
Y++PE + D+Y+ G++L E++ ET+ +
Sbjct: 187 YMSPEQIS---SQDYGKEVDLYALGLILAELLHVCDT--AFETSK------------FFT 229
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 619
L D +++ + ++ + P+DRP+ + +
Sbjct: 230 DLRDGIISDIFDKK----EKTLL---QKLLSKKPEDRPNTSEI 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 73/287 (25%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 409
E++G G +G V+ G+ D LVAVK + F+ E + + H NI+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G C ++ E + G L E L +K LL++ A +EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE---SK 232
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYIAPEIFMRN 527
+H D+ +N L+ K+SDFG+++ + V +G + + APE N
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEAL--N 288
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
G S +SDV+S+G+LL E + P Y L + +FV
Sbjct: 289 YGRYSSESDVWSFGILLWETF-----------------SLGASP---YPNLSNQQTREFV 328
Query: 588 EE------EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
E+ + C + R M C P RPS + + + L S
Sbjct: 329 EKGGRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQS 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-38
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
++ EYM GSL D L + + L+ +L+++A +A + Y+ + +
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D++ N+L+ + KV+DFGLA+ N G + I + APE G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 359
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--- 589
KSDV+S+G+LL E+ T+ P Y ++ E D VE
Sbjct: 360 IKSDVWSFGILLTELT-----------------TKGRVP---YPGMVNREVLDQVERGYR 399
Query: 590 ---EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+C + M C + P++RP+ + L
Sbjct: 400 MPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 437
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-38
Identities = 63/283 (22%), Positives = 104/283 (36%), Gaps = 29/283 (10%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HH 403
+ K++ K+ LG G G + D R VAVK + EV + H
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEH 77
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
N+I D + + E +L + + ++ + + +L
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI--TLLQQTTSGLAHL 134
Query: 464 HNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIG 517
H L I+H D+KP N+L+ +SDFGL K + R S +G GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 518 YIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
+IAPE+ + NP+ D++S G + +I E H S +A
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGACS 246
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 619
++ + I + I ++P+ RPS V
Sbjct: 247 LDCLHPEKHEDVIARELIEK--------MIAMDPQKRPSAKHV 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 406
F ++LG G +G+V ++ G +VAVK L T +F E+ + + H NI
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 407 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
+ G C R LI EY+P GSL D L + KE + +LL+ + +EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLG 131
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 522
R +H D+ +N+L++ + K+ DFGL K +++ + P + I + APE
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ S SDV+S+G++L E+ + + I LI+
Sbjct: 189 LTESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 583 KEDF-VEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
K + + D C I M C N RPS + +
Sbjct: 246 KNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-37
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 41/283 (14%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H ++ +N L+ + KV+DFGL++ + + G + I + APE
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--AYNKF 396
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE- 590
S KSDV+++G+LL E+ T P Y + + + +E++
Sbjct: 397 SIKSDVWAFGVLLWEIA-----------------TYGMSP---YPGIDLSQVYELLEKDY 436
Query: 591 -----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ C + M C Q NP DRPS + + +
Sbjct: 437 RMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFET 475
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 353 FKEKLGTGGYGNVYKGKF--PDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVN 405
+ LG+G +G VYKG + ++ VA+K L + + ++E + + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C ST LI + MP G L D + K+N+ + LL + +A + YL
Sbjct: 79 VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE- 134
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+ R++H D+ +NVL+ K++DFGLAK G + I ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 526 RNLGNPSGKSDVYSYGMLLLEMI 548
+ +SDV+SYG+ + E++
Sbjct: 192 -LHRIYTHQSDVWSYGVTVWELM 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNII 407
+KLG GG VY + D VA+K + F EV ++ H NI+
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
++ + L+ EY+ +L + + L + + I++ H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH--- 128
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMR 526
++RI+H DIKPQN+L+D + T K+ DFG+AKA S + +T T GT+ Y +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 527 NLGNPSGKSDVYSYGMLLLEMI 548
+D+YS G++L EM+
Sbjct: 187 --EATDECTDIYSIGIVLYEML 206
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 406
F ++LG G +G+V ++ G +VAVK L T +F E+ + + H NI
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 407 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
+ G C R LI EY+P GSL D L + KE + +LL+ + +EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLG 162
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 522
R +H D+ +N+L++ + K+ DFGL K +++ + P + I + APE
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ S SDV+S+G++L E+ + + I LI+
Sbjct: 220 LTESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 583 KEDF-VEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
K + + D C I M C N RPS + +
Sbjct: 277 KNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 319
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
++ EYM GSL D L + + L+ +L+++A +A + Y+ + +
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D++ N+L+ + KV+DFGLA+ N G + I + APE G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 442
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--- 589
KSDV+S+G+LL E+ T+ P Y ++ E D VE
Sbjct: 443 IKSDVWSFGILLTELT-----------------TKGRVP---YPGMVNREVLDQVERGYR 482
Query: 590 ---EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+C + M C + P++RP+ + L
Sbjct: 483 MPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 520
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 405
E LG GG V+ + D R VAVKVL ++ + + F E ++H
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 406 IIHLLGFCCDGSTRALIY----EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
I+ + + + EY+ +L D++ E + P R +E+ A+
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALN 130
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIA 520
+ H + I+H D+KP N+++ KV DFG+A+A + + + VT T GT Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
PE + +SDVYS G +L E++
Sbjct: 188 PEQARG--DSVDARSDVYSLGCVLYEVL 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 30/276 (10%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHL 409
+K+G G + VY+ DG VA+K ++ + I E+ + +++H N+I
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKP-ARLLEIALGVAHAIEYLHNGCE 468
+ + ++ E G L ++ K+ L P + + + + A+E++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRN 527
R++H DIKP NV + K+ D GL + S + ++ GT Y++PE
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH-- 209
Query: 528 LGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
N + KSD++S G LL EM L+ N I P D
Sbjct: 210 -ENGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLYSLCKK--IEQCDYPPLPSDH 262
Query: 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
EE R+++ CI +P+ RP +T V ++
Sbjct: 263 YSEE----LRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 38/274 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIH 408
F ++G G + VYKG VA L+ F E + + H NI+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 409 LLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
L+ E M +G+L L R K +K L + +++LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 146
Query: 465 NGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGTIGYIAP 521
I+H D+K N+ + P + K+ D GLA + ++V+ GT ++AP
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEFMAP 199
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
E++ DVY++GM +LEM + S IY ++
Sbjct: 200 EMYEEKYDE---SVDVYAFGMCMLEMATSEYPY------SECQNAAQ-----IYRRVTSG 245
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
K ++ +++I CI+ N +R S
Sbjct: 246 VKPASFDKVAIPEVKEII---EGCIRQNKDERYS 276
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 47/285 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
++LG+G +G V GK+ VAVK++++ S D F E T+ ++ H ++ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C ++ EY+ NG L + L + L+P++LLE+ V + +L + +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 529
H D+ +N L+D D KVSDFG+ + + GT + + APE+F +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEVF--HYF 180
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S KSDV+++G+L+ E+ + P YD E V +
Sbjct: 181 KYSSKSDVWAFGILMWEVF-----------------SLGKMP---YDLYTNSEVVLKVSQ 220
Query: 590 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
I + M C P+ RP+ +++ +
Sbjct: 221 GHRLYRPHLASDTIYQIM----YSCWHELPEKRPTFQQLLSSIEP 261
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-36
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 29/204 (14%)
Query: 355 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI--IH 408
+ GG G +Y +GR V +K L + + + E + + H +I I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 409 LLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
D + Y EY+ SL ++ L A + L + A+ YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIF 524
+ +++ D+KP+N++L + K+ D G + G GT G+ APEI
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-------INSFGYLYGTPGFQAPEIV 249
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMI 548
P+ +D+Y+ G L +
Sbjct: 250 R---TGPTVATDIYTVGRTLAALT 270
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-36
Identities = 67/295 (22%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
++KLG G +G V+ + VAVK ++ S + F+ E + + H ++ L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+I E+M GSL D L + E +L++ + +A + ++ + +
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D++ N+L+ K++DFGLA+ + G + I + APE N G+ +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSFT 363
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE-- 590
KSDV+S+G+LL+E++ T P Y + PE +E
Sbjct: 364 IKSDVWSFGILLMEIV-----------------TYGRIP---YPGMSNPEVIRALERGYR 403
Query: 591 ----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS----SASAEAIEMP 634
++C + M + C + P++RP+ + +L + ++ E+P
Sbjct: 404 MPRPENCPEELYNIM----MRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 28/288 (9%)
Query: 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 405
LG G +G V ++ G VAVK L E N + E+ + ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 406 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
I+ G C + LI E++P+GSL + L + K ++LK + L+ A+ + ++YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKGMDYL 142
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 522
+ +H D+ +NVL++ + K+ DFGL KA ++ T+ R + + + APE
Sbjct: 143 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 523 -IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
+ SDV+S+G+ L E++ + +L+
Sbjct: 200 CLMQSKF---YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQMTVTRLVNT 255
Query: 582 EKEDFV-EEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
KE +C + + M C + P +R S ++E +
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 72/319 (22%), Positives = 129/319 (40%), Gaps = 55/319 (17%)
Query: 353 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 406
+ +LG G +G+V ++ G LVAVK L + +F E+ + +H I
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 407 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
+ G ++ L+ EY+P+G L D L R + L RLL + + +EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLG 144
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 522
R +H D+ +N+L++ + K++DFGLAK ++ + P + I + APE
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ S +SDV+S+G++L E+ T ++ P + +++ E
Sbjct: 202 LSDNIF---SRQSDVWSFGVVLYELF-----------TYCD---KSCSPSAEFLRMMGCE 244
Query: 583 KEDFVEEE--------------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
++ C + M C +P+DRPS + + L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELM----KLCWAPSPQDRPSFSALGPQLDM 300
Query: 626 --ASAEAIEMPPKPLFPSP 642
+ + E P
Sbjct: 301 LWSGSRGCETHAFTAHPEG 319
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 67/285 (23%), Positives = 129/285 (45%), Gaps = 47/285 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
F +++G+G +G V+ G + + VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C + + L+ E+M +G L D L ++ + + LL + L V + YL E ++
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYL---EEACVI 126
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 529
H D+ +N L+ + KVSDFG+ + + T GT + + +PE+F +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVF--SFS 180
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S KSDV+S+G+L+ E+ +E P Y+ E + +
Sbjct: 181 RYSSKSDVWSFGVLMWEVF-----------------SEGKIP---YENRSNSEVVEDIST 220
Query: 590 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ + M C + P+DRP+ +R++ L+
Sbjct: 221 GFRLYKPRLASTHVYQIM----NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 47/285 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
E+LG G +G V+ G + VAVK L++ S D F+ E + ++ H ++ L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+I EYM NGSL D L + + L +LL++A +A + ++ E +
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 529
H D++ N+L+ + K++DFGLA+ N T G I + APE N G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAI--NYG 185
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
+ KSDV+S+G+LL E++ T P Y + PE +E
Sbjct: 186 TFTIKSDVWSFGILLTEIV-----------------THGRIP---YPGMTNPEVIQNLER 225
Query: 590 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
D+C + + M C + P+DRP+ + +L
Sbjct: 226 GYRMVRPDNCPEELYQLM----RLCWKERPEDRPTFDYLRSVLED 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 405
+G GG G+VY+ + D R+VA+K++ + S + E T GR+ +
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
++ + F + + L +L R+ L P R + I + A++ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH- 151
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIF 524
H D+KP+N+L+ D + DFG+A A + + +T G GT+ Y+APE F
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERF 207
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMI 548
+ + ++D+Y+ +L E +
Sbjct: 208 SE--SHATYRADIYALTCVLYECL 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 74/313 (23%), Positives = 130/313 (41%), Gaps = 53/313 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRL-----VAVKVLEKTSNFSDN--FINEVATIGRIHHVN 405
+ LG+G +G V+KG + V +KV+E S + + IG + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
I+ LLG C GS+ L+ +Y+P GSL D + + + L + LL + +A + YL
Sbjct: 77 IVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLE- 132
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
E ++H ++ +NVLL +V+DFG+A + + + + I ++A E
Sbjct: 133 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI- 189
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
+ G + +SDV+SYG+ + E++ T G+ P Y L E D
Sbjct: 190 -HFGKYTHQSDVWSYGVTVWELM-----------TFGAE------P---YAGLRLAEVPD 228
Query: 586 FVEE------EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS-----SASAEAI 631
+E+ C + M + C I+ RP+ + + I
Sbjct: 229 LLEKGERLAQPQICTIDVYMVM----VKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284
Query: 632 EMPPKPLFPSPPQ 644
+ P P+
Sbjct: 285 KRESGPGIAPGPE 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 62/268 (23%), Positives = 100/268 (37%), Gaps = 39/268 (14%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRI-HHVNIIHL 409
+LG G YG V+K DGRL AVK + EV + ++ H + L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G L E SL +L A++ A+ +LH
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP--EAQVWGYLRDTLLALAHLH---SQ 176
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
++HLD+KP N+ L P K+ DFGL + G Y+APE+ G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQ---G 230
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQPEKEDFV 587
+ +DV+S G+ +LE+ + P W + + PE +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PH-----------GGEGWQQLRQGYLPPEFTAGL 277
Query: 588 EEEDDCIARKMIIVGLWCIQINPKDRPS 615
E R ++ + ++ +PK R +
Sbjct: 278 SSE----LRSVL---VMMLEPDPKLRAT 298
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 413 CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ ++ EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +NVL+ D KVSDFGL K S + + + + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--REKKF 363
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE-- 589
S KSDV+S+G+LL E+ + P Y ++ + VE+
Sbjct: 364 STKSDVWSFGILLWEIY-----------------SFGRVP---YPRIPLKDVVPRVEKGY 403
Query: 590 ----EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
D C + M C ++ RP+ ++ E L
Sbjct: 404 KMDAPDGCPPAVYDVM----KNCWHLDAATRPTFLQLREQLEH 442
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 41/283 (14%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRL-VAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K KLG G YG VY+G + L VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +N L+ + KV+DFGL++ + + + G + I + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL--AYNKF 189
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE- 590
S KSDV+++G+LL E+ T P Y + + + +E++
Sbjct: 190 SIKSDVWAFGVLLWEIA-----------------TYGMSP---YPGIDLSQVYELLEKDY 229
Query: 591 -----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ C + M C Q NP DRPS + + +
Sbjct: 230 RMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFET 268
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 67/331 (20%), Positives = 127/331 (38%), Gaps = 41/331 (12%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRI--HHVNIIHL 409
+++G+GG V++ ++ A+K + D++ NE+A + ++ H II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 127
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP N L+ D K+ DFG+A + + V GT+ Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 530 NPSG---------KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580
+ KSDV+S G +L M K T N I D +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK-----TPFQQIINQISKLHA--IIDPNHE 239
Query: 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA--SAEAIEMPPKPL 638
E D E++ + ++ C++ +PK R S+ E+L+ + +
Sbjct: 240 IEFPDIPEKD----LQDVL---KCCLKRDPKQRISIP---ELLAHPYVQIQTHPVNQMAK 289
Query: 639 FPSPPQLQTQNEIISFDSITSELPLQHDSQE 669
+ +++ +S S L E
Sbjct: 290 GTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 60/279 (21%), Positives = 113/279 (40%), Gaps = 42/279 (15%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRI--HHVNIIHL 409
+++G+GG V++ ++ A+K + D++ NE+A + ++ H II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 146
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP N L+ D K+ DFG+A + + V GT+ Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 530 NPSG---------KSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDK 577
+ KSDV+S G +L M K + + N I D
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQISKLHA--IIDP 255
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616
+ E D E++ + ++ C++ +PK R S+
Sbjct: 256 NHEIEFPDIPEKD----LQDVL---KCCLKRDPKQRISI 287
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 47/285 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
F ++LGTG +G V GK+ VA+K++++ S D FI E + + H ++ L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C +I EYM NG L + L + + +LLE+ V A+EYL + L
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 529
H D+ +N L++ KVSDFGL++ + T G+ + + PE+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEVL--MYS 196
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S KSD++++G+L+ E+ + P Y++ E + + +
Sbjct: 197 KFSSKSDIWAFGVLMWEIY-----------------SLGKMP---YERFTNSETAEHIAQ 236
Query: 590 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ M C +RP+ ++ +
Sbjct: 237 GLRLYRPHLASEKVYTIM----YSCWHEKADERPTFKILLSNILD 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 69/315 (21%), Positives = 121/315 (38%), Gaps = 52/315 (16%)
Query: 334 RSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFIN 393
R A + N+ +K + ++ LG G G V GR VAVK + +F D +
Sbjct: 2 RIANIPNFE-QSLKNLVV-SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALM 57
Query: 394 EVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR----EKENLSLKPAR 448
E+ + H N+I + E N +L DL+ ++ K
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-------------PDFTPKVSDFG 495
+ + +A + +LH L+I+H D+KPQN+L+ + +SDFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 496 LAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-----DVYSYGMLLLEMI 548
L K +S + P GT G+ APE+ + + + D++S G + ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 549 EEKKHLRPTETTSGSNTTEAYF----PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 604
+ KH + + SN F ++D+ + E D +
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS---------------Q 278
Query: 605 CIQINPKDRPSMTRV 619
I +P RP+ +V
Sbjct: 279 MIDHDPLKRPTAMKV 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 73/311 (23%), Positives = 127/311 (40%), Gaps = 49/311 (15%)
Query: 353 FKEKLGTGGYGNVYKGKF--PDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVN 405
+ LG+G +G VYKG + ++ VA+K L + + ++E + + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C ST LI + MP G L D + K+N+ + LL + +A + YL
Sbjct: 79 VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE- 134
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
+ R++H D+ +NVL+ K++DFGLAK G + I ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 581
+ +SDV+SYG+ + E++ T G + I L +
Sbjct: 192 -LHRIYTHQSDVWSYGVTVWELM-----------TFG----SKPYDGIPASEISSILEKG 235
Query: 582 EKEDFVEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS-----SASAEAIEM 633
E+ + + C + M + C I+ RP ++ S I+
Sbjct: 236 ER---LPQPPICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288
Query: 634 PPKPLFPSPPQ 644
+ PSP
Sbjct: 289 DERMHLPSPTD 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 64/297 (21%), Positives = 119/297 (40%), Gaps = 60/297 (20%)
Query: 353 FKEKLGTGGYGNVYKGKF--------PDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHH 403
F E LG G + ++KG V +KVL + N+S++F + + ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+++ G C G L+ E++ GSL L + K +++ LE+A +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL--WKLEVAKQLAAAMHFL 129
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTP--------KVSDFGLAKAHSRNRSVVTMTGPRGT 515
E ++H ++ +N+LL + K+SD G++ +V+ +
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------ITVLPKDILQER 180
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575
I ++ PE N N + +D +S+G L E+ + P
Sbjct: 181 IPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC-----------------SGGDKP---L 219
Query: 576 DKLIQPEKEDFVEE-------EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
L K F E+ + +A + C+ P RPS ++ L+S
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAAELANLI----NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 48/297 (16%)
Query: 353 FKEKLGTGGYGNVYKGKF-----PDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 405
LG G +G V + G +VAVK L + + E+ + ++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 406 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
II G C D + L+ EY+P GSL D L R + A+LL A + + YL
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYL 150
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 522
H +H D+ +NVLLD D K+ DFGLAKA + + + + APE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 523 -----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
F SDV+S+G+ L E++ H +++ +
Sbjct: 208 CLKEYKF-------YYASDVWSFGVTLYELL---THCDSSQSPPTKFLELIGIA---QGQ 254
Query: 578 LIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ + +E D C + M C + RP+ ++ +L +
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILKT 307
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 47/305 (15%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 409
+ LG G NV++G+ G L A+KV S D + E + +++H NI+ L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 410 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ +TR LI E+ P GSL +L L + L + V + +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 468 ELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
E I+H +IKP N++ D K++DFG A+ + V++ GT Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM 186
Query: 524 FMRNLGNPSG------KSDVYSYGMLL-------------------LEMIEEKKHLRPTE 558
+ R + D++S G+ E++ + +P+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 559 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
SG E DW D + ++ + + ++ + + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-------LEADQEKCWGFDQ 299
Query: 619 VVEML 623
Sbjct: 300 FFAET 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 74/353 (20%), Positives = 137/353 (38%), Gaps = 42/353 (11%)
Query: 333 YRSALLSNYSYNDIKKMTN-GFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNF 387
+ S + + M +K+G G +G K DGR +K + +S
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 388 SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA 447
+ EVA + + H NI+ + + ++ +Y G L ++ +K L +
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQED 125
Query: 448 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507
++L+ + + A++++H + +ILH DIK QN+ L D T ++ DFG+A+ + +
Sbjct: 126 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182
Query: 508 -TMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 565
GT Y++PEI P + KSD+++ G +L E+ L+ +
Sbjct: 183 RACI---GTPYYLSPEICE---NKPYNNKSDIWALGCVLYELCT----LKHAFE--AGSM 230
Query: 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---------M 616
I P + + R ++ + NP+DRPS +
Sbjct: 231 KNLVLK--IISGSFPPVSLHYSYD-----LRSLV---SQLFKRNPRDRPSVNSILEKGFI 280
Query: 617 TRVVEMLSSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 669
+ +E S A E K Q S + S +P Q ++
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKP 333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 77/325 (23%), Positives = 136/325 (41%), Gaps = 51/325 (15%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 406
+ +G G +G V G K P + VA+K L T +F+ E + +G+ H NI
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
I L G ++ EYM NGSL L R+ + +L+ + G+A ++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDA-QFTVIQLVGMLRGIASGMKYLS-- 164
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFM 525
++ +H D+ +N+L++ + KVSDFGL + + T G + I + +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI- 222
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
+ SDV+SYG++L E++ + P Y ++ +
Sbjct: 223 -AYRKFTSASDVWSYGIVLWEVM-----------------SYGERP---YWEMSNQDVIK 261
Query: 586 FVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS----SASAEAIE 632
V+E DC + + M L C Q + +RP ++V +L + + I
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLM----LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
Query: 633 MPPKPLFPSPPQLQTQNEIISFDSI 657
+ Q+ +I +F +
Sbjct: 318 TSAAARPSNLLLDQSNVDITTFRTT 342
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 413 CCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ I EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +NVL+ D KVSDFGL K S + + + + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--REKKF 191
Query: 532 SGKSDVYSYGMLLLEMI 548
S KSDV+S+G+LL E+
Sbjct: 192 STKSDVWSFGILLWEIY 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 62/307 (20%), Positives = 112/307 (36%), Gaps = 47/307 (15%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 409
+ LG G NV++G+ G L A+KV S D + E + +++H NI+ L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 410 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ +TR LI E+ P GSL +L L + L + V + +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 468 ELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
E I+H +IKP N++ D K++DFG A+ + V++ GT Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDM 186
Query: 524 FMRNLGNPSG------KSDVYSYGMLLLEMI-------------------EEKKHLRPTE 558
+ R + D++S G+ + +P+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 559 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
SG E DW D + ++ + + ++ + + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-------LEADQEKCWGFDQ 299
Query: 619 VVEMLSS 625
S
Sbjct: 300 FFAETSD 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 64/334 (19%), Positives = 126/334 (37%), Gaps = 47/334 (14%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHH--VNIIHL 409
+++G+GG V++ ++ A+K + D++ NE+A + ++ II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 174
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP N L+ D K+ DFG+A + + V G + Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 530 NPSG---------KSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDK 577
+ KSDV+S G +L M K + + N I D
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQISKLHA--IIDP 283
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA--SAEAIEMPP 635
+ E D E++ + ++ C++ +PK R S+ E+L+ + +
Sbjct: 284 NHEIEFPDIPEKD----LQDVL---KCCLKRDPKQRISIP---ELLAHPYVQIQTHPVNQ 333
Query: 636 KPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 669
+ +++ +S S L E
Sbjct: 334 MAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 367
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 59/304 (19%), Positives = 111/304 (36%), Gaps = 38/304 (12%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
F +KLG GG+ V + DG A+K + + E +H NI+ L+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 411 GFCCDGSTRA----LIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHN 465
+C L+ + G+L + + + + L ++L + LG+ +E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-------AHSRNRSVVTMTGPRGTIGY 518
H D+KP N+LL + P + D G + ++ R TI Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 519 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRP---TETTSGSNTTEAYFPDWI 574
APE+F ++DV+S G +L M+ G + A +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMM----FGEGPYDMVFQKGDSVALA-----V 260
Query: 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 634
++L P+ +++ + ++P RP + ++ L + A
Sbjct: 261 QNQLSIPQSPRHSSA-----LWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
Query: 635 PKPL 638
+
Sbjct: 313 TTQI 316
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 354 KEKLGTGGYGNVYKG--KFPDGRL-VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 408
+LG G +G+V +G + ++ VA+KVL ++ + E + ++ + I+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L+G C L+ E G L L ++E + + + E+ V+ ++YL E
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYL---EE 128
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEIFMRN 527
+H D+ +NVLL K+SDFGL+KA + S T + + + APE N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 186
Query: 528 LGNPSGKSDVYSYGMLLLEMI 548
S +SDV+SYG+ + E +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEAL 207
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/270 (21%), Positives = 97/270 (35%), Gaps = 37/270 (13%)
Query: 354 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ ++G G +G V++ K G AVK + + E+ + I+ L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G + E + GSLG L+ + E+ +L + G+ EYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG--QALEGL----EYLH---TR 169
Query: 470 RILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGP---RGTIGYIAPEIFM 525
RILH D+K NVLL D + + DFG A + ++ GT ++APE+ M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
K D++S ++L M+ P + I+
Sbjct: 230 GK--PCDAKVDIWSSCCMMLHMLNGC---HP---WTQYFRGPLCLKIASEPPPIREIPPS 281
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
I ++ P R S
Sbjct: 282 CAPLTAQAIQE--------GLRKEPVHRAS 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 77/314 (24%), Positives = 130/314 (41%), Gaps = 54/314 (17%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR---LVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 405
++ +G G +G VYKG K G+ VA+K L T +F+ E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
II L G +I EYM NG+L L + S+ +L+ + G+A ++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYLA- 164
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIF 524
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
+ + SDV+S+G+++ E++ T P Y +L E
Sbjct: 223 --SYRKFTSASDVWSFGIVMWEVM-----------------TYGERP---YWELSNHEVM 260
Query: 585 DFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS------SASAE 629
+ + DC I + M + C Q RP +V +L +
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316
Query: 630 AIEMPPKPLFPSPP 643
+ P+ P
Sbjct: 317 LADFDPRVSIRLPS 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 79/299 (26%), Positives = 117/299 (39%), Gaps = 51/299 (17%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGRL--VAVKVL----EKTSNFSDNFINEVATIGRIHHV 404
EKLG G +G V +G P G+ VAVK L D+FI EV + + H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N+I L G ++ E P GSL D L + + + L L A+ VA + YL
Sbjct: 82 NLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE 138
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEI 523
R +H D+ +N+LL K+ DFGL +A +N M + + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
S SD + +G+ L EM T G P + L +
Sbjct: 196 L--KTRTFSHASDTWMFGVTLWEMF-----------TYGQE------P---WIGLNGSQI 233
Query: 584 EDFVEEE-------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 632
+++E +DC I M + C P+DRP+ + + L A +
Sbjct: 234 LHKIDKEGERLPRPEDCPQDIYNVM----VQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
+GTG YG K + DG+++ K L+ T ++EV + + H NI+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 411 GFCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKP-ARLLEIALGVAHAIEYLH--N 465
D + L + EY G L ++++ + +L + + A++ H +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIF 524
+LH D+KP NV LD K+ DFGLA+ + + S T GT Y++PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQM 188
Query: 525 MRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
+ KSD++S G LL E+ P S I + +
Sbjct: 189 N---RMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGK-----IREGKFRRIP 237
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
+ +E ++I + + RPS+ ++E
Sbjct: 238 YRYSDE-----LNEII---TRMLNLKDYHRPSVEEILEN 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 406
++ +G+G G V G + P R VA+K L T +F++E + +G+ H NI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
I L G G ++ EYM NGSL L ++ +L+ + GV + YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLS-- 168
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFM 525
+L +H D+ +NVL+D + KVSDFGL++ + T TG + I + APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI- 226
Query: 526 RNLGNPSGKSDVYSYGMLLLEMI 548
S SDV+S+G+++ E++
Sbjct: 227 -AFRTFSSASDVWSFGVVMWEVL 248
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 406
+G G +G+V++G P+ VA+K + + + F+ E T+ + H +I
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
+ L+G + +I E G L L K +L L L+ A ++ A+ YL
Sbjct: 79 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE-- 133
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
R +H DI +NVL+ + K+ DFGL++ + + + + I ++APE
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI-- 189
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
N + SDV+ +G+ + E++ P + + +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL-----------------MHGVKP---FQGVKNNDVIGR 229
Query: 587 VEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+E +C + M C +P RP T + LS+
Sbjct: 230 IENGERLPMPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 273
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 53/298 (17%)
Query: 334 RSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVK-VLEKTSNFSDNF 391
L +Y Y++ + LG G YG VY G+ +A+K + E+ S +S
Sbjct: 12 SDLLEYDYEYDENGD-----RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 392 INEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE 451
E+A + H NI+ LG + + E +P GSL LL + L +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK----AHSRNRSV 506
+ ++YLH + +I+H DIK NVL++ K+SDFG +K + +
Sbjct: 127 YTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP----TETTS- 561
GT+ Y+APEI + +D++S G ++EM K P E +
Sbjct: 184 T------GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK---PPFYELGEPQAA 234
Query: 562 ----GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
G P+ + E + F+ + C + +P R
Sbjct: 235 MFKVGMFKVHPEIPES-----MSAEAKAFILK---------------CFEPDPDKRAC 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 32/249 (12%)
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLE 382
++K + Y + + N + K N ++ L G + + + D + A+K E
Sbjct: 5 SMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYE 63
Query: 383 KT------------------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424
K+ + D+F NE+ I I + + G + +IYE
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 425 YMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNGCELRILHLDIKPQ 479
YM N S+ + I V ++ Y+HN E I H D+KP
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPS 181
Query: 480 NVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYS 539
N+L+D + K+SDFG ++ + ++ + RGT ++ PE F K D++S
Sbjct: 182 NILMDKNGRVKLSDFGESE-YMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 540 YGMLLLEMI 548
G+ L M
Sbjct: 238 LGICLYVMF 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 406
F E +G G +G VY G DG+ AVK L + ++ + F+ E + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 407 IHLLGFCCDGSTRAL-IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C L + YM +G L + + E N ++K L+ L VA ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLA- 145
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR--SVVTMTGPRGTIGYIAPE- 522
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 146 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 523 ----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
F + KSDV+S+G+LL E++
Sbjct: 204 LQTQKF-------TTKSDVWSFGVLLWELM 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 54/286 (18%)
Query: 355 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRI-HHVNIIHL 409
EK+G+G +G+V+K K DG + A+K +K S N + EV + H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
+ + EY GSL D +S + K A L ++ L V + Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 469 LRILHLDIKPQNVLLDPD-------------------FTPKVSDFGLAKAHSRNRSVVTM 509
+ ++H+DIKP N+ + K+ D G S +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 569
G ++A E+ N + K+D+++ + ++ + L P +
Sbjct: 192 ----GDSRFLANEVLQENYTH-LPKADIFALALTVVCAA-GAEPL-PRNGDQWHEIRQGR 244
Query: 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
P I L E + ++ I +P+ RPS
Sbjct: 245 LPR-IPQVL-SQEFTELLK---------------VMIHPDPERRPS 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 46/276 (16%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
LG G +GNVY + ++A+KVL K + EV + H NI+ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ D + LI EY P G++ L + + + +A+A+ Y H R+
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTAT--YITELANALSYCH---SKRV 130
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H DIKP+N+LL K++DFG + H+ + + GT+ Y+ PE+ + +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC---GTLDYLPPEMIEGRMHDE 186
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKED 585
K D++S G+L E + K P E + T E FPD+ + D
Sbjct: 187 --KVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRVEFTFPDF-----VTEGARD 236
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ ++ ++ NP RP + V+E
Sbjct: 237 LI--------SRL-------LKHNPSQRPMLREVLE 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 356 KLGTGGYGNVYKGKFPDGRL---VAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 409
+LG+G +G V KG + ++ VAVK+L+ + D + E + ++ + I+ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G C + + L+ E G L L ++N +K ++E+ V+ ++YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ES 136
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG----PRGTIGYIAPEIFM 525
+H D+ +NVLL K+SDFGL+KA + + P + + APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP---VKWYAPECI- 192
Query: 526 RNLGNPSGKSDVYSYGMLLLEMI 548
N S KSDV+S+G+L+ E
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAF 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 68/310 (21%), Positives = 121/310 (39%), Gaps = 64/310 (20%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR----LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 406
+G G +G VY G++ D A+K L + + F+ E + ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 407 IHLLGFCCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ L+G + YM +G L + + N ++K L+ L VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYLA- 141
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYIAPE- 522
E + +H D+ +N +LD FT KV+DFGLA+ + + A E
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 523 ----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578
F + KSDV+S+G+LL E++ T P Y +
Sbjct: 200 LQTYRF-------TTKSDVWSFGVLLWELL-----------------TRGAPP---YRHI 232
Query: 579 IQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEML-----S 624
+ F+ + + C + + M C + +P RP+ +V + +
Sbjct: 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQIVSA 288
Query: 625 SASAEAIEMP 634
+++P
Sbjct: 289 LLGDHYVQLP 298
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 54/308 (17%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
LG G +G V K K + AVKV+ K + + + EV + ++ H NI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 466
L D S+ ++ E G G+L +++ S A I V I Y+H
Sbjct: 86 LFEILEDSSSFYIVGELY-TG--GELFDEIIKRKRFSEHDAA--RIIKQVFSGITYMH-- 138
Query: 467 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
+ I+H D+KP+N+LL + D K+ DFGL+ +N M GT YIAPE+
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDK 577
K DV+S G++L ++ SG P + I +
Sbjct: 195 LRGTYDE---KCDVWSAGVILYILL------------SG------TPPFYGKNEYDILKR 233
Query: 578 LIQPEKEDFVEEEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVEM--LSSASAEAIEM 633
++ K F + I+ K +I + + +P R + T+ +E + S+E +
Sbjct: 234 -VETGKYAFDLPQWRTISDDAKDLIRKM--LTFHPSLRITATQCLEHPWIQKYSSETPTI 290
Query: 634 PPKPLFPS 641
P S
Sbjct: 291 SDLPSLES 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 406
F E +G G +G VY G DG+ AVK L + ++ + F+ E + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 407 IHLLGFCCDGST-RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C ++ YM +G L + + E N ++K L+ L VA +++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLA- 209
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPE- 522
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 210 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 523 ----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
F + KSDV+S+G+LL E++
Sbjct: 268 LQTQKF-------TTKSDVWSFGVLLWELM 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 74/314 (23%), Positives = 118/314 (37%), Gaps = 56/314 (17%)
Query: 321 GDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVK 379
G G + + +S + LG G +G V K G+ AVK
Sbjct: 1 GPGSMMDHL--HATPGMFVQHSTAIFSDRYK-GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 380 VLEK----TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL 435
V+ K ++ + EV + ++ H NI+ L F D L+ E G G+L
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY-TG--GELF 114
Query: 436 SR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPK 490
++ S A I V I Y+H + +I+H D+KP+N+LL D +
Sbjct: 115 DEIISRKRFSEVDAA--RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIR 169
Query: 491 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE 550
+ DFGL+ ++ M GT YIAPE+ K DV+S G++L ++
Sbjct: 170 IIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGVILYILL-- 221
Query: 551 KKHLRPTETTSGSNTTEAYFPDW------IYDKLIQPEKEDFVEEEDDCIAR--KMIIVG 602
SG P I K ++ K F + ++ K +I
Sbjct: 222 ----------SG------CPPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 603 LWCIQINPKDRPSM 616
+ + P R S
Sbjct: 265 M--LTYVPSMRISA 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 54/291 (18%)
Query: 353 FKEKLGTGGYGNVYKGKF--PDGR--LVAVKVLEKTSNFS--DNFINEVATIGRIHHVNI 406
LG G +G VY+G + G VAVK +K + F++E + + H +I
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 407 IHLLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+ L+G + E P G LG L R K +L + L+ +L + A+ YL
Sbjct: 76 VKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYL 129
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
+ +H DI +N+L+ K+ DFGL++ + R I +++PE
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPES 185
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
N + SDV+ + + + E++ + P + L +
Sbjct: 186 I--NFRRFTTASDVWMFAVCMWEIL-----------------SFGKQP---FFWLENKDV 223
Query: 584 EDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+E+ D C + M C +P DRP T +V LS
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLM----TRCWDYDPSDRPRFTELVCSLSD 270
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 82/323 (25%), Positives = 126/323 (39%), Gaps = 64/323 (19%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
LG G +G VY+G+ VAVK L + + D +F+ E I + +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAI 460
NI+ +G R ++ E M G L L R + SL LL +A +A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 461 EYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGT 515
+YL E +H DI +N LL P K+ DFG+A R+ R+ G
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYRKGGCAM 206
Query: 516 --IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
+ ++ PE FM G + K+D +S+G+LL E+ + Y P
Sbjct: 207 LPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIF-----------------SLGYMP-- 245
Query: 574 IYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
Y E +FV +C + R M C Q P+DRP+ ++E +
Sbjct: 246 -YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIILERIE 300
Query: 625 --SASAEAIEMP-PKPLFPSPPQ 644
+ + I P P +
Sbjct: 301 YCTQDPDVINTALPIEYGPLVEE 323
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 71/324 (21%), Positives = 115/324 (35%), Gaps = 53/324 (16%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFI-NEVATIGRI-HHVNIIHLL 410
+ L GG+ VY+ + GR A+K L + I EV + ++ H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 411 GFCC-------DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
G L+ + G L + L + + L +L+I A++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR---------- 513
H + I+H D+K +N+LL T K+ DFG A S R
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 514 GTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMI------EEKKHLRPTETTSGSNTT 566
T Y PEI P G K D+++ G +L + E+ LR +G +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---IVNGKYS- 267
Query: 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
P + F +I +Q+NP++R S+ VV L
Sbjct: 268 ---IPPH------DTQYTVF---------HSLIR---AMLQVNPEERLSIAEVVHQLQEI 306
Query: 627 SAEAIEMPPKPLFPSPPQLQTQNE 650
+A P P+ Q
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGS 330
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 406
+G G +G+V++G P+ VA+K + + + F+ E T+ + H +I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
+ L+G + +I E G L L K +L L L+ A ++ A+ YL
Sbjct: 454 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLE-- 508
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
R +H DI +NVL+ + K+ DFGL++ + + + + I ++APE
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESI-- 564
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
N + SDV+ +G+ + E++ P + + +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----------------MHGVKP---FQGVKNNDVIGR 604
Query: 587 VEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+E +C + M C +P RP T + LS+
Sbjct: 605 IENGERLPMPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 648
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 354 KEKLGTGGYGNVYKG--KFPDGRL-VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 408
+LG G +G+V +G + ++ VA+KVL ++ + E + ++ + I+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L+G C L+ E G L L ++E + + + E+ V+ ++YL E
Sbjct: 401 LIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYL---EE 454
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEIFMRN 527
+H ++ +NVLL K+SDFGL+KA + S T + + + APE N
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 528 LGNPSGKSDVYSYGMLLLEMI 548
S +SDV+SYG+ + E +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEAL 533
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 56/307 (18%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
LG GG+ ++ + A K++ K+ + + E++ + H +++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
F D ++ E SL +L R K L+ AR + +YLH R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEAR--YYLRQIVLGCQYLHR---NRV 136
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+H D+K N+ L+ D K+ DFGLA K + GT YIAPE+ +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG-- 191
Query: 531 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKE 584
S + DV+S G ++ ++ K P ET+ T E P I
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKP---PFETSCLKETYLRIKKNEYSIPKHINPV------- 241
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE--------MLSSASAEAIEMPPK 636
A +I +Q +P RP++ ++ + + + +PP+
Sbjct: 242 ----------AASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPR 288
Query: 637 PLFPSPP 643
F P
Sbjct: 289 --FSIAP 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 87/314 (27%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVL-EKTSNFSDNFINEVATIGRIHHVN 405
K +LG G +G V+ + + LVAVK L E + + +F E + + H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL------------SREKENLSLKPARLLEIA 453
I+ G C +G +++EYM +G L L + L +LL +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTG 511
VA + YL L +H D+ +N L+ K+ DFG+ SR+ + G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDYYRVG 217
Query: 512 PRGT--IGYIAPEIFMRNLGNPSGKSDVYSYGMLL-------------------LEMIEE 550
R I ++ PE + + +SDV+S+G++L ++ I +
Sbjct: 218 GRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 551 KKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQIN 609
+ L RP P +Y +++ C W Q
Sbjct: 276 GRELERPRAC-----------PPEVYA-IMR-----------GC----------W--QRE 300
Query: 610 PKDRPSMTRVVEML 623
P+ R S+ V L
Sbjct: 301 PQQRHSIKDVHARL 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 37/218 (16%), Positives = 72/218 (33%), Gaps = 29/218 (13%)
Query: 353 FKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNFSDNFI--NEVATIGRIHHV 404
LG G + VY+ D + +KV + +N + +I + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQH 127
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEY 462
+ + L+ E G+L + ++ K + ++ A+ + + IE
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTP-----------KVSDFGLAKAHSRNRSVVTMTG 511
+H + I+H DIKP N +L F + D G + T
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 512 PRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMI 548
T G+ E+ P + D + + M+
Sbjct: 245 KCETSGFQCVEMLS---NKPWNYQIDYFGVAATVYCML 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 70/319 (21%), Positives = 116/319 (36%), Gaps = 96/319 (30%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVN 405
K +LG G +G V+ D LVAVK L + T +F E + + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARLLEI 452
I+ G C DG +++EYM +G L L + L +++L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
A +A + YL +H D+ +N L+ + K+ DFG++ R V +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDV--YSTD 187
Query: 513 ---RGTIGYI-----APEIFMRNLGNPSGKSDVYSYGMLL-------------------L 545
G + PE M + +SDV+S+G++L +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 546 EMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 604
E I + + L RP P +YD + M L
Sbjct: 246 ECITQGRVLERPRVC-----------PKEVYD--V------------------M----LG 270
Query: 605 CIQINPKDRPSMTRVVEML 623
C Q P+ R ++ + ++L
Sbjct: 271 CWQREPQQRLNIKEIYKIL 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 70/321 (21%), Positives = 112/321 (34%), Gaps = 95/321 (29%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
F E+LG +G VYKG VA+K L+ + F +E R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARLLE 451
N++ LLG ++I+ Y +G L + L +L+P +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV----- 506
+ +A +EYL ++H D+ +NVL+ K+SD GL R V
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 507 -VTMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLL-------------------L 545
+ I ++APE I S SD++SYG++L +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 546 EMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 604
EMI ++ L P + P W+Y +I+
Sbjct: 241 EMIRNRQVLPCPDDC-----------PAWVYALMIE------------------------ 265
Query: 605 CIQINPKDRPSMTRVVEMLSS 625
C P RP + L +
Sbjct: 266 CWNEFPSRRPRFKDIHSRLRA 286
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 35/305 (11%), Positives = 68/305 (22%), Gaps = 54/305 (17%)
Query: 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNII 407
E L G V+ + + A+KV + + + R+ +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 408 HLLGFC-----------------------CDGSTRALIYEYMP--NGSLGDLLSR----E 438
D A MP + L L S
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 439 KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498
L + + L ++H P N+ + PD + D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE 558
+ + Y E + + + + G+ + + P
Sbjct: 243 KVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF---LPFG 294
Query: 559 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCI--ARKMIIVGLWCIQINPKDRPSM 616
T W L P + + K +I + + + R
Sbjct: 295 L-----VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF--LNFDRRRRLLP 347
Query: 617 TRVVE 621
+E
Sbjct: 348 LEAME 352
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 46/277 (16%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
LG GG+ ++ + A K++ K+ + + E++ + H +++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
F D ++ E SL +L R K L+ AR + +YLH R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEAR--YYLRQIVLGCQYLHR---NRV 162
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+H D+K N+ L+ D K+ DFGLA K + GT YIAPE+ +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH- 218
Query: 531 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKE 584
S + DV+S G ++ ++ K P ET+ T E P I
Sbjct: 219 -SFEVDVWSIGCIMYTLLVGKP---PFETSCLKETYLRIKKNEYSIPKHINPV------- 267
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
A +I +Q +P RP++ ++
Sbjct: 268 ----------AASLIQ---KMLQTDPTARPTINELLN 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 82/327 (25%), Positives = 124/327 (37%), Gaps = 72/327 (22%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
LG G +G VY+G+ VAVK L + + D +F+ E I + +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAI 460
NI+ +G R ++ E M G L L R + SL LL +A +A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 461 EYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRN---RSVVTMTGPRG 514
+YL E +H DI +N LL P K+ DFG+A+ R R +G
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--------KG 243
Query: 515 TIGYI-----APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 569
+ PE FM G + K+D +S+G+LL E+ + Y
Sbjct: 244 GCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIF-----------------SLGY 284
Query: 570 FPDWIYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVV 620
P Y E +FV +C + R M C Q P+DRP+ ++
Sbjct: 285 MP---YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIIL 337
Query: 621 EMLS--SASAEAIEMP-PKPLFPSPPQ 644
E + + + I P P +
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVEE 364
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-30
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 409
KE+LGTGG+G V + G VA+K + + + + E+ + +++H N++
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 410 L------GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
L EY G L L++ + LK + + ++ A+ YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 464 HNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
H E RI+H D+KP+N++L K+ D G AK + GT+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLA 191
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
PE+ + D +S+G L E I
Sbjct: 192 PELLEQKKYTV--TVDYWSFGTLAFECI 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 353 FKEKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVATIGRI-HHVNI 406
F++ +G G +G V K + A+K +++ ++ D +F E+ + ++ HH NI
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENL-----------SLKPARLLEIA 453
I+LLG C L EY P+G+L D L SR E +L +LL A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGP 512
VA ++YL + + +H D+ +N+L+ ++ K++DFGL SR + V V T
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMG 201
Query: 513 RGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 548
R + ++A E + + SDV+SYG+LL E++
Sbjct: 202 RLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-30
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 62/286 (21%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
+KLG+G YG V + A+K++ K +++ + + EVA + + H NI+
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 466
L F D L+ E G G+L + + A I V + YLH
Sbjct: 101 LYDFFEDKRNYYLVMECY-KG--GELFDEIIHRMKFNEVDAA--VIIKQVLSGVTYLH-- 153
Query: 467 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
+ I+H D+KP+N+LL + D K+ DFGL+ + M GT YIAPE+
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDK 577
+ K DV+S G++L ++ +G Y P I K
Sbjct: 210 LRKKYDE---KCDVWSIGVILFILL------------AG------YPPFGGQTDQEILRK 248
Query: 578 LIQPEKEDFVEEEDDCIA-------RKMIIVGLWCIQINPKDRPSM 616
++ K F E ++ ++M +Q + + R S
Sbjct: 249 -VEKGKYTFDSPEWKNVSEGAKDLIKQM-------LQFDSQRRISA 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 66/341 (19%), Positives = 126/341 (36%), Gaps = 96/341 (28%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
+LG G +G VY+G K VA+K + + ++ + F+NE + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------SREKENLSLKPARLLEIALGVA 457
+++ LLG G +I E M G L L + ++++++A +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGT 515
+ YL+ + +H D+ +N ++ DFT K+ DFG+ R+ + G +G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYRKGGKGL 201
Query: 516 --IGYIAPE-----IFMRNLGNPSGKSDVYSYGMLL-------------------LEMIE 549
+ +++PE +F + SDV+S+G++L L +
Sbjct: 202 LPVRWMSPESLKDGVF-------TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 550 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQIN 609
E L + PD +++ + C Q N
Sbjct: 255 EGGLLDKPDNC----------PDMLFELMRM------------------------CWQYN 280
Query: 610 PKDRPSMTRVVEML-----SSASAEAIEMPPKPLFPSPPQL 645
PK RPS ++ + + + P P +L
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 40/329 (12%), Positives = 86/329 (26%), Gaps = 65/329 (19%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINE------------------- 394
LG + G V V T N I +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 395 -------VATIGRIHHVNIIHLLGFCCDGSTRALIYEYM----PNGSLGD----LLSREK 439
+ + ++ D ++ + +L LLS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 440 ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499
+ SL L++ L V + LH ++H ++P +++LD ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 500 HSRNRSVVTMTGPR-GTIGYIAPEIFMRNLGNP---SGKSDVYSYGMLLLEMIEEKKHLR 555
S V+ G A + +P + D ++ G+ + +
Sbjct: 261 D--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---L 315
Query: 556 PTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
P + +E F ++ + + ++ +DR
Sbjct: 316 PNTDDAALGGSEWIFRSC----------KNIPQPVRALLEG--------FLRYPKEDRLL 357
Query: 616 MTRVVEMLSSASAEAIEMPPKPLFPSPPQ 644
+ +E PL+ + +
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 43/276 (15%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
LG G + VY+ + G VA+K+++K + NEV ++ H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ D + L+ E NG + L + S AR + + YLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLH---SHGI 133
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
LH D+ N+LL + K++DFGLA + T GT YI+PEI R+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKED 585
+SDV+S G + ++ + P +T + NT + P + + E +D
Sbjct: 192 --ESDVWSLGCMFYTLLIGRP---PFDTDTVKNTLNKVVLADYEMPSF-----LSIEAKD 241
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ +++ NP DR S++ V++
Sbjct: 242 LI--------HQLLRR-------NPADRLSLSSVLD 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 411
LG G +GNVY + + ++A+KVL K+ E+ + H NI+ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ D L+ E+ P G L L + + + +A A+ Y H E ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSAT--FMEELADALHYCH---ERKV 135
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H DIKP+N+L+ K++DFG + H+ + TM GT+ Y+ PE+ +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMC---GTLDYLPPEMIEGKTHDE 191
Query: 532 SGKSDVYSYGMLLLEMI 548
K D++ G+L E +
Sbjct: 192 --KVDLWCAGVLCYEFL 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 73/338 (21%), Positives = 122/338 (36%), Gaps = 77/338 (22%)
Query: 310 KKPFSEERQNIGDGLNVKQ--FIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYK 367
S G+ + +++ + +Y KLG+G YG V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYF----------KVRKLGSGAYGEVLL 54
Query: 368 GKF-PDGRLVAVKVLEK--------------TSNFSDNFINEVATIGRIHHVNIIHLLGF 412
K A+KV++K F + NE++ + + H NII L
Sbjct: 55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D L+ E+ G G+L + + A I + I YLH +
Sbjct: 115 FEDKKYFYLVTEFY-EG--GELFEQIINRHKFDECDAA--NIMKQILSGICYLH---KHN 166
Query: 471 ILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
I+H DIKP+N+LL + K+ DFGL+ S++ + GT YIAPE+ +
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKK 223
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDKLIQP 581
K DV+S G+++ ++ G Y P I K ++
Sbjct: 224 YNE---KCDVWSCGVIMYILL------------CG------YPPFGGQNDQDIIKK-VEK 261
Query: 582 EKEDFVEEEDDCI---ARKMIIVGLWCIQINPKDRPSM 616
K F + I A+++I + + R +
Sbjct: 262 GKYYFDFNDWKNISDEAKELI---KLMLTYDYNKRCTA 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD----NFINEVATIGRIHHV 404
+ LG G +G+V +G K DG VAVK + K N S F++E A + H
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 405 NIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLL--SREKEN-LSLKPARLLEIALGV 456
N+I LLG C + S++ +I +M G L L SR + + LL+ + +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
A +EYL LH D+ +N +L D T V+DFGL+K + +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 517 GYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
+IA E ++ + KSDV+++G+ + E+
Sbjct: 214 KWIAIESLADRVY-------TSKSDVWAFGVTMWEIA 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 353 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSDN----FINEVATIGRIHHV 404
LG G +G+V + K DG VAVK+L K + + F+ E A + H
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHP 85
Query: 405 NIIHLLGFCCDGSTRA------LIYEYMPNGSLGDLL--SREKEN-LSLKPARLLEIALG 455
++ L+G + +I +M +G L L SR EN +L L+ +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
+A +EYL +H D+ +N +L D T V+DFGL++ +
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 516 IGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ ++A E ++ + SDV+++G+ + E++
Sbjct: 203 VKWLALESLADNLY-------TVHSDVWAFGVTMWEIM 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 40/281 (14%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
E +G+G V P VA+K LEK D + E+ + + HH NI+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE--IAL---GVAHAIEYLHNG 466
L+ + + GS+ D++ K L E IA V +EYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IG---YIAPE 522
+H D+K N+LL D + +++DFG++ A +T R T +G ++APE
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEK---KHLRPTE-----TTSGSNTTEAYFPDWI 574
+ + G K+D++S+G+ +E+ P + + + E D
Sbjct: 197 VMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255
Query: 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
K + C+Q +P+ RP+
Sbjct: 256 MLKKYGKSFRKMIS---------------LCLQKDPEKRPT 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 403
F + LG G +G V + K VAVK+L+ T++ + ++E+ + + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-----------SREKENLSLKPARLLEI 452
NI++LLG C G +I EY G L + L + N + LL
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
+ VA + +L +H D+ +NVLL K+ DFGLA+ + + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 513 RGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
R + ++APE ++ + +SDV+SYG+LL E+
Sbjct: 227 RLPVKWMAPESIFDCVY-------TVQSDVWSYGILLWEIF 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 38/297 (12%), Positives = 86/297 (28%), Gaps = 60/297 (20%)
Query: 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNII 407
G ++ D R VA+ ++ + ++ + RI +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+L + ++ E++ GSL ++ S P + +A A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAH--- 146
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+ P V + D ++ +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587
+ + D+ G L ++ + P + D + I+P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR---WPLPEAGVRSGLAPAERD-TAGQPIEP------ 225
Query: 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM-PPKPLFPSPP 643
+ D I ++ V +Q + R + T ++ ++ A+A A P+ +P
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSAST-LLNLMQQATAVADRTEVLGPIDEAPV 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
LG G +G V K K + AVKV+ K + + + EV + ++ H NI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L D S+ ++ E G L D + +++ S A I V I Y+H +
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA--RIIKQVFSGITYMH---K 139
Query: 469 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H D+KP+N+LL + D K+ DFGL+ +N M GT YIAPE+
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLR 196
Query: 526 RNLGNPSGKSDVYSYGMLL 544
K DV+S G++L
Sbjct: 197 GTYDE---KCDVWSAGVIL 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 403
F + LG G +G V + K VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------SREKENLSLKPAR 448
+NI++LLG C G +I EY G L + L E + L+L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
LL + VA + +L +H D+ +N+LL K+ DFGLA+ + + V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 509 MTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 548
R + ++APE IF + +SDV+SYG+ L E+
Sbjct: 204 KGNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELF 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 69/331 (20%), Positives = 118/331 (35%), Gaps = 111/331 (33%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
+ +G G +G V++ + P +VAVK+L++ ++ +F E A + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------------SREKENLS 443
NI+ LLG C G L++EYM G L + L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L A L IA VA + YL E + +H D+ +N L+ + K++DFGL+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 504 RSV------VTMTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLL-------- 544
R++ I ++ PE + + +SDV++YG++L
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRY-------TTESDVWAYGVVLWEIFSYGL 274
Query: 545 -----------LEMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
+ + + L P P +Y+ L++
Sbjct: 275 QPYYGMAHEEVIYYVRDGNILACPENC-----------PLELYN-LMR-----------L 311
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
C W P DRPS + +L
Sbjct: 312 C----------W--SKLPADRPSFCSIHRIL 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 53/363 (14%), Positives = 99/363 (27%), Gaps = 76/363 (20%)
Query: 303 KRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGY 362
RIP + SE Q+ D L T + + + + + G LG
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG--TVLGQEDP 86
Query: 363 GNVYKGK-FPDGRLVAVKVLEKTSNFSDNFI----NEVATIGRI---------------- 401
+ G V V T N I EV + +
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 402 ---------HHVNIIHLLGFCCDGSTRALIYEYM-PNGSLGD----LLSREKENLSLKPA 447
+I + D + + Y +L LLS + SL
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 448 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507
L++ L V + LH+ ++H ++P +++LD ++ F
Sbjct: 207 ARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-- 261
Query: 508 TMTGPRGTIGYIAPEIFMRNLGNPSG---------KSDVYSYGMLLLEMIEEKKHLRPTE 558
+ G+ PE+ R D ++ G+++ + P
Sbjct: 262 ----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD---LPIT 314
Query: 559 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
+ +E F I +E ++ +DR +
Sbjct: 315 KDAALGGSEWIFRSCKN---IPQPVRALLE---------------GFLRYPKEDRLLPLQ 356
Query: 619 VVE 621
+E
Sbjct: 357 AME 359
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 23/200 (11%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
F E LG+G + V+ K G+L A+K ++K+ F + NE+A + +I H NI+ L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
+ L+ + + G G+L R E+ + K A + V A++YLH E
Sbjct: 73 DIYESTTHYYLVMQLVS-G--GELFDRILERGVYTEKDAS--LVIQQVLSAVKYLH---E 124
Query: 469 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H D+KP+N+L + + ++DFGL+K M+ GT GY+APE+
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLA 180
Query: 526 RNLGNPSGKS-DVYSYGMLL 544
+ P K+ D +S G++
Sbjct: 181 Q---KPYSKAVDCWSIGVIT 197
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 44/230 (19%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
+ LG G +G V K VAVK+L++ ++ S+ + ++E + +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------------SREKENLS 443
++I L G C LI EY GSL L + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L L+ A ++ ++YL E++++H D+ +N+L+ K+SDFGL++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 504 RSVVTMTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
S V + R + ++A E I+ + +SDV+S+G+LL E++
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIY-------TTQSDVWSFGVLLWEIV 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHL 409
FK KLG+G +G+V+ + G +K + K + E+ + + H NII +
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 410 LGFCCDGSTRALIYEYMPNGSLGD---LLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
D ++ E G L + + LS E+ + +A+ Y H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA--ELMKQMMNALAYFH-- 141
Query: 467 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
++H D+KP+N+L P K+ DFGLA+ + T GT Y+APE+
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEV 197
Query: 524 FMRNLGNPSGKSDVYSYGMLL 544
F R++ K D++S G+++
Sbjct: 198 FKRDVTF---KCDIWSAGVVM 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGR--------LVAVKVLEKTSNFSD--NFINEVATIGRI- 401
+ LG G +G V + VAVK+L+ + D + ++E+ + I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 402 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 448
H NII+LLG C +I EY G+L + L +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
L+ +A +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 509 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
T R + ++APE ++ + +SDV+S+G+L+ E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVY-------THQSDVWSFGVLMWEIF 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 403
F + LG+G +G V K VAVK+L++ ++ S+ ++E+ + ++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL--------------------SREKENLS 443
NI++LLG C LI+EY G L + L E++
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L LL A VA +E+L +H D+ +NVL+ K+ DFGLA+ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 504 RSVVTMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 548
+ V R + ++APE +F + KSDV+SYG+LL E+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIY---TIKSDVWSYGILLWEIF 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 40/214 (18%)
Query: 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483
+ +L D ++R + L I + +A A+E+LH+ ++H D+KP N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFF 197
Query: 484 DPDFTPKVSDFGLAKA----------HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-S 532
D KV DFGL A + + T TG GT Y++PE GN S
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH---GNNYS 254
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE-KEDFVEEED 591
K D++S G++L E+ L T I + + F ++
Sbjct: 255 HKVDIFSLGLILFEL------LYSFST--QMERVR------IITDVRNLKFPLLFTQKYP 300
Query: 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
M+ + +P +RP T +++ +
Sbjct: 301 Q--EHMMV---QDMLSPSPTERPEAT---DIIEN 326
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 65/289 (22%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 410
++G G YG+V K P G+++AVK + T + + + ++ + R I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHN 465
G + E M + S K S+ + E I L A+ +L
Sbjct: 88 GALFREGDCWICMELM-STSFDKFY---KYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAP 521
L+I+H DIKP N+LLD K+ DFG L + ++ R G Y+AP
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-------GCRPYMAP 194
Query: 522 EIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYD- 576
E + +SDV+S G+ L E+ R +P W ++D
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELAT----GRFP------------YPKWNSVFDQ 238
Query: 577 ----------KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+L E+ +F + + C+ + RP
Sbjct: 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNL--------CLTKDESKRPK 279
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 355 EKLGTG--GYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIH 408
+G G V ++ P G V V+ LE SN F+ E+ +H NI+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE--IAL---GVAHAIEYL 463
+ ++ +M GS DL+ + + E IA GV A++Y+
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLIC------THFMDGMNELAIAYILQGVLKALDYI 144
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPR-GTIGY 518
H + +H +K ++L+ D +S + R R V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 519 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549
++PE+ +NL KSD+YS G+ E+
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 353 FKEKLGTGGYGNVYKG--------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI- 401
+ LG G +G V K + VAVK+L+ + D + ++E+ + I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 402 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 448
H NII+LLG C +I EY G+L + L +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
L+ +A +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 509 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
T R + ++APE ++ + +SDV+S+G+L+ E+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVY-------THQSDVWSFGVLMWEIF 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLL 410
+ +G G +G V A K + K D F E+ + + H NII L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D + L+ E G L + + K A I V A+ Y H +L
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAA--RIMKDVLSAVAYCH---KLN 126
Query: 471 ILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+ H D+KP+N L PD K+ DFGLA + M GT Y++P++
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 528 LGNPSGKSDVYSYGMLL 544
G + D +S G+++
Sbjct: 184 YGP---ECDEWSAGVMM 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIH 402
+ LG+G G V + VA++++ K ++ + N E+ + +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 460
H II + F D ++ E M G +L + + L + + A+
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK--LYFYQMLLAV 252
Query: 461 EYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+YLH E I+H D+KP+NVLL + D K++DFG +K + T+ GT
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPT 306
Query: 518 YIAPEIFMRNLGNPSGKS-DVYSYGMLL 544
Y+APE+ + ++ D +S G++L
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 403
+ LG G +G V + K R VAVK+L++ + S+ ++E+ + I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 404 VNIIHLLGFCCD-GSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARL 449
+N+++LLG C G +I E+ G+L L + L L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 450 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509
+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ ++ V
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 510 TGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 548
R + ++APE ++ + +SDV+S+G+LL E+
Sbjct: 208 GDARLPLKWMAPETIFDRVY-------TIQSDVWSFGVLLWEIF 244
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/240 (23%), Positives = 86/240 (35%), Gaps = 51/240 (21%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK------TSNFSDNFINEVATIGRIHHVN 405
K +G G YG V + A+K++ K + EV + ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG---------- 455
I L D L+ E G L D L+ ++ + K A +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 456 ---------------------------VAHAIEYLHNGCELRILHLDIKPQNVLL--DPD 486
+ A+ YLH I H DIKP+N L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 487 FTPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 544
F K+ DFGL+K + + MT GT ++APE+ + K D +S G+LL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 47/294 (15%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLLG 411
+LG G G V+K P G ++A K++ + I E+ + + I+ G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
++ E+M GSL +L K+ + L ++++ V + YL + +I
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 153
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+H D+KP N+L++ K+ DFG++ S S V GT Y++PE R G
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 204
Query: 530 NP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
S +SD++S G+ L+EM + + P + + +P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 589 EEDDCIARKMI--------IV---------GLW----------CIQINPKDRPS 615
+ +R + IV G++ C+ NP +R
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS----------DNFINEVATIGRI 401
KE LG G V + P + AVK+++ T S + + EV + ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 402 -HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460
H NII L + L+++ M G L D L+ EK LS K R +I + I
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETR--KIMRALLEVI 137
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
LH +L I+H D+KP+N+LLD D K++DFG + + GT Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 191
Query: 521 PEIFMRNLGNPS---GKS-DVYSYGMLL 544
PEI ++ + GK D++S G+++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+LG G +G VYK K G L A KV + D +I E+ + H I+ LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHPYIVKLLG 83
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGCE 468
++ E+ P G++ ++ L+ +I + + A+ +LH+
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQVVCRQMLEALNFLHSK-- 136
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
RI+H D+K NVL+ + +++DFG K + S + GT ++APE+
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVV 189
Query: 525 MRNLGNPSG---KSDVYSYGMLLLEMIE 549
M + K+D++S G+ L+EM +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQ 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EK+G G G VY G+ VA++ L++ INE+ + + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLD 84
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 466
G ++ EY+ GSL D++ + E + A+E+LH+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV---------TETCMDEGQIAAVCRECLQALEFLHS- 134
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+++H DIK N+LL D + K++DFG + S+ ++V GT ++APE
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPE 186
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIE 549
+ R P K D++S G++ +EMIE
Sbjct: 187 VVTRKAYGP--KVDIWSLGIMAIEMIE 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EK+G G +G V+KG ++VA+K+ LE+ + ++ E+ + + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 466
+ +I EY+ GS DLL +P L E I + ++YLH+
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLL---------EPGPLDETQIATILREILKGLDYLHS- 137
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+ +H DIK NVLL K++DFG L + + V GT ++APE
Sbjct: 138 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 189
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIE 549
+ ++ + K+D++S G+ +E+
Sbjct: 190 VIKQSAYDS--KADIWSLGITAIELAR 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K+G G G V + GR VAVK+ L K NEV + H N++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYK 109
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 466
G ++ E++ G+L D++ RL E + V A+ YLH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV---------SQVRLNEEQIATVCEAVLQALAYLHA- 159
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 522
++H DIK ++LL D K+SDFG ++K + +S+V GT ++APE
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPE 211
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIE 549
+ R+L + D++S G++++EM++
Sbjct: 212 VISRSLYAT--EVDIWSLGIMVIEMVD 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
KE+LG G + V + G A K++ ++ E ++ H NI+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L + S L+++ + G L + + +E S A + +I Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS--HCIQQILESIAYCH---S 123
Query: 469 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H ++KP+N+LL K++DFGLA + + G GT GY++PE+
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 180
Query: 526 RNLGNPSGKSDVYSYGMLL 544
++ + D+++ G++L
Sbjct: 181 KDPYSK--PVDIWACGVIL 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 413
EKLG G YG+VYK G++VA+K + S+ + I E++ + + +++ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVVKYYGSY 93
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGCELR 470
+ ++ EY GS+ D++ + L+ EIA +EYLH +R
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-----EIATILQSTLKGLEYLHF---MR 145
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+H DIK N+LL+ + K++DFG L ++ +V+ GT ++APE+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE 199
Query: 527 NLGNPSGKSDVYSYGMLLLEMIE 549
N +D++S G+ +EM E
Sbjct: 200 IGYNC--VADIWSLGITAIEMAE 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS------DNFINEVATIGRIHHVN 405
E +G G + V + G+ AVK+++ S ++ E + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLH 464
I+ LL +++E+M L ++ R A + A+ Y H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 465 NGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
+ I+H D+KP VLL + K+ FG+A + V G GT ++AP
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAP 202
Query: 522 EIFMRNLGNPSGKSDVYSYGMLL 544
E+ R DV+ G++L
Sbjct: 203 EVVKREPYGK--PVDVWGCGVIL 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 410
+LG G YG V K + P G+++AVK + T N + + ++ R + +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHN 465
G + E M + SL + + K + E IA+ + A+E+LH+
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVID----KGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAP 521
+L ++H D+KP NVL++ K+ DFG L +++ G Y+AP
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-------GCKPYMAP 178
Query: 522 EIFMRNLGNP--SGKSDVYSYGMLLLEM 547
E L S KSD++S G+ ++E+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLG 411
+G G +G V + D ++ A+K + K N N E+ + + H +++L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCEL 469
D ++ + + G L L + + + +L E+ + A++YL
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVM----ALDYLQ---NQ 134
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
RI+H D+KP N+LLD ++DF +A R + TM G T Y+APE+F G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG---TKPYMAPEMFSSRKG 191
Query: 530 NPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY---------FPDWI 574
+ D +S G+ E++ + RP S +++ E +P
Sbjct: 192 AGYSFAVDWWSLGVTAYELL---RGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 72/309 (23%)
Query: 353 FKEKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSD--NFINEVATIGRI- 401
+ LG G +G V + VAVK+L+ + D + I+E+ + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 402 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 448
H NII+LLG C +I EY G+L + L L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
L+ A VA +EYL + +H D+ +NVL+ D K++DFGLA+
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 509 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 563
T R + ++APE I+ + +SDV+S+G+LL E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY-------THQSDVWSFGVLLWEIF--------------- 287
Query: 564 NTTEAYFPDWIYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRP 614
T P Y + E ++E +C + M C P RP
Sbjct: 288 --TLGGSP---YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMM----RDCWHAVPSQRP 338
Query: 615 SMTRVVEML 623
+ ++VE L
Sbjct: 339 TFKQLVEDL 347
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
E+LG+G +G V++ GR+ K + NE++ + ++HH +I+L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D LI E++ G L D ++ E +S ++++H E
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI--NYMRQACEGLKHMH---EHS 169
Query: 471 ILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+HLDIKP+N++ + K+ DFGLA + + V T T + APEI R
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 226
Query: 529 GNPSGKSDVYSYG----MLL 544
+D+++ G +LL
Sbjct: 227 VGF--YTDMWAIGVLGYVLL 244
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 352 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK-TSNFSDNFINEVATIGRIHHVNIIHL 409
E LG G +G V+K + G +A K+++ + NE++ + ++ H N+I L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+ L+ EY+ G L D + E NL+ + I ++H ++
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI--LFMKQICEGIRHMH---QM 206
Query: 470 RILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
ILHLD+KP+N+L + D K+ DFGLA+ + + GT ++APE+ +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYD 263
Query: 528 LGNPSGKSDVYSYG----MLL 544
+ +D++S G MLL
Sbjct: 264 FVSF--PTDMWSVGVIAYMLL 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 19/200 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
E LG G +G V++ + K ++ E++ + H NI+HL
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+I+E++ + + ++ L+ + V A+++LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIV--SYVHQVCEALQFLH---SHNI 123
Query: 472 LHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
H DI+P+N++ T K+ +FG A+ + + Y APE+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQH--- 177
Query: 530 NPSGKS-DVYSYG----MLL 544
+ + D++S G +LL
Sbjct: 178 DVVSTATDMWSLGTLVYVLL 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 21/201 (10%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS---DNFINEVATIGRIHHVNIIH 408
E+LG G + V + G+ A ++ + E + H NI+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 466
L + LI++ + G G+L +E S A + A+ + H
Sbjct: 75 LHDSISEEGHHYLIFDLVT-G--GELFEDIVAREYYSEADAS--HCIQQILEAVLHCH-- 127
Query: 467 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
++ ++H ++KP+N+LL K++DFGLA + G GT GY++PE+
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEV 184
Query: 524 FMRNLGNPSGKSDVYSYGMLL 544
++ D+++ G++L
Sbjct: 185 LRKDPYGK--PVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 63/298 (21%), Positives = 121/298 (40%), Gaps = 50/298 (16%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRI-HHVNIIHLL 410
++ LG G + V + AVK++EK + EV + + H N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
F + L++E M G G +LS ++ + + A + VA A+++LHN
Sbjct: 78 EFFEEEDRFYLVFEKM-RG--GSILSHIHKRRHFNELEAS--VVVQDVASALDFLHN--- 129
Query: 469 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR-----SVVTMTGPRGTIGYIA 520
I H D+KP+N+L + K+ DF L N S + P G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 521 PEIFMRNLGNPSG---KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 570
PE+ S + D++S G++L ++ + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ--- 246
Query: 571 PDWIYDKLIQPEKEDFVEEEDDCIA-------RKMIIVGLWCIQINPKDRPSMTRVVE 621
+ +++ IQ K +F +++ I+ K+++ + K R S +V++
Sbjct: 247 -NMLFES-IQEGKYEFPDKDWAHISCAAKDLISKLLVR-------DAKQRLSAAQVLQ 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/196 (32%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+ +LG G VY+ K + A+KVL+KT + E+ + R+ H NII L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNIIKLKE 115
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+ +L+ E + G G+L R EK S + A + + A+ YLH E
Sbjct: 116 IFETPTEISLVLELVT-G--GELFDRIVEKGYYSERDAA--DAVKQILEAVAYLH---EN 167
Query: 470 RILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
I+H D+KP+N+L PD K++DFGL+K V M GT GY APEI
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRG 224
Query: 527 NLGNPSGKS-DVYSYG 541
G D++S G
Sbjct: 225 ---CAYGPEVDMWSVG 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 404
E+LG+G + V K + G A K ++K + + + EV+ + ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
NII L + + LI E + G L D L +KE+LS + A + + YLH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEAT--SFIKQILDGVNYLH 132
Query: 465 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 521 PEIFMRNLGNPSGKS-DVYSYG----MLL 544
PEI P G D++S G +LL
Sbjct: 187 PEIVNY---EPLGLEADMWSIGVITYILL 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 404
E+LG+G + V K + G A K ++K + + + EV+ + ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N+I L + + LI E + G L D L +KE+LS + A + + YLH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEAT--SFIKQILDGVNYLH 132
Query: 465 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 521 PEIFMRNLGNPSGKS-DVYSYG----MLL 544
PEI P G D++S G +LL
Sbjct: 187 PEIVNY---EPLGLEADMWSIGVITYILL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 404
E+LG+G + V K + G+ A K ++K S + EV + I H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
NII L + + LI E + G L D L+ EKE+L+ A + + + YLH
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLTEDEAT--QFLKQILDGVHYLH 125
Query: 465 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
RI H D+KP+N++L P+ K+ DFG+A + GT ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 179
Query: 521 PEIFMRNLGNPSGKS-DVYSYG----MLL 544
PEI P G D++S G +LL
Sbjct: 180 PEIVNY---EPLGLEADMWSIGVITYILL 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 411
+ LG G + K + AVK++ K N E+ + H NI+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHE 73
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
D L+ E + NG G+L R +K++ S A I + A+ ++H ++
Sbjct: 74 VFHDQLHTFLVMELL-NG--GELFERIKKKKHFSETEAS--YIMRKLVSAVSHMH---DV 125
Query: 470 RILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
++H D+KP+N+L + + K+ DFG A+ + + P T+ Y APE+ +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQ 183
Query: 527 NLGNPSGKS-DVYSYGMLL 544
N +S D++S G++L
Sbjct: 184 ---NGYDESCDLWSLGVIL 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 65/296 (21%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 412
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 413 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYL 463
+ L+ E+ GS+ DL+ +N + IA + + +L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYI 519
H + +++H DIK QNVLL + K+ DFG L + R + + GT ++
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWM 196
Query: 520 APEIFMRNLGNPSG---KSDVYSYGMLLLEMIEEK---KHLRPTE-----TTSGSNTTEA 568
APE+ + + KSD++S G+ +EM E + P + + ++
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
W + + F+E C+ N RP+ +++
Sbjct: 257 --KKW------SKKFQSFIES---------------CLVKNHSQRPATE---QLMK 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIH 402
+ LG+G G V + VA+K++ K ++ + N E+ + +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 460
H II + F D ++ E M G +L + + L + + A+
Sbjct: 74 HPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK--LYFYQMLLAV 127
Query: 461 EYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+YLH E I+H D+KP+NVLL + D K++DFG +K M GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPT 181
Query: 518 YIAPEIFMRNLGNPSGKS-DVYSYGMLL 544
Y+APE+ + ++ D +S G++L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLG 411
+G G +G V K + ++ A+K+L K F E + I L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL-- 139
Query: 412 FCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGC 467
D + L+ +Y G L LLS+ ++ L + AR L E+ + AI+ +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQ-- 193
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
L +H DIKP N+L+D + +++DFG + +V + GT YI+PEI
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAM 251
Query: 528 LGNPS--GKS-DVYSYGMLLLEMI 548
G G D +S G+ + EM+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEML 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
KE+LG G + V + G A K++ ++ E ++ H NI+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 409 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L + S L+++ + G L + + +E S A + +I Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS--HCIQQILESIAYCH---S 146
Query: 469 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H ++KP+N+LL K++DFGLA + + G GT GY++PE+
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 203
Query: 526 RNLGNPSGKSDVYSYGMLL 544
++ + D+++ G++L
Sbjct: 204 KDPYSK--PVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 404
E+LG+G + V K + G A K ++K S ++ EV+ + I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N+I L + + LI E + G L D L+ EKE+L+ + A E + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEAT--EFLKQILNGVYYLH 131
Query: 465 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
L+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 521 PEIFMRNLGNPSGKSDVYSYG----MLL 544
PEI ++D++S G +LL
Sbjct: 186 PEIVNYEPLGL--EADMWSIGVITYILL 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 345 DIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGR 400
+ ++LG G + V + G+ A K L+K + ++E+A +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 401 I-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAH 458
+I+L + S LI EY G + L E +S + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI--RLIKQILE 142
Query: 459 AIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
+ YLH + I+HLD+KPQN+LL P K+ DFG+++ + + GT
Sbjct: 143 GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GT 196
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYG----MLL 544
Y+APEI + +D+++ G MLL
Sbjct: 197 PEYLAPEILNYDPITT--ATDMWNIGIIAYMLL 227
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---------NFSDNFINEVATIGRIH 402
K+ +G G V + G AVK++E T+ + E + ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 403 -HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHA 459
H +II L+ S L+++ M G +L EK LS K R I + A
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKG---ELFDYLTEKVALSEKETR--SIMRSLLEA 212
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
+ +LH I+H D+KP+N+LLD + ++SDFG + + GT GY+
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYL 266
Query: 520 APEIFMRNLGNPSG----KSDVYSYGMLL 544
APEI ++ + D+++ G++L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLG 411
LG G + V + R A+K+LEK +N + E + R+ H + L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCEL 469
D Y NG L + + R EI A+EYLH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVS----ALEYLH---GK 149
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+KP+N+LL+ D +++DFG AK S GT Y++PE+
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TE 206
Query: 530 NPSGKS-DVYSYGMLLLEMI 548
+ KS D+++ G ++ +++
Sbjct: 207 KSACKSSDLWALGCIIYQLV 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 50/286 (17%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 411
K+ LG G G V + G+ A+K+L S EV + +I+ +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPHIVCILD 89
Query: 412 FCCDGSTRA----LIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
+ +I E M G L + R + + + A EI + AI++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--EIMRDIGTAIQFLH-- 145
Query: 467 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
I H D+KP+N+L + D K++DFG AK ++N + P T Y+APE+
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEV 200
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSG-----SNTTEAYFPDWIYDK 577
KS D++S G+++ ++ G SNT +A P + +
Sbjct: 201 LGP---EKYDKSCDMWSLGVIMYILL------------CGFPPFYSNTGQAISPG-MKRR 244
Query: 578 LIQPEKEDFVEEEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVE 621
I+ + F E ++ K +I L ++ +P +R ++T+ +
Sbjct: 245 -IRLGQYGFPNPEWSEVSEDAKQLIRLL--LKTDPTERLTITQFMN 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 58/283 (20%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGR-IHHVNIIHLL 410
++G+G G V+K +F G ++AVK + + ++ + + I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G + + E M L R + + + L ++ + + A+ YL +
Sbjct: 91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPER--ILGKMTVAIVKALYYLKE--KHG 145
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
++H D+KP N+LLD K+ DFG L +++RS G Y+APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-------GCAAYMAPERIDP 198
Query: 527 NLGNPSG---KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQ- 580
++DV+S G+ L+E+ T + + + ++ L +
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELA----------------TGQFPYKNCKTDFEVLTKV 242
Query: 581 --------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
P F + + C+ + + RP
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKD--------CLTKDHRKRPK 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 353 FKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGR-IHHVNIIHLL 410
KE +G G Y + AVK+++K+ + E+ + R H NII L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLK 82
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
DG ++ E M G +LL + ++ S + A + + +EYLH
Sbjct: 83 DVYDDGKYVYVVTELMKGG---ELLDKILRQKFFSEREAS--AVLFTITKTVEYLH---A 134
Query: 469 LRILHLDIKPQNVLL---DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
++H D+KP N+L + ++ DFG AK + + P T ++APE+
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVL 192
Query: 525 MRNLGNPSGKS-DVYSYGMLL 544
R + D++S G+LL
Sbjct: 193 ER---QGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 73/318 (22%), Positives = 115/318 (36%), Gaps = 73/318 (22%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGR-----------IH 402
LG GG+G V+ G D VA+KV+ + + +++ T
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 460
H +I LL + L+ E DL EK L P+R V AI
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSR--CFFGQVVAAI 152
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
++ H+ ++H DIK +N+L+D K+ DFG A + GT Y
Sbjct: 153 QHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYS 205
Query: 520 APEIFMRNL--GNPSGKSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 570
PE R+ P + V+S G+LL +M+ +++ L E +F
Sbjct: 206 PPEWISRHQYHALP---ATVWSLGILLYDMVCGDIPFERDQEILE----------AELHF 252
Query: 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE---MLSSAS 627
P + DC +I C+ P RPS+ ++ M
Sbjct: 253 PAHV---------------SPDC--CALI---RRCLAPKPSSRPSLEEILLDPWM--QTP 290
Query: 628 AEAIEMPPKPLFPSPPQL 645
AE + + P P+P
Sbjct: 291 AEDVPLNPSKGGPAPLAW 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 35/243 (14%)
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAV 378
V F++ +K++ + +G G + V K G++ A+
Sbjct: 38 YVADFLQWAEP------IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 379 KVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLGFCC--DGSTRALIYEYMPNGSLG 432
K++ K F E + I L D + L+ EY G L
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLL 149
Query: 433 DLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 490
LLS+ E + + AR L EI + AI+ +H L +H DIKP N+LLD +
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVM----AIDSVH---RLGYVHRDIKPDNILLDRCGHIR 202
Query: 491 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS----GKS-DVYSYGMLLL 545
++DFG + +V ++ GT Y++PEI G P G D ++ G+
Sbjct: 203 LADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 546 EMI 548
EM
Sbjct: 262 EMF 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN---------EVATIGRIHHV 404
LG+G +G V+ + V VK ++K D +I E+A + R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEY 462
NII +L + L+ E +G DL + L A I + A+ Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLAS--YIFRQLVSAVGY 145
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
L I+H DIK +N+++ DFT K+ DFG A R + T GTI Y APE
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE 199
Query: 523 IFMRNLGNP-SG-KSDVYSYGMLL 544
+ M GNP G + +++S G+ L
Sbjct: 200 VLM---GNPYRGPELEMWSLGVTL 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 55/278 (19%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHL 409
++G G +G VY + + +VA+K + ++++ + I EV + ++ H N I
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNG 466
G T L+ EY GS DLL K+ L EIA G + YLH+
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV-----EIAAVTHGALQGLAYLHS- 172
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
++H D+K N+LL K+ DFG A + S V GT ++APE+ +
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 224
Query: 527 NLGNP-SGKSDVYSYGMLLLEMIEEK---KHLRPTE-----TTSGSNTTEAYFPDWIYDK 577
GK DV+S G+ +E+ E K ++ + S ++ W
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHW---- 278
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+FV+ C+Q P+DRP+
Sbjct: 279 --SEYFRNFVD---------------SCLQKIPQDRPT 299
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 14/196 (7%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
E+LGTG +G V++ G A K + + E+ T+ + H +++L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D + +IYE+M G L + ++ E +S A E V + ++H E
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMH---ENN 275
Query: 471 ILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
+HLD+KP+N++ K+ DFGL +SV T GT + APE+
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA--EG 330
Query: 529 GNPSGKSDVYSYGMLL 544
+D++S G+L
Sbjct: 331 KPVGYYTDMWSVGVLS 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 30/238 (12%)
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAV 378
N+ F+ Y+ + N I+ + + +G G +G V + ++ A+
Sbjct: 46 NIDNFLSRYKD------TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 379 KVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 434
K+L K + F E + + ++ L D ++ EYMP G L +L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 435 LSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492
+S + K AR E+ L A++ +H + +H D+KP N+LLD K++
Sbjct: 160 MSNYD--VPEKWARFYTAEVVL----ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 548
DFG ++ V T GT YI+PE+ G+ G+ D +S G+ L EM+
Sbjct: 211 DFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFC 413
LG G YG V VAVK+++ + +N E+ ++H N++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRI 471
+G+ + L EY G L D + + A+ ++ GV YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGV----VYLHG---IGI 126
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 532 SGKSDVYSYGMLLLEMI------EEKKHLRPT--ETTSGSNTTEAYFPDWIYDKLIQPEK 583
DV+S G++L M+ ++ + + Y W I
Sbjct: 187 E-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKK---IDSAP 238
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ K+++ NP R ++ + +
Sbjct: 239 LALL--------HKILVE-------NPSARITIPDIKK 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT-----SNFSDNFINEVATIGRIHHVNIIHLL 410
LG G YG V + AVK+L+K N N E+ + R+ H N+I L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 411 GFCCDGSTRALIY---EYMPNGS--LGDLLSREKENLSLKPARLL--EIALGVAHAIEYL 463
+ +Y EY G + D + ++ + A ++ G+ EYL
Sbjct: 73 DVL-YNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGL----EYL 125
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
H+ I+H DIKP N+LL T K+S G+A+A + T +G+ + PEI
Sbjct: 126 HS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 524 FMRNLGNPSGKSDVYSYGMLL 544
K D++S G+ L
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 73/313 (23%), Positives = 120/313 (38%), Gaps = 68/313 (21%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN-------EVATIGRIHHV-- 404
LG+GG+G+VY G D VA+K +EK + EV + ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 405 NIIHLLGFCCDGSTRALIYEY-MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+I LL + + LI E P L D ++ E+ L + AR V A+ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELAR--SFFWQVLEAVRHC 165
Query: 464 HNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
HN +LH DIK +N+L+D + K+ DFG A ++ GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPE 218
Query: 523 IFMRNL--GNPSGKSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYFPDW 573
+ G + V+S G+LL +M+ +++ +R + +F
Sbjct: 219 WIRYHRYHGRS---AAVWSLGILLYDMVCGDIPFEHDEEIIR----------GQVFFRQR 265
Query: 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE----MLSSASAE 629
+ +C + +I WC+ + P DRP+ + E
Sbjct: 266 V---------------SSEC--QHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305
Query: 630 AIEMPPKPLFPSP 642
E+ L P P
Sbjct: 306 TAEIHLHSLSPGP 318
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMTNG---FKEKLGTGGYGNVYKGKF-PDGRLVAVKV 380
+VK+F+ + L + + LGTG +G V K G A+K+
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 381 LEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS 436
L+K ++ +NE + ++ ++ L D S ++ EY+ G + L
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 437 REKENLSLKPARL--LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494
R S AR +I L EYLH L +++ D+KP+N+L+D +V+DF
Sbjct: 134 RIGR-FSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
G AK T T GT +APEI L K+ D ++ G+L+ EM
Sbjct: 186 GFAKRVKGR----TWT-LCGTPEALAPEII---LSKGYNKAVDWWALGVLIYEMA 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLL 410
EK+G G YG VYK K GR+VA+K + + + I E++ + +HH NI+ L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLHN 465
L++E+M L +L K L + LL + + H
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR-------GVAHCH- 136
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIA 520
+ RILH D+KPQN+L++ D K++DFGLA+A RS VVT+ Y A
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-------WYRA 187
Query: 521 PEIFMRNLGNP--SGKSDVYSYGMLLLEMI 548
P++ +G+ S D++S G + EMI
Sbjct: 188 PDVL---MGSKKYSTSVDIWSIGCIFAEMI 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLL 410
+ LG G G V + A+K+L+ EV R +I+ ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 121
Query: 411 GFCCDGSTRA----LIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ ++ E + G L + R + + + A EI + AI+YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH- 178
Query: 466 GCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
+ I H D+KP+N+L P+ K++DFG AK + + ++T P T Y+APE
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPE 233
Query: 523 IFMRNLGNPSGKS-DVYSYGMLL 544
+ KS D++S G+++
Sbjct: 234 VLGP---EKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFC 413
LG G YG V VAVK+++ + +N E+ ++H N++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRI 471
+G+ + L EY G L D + + A+ ++ GV YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGV----VYLHG---IGI 126
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 532 SGKSDVYSYGMLLLEMI------EEKKHLRPT--ETTSGSNTTEAYFPDWIYDKLIQPEK 583
DV+S G++L M+ ++ + + Y W I
Sbjct: 187 E-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKK---IDSAP 238
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ K+++ NP R ++ + +
Sbjct: 239 LALL--------HKILVE-------NPSARITIPDIKK 261
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-22
Identities = 75/331 (22%), Positives = 126/331 (38%), Gaps = 47/331 (14%)
Query: 243 CQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLI----IGATAGSCCMVLVAVAL 298
C R L + + +RK+ + + T + +
Sbjct: 71 CATRPELSRCVAFLDGVAEY----EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLV 126
Query: 299 LVFRKRIPSFF-KKPFSEERQNIGDGLNVKQFIKTYRSALLS---NYSYNDIKKMT-NGF 353
+R+ K F E + + L+V F S + + + + + +T N F
Sbjct: 127 TNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTF 186
Query: 354 KEK--LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNI 406
++ LG GG+G V + G++ A K LEK NE + +++ +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 407 IHLLGFCCDGSTRAL--IYEYMPNGSLGDL---LSRE-KENLSLKPARL--LEIALGVAH 458
+ L + AL + M NG GDL + + A EI
Sbjct: 247 VSL--AYAYETKDALCLVLTLM-NG--GDLKFHIYHMGQAGFPEARAVFYAAEICC---- 297
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
+E LH RI++ D+KP+N+LLD ++SD GLA +++ GT+GY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGY 351
Query: 519 IAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
+APE+ S D ++ G LL EMI
Sbjct: 352 MAPEVV---KNERYTFSPDWWALGCLLYEMI 379
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN---EVATIGRIHHVNIIHLLGF 412
+G G + V + GR VA+K+++KT + EV + ++H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 413 CCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
T +Y EY G + D L + K AR + A++Y H
Sbjct: 83 I---ETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEAR--SKFRQIVSAVQYCHQ---K 133
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
RI+H D+K +N+LLD D K++DFG + + + G Y APE+F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKY 190
Query: 530 NPSGKSDVYSYGMLL 544
+ + DV+S G++L
Sbjct: 191 DGP-EVDVWSLGVIL 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLL 410
EK+G G YG VYK + G A+K + + + I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
L++E++ L LL + L A+ + L + I Y H + R
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL--LNGIAYCH---DRR 120
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEIFM 525
+LH D+KPQN+L++ + K++DFGLA+A R +VT+ Y AP++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-------WYRAPDVL- 172
Query: 526 RNLGNP--SGKSDVYSYGMLLLEMI 548
+G+ S D++S G + EM+
Sbjct: 173 --MGSKKYSTTIDIWSVGCIFAEMV 195
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
EK+G G YG V+K K +VA+K + + + + + E+ + + H NI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLH 464
L++E+ L +L + + LL+ + + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK-------GLGFCH 118
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYI 519
+LH D+KPQN+L++ + K+++FGLA+A R VVT+ Y
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-------WYR 168
Query: 520 APEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRP 556
P++ G S D++S G + E+ + L P
Sbjct: 169 PPDVL---FGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 357 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLG 411
LGTG +G V+ + +GR A+KVL+K + +E + + H II + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCEL 469
D +I +Y+ G L LL + + A+ E+ L A+EYLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCL----ALEYLH---SK 125
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I++ D+KP+N+LLD + K++DFG AK VT T GT YIAPE+
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-LCGTPDYIAPEVV---ST 177
Query: 530 NPSGKS-DVYSYGMLLLEMI 548
P KS D +S+G+L+ EM+
Sbjct: 178 KPYNKSIDWWSFGILIYEML 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKT---------------------------S 385
K+++G G YG V D A+KVL K
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 386 NFSDNFINEVATIGRIHHVNIIHL---LGFCCDGSTRALIY---EYMPNGSLGDLLSREK 439
+ E+A + ++ H N++ L L D +Y E + G + ++ + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVL----DDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 440 ENLSLKPARLL--EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497
LS AR ++ G+ EYLH +I+H DIKP N+L+ D K++DFG++
Sbjct: 134 --LSEDQARFYFQDLIKGI----EYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLL 544
+ ++++ T GT ++APE SG DV++ G+ L
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 38/260 (14%)
Query: 310 KKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEK-------LGTGGY 362
F + I L F K S + + ++ +G GG+
Sbjct: 143 PDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGF 202
Query: 363 GNVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NE---VATIGRIHHVNIIHLLGFCC 414
G VY + D G++ A+K L+K NE ++ + I+ +
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM--SYA 260
Query: 415 DGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELR 470
+ L I + M G L LS+ S R EI L +E++H
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIIL----GLEHMH---NRF 312
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMRNLG 529
+++ D+KP N+LLD ++SD GLA S+ + GT GY+APE+ + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVA 367
Query: 530 NPSGKS-DVYSYGMLLLEMI 548
S D +S G +L +++
Sbjct: 368 Y--DSSADWFSLGCMLFKLL 385
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 415
+G+G +G + LVAVK +E+ + +N E+ + H NI+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRILH 473
+ A+I EY G L + + S AR ++ GV Y H+ ++I H
Sbjct: 88 PTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGV----SYCHS---MQICH 139
Query: 474 LDIKPQNVLLDPDFTP--KVSDFGLAKA---HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
D+K +N LLD P K+ DFG +K+ HS+ +S V GT YIAPE+ +R
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRQE 193
Query: 529 GNPSGKSDVYSYGMLLLEMI 548
+ +DV+S G+ L M+
Sbjct: 194 YDGK-IADVWSCGVTLYVML 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNF----INEVATIGRIHHVNII 407
+ LG G + VYK + ++VA+K L S D + E+ + + H NII
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
LL S +L++++M L ++ + +L L P+ + L +EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLH--- 129
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPE 522
+ ILH D+KP N+LLD + K++DFGLAK+ S NR+ VV T Y APE
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------TRWYRAPE 182
Query: 523 IFMRNLGNP--SGKSDVYSYGMLLLEMI 548
+ G D+++ G +L E++
Sbjct: 183 LL---FGARMYGVGVDMWAVGCILAELL 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
+KLG G Y VYKGK LVA+K LE I EV+ + + H NI+ L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ L++EY+ L L +++ +L L + Y H ++
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLAYCH---RQKV 121
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEIFMR 526
LH D+KPQN+L++ K++DFGLA+A ++ VVT+ Y P+I
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL-------WYRPPDIL-- 172
Query: 527 NLGNP--SGKSDVYSYGMLLLEMI 548
LG+ S + D++ G + EM
Sbjct: 173 -LGSTDYSTQIDMWGVGCIFYEMA 195
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 39/261 (14%)
Query: 310 KKPFSEERQNIGDGLNVKQFIKTYRSALLS---NYSYNDIKKMT-NGFKEK--LGTGGYG 363
F + + L F + S + + + + M + F + LG GG+G
Sbjct: 140 DGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFG 199
Query: 364 NVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLGFCCDGST 418
V+ + G+L A K L K E + ++H I+ L +
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AYAFETK 257
Query: 419 RAL--IYEYMPNGSLGDL------LSREKENLSLKPARL--LEIALGVAHAIEYLHNGCE 468
L + M NG GD+ + + A +I +E+LH +
Sbjct: 258 TDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH---Q 307
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I++ D+KP+NVLLD D ++SD GLA ++ G GT G++APE+ L
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELL---L 362
Query: 529 GNPSGKS-DVYSYGMLLLEMI 548
G S D ++ G+ L EMI
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
EKLG G Y VYKG G VA+K L+ I E++ + + H NI+ L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH----------AIE 461
+ L++E+M N DL K+ + + L + +
Sbjct: 71 VIHTENKLTLVFEFMDN----DL----KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTI 516
+ H +ILH D+KPQN+L++ K+ DFGLA+A + VVT+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL------- 172
Query: 517 GYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMI 548
Y AP++ +G+ S D++S G +L EMI
Sbjct: 173 WYRAPDVL---MGSRTYSTSIDIWSCGCILAEMI 203
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 25/198 (12%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 411
LG G +G V G+ G VAVK+L + S + + E+ + H +II L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 412 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 466
ST + EY+ G L D + + + AR L +I V +Y H
Sbjct: 79 VI---STPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILSAV----DYCHR- 129
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
++H D+KP+NVLLD K++DFGL+ S + T G+ Y APE+
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISG 184
Query: 527 NLGNPSGKSDVYSYGMLL 544
L + D++S G++L
Sbjct: 185 RLYAGP-EVDIWSCGVIL 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 35/208 (16%)
Query: 357 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIG------RIHHVNI 406
LG G +G V+ K D +L A+KVL+K + + V T ++H I
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 407 IHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEY 462
+ L LI +++ G L LS+E + + + L E+AL A+++
Sbjct: 89 VKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELAL----ALDH 141
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 521
LH L I++ D+KP+N+LLD + K++DFGL+K + + GT+ Y+AP
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAP 195
Query: 522 EIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
E+ +S D +S+G+L+ EM+
Sbjct: 196 EVV---NRRGHTQSADWWSFGVLMFEML 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 357 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG--RI-----HHV 404
LGTG YG V+ K D G+L A+KVL+K + T ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSP 119
Query: 405 NIIHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 460
++ L + LI +Y+ G L LS+ + + + + EI L A+
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVL----AL 172
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
E+LH +L I++ DIK +N+LLD + ++DFGL+K + + GTI Y+A
Sbjct: 173 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 228
Query: 521 PEIFMRNLGNPSG--KS-DVYSYGMLLLEMI 548
P+I G SG K+ D +S G+L+ E++
Sbjct: 229 PDIV---RGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 354 KEKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 410
K+G G YG+VYK K D + A+K +E T S + E+A + + H N+I L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQ 84
Query: 411 GFCCDGSTRA--LIYEYMPNGSLGDLLS---------REKENLSLKPARLLEIALGVAHA 459
+ R L+++Y + DL K+ + L + + +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTP----KVSDFGLAKA---------HSRNRSV 506
I YLH +LH D+KP N+L+ + K++D G A+ V
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-V 196
Query: 507 VTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 548
V T Y APE+ LG K+ D+++ G + E++
Sbjct: 197 V-------TFWYRAPELL---LGARHYTKAIDIWAIGCIFAELL 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
K+G G YG V+K + D G++VA+K S + E+ + ++ H N+++L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
L L++EY + +L ++ + + I A+ + H +
Sbjct: 68 LEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---K 120
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEI 523
+H D+KP+N+L+ K+ DFG A+ + V T Y +PE+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-------YRSPEL 173
Query: 524 FMRNLGNPS-GKS-DVYSYGMLLLEMI 548
+G+ G DV++ G + E++
Sbjct: 174 L---VGDTQYGPPVDVWAIGCVFAELL 197
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
KLG G YG VYK VA+K + + + + I EV+ + + H NII L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
LI+EY N DL +N + + + + + + H+
Sbjct: 99 KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR--- 151
Query: 470 RILHLDIKPQNVLLDPDFTP-----KVSDFGLAKAHSR-NRS----VVTMTGPRGTIGYI 519
R LH D+KPQN+LL K+ DFGLA+A R ++ T+ Y
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-------TLWYR 204
Query: 520 APEIFMRNLGNP--SGKSDVYSYGMLLLEMI 548
PEI LG+ S D++S + EM+
Sbjct: 205 PPEIL---LGSRHYSTSVDIWSIACIWAEML 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 28/186 (15%)
Query: 323 GLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVL 381
G +VK ++ ++A++ +Y + LG G G V + A+K+L
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKV---------TSQVLGLGINGKVLQIFNKRTQEKFALKML 51
Query: 382 EKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGD-LL 435
+ EV R +I+ ++ + ++ E + G L +
Sbjct: 52 QD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 436 SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVS 492
R + + + A EI + AI+YLH + I H D+KP+N+L P+ K++
Sbjct: 108 DRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 162
Query: 493 DFGLAK 498
DFG AK
Sbjct: 163 DFGFAK 168
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNF----INEVATIGRIH---HV 404
++G G YG VYK + G VA+K + + EVA + R+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 405 NIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
N++ L+ C T L++E++ L L + L + ++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAETIKDLMRQFLRG 132
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
+++LH I+H D+KP+N+L+ T K++DFGLA+ +S + +T T+ Y
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYR 186
Query: 520 APEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
APE+ L + D++S G + EM
Sbjct: 187 APEVL---LQSTYATPVDMWSVGCIFAEMF 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
+G G YG V K + D GR+VA+K S+ + E+ + ++ H N+++L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLH 464
L C L++E++ + ++ D L L + + ++ I + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------GIGFCH 141
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYI 519
I+H DIKP+N+L+ K+ DFG A+ + V T Y
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-------YR 191
Query: 520 APEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 548
APE+ +G+ GK+ DV++ G L+ EM
Sbjct: 192 APELL---VGDVKYGKAVDVWAIGCLVTEMF 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 357 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG------RIHHVN 405
LG GGYG V+ K + G++ A+KVL+K + + A T + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPF 82
Query: 406 IIHLLGFCC--DGSTRALIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAH 458
I+ L G LI EY+ +G G+L L RE A L EI++
Sbjct: 83 IVDL--IYAFQTGGKLYLILEYL-SG--GELFMQLEREG-IFMEDTACFYLAEISM---- 132
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIG 517
A+ +LH + I++ D+KP+N++L+ K++DFGL K T GTI
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186
Query: 518 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
Y+APEI + + ++ D +S G L+ +M+
Sbjct: 187 YMAPEIL---MRSGHNRAVDWWSLGALMYDML 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 409
K+G G +G V+K + G+ VA+K + N + F + E+ + + H N+++L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 410 LGFCCDGSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGV 456
+ C ++ L++++ + L LLS +L + LL
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN----- 135
Query: 457 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS--RNRSVVTMTGPRG 514
+ Y+H +ILH D+K NVL+ D K++DFGLA+A S +N T
Sbjct: 136 --GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 515 TIGYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEK 551
T+ Y PE+ LG D++ G ++ EM
Sbjct: 191 TLWYRPPELL---LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATI-------GRIHHVNIIH 408
LG G +G V K GR A+K+L+K + + EVA H +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVLQNSRHPFLTA 212
Query: 409 LLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHN 465
L + R + EY G L LSRE+ S AR EI A++YLH+
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVS----ALDYLHS 266
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIF 524
E +++ D+K +N++LD D K++DFGL K ++ T GT Y+APE+
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVL 321
Query: 525 MRNLGNPSGKS-DVYSYGMLLLEMI 548
N G++ D + G+++ EM+
Sbjct: 322 ---EDNDYGRAVDWWGLGVVMYEMM 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATI-------GRIHHVNIIH 408
LG G +G V + GR A+K+L K + + EVA H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD---EVAHTVTESRVLQNTRHPFLTA 69
Query: 409 LLGFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEY 462
L + R + EY NG G+L LSRE+ + + AR EI A+EY
Sbjct: 70 LK-YAFQTHDRLCFVMEYA-NG--GELFFHLSRERV-FTEERARFYGAEIVS----ALEY 120
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 521
LH +++ DIK +N++LD D K++DFGL K S ++ T GT Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAP 174
Query: 522 EIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
E+ N G++ D + G+++ EM+
Sbjct: 175 EVL---EDNDYGRAVDWWGLGVVMYEMM 199
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 48/217 (22%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLLG- 411
+ +G G +G VY+ K G LVA+K K F N E+ + ++ H NI+ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKR-FKNRELQIMRKLDHCNIVRLRYF 115
Query: 412 FCCDGSTRA-----LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVAH 458
F G + L+ +Y+P + SR K+ L + +L ++ +A
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA- 170
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
Y+H+ I H DIKPQN+LLDPD K+ DFG AK R V+
Sbjct: 171 ---YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------- 215
Query: 518 YI------APEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
YI APE+ + + + DV+S G +L E++
Sbjct: 216 YICSRYYRAPEL-IFGATDYTSSIDVWSAGCVLAELL 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 25/198 (12%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 411
LG G +G V GK G VAVK+L + S + + E+ + H +II L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 412 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 466
ST + I+ EY+ G L D + + L K +R L +I GV +Y H
Sbjct: 84 VI---STPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGV----DYCHR- 134
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
++H D+KP+NVLLD K++DFGL+ S + T G+ Y APE+
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISG 189
Query: 527 NLGNPSGKSDVYSYGMLL 544
L + D++S G++L
Sbjct: 190 RLYAGP-EVDIWSSGVIL 206
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V + + G L AVKVL+K D+ + T RI +H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 411 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 464
C R + E++ NG GDL + + + AR EI A+ +LH
Sbjct: 91 -CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRR-FDEARARFYAAEIIS----ALMFLH 141
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
+ I++ D+K NVLLD + K++DFG+ K + T GT YIAPEI
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAPEI 195
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
G + D ++ G+LL EM+
Sbjct: 196 L---QEMLYGPAVDWWAMGVLLYEML 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 44/218 (20%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVK-VLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
G G +G V GK G VA+K V++ F + + + + +HH NI+ L +
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 413 CCDGSTRA-------LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVA 457
R ++ EY+P+ L R + ++ ++ +
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD----TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
LH + + H DIKP NVL++ D T K+ DFG AK S +
Sbjct: 144 ----CLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNV------ 189
Query: 517 GYI------APEIFMRNLGNPSGKSDVYSYGMLLLEMI 548
YI APE+ + + + D++S G + EM+
Sbjct: 190 AYICSRYYRAPEL-IFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
+G G Y V + R+ A+KV++K D I+ V T + +H ++ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 411 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 464
C +R + EY+ NG GDL + R+++ L + AR EI+L A+ YLH
Sbjct: 77 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH 127
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
E I++ D+K NVLLD + K++D+G+ K + T GT YIAPEI
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 181
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
G G S D ++ G+L+ EM+
Sbjct: 182 L---RGEDYGFSVDWWALGVLMFEMM 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 51/218 (23%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLLG-F 412
+ +G G +G V++ K + VA+K K F N E+ + + H N++ L F
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIK---KVLQDKR-FKNRELQIMRIVKHPNVVDLKAFF 101
Query: 413 CCDGSTRA-----LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVAHA 459
+G + L+ EY+P + ++ K+ + + +L ++ +A
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA-- 155
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
Y+H+ + I H DIKPQN+LLDP K+ DFG AK Y
Sbjct: 156 --YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNV------SY 201
Query: 519 I------APEIFMRNLGNP--SGKSDVYSYGMLLLEMI 548
I APE+ G + D++S G ++ E++
Sbjct: 202 ICSRYYRAPELI---FGATNYTTNIDIWSTGCVMAELM 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
+G G Y V + R+ A++V++K D I+ V T + +H ++ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 411 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 464
C +R + EY+ NG GDL + R+++ L + AR EI+L A+ YLH
Sbjct: 120 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH 170
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
E I++ D+K NVLLD + K++D+G+ K + T GT YIAPEI
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 224
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
G G S D ++ G+L+ EM+
Sbjct: 225 L---RGEDYGFSVDWWALGVLMFEMM 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V + L AVK+L+K D+ + R+ + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 411 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 464
C R + EY+ NG GDL + + A EIA+ + +L
Sbjct: 88 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGR-FKEPHAVFYAAEIAI----GLFFLQ 138
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
I++ D+K NV+LD + K++DFG+ K + + T GT YIAPEI
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEI 192
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
P GKS D +++G+LL EM+
Sbjct: 193 I---AYQPYGKSVDWWAFGVLLYEML 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 355 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSNFSDNF----INEVAT---IGRIHHVN 405
++G G YG V+K + GR VA+K + + + I EVA + H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 406 IIHLLGFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPARLLEIALGVAH 458
++ L C T L++E++ DL + + + ++ +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
+++LH R++H D+KPQN+L+ K++DFGLA+ +S + +T T+ Y
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 185
Query: 519 IAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
APE+ L + D++S G + EM
Sbjct: 186 RAPEVL---LQSSYATPVDLWSVGCIFAEMF 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 357 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 411
LG G +G V + + VA+K + + + E++ + + H +II L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 412 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 466
+T I EY G L D + EK+ ++ R +I AIEY H
Sbjct: 77 VI---TTPTDIVMVIEYA-GGELFDYIV-EKKRMTEDEGRRFFQQII----CAIEYCHR- 126
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
+I+H D+KP+N+LLD + K++DFGL+ + + T G+ Y APE+
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVING 181
Query: 527 NLGNPSGKSDVYSYGMLL 544
L + DV+S G++L
Sbjct: 182 KLYAGP-EVDVWSCGIVL 198
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V+ +F + A+K L+K D+ + R+ H + H+
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 83
Query: 411 GFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNG 466
FC + EY+ G L + + L A EI L +++LH
Sbjct: 84 -FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL----GLQFLH-- 135
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
I++ D+K N+LLD D K++DFG+ K + + T T GT YIAPEI
Sbjct: 136 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFC-GTPDYIAPEIL-- 190
Query: 527 NLGNPSGKS-DVYSYGMLLLEMI 548
LG S D +S+G+LL EM+
Sbjct: 191 -LGQKYNHSVDWWSFGVLLYEML 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 413
+G G +G V + AVKVL+K + + + + N+ H L+G
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 414 CDGSTRALIY---EYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLHN 465
T +Y +Y+ NG G+L L RE+ AR EIA A+ YLH
Sbjct: 106 FSFQTADKLYFVLDYI-NG--GELFYHLQRERC-FLEPRARFYAAEIAS----ALGYLH- 156
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIF 524
L I++ D+KP+N+LLD ++DFGL K + N + T GT Y+APE+
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLAPEVL 211
Query: 525 MRNLGNPSGKS-DVYSYGMLLLEMI 548
P ++ D + G +L EM+
Sbjct: 212 ---HKQPYDRTVDWWCLGAVLYEML 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 8e-17
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 357 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 410
LG G +G V + L AVK+L+K D+ + R+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 411 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 464
C R + EY+ NG GDL + + A EIA+ + +L
Sbjct: 409 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGR-FKEPHAVFYAAEIAI----GLFFLQ 459
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 523
I++ D+K NV+LD + K++DFG+ K + + T GT YIAPEI
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEI 513
Query: 524 FMRNLGNPSGKS-DVYSYGMLLLEMI 548
P GKS D +++G+LL EM+
Sbjct: 514 I---AYQPYGKSVDWWAFGVLLYEML 536
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIH 408
KLG G Y V++ + V VK+L+ E+ +I NII
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREI----KILENLRGGPNIIT 95
Query: 409 LLGFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIE 461
L D +R AL++E++ N L + L+ R +L+ A++
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILK-------ALD 144
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
Y H+ I+H D+KP NV++D + ++ D+GLA+ + + + +
Sbjct: 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKG 198
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556
PE+ + + D++S G +L MI K+
Sbjct: 199 PEL-LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/219 (21%), Positives = 83/219 (37%), Gaps = 37/219 (16%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN---FIN---------EVATIGRIH 402
+ +G YG V G +G VA+K + T + + E+ + H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 403 HVNIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEI 452
H NI+ L A L+ E M L ++ ++ +S + + +L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL-- 144
Query: 453 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512
+ LH ++H D+ P N+LL + + DF LA+ + + + T
Sbjct: 145 -----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHY 193
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
Y APE+ + + D++S G ++ EM K
Sbjct: 194 VTHRWYRAPEL-VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 57/249 (22%), Positives = 90/249 (36%), Gaps = 80/249 (32%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLL-G 411
+ LGTG +G V + G+ A+K K + N E+ + + HVNII L+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK---KVLQDP-RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 412 FCCDGSTRA-------------------------------------LIYEYMPNGSLGDL 434
F G +I EY+P+ L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD----TL 124
Query: 435 ------LSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP- 485
R ++ + + ++ V ++H+ L I H DIKPQN+L++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVG----FIHS---LGICHRDIKPQNLLVNSK 177
Query: 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI------APEIFMRNLGNPSGKSDVYS 539
D T K+ DFG AK + YI APE+ M + D++S
Sbjct: 178 DNTLKLCDFGSAKKLIPSE---PSV------AYICSRFYRAPEL-MLGATEYTPSIDLWS 227
Query: 540 YGMLLLEMI 548
G + E+I
Sbjct: 228 IGCVFGELI 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--------- 404
KLG G + V+ K + VA+K++ +++ +E+ + R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 405 --NIIHLLG-FCCDGSTRA---LIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVA 457
+I+ LL F G +++E + +L L+ + + + L + +I+ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--QISKQLL 141
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDP------DFTPKVSDFGLAKAHSRNRSVVTMTG 511
++Y+H C I+H DIKP+NVL++ K++D G A + + + T
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 512 PRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 548
Y +PE+ LG P G D++S L+ E+I
Sbjct: 200 E-----YRSPEVL---LGAPWGCGADIWSTACLIFELI 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
+ +G+G G V R VA+K K S N + E+ + ++H NII
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 408 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
LL F S ++ E M +L + L R+ + + I+
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELD--HERMSYLLYQMLCGIK 141
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
+LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y AP
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 195
Query: 522 EIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 551
E+ LG ++ D++S G ++ EMI+
Sbjct: 196 EVI---LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
+G+G YG+V G VA+K K S + I E+ + + H N+I
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 408 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
LL F S R L+ +M DL S ++ + + ++
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFS--EEKIQYLVYQMLKGLK 140
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
Y+H+ ++H D+KP N+ ++ D K+ DFGLA+ MTG T Y AP
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAP 192
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
E+ + + + + D++S G ++ EM+ K
Sbjct: 193 EV-ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 24/209 (11%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIH 408
+G G YG V + VA+K K S F + E+ + R H NII
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIG 89
Query: 409 LLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+ + ++ + M DL K L + + ++Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYIAPE 522
H+ +LH D+KP N+LL+ K+ DFGLA+ + +T T Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
I M N + D++S G +L EM+ +
Sbjct: 202 I-MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
+ +G+G G V R VA+K K S N + E+ + ++H NII
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 408 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
LL F + L+ E M +L + L + L + I+
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCG--IK 178
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
+LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y AP
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 232
Query: 522 EIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 551
E+ LG ++ D++S G ++ EM+ K
Sbjct: 233 EVI---LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 58/359 (16%), Positives = 124/359 (34%), Gaps = 116/359 (32%)
Query: 356 KLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--------I 406
KLG G + V+ + VA+KV++ ++++ ++E+ + + + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 407 IHLLG-FCCDGST---RALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
+ LL F G +++E + G L + + L + +I V ++
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLD 160
Query: 462 YLHNGCELRILHLDIKPQNVLLDPD----------------------------------- 486
YLH + RI+H DIKP+N+LL +
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 487 --------------FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP- 531
K++D G A ++ T T Y + E+ +G+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVL---IGSGY 270
Query: 532 SGKSDVYSYGMLLLEMIE---------------EKKHLR---------PTETTSGSNTTE 567
+ +D++S + E+ ++ H+ P + ++
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
Query: 568 AYF---PDWIYDKLIQP--------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+F D + ++P EK ++ +EE A L +++ P+ R +
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE----AAGFTDFLLPMLELIPEKRAT 385
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 39/191 (20%)
Query: 443 SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502
L L+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ +
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562
+ V R + ++APE + + +SDV+S+G+LL E+ + G
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF-----------SLG 292
Query: 563 SN-----TTEAYFPDWIYD--KLIQPEKEDFVEEEDDC---IARKMIIVGLWCIQINPKD 612
++ + F + + ++ P+ + + M L C P
Sbjct: 293 ASPYPGVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTM----LDCWHGEPSQ 339
Query: 613 RPSMTRVVEML 623
RP+ + +VE L
Sbjct: 340 RPTFSELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 20/174 (11%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 403
+ LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 404 VNIIHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
+N+++LLG C +I E+ G+L L ++ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY----------KTKGARF 135
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 516
+ + +D+K + + + S F K+ S
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 412
+K+G G +G + GK VA+K LE + + E ++ I + F
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 413 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
G A++ E + G SL DL SLK L IA+ + +EY+H+ +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV--LMIAIQLISRMEYVHS---KNL 126
Query: 472 LHLDIKPQNVLLDPDFTPKVS-----DFGLAK 498
++ D+KP+N L+ DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
+ +G+G YG V G VA+K K + + E+ + + H N+I
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 408 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
LL F D + L+ +M LG L+ EK L R+ + + +
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVYQMLKGLR 142
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
Y+H I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
E+ + N + D++S G ++ EMI K
Sbjct: 195 EV-ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 407
+G+G YG+V G VAVK K S + I+ E+ + + H N+I
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 408 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
LL F S L+ M L +++ +K L + + + ++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK----LTDDHVQFLIYQILRGLK 146
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
Y+H+ I+H D+KP N+ ++ D K+ DFGLA+ + MTG T Y AP
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
EI M N + + D++S G ++ E++ +
Sbjct: 199 EI-MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 36/152 (23%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 412
++G G +G +++G + + VA+K E + + +E T + I ++ F
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 413 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+G L+ + + G SL DLL S+K A + ++ +H E +
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV--AMAAKQMLARVQSIH---EKSL 127
Query: 472 LHLDIKPQNVLLDPDFTPK-----VSDFGLAK 498
++ DIKP N L+ + V DFG+ K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 67/300 (22%), Positives = 109/300 (36%), Gaps = 52/300 (17%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNI 406
K LG G YG V P G +VA+K K F + E+ + H NI
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 407 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
I + S +I E M L ++S + L + A++
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM----LSDDHIQYFIYQTLRAVK 126
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--------MTGPR 513
LH ++H D+KP N+L++ + KV DFGLA+ + + + M
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 514 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573
T Y APE+ M S DV+S G +L E+ ++ + P G +
Sbjct: 184 ATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELF-LRRPIFP-----GRDYRHQL--LL 234
Query: 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV--VEMLSSASAEAI 631
I+ + P ++ + + AR+ I K P +M + + I
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYI-----------KSLPMYPAAPLEKMFPRVNPKGI 283
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 72/256 (28%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNI 406
+ +GTG YG+V + + R+VA+K K ++ I+ E+A + R++H ++
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 407 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLE--IALGVAH- 458
+ +L ++ E + D +L + L H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS----DF------------KKLFRTPVYLTELHI 158
Query: 459 ---------AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509
++Y+H+ ILH D+KP N L++ D + KV DFGLA+ + +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 510 TGPRGTIG-------------------------YIAPEIFMRNLGNPSGKSDVYSYGMLL 544
Y APE+ + N + DV+S G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL-ILLQENYTEAIDVWSIGCIF 274
Query: 545 LEMIEEKKHLRPTETT 560
E++ K
Sbjct: 275 AELLNMIKENVAYHAD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 49/216 (22%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV------NII 407
+ +G G +G V K + VA+K++ F E+ + + N+I
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 408 HLL------GFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVAHAI 460
H+L C + +E + + +L +L+ + K SL R + A + +
Sbjct: 163 HMLENFTFRNHIC------MTFELL-SMNLYELIKKNKFQGFSLPLVR--KFAHSILQCL 213
Query: 461 EYLHNGCELRILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGY 518
+ LH + RI+H D+KP+N+LL + KV DFG + + Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT-----------Y 259
Query: 519 I------APEIFMRNLGNP-SGKSDVYSYGMLLLEM 547
I APE+ LG D++S G +L E+
Sbjct: 260 IQSRFYRAPEVI---LGARYGMPIDMWSLGCILAEL 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 59/330 (17%), Positives = 103/330 (31%), Gaps = 73/330 (22%)
Query: 354 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNI 406
K +G G YG VY + VA+K K + ++ I+ E+ + R+ I
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 407 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
I L ++ E + DL K + L + I +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG---- 517
++H I+H D+KP N LL+ D + KV DFGLA+ + + +
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 518 ----------------YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI----------EEK 551
Y APE+ + N + D++S G + E++ +
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPEL-ILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 552 KHLRPTETTSGSNTTEAYFPDWIYDKLIQ----------PEKEDFVEEEDDCIARKMIIV 601
L P + + Q P ++D K I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE-VIKYI-- 316
Query: 602 GLWCIQINPKDRPSMTRVVEMLSSASAEAI 631
+ ++ + S S + I
Sbjct: 317 ----KLFPHRKPINLK---QKYPSISDDGI 339
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 32/169 (18%)
Query: 355 EKLGTGGYGNVYKGK---------FPDGRLVAVKV------LEKTSNFSDNF-----INE 394
G +Y+ P + ++K+ L NF +N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 395 VATIGRIHHVNIIHLLGF-CCDGSTRALIYEYMPNG-SLGDLLSR-EKENLSLKPARLLE 451
+ + I +GF R L+ + G SL L K LS + L+
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSV--LQ 163
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 498
+A + A+E+LH E +H ++ +N+ +DP+ +V + +G A
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 412
K+G+G +G++Y G G VA+K+ E E + V I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 413 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+G ++ E + G SL DL + SLK L +A + IEY+H+
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS---KNF 126
Query: 472 LHLDIKPQNVLLDPDFTPK---VSDFGLAK 498
+H D+KP N L+ + DFGLAK
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 8e-10
Identities = 45/293 (15%), Positives = 79/293 (26%), Gaps = 79/293 (26%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVL---------EKTSNFSDNFINEVA--------- 396
EK+G G +G V++ D VA+K++ + + E+
Sbjct: 26 EKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 397 TIGRIHHVNIIHLLGFCC------------------------------DGSTRALIYEYM 426
I L C ++ E+
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486
G DL + SL A+ I + ++ LR H D+ NVLL
Sbjct: 145 FGGI--DLEQMRTKLSSLATAK--SILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKT 198
Query: 487 FTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIG--------YIAPEIFMRNLGNPSG 533
K+ K+ S++ T R + ++F G+
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---GDGDY 255
Query: 534 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT-EAYFPDWIYDKLIQPEKED 585
+ D+Y + H SN Y D + ++ K +
Sbjct: 256 QFDIYRLMKKENNNRWGEYHPY-------SNVLWLHYLTDKMLKQMTFKTKCN 301
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 47/216 (21%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI--------HHVN 405
+G G +G V K + VA+K+++ F + EV + + ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY-- 117
Query: 406 IIHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIAL 454
I+HL C L++E + + +L DLL + +SL R + A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFEML-SYNLYDLL---RNTNFRGVSLNLTR--KFAQ 164
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGP 512
+ A+ +L EL I+H D+KP+N+LL +P + K+ DFG + + +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-- 221
Query: 513 RGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 547
R Y +PE+ LG P D++S G +L+EM
Sbjct: 222 R---FYRSPEVL---LGMPYDLAIDMWSLGCILVEM 251
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 31/167 (18%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSN-------------FSDNFINEVATI 398
+K+G+GG+G +Y A V +E N + I +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 399 GRIHHVNIIHLLGF----CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIA 453
++ ++ I G S R ++ E + G L + + L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTV--LQLG 157
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 498
+ + +EY+H E +H DIK N+LL +V +D+GL+
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 32/169 (18%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKV-----LEKTSN-------------FSDNFINEVA 396
+G GG+G +Y V +E + N I +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 397 TIGRIHHVNIIHLLGF----CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLE 451
++ ++ + G S R +I + G L + + S K L+
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV--LQ 156
Query: 452 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 498
++L + +EY+H E +H DIK N+LL+ +V D+GLA
Sbjct: 157 LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIH 408
+ LG GG G V+ + VA+K K +D + E+ I R+ H NI+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIK---KIV-LTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 409 LLGFCCDGSTRA--------------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 454
+ ++ ++ EYM DL + ++ L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQG-PLLEEHARLFMY 127
Query: 455 GVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRS-VVTMTGP 512
+ ++Y+H+ +LH D+KP N+ ++ D K+ DFGLA+ + S ++
Sbjct: 128 QLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
T Y +P + + + N + D+++ G + EM+ K
Sbjct: 185 LVTKWYRSPRL-LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGF 412
K+G+G +G +Y G VA+K+ E + E + I ++ F
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 413 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+G L+ + + G SL DL + LSLK L +A + + +E++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVH---SKSF 124
Query: 472 LHLDIKPQNVLLDPDFTPK---VSDFGLAK 498
LH DIKP N L+ + DFGLAK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 61/238 (25%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIH-HV 404
+KLG G YG V+K G +VAVK K + N + E+ + + H
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 405 NIIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH---- 458
NI++LL + R L+++YM DL + ++ L + H
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET----DL------HAVIRANILEPV-----HKQYV 114
Query: 459 ------AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT---- 508
I+YLH+G +LH D+KP N+LL+ + KV+DFGL+++ R V
Sbjct: 115 VYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 509 ---------------MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551
+T T Y APEI + + D++S G +L E++ K
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEI-LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 8e-07
Identities = 84/622 (13%), Positives = 169/622 (27%), Gaps = 190/622 (30%)
Query: 92 YQVRNFFSSQDDRLITVVDTQLIKD-----LSSGSCESLYNLSVAINS--YSIGSLTLPS 144
YQ ++ S +D + D + ++D LS + + A++ +L
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 145 GNLNLTFFKCPRRLSLSQNFTDKGVSNVSCND---GHVLYL-WRNRTQSGRPSFDP--VS 198
+ F + L ++ F + +Y+ R+R + F VS
Sbjct: 76 EEMVQKFVE--EVLRINYKFLMSPIKTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 199 APSGCDSV------VVPVSSVTSLY---------LGADV--FDTLRQGFPLE--WPKLDD 239
+ + P +V + + DV ++ + W L +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVL-IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 240 C-------EKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRL-------------- 278
C E Q + N + + R S++ RL
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 279 ----PLIIGATAGSCCMVL------VAVALLVFRKRIPS--FFKKPFSEE---------- 316
A SC ++L V L S + +
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 317 RQNIGD----------------GLNVKQFIKTYRSALLSNYSYNDIKKMTNGFK---EKL 357
D +++ + T+ N+ + + K+T + L
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-----DNWKHVNCDKLTTIIESSLNVL 366
Query: 358 GTGGYGNVYK--GKFPDGRLVAVKVL-----EKTSNFSDNFINEVATIGRIHHVNIIHLL 410
Y ++ FP + +L + + +N+
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK---------------- 410
Query: 411 GFCCDGSTRALIYEYMPNG--SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
+L+ + S+ + K L + A LH
Sbjct: 411 --LHK---YSLVEKQPKESTISIPSIYLELKVKLENEYA---------------LHR--- 447
Query: 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI--FMR 526
I+ P+ D D P D Y I ++
Sbjct: 448 -SIVDHYNIPKTFDSD-DLIPPYLD-----------------------QYFYSHIGHHLK 482
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGS--NTTE--AYFPDWIYDKLIQP 581
N+ + + ++ L +E+K +H SGS NT + ++ +I D +
Sbjct: 483 NIEH-PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541
Query: 582 EK-----EDFVEE-EDDCIARK 597
E+ DF+ + E++ I K
Sbjct: 542 ERLVNAILDFLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 59/369 (15%), Positives = 102/369 (27%), Gaps = 107/369 (28%)
Query: 327 KQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAV--KVLEKT 384
K + + A + N+ D++ M K L ++ K + + +L K
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMP---KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 385 SNFSDNFINEVATI------GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL---- 434
F+ EV I I S +Y + D
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQR--------QPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 435 ---LSREKENLSLKPARLLEI--ALGVA-H----------AIE----------------Y 462
+SR + L L+ A LLE+ A V A++ +
Sbjct: 128 KYNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 463 LHNGCELRILHLDIKPQNVL---LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
L+ ++ L +DP++T + HS N + I I
Sbjct: 187 LNLKNCNSP-ETVLEMLQKLLYQIDPNWTSRSD-------HSSN--------IKLRIHSI 230
Query: 520 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE-------TTSGSNTTEAYFPD 572
E+ R L KS Y +L+L ++ K TT T+
Sbjct: 231 QAEL--RRLL----KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM-------LSS 625
+ +E + K + P+D P E+ LS
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLK-------YLDCRPQDLPR-----EVLTTNPRRLSI 332
Query: 626 ASAEAIEMP 634
+ +
Sbjct: 333 IAESIRDGL 341
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 5e-04
Identities = 72/432 (16%), Positives = 122/432 (28%), Gaps = 140/432 (32%)
Query: 117 LSSGSCES-------LYNLSVAIN-SYSIGSLTLPSGNLNLTFFKC-PRRLSLSQNFT-- 165
L+ +C S L L I+ +++ S + L + + RRL S+ +
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 166 --------DKGVS---NVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPVS--- 211
+ N+SC +L R + D +SA + + S
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCK---ILLTTRFKQ-----VTDFLSAATTTHISLDHHSMTL 298
Query: 212 ------SVTSLYLGADVFDTLR----QGFPLEWPKLDDC-EKCQNRSGRCGYNGSLKKIT 260
S+ YL D L P +L E ++ K +
Sbjct: 299 TPDEVKSLLLKYLDCRPQD-LPREVLTTNPR---RLSIIAESIRDGLATWDN---WKHVN 351
Query: 261 CFCKGGRCDSVKRRKSRLPLIIGATAGSCCMVLVA-------VALLVFRK--RIPS---- 307
C D + II S VL L VF IP+
Sbjct: 352 C-------DKLTT-------IIE----SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 308 -FFKKPFSEERQNIGDGLNVKQFI----KTYRSALLSNY-------------------SY 343
+ + + + L+ + K ++ S Y Y
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 344 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD-----NFINEVATI 398
N K + Y + G L ++ E+ + F F+
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGH----HLKNIEHPERMTLFRMVFLDFRFLE----- 504
Query: 399 GRIHHVNIIHLLGFCCDGSTRALI-----YE-YM-PN--------GSLGDLLSREKENLS 443
+I H + + GS + Y+ Y+ N ++ D L + +ENL
Sbjct: 505 QKIRHDS----TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
Query: 444 LKP-ARLLEIAL 454
LL IAL
Sbjct: 561 CSKYTDLLRIAL 572
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 63/232 (27%)
Query: 355 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI------HHVNI 406
+ LG G +G V + GR VAVK+++ + + +E+ + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 407 IHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIALG 455
+ +L + C +++E + S D + KEN L R ++A
Sbjct: 80 VQMLEWFEHHGHIC-------IVFELL-GLSTYDFI---KENGFLPFRLDHIR--KMAYQ 126
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------KVSDFGL 496
+ ++ +LH ++ H D+KP+N+L D+T KV DFG
Sbjct: 127 ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 547
A + S + T Y APE+ L S DV+S G +L+E
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPEVI---LALGWSQPCDVWSIGCILIEY 227
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 67/234 (28%)
Query: 355 EKLGTGGYGNVYKG--KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI--------HHV 404
LG G +G V + VA+K++ + + E+ + +I
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL- 83
Query: 405 NIIHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIA 453
+ + + C + +E + + + L KEN L R +A
Sbjct: 84 -CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFL---KENNFQPYPLPHVR--HMA 129
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------KVSDF 494
+ HA+ +LH E ++ H D+KP+N+L + +F +V+DF
Sbjct: 130 YQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 547
G A + + + T Y PE+ L + DV+S G +L E
Sbjct: 187 GSATFDHEHHTTIVATRH-----YRPPEVI---LELGWAQPCDVWSIGCILFEY 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 82/290 (28%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIH 408
K+G G +G V + + + AVKV+ ++ + E + +I ++ NI+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 409 LLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIALGVA 457
G C LI+E + SL +++ N ++ + + +
Sbjct: 101 YHGKFMYYDHMC-------LIFEPL-GPSLYEII---TRNNYNGFHIEDIK--LYCIEIL 147
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------------KVS 492
A+ YL ++ + H D+KP+N+LL DP F K+
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMI--- 548
DFG A S + T R Y APE+ L SD++S+G +L E+
Sbjct: 205 DFGCATFKSDYHGSIINT--R---QYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 549 ------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
E +HL E+ P + + + +V +++
Sbjct: 257 LLFRTHEHMEHLAMMESIIQP------IPKNMLYEATKTNGSKYVNKDEL 300
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.53 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.26 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.97 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.53 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.48 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=447.95 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=210.0
Q ss_pred HHHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34457899999999999999873 46889999997543 34578999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC
Q 005909 421 LIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 487 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~ 487 (670)
|||||+++|+|.++|+.... +..++|..+++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999965321 23699999999999999999999998 999999999999999999
Q ss_pred CeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCc
Q 005909 488 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 566 (670)
Q Consensus 488 ~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~ 566 (670)
++||+|||+++...............||+.|||||++.+ +.++.++|||||||+||||+| |+.||.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------- 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence 999999999987654433333345679999999999976 478999999999999999998 8889864321
Q ss_pred cccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
..+...+..+..... +..++..+.+++.+||+.||++||||+||+++|+.
T Consensus 254 -----~~~~~~i~~~~~~~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -----QDVVEMIRNRQVLPC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -----HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----HHHHHHHHcCCCCCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 122233333222111 22345678899999999999999999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=436.86 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=200.1
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|++++ .||||+++... ...++|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 467899999999999999854 58999987543 335689999999999999999999998865 568999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.++|+.... .+++.++++|+.|+|+||+|||++ +||||||||+||||++++.+||+|||+|+..........
T Consensus 116 GsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 116 SSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp CBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999999975433 599999999999999999999998 999999999999999999999999999987754443333
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|||||++.+. .+.++.++|||||||+||||+||+.||..... ...+...+.........
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----------RDQIIFMVGRGYASPDL 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHTTCCCCCS
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCCCCCc
Confidence 4556799999999999643 24578999999999999999999999964321 11122222222111111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
......++..+.+++.+||+.||++||||.||+++|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122223456788999999999999999999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=440.88 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=200.2
Q ss_pred hhccccccCceEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.++||+|+||+||+|+++ +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5688999999999999874 47899999998654 3457899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 426 MPNGSLGDLLSREKE------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
+++|+|.++|+.... ...++|.++++|+.|+++||+|||++ +||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 999999999976432 23699999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++...............||+.|||||++.+. .++.++|||||||+||||+| |+.||..... .
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------------~ 267 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------------T 267 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------------H
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH------------H
Confidence 9999977554433333456799999999999764 78999999999999999999 8999864321 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+...+..+.... .+..++.++.+++.+||+.||++||||+||+++|+.+
T Consensus 268 ~~~~~i~~g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 268 EAIDCITQGRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHHTCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1222222221111 1123456788999999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=438.43 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=207.7
Q ss_pred hhhccccccCceEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 35689999999999999874 47889999998654 345789999999999999999999999999999999999
Q ss_pred ecCCCCccccccccc----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeec
Q 005909 425 YMPNGSLGDLLSREK----------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~Df 494 (670)
|+++|+|.++|+..+ ....++|.++++|+.|+++||+|||++ +||||||||+||||++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 999999999997542 234699999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+|+...............||+.|||||++.+. .++.++|||||||++|||+| |+.||..... ..
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------------~~ 238 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------NE 238 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------------HH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------HH
Confidence 999876554433333334589999999999764 78999999999999999999 8999864321 12
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+...+..+..... +..++.++.+++.+||+.||++||||+||++.|+.+
T Consensus 239 ~~~~i~~~~~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 239 VIECITQGRVLQR----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222222221111 123456788999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=418.30 Aligned_cols=270 Identities=23% Similarity=0.295 Sum_probs=203.5
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC----eeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~e~~~~ 428 (670)
+.++||+|+||+||+|++ +|+.||||++.........+..|+..+.+++|||||+++|++.+.+ ..+|||||+++
T Consensus 7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 568899999999999998 6899999999765544444556777888999999999999998654 57899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|+|.++|++. .+++..+++++.|+++||+|||+++ .++||||||||+||||++++++||+|||+|+.....
T Consensus 86 gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999754 4899999999999999999999752 458999999999999999999999999999877544
Q ss_pred Ccee--eecCCCCCccccchhhccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHH
Q 005909 504 RSVV--TMTGPRGTIGYIAPEIFMRNL----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWI 574 (670)
Q Consensus 504 ~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~ 574 (670)
.... ......||+.|||||++.+.. +.++.++|||||||+||||+||+.|+........... ........+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 3322 122356999999999996531 1356799999999999999999988754322111100 011112222
Q ss_pred HHHhcCCcc-ccccc-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 575 YDKLIQPEK-EDFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 575 ~~~~~~~~~-~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...+..... +.... ....+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 333322221 11111 122345677899999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=420.37 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=204.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+++.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..||||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 445678999999999999986 69999999996543 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+. .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+......
T Consensus 156 g~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 156 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 9999999653 499999999999999999999998 9999999999999999999999999999877544322
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+....... .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~~~--~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------------LKAMKMIRDNLPPR--L 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSSCCC--C
T ss_pred ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCC--C
Confidence 2446799999999999764 678999999999999999999999964321 11112221111111 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....++..+.+++.+||+.||++|||+.|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122346678899999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=410.96 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=197.6
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee----CCeeEEEEE
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYE 424 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e 424 (670)
+.++||+|+||+||+|.+. +++.||+|++.... ...+.|.+|+.+|++++|||||++++++.+ ....+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 5578999999999999986 68899999986543 334679999999999999999999999865 345799999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~ 503 (670)
|+++|+|.++|.+.. .+++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 999999999997653 599999999999999999999987 223999999999999984 799999999999865433
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+...+..+..
T Consensus 186 ~~----~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----------~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 186 FA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSGVK 247 (290)
T ss_dssp SB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTTCC
T ss_pred cc----CCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----------HHHHHHHHHcCCC
Confidence 22 23569999999999863 588999999999999999999999964321 1223333333322
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+.. .+...++++.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 PAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 112234568889999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=414.35 Aligned_cols=251 Identities=25% Similarity=0.271 Sum_probs=201.6
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.++||+|+||+||+|+++ +|+.||||+++..... .+|+.++++++|||||++++++.+++..+|||||+++|+|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 4578999999999999985 6899999999765432 4799999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCCcee---
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVV--- 507 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~~~--- 507 (670)
.++|++.+ .+++..++.++.|++.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+..+....
T Consensus 138 ~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 138 GQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99997653 599999999999999999999998 999999999999999987 69999999999775432211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
......||+.|||||++.+. .++.++|||||||++|||++|+.||...... .+...+.. .. . ..
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~---~~-~--~~ 275 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PLCLKIAS---EP-P--PI 275 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CCHHHHHH---SC-C--GG
T ss_pred cCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHc---CC-C--Cc
Confidence 12235699999999999864 6789999999999999999999999753221 11111111 11 0 01
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
...+..++..+.+++.+||+.||++|||+.|++++|..+..+
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 111223466788999999999999999999999999865443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=426.87 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=198.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 456689999999999999985 69999999997654 23567999999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.++|...+ ...+++.+++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.......
T Consensus 106 ~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 180 (350)
T 4b9d_A 106 EGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE- 180 (350)
T ss_dssp TTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred CCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence 9999999997543 23579999999999999999999998 999999999999999999999999999987653221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+..++.....+..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~~~~ 245 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM------------KNLVLKIISGSFPPV 245 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHTCCCCC
T ss_pred -cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCCC
Confidence 12234599999999999764 678999999999999999999999965321 112222222221111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...++..+.+++.+||+.||++|||+.|++++
T Consensus 246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12345678899999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=429.58 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=208.9
Q ss_pred HHHHhhhccccccCceEEEEEEeCC------CcEEEEEEcccCCc--chHHHHHHHHHhccccc-cccccccceeeeC-C
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSN--FSDNFINEVATIGRIHH-VNIIHLLGFCCDG-S 417 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~-~ 417 (670)
...+.+.++||+|+||+||+|++.. ++.||||++..... ..++|.+|+.+|.+++| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 3445567899999999999998642 36899999976543 35679999999999965 9999999999764 5
Q ss_pred eeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC
Q 005909 418 TRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~ 484 (670)
..+||||||++|+|.++|+.... +..+++..++.++.|||+||+|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 68999999999999999975432 23589999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005909 485 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGS 563 (670)
Q Consensus 485 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~ 563 (670)
+++.+||+|||+|+....+..........||+.|||||++.+. .++.++|||||||+||||+| |+.||.....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---- 293 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 293 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999987665544444556789999999999864 78999999999999999998 8999864321
Q ss_pred CCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 564 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...+...+..+..... +...+.++.+++.+||+.||++||||.||+++|+.+
T Consensus 294 -------~~~~~~~i~~g~~~~~----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 -------DEEFCRRLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -------SHHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1122222222211111 122355788999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=412.59 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=205.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|++.+.||+|+||+||+|++. +++.||||++.+. ....+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 556789999999999999985 6899999999753 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.++|.+.+ .+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 114 ~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 114 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999997654 599999999999999999999998 999999999999999999999999999998765443
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
........||+.|||||++.+. .++.++||||+||++|||++|+.||..... ..+..++..... .
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~-~ 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE------------GLIFAKIIKLEY-D 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCC-C
T ss_pred cccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCC-C
Confidence 3334456799999999999864 678899999999999999999999964321 122222222211 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 620 (670)
. +..++.++.+++.+||+.||++|||++|++
T Consensus 253 ~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 F----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 122456788999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=422.50 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=204.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|++.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 445688999999999999986 69999999997544 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+......
T Consensus 233 G~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 233 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 9999998653 499999999999999999999998 9999999999999999999999999999877544322
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+....... .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~~~--~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------------LKAMKMIRDNLPPR--L 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSCCCC--C
T ss_pred ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCC--C
Confidence 2345699999999999764 678999999999999999999999964321 11112221111111 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....++..+.+++.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122345678899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=398.88 Aligned_cols=244 Identities=21% Similarity=0.368 Sum_probs=189.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.+.||+|+||+||+|++. +|+.||||++.+.. ...+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999975 69999999997543 3456799999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+ +|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.......
T Consensus 95 ~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 95 A-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp C-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred C-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9 789999986543 599999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....||+.|||||++.+. ...+.++||||+||++|||++|+.||..... ..+...+......
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~------------~~~~~~i~~~~~~- 230 (275)
T 3hyh_A 168 ---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI------------PVLFKNISNGVYT- 230 (275)
T ss_dssp ----------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCCC-
T ss_pred ---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 2345699999999999764 2346799999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. +..++..+.+++.+||+.||++|||++|++++
T Consensus 231 ~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 12245678899999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=402.88 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=193.1
Q ss_pred HhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
|++.+.||+|+||+||+|+.. .++.||||++++.. .....+.+|+++|++++|||||++++++.+.+..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456789999999999999863 47899999997543 23457889999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.++|.+.+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999997654 599999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ......||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~ 243 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR------------KETMTMILKAKL 243 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC
T ss_pred Cc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH------------HHHHHHHHcCCC
Confidence 22 12345699999999999764 678899999999999999999999965322 112222221111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
.. +..++.++.+++.+||+.||++|||+ +|++++
T Consensus 244 -~~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 -GM----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -CC----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -CC----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11 12245678899999999999999984 676653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=399.60 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=187.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC----------
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS---------- 417 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---------- 417 (670)
+++.+.||+|+||+||+|+++ +|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 345689999999999999985 68999999997544 23467999999999999999999999987544
Q ss_pred --eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 418 --TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 418 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
..++||||+++|+|.+++.........++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 3689999999999999997654433467778899999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcee----------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005909 496 LAKAHSRNRSVV----------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 565 (670)
Q Consensus 496 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~ 565 (670)
+|+......... ..++..||+.|||||++.+. .++.++|||||||++|||++ ||.....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~------ 232 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME------ 232 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH------
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH------
Confidence 998775432211 12345699999999999764 68899999999999999996 5532100
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .....+.... .+.......+.+.+++.+||+.||++|||+.|++++
T Consensus 233 ----~~-~~~~~~~~~~----~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 ----RV-RTLTDVRNLK----FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ----HH-HHHHHHHTTC----CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HH-HHHHHHhcCC----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 1111111111 112233344567789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=392.86 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=197.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeee------CCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~ 420 (670)
|.+.++||+|+||+||+|++. +|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.. .+..|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 456689999999999999985 799999999976542 34578899999999999999999998764 35789
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
|||||++ |+|.+++.+.+ .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+
T Consensus 136 ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9999995 78999986543 699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc--eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 501 SRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 501 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
..... ........||+.|+|||++.+. ..++.++||||+||++|||++|+.||..... ......+....
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--------~~~l~~I~~~~ 279 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--------VHQLQLIMMVL 279 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--------HHHHHHHHHHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHhc
Confidence 43321 1223456799999999998764 3568899999999999999999999975322 00011111111
Q ss_pred cCCc----------------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPE----------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~----------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+. ............+..+.+++.+||+.||++|||+.|++++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100 0000000111234578899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=380.12 Aligned_cols=196 Identities=23% Similarity=0.345 Sum_probs=166.6
Q ss_pred HhhhccccccCceEEEEEEeC----CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|.++ +||||+++++++.+.+..++||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 456789999999999999763 46899999987654 356788999999998 699999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~~~~ 504 (670)
+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 102 ~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 102 LEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999983 388999999999999999999998 99999999999999876 799999999998654321
Q ss_pred ce--------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 505 SV--------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 505 ~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
.. .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 10 112334699999999999764 35788999999999999999999999653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=396.84 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=205.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.+.||+|+||+||+|+++ +|+.||+|++.... ...+.+.+|+.+|++++|||||++++++.+....+|||||+++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 456789999999999999986 68999999997654 3456788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC--CCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD--FTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~--~~~ki~DfGla~~~~~~~~~ 506 (670)
|+|.++|..... .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+......
T Consensus 239 g~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 239 GELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999865432 589999999999999999999998 99999999999999854 89999999999988665443
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
. ...||+.|||||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 314 ~---~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------------~~~~~~i~~~~~-~~ 375 (573)
T 3uto_A 314 K---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND------------DETLRNVKSCDW-NM 375 (573)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHHHTTCC-CC
T ss_pred e---eeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHhCCC-CC
Confidence 2 34589999999999864 678899999999999999999999965322 112222222111 11
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++..+.+|+.+||+.||++|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122223345678899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=392.36 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHH---HHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFI---NEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||+||+|+.. +|+.||||++.+.. .....+. .++.+++.++|||||++++++.+.+..|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 345688999999999999986 69999999996532 2223333 446778888999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++|+|.++|.+.+ .+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999997653 599999999999999999999998 999999999999999999999999999987754
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... ....||+.|||||++.+. ..++.++|+|||||++|||++|+.||...... . ...+........
T Consensus 345 ~~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--------~-~~~i~~~i~~~~ 410 (689)
T 3v5w_A 345 KKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------D-KHEIDRMTLTMA 410 (689)
T ss_dssp CCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--------C-HHHHHHHHHHCC
T ss_pred CCC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------H-HHHHHHhhcCCC
Confidence 432 345799999999999643 35788999999999999999999999643220 0 111222221111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 623 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 623 (670)
. ..+..++.++.+++.+||+.||++|++ +.||++|=
T Consensus 411 ~-----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 411 V-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp C-----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred C-----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 1 111224567889999999999999998 67877653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=364.02 Aligned_cols=265 Identities=32% Similarity=0.549 Sum_probs=213.9
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.+.||+|+||+||+|++++++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 347899999999999999889999999987654 4467899999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 432 GDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 432 ~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++............
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 999976432 23589999999999999999999998 99999999999999999999999999998654332222223
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc-----ccc
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE-----KED 585 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 585 (670)
...||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......|......... ...
T Consensus 200 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-----MVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-----CCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-----HHHHHHHhhhccccccHHHhcChh
Confidence 34589999999999763 68899999999999999999999997543311 1112222222221111 112
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.........+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222334567888999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=362.49 Aligned_cols=282 Identities=38% Similarity=0.647 Sum_probs=223.8
Q ss_pred cCCCCHHHHHHHHHhh--hccccccCceEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHHhcccccccccccccee
Q 005909 338 LSNYSYNDIKKMTNGF--KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFC 413 (670)
Q Consensus 338 ~~~~~~~~l~~~~~~~--~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 413 (670)
...|++.++.....+| .+.||+|+||+||+|++.+++.||||++.... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4557777777665555 47899999999999998889999999997644 2334789999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 414 CDGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 414 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
.+....++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976543 3359999999999999999999999766699999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......+
T Consensus 177 Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 250 (326)
T 3uim_A 177 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLAN---DDDVMLLD 250 (326)
T ss_dssp CCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT---TSCSBHHH
T ss_pred cCccccccCcccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCccccccccc---ccchhHHH
Confidence 999998765443322 3445689999999999753 67889999999999999999999996322111 11222333
Q ss_pred HHHHHhcCCcc-----ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 573 WIYDKLIQPEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 573 ~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
|+......... ...........+..+.+++.+||+.||++|||+.||+++|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 33222222111 112223345667889999999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.74 Aligned_cols=275 Identities=34% Similarity=0.578 Sum_probs=223.2
Q ss_pred cCCCCHHHHHHHHHhhh--------ccccccCceEEEEEEeCCCcEEEEEEcccCC-----cchHHHHHHHHHhcccccc
Q 005909 338 LSNYSYNDIKKMTNGFK--------EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHV 404 (670)
Q Consensus 338 ~~~~~~~~l~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~ 404 (670)
...|++.++.+++.+|. ++||+|+||+||+|+. +++.||||++.... ...+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 46789999999998886 4599999999999987 68899999986532 3457899999999999999
Q ss_pred ccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC
Q 005909 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 405 nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~ 484 (670)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999997655555799999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 485 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 485 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
+++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 241 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--- 241 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence 999999999999987654433333344568999999999864 57889999999999999999999997543311
Q ss_pred CccccchHHHHHHhcCCc------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 565 TTEAYFPDWIYDKLIQPE------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+..+. ..+.... ............+..+.+++.+||+.||++||++.+|+++|+++.
T Consensus 242 ----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 ----LLLDIK-EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp ----BTTHHH-HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ----HHHHHH-HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111 1111100 011112234556778999999999999999999999999999653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=362.44 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||+||+|++ +++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 44568999999999999988 68889999987654 234578999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+|+|.+++........+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 999999997654333489999999999999999999998 7 99999999999999999999999999986543321
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++.+. ..+.++||||||+++|||++|+.||..... ...............
T Consensus 195 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 195 --SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNP-----------AQVVAAVGFKCKRLE 259 (309)
T ss_dssp ---------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHHHSCCCCC
T ss_pred --ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhcCCCCC
Confidence 12335689999999999764 678899999999999999999999964321 011111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
. ...++..+.+++.+||+.||++|||+.++++.|+.....
T Consensus 260 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 I----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1 122345788999999999999999999999999966543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=358.18 Aligned_cols=271 Identities=24% Similarity=0.295 Sum_probs=208.4
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC----eeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~e~~~ 427 (670)
.+.++||+|+||+||+|++. ++.||||++.........+..|+.++.+++||||+++++++.+.. ..++||||++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 45688999999999999985 799999999876666667788999999999999999999998754 3699999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 106 KGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp TCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 99999999654 4899999999999999999999741 228999999999999999999999999999877
Q ss_pred CCCCceeeecCCCCCccccchhhccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcc----ccchHH
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE----AYFPDW 573 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~ 573 (670)
.............||+.|+|||++.+.. ..++.++||||||+++|||++|+.||............. ......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 6544433344467899999999997521 134568899999999999999999997643321111100 001111
Q ss_pred HHHHhcCCcc-ccccc-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 574 IYDKLIQPEK-EDFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 574 ~~~~~~~~~~-~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+......... +.... .........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2222222211 11111 112234567999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.91 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=206.1
Q ss_pred HhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCCee
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 419 (670)
+.+.+.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 345688999999999999862 356899999976542 346799999999999 899999999999999999
Q ss_pred EEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 420 ALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 999999999999999976431 13589999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 565 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~ 565 (670)
+.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~------ 311 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 311 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 99999999999876544332223345578899999999763 68899999999999999999 9998864321
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+...+........ ...++..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 312 ------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 ------EELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ------GGHHHHHHTTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111222222211111 1223457889999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.79 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=210.6
Q ss_pred HHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.+.||+|+||.||+++++++..||+|++.......+++.+|+.++.+++||||+++++++.+....++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 34566899999999999999998889999999887777788999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 89 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 162 (268)
T 3sxs_A 89 CLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SS 162 (268)
T ss_dssp BHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-EC
T ss_pred cHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cc
Confidence 99999976532 489999999999999999999998 9999999999999999999999999999876554332 23
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.+..+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ......+........
T Consensus 163 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-- 226 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------------SEVVLKVSQGHRLYR-- 226 (268)
T ss_dssp CSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------------HHHHHHHHTTCCCCC--
T ss_pred cCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccCh------------HHHHHHHHcCCCCCC--
Confidence 455678889999999753 67889999999999999999 9999864322 111122222111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112456888999999999999999999999999654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=350.73 Aligned_cols=254 Identities=24% Similarity=0.459 Sum_probs=209.4
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.+.||+|+||+||+|++.+++.||+|++.......+++.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 34568999999999999999889999999999877777889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 92 L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 165 (269)
T 4hcu_A 92 LSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 165 (269)
T ss_dssp HHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STT
T ss_pred HHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-ccc
Confidence 9999965432 589999999999999999999998 9999999999999999999999999999876543221 223
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 166 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------------~~~~~~~~~~~~~~~--- 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SEVVEDISTGFRLYK--- 228 (269)
T ss_dssp STTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCCCCC---
T ss_pred CcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHhcCccCCC---
Confidence 44578889999999753 68899999999999999999 8888864221 112222222211111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
....+..+.+++.+||+.||++||++.|++++|+++..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11224568889999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.56 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=209.6
Q ss_pred CCCCHHHHHHHHHh------------hhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhcccccc
Q 005909 339 SNYSYNDIKKMTNG------------FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHV 404 (670)
Q Consensus 339 ~~~~~~~l~~~~~~------------~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~ 404 (670)
..+++++++.++.. ..++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777777653 2357999999999999986 79999999997654 4457799999999999999
Q ss_pred ccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC
Q 005909 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 405 nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~ 484 (670)
||+++++++...+..++||||+++++|.+++.+. .+++..+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 9999999999999999999999999999998643 489999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 485 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 485 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----- 246 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----- 246 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 9999999999999876543322 234568999999999975 3678899999999999999999999964321
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......+........ ......+..+.+++.+||+.||++|||+.|++++-
T Consensus 247 -------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 247 -------VQAMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp -------HHHHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -------HHHHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111111111111111 11122355788899999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.51 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.++||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 345688999999999999974 78999999986543 4467789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 172 (297)
T 3fxz_A 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (297)
T ss_dssp CBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--
Confidence 9999999654 489999999999999999999998 9999999999999999999999999999876544332
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ........... .. ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~-~~--~~ 236 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNG-TP--EL 236 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHC-SC--CC
T ss_pred cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCC-CC--CC
Confidence 2345689999999999764 678999999999999999999999964321 00111100000 00 01
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.....++..+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 11223456788999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=359.34 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=204.2
Q ss_pred HHhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.+.||+|+||+||+|++. .+..||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3445688999999999999984 35569999998643 34567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 130 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp ECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999965432 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cc-eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 504 RS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 504 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. ........+|+.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------~~~~~~~~~~ 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN------------RDVISSVEEG 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------HHHHHHHHTT
T ss_pred ccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHHcC
Confidence 22 2223344568899999999753 67889999999999999999 9999864322 1122222222
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... ....++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 271 ~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 271 YRLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 112235578899999999999999999999999996644
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.33 Aligned_cols=257 Identities=21% Similarity=0.366 Sum_probs=204.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.||+|+||+||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++||||++++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 35688999999999999985 68999999886544 45678999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee--
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-- 507 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~-- 507 (670)
+|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 93 TLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp BHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred cHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99999976432 589999999999999999999998 99999999999999999999999999998764332211
Q ss_pred ----------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 508 ----------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 508 ----------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.......... ........ ..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--~~~~~~~~-~~ 242 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNVRGFL-DR 242 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--SBCHHHHH-HH
T ss_pred cccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--hhhhhccc-cc
Confidence 0113468999999999976 367889999999999999999999886533211100 01111111 11
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
.. ...++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 243 ~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 YC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TC-----------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 111234678899999999999999999999999866543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=351.19 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=201.1
Q ss_pred hhhccccccCceEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||+|++ .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 4568899999999999998 479999999997643 334678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 98 GGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp TCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 999999997653 589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|+|||++.+. ...+.++|||||||++|||++|+.||..... ..+...+..+... .
T Consensus 170 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~-~- 233 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------------KELRERVLRGKYR-I- 233 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-C-
T ss_pred -cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-C-
Confidence 2345689999999999764 2335799999999999999999999965321 1122222222111 0
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+...+..+.+++.+||+.||++|||+.|++++
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11134567889999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.54 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=204.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||.||+|++. +++.||||+++... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 345689999999999999986 78999999987653 234578899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 196 ~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 196 GGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp TCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999975432 489999999999999999999998 99999999999999999999999999998654432211
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......+++.|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 271 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSN------------QQTREFVEKGGRLPC 336 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------------HHHHHHHHTTCCCCC
T ss_pred cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC
Confidence 1111235778999999975 367889999999999999998 8888864321 112222222211111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 337 ----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 ----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1123457888999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.15 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=200.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 35688999999999999986 78999999986543 3346788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 90 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 90 GELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999996543 489999999999999999999998 999999999999999999999999999987654433333
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. ...+.++||||||+++|||++|+.||...... ...+..+. ..... .
T Consensus 164 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~----~~~~~----~ 228 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK----EKKTY----L 228 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHH----TTCTT----S
T ss_pred cCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh----ccccc----C
Confidence 3456789999999999754 23477899999999999999999999653221 11111111 11100 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.....+...+.+++.+||+.||++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 11123455678899999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.39 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=206.8
Q ss_pred HHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.+.||+|+||+||++++.++..||+|++.......+++.+|+.++.+++||||+++++++.+....++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 34456899999999999999998999999999987777788999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 105 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~ 178 (283)
T 3gen_A 105 CLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 178 (283)
T ss_dssp BHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-ST
T ss_pred cHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-cc
Confidence 99999976433 489999999999999999999998 9999999999999999999999999999876543221 12
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ......+.........
T Consensus 179 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~~- 243 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYRP- 243 (283)
T ss_dssp TSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------------HHHHHHHHTTCCCCCC-
T ss_pred cCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccCh------------hHHHHHHhcccCCCCC-
Confidence 344578899999999764 67889999999999999998 9999864321 1112222222111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...+..+.+++.+||+.||++|||+++++++|+.+.
T Consensus 244 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 112456888999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=345.80 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=202.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.+.||+|+||+||++++. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 445689999999999999975 68999999985433 2346789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 93 IEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999997653 589999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... .......+ ......
T Consensus 167 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~-~~~~~~ 231 (294)
T 4eqm_A 167 T-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSIAIKHI-QDSVPN 231 (294)
T ss_dssp ---------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHHHHHHH-SSCCCC
T ss_pred c-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHh-hccCCC
Confidence 1 12234589999999999764 678899999999999999999999964321 11111111 111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhhccc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSASA 628 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~ 628 (670)
........++..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11112223456788999999999999998 99999999986543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.20 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=206.9
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||+||+|+++++..||||+++......++|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 4466899999999999999988999999999887777889999999999999999999999986 567899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 269 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~ 343 (454)
T 1qcf_A 269 LLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-ARE 343 (454)
T ss_dssp HHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTC
T ss_pred HHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccC
Confidence 9999975432 2488999999999999999999998 9999999999999999999999999999876543211 123
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...+++.|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+...... .
T Consensus 344 ~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~----~ 405 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------PEVIRALERGYRM----P 405 (454)
T ss_dssp SSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HHHHHHHHHTCCC----C
T ss_pred CCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC----C
Confidence 3456889999999975 478899999999999999999 9999864221 1111222111111 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11223567889999999999999999999999999654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.70 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=196.7
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcc--ccccccccccceeeeC----CeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCDG----STRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~~lv~e~ 425 (670)
.+.+.||+|+||+||+|++ +++.||||++.... .+.+..|.+++.. ++||||+++++++.+. ...++||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 4568999999999999998 78999999987643 3455556665555 7999999999987643 457899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH--------NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
+++|+|.++++.. .+++..+++++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 88 HEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999999543 5899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCceee--ecCCCCCccccchhhcccccC----CCCccchhHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 005909 498 KAHSRNRSVVT--MTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEE----------KKHLRPTETTS 561 (670)
Q Consensus 498 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~~sDV~SlGvvl~elltg----------~~p~~~~~~~~ 561 (670)
+.......... .....||+.|+|||++.+... .++.++||||||+++|||++| +.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~-- 238 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP-- 238 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC--
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC--
Confidence 87654433321 223468999999999975321 234689999999999999999 666643221
Q ss_pred CCCCccccchHHHHHHhcC-Cccccc-cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 562 GSNTTEAYFPDWIYDKLIQ-PEKEDF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
....+.. +...... ...... ........+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 239 ----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 ----NDPSFED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ----SSCCHHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcchhh-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111 1222211 111111 1122345678899999999999999999999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.65 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=205.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
|.+.+.||+|+||+||++++. +++.+|+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 345688999999999999986 6889999999876666678899999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC--CCCeEEeecCCccccCCCCcee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++........
T Consensus 87 ~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~- 160 (321)
T 1tki_A 87 DIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF- 160 (321)
T ss_dssp BHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE-
T ss_pred CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc-
Confidence 9999996543 2589999999999999999999998 9999999999999987 789999999999887654432
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+..... ...
T Consensus 161 --~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~~-~~~ 223 (321)
T 1tki_A 161 --RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN------------QQIIENIMNAEY-TFD 223 (321)
T ss_dssp --EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-CCC
T ss_pred --ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCH------------HHHHHHHHcCCC-CCC
Confidence 223479999999999753 568899999999999999999999964321 111122211111 111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
......++..+.+++.+||+.||++|||+.|++++-
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 122233466788999999999999999999999854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.98 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=193.5
Q ss_pred HhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|++. ++..||||+++... ...++|.+|+.++++++||||+++++++.+....++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 345688999999999999875 57789999997653 345679999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 127 ~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 127 YMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp CCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999997543 2589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 505 SV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 505 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.. .......+++.|+|||++.+ ..++.++||||||+++|||++ |+.||..... ..+...+....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------------~~~~~~i~~~~ 267 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------------QDVIKAVDEGY 267 (373)
T ss_dssp ------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------------HHHHHHHHTTE
T ss_pred ccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCC
Confidence 21 11223345788999999975 378899999999999999998 9999854321 11222222221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... ....+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 268 ~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 RLPP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ECCC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111 11234578899999999999999999999999986643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=377.83 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=211.4
Q ss_pred HHHHhhhccccccCceEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
...+.+.++||+|+||.||+|+++. ++.||||+++......++|.+|+.+|++++||||+++++++.+....++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 3345567899999999999999874 889999999887777889999999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred CCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 99999999975432 3589999999999999999999998 999999999999999999999999999987754332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....+..+++.|+|||++.. ..++.++||||||+++|||++ |+.||..... ..+.+.+......
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYELLEKDYRM- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------GGHHHHHHTTCCC-
T ss_pred eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 22344557789999999975 368899999999999999999 8888864321 1112222221111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+..++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111223567889999999999999999999999999653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.51 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=208.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC--eeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~e~ 425 (670)
+.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 345688999999999999986 58999999997643 34577889999999999999999999988765 67999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE----CCCCCeEEeecCCccccC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll----~~~~~~ki~DfGla~~~~ 501 (670)
+++++|.+++........+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999998766555699999999999999999999998 99999999999999 888889999999998775
Q ss_pred CCCceeeecCCCCCccccchhhcccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRN------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
..... ....||+.|+|||++... ...++.++||||||+++|||++|+.||...... ......+.
T Consensus 168 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~ 237 (319)
T 4euu_A 168 DDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-------RRNKEVMY 237 (319)
T ss_dssp TTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-------GGCHHHHH
T ss_pred CCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------chhHHHHH
Confidence 54322 334589999999998631 246788999999999999999999999753321 01111111
Q ss_pred HHhcC-C--c----------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 576 DKLIQ-P--E----------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 576 ~~~~~-~--~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
..+.. + . ...............+.+++.+||+.||++|||++|++++...
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 11100 0 0 0001112345677889999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.53 Aligned_cols=268 Identities=25% Similarity=0.435 Sum_probs=201.5
Q ss_pred HHhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeC--CeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 421 (670)
.+.+.++||+|+||+||++++ .+++.||||++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 345678999999999999984 368899999997654 3456899999999999999999999998653 45899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999976543 489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----CCCCccccchHHHHH
Q 005909 502 RNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIYD 576 (670)
Q Consensus 502 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 576 (670)
..... .......++..|+|||.+.+. .++.++||||||+++|||++|..|+....... ............+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 43322 112234577889999999764 68899999999999999999998875421100 000000001111112
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.+...... .....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 244 ~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCCC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCcC----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 22211111 1122345678899999999999999999999999986543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.51 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=211.2
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCCc--chHHHHHHHHHhccc-ccccccccccee
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFC 413 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 413 (670)
++....+.+.++||+|+||+||+|++. .+..||||+++.... ..+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344445566789999999999999862 346899999976543 346789999999999 999999999999
Q ss_pred eeCCeeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCc
Q 005909 414 CDGSTRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480 (670)
Q Consensus 414 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 480 (670)
.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999976432 13589999999999999999999998 99999999999
Q ss_pred EEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTET 559 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~ 559 (670)
||+++++.+||+|||+++...............+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999987755433333344567889999999975 378899999999999999999 9988864321
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..+...+......... ..++..+.+++.+||+.||++||++.||+++|+.+..
T Consensus 300 ------------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 ------------EELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ------------HHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222222211111 1234578899999999999999999999999996643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.49 Aligned_cols=254 Identities=27% Similarity=0.379 Sum_probs=198.0
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|++.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 102 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME- 102 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence 3568899999999999999889999999997543 234678999999999999999999999999999999999996
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 103 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 175 (311)
T 3niz_A 103 KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-- 175 (311)
T ss_dssp EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--
Confidence 57888776543 2589999999999999999999998 9999999999999999999999999999876533222
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc-----
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK----- 583 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 583 (670)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||....... ....+...+.....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--------QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp --CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--------HHHHHHHHHCCCCTTTSGG
T ss_pred ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHHCCCChHHhhh
Confidence 2334689999999998753 467889999999999999999999997543211 01111111111000
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.............++.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000001112234578899999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=364.22 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=203.7
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.++||+|+||+||+|++. +++.||||+++... ....++.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456789999999999999853 46789999997543 334578999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeec
Q 005909 422 IYEYMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDF 494 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~Df 494 (670)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 9999999999999976432 23589999999999999999999998 999999999999999554 5999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+++...............+|+.|+|||++.+. .++.++|||||||++|||++ |+.||..... ..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~------------~~ 294 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------QE 294 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HH
Confidence 999755322211112234578999999999764 78899999999999999998 8888864321 11
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+...+........ ...++..+.+++.+||+.||++||++.+|+++|+....
T Consensus 295 ~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 295 VLEFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 2222222221111 11234568899999999999999999999999986543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.86 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=198.0
Q ss_pred hhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.+.||+|+||+||+|++. +++ .||+|++.... ...+.+.+|+.++.+++||||+++++++. +...++|+|
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 35688999999999999875 344 37888875433 33467789999999999999999999886 456889999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp CCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred eCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999976533 588899999999999999999998 99999999999999999999999999999876554
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.........++..|+|||++.+. .++.++||||||+++|||++ |+.||..... . .+...+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~----~~~~~~~~~~~ 235 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------A----EVPDLLEKGER 235 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------T----HHHHHHHTTCB
T ss_pred ccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCH--------H----HHHHHHHcCCC
Confidence 43333445678899999999753 68899999999999999999 9999965322 1 11122222111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..... ..+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 236 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQPQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCCT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 123357789999999999999999999999986644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.51 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=202.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
|.+.+.||+|+||+||+++.. +|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 345689999999999999986 689999999976432 346899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC----CeEEeecCCcc
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLAK 498 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla~ 498 (670)
|||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||+++++ .+||+|||+++
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 94 LELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999996543 599999999999999999999998 999999999999998877 79999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+
T Consensus 168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------------~~~~~~i 230 (361)
T 2yab_A 168 EIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLANI 230 (361)
T ss_dssp ECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHH
T ss_pred EcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHH
Confidence 7654332 2335689999999999753 678899999999999999999999965321 1112222
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... .........++..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 231 TAVSY-DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCC-CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22111 11112223345678899999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.91 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=200.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.+ +++.||+|++++. ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45688999999999999986 6899999999753 345677899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 88 NGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp TTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999987543 589999999999999999999998 999999999999999999999999999986433221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+..... ..
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~-~~ 224 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEI-RF 224 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-CC
T ss_pred -cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC-CC
Confidence 12334589999999999754 678899999999999999999999964321 111222211111 01
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
+..++..+.+++.+||+.||++|| +++||+++-
T Consensus 225 ----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 112355788899999999999999 899998763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.52 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=197.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC----------
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS---------- 417 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---------- 417 (670)
+.+.+.||+|+||+||+|++. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 345689999999999999986 79999999987533 34578999999999999999999999986543
Q ss_pred -----------------------------------------------eeEEEEEecCCCCcccccccccCCCCCCHHHHH
Q 005909 418 -----------------------------------------------TRALIYEYMPNGSLGDLLSREKENLSLKPARLL 450 (670)
Q Consensus 418 -----------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~ 450 (670)
..++||||+++++|.+++.+.......++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 278999999999999999876554557788899
Q ss_pred HHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce----------eeecCCCCCccccc
Q 005909 451 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV----------VTMTGPRGTIGYIA 520 (670)
Q Consensus 451 ~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~----------~~~~~~~gt~~y~a 520 (670)
.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999998 9999999999999999999999999999877654221 11234568999999
Q ss_pred hhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHH
Q 005909 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMII 600 (670)
Q Consensus 521 PE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 600 (670)
||++.+. .++.++||||||+++|||++|..|+.. ........... ............+.+
T Consensus 245 PE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~--------------~~~~~~~~~~~----~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 245 PEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQME--------------RVRIITDVRNL----KFPLLFTQKYPQEHM 304 (332)
T ss_dssp HHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHH--------------HHHHHHHHHTT----CCCHHHHHHCHHHHH
T ss_pred hHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhH--------------HHHHHHHhhcc----CCCcccccCChhHHH
Confidence 9999764 678999999999999999997654311 00111111111 122233444567789
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 005909 601 VGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 601 l~~~cl~~dP~~RPs~~evl~~ 622 (670)
++.+||+.||++||++.|++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=350.16 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=207.6
Q ss_pred HhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||.||+|.+ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34568899999999999986 245899999997654 3346789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 423 YEYMPNGSLGDLLSREKE---------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
|||+++++|.+++..... ...+++..++.++.|+++||+|||++ +|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999976432 12488999999999999999999998 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 560 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~ 560 (670)
++++++.+||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.||.....
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 258 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999877655444333445678899999999753 67889999999999999999 9999864322
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+...+........ ...++..+.+++.+||+.||++||++.|++++|+++.
T Consensus 259 -----------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 -----------ERLFNLLKTGHRMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -----------GGHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------HHHHHHhhcCCcCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111222222211111 1223567889999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.47 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred HhhhccccccCceEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCC-eeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-TRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~~~ 420 (670)
+.+.+.||+|+||.||+|++ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+ ..+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 44568999999999999974 2468999999976543 346799999999999 7999999999988765 489
Q ss_pred EEEEecCCCCcccccccccC------------------------------------------------------------
Q 005909 421 LIYEYMPNGSLGDLLSREKE------------------------------------------------------------ 440 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 440 (670)
+||||+++|+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999976432
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCcc
Q 005909 441 ---NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517 (670)
Q Consensus 441 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~ 517 (670)
+..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 11288999999999999999999998 999999999999999999999999999987655444334445568999
Q ss_pred ccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHH
Q 005909 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIAR 596 (670)
Q Consensus 518 y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (670)
|+|||++.+ ..++.++||||||+++|||++ |+.||..... . ..+...+........ ....+.
T Consensus 261 y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~----~~~~~~~~~~~~~~~----~~~~~~ 323 (359)
T 3vhe_A 261 WMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------D----EEFCRRLKEGTRMRA----PDYTTP 323 (359)
T ss_dssp GCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-------S----HHHHHHHHHTCCCCC----CTTCCH
T ss_pred eEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccch-------h----HHHHHHHHcCCCCCC----CCCCCH
Confidence 999999976 378899999999999999998 9999864322 1 111111111111111 112345
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 597 KMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 597 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 6888999999999999999999999998653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.84 Aligned_cols=254 Identities=25% Similarity=0.427 Sum_probs=197.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.++||+|+||+||+|++. +++ .||+|.+.... ...+++.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 345689999999999999874 344 36888876433 45678999999999999999999999998764 77999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp ECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999976543 589999999999999999999998 9999999999999999999999999999877655
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..........+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||..... .. +...+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~----~~~~~~~~~ 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE----ISSILEKGE 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GG----HHHHHHTTC
T ss_pred cccccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HH----HHHHHHcCC
Confidence 44433445567889999999976 478899999999999999999 9999864322 11 112222211
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... ....+..+.+++.+||+.||++||++.|++++|+.+..
T Consensus 237 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111 11234568889999999999999999999999986543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.22 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=206.1
Q ss_pred HhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 345688999999999999874 34889999997654 2356799999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 423 YEYMPNGSLGDLLSREKE---------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
|||+++|+|.+++..... ...+++..++.++.|+++||+|||++ +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 999999999999976421 14689999999999999999999998 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 560 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~ 560 (670)
|++.++.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 9999999999999999866433322223345678999999999764 68899999999999999999 9989864321
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..+...+........ ...++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 283 -----------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 -----------EEVIYYVRDGNILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp -----------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----------HHHHHHHhCCCcCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 112222222222111 12234578899999999999999999999999997543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=367.47 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=201.8
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||.||+|+++++..||||+++......++|.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 34568999999999999999888899999998776667889999999999999999999999876 67899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 265 L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~ 339 (452)
T 1fmk_A 265 LLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 339 (452)
T ss_dssp HHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-ccc
Confidence 9999975422 2589999999999999999999998 9999999999999999999999999999876543221 123
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+..+....
T Consensus 340 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~~---- 401 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMP---- 401 (452)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCC----
T ss_pred CCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC----
Confidence 3457889999999975 478899999999999999999 8888864221 11222222221111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11234567889999999999999999999999999654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=341.08 Aligned_cols=253 Identities=24% Similarity=0.452 Sum_probs=208.1
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.+.||+|+||.||++++.+++.||+|++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34568899999999999999889999999998877677889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....... ....
T Consensus 90 L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 163 (267)
T 3t9t_A 90 LSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST 163 (267)
T ss_dssp HHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTT
T ss_pred HHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-cccc
Confidence 9999975432 589999999999999999999998 999999999999999999999999999987643221 1123
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 164 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~i~~~~~~~~--- 226 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SEVVEDISTGFRLYK--- 226 (267)
T ss_dssp STTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCCCCC---
T ss_pred cccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH------------HHHHHHHhcCCcCCC---
Confidence 34578899999999753 67889999999999999999 8888864221 112222222211111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
....+..+.+++.+||+.||++||++.+++++|+++.
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1123456888999999999999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=364.97 Aligned_cols=248 Identities=28% Similarity=0.457 Sum_probs=201.6
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC-eeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lv~e~~~~gs 430 (670)
.+.++||+|+||.||+|+++ ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||+++|+
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 45689999999999999985 7899999998654 5678999999999999999999999987765 7899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 274 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~ 344 (450)
T 1k9a_A 274 LVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 344 (450)
T ss_dssp HHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----c
Confidence 9999976532 2479999999999999999999998 99999999999999999999999999998654321 1
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...+++.|+|||++.+ ..++.++||||||+++|||++ |+.||...... . +...+..+... .
T Consensus 345 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~----~~~~i~~~~~~----~ 406 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------D----VVPRVEKGYKM----D 406 (450)
T ss_dssp --CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------T----HHHHHHTTCCC----C
T ss_pred CCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------H----HHHHHHcCCCC----C
Confidence 2246889999999975 478899999999999999998 99998643220 1 11222222111 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112345678899999999999999999999999986543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.77 Aligned_cols=257 Identities=19% Similarity=0.265 Sum_probs=202.5
Q ss_pred hhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
.+.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++......++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 3568899999999999997 4789999999875542 45688999999999 9999999999999999999999999 99
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC-----eEEeecCCccccCCCC
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-----PKVSDFGLAKAHSRNR 504 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~-----~ki~DfGla~~~~~~~ 504 (670)
+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 90 SLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999997642 2599999999999999999999998 9999999999999998887 9999999998764432
Q ss_pred cee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 505 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 505 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . . ......+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~----~----~-~~~~~~i~ 233 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKAD----T----L-KERYQKIG 233 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS----S----H-HHHHHHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccc----c----H-HHHHHHHH
Confidence 211 12345689999999999763 6789999999999999999999999754220 1 1 11111111
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...............+ .+.+++.+||+.||++||++.+|++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 1110000111111123 7889999999999999999999999998554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=349.82 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=192.1
Q ss_pred HHhhhccccccCceEEEEEEeCCC----cEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeCCee---
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPDG----RLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR--- 419 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~--- 419 (670)
.+.+.+.||+|+||+||+|++... ..||||+++.. ....+.+.+|+.++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 445678999999999999987643 27999999764 23457899999999999999999999999877655
Q ss_pred ---EEEEEecCCCCcccccccccC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 420 ---ALIYEYMPNGSLGDLLSREKE---NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 420 ---~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
++|+||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 899999999999999965432 22589999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... .
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~---- 246 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------A---- 246 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------G----
T ss_pred ccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccCh--------H----
Confidence 9999876554433333445578899999999764 67899999999999999999 8888864322 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.+...+........ ....+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 247 EIYNYLIGGNRLKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp GHHHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11222222111111 11234578899999999999999999999999996644
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.78 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=193.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---------------------------chHHHHHHHHHhcccc
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------------------------FSDNFINEVATIGRIH 402 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~ 402 (670)
+.+.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 345688999999999999875 689999999865431 1356899999999999
Q ss_pred ccccccccceeee--CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCc
Q 005909 403 HVNIIHLLGFCCD--GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480 (670)
Q Consensus 403 H~nIv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 480 (670)
||||+++++++.+ ....++||||+++++|.+++... .+++..++.++.|+++||+|||++ +|+||||||+|
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 9999999999986 56789999999999999876432 599999999999999999999998 99999999999
Q ss_pred EEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN-PSGKSDVYSYGMLLLEMIEEKKHLRPTET 559 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~sDV~SlGvvl~elltg~~p~~~~~~ 559 (670)
||++.++.+||+|||+++........ .....||+.|+|||.+.+.... .+.++||||||+++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999876544322 2345689999999999754211 36789999999999999999999864321
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+...+...... . .....++..+.+++.+||+.||++||++.|++++
T Consensus 246 ------------~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 ------------MCLHSKIKSQALE-F--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ------------HHHHHHHHHCCCC-C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ------------HHHHHHHhcccCC-C--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111111111100 0 0011234568899999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.20 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=202.5
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.|.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3556789999999999999986 689999999875431 35789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC----CeEEeecCCc
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 497 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla 497 (670)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999996543 589999999999999999999998 999999999999999887 8999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~ 228 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLAN 228 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHH
T ss_pred eECCCCCc---cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------------HHHHHH
Confidence 87754332 233468999999999965 3678899999999999999999999964321 011111
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+.... ...........+..+.+++.+||+.||++|||+.|++++-
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 229 VSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHhcC-CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 11100 0111111223356788999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=345.39 Aligned_cols=264 Identities=27% Similarity=0.464 Sum_probs=193.8
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
|+....+.+.++||+|+||+||+|++.+ .+|+|+++.... ..+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 3334445567899999999999998743 599999876542 346789999999999999999999965 4556899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999965432 589999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCceeeecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
............||+.|+|||.+... ...++.++||||||+++|||++|+.||..... ...+...+......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccC
Confidence 43333333445689999999998621 24678899999999999999999999964322 11111111111111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.. .......++..+.+++.+||+.||++||++.++++.|+++.
T Consensus 245 ~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PD----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CC----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cc----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 11111234567889999999999999999999999999654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=353.52 Aligned_cols=259 Identities=28% Similarity=0.413 Sum_probs=205.6
Q ss_pred HHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 125 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence 445668999999999999986 245689999997543 3457899999999999 8999999999999999999
Q ss_pred EEEEecCCCCcccccccccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKEN--------------------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 480 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 480 (670)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~N 202 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 202 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhh
Confidence 999999999999999765321 2479999999999999999999998 99999999999
Q ss_pred EEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 005909 481 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTET 559 (670)
Q Consensus 481 Ill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~ 559 (670)
||++.++.+||+|||+++...............+|+.|+|||.+.+ +.++.++||||||+++|||++ |+.||.....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999987655443333344557889999999976 368899999999999999998 9999865322
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
. ..+...+........ ....+..+.+++.+||+.||++||++.+++++|+....
T Consensus 281 -------~----~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 281 -------D----ANFYKLIQNGFKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp -------S----HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------H----HHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 111111211111111 11234578889999999999999999999999996544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.20 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=207.0
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.+.||+|+||+||+|++.+++.||+|++.......+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 4456899999999999999988889999999877767789999999999999999999999986 446899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 94 L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 168 (279)
T 1qpc_A 94 LVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168 (279)
T ss_dssp HHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCT
T ss_pred HHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-ccc
Confidence 9999975432 2489999999999999999999998 9999999999999999999999999999877544322 223
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||.+.+ +.++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 169 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~---- 230 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------------PEVIQNLERGYRMV---- 230 (279)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCC----
T ss_pred CCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------------HHHHHHHhcccCCC----
Confidence 4457889999999975 367889999999999999999 8888864221 11122222211111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
....++..+.+++.+||+.||++|||+.++++.|++...
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 112234578899999999999999999999999997654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.42 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=208.2
Q ss_pred HhhhccccccCceEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.+.||+|+||+||+|++ .+++.||+|++..... ..+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 44668999999999999985 3568999999986543 357799999999999 99999999999999999999
Q ss_pred EEEecCCCCcccccccccC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 422 IYEYMPNGSLGDLLSREKE---------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 9999999999999976532 12489999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 565 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~ 565 (670)
+.+||+|||+++...............+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------ 253 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc------
Confidence 9999999999987765544333344557889999999876 378899999999999999999 9998864322
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
...+...+.... ... .....+..+.+++.+||+.||++|||+.|++++|++...
T Consensus 254 -~~~~~~~~~~~~-~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 254 -DSKFYKMIKEGF-RML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp -SHHHHHHHHHTC-CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhHHHHHhccCC-CCC-------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111111111111 110 111234578899999999999999999999999986544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.50 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=196.2
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-
Confidence 4568899999999999999889999999987543 234778999999999999999999999999999999999996
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (288)
T 1ob3_A 84 QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (288)
T ss_dssp EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--c
Confidence 589888865432 589999999999999999999998 999999999999999999999999999987643322 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc-----
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK----- 583 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 583 (670)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+...+.....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--------DQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHHCCCChhhchh
Confidence 2334579999999999653 35788999999999999999999999653210 000011111100000
Q ss_pred ---------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 ---------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ---------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..........++..+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000001112245678899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.40 Aligned_cols=254 Identities=19% Similarity=0.302 Sum_probs=203.2
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
...|.+.+.||+|+||+||++.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345667789999999999999885 68999999986421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC---eEEeecCC
Q 005909 421 LIYEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGL 496 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~---~ki~DfGl 496 (670)
+||||+++++|.+.+.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876543 233589999999999999999999998 9999999999999986654 99999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+..
T Consensus 180 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~~ 242 (351)
T 3c0i_A 180 AIQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE-------------RLFE 242 (351)
T ss_dssp CEECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------------HHHH
T ss_pred eeEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------------HHHH
Confidence 9877543321 2345689999999999763 678999999999999999999999964211 1112
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+..... .........++..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 243 GIIKGKY-KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHTCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCC-CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2211111 11111122345678899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.47 Aligned_cols=268 Identities=18% Similarity=0.248 Sum_probs=200.6
Q ss_pred Hhhhcccccc--CceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
|.+.++||+| +||+||++++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4466899999 99999999986 68999999997643 234678889999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 107 FMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp CCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred ccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999999976432 2589999999999999999999998 99999999999999999999999999986543221
Q ss_pred ce-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-CccccchHHHH---
Q 005909 505 SV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-TTEAYFPDWIY--- 575 (670)
Q Consensus 505 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~--- 575 (670)
.. .......||+.|+|||++.+....++.++|||||||++|||++|+.||.......... ......+....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 11 1112246899999999997643468899999999999999999999997533211000 00000000000
Q ss_pred --------------------HHhcC----Cc-cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 --------------------DKLIQ----PE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 --------------------~~~~~----~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... .. ...........++..+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00 0000011223345678999999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.41 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=194.1
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.+.||+|+||+||++++. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+++++|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L 86 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence 35688999999999999984 788999998754 346789999999999999999999998863 47899999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC-eEEeecCCccccCCCCceeeec
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-PKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~-~ki~DfGla~~~~~~~~~~~~~ 510 (670)
.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++....... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~ 161 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----T 161 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----c
Confidence 999976544335789999999999999999999832238999999999999988876 7999999997654321 2
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..... ............
T Consensus 162 ~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~-~~~~~~~~~~~~--- 226 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFRIM-WAVHNGTRPPLI--- 226 (307)
T ss_dssp ---CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---------HHHHH-HHHHTTCCCCCB---
T ss_pred cCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---------HHHHH-HHHhcCCCCCcc---
Confidence 2358999999999975 36789999999999999999999999643210 00111 111111111111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus 227 -~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1234568889999999999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.50 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=195.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.++||+|+||+||+++++ +++.+|+|++++.. ...+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 345689999999999999986 57899999997643 2345688999999887 89999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|..++.+.. .+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 134 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999999997643 599999999999999999999998 99999999999999999999999999998633222
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .........+...+......
T Consensus 208 ~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 208 D--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp C--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCCC
T ss_pred C--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccccc---ccchhhHHHHHHHHhccccC
Confidence 1 12345689999999999764 67899999999999999999999996432211 01111122233332221111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 616 (670)
. +..++..+.+++.+||+.||++||++
T Consensus 281 -~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -I----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -C----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 11235568889999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=357.18 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=201.4
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.|.+.++||+|+||+||++... +|+.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 3556789999999999999875 78999999997654 2346789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCccccCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla~~~~~ 502 (670)
+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 ~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 92 VTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999987643 599999999999999999999998 999999999999998 568899999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 166 ~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~ 229 (444)
T 3soa_A 166 EQQA--WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ------------HRLYQQIKAGA 229 (444)
T ss_dssp TCCB--CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHTC
T ss_pred CCce--eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH------------HHHHHHHHhCC
Confidence 4322 2345699999999999753 678899999999999999999999964321 11122222111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .........++..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 Y-DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C-CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 11111122345678899999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.23 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=207.1
Q ss_pred HHHhhhccccccCceEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCC
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS 417 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 417 (670)
..+.+.+.||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 34556789999999999999873 46789999997654 2346789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC
Q 005909 418 TRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~ 484 (670)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 99999999999999999976432 12489999999999999999999998 999999999999999
Q ss_pred CCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005909 485 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGS 563 (670)
Q Consensus 485 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~ 563 (670)
.++.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 9999999999999877654433333445678899999999753 67889999999999999999 9998864221
Q ss_pred CCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 564 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..+...+........ ...++..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 266 --------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 --------EELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --------HHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHHhcCCCCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111111111 11234578889999999999999999999999997644
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.54 Aligned_cols=260 Identities=29% Similarity=0.466 Sum_probs=212.3
Q ss_pred HHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 346 IKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 346 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+....+.+.+.||+|+||+||+|.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 33344556789999999999999986 48899999998877777899999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999976432 3589999999999999999999998 99999999999999999999999999998776443
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... .. +...+.....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~----~~~~~~~~~~ 230 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQ----VYELLEKDYR 230 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GG----HHHHHHTTCC
T ss_pred cc-cccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH----HHHHHhccCC
Confidence 32 23444578899999999764 67899999999999999999 8888864322 11 1112211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.. ....++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 231 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 231 ME----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11 112234578899999999999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.58 Aligned_cols=241 Identities=28% Similarity=0.367 Sum_probs=199.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 45688999999999999986 68999999997532 34567889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 89 EGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp CSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 9999999997643 589999999999999999999998 99999999999999999999999999998765322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+..... ..
T Consensus 161 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~-~~ 222 (318)
T 1fot_A 161 ---YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MKTYEKILNAEL-RF 222 (318)
T ss_dssp ---CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHCCC-CC
T ss_pred ---ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC
Confidence 234589999999999764 678899999999999999999999964321 111222221111 01
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
+...+..+.+++.+||+.||++|| +++|++++
T Consensus 223 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112345688899999999999999 88998865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=339.30 Aligned_cols=260 Identities=17% Similarity=0.237 Sum_probs=205.4
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||+ +
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 34568899999999999997 478999999986543 345688999999999 7999999999999999999999999 9
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC-----eEEeecCCccccCCC
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-----PKVSDFGLAKAHSRN 503 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~-----~ki~DfGla~~~~~~ 503 (670)
++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 90 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 90 PSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999976432 589999999999999999999998 9999999999999987776 999999999876543
Q ss_pred Cce-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 504 RSV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 504 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .. ......+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~-----~~~~~~~ 233 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TN-----KQKYERI 233 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CH-----HHHHHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcc----cc-----HHHHHHH
Confidence 221 112345689999999998763 6789999999999999999999999753321 11 1111111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
...............++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 11111111111112345678899999999999999999999999997654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.81 Aligned_cols=248 Identities=28% Similarity=0.479 Sum_probs=189.3
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC-----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+|++. ++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 45688999999999999984 8899999987543 23467899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC--------CCCeEEeecCCcc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--------DFTPKVSDFGLAK 498 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~--------~~~~ki~DfGla~ 498 (670)
++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+|||+++
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 89 RGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp TTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999998543 5899999999999999999999982122999999999999986 7789999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
....... ....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ........
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~ 227 (271)
T 3dtc_A 165 EWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVA 227 (271)
T ss_dssp ---------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHH
T ss_pred ccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHhhh
Confidence 6654322 234589999999999763 678899999999999999999999964321 01111111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
....... .....+..+.+++.+||+.||++|||+.|++++|++
T Consensus 228 ~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKLALP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCCCCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111 112234578899999999999999999999999984
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=357.99 Aligned_cols=254 Identities=21% Similarity=0.222 Sum_probs=201.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+|+++ +++.||+|++.+.. ...+.+.+|..++.+++||||+++++++.+.+..++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 34578999999999999986 47899999997532 23345889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+.. ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 157 ~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 157 VGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999997632 2599999999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
......||+.|+|||++... .+.++.++|||||||++|||++|+.||..... .....++.....
T Consensus 232 -~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~ 298 (437)
T 4aw2_A 232 -QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHKE 298 (437)
T ss_dssp -ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTHHH
T ss_pred -ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------------hHHHHhhhhccc
Confidence 23345799999999999631 24678899999999999999999999965321 111222221110
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 623 (670)
..........++..+.+++.+||..+|++ ||+++|++++-
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 00001111123456788999999888888 99999998863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=349.27 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=202.2
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
..|.+.+.||+|+||.||++.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34566789999999999999986 68999999997654 234678899999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC---CCeEEeecCCccccC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHS 501 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~---~~~ki~DfGla~~~~ 501 (670)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 109 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 109 LVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999886543 589999999999999999999998 99999999999999765 459999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------------~~~~~~i~~~ 245 (362)
T 2bdw_A 183 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYAQIKAG 245 (362)
T ss_dssp TCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHT
T ss_pred CCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhC
Confidence 4332 2345689999999999753 678899999999999999999999964321 1111222111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .........++..+.+++.+||+.||++||++.|++++
T Consensus 246 ~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 11111223345678899999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.59 Aligned_cols=273 Identities=25% Similarity=0.340 Sum_probs=197.8
Q ss_pred HHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhc--cccccccccccceeeeC----Ce
Q 005909 345 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIG--RIHHVNIIHLLGFCCDG----ST 418 (670)
Q Consensus 345 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~g~~~~~----~~ 418 (670)
+.....+.+.++||+|+||.||+|++. ++.||||++..... ..+..|.+++. .++||||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 334445667789999999999999985 89999999875543 33444555444 45999999999999877 67
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCcEEECCCCCeEEee
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-----ELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999654 4899999999999999999999741 23899999999999999999999999
Q ss_pred cCCccccCCCCceee--ecCCCCCccccchhhcccccCCCCc------cchhHHHHHHHHHHHhCCCCCCCCCCCCCC--
Q 005909 494 FGLAKAHSRNRSVVT--MTGPRGTIGYIAPEIFMRNLGNPSG------KSDVYSYGMLLLEMIEEKKHLRPTETTSGS-- 563 (670)
Q Consensus 494 fGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~------~sDV~SlGvvl~elltg~~p~~~~~~~~~~-- 563 (670)
||+++.......... .....||+.|+|||++.+. ..+. ++||||||+++|||++|..|+.........
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999987654332211 1234689999999999754 2233 489999999999999995444221110000
Q ss_pred --CCccccchHHHHHHhcCCcc-cccc-chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 564 --NTTEAYFPDWIYDKLIQPEK-EDFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 564 --~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
........ ........... .... ......++..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 264 DLVPSDPSYE-DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTSCSSCCHH-HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCchh-hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 00111111 11222211111 1111 1123456788999999999999999999999999999654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.89 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=198.7
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.+.||+|+||+||+|.+ .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 34568999999999999998 47899999998653 23356789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+ +|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++........
T Consensus 91 ~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 91 A-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp C-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred C-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9 789988886543 599999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......... .+....
T Consensus 164 ~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------------~i~~~~--- 224 (336)
T 3h4j_B 164 L---KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------------KVNSCV--- 224 (336)
T ss_dssp T---CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------------CCCSSC---
T ss_pred c---ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------------HHHcCC---
Confidence 2 334589999999999754 233789999999999999999999997543211000 000000
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+...+..+.+++.+||+.||++|||+.|++++-
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 011112345678899999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=341.54 Aligned_cols=250 Identities=24% Similarity=0.286 Sum_probs=197.2
Q ss_pred HHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccc-cccccccccceeeeCC
Q 005909 343 YNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS 417 (670)
Q Consensus 343 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 417 (670)
..++....+.+.++||+|+||+||+|++. +++.||||++..... ....+..|+..+.++ +||||+++++++.+++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34455556667789999999999999986 799999999865432 234556666666666 8999999999999999
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 7799988876532 599999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.++.... .+..
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~---------------~~~~ 263 (311)
T 3p1a_A 205 VELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE---------------GWQQ 263 (311)
T ss_dssp EECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------------HHHH
T ss_pred eecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------------HHHH
Confidence 87654332 233458999999999864 67889999999999999999977654311 1122
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... .......++..+.+++.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 264 LRQGYL---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTTCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 222111 111222345678899999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.63 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=196.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 45688999999999999986 68999999997543 334778999999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+ +|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 85 Q-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp E-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred C-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 5 5555554332 2599999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc----
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK---- 583 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 583 (670)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.|+..... .. .....+.........
T Consensus 158 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~------~~-~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND------VD-DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS------HH-HHHHHHHHHHCCCCTTTCT
T ss_pred -ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCC------HH-HHHHHHHHHhCCCChhhhh
Confidence 2345689999999999754 3478899999999999999999888643221 00 011111111111000
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..............+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000011112345678899999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.26 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||+||+++++ +++.||||++++.. ...+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 345689999999999999986 68999999997532 3456788999999988 79999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999997653 599999999999999999999998 99999999999999999999999999998643322
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 179 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 242 (353)
T 3txo_A 179 V--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENE------------DDLFEAILNDEVV 242 (353)
T ss_dssp ---------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC
T ss_pred c--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCC
Confidence 1 12335689999999999765 678899999999999999999999965322 1122222221110
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 622 (670)
. +......+.+++.+||+.||++||++ .|++++
T Consensus 243 -~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 -Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 11134567889999999999999998 777764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.62 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=198.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--------chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.+.||+|+||+||+|++. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 345688999999999999985 789999999865332 1167899999999999999999999986655 69
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEECCCCC-----eEEeec
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFT-----PKVSDF 494 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~~~~~-----~ki~Df 494 (670)
||||+++++|.+.+..... .+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||+||
T Consensus 99 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred EEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 9999999999988865432 589999999999999999999998 7 999999999999988776 999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
|+++..... .....||+.|+|||++......++.++||||||+++|||++|+.||..... ....+...+
T Consensus 174 g~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~ 242 (287)
T 4f0f_A 174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFINMI 242 (287)
T ss_dssp TTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHHHHH
T ss_pred Ccccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHHHHH
Confidence 999755432 233568999999999854434678899999999999999999999964322 011111111
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
.. ...... ....++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 243 ~~---~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 RE---EGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HH---SCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hc---cCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 111111 112235678899999999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=348.43 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=192.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
|.+.++||+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 446689999999999999986 7899999999877766788999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC--eEEeecCCccccCCCCcee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~--~ki~DfGla~~~~~~~~~~ 507 (670)
+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.......
T Consensus 102 ~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 102 ELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC--
Confidence 9999986543 589999999999999999999998 9999999999999987765 99999999975432221
Q ss_pred eecCCCCCccccchhhcccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPS-GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s-~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....||+.|+|||++.+. .++ .++||||||+++|||++|+.||...... ..+...+ ..+.......
T Consensus 174 -~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~~~-~~~~~~~~~~- 241 (361)
T 3uc3_A 174 -PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------RDYRKTI-QRILSVKYSI- 241 (361)
T ss_dssp --------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----C-------CCHHHHH-HHHHTTCCCC-
T ss_pred -CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-------HHHHHHH-HHHhcCCCCC-
Confidence 2234589999999999764 443 4589999999999999999999753321 1111111 1221111100
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....++..+.+++.+||+.||++|||+.|++++
T Consensus 242 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 --PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011234567889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=352.10 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=201.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.++||+|+||+||+++++ +++.+|+|++.+.. ...+.+.+|+.++..++||||+++++++.+....++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999986 58999999987532 33456889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 152 ~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 152 PGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp TTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999998653 489999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeecCCCCCccccchhhcccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLG--NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~--~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
......||+.|+|||++.+..+ .++.++|||||||++|||++|+.||..... .....++......
T Consensus 225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMNHKNS 291 (410)
T ss_dssp -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTHHHH
T ss_pred -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------------hhHHHHHHhcccc
Confidence 2335679999999999975421 267899999999999999999999964321 1122222221100
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~ 624 (670)
........++..+.+++.+||+.+|++ ||++.||+++-=
T Consensus 292 -~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 292 -LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp -CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred -ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 000001123557888999999999988 999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.42 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=205.1
Q ss_pred HhhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 445689999999999999864 367899999976543 345789999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 423 YEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence 999999999999975321 13578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
+++...............+++.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~ 249 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------------EQV 249 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------------HHH
T ss_pred cccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH------------HHH
Confidence 99876543332222334568899999999753 67889999999999999999 7888754321 112
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...+........ ...++..+.+++.+||+.||++||++.|++++|++..
T Consensus 250 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFVMEGGLLDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 222222211111 1223456888999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.87 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=201.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.+.||+|+||+||+|... +++.+|+|++.... .....+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 456689999999999999986 68999999987654 2345789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC--CCCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~ 506 (670)
|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++........
T Consensus 133 g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 133 GELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999986543 2589999999999999999999998 9999999999999974 578999999999887654332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... . . ....+..... ..
T Consensus 208 ~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~---~-~~~~i~~~~~-~~ 269 (387)
T 1kob_A 208 K---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------L---E-TLQNVKRCDW-EF 269 (387)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------H---H-HHHHHHHCCC-CC
T ss_pred e---eeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------H---H-HHHHHHhCCC-CC
Confidence 2 23589999999999753 678899999999999999999999965321 0 1 1111111100 01
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++..+.+++.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111112345678899999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.66 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=201.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 345688999999999999986 68999999986532 3457889999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 123 VAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 99999999997643 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+......
T Consensus 196 ----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~~- 256 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP------------IQIYEKIVSGKVR- 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred ----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 224589999999999764 678899999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 623 (670)
. +..++..+.+++.+||+.||++||+ ++||+++-
T Consensus 257 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 257 F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 1 1123557889999999999999998 88888754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.85 Aligned_cols=273 Identities=24% Similarity=0.378 Sum_probs=205.6
Q ss_pred HhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceee--eCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCC--DGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lv 422 (670)
+.+.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|+.++++++||||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34568999999999999984 368899999997654 34567999999999999999999999887 45568899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999976433 489999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC---CCCCccccchHHHHHHh
Q 005909 503 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---GSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 578 (670)
..... ......+++.|+|||++.+. .++.++||||||+++|||++|+.|+....... ............+...+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43322 22334578889999999763 67889999999999999999999885422100 00000000111111222
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccccccCC
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 634 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 634 (670)
...... .....++..+.+++.+||+.||++|||+.|++++|+.+........
T Consensus 258 ~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 258 EEGQRL----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred hcccCC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 221111 1122345678899999999999999999999999997766544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=345.63 Aligned_cols=256 Identities=25% Similarity=0.296 Sum_probs=197.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC------CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 445689999999999999885 6889999998643 345578999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccC-------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005909 424 EYMPNGSLGDLLSREKE-------------------------------------NLSLKPARLLEIALGVAHAIEYLHNG 466 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~ 466 (670)
||+++|+|.+++..... ...+++..++.++.|++.||+|||++
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999853110 11235777889999999999999998
Q ss_pred CCCCeEecCCCCCcEEECCCC--CeEEeecCCccccCCCC--ceeeecCCCCCccccchhhcccccCCCCccchhHHHHH
Q 005909 467 CELRILHLDIKPQNVLLDPDF--TPKVSDFGLAKAHSRNR--SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 542 (670)
Q Consensus 467 ~~~~ivH~dlkp~NIll~~~~--~~ki~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGv 542 (670)
+|+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||++.+....++.++||||||+
T Consensus 188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999998776 89999999998653321 11123345689999999999754457788999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 543 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 543 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
++|||++|+.||..... .+.+...+.... .........++..+.+++.+||+.||++||++.|++++
T Consensus 265 il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVND-----------ADTISQVLNKKL--CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCC--CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHCCCCCCCCCh-----------HHHHHHHHhccc--ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999964322 111111111111 01111122245678899999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=371.61 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=206.9
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||.||+|+++++..||||+++......++|.+|+.+|++++|+||+++++++.+ +..++||||+++|+
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 44668999999999999999888899999998776667889999999999999999999999876 67899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.++|..... ..+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 348 L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~ 422 (535)
T 2h8h_A 348 LLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 422 (535)
T ss_dssp HHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTC
T ss_pred HHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-ccc
Confidence 9999975432 2589999999999999999999998 9999999999999999999999999999876532211 123
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 423 ~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~~---- 484 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMP---- 484 (535)
T ss_dssp STTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------------HHHHHHHHTTCCCC----
T ss_pred CCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC----
Confidence 3456889999999975 478899999999999999999 8888864221 11222222221111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
....++..+.+++.+||+.||++||++.+|++.|+...
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11223557889999999999999999999999999654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.25 Aligned_cols=249 Identities=22% Similarity=0.393 Sum_probs=199.3
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC--CeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+|+++ ++.||||++.... ...+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 45689999999999999984 8899999997654 3346799999999999999999999999877 6789999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
++|+|.+++..... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++......
T Consensus 92 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~- 166 (271)
T 3kmu_A 92 PYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP- 166 (271)
T ss_dssp TTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT-
T ss_pred CCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc-
Confidence 99999999976432 3589999999999999999999987 7 999999999999999999999999887653322
Q ss_pred ceeeecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
...||+.|+|||.+.+.. ...+.++||||||+++|||++|+.||..... .............
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVALEGLR 229 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHHSCCC
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHhcCCC
Confidence 235799999999997531 2234479999999999999999999864321 1111111111111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
... ...++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 230 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 1223557889999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.26 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=190.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||+||+|... +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 445688999999999999885 68999999987543 345788999999999999999999999999999999999997
Q ss_pred CCCccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 69999886532 123589999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc--
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE-- 582 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 582 (670)
. ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+.+.+....
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 163 N--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--------EQLKLIFDIMGTPNES 231 (317)
T ss_dssp C--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCCTT
T ss_pred c--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCChh
Confidence 2 12334689999999999753 35788999999999999999999999653220 00011111110000
Q ss_pred --------------ccc---------ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 --------------KED---------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 --------------~~~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ............+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0000011234578899999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=342.26 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=184.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.||+|+||+||++++. +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999986 6899999998653 3567889999999997 999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEeecCCccccCCCCceeee
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 95 ~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~ 166 (325)
T 3kn6_A 95 ERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L 166 (325)
T ss_dssp HHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence 9997643 599999999999999999999998 999999999999997665 8999999999876543322 2
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......+...+..+.. .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~i~~~~~-~~~~~ 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-----TCTSAVEIMKKIKKGDF-SFEGE 238 (325)
T ss_dssp -----------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC------------CCCHHHHHHHHTTTCC-CCCSH
T ss_pred cccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccc-----ccccHHHHHHHHHcCCC-CCCcc
Confidence 344579999999999764 67889999999999999999999997543211 11112223333333222 12223
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....++..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 334456788999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.18 Aligned_cols=253 Identities=22% Similarity=0.233 Sum_probs=200.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+++.+ +++.||+|++++.. ...+.+.+|..++.+++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34578999999999999985 68999999997532 23456889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++........
T Consensus 144 ~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 144 VGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999976432 589999999999999999999998 9999999999999999999999999999877554332
Q ss_pred eeecCCCCCccccchhhcccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 507 VTMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
......||+.|+|||++... ...++.++|||||||++|||++|+.||..... .....++...
T Consensus 219 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~ 285 (412)
T 2vd5_A 219 -RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------------AETYGKIVHY 285 (412)
T ss_dssp -ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTH
T ss_pred -ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhc
Confidence 22345699999999999742 13578899999999999999999999965321 1112222211
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCC---CCHHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDR---PSMTRVVEML 623 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~L 623 (670)
............++..+.+++.+||+ +|++| |+++||+++-
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 10000111112345678899999999 99998 5899998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.59 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=193.0
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCc---chHHHHHHHHHhccccc--cccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.+.||+|+||.||++...+++.||||++..... ..+.+.+|+.++.+++| +||+++++++.+....++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 345689999999999999998999999999875442 34678999999999976 999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 90 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 90 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 45889999997643 589999999999999999999998 999999999999997 57899999999987765443
Q ss_pred eeeecCCCCCccccchhhcccc---------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
........||+.|+|||++.+. ...++.++||||||+++|||++|+.||..... .......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~~~~ 232 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLHA 232 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHH
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----------HHHHHHH
Confidence 3333455699999999998641 14678899999999999999999999964211 0011111
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+........... ....+.+++.+||+.||++|||+.|++++.
T Consensus 233 ~~~~~~~~~~~~~----~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 233 IIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HhcCCcccCCccc----CCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111111111 134678899999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.34 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=195.1
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
.+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999875 68999999998655 3457899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE--CCCCCeEEeecCCccccCCCCceeee
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll--~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
.+++..... .+++..++.++.|+++||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--- 245 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--- 245 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence 998865432 489999999999999999999998 99999999999999 67789999999999877544322
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... . + ....+..... .....
T Consensus 246 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~----~-~~~~i~~~~~-~~~~~ 310 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-------A----E-TLNNILACRW-DLEDE 310 (373)
T ss_dssp CCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-------H----H-HHHHHHHTCC-CSCSG
T ss_pred ccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------H----H-HHHHHHhccC-CCChh
Confidence 23458999999999865 3678899999999999999999999965322 0 1 1111111110 11111
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....++..+.+++.+||+.||++||++.|++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 222345678899999999999999999999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.82 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=191.2
Q ss_pred HHhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.+.||+|+||+||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 34567899999999999998743 4579999987643 33567999999999999999999999974 45788999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999999997543 2589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... ......+++.|+|||++... .++.++||||||+++|||++ |+.||..... .. +...+....
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~----~~~~i~~~~ 234 (281)
T 1mp8_A 170 TYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------ND----VIGRIENGE 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GG----HHHHHHTTC
T ss_pred ccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HH----HHHHHHcCC
Confidence 321 12233467899999999753 67889999999999999996 8889864322 11 112222211
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... ...++..+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 235 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 1223567889999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=345.56 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=186.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.+.||+|+||+||+|++. +++.||||++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 345688999999999999986 57899999997654 3467889999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCce
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~~ 506 (670)
+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 134 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 134 ELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp BHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 9999986543 589999999999999999999998 9999999999999975 88999999999987654322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+...... .
T Consensus 207 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~i~~~~~~-~ 270 (349)
T 2w4o_A 207 --MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERG-----------DQFMFRRILNCEYY-F 270 (349)
T ss_dssp --------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----------HHHHHHHHHTTCCC-C
T ss_pred --cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcc-----------cHHHHHHHHhCCCc-c
Confidence 2234589999999999753 678899999999999999999999864321 11122222222111 1
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++..+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122345678899999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.41 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=194.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.++||+|+||+||+|++. +++ .|++|.+.... ...+.+.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 345689999999999999875 444 35777775432 45678999999999999999999999998765 78999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999976543 589999999999999999999998 9999999999999999999999999999877554
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..........+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+ ...+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~----~~~~~~~~ 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----SSILEKGE 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGH----HHHHHTTC
T ss_pred cccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHH----HHHHHcCC
Confidence 443334445678899999999764 68899999999999999999 9999865322 111 11121111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... ....+..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 237 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 11234568889999999999999999999999986643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=347.63 Aligned_cols=263 Identities=15% Similarity=0.199 Sum_probs=196.9
Q ss_pred HHhhhccccccCceEEEEEEeCC------CcEEEEEEcccCCcc------------hHHHHHHHHHhccccccccccccc
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNF------------SDNFINEVATIGRIHHVNIIHLLG 411 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~H~nIv~l~g 411 (670)
.+.+.++||+|+||+||+|.+.. ++.||||++...... ...+..|+..+.+++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 34466899999999999998864 478999998765421 123455667788889999999999
Q ss_pred eeeeC----CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC--C
Q 005909 412 FCCDG----STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--P 485 (670)
Q Consensus 412 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~--~ 485 (670)
++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 98764 4579999999 999999997643 2599999999999999999999998 999999999999998 8
Q ss_pred CCCeEEeecCCccccCCCCcee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 005909 486 DFTPKVSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 560 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~ 560 (670)
++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~~- 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNLK- 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence 8999999999998764332211 11234589999999999764 688999999999999999999999974211
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchh--hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
............... ........ ....+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 267 ------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 ------DPKYVRDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp ------CHHHHHHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ------CHHHHHHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 011111111111000 00000000 01225678899999999999999999999999986644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=351.26 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=194.4
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhcccc--ccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|.+.+.||+|+||+||++...+++.||||++.... ...+.+.+|+.++.+++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 45668999999999999999889999999997543 23467899999999996 5999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 137 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 56899999997643 588999999999999999999998 999999999999996 57999999999987755443
Q ss_pred eeeecCCCCCccccchhhcccc---------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
........||+.|+|||++.+. ...++.++|||||||++|||++|+.||..... ....+ .
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~~~~~-~ 278 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKL-H 278 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHH-H
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------HHHHH-H
Confidence 3333456799999999998641 13578899999999999999999999964211 01111 1
Q ss_pred HhcCCcc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+..... ...... ....+.+++.+||+.||++||++.|++++-
T Consensus 279 ~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 279 AIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHhCccccCCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1222111 111111 134678899999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.97 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 345689999999999999975 6899999999753 23446788999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+||||+.++.+||+|||+++......
T Consensus 230 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 230 ANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999997643 58999999999999999999997 6 99999999999999999999999999998644332
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+.....
T Consensus 304 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~- 366 (446)
T 4ejn_A 304 A--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEI- 366 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-
T ss_pred c--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHHhCCC-
Confidence 2 23446799999999999753 678999999999999999999999964321 111111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
.. +..++..+.+++.+||+.||++|| +++|++++-
T Consensus 367 ~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 367 RF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 01 112345788899999999999999 999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=332.53 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=196.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC-----CcchHHHHHHHHHhccccccccccccceee--eCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT-----SNFSDNFINEVATIGRIHHVNIIHLLGFCC--DGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lv~ 423 (670)
.+.+.||+|+||.||++.+. +++.+|+|++... ....+.+.+|+.++++++||||+++++++. +....++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 45688999999999999985 6889999998754 234578999999999999999999999984 455789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||++++ |.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp ECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred hhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 999766 777765433 23689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
..........|++.|+|||++.+.....+.++||||||+++|||++|+.||..... ......+.....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~i~~~~~ 230 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------------YKLFENIGKGSY 230 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHCCC
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------------HHHHHHHhcCCC
Confidence 33333445668999999999875423447799999999999999999999864321 111122211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. . .......+.+++.+||+.||++||++.|++++-
T Consensus 231 ~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 A-I----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp C-C----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred C-C----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0 1 112345678899999999999999999999763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.60 Aligned_cols=264 Identities=23% Similarity=0.395 Sum_probs=202.7
Q ss_pred HhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeC--CeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 421 (670)
+.+.++||+|+||.||++++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 45568999999999999984 368999999997543 3457899999999999999999999999876 56899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999965433 589999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----CCCCccccchHHHHH
Q 005909 502 RNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIYD 576 (670)
Q Consensus 502 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 576 (670)
...... ......+|..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ....... ....+..
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-TVTRLVN 254 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG-HHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc-CHHHHHH
Confidence 544322 22345688899999999764 67789999999999999999998764221000 0000000 0111112
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.+....... ....++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 255 ~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGKRLP----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCCCC----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 221111111 1122356788999999999999999999999999854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=344.36 Aligned_cols=244 Identities=21% Similarity=0.332 Sum_probs=198.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||+||+|+++ +++.||+|+++.. ....+.+..|..++.++ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 35688999999999999986 6899999999764 34456788999999887 899999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 100 LNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999997643 589999999999999999999998 999999999999999999999999999986533222
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... .
T Consensus 174 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~-~ 236 (345)
T 1xjd_A 174 K--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------------EELFHSIRMDNP-F 236 (345)
T ss_dssp C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-C
T ss_pred c--ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHhCCC-C
Confidence 1 2345689999999999764 678999999999999999999999964321 112222221111 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 622 (670)
. +..++..+.+++.+||+.||++||++. +|+++
T Consensus 237 ~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1 112345788899999999999999997 66643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.33 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=190.4
Q ss_pred HhhhccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 44668999999999999987 478999999997642 234567899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999997543 588999999999999999999998 99999999999999999999999999997643
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+...
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~ 236 (327)
T 3a62_A 173 HDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENR------------KKTIDKILKC 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHT
T ss_pred cCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhC
Confidence 3222 12345689999999999753 678899999999999999999999964321 1111121111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 623 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 623 (670)
.. .. +..++..+.+++.+||+.||++|| ++.|++++-
T Consensus 237 ~~-~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 237 KL-NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp CC-CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CC-CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 11 01 112345788899999999999999 788888754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=341.47 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=200.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345689999999999999986 5889999998653 24457889999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 97 LLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp CTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999997543 599999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.....||+.|+|||++... ...++.++|||||||++|||++|+.||...... . ...+...+.....
T Consensus 171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------~-~~~~~~~~~~~~~- 237 (384)
T 4fr4_A 171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--------S-SKEIVHTFETTVV- 237 (384)
T ss_dssp ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--------C-HHHHHHHHHHCCC-
T ss_pred ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--------c-HHHHHHHHhhccc-
Confidence 2345689999999999643 135788999999999999999999999643221 0 1111111111110
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPS-MTRVVE 621 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 621 (670)
..+..++..+.+++.+||+.||++||+ +.+|++
T Consensus 238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011123457889999999999999998 777765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.41 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 445689999999999999986 68999999986543 345789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 89 GGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999996543 589999999999999999999998 99999999999999999999999999998764333222
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
......|++.|+|||.+.+. ...+.++||||||+++|||++|+.||...... ...+..+. .....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-----~~~~~--- 227 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK-----EKKTY--- 227 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHH-----TTCTT---
T ss_pred cccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhh-----hcccc---
Confidence 23445689999999999753 23467899999999999999999999753321 11111111 11000
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......++..+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01112345578889999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.22 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=197.8
Q ss_pred HHhhhccccccCceEEEEEEeCC-C-------cEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD-G-------RLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.+.||+|+||+||+|++.. + ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 34466899999999999998753 3 579999987644 45678999999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC--------eEEe
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--------PKVS 492 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~--------~ki~ 492 (670)
+||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+
T Consensus 89 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999976542 389999999999999999999998 9999999999999988887 9999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
|||++........ ..+++.|+|||++.+. ..++.++||||||+++|||++|+.|+..... . ..
T Consensus 164 Dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~---~~ 226 (289)
T 4fvq_A 164 DPGISITVLPKDI------LQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALD-------S---QR 226 (289)
T ss_dssp CCCSCTTTSCHHH------HHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------H---HH
T ss_pred cCcccccccCccc------cCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccc-------h---HH
Confidence 9999876543221 2368899999999753 3678899999999999999997655432211 0 00
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.............. .+..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 227 ~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 KLQFYEDRHQLPAP-------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHTTCCCCCC-------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHhhccCCCCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00000111111111 13357789999999999999999999999996543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.62 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=202.2
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.||+|+||+||+|.+. +++.||+|+++... ...+.+.+|+.++++++||||+++++++ +.+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999864 57889999998754 3457799999999999999999999999 556789999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee-
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT- 508 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~- 508 (670)
+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 95 ~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 95 PLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp EHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 9999996543 2589999999999999999999998 999999999999999999999999999987754433221
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....+|+.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 170 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~~~~~i~~~~~~~~- 234 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRMEC- 234 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------HHHHHHHHTTCCCCC-
T ss_pred cccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHhcCCcCCC-
Confidence 2234568999999999753 67889999999999999998 9999864321 111222222211111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+..++..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 235 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 235 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12345678899999999999999999999999986654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.58 Aligned_cols=244 Identities=23% Similarity=0.404 Sum_probs=201.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45688999999999999986 79999999997532 34567899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 99 SGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp SSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 9999999996543 599999999999999999999998 999999999999999999999999999987754432
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..... ..+..++.......
T Consensus 172 --~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~~- 235 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV------------PTLFKKICDGIFYT- 235 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------------HHHHHHHHTTCCCC-
T ss_pred --ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHhcCCcCC-
Confidence 2334689999999999764 2346799999999999999999999964322 11222332222111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+......+.+++.+||+.||++|||+.|++++
T Consensus 236 ----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 ----PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11134567889999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=350.07 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=189.6
Q ss_pred hhhccccccCceEEEEEEeC--C--CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeee-CCeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP--D--GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lv~e 424 (670)
.+.+.||+|+||+||+|++. + +..||+|.++... ...+++.+|+.++++++||||+++++++.+ .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999864 2 2468999987543 345789999999999999999999998764 457899999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 172 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999975432 588999999999999999999998 99999999999999999999999999998664332
Q ss_pred ce--eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 505 SV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 505 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||++ |..||..... ..... .+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--------~~~~~----~~~~~ 312 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITV----YLLQG 312 (373)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--------SCHHH----HHHTT
T ss_pred cccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--------HHHHH----HHHcC
Confidence 11 12234457889999999976 378899999999999999999 5666643221 11111 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..... +..++..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 313 ~~~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 313 RRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11234568899999999999999999999999996543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.53 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=198.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.+.+.||+|+||.||+++++ +++.||+|++.+.. ...+.+.+|..++.++ +||||+++++++.+....++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 45688999999999999986 58999999997643 2345688999999988 899999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 92 VNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999986432221
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ........+...+..... .
T Consensus 166 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~i~~~~~-~ 237 (345)
T 3a8x_A 166 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQI-R 237 (345)
T ss_dssp --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCC-C
T ss_pred --cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccc---cccccHHHHHHHHHcCCC-C
Confidence 12345689999999999764 678899999999999999999999965322110 011112222222222111 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 622 (670)
. +...+..+.+++.+||+.||++||++ .|++++
T Consensus 238 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1 11235578889999999999999995 566654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.70 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=204.3
Q ss_pred hhhccccccCceEEEEEEeC-----CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeC--CeeEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 422 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lv 422 (670)
.+.++||+|+||+||++.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45689999999999998653 68899999998654 3356789999999999999999999999874 578999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999654 389999999999999999999998 999999999999999999999999999987765
Q ss_pred CCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--CCccccc-hHHHHHHh
Q 005909 503 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--NTTEAYF-PDWIYDKL 578 (670)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~ 578 (670)
..... ......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ....... ...+...+
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 43322 22334578899999999763 6778999999999999999999988642110000 0000000 00111111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccccc
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 630 (670)
..... ......++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 265 ~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERGER----LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcccC----CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111 1112234567889999999999999999999999999765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=335.06 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 67999999999999975 78999999997654 4467899999999985 799999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC---eEEeecCCccccCCCCc---
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLAKAHSRNRS--- 505 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~---~ki~DfGla~~~~~~~~--- 505 (670)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 99 LSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 99997643 589999999999999999999998 9999999999999988776 99999999976542211
Q ss_pred --eeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccc---hHHHHHH
Q 005909 506 --VVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF---PDWIYDK 577 (670)
Q Consensus 506 --~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 577 (670)
........||+.|+|||++.+. ...++.++||||||+++|||++|+.||................ ...+...
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 1112234589999999998641 1246789999999999999999999997643321111111111 1111222
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+..... .........++..+.+++.+||+.||++|||+.|++++-
T Consensus 253 i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 253 IQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 221111 111111123456788999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=342.71 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=205.0
Q ss_pred HHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCC-ee
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-TR 419 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~~ 419 (670)
.+.+.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 344668999999999999974 3568999999976543 346789999999999 7999999999987755 58
Q ss_pred EEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 420 ALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
++||||+++++|.+++..... +..+++..++.++.|++.||.|||++ +|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 999999999999999976542 12378999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 565 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~ 565 (670)
+.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------ 256 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 256 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccch------
Confidence 99999999999877554443334445678999999999763 67899999999999999998 9999864321
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
. ..+...+........ ....+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 257 -~----~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 257 -D----EEFCRRLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp -S----HHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -h----HHHHHHhccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111111111111111 1113456888999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.65 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=191.8
Q ss_pred HHhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCe----
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST---- 418 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 418 (670)
.+.+.+.||+|+||+||+|++. .++.||+|++.... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3445688999999999999864 34589999997543 234678999999999999999999999987553
Q ss_pred -eEEEEEecCCCCccccccccc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeec
Q 005909 419 -RALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494 (670)
Q Consensus 419 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~Df 494 (670)
.++|+||+++++|.+++.... ....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 489999999999999985322 234699999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+++...............+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||..... . .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~----~ 257 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------H----E 257 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------G----G
T ss_pred CcceecccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------H----H
Confidence 99987654432222333457889999999975 367889999999999999999 8888854322 1 1
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+...+........ ...++..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 258 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 258 MYDYLLHGHRLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHHTTCCCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222211111 12234578899999999999999999999999996543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=336.18 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=202.6
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.+.||+|+||.||++++. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4556789999999999999986 689999999875431 35779999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC----CeEEeecCCc
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 497 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla 497 (670)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999996543 589999999999999999999998 999999999999999888 7999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~ 229 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLAN 229 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHH
T ss_pred eecCcccc---ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH
Confidence 87654332 233458999999999975 3678899999999999999999999964321 111112
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 230 i~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 230 ITSVSY-DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHhccc-ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 211111 11111122345678899999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=345.18 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+...+.||+|+||+||+|+. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 44567899999999999997 4789999999975432 235789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+. |+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp CS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 96 78888875433 2589999999999999999999998 9999999999999999999999999999876532
Q ss_pred eeeecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
....||+.|+|||++.. ..+.++.++||||||+++|||++|+.||..... ...+...... ...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------~~~~~~~~~~-~~~ 271 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQN-ESP 271 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHS-CCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhc-CCC
Confidence 23458999999999853 124678899999999999999999999864321 1111111111 111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
... ....+..+.+++.+||+.||++|||+.+++++.-
T Consensus 272 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 272 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111 1123456788999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.33 Aligned_cols=264 Identities=21% Similarity=0.325 Sum_probs=208.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC--eeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv~e~ 425 (670)
|.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 345688999999999999986 58999999997643 34577889999999999999999999988765 67999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE----CCCCCeEEeecCCccccC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll----~~~~~~ki~DfGla~~~~ 501 (670)
+++|+|.+++........+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999998765555699999999999999999999998 99999999999999 778889999999998765
Q ss_pred CCCceeeecCCCCCccccchhhccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNL------GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
.... .....||+.|+|||++.+.. ..++.++||||||+++|||++|+.||.+..... ...+.+.
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-------~~~~~~~ 237 (396)
T 4eut_A 168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RNKEVMY 237 (396)
T ss_dssp CGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-------TCHHHHH
T ss_pred CCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-------chHHHHH
Confidence 4432 23356899999999986420 245778999999999999999999997543211 0111111
Q ss_pred HHhcCCcc-------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 576 DKLIQPEK-------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 576 ~~~~~~~~-------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+..... ..............+.+++.+||+.||++||++.|+++.++.+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 11111000 00111223567788999999999999999999999999987553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=328.79 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=201.6
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.+.||+|+||+||+|.+. ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 3456689999999999999986 47789999987643 456789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 90 GGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp SCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999886543 589999999999999999999998 99999999999999 788999999999998765443
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. .....||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ..+...+.....
T Consensus 164 ~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~- 224 (277)
T 3f3z_A 164 M---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------------SEVMLKIREGTF- 224 (277)
T ss_dssp C---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-
T ss_pred c---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhCCC-
Confidence 2 233458999999999864 578899999999999999999999964321 111112111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........++..+.+++.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112345678899999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.13 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=195.3
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.++||+|+||+||+++.. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 3556789999999999999985 68899999987644 34578999999999999999999999999999999999999
Q ss_pred CCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCC
Q 005909 427 PNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 427 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~ 502 (670)
++++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999986532 224699999999999999999999998 99999999999999 4568899999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc--C
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI--Q 580 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 580 (670)
... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ..+..... .
T Consensus 180 ~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~------------~~~~~~~~~~~ 241 (285)
T 3is5_A 180 DEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------------EEVQQKATYKE 241 (285)
T ss_dssp ----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCC
T ss_pred ccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCH------------HHHHhhhccCC
Confidence 322 233458999999999853 678899999999999999999999964321 11111111 1
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111100 01134567889999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.48 Aligned_cols=272 Identities=25% Similarity=0.311 Sum_probs=195.7
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee-----CCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-----GSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+|++ +++.||||++............|+..+..++||||+++++.+.. ....++||||+
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 3568899999999999987 68999999997654333333445555666899999999985542 23568999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
++|+|.+++.... .++..++.++.|+++||+|||++. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 95 PNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp TTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 9999999996543 588999999999999999999752 228999999999999999999999999999876
Q ss_pred CCCCc------eeeecCCCCCccccchhhccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc---
Q 005909 501 SRNRS------VVTMTGPRGTIGYIAPEIFMRNL-----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT--- 566 (670)
Q Consensus 501 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~--- 566 (670)
..... ........||+.|+|||++.+.. ..++.++||||||+++|||++|+.|+............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 53321 11223446899999999997521 13456899999999999999998877554331111000
Q ss_pred ---cccchHHHHHHhcCCcc-ccc--cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 567 ---EAYFPDWIYDKLIQPEK-EDF--VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 567 ---~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.......+...+..... ... ........+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 00001111111111111 111 111123456789999999999999999999999999996643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.55 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=197.7
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---------chHHHHHHHHHhccccccccccccceeeeCCee
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 419 (670)
.|.+.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 3445688999999999999875 689999999976531 234677899999999999999999999999999
Q ss_pred EEEEEecCCC-CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 420 ALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 420 ~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
++||||+..| +|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999777 9999886543 599999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
........ ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......
T Consensus 179 ~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------- 237 (335)
T 3dls_A 179 YLERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------- 237 (335)
T ss_dssp ECCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------
T ss_pred ECCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------
Confidence 77654332 224589999999999764 233789999999999999999999996432200
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..... ....++..+.+++.+||+.||++|||+.|++++-
T Consensus 238 -~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 -EAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -TTCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -hhccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00000 0001245688899999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.59 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=204.7
Q ss_pred HhhhccccccCceEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.+.||+|+||.||+|.+.. .+.||+|++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 4456899999999999998742 2489999997654 3456789999999999 89999999999999999999
Q ss_pred EEEecCCCCcccccccccC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeE
Q 005909 422 IYEYMPNGSLGDLLSREKE-----------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 490 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~k 490 (670)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 9999999999999975421 23589999999999999999999998 999999999999999999999
Q ss_pred EeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCcccc
Q 005909 491 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAY 569 (670)
Q Consensus 491 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 569 (670)
|+|||+++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ...
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~ 275 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------NSK 275 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------SHH
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccch-------hHH
Confidence 9999999876544433333445578899999998763 68899999999999999998 8888864321 111
Q ss_pred chHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+...+.... .... ....+..+.+++.+||+.||++|||+.||++.|++..
T Consensus 276 ~~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLVKDGY-QMAQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTC-CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCC-CCCC-------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111111111 1111 1112456888999999999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.05 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=196.8
Q ss_pred HhhhccccccCceEEEEEEeCC----CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceee-eCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lv~ 423 (670)
+.+.+.||+|+||+||+|++.+ ...+|+|.+..... ..+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456899999999999998643 23689999876443 4467999999999999999999999865 455789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 107 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999997543 2589999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cc--eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 504 RS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 504 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
.. ........+|+.|+|||.+.+. .++.++||||||+++|||++|+. |+..... .... .....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~----~~~~~ 247 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDIT----VYLLQ 247 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHH----HHHHT
T ss_pred chhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHH----HHHhc
Confidence 22 1223345678899999999764 67889999999999999999555 4432211 1111 11111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
...... ....+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 248 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 248 GRRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp TCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 11124568889999999999999999999999996544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.55 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=190.7
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCe----eEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST----RAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----~~l 421 (670)
|.+.+.||+|+||+||++++ .+++.||||++.... ...+.+.+|+.++.+++||||+++++++..... .++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 34568999999999999997 478999999997643 223578899999999999999999999876543 489
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999997543 589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 502 RNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 502 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~ 234 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRE 234 (311)
T ss_dssp --------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHC
T ss_pred ccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcC
Confidence 43222 122334589999999999764 678899999999999999999999964322 1111111111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHh
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV-EMLS 624 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~L~ 624 (670)
.... .......++..+.+++.+||+.||++||++.+++ ..|.
T Consensus 235 ~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 235 DPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCCC--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCC--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 1110 1111122456788999999999999999666555 4554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.04 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=196.6
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHhcccc---ccccccccceeeeCC
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIH---HVNIIHLLGFCCDGS 417 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~ 417 (670)
...|.+.++||+|+||+||+|++. +++.||+|++.... .....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 334556789999999999999974 78999999986432 22356778888877775 999999999998755
Q ss_pred -----eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEe
Q 005909 418 -----TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 492 (670)
Q Consensus 418 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~ 492 (670)
..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4789999995 699999876543 2489999999999999999999998 99999999999999999999999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .....
T Consensus 163 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~ 229 (308)
T 3g33_A 163 DFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSE--------ADQLG 229 (308)
T ss_dssp SCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--------HHHHH
T ss_pred eCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 9999987654332 2334589999999999764 678899999999999999999999965322 01111
Q ss_pred HHHHHhcCCcc------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 573 WIYDKLIQPEK------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 573 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+.+.+..... ..........+...+.+++.+||+.||++|||+.|++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11111111000 000011112345678899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.03 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=197.9
Q ss_pred cccccCceEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 356 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+||+|+||.||+|.+. ++..||||+++... ...+++.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46689999998643 356789999999999999999999999876 56899999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-ee
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TM 509 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~-~~ 509 (670)
|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++......... ..
T Consensus 422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 999996543 3589999999999999999999998 99999999999999999999999999998765433221 11
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
....+++.|+|||++.. +.++.++|||||||++|||++ |+.||..... ..+...+..+.....
T Consensus 497 ~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------~~~~~~i~~~~~~~~-- 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRMEC-- 560 (613)
T ss_dssp -----CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------------HHHHHHHHTTCCCCC--
T ss_pred cCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------------HHHHHHHHcCCCCCC--
Confidence 22346789999999975 478899999999999999998 9999865322 112223322221111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+..++..+.+++.+||+.||++||++.+|++.|+....
T Consensus 561 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 561 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp --CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12245678899999999999999999999999986543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.36 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=199.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||+||+++.+ +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 345688999999999999986 4789999999753 24456788999999988 89999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999997643 489999999999999999999998 99999999999999999999999999998643222
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 176 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 239 (353)
T 2i0e_A 176 V--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNVA 239 (353)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC
T ss_pred c--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhCCCC
Confidence 1 12345689999999999754 678899999999999999999999964321 1122222221110
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
. +..++..+.+++.+||+.||++||+ +.+|+++
T Consensus 240 -~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 -Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1124567888999999999999995 5777765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.99 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=199.6
Q ss_pred hhccccccCceEEEEEEeCC----CcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCee-EEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR-ALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lv~e~ 425 (670)
..++||+|+||+||+|++.+ +..+|+|++..... ..+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 34789999999999998632 23799999876443 346789999999999999999999999876655 899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999997643 3589999999999999999999998 999999999999999999999999999986543321
Q ss_pred --eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 506 --VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 506 --~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
........+++.|+|||.+.+. .++.++||||||+++|||++|+.|+..... .... ...+.....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~-------~~~~----~~~~~~~~~ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDL----THFLAQGRR 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------GGGH----HHHHHTTCC
T ss_pred cccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCC-------HHHH----HHHhhcCCC
Confidence 1122334578999999999753 678899999999999999997766543211 1111 111211111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
... ....+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 247 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 247 LPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 112345688999999999999999999999999976543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=336.67 Aligned_cols=267 Identities=23% Similarity=0.347 Sum_probs=205.3
Q ss_pred HHHHHHHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcc--ccccccccccceeeeCC----
Q 005909 344 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCDGS---- 417 (670)
Q Consensus 344 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~---- 417 (670)
.+.....+.+.+.||+|+||+||+|++ +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 344445566778999999999999998 5899999998654 34667788888877 78999999999998776
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCcEEECCCCCe
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH--------NGCELRILHLDIKPQNVLLDPDFTP 489 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dlkp~NIll~~~~~~ 489 (670)
..++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 789999999999999999653 4899999999999999999999 66 99999999999999999999
Q ss_pred EEeecCCccccCCCCcee--eecCCCCCccccchhhcccccC----CCCccchhHHHHHHHHHHHhC----------CCC
Q 005909 490 KVSDFGLAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEE----------KKH 553 (670)
Q Consensus 490 ki~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDV~SlGvvl~elltg----------~~p 553 (670)
||+|||+++......... ......||+.|+|||++.+... ..+.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765543322 1234568999999999975311 123689999999999999999 555
Q ss_pred CCCCCCCCCCCCccccchHHHHHHhcCCcc-ccccc-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 554 LRPTETTSGSNTTEAYFPDWIYDKLIQPEK-EDFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
|..... ...... .+...+..... ..... .........+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 267 ~~~~~~------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVP------SDPSVE-EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSC------SSCCHH-HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCc------CcccHH-HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 543211 011111 22222222211 11111 122356678999999999999999999999999999654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=342.36 Aligned_cols=198 Identities=25% Similarity=0.348 Sum_probs=172.8
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-----ccccccccceeeeCCeeEE
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----HVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~g~~~~~~~~~l 421 (670)
...+.+.++||+|+||+||+|++. +++.||||+++......+.+..|+.+++++. ||||+++++++...+..++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 334556789999999999999985 6899999999876666677888999999986 9999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC----------------
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---------------- 485 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---------------- 485 (670)
||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred EEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence 99999 9999999976543 2589999999999999999999998 9999999999999975
Q ss_pred ---------CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 486 ---------DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 486 ---------~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 7899999999998654332 234589999999999764 688999999999999999999999975
Q ss_pred C
Q 005909 557 T 557 (670)
Q Consensus 557 ~ 557 (670)
.
T Consensus 262 ~ 262 (360)
T 3llt_A 262 H 262 (360)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.69 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=195.9
Q ss_pred hhccccccCceEEEEEEeCC-----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.||+|+||+||+|++.. +..||||++.... .....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 45789999999999998742 2469999997644 2345789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 128 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 128 MENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp CTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999999997543 2589999999999999999999998 999999999999999999999999999987654322
Q ss_pred e-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 506 V-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 506 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
. .......+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||..... ..+...+.....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSN------------HEVMKAINDGFR 268 (333)
T ss_dssp --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCC
T ss_pred cccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHHCCCc
Confidence 1 11223346789999999975 367889999999999999999 9999854221 112222222211
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
... ....+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 269 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 LPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 11234578899999999999999999999999986543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.01 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=200.0
Q ss_pred HHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.+.||+|+||.||+|++ .+++.||||++.... ....++.+|+.++++++||||+++++++.+....++
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence 445678999999999999984 257789999997543 345678999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeec
Q 005909 422 IYEYMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDF 494 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~Df 494 (670)
||||+++++|.+++..... ...+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+||+||
T Consensus 111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcc
Confidence 9999999999999976532 13589999999999999999999998 9999999999999984 456999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
|+++...............+++.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~ 253 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------QE 253 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HH
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------------HH
Confidence 999865443322222334578999999999763 67889999999999999998 8888854221 11
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
+...+........ ...++..+.+++.+||+.||++||++.+|+++|+....
T Consensus 254 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 254 VLEFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 2222222211111 11234578889999999999999999999999986544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.63 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=192.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|+.. +++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 45688999999999999986 789999999875432 22345689999999999999999999999999999999996
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 156 (324)
T 3mtl_A 84 KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 156 (324)
T ss_dssp EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence 688888865432 589999999999999999999998 999999999999999999999999999986543322 1
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc-----
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK----- 583 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 583 (670)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+...+..+..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--------EQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCTTTSTT
T ss_pred cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChHhchh
Confidence 2334579999999998753 36788999999999999999999999653220 011111111111100
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 584 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 584 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000111123356788999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.34 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=195.2
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||+||+|++. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 45688999999999999986 589999999866543 24678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 158 (311)
T 4agu_A 86 HTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY- 158 (311)
T ss_dssp EEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence 999998876543 589999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC-------
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ------- 580 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 580 (670)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... . ....+...+..
T Consensus 159 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-------D-QLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp --------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHHHHCSCCHHHHH
T ss_pred -cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHHHhccccccccc
Confidence 2334689999999999753 46788999999999999999999999653220 0 00001110000
Q ss_pred ---------C-cccc-----ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 ---------P-EKED-----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ---------~-~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .... ........++..+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000 0000112345668899999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.92 Aligned_cols=264 Identities=16% Similarity=0.171 Sum_probs=200.1
Q ss_pred HHhhhccccccCceEEEEEEeCC---------CcEEEEEEcccCCcchHHHHHHHHHhcccccccccc------------
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD---------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH------------ 408 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~------------ 408 (670)
.+.+.+.||+|+||.||+|++.. ++.||+|++... +.+.+|+.++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 34566899999999999999864 789999998754 46789999999999999998
Q ss_pred ---ccceeee-CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC
Q 005909 409 ---LLGFCCD-GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 484 (670)
Q Consensus 409 ---l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~ 484 (670)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 5666665 67889999999 999999997642 23699999999999999999999998 999999999999999
Q ss_pred CCC--CeEEeecCCccccCCCCcee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 485 PDF--TPKVSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 485 ~~~--~~ki~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
.++ .+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 99999999998765332211 11234689999999999763 6788999999999999999999999643
Q ss_pred CCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccccc
Q 005909 558 ETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630 (670)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 630 (670)
.. ............................++..+.+++.+||+.||++||++.+|++.|+++....
T Consensus 272 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LP------NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TT------CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Cc------CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 21 01111111111111110000000001123467889999999999999999999999999765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.78 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=189.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---------cchHHHHHHHHHhccccccccccccceeeeCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 420 (670)
+.+.++||+|+||+||+|.+. +++.||||++.... .....+.+|+.+|++++||||+++++++. .+..+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceE
Confidence 445688999999999999875 68999999986532 12235889999999999999999999975 45679
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC---CCeEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~---~~~ki~DfGla 497 (670)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 216 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999999986543 589999999999999999999998 99999999999999654 45999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
+....... .....||+.|+|||++.. ....++.++||||||+++|||++|+.||..... ...+...
T Consensus 290 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-------~~~~~~~--- 356 (419)
T 3i6u_A 290 KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-------QVSLKDQ--- 356 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-------SCCHHHH---
T ss_pred eecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-------hHHHHHH---
Confidence 87654322 233468999999999853 224667899999999999999999999965322 1111111
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... .........++..+.+++.+||+.||++||++.|++++
T Consensus 357 -i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 -ITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -HHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111 11122223346678899999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.21 Aligned_cols=262 Identities=18% Similarity=0.230 Sum_probs=195.2
Q ss_pred HHHhhhccccccCceEEEEEEeC----CCcEEEEEEcccCCc------------chHHHHHHHHHhccccccccccccce
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSN------------FSDNFINEVATIGRIHHVNIIHLLGF 412 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~H~nIv~l~g~ 412 (670)
..+.+.+.||+|+||+||+|++. ++..+|+|++..... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 34456789999999999999986 578899999876542 12346788899999999999999999
Q ss_pred eee----CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-
Q 005909 413 CCD----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF- 487 (670)
Q Consensus 413 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~- 487 (670)
+.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 987 67889999999 999999997654 589999999999999999999998 999999999999998877
Q ss_pred -CeEEeecCCccccCCCCcee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005909 488 -TPKVSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 561 (670)
Q Consensus 488 -~~ki~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~ 561 (670)
.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~-- 265 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK-- 265 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 99999999998764322111 11345689999999999763 678999999999999999999999953211
Q ss_pred CCCCccccchHHHHHHhcCCccccccch--hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 562 GSNTTEAYFPDWIYDKLIQPEKEDFVEE--EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..... ........... +..... ....++..+.+++.+||+.||++||++.+|++.|+...
T Consensus 266 ----~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 266 ----DPVAV-QTAKTNLLDEL-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp ----CHHHH-HHHHHHHHHTT-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ----ccHHH-HHHHHhhcccc-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00001 11111111000 000000 00134557899999999999999999999999999543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.69 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=199.0
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 45688999999999999986 58999999987544 234678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC---eEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~---~ki~DfGla~~~~~~~ 504 (670)
+++|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 89 GGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 999998886543 589999999999999999999998 9999999999999976655 9999999998765433
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... . .....+.....
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~----~~~~~~~~~~~- 224 (284)
T 3kk8_A 163 A---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------H----RLYAQIKAGAY- 224 (284)
T ss_dssp B---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H----HHHHHHHHTCC-
T ss_pred c---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCch--------h----HHHHHHHhccc-
Confidence 2 2335689999999999763 678899999999999999999999864321 1 11111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........++..+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01111112335678899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.31 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
..||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999975 68899999987654 34578999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccccCCCCceeeecC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
+++........+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++........ ...
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccc
Confidence 9997765445678999999999999999999998 9999999999999987 899999999999876543221 233
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..|++.|+|||++.+....++.++||||||+++|||++|+.||..... ............ .... ..
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~-~~~~----~~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---------PQAAMFKVGMFK-VHPE----IP 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---------HHHHHHHHHHHC-CCCC----CC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---------hhHHHHhhcccc-cccc----cc
Confidence 468999999999976433478899999999999999999999853211 000111111111 0111 11
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..++..+.+++.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2234578889999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=348.21 Aligned_cols=198 Identities=24% Similarity=0.361 Sum_probs=163.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC-----CeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 421 (670)
|.+.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+|++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 345689999999999999985 68899999997543 2346789999999999999999999998766 56899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+. ++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999985 69999986542 599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce--------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 005909 502 RNRSV--------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556 (670)
Q Consensus 502 ~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~ 556 (670)
..... ...+...||+.|+|||++... ..++.++|||||||++|||++|..|+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccc
Confidence 43211 123456789999999987543 4688999999999999999987666543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=333.83 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=194.3
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC-CeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~e~~~~g 429 (670)
+.+.+.||+|+||+||++++ +++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++|+||++++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 34568899999999999988 48899999997654 467899999999999999999999987654 4789999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---- 172 (278)
T 1byg_A 101 SLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 172 (278)
T ss_dssp EHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc----
Confidence 99999975432 1378999999999999999999998 999999999999999999999999999876543321
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
...+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 173 -~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~--- 234 (278)
T 1byg_A 173 -TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPRVEKGYKMD--- 234 (278)
T ss_dssp ----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------------GGHHHHHTTTCCCC---
T ss_pred -CCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHhcCCCCC---
Confidence 23468899999999753 67889999999999999998 9998864321 11122222221111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.....+..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 235 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112235678899999999999999999999999986644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=327.37 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=199.3
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.+.+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 4566789999999999999986 68999999987543 135789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC----CeEEeecCCc
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 497 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla 497 (670)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 86 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999996543 589999999999999999999998 999999999999998877 8999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
........ .....|++.|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~ 222 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETK------------QETLTN 222 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHH
T ss_pred eeccCCCc---ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcch------------HHHHHH
Confidence 87654322 223458999999999975 3678899999999999999999999864321 111111
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... ..........+..+.+++.+||+.||++||++.|++++
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 223 ISAVNY-DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hHhccc-CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 111111 11111122335578899999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.90 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeee----CCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||++.+. +++.||||++.. ...+.+|+.++.++ +||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999986 689999999864 34567888887554 89999999998875 5578999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~ 505 (670)
|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 144 g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 144 GELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp EEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 99999997643 23589999999999999999999998 9999999999999987 78999999999987653322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+.. ... .
T Consensus 220 ---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~i~~----~~~-~ 285 (400)
T 1nxk_A 220 ---LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRM----GQY-E 285 (400)
T ss_dssp ----------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS----SCCSHHHHHHH----TCC-C
T ss_pred ---cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc----ccHHHHHHHHc----Ccc-c
Confidence 234568999999999965 477889999999999999999999997543211 00111111111 111 0
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
........++..+.+++.+||+.||++|||+.|++++-
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11111123456788999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.15 Aligned_cols=249 Identities=23% Similarity=0.415 Sum_probs=201.4
Q ss_pred HHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee----------
Q 005909 347 KKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD---------- 415 (670)
Q Consensus 347 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---------- 415 (670)
....+.+.+.||+|+||.||+|++. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3444556789999999999999986 78999999997654 356789999999999999999998864
Q ss_pred ------CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCe
Q 005909 416 ------GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 489 (670)
Q Consensus 416 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ 489 (670)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 3457899999999999999975432 3689999999999999999999998 99999999999999999999
Q ss_pred EEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCcccc
Q 005909 490 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 569 (670)
Q Consensus 490 ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 569 (670)
||+|||+++....... .....|++.|+|||++.+. .++.++||||||+++|||++|+.|+...
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~------------ 224 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET------------ 224 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH------------
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH------------
Confidence 9999999987654432 2234589999999999753 6788999999999999999998775311
Q ss_pred chHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
......+....... .++..+.+++.+||+.||++||++.|++++|+....
T Consensus 225 --~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 --SKFFTDLRDGIISD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp --HHHHHHHHTTCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred --HHHHHHhhcccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 01112222211111 123467789999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.13 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=199.4
Q ss_pred hhc-cccccCceEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKE-KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+ .||+|+||+||+|.+. .++.||||++.... ...+++.+|+.++++++||||+++++++ +.+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 445 8999999999999652 46889999997643 2357899999999999999999999998 56678999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 99 AELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp CTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999999997643 589999999999999999999998 999999999999999999999999999987754433
Q ss_pred ee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 506 VV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 506 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+...+.....
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~ 238 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGER 238 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCC
T ss_pred cccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 22 12234467899999999753 67889999999999999999 9999864321 112222222221
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
... ...++..+.+++.+||+.||++||++.++++.|+....
T Consensus 239 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 12335678899999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=335.19 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=199.7
Q ss_pred HHHHHHHhhh-ccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccc-cccccccccceeeeCCe
Q 005909 345 DIKKMTNGFK-EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 418 (670)
Q Consensus 345 ~l~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 418 (670)
+.....+.+. +.||+|+||+||+|+.. +++.||+|++.... .....+.+|+.++.++ +||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3333344444 78999999999999986 68999999987543 3457899999999999 56999999999999999
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecC
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFG 495 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfG 495 (670)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999865422 3689999999999999999999998 9999999999999988 7899999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
+++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~ 242 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDN------------QETY 242 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred cccccCCccc---cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------------hHHH
Confidence 9987654322 223468999999999975 3678899999999999999999999964322 0111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..+.... ..........++..+.+++.+||+.||++|||+.|++++-
T Consensus 243 ~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 243 LNISQVN-VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHHHHTC-CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHHHhcc-cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 1111100 0111111223456788899999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=328.44 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=195.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee----CCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ 423 (670)
.+.+.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 34578999999999999885 67899999987543 345678999999999999999999998875 34678999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEEC-CCCCeEEeecCCcccc
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLD-PDFTPKVSDFGLAKAH 500 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~-~~~~~ki~DfGla~~~ 500 (670)
||+++++|.+++.... .+++..++.++.|++.||.|||++ + |+||||||+|||++ +++.+||+|||++...
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999997643 589999999999999999999997 6 99999999999997 7899999999999765
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..... ....|++.|+|||++.+ .++.++||||||+++|||++|+.||..... ...+...+..
T Consensus 183 ~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~ 244 (290)
T 1t4h_A 183 RASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTS 244 (290)
T ss_dssp CTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTT
T ss_pred ccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----------HHHHHHHHhc
Confidence 54332 22458999999998863 578899999999999999999999964322 1112222222
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... ......+..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 245 GVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCcc---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 21111 1111223568899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.86 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=186.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhcccc-ccccccccceeeeCC--eeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGS--TRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~lv~ 423 (670)
|.+.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++...+ ..++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 345689999999999999875 68999999986532 33467889999999997 999999999997544 689999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||++ ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 91 DYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp ECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred cccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9996 6898888653 589999999999999999999998 9999999999999999999999999999865321
Q ss_pred C-------------------ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 504 R-------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 504 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
. .....+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---- 237 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTM---- 237 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 1 11122345689999999999753 46788999999999999999999999653220
Q ss_pred CccccchHHHHHHhcCCcc-----------------------------ccccch---------hhHHHHHHHHHHHHhcc
Q 005909 565 TTEAYFPDWIYDKLIQPEK-----------------------------EDFVEE---------EDDCIARKMIIVGLWCI 606 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~---------~~~~~~~~l~~l~~~cl 606 (670)
. ....+...+..+.. ...... .....+..+.+++.+||
T Consensus 238 ---~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 238 ---N-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ---H-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ---H-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 0 00001111110000 000000 00022457889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 005909 607 QINPKDRPSMTRVVEM 622 (670)
Q Consensus 607 ~~dP~~RPs~~evl~~ 622 (670)
+.||++|||+.|++++
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.96 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=197.0
Q ss_pred HhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||+||+|++.+ +..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 3456889999999999998642 3469999997653 345789999999999999999999999765 45689999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 93 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 93 LYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp CCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred cCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999976432 589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ......+++.|+|||++.+ ..++.++||||||+++|||++ |+.||..... ......+.. ...
T Consensus 168 ~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~~~~~~----~~~ 232 (281)
T 3cc6_A 168 YY-KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVIGVLEK----GDR 232 (281)
T ss_dssp ------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHHHHHHH----TCC
T ss_pred cc-ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHHHHHhc----CCC
Confidence 21 1233457889999999975 367889999999999999998 9999864322 111111111 111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
... ....+..+.+++.+||+.||++||++.|++++|+.+.
T Consensus 233 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 LPK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 111 1123456888999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.00 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=195.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 456689999999999999974 78999999987532 2346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++++|.+++.... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999986532 234689999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.. .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .. ..+...+......
T Consensus 191 ~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~-~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 191 TA--AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NL-YSLCKKIEQCDYP 256 (310)
T ss_dssp ----------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---C---------CH-HHHHHHHHTTCSC
T ss_pred cc--ccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccch---------hH-HHHHHHhhcccCC
Confidence 21 123458999999999875 3678899999999999999999999864321 01 1111222221111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccccc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 630 (670)
... ...++..+.+++.+||+.||++||++.+|++.|+++....
T Consensus 257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 111 1223557889999999999999999999999999765543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.23 Aligned_cols=193 Identities=25% Similarity=0.419 Sum_probs=151.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC-----CeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 421 (670)
+.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+|++++||||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 456689999999999999876 68999999987543 2346789999999999999999999998543 46899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99998 678998886543 599999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCce-------------------------eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCC
Q 005909 502 RNRSV-------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 551 (670)
Q Consensus 502 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~ 551 (670)
..... ...+...||+.|+|||++... ..++.++|||||||++|||++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhc
Confidence 32110 123445689999999987543 46889999999999999999943
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=327.03 Aligned_cols=243 Identities=28% Similarity=0.429 Sum_probs=195.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 35688999999999999886 57899999986532 33567899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~- 164 (279)
T 3fdn_A 92 PLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 164 (279)
T ss_dssp TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc-
Confidence 9999999987643 589999999999999999999988 999999999999999999999999999865543321
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
....|++.|+|||.+.+. ..+.++||||||+++|||++|+.||..... ......+..... .
T Consensus 165 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~- 225 (279)
T 3fdn_A 165 ---TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------QETYKRISRVEF-T- 225 (279)
T ss_dssp ------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-C-
T ss_pred ---cccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH------------HHHHHHHHhCCC-C-
Confidence 234589999999999753 678899999999999999999999864321 111111111110 0
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+...+..+.+++.+||+.||++||++.|++++-
T Consensus 226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0112345678899999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=342.84 Aligned_cols=266 Identities=25% Similarity=0.439 Sum_probs=203.7
Q ss_pred HhhhccccccCceEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCC--eeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lv 422 (670)
+.+.+.||+|+||.||++++ .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 44668999999999999984 368899999997654 34578999999999999999999999887654 67999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+++++|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 123 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp ECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999976532 589999999999999999999998 999999999999999999999999999987755
Q ss_pred CCceee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC----CCCCccccchHHHHHH
Q 005909 503 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIYDK 577 (670)
Q Consensus 503 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 577 (670)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... +...........+.+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 433222 2234577889999999763 67889999999999999999998875321000 0000000011111122
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+....... ....++..+.+++.+||+.||++||++.||++.|+++.
T Consensus 276 ~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRLP----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCC----CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21111111 11224567889999999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.84 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=202.1
Q ss_pred hhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhcccccccccccccee-eeCCeeEEEEEecCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC-CDGSTRALIYEYMPNG 429 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~e~~~~g 429 (670)
.+.+.||+|+||.||+|++ .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+....++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 4568899999999999997 5789999999876543 45789999999999998877776665 5667789999999 99
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCCCCce
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 90 ~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 90 SLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp BHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99999974332 599999999999999999999998 99999999999999 48899999999999876544321
Q ss_pred e-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 507 V-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 507 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+...........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEKKMSTP 238 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCch----hhhhhhhhhcccccCCc
Confidence 1 12345689999999999764 6788999999999999999999999754321 11111111111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
.......++..+.+++.+||+.||++||++.+|++.|+++...
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 1111122356788999999999999999999999999966443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=368.30 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++||+|+||.||+|.+. .++.||||+++... ...+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999663 46789999997643 235789999999999999999999999864 557899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce-e
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-V 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~-~ 507 (670)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999996543 589999999999999999999998 9999999999999999999999999999876543321 1
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||..... ..+...+........
T Consensus 528 ~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------~~~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGERMGC 593 (635)
T ss_dssp -------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCCC
T ss_pred cccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC
Confidence 2233456889999999975 478899999999999999998 9999864322 122233332222111
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...++..+.+++.+||+.||++||++.+|++.|+...
T Consensus 594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123567889999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.57 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=180.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++|+||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 34578999999999999974 78999999986532 33578899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 94 ~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 94 HNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp TTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999997543 2589999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....|++.|+|||.+.+. ..+.++||||||+++|||++|+.||........ ......... .
T Consensus 169 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~~~~~-~- 230 (278)
T 3cok_A 169 --HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------LNKVVLADY-E- 230 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCSSCC-C-
T ss_pred --ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------HHHHhhccc-C-
Confidence 1234589999999998754 678899999999999999999999975332110 011111000 0
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+..++..+.+++.+||+.||++||++.+++++
T Consensus 231 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 ---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011234567889999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.23 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=198.2
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.|.+.+.||+|+||.||++.++ +++.||+|++..... ...+|++++.++ +||||+++++++.++...++||||++
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 3456689999999999999986 689999999976543 235788888888 79999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC----CCeEEeecCCccccCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~----~~~ki~DfGla~~~~~~ 503 (670)
+|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 100 gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 100 GGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp SCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999986543 589999999999999999999998 99999999999998443 35999999999876543
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .....+...+..+..
T Consensus 174 ~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 174 NGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPD---------DTPEEILARIGSGKF 240 (342)
T ss_dssp TCC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---------SCHHHHHHHHHHCCC
T ss_pred CCc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCc---------CCHHHHHHHHccCCc
Confidence 321 2345689999999999764 567899999999999999999999964321 111222222222211
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. ........++..+.+++.+||+.||++||++.|++++-
T Consensus 241 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 241 S-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp C-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred c-cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 1 11111223456788999999999999999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.24 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=201.1
Q ss_pred HHhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhcccccccccccccee-eeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC-CDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lv~e~~~ 427 (670)
.+.+.+.||+|+||+||+|++ .+++.||||++..... .+++.+|+.++.+++|++++..++.+ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 345668999999999999997 4789999998765432 34688999999999988877777765 5667889999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 88 GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999999975432 589999999999999999999998 99999999999999 788999999999998765443
Q ss_pred cee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 505 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 505 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... ..............
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMS 236 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHHHHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhh----hhhhhhhhhccccc
Confidence 211 12245689999999999764 67889999999999999999999997543311 11111111111111
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.. .......++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 237 ~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 237 TP-----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SC-----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ch-----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 11 111112235678899999999999999999999999986654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.87 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=200.3
Q ss_pred HhhhccccccCceEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
+.+.+.||+|+||+||+++. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34568899999999999987 368999999987532 3346678899999999 6999999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 136 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999997643 589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
....... .....||+.|+|||++.+....++.++||||||+++|||++|+.||...... ... ..+...+..
T Consensus 210 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~-~~~~~~~~~ 280 (355)
T 1vzo_A 210 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-------NSQ-AEISRRILK 280 (355)
T ss_dssp CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-------CCH-HHHHHHHHH
T ss_pred ccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-------chH-HHHHHHHhc
Confidence 4322211 1234589999999999754345788999999999999999999999643221 111 111122111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHHh
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEMLS 624 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 624 (670)
... .. ...++..+.+++.+||+.||++|| ++.|++++.-
T Consensus 281 ~~~-~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 SEP-PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCC-CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cCC-CC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111 11 112345678899999999999999 9999998774
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=333.16 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=196.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||+||++.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345688999999999999986 688999999976432 246789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 116 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 116 INGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999997643 589999999999999999999998 999999999999999999999999999977654322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ..+...+.....
T Consensus 190 ~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~-- 252 (309)
T 2h34_A 190 T-QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL------------SVMGAHINQAIP-- 252 (309)
T ss_dssp --------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH------------HHHHHHHHSCCC--
T ss_pred c-cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH------------HHHHHHhccCCC--
Confidence 1 12334589999999999753 678899999999999999999999864321 111121111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhhcccc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSASAE 629 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~ 629 (670)
........++..+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 01111223355788899999999999999 999999999965443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.95 Aligned_cols=243 Identities=24% Similarity=0.329 Sum_probs=187.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHH-hccccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVAT-IGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||+||+++.+ +++.+|+|++.+.. ...+.+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 446689999999999999986 58899999997643 233456777776 577899999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 120 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 120 YINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999997643 588999999999999999999998 99999999999999999999999999998643222
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~- 256 (373)
T 2r5t_A 194 S--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------------AEMYDNILNKPL- 256 (373)
T ss_dssp C--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------------HHHHHHHHHSCC-
T ss_pred C--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhccc-
Confidence 1 12345689999999999764 678899999999999999999999964321 112222222111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 620 (670)
... ..++..+.+++.+||+.||++||++.+.+
T Consensus 257 ~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 QLK----PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 011 12345678899999999999999985433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=328.39 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=197.1
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.+.+.||+|+||+||+|++. +++.||+|++.... ....++.+|+..+.++ +||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 3445689999999999999986 78999999987542 3456788999999999 99999999999999999999999
Q ss_pred ecCCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC------------------
Q 005909 425 YMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP------------------ 485 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~------------------ 485 (670)
|+++++|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 9999999999976432 23689999999999999999999998 9999999999999984
Q ss_pred -CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 486 -DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 486 -~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
...+||+|||++........ ..||+.|+|||++.+. ...+.++||||||+++|||++|+.++....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp -CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred CceEEEEcccccccccCCccc------cCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 44799999999987654322 3489999999999754 355679999999999999999987653211
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
....+......... ..++..+.+++.+||+.||++|||+.|++++-
T Consensus 236 ---------~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 236 ---------QWHEIRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp ---------HHHHHHTTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred ---------HHHHHHcCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 11122222221111 12345788899999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.36 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=200.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---------chHHHHHHHHHhccc-cccccccccceeeeCCee
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 419 (670)
+.+.+.||+|+||+||+|++. +|+.||||++..... ..+.+.+|+.++.++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 344578999999999999986 799999999875431 135678999999999 799999999999999999
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999999997543 589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
...... .....||+.|+|||++.+. ...++.++||||||+++|||++|+.||..... ....
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------------~~~~ 314 (365)
T 2y7j_A 250 LEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------------ILML 314 (365)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred cCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------------HHHH
Confidence 754432 2335689999999998642 12468899999999999999999999964221 1111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+..... ..........+..+.+++.+||+.||++||++.|++++
T Consensus 315 ~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIMEGQY-QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHTCC-CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCC-CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111 01111112234568899999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.56 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=190.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 420 (670)
|.+.++||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 345688999999999999875 68999999997542 3456788999999999999999999998654 3569
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 144 lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 99999965 46565532 388999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC---------CCC--cccc
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---------SNT--TEAY 569 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~---------~~~--~~~~ 569 (670)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ... ....
T Consensus 215 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 215 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp --CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred CCCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 54322 2345689999999999764 678899999999999999999999975331000 000 0000
Q ss_pred chHHHHHHhcCC-c-------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 570 FPDWIYDKLIQP-E-------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 570 ~~~~~~~~~~~~-~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
........+... . ......+........+.+++.+||+.||++|||+.|++++-
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000000000 0 00011122233467789999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.52 Aligned_cols=249 Identities=16% Similarity=0.126 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEE------eCCCcEEEEEEcccCCcchHHHHHHHHHhcccc---ccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.++||+|+||+||+|. ..+++.||||++... ..+++..|+.++.+++ |+||+++++++...+..++
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 4456789999999999994 346889999998754 3567778888777776 9999999999999999999
Q ss_pred EEEecCCCCccccccccc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-----------CCC
Q 005909 422 IYEYMPNGSLGDLLSREK--ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----------DFT 488 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-----------~~~ 488 (670)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||||+. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 999999999999997532 233699999999999999999999998 9999999999999998 899
Q ss_pred eEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccc
Q 005909 489 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568 (670)
Q Consensus 489 ~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~ 568 (670)
+||+|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 999999999765433333344567799999999999764 57899999999999999999999985432200
Q ss_pred cchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhhcc
Q 005909 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR-PSMTRVVEMLSSAS 627 (670)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~ 627 (670)
.. ......... ....+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 293 ~~--------~~~~~~~~~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 CK--------PEGLFRRLP------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EE--------ECSCCTTCS------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ee--------echhccccC------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00 000000010 13356678889999999999 68888888887543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=336.38 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=200.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcE--EEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRL--VAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+|++. ++.. +++|.+.... ...+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 346689999999999999875 4554 4899887532 3456799999999999 89999999999999999999999
Q ss_pred ecCCCCccccccccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEE
Q 005909 425 YMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 491 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki 491 (670)
|+++++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999997643 223689999999999999999999998 9999999999999999999999
Q ss_pred eecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccc
Q 005909 492 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYF 570 (670)
Q Consensus 492 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 570 (670)
+|||+++...... ......+++.|+|||.+.+. .++.++||||||+++|||++ |+.||.....
T Consensus 184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------- 247 (327)
T 1fvr_A 184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------- 247 (327)
T ss_dssp CCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------
T ss_pred cccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----------
Confidence 9999987533211 11223468899999999753 67889999999999999998 9999864321
Q ss_pred hHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
..+...+........ ...++..+.+++.+||+.||++||++.|++++|+.+..
T Consensus 248 -~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 248 -AELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -HHHHHHGGGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhhcCCCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112222222211111 11234578899999999999999999999999986644
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.37 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=202.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||++++. +|+.||+|++... ......+.+|+.+|.+++||||+++++++.+.+..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999986 6899999999653 234567889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 267 ~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 267 NGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp CSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 9999999987643 23589999999999999999999998 999999999999999999999999999987755432
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+..... ..
T Consensus 342 --~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--------~~~~~i~~~i~~~~~-~~ 408 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IKREEVERLVKEVPE-EY 408 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--------CCHHHHHHHHHHCCC-CC
T ss_pred --ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccc--------hhHHHHHHHhhcccc-cC
Confidence 2334689999999999763 6788999999999999999999999753321 111122222211110 11
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
...++..+.+++.+||+.||++|| ++.||+++
T Consensus 409 ----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 ----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 122356788999999999999999 78888875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.64 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=183.8
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhcccc-ccccccccceee--------eCCe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-HVNIIHLLGFCC--------DGST 418 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~--------~~~~ 418 (670)
.+.+.++||+|+||.||++++. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 3456689999999999999975 78999999986554 34567899999999996 999999999984 3345
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCcEEECCCCCeEEeecCC
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
.++|+||+ +|+|.+++........+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 78999999 489999987644444699999999999999999999997 7 99999999999999999999999999
Q ss_pred ccccCCCCcee----------eecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005909 497 AKAHSRNRSVV----------TMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 565 (670)
Q Consensus 497 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~ 565 (670)
++......... ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1113458999999999842 12467889999999999999999999996432210
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
......... ... .....+.+++.+||+.||++||++.|++++|+....
T Consensus 261 -------~~~~~~~~~-~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 -------IVNGKYSIP-PHD-------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------CCCC-TTC-------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------hhcCcccCC-ccc-------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000111100 011 112346789999999999999999999999986643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.62 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=195.3
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---------cchHHHHHHHHHhccccccccccccceeeeCCe
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST 418 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 418 (670)
..|.+.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 34566789999999999999986 58899999986532 12345889999999999999999999987655
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC---eEEeecC
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFG 495 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~---~ki~DfG 495 (670)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999886543 589999999999999999999998 9999999999999987654 9999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH
Q 005909 496 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 496 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
+++........ ....||+.|+|||++.. ....++.++||||||+++|||++|+.||..... ...+...+
T Consensus 163 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~ 232 (322)
T 2ycf_A 163 HSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-------QVSLKDQI 232 (322)
T ss_dssp TCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-------SSCHHHHH
T ss_pred cceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-------HHHHHHHH
Confidence 99876543221 22347999999999853 124678899999999999999999999964322 11111111
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ..........++..+.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGK-----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTC-----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCc-----cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1111 011112222345678899999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.60 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=189.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|.+.++||+|+||+||+|++. +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 445689999999999999875 789999999975442 3456789999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE-----CCCCCeEEeecCCccccC
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll-----~~~~~~ki~DfGla~~~~ 501 (670)
+ |+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 116 ~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 116 E-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp S-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred C-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 6 59999886543 589999999999999999999998 99999999999999 455669999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ...+. .+......+
T Consensus 189 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~-~~~~~~~~~ 257 (329)
T 3gbz_A 189 IPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-------IDQLF-KIFEVLGLP 257 (329)
T ss_dssp -------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH-HHHHHHCCC
T ss_pred Cccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-------HHHHH-HHHHHhCCC
Confidence 3322 12334579999999999753 3578899999999999999999999965322 00000 011111000
Q ss_pred cc----------------cc-----ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EK----------------ED-----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~----------------~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .. ........+...+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 00 0001111234678899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=359.33 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=201.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
+++.+.||+|+||+||+|++. +++.||||++++. ....+.+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445688999999999999986 5889999999753 24456788999999988 79999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++......
T Consensus 423 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred CcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999997653 599999999999999999999998 99999999999999999999999999998643322
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 497 ~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~~~ 560 (674)
T 3pfq_A 497 V--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNVA 560 (674)
T ss_dssp C--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHSSCCC
T ss_pred c--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhCCCC
Confidence 2 12345699999999999754 778999999999999999999999965322 2233333332211
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
. +..++.++.+++.+||+.||++||++ +||+++
T Consensus 561 -~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 -Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -C----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -C----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 12245678899999999999999997 677654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.49 Aligned_cols=248 Identities=27% Similarity=0.370 Sum_probs=198.3
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.|.+.++||+|+||+||+|++. +++.+|+|++.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4566789999999999999986 68899999997643 3457889999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~ 502 (670)
+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 118 ~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 118 YKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999886543 589999999999999999999998 9999999999999976 45599999999987754
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~ 253 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTD------------QEILRKVEKGK 253 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTC
T ss_pred Ccc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 432 234568999999999863 678899999999999999999999965322 11222222111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .........++..+.+++.+||+.||++|||+.|++++
T Consensus 254 ~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 Y-TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 11111222345678899999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.93 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=196.8
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
.|.+.+.||+|+||.||+|++. +|+.||||++..... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 3455689999999999999986 589999999975321 235788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999975 8888886543 2588889999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... ......+........
T Consensus 165 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~--------~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 165 PNRA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFETLGTPT 233 (346)
T ss_dssp CCCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCCC
T ss_pred Cccc--CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHHcCCCC
Confidence 3221 2345689999999998653 3578899999999999999999998865321 000111111111110
Q ss_pred cc------------------c-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 583 KE------------------D-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 583 ~~------------------~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
.. . .........+..+.+++.+||+.||++|||+.|++++--
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00 0 000011233467889999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.25 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=199.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||+||++++. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 34588999999999999986 57899999986543 23567889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 98 ~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 98 RRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp TTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999886543 589999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....|++.|+|||.+.+. ..+.++||||||+++|||++|+.||..... ......+...... .
T Consensus 172 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~-~ 234 (294)
T 2rku_A 172 --KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL------------KETYLRIKKNEYS-I 234 (294)
T ss_dssp --BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCCC-C
T ss_pred --cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhhccCC-C
Confidence 2334589999999999753 678899999999999999999999864321 1111111111110 1
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+...+.+++.+||+.||++||++.|++++-
T Consensus 235 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 235 ----PKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 112345678899999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=332.05 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=198.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||++++. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 35688999999999999986 57899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 124 ~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 124 RRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp TTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999886543 589999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... .+ ....+..... ..
T Consensus 198 --~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~-~~~~~~~~~~-~~ 260 (335)
T 2owb_A 198 --KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KE-TYLRIKKNEY-SI 260 (335)
T ss_dssp --BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HH-HHHHHHHTCC-CC
T ss_pred --ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HH-HHHHHhcCCC-CC
Confidence 2334589999999999753 678899999999999999999999864321 01 1111111110 00
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+...+.+++.+||+.||++||++.|++++
T Consensus 261 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 ----PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11234567889999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=344.48 Aligned_cols=240 Identities=16% Similarity=0.146 Sum_probs=183.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHH---HHhcccccccccccc-------ceeeeC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEV---ATIGRIHHVNIIHLL-------GFCCDG 416 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~~~~~ 416 (670)
.+.+.||+|+||+||+|++. +|+.||||++... ....+.+.+|+ ..+++++||||++++ +++.+.
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 34578999999999999974 6999999999743 23457889999 566666899999998 555444
Q ss_pred C-----------------eeEEEEEecCCCCcccccccccCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 005909 417 S-----------------TRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 475 (670)
Q Consensus 417 ~-----------------~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~d 475 (670)
+ ..++||||+ +|+|.+++.....- ..+++..++.|+.|++.||+|||++ +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 2 278999999 68999999764311 1234588889999999999999998 999999
Q ss_pred CCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccc---------cCCCCccchhHHHHHHHHH
Q 005909 476 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLE 546 (670)
Q Consensus 476 lkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDV~SlGvvl~e 546 (670)
|||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. ...++.++|||||||++||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999986433 1233457 999999999753 0157889999999999999
Q ss_pred HHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 547 MIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 547 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
|++|+.||........ . ..+... ...++..+.+++.+||+.||++||++.|++++
T Consensus 306 lltg~~Pf~~~~~~~~-------~-----~~~~~~---------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 306 IWCADLPITKDAALGG-------S-----EWIFRS---------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHSSCCC------CC-------S-----GGGGSS---------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHCCCCCcccccccc-------h-----hhhhhh---------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999965332110 0 000000 01224568889999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.91 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=200.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 44688999999999999875 68999999987543 4467899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 105 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 175 (303)
T 3a7i_A 105 GSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175 (303)
T ss_dssp EEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence 9999998643 589999999999999999999998 9999999999999999999999999999876543321
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+.........
T Consensus 176 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~~- 240 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP------------MKVLFLIPKNNPPTLE- 240 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSCCCCCC-
T ss_pred cCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH------------HHHHHHhhcCCCCCCc-
Confidence 2345689999999999753 678899999999999999999999864221 0111111111111111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
..++..+.+++.+||+.||++|||+.|++++.
T Consensus 241 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 241 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 12345688899999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.90 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=195.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--------CCe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--------GST 418 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~~ 418 (670)
|.+.++||+|+||+||+|++. +++.||+|++.... .....+.+|+.++++++||||+++++++.. .+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 445689999999999999984 78999999986543 334678899999999999999999999887 346
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.++||||++ ++|.+.+..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 99 IYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 899999996 577777755432 489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc--eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 499 AHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 499 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
....... ........||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~ 243 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--------HQLALISQ 243 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHH
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHH
Confidence 7643221 1223445689999999998653 35788999999999999999999998753220 00011111
Q ss_pred HhcCCcc------------------ccccchhhH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEK------------------EDFVEEEDD-----CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~------------------~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
....... ......... .....+.+++.+||+.||++|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 0000000 000000001 1134688999999999999999999999763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.14 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=199.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--------------cchHHHHHHHHHhccccccccccccceeee
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--------------NFSDNFINEVATIGRIHHVNIIHLLGFCCD 415 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 415 (670)
|.+.++||+|+||+||+|++. +++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445689999999999999986 57899999987543 235678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---CeEEe
Q 005909 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVS 492 (670)
Q Consensus 416 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~---~~ki~ 492 (670)
....++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999886543 599999999999999999999998 999999999999998775 69999
Q ss_pred ecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchH
Q 005909 493 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 493 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 572 (670)
|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... .
T Consensus 192 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~ 253 (504)
T 3q5i_A 192 DFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQND------------Q 253 (504)
T ss_dssp CCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------H
T ss_pred ECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------------H
Confidence 9999987755432 234568999999999863 578899999999999999999999965322 1
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+...+..... .........++..+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 254 DIIKKVEKGKY-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCC-CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 12222222111 11111223345678899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.89 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=199.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 345688999999999999986 5789999998653 23456789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 96 APRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999999997653 589999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+..... .
T Consensus 170 ----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~-~ 230 (284)
T 2vgo_A 170 ----RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSH------------TETHRRIVNVDL-K 230 (284)
T ss_dssp ----CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCC-C
T ss_pred ----ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCH------------hHHHHHHhcccc-C
Confidence 234589999999999753 678899999999999999999999864321 111122221111 0
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. ...++..+.+++.+||+.||++||++.+++++-
T Consensus 231 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 231 F----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred C----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 1 112345678899999999999999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.89 Aligned_cols=248 Identities=27% Similarity=0.357 Sum_probs=201.2
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
.|.+.++||+|+||+||++++. +++.||||++... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 4556789999999999999986 7899999998642 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCccccCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla~~~~~ 502 (670)
+++|+|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 103 ~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 103 YTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999886543 589999999999999999999998 999999999999995 456899999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 177 ~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~ 238 (486)
T 3mwu_A 177 NTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE------------YDILKRVETGK 238 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTC
T ss_pred CCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 432 234568999999999864 578899999999999999999999964321 11112222111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .........++..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 Y-AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111223345678899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.45 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=203.9
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
..|.+.+.||+|+||+||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45566789999999999999986 7899999998653 234678999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCcccc
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~ 500 (670)
||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 106 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999886543 589999999999999999999998 99999999999999 56789999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+...+..
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~ 241 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANE------------YDILKKVEK 241 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHH
T ss_pred ccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHc
Confidence 54432 223458999999999864 578899999999999999999999965322 111222221
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
... .........++..+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 242 GKY-TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp CCC-CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCC-CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 111 111112233466788999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.19 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=198.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--CCeeEEEEEe
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEY 425 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e~ 425 (670)
.+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 35688999999999999986 68999999997543 334678999999999999999999998754 5678999999
Q ss_pred cCCCCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 426 MPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELR-----ILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
+++++|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 999999999975432 33589999999999999999999997 6 99999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
....... .....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ..+...+.
T Consensus 166 ~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~i~ 229 (279)
T 2w5a_A 166 LNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------KELAGKIR 229 (279)
T ss_dssp C---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHH
T ss_pred ecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH------------HHHHHHHh
Confidence 6543221 1123479999999999753 678899999999999999999999864321 11122222
Q ss_pred CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 580 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
....... ...++..+.+++.+||+.||++||++.||++++.
T Consensus 230 ~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 EGKFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hcccccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 2111111 1123557889999999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=349.01 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=200.5
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.||+|+||+||++++. +|+.||+|++.... ...+.+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 467999999999999986 69999999996532 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccccC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 429 GSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 429 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
|+|.+++..... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~- 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence 999999875432 33699999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+..... ..
T Consensus 346 -~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~--------~~~~~~~~~i~~~~~-~~- 412 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEK--------VENKELKQRVLEQAV-TY- 412 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--------CCHHHHHHHHHHCCC-CC-
T ss_pred -cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccc--------hhHHHHHHHHhhccc-CC-
Confidence 2334689999999999763 6789999999999999999999999753220 011122222221111 01
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 622 (670)
+..++..+.+++.+||+.||++||++ .+|+++
T Consensus 413 ---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 413 ---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 12235678889999999999999975 666653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.98 Aligned_cols=278 Identities=19% Similarity=0.263 Sum_probs=205.6
Q ss_pred HhhccccCCCCHHHHHHHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc--------
Q 005909 332 TYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-------- 402 (670)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------- 402 (670)
.+.......+...++....|.+.++||+|+||+||+|+.. +++.||||+++......+.+.+|+.++++++
T Consensus 20 ~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 20 DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp --CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred cCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCC
Confidence 3333334445555555556677889999999999999875 6889999999876666778999999999996
Q ss_pred ccccccccceee----eCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 005909 403 HVNIIHLLGFCC----DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 478 (670)
Q Consensus 403 H~nIv~l~g~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp 478 (670)
|+||+++++++. +....++||||+ +++|.+.+.... ...+++..++.++.|++.||+|||+++ +|+||||||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp 175 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKP 175 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSG
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCH
Confidence 788999999987 456789999999 666666665432 125899999999999999999999842 899999999
Q ss_pred CcEEECCCC-------------------------------------------------CeEEeecCCccccCCCCceeee
Q 005909 479 QNVLLDPDF-------------------------------------------------TPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 479 ~NIll~~~~-------------------------------------------------~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|||++.++ .+||+|||+++..... .
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~ 250 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----F 250 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----S
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----C
Confidence 999999775 8999999999876533 2
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc-------
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE------- 582 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 582 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........+...+....
T Consensus 251 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~ 326 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAG 326 (397)
T ss_dssp CSCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred ccCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhcc
Confidence 334689999999999764 6788999999999999999999999764321100 00000011111100000
Q ss_pred ------------c---cc-----------ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 ------------K---ED-----------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ------------~---~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .. ............+.+++.+||+.||++|||+.|++++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 00 0001234567789999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.46 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=198.7
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.+.||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 4556789999999999999986 789999999986542 34678899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~~~ 504 (670)
+++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 90 GGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp SCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999999986543 589999999999999999999998 99999999999999 788999999999987654322
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ....|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ..+...+.....
T Consensus 164 ~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~i~~~~~- 224 (304)
T 2jam_A 164 M----STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETE------------SKLFEKIKEGYY- 224 (304)
T ss_dssp T----HHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHCCC-
T ss_pred c----ccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCC-
Confidence 1 12347999999999975 3678899999999999999999999864321 111112111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.........++..+.+++.+||+.||++||++.|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 011111123456788999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.47 Aligned_cols=244 Identities=23% Similarity=0.413 Sum_probs=191.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 45688999999999999986 78999999986532 34568899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..++.++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||++........
T Consensus 94 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 94 SGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred CCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999999997643 489999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....+++.|+|||.+.+. ...+.++||||||+++|||++|+.||..... ..+...+..... ..
T Consensus 167 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~~ 230 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV------------PTLFKKIRGGVF-YI 230 (276)
T ss_dssp ------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-CC
T ss_pred --eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH------------HHHHHHhhcCcc-cC
Confidence 1234579999999999753 2336799999999999999999999864221 111122111111 00
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......+.+++.+||+.||++|||+.|++++
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11224567889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.20 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=184.9
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCe-------eEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-------RALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-------~~lv~ 423 (670)
.+.+.||+|+||+||+|++. +++.||||++.........+.+|+..+..++||||+++++++..... .++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 34578999999999999985 68999999997776666778889999999999999999999875433 78999
Q ss_pred EecCCCCccccccc-ccCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEecCCCCCcEEECC-CCCeEEeecCCccc
Q 005909 424 EYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLH--NGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKA 499 (670)
Q Consensus 424 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~~ 499 (670)
||+++ +|.+.+.. ......+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 99975 55444432 223346899999999999999999999 76 9999999999999996 89999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH-----
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI----- 574 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 574 (670)
....... ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... ...+...+
T Consensus 182 ~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 182 LSPSEPN---VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-------AGQLHEIVRVLGC 250 (360)
T ss_dssp CCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHHHCC
T ss_pred cCCCCCc---ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-------HHHHHHHHHHcCC
Confidence 7644322 334689999999998654 3578999999999999999999999975322 11111111
Q ss_pred -----HHHhcCCcc----c--------cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 -----YDKLIQPEK----E--------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 -----~~~~~~~~~----~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+..... . ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011100000 0 00001111235678999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.61 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=196.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
+.+.+.||+|+||.||+|.+. +|+.||+|++.... ..+.+.+|+.++.+++||||+++++++.+....++||||++++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 445688999999999999986 58999999997654 3577899999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~ 509 (670)
+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 110 ~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~ 182 (314)
T 3com_A 110 SVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--R 182 (314)
T ss_dssp EHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--B
T ss_pred CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--c
Confidence 9999986432 2589999999999999999999998 9999999999999999999999999999876543221 2
Q ss_pred cCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+.. +........ .
T Consensus 183 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~~~~~--~ 246 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAIFM-IPTNPPPTF--R 246 (314)
T ss_dssp CCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHH-HHHSCCCCC--S
T ss_pred CccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHH-HhcCCCccc--C
Confidence 334689999999999753 678899999999999999999999864321 001111 110000000 1
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....++..+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112235578899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.86 Aligned_cols=195 Identities=23% Similarity=0.336 Sum_probs=169.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc------cccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI------HHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.++||+|+||+||+|.+. +++.||||+++......+++.+|+.++..+ +|+||+++++++......++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 456689999999999999876 589999999987666667888898888887 4679999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC--eEEeecCCccccC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKAHS 501 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~--~ki~DfGla~~~~ 501 (670)
||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 179 e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred eccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9995 799998876532 2589999999999999999999998 9999999999999999887 9999999997654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 254 ~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 322 234689999999999764 6789999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.97 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=194.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.+.||+|+||.||++++. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 345678999999999999986 589999999865442 2456789999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 107 ~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 107 DHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp SEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999988765433 589999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC----ccccchHHH--HHH--h
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWI--YDK--L 578 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~--~~~--~ 578 (670)
.....|++.|+|||++.+. ..++.++||||||+++|||++|+.||........... .....+... +.. .
T Consensus 181 --~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 181 --YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred --cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 2334589999999999753 3678899999999999999999999965322000000 000000000 000 0
Q ss_pred cCCc-cc-----cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPE-KE-----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~-~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... .+ .........++..+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 00111112345678999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.61 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=190.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 420 (670)
|.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 345678999999999999985 68999999996533 23467889999999999999999999987653 459
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 999999 88999998653 489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHHHHH
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDK 577 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 577 (670)
... .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||........... .....+......
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 432 2345689999999998753 4678899999999999999999999975432000000 000000000000
Q ss_pred hc-----------CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LI-----------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~-----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+. ...............+..+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0000000111112235678899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.26 Aligned_cols=258 Identities=20% Similarity=0.299 Sum_probs=200.5
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHhccccc-cccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.++||+|+||.||+|++ .+++.||||++..... .+++..|++++..++| ++|..+..++.+.+..++||||+ +
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 34568999999999999997 4689999998765443 3468899999999976 55556666677788899999999 9
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE---CCCCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll---~~~~~~ki~DfGla~~~~~~~~ 505 (670)
++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.......
T Consensus 87 ~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 87 PSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999999975432 599999999999999999999998 99999999999999 6889999999999987654432
Q ss_pred ee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 506 VV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 506 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+.......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~-- 233 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKV-- 233 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SHHHHHHHHHHHHH--
T ss_pred ccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccch----hHHHHHHHHhhccc--
Confidence 11 11245689999999999764 6789999999999999999999999754321 11111111111111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..........++.++.+++.+||+.||++||++.+|++.|+.+
T Consensus 234 ---~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ---ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ---HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ---cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111223456789999999999999999999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.06 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=196.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeee--CCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCD--GSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lv~e~~ 426 (670)
+.+.++||+|+||+||+|++. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||||+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 445689999999999999874 7899999998753 3578899999999997 9999999999987 56789999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~~ 505 (670)
++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 116 ~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 116 NNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred CchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999884 278999999999999999999998 999999999999999776 899999999987654432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC------ccccchHHHHH---
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYD--- 576 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~------~~~~~~~~~~~--- 576 (670)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||........... ....+.+++..
T Consensus 187 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 187 ---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp ---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred ---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2334589999999998653 4678899999999999999999999954322000000 00000000000
Q ss_pred --------HhcCCcc----ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 577 --------KLIQPEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 577 --------~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ..........++..+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 001111122246678999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.99 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=190.9
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCe------eEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------RALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~lv~e 424 (670)
|.+.+.||+|+||+||+|++..+..+|+|++....... .+|+.++++++||||+++++++..... .++|||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 44568999999999999999877779998886544322 369999999999999999999865432 789999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla~~~~~~ 503 (670)
|++++.+.........+..+++..++.++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 997654444333222334699999999999999999999998 999999999999998 7999999999999876544
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC---
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ--- 580 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 580 (670)
... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ...+.. +...+..
T Consensus 196 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~l~~-i~~~~g~p~~ 263 (394)
T 4e7w_A 196 EPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESG-------IDQLVE-IIKVLGTPSR 263 (394)
T ss_dssp CCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH-HHHHHCCCCH
T ss_pred CCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHHHhCCCCH
Confidence 322 234689999999998654 3578899999999999999999999975322 001111 1111000
Q ss_pred ------------Ccccccc-----chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 ------------PEKEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ------------~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+... .......+..+.+++.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000 00111245678999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=333.27 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=181.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.+.||+|+||.||+|.+. +++.||||++.... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 345688999999999999875 68999999987543 345678899999999999999999999999999999999999
Q ss_pred CCCccccccccc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 428 NGSLGDLLSREK-----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 428 ~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999986421 123589999999999999999999998 999999999999999999999999999876643
Q ss_pred CCce---eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc
Q 005909 503 NRSV---VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 503 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (670)
.... .......||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~ 241 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPM-----------KVLMLTLQ 241 (303)
T ss_dssp --------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----------GHHHHHHT
T ss_pred CCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----------hHHHHHhc
Confidence 2211 111234589999999998653 25788999999999999999999999653220 00111111
Q ss_pred CCcc--cc--ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEK--ED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~--~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... .. ........++..+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1000 00 0001111234568889999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.46 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=199.3
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCc----c--------------hHHHHHHHHHhccccccccccccce
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN----F--------------SDNFINEVATIGRIHHVNIIHLLGF 412 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~--------------~~~~~~E~~~l~~l~H~nIv~l~g~ 412 (670)
+.+.+.||+|+||.||+|+. +++.||+|++..... . .+.+.+|+.++.+++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34568899999999999999 999999999865321 1 1789999999999999999999999
Q ss_pred eeeCCeeEEEEEecCCCCcccc------cccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECC
Q 005909 413 CCDGSTRALIYEYMPNGSLGDL------LSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 413 ~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~ 485 (670)
+.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||+|||+ + +|+||||||+||+++.
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 9999999999999999999999 54321 3469999999999999999999998 7 9999999999999999
Q ss_pred CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
++.+||+|||++...... ......|+..|+|||.+.+. ..++. ++||||||+++|||++|+.||......
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 999999999999876543 23445689999999999753 23444 899999999999999999999753220
Q ss_pred CccccchHHHHHHhcCCccccc--------------cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDF--------------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......+........ .......++..+.+++.+||+.||++||++.|++++
T Consensus 259 -------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111122221111000 000112345678899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.89 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=191.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee-------------C
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-------------G 416 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-------------~ 416 (670)
+.+.+.||+|+||+||+|+.. +++.||||++.......+.+.+|+.++++++||||+++++++.+ .
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 445688999999999999985 78999999997766666789999999999999999999998865 3
Q ss_pred CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 417 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 567899999999999999975432 478899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc------------eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 005909 497 AKAHSRNRS------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 564 (670)
Q Consensus 497 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~ 564 (670)
++....... ........|++.|+|||++.+. +.++.++||||||+++|||++ |+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~----- 233 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME----- 233 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh-----
Confidence 987643211 1112334589999999998753 467889999999999999997 4321100
Q ss_pred CccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 565 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+...+.... ...........+..+.+++.+||+.||++|||+.+++++
T Consensus 234 ------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ------RVNILKKLRSVS-IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ------HHHHHHHHHSTT-CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHhccccc-cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 011112221111 111111222334567889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.29 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=193.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeee------CCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD------GSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~lv~ 423 (670)
.+.+.||+|+||.||+|++. +++.||||++.......+.+.+|+.++.++ +||||+++++++.. ....++||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 35688999999999999985 789999999987776778899999999999 89999999999986 46789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp ECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999999976432 2589999999999999999999998 9999999999999999999999999999876432
Q ss_pred CceeeecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
... .....|++.|+|||++... ...++.++||||||+++|||++|+.||..... ...... +..
T Consensus 183 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~-~~~ 248 (326)
T 2x7f_A 183 VGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFL-IPR 248 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHH-HHH
T ss_pred ccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HHHHHH-hhc
Confidence 211 2234589999999998631 24678899999999999999999999864321 001111 111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ...++..+.+++.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111110 11234578889999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=328.66 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=192.7
Q ss_pred HhhhccccccCceEEEEEEeC--CCc--EEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--DGR--LVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+.+.+.||+|+||+||+|++. +++ .||+|+++... ...+.+.+|+.++++++||||+++++++.+.. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 445689999999999999863 333 68999987532 34578999999999999999999999988765 8899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+++++|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999976432 489999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 503 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..... ......++..|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+...+..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~ 239 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILHKIDK 239 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHT
T ss_pred cccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCH------------HHHHHHHHc
Confidence 43322 12234578899999999753 67889999999999999999 9999864321 111122211
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... ......++..+.+++.+||+.||++||++.++++.|+++.
T Consensus 240 ~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 240 EGER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1110 0111224567889999999999999999999999999654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.67 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=199.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----------cchHHHHHHHHHhcccc-ccccccccceeeeCCee
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----------NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 419 (670)
.+.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+++++. ||||+++++++.+....
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34578999999999999986 68999999986543 12356889999999995 99999999999999999
Q ss_pred EEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 420 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 100 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999997543 589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhcccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 500 HSRNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
...... .....|++.|+|||++... ...++.++||||||+++|||++|+.||..... ....
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~ 238 (298)
T 1phk_A 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------MLML 238 (298)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred cCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------------HHHH
Confidence 654332 2334589999999998631 23578899999999999999999999864321 1111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+..... .........++..+.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 239 RMIMSGNY-QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHTCC-CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcCCc-ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111111 11111122345678899999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.70 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=195.3
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.+.||+|+||.||+|++.+ .+|+|++.... ...+.+.+|+.++++++||||+++++++.+....++|+||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3456899999999999999854 48999987543 334567899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc--
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS-- 505 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~-- 505 (670)
+++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++.......
T Consensus 113 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 113 GRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp SEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999997643 2588999999999999999999998 999999999999998 67999999999876532111
Q ss_pred -eeeecCCCCCccccchhhcccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 506 -VVTMTGPRGTIGYIAPEIFMRN-------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 506 -~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
........|++.|+|||++... ...++.++||||||+++|||++|+.||..... ..+...
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~ 254 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------------EAIIWQ 254 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------------HHHHHH
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHH
Confidence 1112334589999999998642 13468899999999999999999999864321 111122
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcccc
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 629 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 629 (670)
+.......... ..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 255 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 MGTGMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHTTCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred hccCCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 22221111111 01234678899999999999999999999999976543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.55 Aligned_cols=264 Identities=21% Similarity=0.315 Sum_probs=182.2
Q ss_pred hccccccCceEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee--CCeeEEEEEecCC
Q 005909 354 KEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPN 428 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e~~~~ 428 (670)
.++||+|+||+||+|++. +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 357999999999999975 57899999997654 34678899999999999999999999954 668899999995
Q ss_pred CCccccccccc------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE----CCCCCeEEeecCCcc
Q 005909 429 GSLGDLLSREK------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAK 498 (670)
Q Consensus 429 gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll----~~~~~~ki~DfGla~ 498 (670)
++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 68887775322 122489999999999999999999998 99999999999999 778999999999998
Q ss_pred ccCCCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC-CCccccchHHHHH
Q 005909 499 AHSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-NTTEAYFPDWIYD 576 (670)
Q Consensus 499 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 576 (670)
........ .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||......... ..........+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 76543211 122345689999999999753 35788999999999999999999999754321100 0000001111111
Q ss_pred HhcCCccccc---------------------cc-hh-------hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEKEDF---------------------VE-EE-------DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~~~~---------------------~~-~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+..+..... .. .. .......+.+++.+||+.||++|||+.|++++-
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1111100000 00 00 000134678899999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.04 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=199.1
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.+.+.++||+|+||+||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 4456689999999999999986 68999999997653 33567899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++++|.+++.... .+++..+..++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 114 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 9999999997653 489999999999999999999973 179999999999999999999999999997553221
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC----------CC--------c--
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----------NT--------T-- 566 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~----------~~--------~-- 566 (670)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||......... .. .
T Consensus 187 --~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1234589999999999763 6788999999999999999999999653220000 00 0
Q ss_pred -----------cccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 567 -----------EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 567 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
....... .+.+....... .....++..+.+++.+||+.||++|||+.|++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFEL-LDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp -----------CCCHHHH-HHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cccccccCCCCcccchhh-hhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0000000 00000000000 01112345788999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.71 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=197.7
Q ss_pred HhhhccccccCceEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeee----CCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e 424 (670)
+.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.. ....++|+|
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 44568999999999999998 478999999986544 345788999999999999999999999873 347789999
Q ss_pred ecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 425 YMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|+++++|.+++.... ....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 999999999997632 234699999999999999999999998 9999999999999999999999999998765321
Q ss_pred Cce-------eeecCCCCCccccchhhccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHH
Q 005909 504 RSV-------VTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 504 ~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
... .......||+.|+|||++.... ..++.++||||||+++|||++|+.||...... .......+.
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~ 261 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDSVALAVQ 261 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------TSCHHHHHH
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------cchhhHHhh
Confidence 100 0011234689999999986431 13578999999999999999999998532110 000111111
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..... ......+..+.+++.+||+.||++||++.+++++|+..
T Consensus 262 ----~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 ----NQLSI----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp ----CC--C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----ccCCC----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 10000 00112345788999999999999999999999999954
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.38 Aligned_cols=251 Identities=10% Similarity=0.017 Sum_probs=177.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccc--ccccccccc-------ceeeeC-
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRI--HHVNIIHLL-------GFCCDG- 416 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~H~nIv~l~-------g~~~~~- 416 (670)
.+.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++..+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 35678999999999999976 789999999987542 345677785444444 699988754 333322
Q ss_pred ----------------CeeEEEEEecCCCCcccccccccCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeEec
Q 005909 417 ----------------STRALIYEYMPNGSLGDLLSREKENLSLKPARL------LEIALGVAHAIEYLHNGCELRILHL 474 (670)
Q Consensus 417 ----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH~ 474 (670)
...++||||++ |+|.+++..... .+.+..+ +.++.|++.||+|||++ +|+||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 33799999998 899999976533 2455555 67889999999999998 99999
Q ss_pred CCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 005909 475 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554 (670)
Q Consensus 475 dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~ 554 (670)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+....++.++|||||||++|||++|+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998764321 133467999999999752236789999999999999999999999
Q ss_pred CCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 555 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
................ ...............++..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSL--------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCCBCCT--------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchhhhhh--------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7643211110000000 0000001111111234567889999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.64 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=197.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeC-----CeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lv 422 (670)
|.+.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+.++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 345689999999999999875 688999999975442 346789999999999999999999998754 367999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
+||+. ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 109 ~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99996 6899888653 489999999999999999999998 999999999999999999999999999987653
Q ss_pred CCcee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
..... ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... . ....+...+..+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~~~~~ 251 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-------D-QLNHILGILGSP 251 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-------G-HHHHHHHHHCSC
T ss_pred CCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-------H-HHHHHHHHhCCC
Confidence 32211 12334689999999987654 35788999999999999999999999654321 0 001111111000
Q ss_pred cc--------------------cc--ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 582 EK--------------------ED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 582 ~~--------------------~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.. .. ............+.+++.+||+.||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 00 00011112345788999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.75 Aligned_cols=258 Identities=23% Similarity=0.262 Sum_probs=187.5
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 421 (670)
.+.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 45688999999999999875 68999999997543 23467889999999999999999999987654 6799
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999996 578777742 488999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC---------CCCC--ccccc
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNT--TEAYF 570 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~---------~~~~--~~~~~ 570 (670)
.... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... +... ....+
T Consensus 179 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 179 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccc---cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 3321 2334689999999999763 67889999999999999999999997543200 0000 00000
Q ss_pred hHHHHHHhcC-Cc-------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 571 PDWIYDKLIQ-PE-------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 571 ~~~~~~~~~~-~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+...... .. ...............+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000000 00 00011122334567899999999999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.35 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=191.7
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhcccc--ccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||.||++.+.+++.||||++.... ...+.+.+|+.++.+++ |+||+++++++.+.+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 44568999999999999999889999999996543 23467899999999997 5999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+++|.+++.... .+++..++.++.|+++||.|||++ +|+||||||+|||+++ +.+||+|||+++.......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 109 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 56899999997643 589999999999999999999998 9999999999999965 8999999999987654433
Q ss_pred eeeecCCCCCccccchhhcccc---------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
........|++.|+|||.+.+. ...++.++||||||+++|||++|+.||..... .......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~~~~~ 251 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLHA 251 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHH
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----------HHHHHHH
Confidence 2222345689999999998641 13578899999999999999999999864221 0011111
Q ss_pred HhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.+........... ....+.+++.+||+.||++||++.|++++-
T Consensus 252 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 252 IIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHhcccccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111111111111 134678899999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.88 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=194.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 345688999999999999986 58999999987544 4567899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
++|.+++..... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 173 (302)
T 2j7t_A 101 GAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--K 173 (302)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C
T ss_pred CcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--c
Confidence 999998865432 589999999999999999999998 999999999999999999999999998754321111 1
Q ss_pred ecCCCCCccccchhhccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 509 MTGPRGTIGYIAPEIFMR---NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~---~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....|++.|+|||++.. ....++.++||||||+++|||++|+.|+..... .... ..+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~-~~~~~~~~~~ 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVL-LKIAKSDPPT 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHH-HHHHHSCCCC
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHH-HHHhccCCcc
Confidence 122458999999999842 124678899999999999999999999864321 0111 1111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. .....++..+.+++.+||+.||++|||+.+++++
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 1112235578899999999999999999998864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.76 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=178.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeC------CeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l 421 (670)
.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 45688999999999999875 68999999997543 2346788999999999999999999998654 45789
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+|++ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 112 VTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred Eeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 99999 78999988652 599999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+...+..+
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~l~~i~~~~g~p 249 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLILRLVGTP 249 (367)
T ss_dssp ------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSC
T ss_pred cc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence 32 2334689999999998753 46788999999999999999999999653320 0001111111100
Q ss_pred c---------------------cc-cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 582 E---------------------KE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 582 ~---------------------~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. .. .............+.+++.+||+.||++|||+.|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 00 000000112245688999999999999999999999763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.54 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=188.3
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCc------------chHHHHHHHHHhccccccccccccceeeeC---
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN------------FSDNFINEVATIGRIHHVNIIHLLGFCCDG--- 416 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--- 416 (670)
.+.+.||+|+||.||+|...+++.||||++..... ..+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (362)
T 3pg1_A 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104 (362)
T ss_dssp EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence 34578999999999999998899999999865321 126799999999999999999999998542
Q ss_pred --CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeec
Q 005909 417 --STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494 (670)
Q Consensus 417 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~Df 494 (670)
...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 105 AMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 35799999996 68888886543 3589999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
|+++....... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... ...+ ..+
T Consensus 179 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~-~~i 246 (362)
T 3pg1_A 179 NLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-------YNQL-NKI 246 (362)
T ss_dssp TC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH-HHH
T ss_pred Ccccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-------HHHH-HHH
Confidence 99976543322 2234579999999998753 4678899999999999999999999975321 0000 001
Q ss_pred HHHhcC-------------------Ccc----ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 575 YDKLIQ-------------------PEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 575 ~~~~~~-------------------~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...... ... ..............+.+++.+||+.||++|||+.|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 110000 000 0000111122345688999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.75 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=194.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeC-----CeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lv~ 423 (670)
.+.+.||+|+||+||+|++. +|+.||||++.... .....+.+|+.++++++||||+++++++... ...++|+
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 35688999999999999986 68999999997544 2346788999999999999999999987754 5789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+. ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 94 ELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 9996 6898888653 589999999999999999999998 9999999999999999999999999999876532
Q ss_pred Ccee--------eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC-------------C
Q 005909 504 RSVV--------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-------------G 562 (670)
Q Consensus 504 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~-------------~ 562 (670)
.... ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||....... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 2111 12234689999999988643 467889999999999999999999997543100 0
Q ss_pred CCCccccchHHHHHHhcC-Ccc-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 563 SNTTEAYFPDWIYDKLIQ-PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.............+.... ... ..........++..+.+++.+||+.||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000000000000000 000 0000111123456788999999999999999999998753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.14 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=189.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC------CeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lv~ 423 (670)
|.+.+.||+|+||.||+|++. +++.||||++..... .+.+|++++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 345678999999999999986 689999999876442 234799999999999999999988542 1357899
Q ss_pred EecCCCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-CCeEEeecCCccccC
Q 005909 424 EYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHS 501 (670)
Q Consensus 424 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-~~~ki~DfGla~~~~ 501 (670)
||+++ +|.+++... .....+++..++.++.|+++||+|||++ +|+||||||+||||+.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99964 666655432 2234699999999999999999999998 99999999999999955 678999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC-
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ- 580 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 580 (670)
..... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ...+... ...+..
T Consensus 209 ~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-------~~~l~~i-~~~lg~p 276 (420)
T 1j1b_A 209 RGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-------VDQLVEI-IKVLGTP 276 (420)
T ss_dssp TTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH-HHHHCSC
T ss_pred cCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH-HHHhCCC
Confidence 43322 234689999999998653 3678899999999999999999999975322 0111111 111000
Q ss_pred ---------C-----ccccccch-----hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 581 ---------P-----EKEDFVEE-----EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 581 ---------~-----~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. ..+..... .....+..+.+++.+||+.||++||++.|++++-
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0 00000000 0112356788999999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.35 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=182.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcc---hHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF---SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.+.++||+|+||+||++++. +++.||+|++...... .+.+.++...++.++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 345689999999999999984 7899999999765422 233445555688889999999999999999999999999
Q ss_pred CCCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 427 PNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 427 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+ |+|.+++... .....+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 6 6888877542 1234699999999999999999999974 2899999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhccc--ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMR--NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
. ....||+.|+|||++.. ....++.++||||||+++|||++|+.||..... . ...+.........
T Consensus 166 ~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~~~~ 232 (290)
T 3fme_A 166 K---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---------P-FQQLKQVVEEPSP 232 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---------H-HHHHHHHHHSCCC
T ss_pred c---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---------h-HHHHHHHhccCCC
Confidence 2 22358999999999732 124678899999999999999999999864211 0 0111111111111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. .....+..+.+++.+||+.||++|||+.|++++
T Consensus 233 -~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 -QL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -Cc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11 112235578899999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.83 Aligned_cols=261 Identities=19% Similarity=0.313 Sum_probs=200.0
Q ss_pred HHhhhccccccCceEEEEEEe-C-CCcEEEEEEcccCCcchHHHHHHHHHhccccccc------cccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF-P-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN------IIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~l 421 (670)
.+.+.+.||+|+||+||++.+ . +++.||||+++......+.+.+|+.++.+++|+| ++++++++.+.+..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 345678999999999999987 3 6889999999876666678999999999998765 9999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC----------------
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---------------- 485 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---------------- 485 (670)
||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99999 8999999876432 3588999999999999999999998 9999999999999987
Q ss_pred ---CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005909 486 ---DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562 (670)
Q Consensus 486 ---~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~ 562 (670)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6789999999998754332 234589999999999753 678999999999999999999999965322000
Q ss_pred CCC---ccccchHHHHHHhcCCcc------------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCC
Q 005909 563 SNT---TEAYFPDWIYDKLIQPEK------------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615 (670)
Q Consensus 563 ~~~---~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 615 (670)
... ....++............ ..............+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 000 000001111111000000 00000112234677899999999999999999
Q ss_pred HHHHHHH
Q 005909 616 MTRVVEM 622 (670)
Q Consensus 616 ~~evl~~ 622 (670)
+.|++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=335.78 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=191.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC-------------
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------------- 416 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------------- 416 (670)
+.+.+.||+|+||+||+|++. +++.||||++...... ..+|+.++++++||||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 445689999999999999874 7899999998765432 23799999999999999999998543
Q ss_pred -------------------------CeeEEEEEecCCCCcccccccc-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 005909 417 -------------------------STRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELR 470 (670)
Q Consensus 417 -------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 470 (670)
...++||||++ ++|.+.+... .....+++..+..++.|+++||+|||++ +
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence 34789999997 6888777642 2233699999999999999999999988 9
Q ss_pred eEecCCCCCcEEEC-CCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh
Q 005909 471 ILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549 (670)
Q Consensus 471 ivH~dlkp~NIll~-~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt 549 (670)
|+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||++.+. ..++.++||||||+++|||++
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHH
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHh
Confidence 99999999999997 6889999999999876544322 234579999999998754 357889999999999999999
Q ss_pred CCCCCCCCCCCCCCCCccccchHHHHHHhcCC---------------cccc-----ccchhhHHHHHHHHHHHHhccccC
Q 005909 550 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP---------------EKED-----FVEEEDDCIARKMIIVGLWCIQIN 609 (670)
Q Consensus 550 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-----~~~~~~~~~~~~l~~l~~~cl~~d 609 (670)
|+.||..... ...+.. +...+..+ ..+. .........+..+.+++.+||+.|
T Consensus 238 g~~pf~~~~~-------~~~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 238 GKPLFSGETS-------IDQLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp SSCSSCCSSH-------HHHHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred CCCCCCCCCh-------HHHHHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999975322 011111 11111000 0000 000111224556889999999999
Q ss_pred CCCCCCHHHHHHH
Q 005909 610 PKDRPSMTRVVEM 622 (670)
Q Consensus 610 P~~RPs~~evl~~ 622 (670)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.64 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=199.8
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
..+.+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 34566789999999999999986 68999999986532 356789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC---CCeEEeecCCccccC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHS 501 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~---~~~ki~DfGla~~~~ 501 (670)
|+++++|.+.+.... .+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++....
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999886543 589999999999999999999998 99999999999999764 479999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
..... ....+++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ..+...+...
T Consensus 176 ~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~ 237 (287)
T 2wei_A 176 QNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE------------YDILKRVETG 237 (287)
T ss_dssp CCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHC
T ss_pred CCCcc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcC
Confidence 43321 22347889999999864 578899999999999999999999864321 1111121111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ........++..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 238 KYA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCC-CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCC-CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 110 1111112345678899999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.49 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=194.6
Q ss_pred HhhhccccccCceEEEEEEe--CCCcEEEEEEcccCC---cchHHHHHHHHHhccc---cccccccccceee-----eCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKF--PDGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCC-----DGS 417 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~~ 417 (670)
|.+.+.||+|+||+||+|++ .+++.||+|++.... .....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34568999999999999998 368899999986533 2234667788777766 8999999999987 456
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++|+||++ |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred eEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 7899999996 799999876432 2589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+...
T Consensus 168 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~ 234 (326)
T 1blx_A 168 RIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGKILDV 234 (326)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHH
T ss_pred ccccCCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHH
Confidence 87653321 2335689999999999763 678899999999999999999999975322 0001111111
Q ss_pred hcCCc------------------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPE------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+.... ...........++..+.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000 0001111122345678899999999999999999999965
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.60 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=187.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceee--------------e
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCC--------------D 415 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--------------~ 415 (670)
.+.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 45688999999999999986 48999999987654 34578899999999999999999998873 3
Q ss_pred CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeec
Q 005909 416 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDF 494 (670)
Q Consensus 416 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~Df 494 (670)
....++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++.+||+||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 467899999996 6999988642 589999999999999999999998 999999999999997 5679999999
Q ss_pred CCccccCCCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC--------C
Q 005909 495 GLAKAHSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN--------T 565 (670)
Q Consensus 495 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~--------~ 565 (670)
|+++........ .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.......... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876432211 112234578999999998653 467889999999999999999999997533200000 0
Q ss_pred cc-------ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 566 TE-------AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 566 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ...+..+........ .........++..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPH--KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCC--CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcCcccccccccCCC--CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 000000000000000 00001112345678999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.37 Aligned_cols=197 Identities=24% Similarity=0.312 Sum_probs=167.2
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-cc-----ccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HV-----NIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~~~lv~ 423 (670)
+.+.+.||+|+||+||+|++. +++.||||+++......+++..|+.++..++ |+ +|+++++++...+..++||
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 445688999999999999876 6889999999876655677888999888885 44 4999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC--CCCCeEEeecCCccccC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~--~~~~~ki~DfGla~~~~ 501 (670)
||++ ++|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++...
T Consensus 136 e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp ECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred ecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 9995 699999876532 2589999999999999999999963 34899999999999994 57889999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 557 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~ 557 (670)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 213 ~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 332 234689999999999764 6789999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=355.30 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=198.7
Q ss_pred HHHhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
..+.+.+.||+|+||+||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 344566889999999999998742 4679999987643 23478999999999999999999999985 4568999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 469 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 99999999999997543 2589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.... ......+++.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 544 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------------~~~~~~i~~~ 608 (656)
T 2j0j_A 544 STYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENG 608 (656)
T ss_dssp -----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHHT
T ss_pred Ccce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHcC
Confidence 3322 12234567899999999753 78899999999999999997 8888864321 1111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..... ...++..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 609 ~~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 ERLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 1123457889999999999999999999999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.00 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=189.8
Q ss_pred HHHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHhccc----cccccccccceeee
Q 005909 348 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRI----HHVNIIHLLGFCCD 415 (670)
Q Consensus 348 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~H~nIv~l~g~~~~ 415 (670)
...|.+.+.||+|+||.||+|++. +++.||||++..... ....+.+|+.++.++ +|+||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 344566789999999999999875 688999999975432 223456799999888 89999999999999
Q ss_pred CCeeEEEEEe-cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEee
Q 005909 416 GSTRALIYEY-MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSD 493 (670)
Q Consensus 416 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~D 493 (670)
.+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++.+||+|
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999 78999999997643 589999999999999999999998 999999999999998 889999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 573 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 573 (670)
||+++...... .....|+..|+|||++.+. ...+.++||||||+++|||++|+.||.....
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------- 244 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE-------------- 244 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------
Confidence 99998765432 2334589999999998753 2334589999999999999999999853211
Q ss_pred HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
+..... . . ...+...+.+++.+||+.||++||++.|++++-
T Consensus 245 ~~~~~~--~---~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 245 ILEAEL--H---F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HHHTCC--C---C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred Hhhhcc--C---C----cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111100 0 0 112345678899999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.93 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=190.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCee------EE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR------AL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~------~l 421 (670)
.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 34578999999999999875 68999999997643 2346788999999999999999999999877654 99
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+. ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 125 v~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 999996 688777732 389999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH-------
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI------- 574 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 574 (670)
.. .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... ..+...+
T Consensus 196 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 196 AE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------DQLTQILKVTGVPG 262 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCC
T ss_pred cC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCc
Confidence 32 2345689999999998753 36788999999999999999999999753210 0000000
Q ss_pred ---------------HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 575 ---------------YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 575 ---------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
...+.... ...........+..+.+++.+||+.||++|||+.|++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhhhhhhhhhhhccCCCc-chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000000 0000111122356788999999999999999999998763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.96 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=185.7
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+....++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998776678999999998653 345678999999987 89999999999999999999999995 7999
Q ss_pred cccccccCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC-------------CCeEEeecC
Q 005909 433 DLLSREKENL----SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-------------FTPKVSDFG 495 (670)
Q Consensus 433 ~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~-------------~~~ki~DfG 495 (670)
+++....... ..++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 9997643211 113334578999999999999998 99999999999999654 489999999
Q ss_pred CccccCCCCcee--eecCCCCCccccchhhcccc-----cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCcc
Q 005909 496 LAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 567 (670)
Q Consensus 496 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 567 (670)
+++......... ......||+.|+|||++.+. ...++.++|||||||++|||++ |+.||..... .
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~- 246 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------R- 246 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT------H-
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh------h-
Confidence 998776543221 12345689999999999651 1467889999999999999999 8989854211 0
Q ss_pred ccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... +...... ...........++..+.+++.+||+.||++|||+.||+++
T Consensus 247 --~~~-i~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 --ESN-IIRGIFS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp --HHH-HHHTCCC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHH-HhcCCCC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 011 1111111 1111112234567789999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.58 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=190.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCe------eEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------RAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~l 421 (670)
.+.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++..... .++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 34578999999999999985 68999999997643 234678899999999999999999999987654 499
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+. ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 107 v~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred Eecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 999996 688887743 389999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc--
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI-- 579 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 579 (670)
.. .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||...... ..+. .+.....
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~-~i~~~~~~~ 243 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-------DQLT-QILKVTGVP 243 (353)
T ss_dssp -----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-------HHHH-HHHHHHCBC
T ss_pred CC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHHHhCCC
Confidence 32 2234589999999998753 36788999999999999999999999653210 0000 0000000
Q ss_pred --------------------CCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 --------------------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 --------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...............+..+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000111112345678899999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.17 Aligned_cols=261 Identities=17% Similarity=0.259 Sum_probs=196.6
Q ss_pred HHhhhccccccCceEEEEEEeC-C-CcEEEEEEcccCCcchHHHHHHHHHhccccccc------cccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN------IIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~l 421 (670)
.+.+.+.||+|+||+||++... + ++.||+|+++......+.+.+|+.++++++|++ ++.+++++......++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 3456689999999999999875 3 478999999876666778899999999998876 8899999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE------------------
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL------------------ 483 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll------------------ 483 (670)
||||+ +++|.+.+..... ..+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence 99999 6777777755432 2589999999999999999999998 99999999999999
Q ss_pred -CCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005909 484 -DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562 (670)
Q Consensus 484 -~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~ 562 (670)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||........
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567899999999998654332 234689999999999753 678899999999999999999999975322000
Q ss_pred CC---CccccchHHHHHHhcCCcc------------------------ccccchhhHHHHHHHHHHHHhccccCCCCCCC
Q 005909 563 SN---TTEAYFPDWIYDKLIQPEK------------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615 (670)
Q Consensus 563 ~~---~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 615 (670)
.. ......+............ ..............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 00 0000001111110000000 00000111233567889999999999999999
Q ss_pred HHHHHHH
Q 005909 616 MTRVVEM 622 (670)
Q Consensus 616 ~~evl~~ 622 (670)
+.|++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.59 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=197.2
Q ss_pred HHHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-----------ccccccccceeeeC
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----------HVNIIHLLGFCCDG 416 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~ 416 (670)
..+.+.+.||+|+||+||+|++. +++.||||++.......+.+.+|+.++.+++ |+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 34556789999999999999974 7899999999876656678899999999886 89999999998765
Q ss_pred C----eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC------CC
Q 005909 417 S----TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD------PD 486 (670)
Q Consensus 417 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~------~~ 486 (670)
+ ..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ .+|+||||||+|||++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCc
Confidence 4 678999999 8999999976432 2589999999999999999999984 2899999999999994 44
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 566 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~ 566 (670)
+.+||+|||+++..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.......... .
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~ 246 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-D 246 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------C-H
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-h
Confidence 58999999999876532 2234589999999999764 67899999999999999999999997543211000 0
Q ss_pred cccchHHHHHHhcCC-----------------c-------cc---------cccchhhHHHHHHHHHHHHhccccCCCCC
Q 005909 567 EAYFPDWIYDKLIQP-----------------E-------KE---------DFVEEEDDCIARKMIIVGLWCIQINPKDR 613 (670)
Q Consensus 567 ~~~~~~~~~~~~~~~-----------------~-------~~---------~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 613 (670)
...+. .+...+... . .. ..........+..+.+++.+||+.||++|
T Consensus 247 ~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIA-QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHH-HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHH-HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 00000 011100000 0 00 00011234567889999999999999999
Q ss_pred CCHHHHHHHH
Q 005909 614 PSMTRVVEML 623 (670)
Q Consensus 614 Ps~~evl~~L 623 (670)
||+.|++++-
T Consensus 326 pt~~ell~hp 335 (373)
T 1q8y_A 326 ADAGGLVNHP 335 (373)
T ss_dssp BCHHHHHTCG
T ss_pred CCHHHHhhCh
Confidence 9999998753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=325.71 Aligned_cols=239 Identities=26% Similarity=0.352 Sum_probs=194.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHhcccc--ccccccccceeeeCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~ 420 (670)
+.+.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 445689999999999999874 689999999875431 2245778999999996 599999999999999999
Q ss_pred EEEEecCC-CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeecCCcc
Q 005909 421 LIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAK 498 (670)
Q Consensus 421 lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla~ 498 (670)
+|+|++.+ ++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+|||++ +++.+||+|||+++
T Consensus 125 lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999976 89999987643 589999999999999999999998 999999999999998 78999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
...... .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..... ......
T Consensus 199 ~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~~ 260 (320)
T 3a99_A 199 LLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV 260 (320)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCC
T ss_pred cccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhcccc
Confidence 765432 2234589999999998754 2346789999999999999999999853211 000000
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
. .. ..++..+.+++.+||+.||++||++.||+++-
T Consensus 261 ~---~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 261 F---FR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp C---CS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred c---cc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 00 11245678899999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.42 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=168.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeee----CCeeEEEEEecCCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYEYMPNG 429 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~e~~~~g 429 (670)
+.||+|+||+||+|++. +++.||||++.......+ +....+..++||||+++++++.. +...++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 46999999999999986 689999999876432222 22234556689999999999876 44578999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCce
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~~ 506 (670)
+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 112 ~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-- 185 (336)
T 3fhr_A 112 ELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185 (336)
T ss_dssp EHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence 99999976532 3699999999999999999999998 9999999999999976 4569999999998665332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
.....||+.|+|||++.. ..++.++||||||+++|||++|+.||........ .......+.... ...
T Consensus 186 --~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~-~~~ 252 (336)
T 3fhr_A 186 --LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--------SPGMKRRIRLGQ-YGF 252 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CC
T ss_pred --cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--------hhhHHHhhhccc-ccc
Confidence 123457999999999865 3678899999999999999999999965432110 000001111100 011
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
.......++..+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 1111123456788999999999999999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=330.98 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=183.5
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
...+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||+. |+
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 34578999999997665556899999999865432 3356899999999 79999999999999999999999995 69
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-----CCCeEEeecCCccccCCCCc
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-----~~~~ki~DfGla~~~~~~~~ 505 (670)
|.+++..... ...+..++.++.|++.||+|||++ +|+||||||+|||++. ...+||+|||+++.......
T Consensus 104 L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 104 LQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999976543 244455678999999999999998 9999999999999943 34688999999987654322
Q ss_pred e-eeecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 506 V-VTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 506 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
. .......||+.|+|||++.+. ....+.++|||||||++|||++ |+.||..... ...........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------------~~~~~~~~~~~ 246 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------------RQANILLGACS 246 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------------HHHHHHTTCCC
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------------HHHHHHhccCC
Confidence 1 223445699999999999642 2456789999999999999999 8888843211 11111111111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... .........+.+++.+||+.||++|||+.||+++
T Consensus 247 ~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 LDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 1112334567889999999999999999999954
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.29 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=175.3
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHH-HhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
+.+.||+|+||.||+|.+. +++.||||++..... ...++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~- 104 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS- 104 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-
Confidence 4578999999999999985 689999999976542 3345666666 7778899999999999999999999999996
Q ss_pred CCcccccccc--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSRE--KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++|.+++... .....+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 181 (327)
T 3aln_A 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181 (327)
T ss_dssp EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc-
Confidence 5887777531 1133689999999999999999999984 3899999999999999999999999999987654322
Q ss_pred eeecCCCCCccccchhhccc--ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMR--NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~--~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.....||+.|+|||++.. ....++.++||||||+++|||++|+.||........ . ...+......
T Consensus 182 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~-~~~~~~~~~~ 248 (327)
T 3aln_A 182 --KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----------Q-LTQVVKGDPP 248 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSCCC
T ss_pred --cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----------H-HHHHhcCCCC
Confidence 122358999999999842 113578899999999999999999999965321000 0 0011111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.........++..+.+++.+||+.||++||++.+++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111112235578899999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.67 Aligned_cols=231 Identities=15% Similarity=0.131 Sum_probs=181.4
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.|.+.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+..+.+++||||+++++++.+.+..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 4556789999999999999986 489999999986543 23789999999999999999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++.+. ....++.+++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred ecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999998542 35567889999999999999998 99999999999999999999997443
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
|++ ..+.++||||||+++|||++|+.||............... .... .
T Consensus 175 -------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~-~ 222 (286)
T 3uqc_A 175 -------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD---------TAGQ-P 222 (286)
T ss_dssp -------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC---------TTSC-B
T ss_pred -------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH---------hccC-C
Confidence 333 3567999999999999999999999764331100000000 0000 0
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccccc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 630 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 630 (670)
.........++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00011112345678899999999999999 9999999999765443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=313.97 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=174.7
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcc--h-HHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF--S-DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.+.||+|+||.||+|++. +++.||||++...... . +.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34578999999999999986 6899999999765432 2 23444455778889999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
++.+..+..... ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 107 GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 455555443322 258999999999999999999997 4 899999999999999999999999999976654322
Q ss_pred eeecCCCCCccccchhhccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 507 VTMTGPRGTIGYIAPEIFMR---NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.....|++.|+|||++.. ....++.++||||||+++|||++|+.||..... .......+.....
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----------DFEVLTKVLQEEP 247 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----------HHHHHHHHHHSCC
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----------cHHHHHHHhccCC
Confidence 123458999999999853 124678899999999999999999999864221 0111111111111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ....++..+.+++.+||+.||++||++.+++++
T Consensus 248 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1110 011234568889999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.52 Aligned_cols=235 Identities=21% Similarity=0.290 Sum_probs=188.3
Q ss_pred HhhhccccccCceEEEEEEeC--CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCe-----eEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-----RAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~~l 421 (670)
+.+.+.||+|+||+||++.+. +++.||||++.... ...+.+.+|+.++.+++||||+++++++.+.+. .++
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 345688999999999999985 58999999987543 334678999999999999999999999987655 699
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++.. .+++..++.++.|+++||.|||++ +|+||||||+|||++.+ .+||+|||+++...
T Consensus 162 v~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 9999999999987754 489999999999999999999998 99999999999999986 99999999998765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. ....||+.|+|||++.+ ..+.++||||||+++|||++|..|+....... .+
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~---------- 285 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LP---------- 285 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CC----------
T ss_pred cC------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc--------cc----------
Confidence 43 23458999999999875 34889999999999999999988775421100 00
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhhc
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 626 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 626 (670)
...........+.+++.+||+.||++|| +++++...|...
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011122345788899999999999999 566666666543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=342.79 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=194.6
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeee------CCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~ 420 (670)
.+.+.++||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.++.+++||||+++++++.. ++..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 3556789999999999999885 68999999987643 335678999999999999999999998765 66789
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC---eEEeecCCc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLA 497 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~---~ki~DfGla 497 (670)
+||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 9999999999999998765545689999999999999999999998 9999999999999987665 999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC--CCcc-----ccc
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--NTTE-----AYF 570 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~--~~~~-----~~~ 570 (670)
+....... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+....... .... ...
T Consensus 172 ~~~~~~~~---~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 172 KELDQGEL---CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CBTTSCCC---CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccc---cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 87654432 233568999999999975 37788999999999999999999999653110000 0000 000
Q ss_pred hHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 005909 571 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618 (670)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 618 (670)
.......................++..+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000000001111122345678899999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.05 Aligned_cols=226 Identities=19% Similarity=0.265 Sum_probs=175.4
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHh-ccccccccccccceeee----CCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATI-GRIHHVNIIHLLGFCCD----GSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~lv~e~~~~ 428 (670)
+.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 67999999999999985 689999999864 34677888888 55589999999999876 6678999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~ 505 (670)
++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 100 ~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--- 172 (299)
T 3m2w_A 100 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--- 172 (299)
T ss_dssp CBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---
T ss_pred CcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc---
Confidence 999999976432 3589999999999999999999998 9999999999999998 78999999999864321
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
..++.++||||||+++|||++|+.||.............. .+... ...
T Consensus 173 -----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------~~~~~-~~~ 220 (299)
T 3m2w_A 173 -----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------RIRMG-QYE 220 (299)
T ss_dssp -----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------SSCTT-CCS
T ss_pred -----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------HHhhc-ccc
Confidence 2456789999999999999999999965432110000000 00000 001
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
........++..+.+++.+||+.||++|||+.|++++-
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11111123466788999999999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=305.35 Aligned_cols=240 Identities=15% Similarity=0.133 Sum_probs=183.1
Q ss_pred HHHhhhccccccCceEEEEEEeCCCcEEEEEEcccCC---------cchHHHHHHHHHhcccc-----------------
Q 005909 349 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---------NFSDNFINEVATIGRIH----------------- 402 (670)
Q Consensus 349 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~----------------- 402 (670)
..+.+.++||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.++++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4466779999999999999998 78999999997543 22378899999998886
Q ss_pred ---------ccccccccceeee-------------CCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHH
Q 005909 403 ---------HVNIIHLLGFCCD-------------GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460 (670)
Q Consensus 403 ---------H~nIv~l~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 460 (670)
||||+++++++.+ ....++||||+++|++.+.+.+ ..+++..++.++.|++.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 5555555655554 6789999999999977776643 2589999999999999999
Q ss_pred HHHH-cCCCCCeEecCCCCCcEEECCCC--------------------CeEEeecCCccccCCCCceeeecCCCCCcccc
Q 005909 461 EYLH-NGCELRILHLDIKPQNVLLDPDF--------------------TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519 (670)
Q Consensus 461 ~yLH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~ 519 (670)
+||| ++ +|+||||||+|||++.++ .+||+|||+++...... ..||+.|+
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~-------~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI-------VVFCDVSM 244 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE-------EECCCCTT
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc-------EEEeeccc
Confidence 9999 87 999999999999999887 89999999998765431 24899999
Q ss_pred chhhcccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhc-CCc-cccccchhhHHHHH
Q 005909 520 APEIFMRNLGNPSGKSDVYSYGML-LLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI-QPE-KEDFVEEEDDCIAR 596 (670)
Q Consensus 520 aPE~~~~~~~~~s~~sDV~SlGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~ 596 (670)
|||++.+. .+.++||||+|++ .+++++|..||... .+.....+.+. ... ...........++.
T Consensus 245 aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 245 DEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp CSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred ChhhhcCC---CccceehhhhhCCCCcccccccCCCcch-----------hhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence 99999754 3789999998776 77788888776310 00011111221 111 11122334556788
Q ss_pred HHHHHHHhccccCCCCCCCHHHHH-HH
Q 005909 597 KMIIVGLWCIQINPKDRPSMTRVV-EM 622 (670)
Q Consensus 597 ~l~~l~~~cl~~dP~~RPs~~evl-~~ 622 (670)
.+.+++.+||+.| |+.|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 9999999999977 999988 53
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=314.24 Aligned_cols=237 Identities=16% Similarity=0.137 Sum_probs=174.1
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccc-cccccccce---------------
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHH-VNIIHLLGF--------------- 412 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H-~nIv~l~g~--------------- 412 (670)
.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++..++| +|......+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 468999999999999964 68999999987433 235789999999999977 322211111
Q ss_pred ------eee-----CCeeEEEEEecCCCCcccccccc----cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 005909 413 ------CCD-----GSTRALIYEYMPNGSLGDLLSRE----KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 477 (670)
Q Consensus 413 ------~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk 477 (670)
... ....+++|+++ +++|.+++... .....+++..++.++.|+++||+|||++ +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 111 12345666655 78999988421 1122578889999999999999999998 99999999
Q ss_pred CCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccc--------cCCCCccchhHHHHHHHHHHHh
Q 005909 478 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN--------LGNPSGKSDVYSYGMLLLEMIE 549 (670)
Q Consensus 478 p~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~~sDV~SlGvvl~ellt 549 (670)
|+||||+.++.+||+|||+++..... .....| +.|+|||++... ...++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999998765432 234557 999999999421 1246789999999999999999
Q ss_pred CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 550 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 550 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
|+.||........ . ..+.... ..++..+.+++.+||+.||++||++.++++
T Consensus 313 g~~Pf~~~~~~~~--------~----~~~~~~~---------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG--------S----EWIFRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC--------S----GGGGSSC---------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh--------H----HHHHhhc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999975432110 0 0111100 012356888999999999999999877754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-30 Score=285.35 Aligned_cols=184 Identities=16% Similarity=0.136 Sum_probs=129.6
Q ss_pred cccccCceEEEEEEe-CCCcEEEEEEcccCC-----------cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEE
Q 005909 356 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-----------NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv 422 (670)
..+.|+.|.+..++. --|+.+++|++.... ...++|.+|+++|+++ +|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356666666655432 358889999996542 2235799999999999 799999999999999999999
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||++|++|.++|.+.+ .+++. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997653 46654 4889999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCC
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 553 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p 553 (670)
.... .....||+.|+|||++.+ ....++|+||+|+++++|.++..+
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCcc--ccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 3321 233568999999999975 456789999999998888665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-26 Score=252.04 Aligned_cols=184 Identities=18% Similarity=0.229 Sum_probs=144.8
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCc---------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEE
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
.+.||+|+||+||+++. .++.+++|+...... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999955 577888887643221 13458999999999999999987777778888899999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++++|.+++.. ++.++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999965 468999999999999998 9999999999999998 99999999999875432
Q ss_pred cee-----eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 005909 505 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554 (670)
Q Consensus 505 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~ 554 (670)
... ......||+.|+|||++......++...|+|+..+-.++.+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 01234589999999999763335677889999999999888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=205.14 Aligned_cols=140 Identities=16% Similarity=0.091 Sum_probs=116.0
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCCc-------------------chHHHHHHHHHhccccccccccccceee
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------FSDNFINEVATIGRIHHVNIIHLLGFCC 414 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 414 (670)
.+.||+|+||.||+|.+.+|+.||+|+++.... ....+.+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999997799999999964321 2456899999999999 5 77777654
Q ss_pred eCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeec
Q 005909 415 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 494 (670)
Q Consensus 415 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~Df 494 (670)
. +..++||||+++++|.+ +.. .....++.|++.||.|||++ +|+||||||+|||++ ++.+||+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred c-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 4 56699999999999998 522 12346999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhccc
Q 005909 495 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526 (670)
Q Consensus 495 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 526 (670)
|+++. +..++|||++.+
T Consensus 237 G~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE---------------TTSTTHHHHHHH
T ss_pred CCCeE---------------CCCCCHHHHHHH
Confidence 99853 345789998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-19 Score=178.53 Aligned_cols=133 Identities=20% Similarity=0.224 Sum_probs=102.7
Q ss_pred hhccccccCceEEEEEEe-CCCcE--EEEEEcccCCcc-------------------------hHHHHHHHHHhcccccc
Q 005909 353 FKEKLGTGGYGNVYKGKF-PDGRL--VAVKVLEKTSNF-------------------------SDNFINEVATIGRIHHV 404 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~H~ 404 (670)
+.+.||+|+||.||+|.+ .+|+. ||||+++..... ...+.+|+..+.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999998 68888 999997543211 13688999999999988
Q ss_pred cc--ccccceeeeCCeeEEEEEecCC-C----CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCC
Q 005909 405 NI--IHLLGFCCDGSTRALIYEYMPN-G----SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDI 476 (670)
Q Consensus 405 nI--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dl 476 (670)
++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 64 333322 356899999942 5 44443321 224456789999999999999 87 9999999
Q ss_pred CCCcEEECCCCCeEEeecCCcccc
Q 005909 477 KPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 477 kp~NIll~~~~~~ki~DfGla~~~ 500 (670)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=166.88 Aligned_cols=137 Identities=12% Similarity=0.106 Sum_probs=97.6
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---------------cchHHHHHHHHHhccccccccccccceee--
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---------------NFSDNFINEVATIGRIHHVNIIHLLGFCC-- 414 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-- 414 (670)
.+.++||+|++|.||+|...+|+.||||+++... ........+.++.....|+|+.+++....
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3557899999999999999999999999975421 01122333333333344555555443221
Q ss_pred ----eCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC---
Q 005909 415 ----DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF--- 487 (670)
Q Consensus 415 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~--- 487 (670)
.....+|||||+++++|.++... + ....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 178 p~p~~~~~~~LVME~i~G~~L~~l~~~-------~--~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 178 PEPIAQSRHTIVMSLVDALPMRQVSSV-------P--DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCEEEEETTEEEEECCSCEEGGGCCCC-------S--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred CeeeeccCceEEEEecCCccHhhhccc-------H--HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence 11234699999999888766431 1 2346789999999999998 999999999999998876
Q ss_pred -------CeEEeecCCcccc
Q 005909 488 -------TPKVSDFGLAKAH 500 (670)
Q Consensus 488 -------~~ki~DfGla~~~ 500 (670)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=3e-11 Score=121.28 Aligned_cols=135 Identities=14% Similarity=0.066 Sum_probs=106.0
Q ss_pred hccccccCceEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 354 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. |..+.++++++.+.+..++||||+++.+|
T Consensus 19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 456788888999999864 6889999987532 22346889999999884 67788999999888899999999999998
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------------------------------------------- 467 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 467 (670)
.+.+.. ......++.+++++|+.||+..
T Consensus 98 ~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 98 SEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 776421 1123468889999999999810
Q ss_pred ------------CCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 468 ------------ELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 468 ------------~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
...++|+|+++.||+++++..+.|+||+.+
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 135899999999999987666789999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.8e-10 Score=115.08 Aligned_cols=130 Identities=18% Similarity=0.145 Sum_probs=98.6
Q ss_pred ccc-ccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc--cccccceeeeCCeeEEEEEecCCCCcc
Q 005909 356 KLG-TGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 356 ~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 55569999998877888999997654 2356788999999986544 456888888777889999999998884
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--------------------------------------------- 467 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 467 (670)
... ... ..++.++++.|..||+..
T Consensus 104 --~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 121 357788888888888742
Q ss_pred ----------CCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 468 ----------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 468 ----------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
...++|+|++|.||++++++.++|+|||.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999887677899999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=115.37 Aligned_cols=139 Identities=19% Similarity=0.243 Sum_probs=105.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcc--cCC--cchHHHHHHHHHhcccc--ccccccccceeeeC---CeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLE--KTS--NFSDNFINEVATIGRIH--HVNIIHLLGFCCDG---STRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lv~e~ 425 (670)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568999999999998754 577888776 332 22456788999999986 45688888888766 357899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------------------------------------- 467 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 467 (670)
+++..+.+... ..+++.....++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99888755221 13678888999999999999999731
Q ss_pred -----------------CCCeEecCCCCCcEEECCCCC--eEEeecCCccc
Q 005909 468 -----------------ELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKA 499 (670)
Q Consensus 468 -----------------~~~ivH~dlkp~NIll~~~~~--~ki~DfGla~~ 499 (670)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2.4e-09 Score=109.90 Aligned_cols=186 Identities=19% Similarity=0.189 Sum_probs=121.7
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccc--cccccceeeeCC---eeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVN--IIHLLGFCCDGS---TRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lv~e~~~~ 428 (670)
+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..++|||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999863 45788875533 34567889999998883 332 334444433333 34789999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC----------------------------------------- 467 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 467 (670)
.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 888754321 3677888889999999999999611
Q ss_pred --------------CCCeEecCCCCCcEEECC--CCCeEEeecCCccccCCCCceeeecCC---CC---------Ccccc
Q 005909 468 --------------ELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSVVTMTGP---RG---------TIGYI 519 (670)
Q Consensus 468 --------------~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~~~~~~~---~g---------t~~y~ 519 (670)
...++|+|+++.||++++ +..+.|+||+.+............... .+ ..+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 135899999999999988 566899999988654321110000000 00 00111
Q ss_pred c-hhhcccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 005909 520 A-PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 554 (670)
Q Consensus 520 a-PE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~ 554 (670)
. |+...+ .....+.|++|.++|++.+|+.++
T Consensus 256 ~~~~~~~r----~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEK----YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHH----HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHH----HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2 232211 112368999999999999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.3e-06 Score=87.56 Aligned_cols=135 Identities=19% Similarity=0.150 Sum_probs=94.3
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccc---ccccccceee-eCCeeEEEEEecCCCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV---NIIHLLGFCC-DGSTRALIYEYMPNGS 430 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lv~e~~~~gs 430 (670)
+.++.|....||+. ++.+++|+-.. ......+.+|..+|..+.+. .|.+.+.+.. ..+..++||||+++.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899988 56678887432 23456788999999999642 3555666654 3456789999999988
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG-------------------------------------------- 466 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 466 (670)
|.+.... .++......++.++++.|+.||+.
T Consensus 100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 8663211 245555566666666666666643
Q ss_pred -------------CCCCeEecCCCCCcEEECC---CCC-eEEeecCCccc
Q 005909 467 -------------CELRILHLDIKPQNVLLDP---DFT-PKVSDFGLAKA 499 (670)
Q Consensus 467 -------------~~~~ivH~dlkp~NIll~~---~~~-~ki~DfGla~~ 499 (670)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 355 58999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2e-06 Score=86.15 Aligned_cols=134 Identities=15% Similarity=0.155 Sum_probs=96.6
Q ss_pred cccccCce-EEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 356 KLGTGGYG-NVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 356 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--|.++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34555554 69988765 4667889975533 3457888999988884 444777888898899999999999988876
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--------------------------------------------- 467 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 467 (670)
+..... ......+..++++.|+-||+..
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 654321 1223456667777777777421
Q ss_pred ----------CCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 468 ----------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 468 ----------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0127999999999999988778899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=5e-06 Score=86.95 Aligned_cols=80 Identities=11% Similarity=0.044 Sum_probs=57.1
Q ss_pred ccc-cccCceEEEEEEeC-------CCcEEEEEEcccCC---c-chHHHHHHHHHhcccc-c--cccccccceeeeC---
Q 005909 355 EKL-GTGGYGNVYKGKFP-------DGRLVAVKVLEKTS---N-FSDNFINEVATIGRIH-H--VNIIHLLGFCCDG--- 416 (670)
Q Consensus 355 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~--- 416 (670)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 26778889865432 1 1356788999988884 3 3567788777655
Q ss_pred CeeEEEEEecCCCCcccc
Q 005909 417 STRALIYEYMPNGSLGDL 434 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~ 434 (670)
+..++||||+++.++.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999998877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=3e-05 Score=80.25 Aligned_cols=139 Identities=13% Similarity=0.108 Sum_probs=80.4
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc--cccccccc------eeeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLG------FCCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g------~~~~~~~~~lv~e~~ 426 (670)
+.|+.|..+.||+....+|+ +++|+.... ..++..|+.++..+.. -.+.+++. +....+..+++++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 34666778999999876554 888988753 2344456666665532 12334443 223456788999999
Q ss_pred CCCCccc--------------ccccccCCC-----------CCCHHHH-------------------------------H
Q 005909 427 PNGSLGD--------------LLSREKENL-----------SLKPARL-------------------------------L 450 (670)
Q Consensus 427 ~~gsL~~--------------~l~~~~~~~-----------~l~~~~~-------------------------------~ 450 (670)
++.++.. .+|...... ...|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9876531 112111000 0122211 1
Q ss_pred HHHHHHHHHHHHHHc----------CCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 451 EIALGVAHAIEYLHN----------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 451 ~i~~~ia~gL~yLH~----------~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 111224445666763 02358999999999999988889999999965
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=5.5e-05 Score=80.23 Aligned_cols=73 Identities=14% Similarity=0.089 Sum_probs=49.0
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCC--------cchHHHHHHHHHhccccc--cc-cccccceeeeCCeeEEE
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--------NFSDNFINEVATIGRIHH--VN-IIHLLGFCCDGSTRALI 422 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~H--~n-Iv~l~g~~~~~~~~~lv 422 (670)
+.||.|..+.||++... +++.++||...... ...+.+..|.+++..+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57999999999999764 46889999764321 123566789988887742 33 3445543 44556899
Q ss_pred EEecCCC
Q 005909 423 YEYMPNG 429 (670)
Q Consensus 423 ~e~~~~g 429 (670)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=73.43 Aligned_cols=137 Identities=18% Similarity=0.179 Sum_probs=91.2
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccc---ccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4689999999999986 5677888986643 3567889999998884 35688888888877889999999998765
Q ss_pred cc-----------ccccccC--C-----------------CCCCHHHHH---HHH----------------HHHHHH-HH
Q 005909 432 GD-----------LLSREKE--N-----------------LSLKPARLL---EIA----------------LGVAHA-IE 461 (670)
Q Consensus 432 ~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~----------------~~ia~g-L~ 461 (670)
.. .||+... . -.-+|.... ++. ..+.+- ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 31 1222111 0 012344321 111 111111 22
Q ss_pred HHHc-CCCCCeEecCCCCCcEEECCCCCeEEeecC
Q 005909 462 YLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFG 495 (670)
Q Consensus 462 yLH~-~~~~~ivH~dlkp~NIll~~~~~~ki~DfG 495 (670)
.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2246899999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00043 Score=69.76 Aligned_cols=73 Identities=18% Similarity=0.306 Sum_probs=53.1
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHhcccccc---ccccccceeeeCCeeEEEEEecCCCC
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHV---NIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+|.|..+.||+.+..+|+.+++|+..... .....|..|+..|+.|... -+.+.+++ +..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 5689999999999999999999999876543 3345678899988887421 23444433 23478999998765
Q ss_pred c
Q 005909 431 L 431 (670)
Q Consensus 431 L 431 (670)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00043 Score=73.91 Aligned_cols=81 Identities=11% Similarity=0.089 Sum_probs=47.9
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccC-CCCccchhHHHHHHHHHH
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG-NPSGKSDVYSYGMLLLEM 547 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDV~SlGvvl~el 547 (670)
..++|+|+++.|||++.++ ++|+||+.+..-........... .-...|.+|+......+ ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998876 99999998865332110000000 00134566665431100 112235566788888888
Q ss_pred HhCC
Q 005909 548 IEEK 551 (670)
Q Consensus 548 ltg~ 551 (670)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00079 Score=71.98 Aligned_cols=73 Identities=14% Similarity=0.280 Sum_probs=50.5
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~ 425 (670)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 578899987432 222566789999998854444 456665432 289999
Q ss_pred cCCCCcc
Q 005909 426 MPNGSLG 432 (670)
Q Consensus 426 ~~~gsL~ 432 (670)
+++.+|.
T Consensus 154 l~G~~l~ 160 (429)
T 1nw1_A 154 IPSRPLS 160 (429)
T ss_dssp CCEEECC
T ss_pred eCCcccC
Confidence 9865553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00077 Score=68.34 Aligned_cols=71 Identities=14% Similarity=0.146 Sum_probs=44.6
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEec-CCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYM-PNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~-~~gsL~ 432 (670)
+.|+.|....+|+. +.+++|+........-+..+|+..++.+....+ .+++++ +.+..++++||+ ++.+|.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 67888999999998 557888876533222233568888877753333 344443 344457899999 665553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0025 Score=65.24 Aligned_cols=141 Identities=14% Similarity=0.120 Sum_probs=83.1
Q ss_pred cccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccc--ccccccce-----eeeCCeeEEEEEecCC
Q 005909 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF-----CCDGSTRALIYEYMPN 428 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~-----~~~~~~~~lv~e~~~~ 428 (670)
.++ |....||+....+|+.+++|+..........+..|..++..+... .+.+++.. ....+..+++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 466 778899998877787899999875433456777788888877422 24444443 1224456789999987
Q ss_pred CCccc----c----------cccccC------CCCCCHHHH----HHH---------------HHHHHHHHHHHHcC---
Q 005909 429 GSLGD----L----------LSREKE------NLSLKPARL----LEI---------------ALGVAHAIEYLHNG--- 466 (670)
Q Consensus 429 gsL~~----~----------l~~~~~------~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~--- 466 (670)
.++.. . +|.... ...+++... ..+ ...+.+.++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 65431 0 111000 011222211 000 11111223333221
Q ss_pred -CCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 467 -CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 467 -~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987644
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00093 Score=69.93 Aligned_cols=140 Identities=15% Similarity=0.181 Sum_probs=83.1
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHhccccccc-cccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lv~e~ 425 (670)
+.|..|....+|+....+ ++.+++|+..........+.+|..+++.+.-.. ..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 457778888899988752 478999986443334567779999998885323 3456655543 289999
Q ss_pred cCCCCcccc-----------------ccccc---CCCCC-CHHHHHHHHHHHHH-------------------HHHHHH-
Q 005909 426 MPNGSLGDL-----------------LSREK---ENLSL-KPARLLEIALGVAH-------------------AIEYLH- 464 (670)
Q Consensus 426 ~~~gsL~~~-----------------l~~~~---~~~~l-~~~~~~~i~~~ia~-------------------gL~yLH- 464 (670)
+++.+|..- ||... .+... -+.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998666421 11110 11111 23445555444322 233332
Q ss_pred ---cC-CCCCeEecCCCCCcEEECCC----CCeEEeecCCcc
Q 005909 465 ---NG-CELRILHLDIKPQNVLLDPD----FTPKVSDFGLAK 498 (670)
Q Consensus 465 ---~~-~~~~ivH~dlkp~NIll~~~----~~~ki~DfGla~ 498 (670)
.. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23468999999999999876 789999999774
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=67.67 Aligned_cols=141 Identities=14% Similarity=0.109 Sum_probs=79.5
Q ss_pred ccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccc--cccccce------eeeCCeeEEEEEec
Q 005909 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGF------CCDGSTRALIYEYM 426 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lv~e~~ 426 (670)
+.|+.|....+|+....++ .+++|+..... ..+.+..|+.++..+.... +.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3567788899999987666 57788876531 2345567777777774222 3333321 12345678999999
Q ss_pred CCCCcccc--------------cccccCCC------CC---CHHHHHH------------HHHHHHHHHHHHHcC----C
Q 005909 427 PNGSLGDL--------------LSREKENL------SL---KPARLLE------------IALGVAHAIEYLHNG----C 467 (670)
Q Consensus 427 ~~gsL~~~--------------l~~~~~~~------~l---~~~~~~~------------i~~~ia~gL~yLH~~----~ 467 (670)
++..+... +|...... .. .|..... +...+.+.+++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 88665321 11110000 01 1221110 011244455566532 1
Q ss_pred CCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 468 ~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
...++|+|+++.|||++++..+.|+||+.+
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 347999999999999988766689999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0019 Score=69.41 Aligned_cols=74 Identities=16% Similarity=0.052 Sum_probs=47.8
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEecCCCCcc
Q 005909 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.|+.|....+|+....+ +..+++|+........-+..+|..++..+...++ .++++.+. + .+|+||+++.+|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l~ 189 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYALS 189 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccCC
Confidence 457888889999998865 5788899875432221122588888888864444 45666652 2 2599999876553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0013 Score=68.81 Aligned_cols=73 Identities=16% Similarity=0.190 Sum_probs=45.3
Q ss_pred ccccccCceEEEEEEeCC---------CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEE
Q 005909 355 EKLGTGGYGNVYKGKFPD---------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e 424 (670)
+.|+.|....+|+....+ ++.+++|+.........+...|..++..+...++ .++++.. . .++|+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457788889999998754 2688899876533222234678888888853343 3555443 2 368999
Q ss_pred ecCCCCc
Q 005909 425 YMPNGSL 431 (670)
Q Consensus 425 ~~~~gsL 431 (670)
|+++.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0043 Score=63.69 Aligned_cols=142 Identities=15% Similarity=0.149 Sum_probs=72.3
Q ss_pred ccccccCceE-EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc--cccccccceeeeCCeeEEEEEecCCCCc
Q 005909 355 EKLGTGGYGN-VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 355 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
+.|+.|+... +|+....+++.+++|...... ..++..|+.++..+.. -.+.+++.+..+. .+++||++.+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 3465555544 667766446777777654432 1334456676666642 2345566553332 3789999876555
Q ss_pred ccccccc---------------------cCC--CCCCHHHHH-------HH-------------HHHHHHHHHHHH---c
Q 005909 432 GDLLSRE---------------------KEN--LSLKPARLL-------EI-------------ALGVAHAIEYLH---N 465 (670)
Q Consensus 432 ~~~l~~~---------------------~~~--~~l~~~~~~-------~i-------------~~~ia~gL~yLH---~ 465 (670)
.+.+... ... ..++..... .+ ...+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4332110 000 012221110 00 011122222331 1
Q ss_pred CCCCCeEecCCCCCcEEECCC----CCeEEeecCCcccc
Q 005909 466 GCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKAH 500 (670)
Q Consensus 466 ~~~~~ivH~dlkp~NIll~~~----~~~ki~DfGla~~~ 500 (670)
.....++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 68999999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.004 Score=58.76 Aligned_cols=99 Identities=9% Similarity=0.077 Sum_probs=65.3
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
-||.++|..... ++++++++.++.|.+++|.-+-.+.. + ..+=+.|..|+|..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 478888876543 79999999999999999887732111 1 1333467899999999988763 1110
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 549 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt 549 (670)
.....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 0123466888763 245678899999999999984
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0098 Score=61.26 Aligned_cols=68 Identities=12% Similarity=0.087 Sum_probs=44.1
Q ss_pred cccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc---cccccccce------eeeCCeeEEEEEecCC
Q 005909 358 GTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH---VNIIHLLGF------CCDGSTRALIYEYMPN 428 (670)
Q Consensus 358 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~------~~~~~~~~lv~e~~~~ 428 (670)
|.|....||+....+| .+++|+...... ..|+..+..|.. ++|.+.+.. ....+..+++|+|+++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999988777 889998765442 355555555531 224444432 2345677899999998
Q ss_pred CCc
Q 005909 429 GSL 431 (670)
Q Consensus 429 gsL 431 (670)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.028 Score=59.52 Aligned_cols=140 Identities=13% Similarity=0.149 Sum_probs=83.9
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~ 425 (670)
+.+..|-...+|+....+ ++.+++|+........-+..+|..+++.+...++ .++++.+ . .++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 457778889999998763 5788999875433222234578888888853333 4455432 2 3689999
Q ss_pred cCCCCcccc-c----------------cccc----------CCCCCCHHHHHHHHHHH-------------------HHH
Q 005909 426 MPNGSLGDL-L----------------SREK----------ENLSLKPARLLEIALGV-------------------AHA 459 (670)
Q Consensus 426 ~~~gsL~~~-l----------------~~~~----------~~~~l~~~~~~~i~~~i-------------------a~g 459 (670)
+++.+|..- + |... .+.+.-+.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 998765321 0 1100 11111234433333222 222
Q ss_pred HHHHHc---------------------CCCCCeEecCCCCCcEEECCCCCeEEeecCCccc
Q 005909 460 IEYLHN---------------------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 499 (670)
Q Consensus 460 L~yLH~---------------------~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~ 499 (670)
+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11246899999999999 7788999999998753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.26 E-value=0.16 Score=34.39 Aligned_cols=25 Identities=20% Similarity=0.409 Sum_probs=11.4
Q ss_pred eEeehhhhHHHHHHHHHHHHHHHhc
Q 005909 280 LIIGATAGSCCMVLVAVALLVFRKR 304 (670)
Q Consensus 280 iii~~~~~~~~~~l~~~~~~~~r~r 304 (670)
++.+++.|+++++++++.++++.||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 3344444455544444444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.85 E-value=0.1 Score=35.19 Aligned_cols=28 Identities=32% Similarity=0.413 Sum_probs=14.2
Q ss_pred CcceEeehhhhHHHHHHHHHHHHHHHhc
Q 005909 277 RLPLIIGATAGSCCMVLVAVALLVFRKR 304 (670)
Q Consensus 277 ~~~iii~~~~~~~~~~l~~~~~~~~r~r 304 (670)
..+.++++++|+++++++.+.+++|.||
T Consensus 10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RR 37 (44)
T 2jwa_A 10 PLTSIISAVVGILLVVVLGVVFGILIKR 37 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHHHHHHhheeh
Confidence 3444566666655555444444444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.97 E-value=0.23 Score=52.21 Aligned_cols=29 Identities=24% Similarity=0.291 Sum_probs=24.6
Q ss_pred eEecCCCCCcEEE------CCCCCeEEeecCCccc
Q 005909 471 ILHLDIKPQNVLL------DPDFTPKVSDFGLAKA 499 (670)
Q Consensus 471 ivH~dlkp~NIll------~~~~~~ki~DfGla~~ 499 (670)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.53 E-value=0.2 Score=33.78 Aligned_cols=25 Identities=24% Similarity=0.539 Sum_probs=10.9
Q ss_pred eEeehhhhHHHHHHHHHHHHHHHhc
Q 005909 280 LIIGATAGSCCMVLVAVALLVFRKR 304 (670)
Q Consensus 280 iii~~~~~~~~~~l~~~~~~~~r~r 304 (670)
++.+++.|+++++++.+.++++.||
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RR 36 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRR 36 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhh
Confidence 3334444444444444444444333
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.48 E-value=0.2 Score=53.78 Aligned_cols=60 Identities=8% Similarity=0.043 Sum_probs=18.6
Q ss_pred hhccccccCceEEEEEEeCC-CcEEEE------EEcccCC---cchHHHHHHHHHhccccccccccccceeee
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-GRLVAV------KVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD 415 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 415 (670)
+.++|| ||.||+|.+.. ..+||| |..+... +....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 446777 99999999864 467888 6655422 234568889999999999999999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 670 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-68
Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 23/275 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 409
+++G+G +G VYKGK+ VAVK+L T+ F NEV + + HVNI+
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G+ A++ ++ SL L + + +L++IA A ++YLH
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS-- 124
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I+H D+K N+ L D T K+ DFGLA SR G+I ++APE+
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 530 NP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
NP S +SDVY++G++L E++ + P + D I + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ---LPYSNINN--------RDQIIFMVGRGYLSPDLS 232
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + M + C++ +RP +++ +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 8e-66
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 23/271 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
E+LG G +G V+ G + VAVK L++ S D F+ E + ++ H ++ L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+I EYM NGSL D L + + L +LL++A +A + ++ E +
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D++ N+L+ + K++DFGLA+ N G + I + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--GTFT 188
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSDV+S+G+LL E++ + +P ++IQ + + D
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVRPD 233
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
++ + C + P+DRP+ + +L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-63
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
F ++LGTG +G V GK+ VA+K++++ S D FI E + + H ++ L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C +I EYM NG L + L + +LLE+ V A+EYL + + L
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+ +N L++ KVSDFGL++ + + + G + + + PE+ M S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFS 179
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSD++++G+L+ E+ + G E + + + Q +
Sbjct: 180 SKSDIWAFGVLMWEIY-----------SLGKMPYERFTNSETAEHIAQGLRLYR----PH 224
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ K+ + C +RP+ ++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-62
Identities = 62/272 (22%), Positives = 127/272 (46%), Gaps = 23/272 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
F +++G+G +G V+ G + + VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
C + + L++E+M +G L D L ++ + LL + L V + YL C ++
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D+ +N L+ + KVSDFG+ + ++ + G + + + +PE+F S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF--SRYS 180
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSDV+S+G+L+ E+ + G E + + + +
Sbjct: 181 SKSDVWSFGVLMWEVF-----------SEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+ + C + P+DRP+ +R++ L+
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-61
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 26/302 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+E +G G +G V++GK+ G VAVK+ S E+ + H NI+ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 413 CCDG----STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC- 467
+ L+ +Y +GSL D L+R + ++++AL A + +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 468 ----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SRNRSVVTMTGPRGTIGYIAP 521
+ I H D+K +N+L+ + T ++D GLA H + + + GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 522 EIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDW 573
E+ ++ ++D+Y+ G++ E+ E ++ +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 574 IYDKLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS-ASAEAI 631
Q + + C R M + C N R + R+ + LS + E I
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
Query: 632 EM 633
+M
Sbjct: 302 KM 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-60
Identities = 64/285 (22%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
+ ++ EYM GSL + + L+ +L+++A +A + Y+ + +
Sbjct: 81 VSEEP-IYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H D++ N+L+ + KV+DFGLA+ N G + I + APE + G +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--GRFT 192
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
KSDV+S+G+LL E+ T G + D++ + + E +
Sbjct: 193 IKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKP 637
+ + C + P++RP+ + L + E +P
Sbjct: 242 SLHD----LMCQCWRKEPEERPTFEYLQAFLEDYFT-STEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 1e-59
Identities = 70/303 (23%), Positives = 130/303 (42%), Gaps = 42/303 (13%)
Query: 341 YSYNDIKKMTNGF-----------KEKLGTGGYGNVYKGKFP----DGRLVAVKVLEK-- 383
+++ D + F ++ +G G +G V G VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 384 TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS 443
T +F++E + +G+ H N+IHL G + +I E+M NGSL L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
+ +L+ + G+A ++YL + +H D+ +N+L++ + KVSDFGL++ +
Sbjct: 127 VI--QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 504 RSVVTMT---GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 560
S T T G + I + APE + SDV+SYG+++ E++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGER------- 232
Query: 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620
+ D +I ++D+ + + L C Q + RP ++V
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 621 EML 623
L
Sbjct: 285 NTL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-59
Identities = 75/272 (27%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 412
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 413 CCDGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ ++ EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +NVL+ D KVSDFGL K S T + + + APE
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE--KKF 177
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591
S KSDV+S+G+LL E+ + P + ++ + K D +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRVEKGYKMDAPDGCP 226
Query: 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ V C ++ RPS ++ E L
Sbjct: 227 PAVYE----VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 5e-59
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
+H D+ +N L+ + KV+DFGL++ + + G + I + APE
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAY--NKF 193
Query: 532 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591
S KSDV+++G+LL E+ + +P ++ + ++D+ E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGM---------------SPYPGIDLSQVYELLEKDYRMERP 238
Query: 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ K+ + C Q NP DRPS + + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 60/276 (21%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 356 KLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHLL 410
+LG G +G+V +G + VA+KVL++ + +D + E + ++ + I+ L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
G C L+ E G L L ++E + + + E+ V+ ++YL
Sbjct: 76 G-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KN 129
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+H D+ +NVLL K+SDFGL+KA + + + + + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--R 187
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S +SDV+SYG+ + E + + G + + + Q ++ + E
Sbjct: 188 KFSSRSDVWSYGVTMWEAL-----------SYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
++ + C +DRP V + + +
Sbjct: 237 ----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 3e-57
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 49/300 (16%)
Query: 353 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHV 404
+ +G G +G V++ + P +VAVK+L E +++ +F E A + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS--------------------- 443
NI+ LLG C G L++EYM G L + L +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L A L IA VA + YL E + +H D+ +N L+ + K++DFGL++
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 563
I ++ PE N + +SDV++YG++L E+
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 247
Query: 564 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+ + + E ++ + C P DRPS + +L
Sbjct: 248 -------HEEVIYYVRDGNILACPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-57
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 356 KLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHL 409
+LG+G +G V KG + + VAVK+L+ +N D + E + ++ + I+ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
+G C S L+ E G L L + + +K ++E+ V+ ++YL
Sbjct: 74 IGICEAES-WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
+H D+ +NVLL K+SDFGL+KA + T + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-- 184
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
S KSDV+S+G+L+ E + G + L + E+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAF-----------SYGQKPYRGMKGSEVTAMLEKGERMGC-- 231
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
R+M + C + ++RP V L +
Sbjct: 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 9e-57
Identities = 74/301 (24%), Positives = 131/301 (43%), Gaps = 43/301 (14%)
Query: 353 FKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 403
F + LG G +G V + VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---------------EKENLSLKPAR 448
+NI++LLG C G +I EY G L + L R E + L+L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
LL + VA + +L +H D+ +N+LL K+ DFGLA+ + + V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568
R + ++APE + +SDV+SYG+ L E+ + GS+
Sbjct: 204 KGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELF-----------SLGSSPYPG 250
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628
D + K+I KE F + +M + C +P RP+ ++V+++ +
Sbjct: 251 MPVDSKFYKMI---KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 629 E 629
E
Sbjct: 308 E 308
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 61/314 (19%), Positives = 120/314 (38%), Gaps = 43/314 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHL 409
+LG G G V+K P G ++A K++ + I E+ + + I+
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G ++ E+M GSL +L + + L ++++ V + YL +
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KH 124
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
+I+H D+KP N+L++ K+ DFG++ + + GT Y++PE
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQG--T 178
Query: 530 NPSGKSDVYSYGMLLLEMI---------------------------EEKKHLRPTETTSG 562
+ S +SD++S G+ L+EM E R
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
S ++ P I++ L E + + + C+ NP +R + +++
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 623 --LSSASAEAIEMP 634
+ + AE ++
Sbjct: 299 AFIKRSDAEEVDFA 312
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (485), Expect = 5e-56
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 33/273 (12%)
Query: 355 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHVNIIHL 409
++G G +G VY + + +VA+K + + S+ + I EV + ++ H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G T L+ EY + L +K L+ + + G + YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM-RNL 528
++H D+K N+LL K+ DFG A + S V GT ++APE+ + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
G GK DV+S G+ +E+ E P F L + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAE---RKPP------------LFNMNAMSALYHIAQNESPA 233
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ + C+Q P+DRP+ +++
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-56
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 24/272 (8%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHL 409
+ LG G YG V VAVK+++ + +N E+ ++H N++
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G +G+ + L EY G L D + + ++ + + + YLH +
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH---GI 122
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
I H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
+ DV+S G++L M+ + + + + DW K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ + + NP R ++ + +
Sbjct: 236 PLALLHK--------ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-56
Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 353 FKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 403
F + LG+G +G V VAVK+L++ ++ S+ ++E+ + ++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-------------------- 443
NI++LLG C LI+EY G L + L ++E S
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 444 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503
L LL A VA +E+L +H D+ +NVL+ K+ DFGLA+ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 563
+ V R + ++APE G + KSDV+SYG+LL E+ + P
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 271
Query: 564 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
D + KLIQ F ++ ++ I+ C + + RPS + L
Sbjct: 272 -------VDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 624 SS 625
Sbjct: 322 GC 323
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 76/283 (26%), Positives = 113/283 (39%), Gaps = 31/283 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEK----TSNFSDNFINEVATIGRIHHV 404
EKLG G +G V +G++ VAVK L+ D+FI EV + + H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N+I L G + ++ E P GSL D L + + + L L A+ VA + YL
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE 128
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEI 523
R +H D+ +N+LL K+ DFGL +A +N M R + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
S SD + +G+ L EM T G I K+ K
Sbjct: 186 LKT--RTFSHASDTWMFGVTLWEMF-----------TYGQEPWIGLNGSQILHKID---K 229
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
E + + + V + C P+DRP+ + + L A
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-55
Identities = 64/278 (23%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
F ++G G + VYKG + VA L+ T + F E + + H NI+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 409 LLGFCCDGSTR----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
L+ E M +G+L L R K +K L + +++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 129
Query: 465 NGCELRILHLDIKPQNVLL-DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
I+H D+K N+ + P + K+ D GLA + GT ++APE+
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM 184
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
+ DVY++GM +LEM TS +E IY ++ K
Sbjct: 185 YE---EKYDESVDVYAFGMCMLEMA-----------TSEYPYSECQNAAQIYRRVTSGVK 230
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
++ +++I CI+ N +R S+ ++
Sbjct: 231 PASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-54
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 408
+GTG YG K + DG+++ K L+ T ++EV + + H NI+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 409 LLGFCCDGSTRAL--IYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLH- 464
D + L + EY G L ++++ KE L +L + + A++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 465 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 523
+ +LH D+KP NV LD K+ DFGLA+ + + S GT Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQ 185
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
R + + KSD++S G LL E+ + A+ + K+ + +
Sbjct: 186 MNR--MSYNEKSDIWSLGCLLYELC------------ALMPPFTAFSQKELAGKIREGKF 231
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
D ++I + + RPS+ ++E
Sbjct: 232 RRIPYRYSDE-LNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI 406
F E +G G +G VY G D AVK L + ++ F+ E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 407 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C ++ YM +G L + + E N ++K L+ L VA +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKG---MKF 145
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEI 523
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
+ KSDV+S+G+LL E++ P NT + +L+QPE
Sbjct: 206 LQT--QKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGRRLLQPEY 258
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ V L C + RPS + +V +S+
Sbjct: 259 ----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-54
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFPDG-----RLVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 405
++ +G G +G VYKG VA+K L+ T +F+ E +G+ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
II L G +I EYM NG+L L + S +L+ + G+A ++YL N
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIAAGMKYLAN 128
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
+ SDV+S+G+++ E++ T G + + +
Sbjct: 186 SY--RKFTSASDVWSFGIVMWEVM-----------TYGERPYWELSNHEVMKAINDGFRL 232
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ + + + C Q RP +V +L
Sbjct: 233 PTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 36/275 (13%)
Query: 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNII 407
LG G +GNVY + ++A+KVL K + EV + H NI+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
L G+ D + LI EY P G++ L + R +A+A+ Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH--- 123
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
R++H DIKP+N+LL K++DFG + +R T GT+ Y+ PE+
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG- 178
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF-PDWIYDKLIQPEKEDF 586
K D++S G+L E + K P E + T + ++ + + D
Sbjct: 179 -RMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ ++ NP RP + V+E
Sbjct: 235 IS---------------RLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-53
Identities = 60/289 (20%), Positives = 121/289 (41%), Gaps = 31/289 (10%)
Query: 343 YNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEV 395
Y + + N +LG G +G VYK + + L A KV++ S ++++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 455
+ H NI+ LL + ++ E+ G++ ++ + L+ +++ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQ 118
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
A+ YLH + +I+H D+K N+L D K++DFG++ ++R GT
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGT 173
Query: 516 IGYIAPEIFMRNLGNPSG---KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 572
++APE+ M K+DV+S G+ L+EM P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA------------EIEPPHHELNPM 221
Query: 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ K+ + E + K + C++ N R + +++++
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFL--KKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 47/302 (15%)
Query: 342 SYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVA 396
+NDIK F++ +G G +G V K + A+K +++ ++ D +F E+
Sbjct: 8 DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 397 TIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-------------EKENL 442
+ ++ HH NII+LLG C L EY P+G+L D L +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 443 SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502
+L +LL A VA ++YL + + +H D+ +N+L+ ++ K++DFGL++
Sbjct: 123 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 562
V T R + ++A E + SDV+SYG+LL E++ + G
Sbjct: 180 Y---VKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIV-----------SLG 223
Query: 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
+Y+KL Q + + DD ++ + C + P +RPS +++
Sbjct: 224 GTPYCGMTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVS 279
Query: 623 LS 624
L+
Sbjct: 280 LN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-52
Identities = 65/319 (20%), Positives = 130/319 (40%), Gaps = 35/319 (10%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 405
+ LG+G +G VYKG + P+G V + V K + + ++E + + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 406 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ LLG C + + LI + MP G L D + K+N+ + LL + +A + YL +
Sbjct: 73 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLED 129
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
R++H D+ +NVL+ K++DFGLAK G + I ++A E +
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 526 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585
+ +SDV+SYG+ + E++ + ++ ++
Sbjct: 187 H--RIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKG 229
Query: 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE-----AIEMPPKPLFP 640
+ + ++ + C I+ RP ++ S + + I+ + P
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 641 SPPQLQTQNEIISFDSITS 659
SP ++ + +
Sbjct: 290 SPTDSNFYRALMDEEDMDD 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-51
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 30/279 (10%)
Query: 353 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI 406
+G G +G+V++G + VA+K + ++ + F+ E T+ + H +I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
+ L+G + +I E G L + SL A L+ A ++ A+ YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
R +H DI +NVL+ + K+ DFGL++ + G + I ++APE
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINF 183
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586
+ SDV+ +G+ + E++ G + + + ++ E+
Sbjct: 184 --RRFTSASDVWMFGVCMWEIL-----------MHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ M C +P RP T + LS+
Sbjct: 231 PPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 59/286 (20%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 404
+LG G +G VY+G K VA+K + + ++ + F+NE + + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-------LKPARLLEIALGVA 457
+++ LLG G +I E M G L L + ++ ++++++A +A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 458 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
+ YL + +H D+ +N ++ DFT K+ DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577
+++PE G + SDV+S+G++L E+ T + + +
Sbjct: 201 WMSPESLKD--GVFTTYSDVWSFGVVLWEIA-----------TLAEQPYQGLSNEQVLRF 247
Query: 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623
+++ D + D + + C Q NPK RPS ++ +
Sbjct: 248 VMEGGLLDKPDNCPD----MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-50
Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 42/296 (14%)
Query: 353 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 403
+ LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 404 VNIIHLLGFCC-DGSTRALIYEYMPNGSLGDLLSREKENLS-------------LKPARL 449
+N+++LLG C G +I E+ G+L L ++ L L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 450 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509
+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ ++ V
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 569
R + ++APE + +SDV+S+G+LL E+ P
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------- 242
Query: 570 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625
+ +L + + D +M L C P RP+ + +VE L +
Sbjct: 243 -DEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 27/269 (10%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGF 412
EK+G G G VY G+ VA++ + + INE+ + + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 413 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 472
G ++ EY+ GSL D+++ + ++ + A+E+LH +++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH---SNQVI 138
Query: 473 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 532
H DIK N+LL D + K++DFG + +S + GT ++APE+ R
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR--KAYG 194
Query: 533 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 592
K D++S G++ +EMIE + N A + E D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 593 CIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ R C+ ++ + R S +++
Sbjct: 249 FLNR--------CLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 44/296 (14%)
Query: 353 FKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSNFSD--NFINEVATIGRI- 401
+ LG G +G V + VAVK+L+ + D + I+E+ + I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 402 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK-------------ENLSLKPAR 448
H NII+LLG C +I EY G+L + L + L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 449 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508
L+ A VA +EYL + +H D+ +NVL+ D K++DFGLA+
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 568
T R + ++APE + +SDV+S+G+LL E+
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGS--------------- 236
Query: 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624
+P ++L + KE ++ ++ ++ C P RP+ ++VE L
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 1e-46
Identities = 60/306 (19%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLL 410
E+LGTG +G V++ G A K + + + E+ T+ + H +++L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D + +IYE+M G L + ++ E +S A E V + ++H E
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMH---ENN 144
Query: 471 ILHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
+HLD+KP+N++ + K+ DFGL +SV TG + APE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKP 201
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
+D++S G+L ++ G N E + ++ + +
Sbjct: 202 VGY--YTDMWSVGVLSYILLSGLSPFG------GENDDETL-------RNVKSCDWNMDD 246
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM----LSSASAEAIEMPPKPLFPSPPQ 644
I+ + +P R ++ + +E +A ++P
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 645 LQTQNE 650
++T+ +
Sbjct: 307 IKTKYD 312
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 36/272 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNII 407
F + LG G + V + R A+K+LEK +N E + R+ H +
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
L D Y NG L + + S + A+EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH--- 125
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
I+H D+KP+N+LL+ D +++DFG AK S GT Y++PE+
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 184
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---KE 584
+ SD+++ G ++ +++ +G A I+ K+I+ E E
Sbjct: 185 -KSACKSSDLWALGCIIYQLV------------AGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616
F + D + + + ++ R
Sbjct: 232 KFFPKARDLVEK--------LLVLDATKRLGC 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (403), Expect = 7e-45
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 38/285 (13%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----------NFSDNFINEVATIGRI 401
KE LG G V + P + AVK+++ T + + EV + ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 402 H-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 460
H NII L + L+++ M G L D L+ + +L +I + I
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVI 123
Query: 461 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
LH +L I+H D+KP+N+LLD D K++DFG + + GT Y+A
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 177
Query: 521 PEIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576
PEI ++ + + D++S G+++ ++ P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSGNY-- 232
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ PE +D+ + D ++R + + P+ R + +
Sbjct: 233 QFGSPEWDDYSDTVKDLVSR--------FLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 7e-44
Identities = 57/308 (18%), Positives = 112/308 (36%), Gaps = 30/308 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
E LG G +G V++ + K ++ E++ + H NI+HL
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+I+E++ + + ++ L+ ++ V A+++LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELN--EREIVSYVHQVCEALQFLH---SHNI 123
Query: 472 LHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
H DI+P+N++ + K+ +FG A+ + + Y APE+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH--D 178
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S +D++S G L+ ++ SG N A I + I + F EE
Sbjct: 179 VVSTATDMWSLGTLVYVLL------------SGINPFLAETNQQIIEN-IMNAEYTFDEE 225
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPPKPLFPSPPQLQTQ 648
I+ + + + K R + + E L + IE + + +
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTAS---EALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 649 NEIISFDS 656
+ +I D
Sbjct: 283 HTLIKKDL 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 2e-43
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 24/272 (8%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVNIIHL 409
F++ LGTG + V + +LVA+K + K + NE+A + +I H NI+ L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 410 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 469
G LI + + G L D + + + V A++YLH+ +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 470 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 529
LD D +SDFGL+K ++ GT GY+APE+ +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ--K 184
Query: 530 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589
S D +S G++ ++ P + + E + P +D +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGY---PPFYDENDAKLFEQILKAEY--EFDSPYWDDISDS 239
Query: 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
D I ++ +P+ R + + ++
Sbjct: 240 AKDFIRH--------LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 3e-43
Identities = 58/273 (21%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 410
E+LG+G +G V++ GR+ K + NE++ + ++HH +I+L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
D LI E++ G L D ++ E +S A ++ ++++H E
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS--EAEVINYMRQACEGLKHMH---EHS 147
Query: 471 ILHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 528
I+HLDIKP+N++ + K+ DFGLA + + + T + APEI R
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR-- 202
Query: 529 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
+D+++ G+L ++ SG + ++ +F E
Sbjct: 203 EPVGFYTDMWAIGVLGYVLL------------SGLSPFAGEDDLETLQN-VKRCDWEFDE 249
Query: 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ ++ + +Q P+ R ++ +E
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 6e-43
Identities = 71/339 (20%), Positives = 125/339 (36%), Gaps = 47/339 (13%)
Query: 353 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHV 404
+G GG+G VY + D G++ A+K L+K + N ++ +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
I+ + + I + M G L LS+ A + A + +E++H
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMH 124
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+++ D+KP N+LLD ++SD GLA S+ + ++ GT GY+APE+
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 177
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
+ + +D +S G +L +++ R T + + D + + +
Sbjct: 178 QKGVAY-DSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELPD 230
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV--EMLSS--------ASAEAIEMP 634
F E + +Q + R E+ S + P
Sbjct: 231 SFSPELRSLLEG--------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 282
Query: 635 PKPLFPSP--PQLQTQNEIISFDS-ITSELPLQHDSQEL 670
P PL P +I SFD T + L QEL
Sbjct: 283 P-PLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQEL 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 2e-42
Identities = 52/283 (18%), Positives = 98/283 (34%), Gaps = 26/283 (9%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
K+G+G +G++Y G G VA+K+ E + I +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+C ++ + SL DL + SLK L +A + IEY+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIH---SKNF 124
Query: 472 LHLDIKPQNVL---LDPDFTPKVSDFGLAKAHSRNRS-----VVTMTGPRGTIGYIAPEI 523
+H D+KP N L + DFGLAK + R+ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 524 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
+ S + D+ S G +L+ + + + Y+++ + +
Sbjct: 185 HLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---------KRQKYERISEKKM 233
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
+E + +C + D+P + + ++ +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (381), Expect = 8e-42
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 31/273 (11%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNII 407
E LG GG V+ + R VAVKVL +F F E ++H I+
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 408 HLLGFCCD----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 463
+ G ++ EY+ +L D++ E + P R +E+ A+ +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFS 127
Query: 464 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPE 522
+ I+H D+KP N+++ KV DFG+A+A + + + VT T GT Y++PE
Sbjct: 128 ---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
+ +SDVYS G +L E++ + P G + + D +
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGE---PPFT---GDSPVSVAYQHVREDPIPPSA 236
Query: 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 615
+ + + + ++ L + NP++R
Sbjct: 237 RHEGLSAD----LDAVV---LKALAKNPENRYQ 262
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-41
Identities = 79/347 (22%), Positives = 128/347 (36%), Gaps = 41/347 (11%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIG 399
SY D K +G G +G VY+ K D G LVA+K + + F E+ +
Sbjct: 20 VSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMR 68
Query: 400 RIHHVNIIHLLGFCCDGSTR------ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 453
++ H NI+ L F + L+ +Y+P + +L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 454 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGP 512
+ ++ Y+H I H DIKPQN+LLDPD K+ DFG AK R V+
Sbjct: 129 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGS 563
R Y APE+ + DV+S G +L E++ L G+
Sbjct: 186 R---YYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 564 NTTEAYF---PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 620
T E P++ K Q + + + + I + ++ P R +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 621 EM--LSSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQH 665
+++P P+ TQ E+ S + + L H
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQ-ELSSNPPLATILIPPH 347
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 50/326 (15%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN----FINEVATIGR-IHHVNI 406
+ LG G +G V+ +F + A+K L+K D+ + E + H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 407 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 466
H+ + EY+ G L + + +R A + +++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL--- 119
Query: 467 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 526
I++ D+K N+LLD D K++DFG+ K + + GT YIAPEI +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177
Query: 527 NLGNPSGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583
+ D +S+G+LL EM+ + E ++P W ++ E
Sbjct: 178 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEKEA 230
Query: 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV---EMLSSASAEAI---EMPPKP 637
+D + P+ R + + + + E + E+ P
Sbjct: 231 KDLLV---------------KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP-- 273
Query: 638 LFPSPPQLQTQNEIISFDS-ITSELP 662
P P++++ + +FD +E P
Sbjct: 274 --PFRPKVKSPFDCSNFDKEFLNEKP 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 63/327 (19%), Positives = 127/327 (38%), Gaps = 36/327 (11%)
Query: 354 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 411
+ LG G G V + A+K+L+ EV R +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVD 72
Query: 412 FCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
+ ++ E + G L + +++ + + EI + AI+YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 468 ELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ I H D+KP+N+L P+ K++DFG AK + + S+ T T Y+APE+
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVL 185
Query: 525 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
D++S G+++ ++ P + G + I+ +
Sbjct: 186 GP--EKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMK------TRIRMGQY 234
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPPKPLFPSPP 643
+F E ++ ++ ++ ++ P R ++T E ++ ++ ++P PL S
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT---EFMNHPWIMQSTKVPQTPLHTSRV 291
Query: 644 QLQTQNEIISFDS-ITSELPLQHDSQE 669
+ + +TS L E
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 1e-40
Identities = 42/285 (14%), Positives = 99/285 (34%), Gaps = 28/285 (9%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
++G G +G +++G + + VA+K + S+ + +E T + I +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVY 67
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ ++ + SL DLL S+K + A + ++ +H E +
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIH---EKSL 122
Query: 472 LHLDIKPQNVLLDPDFTP-----KVSDFGLAKAHSRNRS-----VVTMTGPRGTIGYIAP 521
++ DIKP N L+ + V DFG+ K + + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
+ S + D+ + G + + + + + + Y+++ +
Sbjct: 183 NTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---------NKQKYERIGEK 231
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626
++ + E + + + P + + S
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 68/289 (23%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNII 407
+ LG G + VYK + ++VA+K ++ + + E+ + + H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
LL S +L++++M + + +L L P+ + L +EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
ILH D+KP N+LLD + K++DFGLAK+ T T Y APE+
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGA 175
Query: 528 LGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAY-----FPDW 573
D+++ G +L E++ + L T G+ T E + PD+
Sbjct: 176 RMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 574 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622
+ K + +I NP R + T+ ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLI---QGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 61/322 (18%), Positives = 117/322 (36%), Gaps = 26/322 (8%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLG 411
+G G YG V + VA+K + + + + E+ + R H NII +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
+ + Y+ +G L + + L + + ++Y+H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
LH D+KP N+LL+ K+ DFGLA+ A + +T T Y APEI + + G
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 531 PSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTE-----AYFPDWIYD 576
D++S G +L EM+ L GS + E Y
Sbjct: 191 TK-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 577 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPP 635
+ + + K + + + NP R + + L+ + +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE---QALAHPYLEQYYDPSD 306
Query: 636 KPLFPSPPQLQTQNEIISFDSI 657
+P+ +P + + + + + +
Sbjct: 307 EPIAEAPFKFDMELDDLPKEKL 328
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-40
Identities = 62/280 (22%), Positives = 98/280 (35%), Gaps = 44/280 (15%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN-------FINEVATIGRIH-- 402
LG+GG+G+VY G D VA+K +EK EV + ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
+I LL + + LI E DL E +L+ V A+ +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 463 LHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
+LH DIK +N+L+D + K+ DFG T GT Y P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
E +R + V+S G+LL +M+ P E + +F + +
Sbjct: 179 EW-IRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHDEEIIRGQVFFRQRVSSECQ-- 232
Query: 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ WC+ + P DRP+ +
Sbjct: 233 ---HLIR---------------WCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 1e-38
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 24/282 (8%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLG 411
EK+G G YG VYK + G A+K + I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 412 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 471
L++E++ L E L+ L + + I Y H + R+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 472 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 531
LH D+KPQN+L++ + K++DFGLA+A T T+ Y AP++ M +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-KKY 178
Query: 532 SGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588
S D++S G + EM+ + + + + + K D
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 589 EEDDCIARKMIIVGL---------WCIQINPKDRPSMTRVVE 621
+ + + + GL ++++P R + + +E
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 46/314 (14%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG VYK + G +VA+K + T I E++ + ++H NI+ LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
+ L++E++ + + + L + + + + H+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSHR--- 122
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+LH D+KPQN+L++ + K++DFGLA+A T T+ Y APEI +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KY 179
Query: 531 PSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581
S D++S G + EM+ E L T G+ E +P +P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGVTSMPDYKP 238
Query: 582 EKEDFVEEEDDCIARKMIIVGL----WCIQINPKDRPSMTRVVEMLSSASAEAIEMP--- 634
+ ++ + + G + +P R S A+ P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----------KAALAHPFFQ 287
Query: 635 --PKPLFPSPPQLQ 646
KP+ P L+
Sbjct: 288 DVTKPV----PHLR 297
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (352), Expect = 2e-37
Identities = 77/350 (22%), Positives = 130/350 (37%), Gaps = 58/350 (16%)
Query: 341 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEV 395
YS D + LGTG +G V+ + +GR A+KVL+K ++ +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 396 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 455
+ + H II + G D +I +Y+ G L LL + + A
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAE 112
Query: 456 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 515
V A+EYLH I++ D+KP+N+LLD + K++DFG AK GT
Sbjct: 113 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 164
Query: 516 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPD 572
YIAPE+ + D +S+G+L+ EM+ +T E FP
Sbjct: 165 PDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222
Query: 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLS------ 624
+ + + D ++R I + R + ++ +
Sbjct: 223 FFNEDVK------------DLLSR--------LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
Query: 625 ----SASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQEL 670
+ IE P +P +Q + + I + + +L
Sbjct: 263 VVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADL 312
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 59/290 (20%), Positives = 115/290 (39%), Gaps = 33/290 (11%)
Query: 355 EKLGTGGYGNVYKGKF--PDGRLVAVKVLEKTSNFSD------NFINEVATIGRIHHVNI 406
++G G YG V+K + GR VA+K + + + + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 407 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 461
+ L C T L++E++ L + + + + ++ + ++
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 130
Query: 462 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 521
+LH R++H D+KPQN+L+ K++DFGLA+ +S ++ ++ T+ Y AP
Sbjct: 131 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAP 184
Query: 522 EIFMRNLGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAYFPD 572
E+ ++ + + D++S G + EM + L G E + D
Sbjct: 185 EVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 573 WIYDKLIQPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ K +E+ I + L C+ NP R S +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN-------FINEVATIGRIHHV 404
E+LG+G + V K + G A K ++K S EV+ + I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 405 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
N+I L + + LI E + G L D EKE+L+ + A + + ++
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEF-----LKQILNGVY 127
Query: 465 NGCELRILHLDIKPQNVLLDPDFTP----KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 520
L+I H D+KP+N++L P K+ DFGLA GT ++A
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVA 184
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580
PEI ++D++S G++ ++ G E +
Sbjct: 185 PEIVNY--EPLGLEADMWSIGVITYILLSGASPFL------GDTKQETL-------ANVS 229
Query: 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+F +E + + +PK R ++ ++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 42/299 (14%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLL 410
K+G G +G V+K + G+ VA+K + + F + E+ + + H N+++L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 411 GFCCDGSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
C ++ L++++ + G L + + + R++++ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL------NG 129
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIA 520
L+ +ILH D+K NVL+ D K++DFGLA+A S ++ T T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 521 PEIFMRNLGNPSGKSDVYSYGMLLLEM------------------IEEKKHLRPTETTSG 562
PE + + D++ G ++ EM I + E
Sbjct: 190 PE-LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 563 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ E Y + + K+ D A +I + ++P R +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 72/350 (20%), Positives = 131/350 (37%), Gaps = 52/350 (14%)
Query: 341 YSYNDIKKMTNGFK------EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDN 390
+ ++ K + + +G+G YG V G VA+K L + F+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 391 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE-YMPNGSLGDLLSREKENLSLKPARL 449
E+ + + H N+I LL T + Y+ +G L + ++ L R+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 450 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 509
+ + + Y+H I+H D+KP N+ ++ D K+ DFGLA+ M
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EM 175
Query: 510 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---------------EEKKHL 554
TG T Y APE+ + + D++S G ++ EMI +E +
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQ-TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 555 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDC--IARKMIIVGLWCIQINPKD 612
T ++ L + EK+DF + +A ++ + ++ +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL---EKMLVLDAEQ 291
Query: 613 RPSMTRVVEMLSSASAEAIEMP-PKPLFPSPPQLQTQNEIISFDSITSEL 661
R + EA+ P + L + + Q Q SFD + L
Sbjct: 292 RVTA-----------GEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTL 330
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 8e-35
Identities = 66/335 (19%), Positives = 115/335 (34%), Gaps = 52/335 (15%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNII 407
+ + LG G +G V + GR A+K+L K + + + E + H +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 408 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 467
L + EY G L LSRE+ R + A L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSA---LEYLH 122
Query: 468 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+++ DIK +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN 180
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPDWIYDKLIQPEKE 584
D + G+++ EM+ + E FP + PE +
Sbjct: 181 DYGR--AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPEAK 233
Query: 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLSS--------ASAEAIEMP 634
+ ++ +PK R E++ ++
Sbjct: 234 SLLA---------------GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278
Query: 635 PKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 669
P P PQ+ ++ + FD + + +
Sbjct: 279 P----PFKPQVTSEVDTRYFDDEFTAQSITITPPD 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 1e-34
Identities = 68/354 (19%), Positives = 128/354 (36%), Gaps = 52/354 (14%)
Query: 325 NVKQFIKTYRSALLSNYSYNDIKKMT-NGFK--EKLGTGGYGNVYKGKF-PDGRLVAVKV 380
+VK+F+ + L + + F + LGTG +G V K G A+K+
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 381 LEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS 436
L+K ++ +NE + ++ ++ L D S ++ EY+ G + L
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 437 REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496
R A + EYLH L +++ D+KP+N+L+D +V+DFG
Sbjct: 134 RIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 556
AK GT +APEI + + D ++ G+L+ EM
Sbjct: 188 AKRVKGR-----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFF- 239
Query: 557 TETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 616
+ Y + I ++ F + D + +Q++ R
Sbjct: 240 -----ADQPIQIY--EKIVSGKVRF-PSHFSSDLKDLLRN--------LLQVDLTKRFGN 283
Query: 617 TR--VVEMLSS--------ASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSE 660
+ V ++ + + ++ P P+ + + +FD E
Sbjct: 284 LKNGVNDIKNHKWFATTDWIAIYQRKVEA----PFIPKFKGPGDTSNFDDYEEE 333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-34
Identities = 55/284 (19%), Positives = 102/284 (35%), Gaps = 26/284 (9%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 410
EK+G G YG V+K K +VA+K + + + + E+ + + H NI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 411 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 470
L++E+ S + + + ++ L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------DPEIVKSFLFQLLKGLGFCHSRN 121
Query: 471 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 530
+LH D+KPQN+L++ + K+++FGLA+A + T+ Y P++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA-KL 178
Query: 531 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYFPDWIYDKLIQP 581
S D++S G + E+ + L P TE +P +P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 582 EKEDFVEEEDDCIARKMIIVGL----WCIQINPKDRPSMTRVVE 621
+ K+ G ++ NP R S ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 30/276 (10%)
Query: 353 FKEKLGTGGYGNVYKGK----FPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-H 402
+ LGTG YG V+ + G+L A+KVL+K + +++ E + I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 403 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 462
++ L + LI +Y+ G L LS+ + E+ + V +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLA 141
Query: 463 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 522
L + +L I++ DIK +N+LLD + ++DFGL+K + + GTI Y+AP+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPD 200
Query: 523 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582
I D +S G+L+ E++ P N+ + + P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEKNSQAEISRRILKSEPPYP- 256
Query: 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618
++ D I R + +PK R
Sbjct: 257 -QEMSALAKDLIQR--------LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 6e-32
Identities = 52/295 (17%), Positives = 104/295 (35%), Gaps = 41/295 (13%)
Query: 353 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLL 410
KLG G Y V++ + V VK+L+ E+ + + NII L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLA 96
Query: 411 GFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 468
D +R AL++E++ N L L + + A++Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---S 147
Query: 469 LRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 527
+ I+H D+KP NV++D + ++ D+GLA+ + + + + PE+ +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDY 204
Query: 528 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT---------------------SGSNTT 566
D++S G +L MI K+ +
Sbjct: 205 QMYDY-SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621
+ F D + + + E ++ + + ++ + + R + +E
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 3e-29
Identities = 56/339 (16%), Positives = 119/339 (35%), Gaps = 53/339 (15%)
Query: 353 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 411
KLG G + V+ K + VA+K++ +++ +E+ + R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 412 FCCDGSTRALIY-------------EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 458
+ + L + + G L ++ E+ + + +I+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 459 AIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 517
++Y+H C I+H DIKP+NVL++ D + +A + T T
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 518 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW---- 573
Y +PE+ + +D++S L+ E+I P E S + +
Sbjct: 195 YRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 574 -IYDKLIQPEKEDFVEEEDDCIARKMIIVGLW--------------------------CI 606
+ L++ K + R + + W +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 607 QINPKDRPSMTRVVE---MLSSASAEAIEMPPKPLFPSP 642
Q++P+ R +V + + E I +P + L+ S
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 351
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 2e-28
Identities = 61/325 (18%), Positives = 110/325 (33%), Gaps = 52/325 (16%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 410
+ +G+G G V R VA+K L + + E+ + ++H NII LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 411 GFCCDGSTR------ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 464
T L+ E M + R+ + + I++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLCGIKHLH 136
Query: 465 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 524
+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y APE+
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 525 MRNLGNPSGKSDVYSYGMLLLEM------------------IEEKKHLRPTETTSGSNTT 566
+ D++S G ++ EM + E+ E T
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 567 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGL-------WCIQINPKDRPSMTRV 619
+ + + F + + + + I+P R S+
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 620 VE---MLSSASAEAIEMPPKPLFPS 641
++ + +E PP ++
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDK 333
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-28
Identities = 62/338 (18%), Positives = 121/338 (35%), Gaps = 55/338 (16%)
Query: 355 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 410
+G+G YG+V G VAVK L + + E+ + + H N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 411 GFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 465
+ + ++ L +++ +K L + + + ++Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH- 138
Query: 466 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 525
I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y APEI +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIML 191
Query: 526 RNLGNPSGKSDVYSYGMLL------------------LEMIEEKKHLRPTETTSGSNTTE 567
+ + D++S G ++ L++I E ++
Sbjct: 192 NW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 568 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE-----M 622
A ++ + + + +A ++ + ++ R + + +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANP-LAVDLL---EKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 623 LSSASAEAIEMPPKPLFPSPPQLQTQ------NEIISF 654
E + P F S L + +E+ISF
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 28/215 (13%), Positives = 55/215 (25%), Gaps = 52/215 (24%)
Query: 355 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN-----------FINEVATIGRIHH 403
+ +G G V+ VK + F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 404 VNIIHLLGFCC----DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 459
+ L G A++ E + E ++ E+ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 460 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 519
+ ++ I+H D+ NVL+ + + DF +
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--------------- 156
Query: 520 APEIFMRNLGNPSG--------KSDVYSYGMLLLE 546
EI R++ N + D+ S +L+
Sbjct: 157 WREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 670 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.01 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=414.26 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=199.3
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|++++ .||||+++... ...+.|.+|+.++++++|||||+++|++.+ ...++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 356889999999999998743 59999997543 445789999999999999999999998754 568999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++..... .+++..++.++.|+++||+|||++ +||||||||+||||+.++.+||+|||+|+..........
T Consensus 88 g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 88 SSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999975433 599999999999999999999998 999999999999999999999999999988765444334
Q ss_pred ecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
.....||+.|+|||++... .+.++.++|||||||++|||+||+.||..... .......+......+. .
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~p~----~ 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRGYLSPD----L 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHHTSCCCC----G
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCc----c
Confidence 4556799999999998643 23578899999999999999999999964321 1111111111111111 1
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
......+++.+.+++.+||+.||++||||+||+++|+.+.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222234567889999999999999999999999998653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=412.96 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=198.1
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCc
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL 431 (670)
++.++||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|++.+.+..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 35688999999999999999899999999988777788999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecC
Q 005909 432 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 511 (670)
Q Consensus 432 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~ 511 (670)
.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 88 ~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~ 161 (263)
T d1sm2a_ 88 SDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 161 (263)
T ss_dssp HHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-eecc
Confidence 99986543 2589999999999999999999998 9999999999999999999999999999876544332 2234
Q ss_pred CCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 512 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
..||+.|+|||++.+. .++.++|||||||++|||+|++.|+..... ...+...+..+..... +
T Consensus 162 ~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i~~~~~~~~----p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSEVVEDISTGFRLYK----P 224 (263)
T ss_dssp ---CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----------HHHHHHHHHHTCCCCC----C
T ss_pred eecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----c
Confidence 5689999999999764 789999999999999999996555432211 1112222222111111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...+.++.+++.+||+.||++||||+||+++|+++
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12345788999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=412.33 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=208.2
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 44668899999999999999988999999998877778899999999999999999999998765 56789999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++..... ..+++..+++|+.|+++||+|||++ +|+||||||+||||++++.+||+|||+|+........ ...
T Consensus 94 L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~ 168 (272)
T d1qpca_ 94 LVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168 (272)
T ss_dssp HHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCT
T ss_pred HHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc-ccc
Confidence 9998865432 2589999999999999999999998 9999999999999999999999999999987654332 234
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...||+.|+|||++.+ +.++.++|||||||++|||+||+.|+..... ...+...+..+.....
T Consensus 169 ~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----------~~~~~~~i~~~~~~~~---- 231 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----------NPEVIQNLERGYRMVR---- 231 (272)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------HHHHHHHHHTTCCCCC----
T ss_pred ccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----
Confidence 5678999999999975 3688999999999999999997766543211 1122233332221111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
+..++..+.+++.+||+.||++||||+||++.|+...
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1223557889999999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=414.65 Aligned_cols=264 Identities=25% Similarity=0.443 Sum_probs=199.9
Q ss_pred CCHHHHHHHHHhh-----------hccccccCceEEEEEEeCC-C---cEEEEEEcccCC--cchHHHHHHHHHhccccc
Q 005909 341 YSYNDIKKMTNGF-----------KEKLGTGGYGNVYKGKFPD-G---RLVAVKVLEKTS--NFSDNFINEVATIGRIHH 403 (670)
Q Consensus 341 ~~~~~l~~~~~~~-----------~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H 403 (670)
++|+|+++++.+| .+.||+|+||+||+|+++. + ..||||.+.... ...++|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555555555554 3579999999999999852 2 368999887543 345689999999999999
Q ss_pred cccccccceeeeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEE
Q 005909 404 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 483 (670)
Q Consensus 404 ~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll 483 (670)
||||+++|++.+.+..++||||+++|+|.+++..... .+++.++++++.|+++||+|||++ +|+||||||+||||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999998875433 589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecCCccccCCCCcee---eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 005909 484 DPDFTPKVSDFGLAKAHSRNRSVV---TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTET 559 (670)
Q Consensus 484 ~~~~~~ki~DfGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~ 559 (670)
+.++++||+|||+++......... ...+..||+.|+|||.+.+ +.++.++|||||||++|||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 999999999999998775443322 1223457999999999975 478899999999999999998 8888864321
Q ss_pred CCCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 560 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+...+..+..... +..++..+.+++.+||+.||++||||.||++.|+++.
T Consensus 240 ------------~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 ------------QDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ------------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112222322221111 1224567889999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-51 Score=415.36 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=212.2
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.+.++||+|+||+||+|++. +++.||||+++......++|.+|+.+|++++|||||+++|++.+++..++||||+++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 4456789999999999999986 588999999988777788999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+... ..+++..++.++.|+++||+|||++ +|+||||||+||||++++.+||+|||+++........ .
T Consensus 98 g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~ 172 (287)
T d1opja_ 98 GNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-A 172 (287)
T ss_dssp CBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-E
T ss_pred cchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce-e
Confidence 999999975432 3689999999999999999999998 9999999999999999999999999999987654332 3
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
..+..|++.|+|||++.+. .++.++|||||||++|||++|+.|+..... ...+.+.+..+....
T Consensus 173 ~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----------~~~~~~~i~~~~~~~--- 236 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------LSQVYELLEKDYRME--- 236 (287)
T ss_dssp ETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------HHHHHHHHHTTCCCC---
T ss_pred eccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcch-----------HHHHHHHHhcCCCCC---
Confidence 3455689999999999764 788999999999999999998877643221 111222222221111
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+..++..+.+++.+||+.||++||||.||++.|+...
T Consensus 237 -~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11224567889999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=408.25 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=200.8
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++.++||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 45689999999999999985 68999999987543 3446789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.++|.... .+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 88 g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 88 GELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999996543 599999999999999999999998 999999999999999999999999999998765444333
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. ...+.++|||||||++|||++|+.||...... .. . ......... ..
T Consensus 162 ~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~----~-~~~~~~~~~---~~ 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQ----E-YSDWKEKKT---YL 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------SH----H-HHHHHTTCT---TS
T ss_pred ccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------HH----H-HHHHhcCCC---CC
Confidence 4556799999999999764 23467899999999999999999999643220 00 0 111111111 11
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122335577889999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=399.82 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=210.5
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
+.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++||||++++|++.+.+..++||||+++|+|.
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 66899999999999999998999999999988777889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeecCC
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 512 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~ 512 (670)
+++..... .+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 88 ~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 88 NYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp HHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred Hhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 99765543 588999999999999999999998 9999999999999999999999999999876544332 23456
Q ss_pred CCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchhh
Q 005909 513 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 591 (670)
Q Consensus 513 ~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (670)
.||+.|+|||.+.+. .++.++|||||||++|||+| |+.||..... ..+...+..+..... +
T Consensus 162 ~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------------~~~~~~i~~~~~~~~----p 223 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYR----P 223 (258)
T ss_dssp CCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------HHHHHHHHTTCCCCC----C
T ss_pred CCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH------------HHHHHHHHhCCCCCC----c
Confidence 789999999999764 78899999999999999998 7888864321 122333333222111 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhh
Q 005909 592 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 625 (670)
Q Consensus 592 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 625 (670)
...+..+.+++.+||+.||++|||++||+++|..
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2234578899999999999999999999999963
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=394.07 Aligned_cols=243 Identities=28% Similarity=0.442 Sum_probs=203.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.+.||+|+||+||+|+++ +++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999986 6899999998643 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.+.. .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 88 APLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred cCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999997643 599999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 162 ----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~~- 222 (263)
T d2j4za1 162 ----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------QETYKRISRVEFT- 222 (263)
T ss_dssp ----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCCC-
T ss_pred ----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 235689999999999864 678899999999999999999999964321 1222333222211
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. +..++..+.+++.+||+.||++|||++|++++
T Consensus 223 ~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 F----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1 11235678889999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=399.34 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=203.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 456689999999999999975 69999999987544 4567899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++........
T Consensus 102 g~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-- 172 (293)
T d1yhwa1 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (293)
T ss_dssp CBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence 9999987643 499999999999999999999998 9999999999999999999999999999877544322
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccc
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 588 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+........ .. .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~~~~~~~-~~--~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGT-PE--L 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCS-CC--C
T ss_pred ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCC-CC--C
Confidence 2345699999999999763 678899999999999999999999964321 011111111111 00 1
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 589 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 589 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..+..++..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345678899999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=392.45 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=197.6
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee----CCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lv~ 423 (670)
+|.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35578999999999999986 68899999986543 334678999999999999999999999865 34578999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC-CCCCeEEeecCCccccCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~-~~~~~ki~DfGla~~~~~ 502 (670)
||+++|+|.+++.+.. .+++..++.++.|+++||+|||++ ..+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997653 589999999999999999999987 22399999999999996 578999999999986554
Q ss_pred CCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 503 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...+...+..+.
T Consensus 168 ~~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----------~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 168 SFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSGV 229 (270)
T ss_dssp TSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTTC
T ss_pred Ccc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----------HHHHHHHHHcCC
Confidence 332 23568999999999864 578999999999999999999999964221 122333333332
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.+.. .....++++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcc---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 2111 112234568899999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=397.53 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEeCC---CcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
++||+|+||+||+|.+++ ++.||||+++... ...++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998743 4689999996533 235689999999999999999999999864 467899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee-
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 507 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~- 507 (670)
|+|.+++.+.. .+++..+++++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987543 599999999999999999999998 99999999999999999999999999998776544332
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
......||+.|+|||.+.+ +.++.++|||||||++|||++ |+.||..... ..+...+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------------~~~~~~i~~~~~~~~ 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGERMGC 231 (277)
T ss_dssp C----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCCC
T ss_pred cccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCH------------HHHHHHHHcCCCCCC
Confidence 2334568999999999976 367889999999999999998 8999864221 122233333222211
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+..++.++.+++.+||+.||++||||.+|++.|+..
T Consensus 232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 122456788999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=397.38 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred hc-cccccCceEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 354 KE-KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 354 ~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+ +||+|+||+||+|.++ ++..||||+++... ...++|.+|+++|++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 35 5999999999999874 35589999997654 345789999999999999999999999865 46789999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++...+. .+++..+++++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 ~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 92 GGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999998865432 589999999999999999999998 99999999999999999999999999999876544332
Q ss_pred -eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 508 -TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 508 -~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
......||+.|+|||++... .++.++|||||||++|||+| |+.||..... ..+...+..+....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------------~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRME 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------HHHHHHHHTTCCCC
T ss_pred ccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC
Confidence 22345689999999999753 78899999999999999998 8999864321 11223333322222
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
. +..++.++.+++.+||+.||++||||.+|++.|+...
T Consensus 233 ~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 233 C----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1234567889999999999999999999999998543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=400.07 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=190.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--CCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lv~e 424 (670)
|++.+.||+|+||+||+|+++ +|+.||+|++.... ...+.+.+|++++++++|||||++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345689999999999999885 68999999987654 234678999999999999999999999865 456799999
Q ss_pred ecCCCCccccccccc-CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 425 YMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
|+++|+|.+++.+.. .+..+++..++.++.|++.||+|||++. ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999986532 2346999999999999999999999861 1249999999999999999999999999998875
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 166 ~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------------~~~~~~i~~~ 229 (269)
T d2java1 166 HDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------KELAGKIREG 229 (269)
T ss_dssp ------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHT
T ss_pred cCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH------------HHHHHHHHcC
Confidence 44322 2345689999999999753 678999999999999999999999964321 1122222222
Q ss_pred ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..... +..++.++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 KFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22111 12245678899999999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=399.40 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=202.2
Q ss_pred HhhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 430 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~gs 430 (670)
+.+.++||+|+||+||+|++++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence 45678999999999999999988899999998877777899999999999999999999999854 56789999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||||+.++++||+|||+++........ ...
T Consensus 98 l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~ 172 (285)
T d1fmka3 98 LLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 172 (285)
T ss_dssp HHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce-eec
Confidence 99998764332 599999999999999999999998 9999999999999999999999999999876543322 234
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccchh
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 590 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (670)
...||+.|+|||++.. +.++.++||||||+++|||++|+.|+..... ...+...+........
T Consensus 173 ~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----------~~~~~~~i~~~~~~~~---- 235 (285)
T d1fmka3 173 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----------NREVLDQVERGYRMPC---- 235 (285)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------HHHHHHHHHTTCCCCC----
T ss_pred cccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----
Confidence 4568999999999976 4788999999999999999998776643211 1112222222221111
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 591 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 591 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
...++.++.+++.+||+.||++||+|++|++.|+...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1223557889999999999999999999999998543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=406.90 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=203.7
Q ss_pred HhhhccccccCceEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 421 (670)
+.+.++||+|+||+||+|++.. ...||+|++.... ...+.+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 4567899999999999998742 2369999986543 3456899999999998 89999999999999999999
Q ss_pred EEEecCCCCcccccccccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcE
Q 005909 422 IYEYMPNGSLGDLLSREKE--------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 481 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 481 (670)
||||+++|+|.++|+.... ...+++..++.++.|+++||+|||++ +|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence 9999999999999976432 12589999999999999999999998 999999999999
Q ss_pred EECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005909 482 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 560 (670)
Q Consensus 482 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~ 560 (670)
|++.++.+||+|||+|+...............||+.|+|||++.+ +.++.++|||||||++|||++ |+.||.....
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999988765554444455668999999999976 478999999999999999998 8999864322
Q ss_pred CCCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 005909 561 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 624 (670)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 624 (670)
. ..+...+..+..... +...+..+.+++.+||+.||++||||+||+++|.
T Consensus 273 ------~----~~~~~~~~~~~~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 ------D----ANFYKLIQNGFKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------S----HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------H----HHHHHHHhcCCCCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 111122222111111 1223557889999999999999999999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=396.93 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=195.8
Q ss_pred hhccccccCceEEEEEEeCCC-----cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFPDG-----RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+.+.||+|+||+||+|++++. ..||||++.... ...++|.+|+.++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 457899999999999987532 479999987544 3345799999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+++|.+++..... .+++.++++++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 91 ~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 91 MENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred cccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 999999988765433 599999999999999999999998 999999999999999999999999999987654322
Q ss_pred e-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 V-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. ....+..||+.|+|||++.+ +.++.++|||||||++|||++|+.|+..... ...+...+..+...
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------NHEVMKAINDGFRL 232 (283)
T ss_dssp --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTTCCC
T ss_pred cceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCC-----------HHHHHHHHhccCCC
Confidence 2 22344568999999999976 4788999999999999999997776543211 11222333332222
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
... ...+..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 233 ~~~----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 233 PTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp CCC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCc----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111 223457889999999999999999999999998543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=396.63 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=202.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|++.++||+|+||+||+|++. +++.||||+++... ...+.+.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 345688999999999999985 68999999997643 4567899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
|+|.+++.+... .+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 94 g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~ 166 (288)
T d2jfla1 94 GAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 166 (288)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence 999998865432 599999999999999999999998 999999999999999999999999999976543211 1
Q ss_pred ecCCCCCccccchhhcccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 509 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~---~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....||+.|+|||++... ...++.++|||||||++|||++|+.||..... .. +...+.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-------~~-----~~~~i~~~~~~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------MR-----VLLKIAKSEPPT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GG-----HHHHHHHSCCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-------HH-----HHHHHHcCCCCC
Confidence 2345689999999998532 23568899999999999999999999965322 01 111111111111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......++..+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 --LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345678899999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=394.10 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=200.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456789999999999999985 6899999998643 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 90 ~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999887654 599999999999999999999998 999999999999999999999999999998765443
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+..++..... .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~i~~~~~-~ 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE------------YLIFQKIIKLEY-D 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHTTCC-C
T ss_pred ccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH------------HHHHHHHHcCCC-C
Confidence 3333456799999999999764 678899999999999999999999964321 122333332221 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 621 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 621 (670)
. +..++..+.+++.+||+.||++|||++|+++
T Consensus 229 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1123557889999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=399.43 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=199.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+...++||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 455688999999999999975 689999999976542 335789999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|..++.... .+++..++.++.|++.||.|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 97 ~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred cCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999977664432 599999999999999999999998 9999999999999999999999999999876532
Q ss_pred eeeecCCCCCccccchhhcccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||..... .+. ..++......
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------~~~-~~~i~~~~~~ 232 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSA-LYHIAQNESP 232 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHH-HHHHHHSCCC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------HHH-HHHHHhCCCC
Confidence 234589999999998642 24578899999999999999999999864221 111 1111111111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ...++..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 11235578899999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=405.71 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=199.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
+.+.++||+|+||+||+|++. +|+.||+|+++... ...+++.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 445689999999999999985 68999999997543 345789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|+|.+++.+.. .+++..+..++.|+++||.|||++ .+|+||||||+||||++++.+||+|||+|+......
T Consensus 88 gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 88 GGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred CCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 999999997654 589999999999999999999963 179999999999999999999999999998764322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC----------CCCccccchHH----
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG----------SNTTEAYFPDW---- 573 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~----------~~~~~~~~~~~---- 573 (670)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+...... ..........+
T Consensus 160 -~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 1234699999999999864 788999999999999999999999975432100 00000000000
Q ss_pred ----------------HHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 574 ----------------IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 574 ----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
..........+.. .....+.++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKL---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCC---CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 011134578899999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=393.44 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=188.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
|++.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+|++++||||+++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 556789999999999999986 68999999997543 334568899999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCccccCCCC
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla~~~~~~~ 504 (670)
+|+|.++|.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||+|||+++......
T Consensus 91 gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 91 GGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp SCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999996543 599999999999999999999998 999999999999994 57899999999998765443
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 165 ~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 165 V---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDEND------------AKLFEQILKAEYE 227 (307)
T ss_dssp -----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHTTCCC
T ss_pred e---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHhccCCC
Confidence 2 2335689999999999764 678999999999999999999999964321 1122222222211
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........++..+.+++.+||+.||++|||+.|++++
T Consensus 228 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 -FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111122345678899999999999999999999885
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-47 Score=393.82 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=204.9
Q ss_pred hhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
++.++||+|+||+||+|+++ +++.||||+++.... ..++|.+|+.+|++++||||+++++++.+.+..++|+
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 45689999999999999864 357899999976543 3567999999999999999999999999999999999
Q ss_pred EecCCCCcccccccccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEE
Q 005909 424 EYMPNGSLGDLLSREKE---------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 482 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIl 482 (670)
||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +||||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 99999999999864321 22489999999999999999999998 9999999999999
Q ss_pred ECCCCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCC
Q 005909 483 LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTS 561 (670)
Q Consensus 483 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~ 561 (670)
||.++.+||+|||+++...............|++.|+|||.+.+. .++.++|||||||++|||++|.. ||.....
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999876544333333456689999999999864 78999999999999999999965 5543211
Q ss_pred CCCCccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 562 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..+...+..+..... +..++.++.+++.+||+.||++||||.||++.|+++
T Consensus 249 ----------~e~~~~v~~~~~~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 ----------EEVIYYVRDGNILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp ----------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----------HHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122233333332222 122345788999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=385.17 Aligned_cols=247 Identities=29% Similarity=0.450 Sum_probs=194.5
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC-CeeEEEEEecCCCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIYEYMPNGS 430 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~e~~~~gs 430 (670)
.+.++||+|+||.||+|++ .|+.||||+++.+. ..++|.+|++++++++||||++++|++.+. +..++||||+++|+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 4668899999999999999 57789999997654 467899999999999999999999998654 56799999999999
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceeeec
Q 005909 431 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 510 (670)
Q Consensus 431 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~ 510 (670)
|.++|..... ..+++..+++++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~ 158 (262)
T d1byga_ 88 LVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 158 (262)
T ss_dssp HHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred HHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----c
Confidence 9999965432 2489999999999999999999998 99999999999999999999999999998764432 2
Q ss_pred CCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccccch
Q 005909 511 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 589 (670)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (670)
...++..|+|||++.+ +.++.++||||||+++|||+| |+.|+..... ..+...+..+.......
T Consensus 159 ~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~------------~~~~~~i~~~~~~~~~~- 223 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPRVEKGYKMDAPD- 223 (262)
T ss_dssp ---CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------------GGHHHHHTTTCCCCCCT-
T ss_pred cccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH------------HHHHHHHHcCCCCCCCc-
Confidence 2347899999999976 478999999999999999998 5666643211 11223333322222222
Q ss_pred hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 590 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 590 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..+.++.+++.+||+.||++||||.||+++|+++.
T Consensus 224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 23467889999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-46 Score=393.74 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=203.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..++||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456789999999999999985 68999999997655 3356789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC--CCCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~ 506 (670)
|+|.+++.+... .+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++........
T Consensus 108 g~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 108 GELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999865432 599999999999999999999998 9999999999999954 688999999999987655443
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... ..
T Consensus 183 ~---~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~-~~ 244 (350)
T d1koaa2 183 K---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND------------DETLRNVKSCDW-NM 244 (350)
T ss_dssp E---EECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCC-CS
T ss_pred c---eecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC
Confidence 2 24589999999999764 678899999999999999999999964321 111122211111 11
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++..+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112222345678899999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=384.08 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=203.5
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCC----eeEEEEEecCC
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMPN 428 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~e~~~~ 428 (670)
+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++||||+++++++.+.+ ..++||||+++
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 457899999999999998 6889999999765543334455667777899999999999998654 57899999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
|+|.++|++. .+++..+++++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 9999999764 4899999999999999999999631 349999999999999999999999999999877544
Q ss_pred Ccee--eecCCCCCccccchhhcccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---CccccchHHH
Q 005909 504 RSVV--TMTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---TTEAYFPDWI 574 (670)
Q Consensus 504 ~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~ 574 (670)
.... ......||+.|+|||++.+... .++.++|||||||+||||+||..|+.......... .........+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 3322 2334679999999999865311 24668999999999999999998875432211111 1111222333
Q ss_pred HHHhcCCcc-cccc-chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 575 YDKLIQPEK-EDFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 575 ~~~~~~~~~-~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
......... +... ..........+.+++.+||+.||++||||.||+++|+++.
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 333333222 1211 1123345667899999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-46 Score=392.72 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=203.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|++.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456789999999999999985 79999999987654 3346788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC--CCCCeEEeecCCccccCCCCce
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~--~~~~~ki~DfGla~~~~~~~~~ 506 (670)
|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+........
T Consensus 111 g~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 111 GELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred ChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 99998876543 2599999999999999999999998 999999999999997 5789999999999987765443
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccccc
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 586 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (670)
. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... ..
T Consensus 186 ~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~~-~~ 247 (352)
T d1koba_ 186 K---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------------LETLQNVKRCDW-EF 247 (352)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHHHHCCC-CC
T ss_pred e---eccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC
Confidence 2 23479999999999764 688999999999999999999999964322 111111111111 11
Q ss_pred cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 587 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.......++..+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122345678899999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=383.46 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=203.9
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHhccccccccccccceeeeCCeeEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 421 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 421 (670)
.|++.+.||+|+||+||+|+++ +|+.||||++.+.. ...+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556789999999999999985 78999999986432 235789999999999999999999999999999999
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC----CeEEeecCCc
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 497 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~----~~ki~DfGla 497 (670)
||||+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999997653 599999999999999999999998 999999999999998776 4999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~ 227 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLAN 227 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHH
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCH------------HHHHHH
Confidence 88754432 2335689999999999763 678999999999999999999999964321 111222
Q ss_pred hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+..... .........++..+.+++.+||+.||++|||++|++++
T Consensus 228 i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 228 VSAVNY-EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHTTCC-CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhcCC-CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222111 11112223345678899999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=392.58 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=197.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
+++.++||+|+||+||+|++. +|+ .||+|+++... ...++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 345689999999999999875 343 58899886533 4567899999999999999999999999865 567888
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+.+|+|.+.+..... .+++..+++++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998866433 589999999999999999999998 9999999999999999999999999999987665
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
..........||+.|+|||++.+. .++.++|||||||++|||+| |+.||..... ..+ ...+..+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~----~~~i~~~~ 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----SSILEKGE 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGH----HHHHHHTC
T ss_pred cccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHH----HHHHHcCC
Confidence 554444556789999999999764 78999999999999999998 6777754321 111 12222111
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... +..++..+.+++.+||+.||++|||+.||+++|+...
T Consensus 231 ~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1123457889999999999999999999999997653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=387.26 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=202.0
Q ss_pred hhhccccccCceEEEEEEeCCC----cEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeC-CeeEEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDG----RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIYE 424 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lv~e 424 (670)
+|.++||+|+||+||+|++.++ ..||||+++... ...++|.+|+++|++++||||++++|++.+. ...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999997542 368999997533 3457899999999999999999999998764 57899999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++..... .+++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999875443 578889999999999999999998 99999999999999999999999999998765433
Q ss_pred cee--eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 505 SVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 505 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
... ......||+.|+|||.+.. +.++.++||||||+++|||++|+.|+..... .......+ ..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i----~~g~ 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYL----LQGR 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHH----HTTC
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHH----HcCC
Confidence 221 2234568999999999976 4789999999999999999998888754221 11112222 2221
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhccc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 628 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 628 (670)
.... +...+..+.+++.+||+.||++||+|.||+++|+++..
T Consensus 252 ~~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 11234578899999999999999999999999997643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-46 Score=382.93 Aligned_cols=242 Identities=28% Similarity=0.361 Sum_probs=201.3
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+++.+.||+|+||+||+|+++ +|+.||||++++. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 346789999999999999985 6999999998643 34567899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999886554 588899999999999999999998 99999999999999999999999999998775432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+..++..... .
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~------------~~~~~~i~~~~~-~ 219 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MKTYEKILNAEL-R 219 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHCCC-C
T ss_pred ----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH------------HHHHHHHHcCCC-C
Confidence 235699999999999764 678899999999999999999999965322 112222222111 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
. +..++..+.+++.+||+.||++|+ |+++++++
T Consensus 220 ~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 112345688899999999999996 89999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=384.27 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=202.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+++.+.||+|+||+||+|+.+ +|+.||||++++. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 346689999999999999985 7999999999753 34567889999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+++|+|.+++.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999987654 589999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... .
T Consensus 161 ~--~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~------------~~~~~~i~~~~~-~ 223 (337)
T d1o6la_ 161 T--MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEI-R 223 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-C
T ss_pred c--cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH------------HHHHHHHhcCCC-C
Confidence 1 2345689999999999764 678999999999999999999999965322 112222221111 1
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
. +..++.++.+++.+||+.||++||+ ++|++++
T Consensus 224 ~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 1224557888999999999999995 8888875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=381.97 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=192.8
Q ss_pred HHhhhccccccCceEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+++.+.||+|+||+||+|++.. +..||||+++... ...+.|.+|+.++++++||||++++|++. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 34567899999999999998753 3578999987544 33567999999999999999999999986 45789999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 87 E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999876543 2589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcCCc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 582 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (670)
.... .....||+.|+|||++.+. .++.++|||||||++|||++ |+.||..... ..+...+..+.
T Consensus 162 ~~~~-~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------------~~~~~~i~~~~ 226 (273)
T d1mp8a_ 162 TYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENGE 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHHHHHHTTC
T ss_pred ccee-ccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCC
Confidence 3322 2345689999999999764 78889999999999999998 7888864322 11222333322
Q ss_pred cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 583 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 583 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.... +..++..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 227 ~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2211 1234567889999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=387.05 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=194.4
Q ss_pred HHhhhccccccCceEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeC-Cee
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-STR 419 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~ 419 (670)
.+.+.++||+|+||.||+|++. +++.||||+++... ...+.+.+|...+.++ +|+||+.+++++.+. ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 3456789999999999999863 34689999997544 3356788898888887 789999999988765 468
Q ss_pred EEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 420 ALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
++||||+++|+|.++|+.... +..+++..++.++.|+++||+|||++ +|+||||||+||||+++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence 999999999999999965432 23589999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCC
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNT 565 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~~~~~ 565 (670)
+++||+|||+|+...............||+.|+|||++.+ +.++.++|||||||++|||++|.. ||.....
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------ 242 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 242 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999987655444433445679999999999976 478999999999999999999754 5543221
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
...+...+..+..... +...++++.+++.+||+.||++||||.||+++|+.+
T Consensus 243 -----~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 -----DEEFCRRLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -----SHHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHhcCCCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112222222211111 122345788999999999999999999999999854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=381.57 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=192.7
Q ss_pred HhhhccccccCceEEEEEEeC--CC--cEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCCeeEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP--DG--RLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv 422 (670)
+++.+.||+|+||+||+|++. ++ ..||||+++... ...++|.+|+.+|++++||||++++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 346789999999999999863 23 378999987532 345689999999999999999999999976 467899
Q ss_pred EEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCC
Q 005909 423 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 502 (670)
Q Consensus 423 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~ 502 (670)
|||+++|+|.+++..... .+++..+++++.|+++||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999998865443 489999999999999999999998 999999999999999999999999999998755
Q ss_pred CCceee-ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 503 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 503 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
...... .....|+..|+|||.+.+. .++.++|||||||++|||+| |+.||..... ..+...+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------------~~~~~~i~~ 229 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILHKIDK 229 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHT
T ss_pred CCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------------HHHHHHHHh
Confidence 433222 2334578899999999764 78889999999999999998 8999864322 111222222
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
.... ......++..+.+++.+||+.||++||||.||++.|+++
T Consensus 230 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 111123355788999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8e-46 Score=374.79 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=203.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc----------chHHHHHHHHHhcccc-ccccccccceeeeCCe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----------FSDNFINEVATIGRIH-HVNIIHLLGFCCDGST 418 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 418 (670)
|++.+.||+|+||+||+|++. +++.+|||++..... ..+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 345689999999999999984 789999999875431 1246889999999997 9999999999999999
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.+|||||+++|+|.++|.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999997643 599999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccc----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHH
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 574 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 574 (670)
........ ....||+.|+|||.+.+. ...++.++||||+||++|||++|+.||..... ..+
T Consensus 159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------------~~~ 223 (277)
T d1phka_ 159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------MLM 223 (277)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHH
T ss_pred EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------------HHH
Confidence 87654322 345689999999999642 12457899999999999999999999975321 112
Q ss_pred HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...+..... .........+++++.+++.+||+.||++|||+.||+++
T Consensus 224 ~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 LRMIMSGNY-QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHTCC-CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCC-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222222111 11111222356678899999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=383.42 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=199.4
Q ss_pred hhccccccCceEEEEEEeCC-Cc--EEEEEEcccCC--cchHHHHHHHHHhccc-cccccccccceeeeCCeeEEEEEec
Q 005909 353 FKEKLGTGGYGNVYKGKFPD-GR--LVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
+.++||+|+||+||+|++++ +. .||||++.... ...+.|.+|+++|+++ +|||||+++|++.+++..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 56889999999999998863 43 57788875432 3456899999999999 7999999999999999999999999
Q ss_pred CCCCccccccccc-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 427 PNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 427 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
++|+|.++|+... ....+++..+++++.|+++||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcc
Confidence 9999999997541 234699999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCCccccchH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPD 572 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~ 572 (670)
||+++....... .....||..|+|||.+.+ +.++.++|||||||++|||++|.. ||.... ..
T Consensus 171 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------------~~ 233 (309)
T d1fvra_ 171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------CA 233 (309)
T ss_dssp TTCEESSCEECC---C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------------HH
T ss_pred cccccccccccc---ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCC------------HH
Confidence 999976543221 123458999999999976 478999999999999999999765 453221 12
Q ss_pred HHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 573 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
.+...+..+..... +..++.++.+++.+||+.||++||||+||+++|+...
T Consensus 234 ~~~~~i~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 234 ELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHHHGGGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 23333333222211 1224567889999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=379.35 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=203.3
Q ss_pred HhhhccccccCceEEEEEEeCC--------CcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCCee
Q 005909 351 NGFKEKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTR 419 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 419 (670)
+++.+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||++++++.+....
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 4466899999999999998632 34799999976553 447889999999998 899999999999999999
Q ss_pred EEEEEecCCCCcccccccccC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCC
Q 005909 420 ALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 486 (670)
Q Consensus 420 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~ 486 (670)
++||||+++|+|.++|..... ...+++..+++++.|++.||+|||++ +||||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence 999999999999999965431 23589999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005909 487 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 565 (670)
Q Consensus 487 ~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~ellt-g~~p~~~~~~~~~~~~ 565 (670)
+.+||+|||+++...............|++.|+|||.+.+ +.++.++||||||+++|||++ |+.||.....
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 9999999999997765544433455668999999999976 478999999999999999998 5777653221
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
+.+...+..+...... ..++..+.+++.+||+.||++||||.||++.|+++
T Consensus 244 ------~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 ------EELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ------HHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHcCCCCCCC----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2233333333222221 12355788999999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=380.27 Aligned_cols=249 Identities=19% Similarity=0.272 Sum_probs=204.7
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 429 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~g 429 (670)
|.+.+.||+|+||+||+|.+. +++.||||+++........+.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 346689999999999999986 6889999999887666677899999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC--CCCeEEeecCCccccCCCCcee
Q 005909 430 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 430 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~--~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++.........
T Consensus 87 ~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 87 DIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp BHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 9999997543 2589999999999999999999998 9999999999999975 4589999999998876544332
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccccc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 587 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (670)
. ..+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+...+..... ...
T Consensus 162 ~---~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------------~~~~~~i~~~~~-~~~ 223 (321)
T d1tkia_ 162 L---LFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN------------QQIIENIMNAEY-TFD 223 (321)
T ss_dssp E---EESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-CCC
T ss_pred c---cccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CCC
Confidence 2 3479999999998764 678899999999999999999999965321 112222222111 111
Q ss_pred chhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 588 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 588 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
......++.++.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12222345678899999999999999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=383.77 Aligned_cols=259 Identities=26% Similarity=0.450 Sum_probs=208.0
Q ss_pred HHhhhccccccCceEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHhccc-cccccccccceeeeCCeeE
Q 005909 350 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 420 (670)
.+.+.++||+|+||.||+|++ .+++.||||+++.... ...+|.+|+.+++++ +|||||+++|++.+....+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 345678999999999999986 2467899999976543 345789999999999 6999999999999999999
Q ss_pred EEEEecCCCCcccccccccC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC
Q 005909 421 LIYEYMPNGSLGDLLSREKE---------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 485 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~ 485 (670)
+||||+++|+|.++++.... ...+++..+++++.||++||+|||++ +++||||||+|||++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccccc
Confidence 99999999999999975431 23589999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005909 486 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 565 (670)
Q Consensus 486 ~~~~ki~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~ 565 (670)
++.+||+|||+++...............||+.|+|||.+.+ +.++.++|||||||++|||+|++.|+.....
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~------ 252 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP------ 252 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC------
Confidence 99999999999998766555455566779999999999975 4789999999999999999996555432211
Q ss_pred ccccchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 566 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
....+...+.... .... +...+..+.+++.+||+.||++||||.||+++|++..
T Consensus 253 ~~~~~~~~i~~~~----~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 253 VDSKFYKMIKEGF----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SSHHHHHHHHHTC----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCC----CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1111112222211 1111 1123457889999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-45 Score=379.66 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=201.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~ 425 (670)
+++.++||+|+||+||+|+++ +|+.||||++... ....+.+.+|+.+|++++||||+++++++.+....++|+||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 456689999999999999985 7999999998643 24457899999999999999999999999999999999999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCc
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~ 505 (670)
+.+|+|.+++.+.. .+++..++.++.||+.||.|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 123 ~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 99999999997654 599999999999999999999998 99999999999999999999999999998875432
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~------------~~~~~~i~~~~~~- 256 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP------------IQIYEKIVSGKVR- 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred ----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH------------HHHHHHHhcCCCC-
Confidence 234589999999999764 678899999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
. +..++..+.+++.+||+.||++|+ |++|++++
T Consensus 257 ~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 F----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 112355788999999999999994 89999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=381.10 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=205.9
Q ss_pred hhhccccccCceEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.++||+|+||+||+|.++ +++.||||+++.... ....|.+|+.++++++||||++++|++...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 45688999999999999873 357899999976543 3356899999999999999999999999999999999
Q ss_pred EecCCCCccccccccc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCC
Q 005909 424 EYMPNGSLGDLLSREK-------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 496 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGl 496 (670)
||+++|+|.+++.... ....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999986532 123578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCCccccchHHHH
Q 005909 497 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIY 575 (670)
Q Consensus 497 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 575 (670)
++...............||+.|+|||.+.+. .++.++||||||+++|||+||+ .|+..... ..+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------------~~~~ 245 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------------EQVL 245 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------------HHHH
T ss_pred ceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH------------HHHH
Confidence 9877655444434445689999999999764 7788999999999999999986 45532211 1222
Q ss_pred HHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 576 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
..+.++...... ...+..+.+++.+||+.||++||||++|+++|++.
T Consensus 246 ~~i~~~~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 RFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHhCCCCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 333333222211 22345789999999999999999999999999854
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=375.96 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=193.9
Q ss_pred hccccccCceEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 354 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 354 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
.++||+|+||+||+|+++ +|+.||||+++.... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999985 689999999975432 2356899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
.++++..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 888777666433 2588899999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc---
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK--- 583 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 583 (670)
.....||+.|+|||++... ..++.++|||||||++|||++|+.||...... .....+.+.+..+..
T Consensus 157 --~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--------~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCCCTTTS
T ss_pred --ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--------HHHHHHHHhcCCCChhhc
Confidence 2345689999999998653 35688999999999999999999998643220 000011111100000
Q ss_pred ------------ccc----cchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 584 ------------EDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 584 ------------~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... ...........+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 000111234578899999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-44 Score=379.14 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=197.1
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHH---HHHHHhccccccccccccceeeeCCeeEEEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFI---NEVATIGRIHHVNIIHLLGFCCDGSTRALIY 423 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~ 423 (670)
.+.+.||+|+||+||+|++. +|+.||||++.... .....+. +|+.+++.++|||||++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 45689999999999999986 69999999986432 2223333 4477888889999999999999999999999
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
||+++|+|.++|.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999997653 588999999999999999999998 9999999999999999999999999999877644
Q ss_pred CceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcc
Q 005909 504 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 583 (670)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (670)
.. ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... -...+.........
T Consensus 161 ~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~~~~~~~~~~ 226 (364)
T d1omwa3 161 KP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLTMAV 226 (364)
T ss_dssp CC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---------CHHHHHHHSSSCCC
T ss_pred cc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcccCCC
Confidence 32 335699999999999653 35788999999999999999999999753221 01122222222111
Q ss_pred ccccchhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 005909 584 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 622 (670)
Q Consensus 584 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 622 (670)
.. +..++..+.+++.+||+.||++||| ++|++++
T Consensus 227 -~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 -EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11 1123557889999999999999999 6888764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-45 Score=371.73 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=196.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHhccccccccccccceeeeCC----eeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 421 (670)
|.+.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456789999999999999974 79999999997543 23457899999999999999999999987643 3789
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+++++|.+++...+ .+++.+++.++.|++.||+|||++ +|+||||||+|||++.++..+|+|||.++...
T Consensus 89 vmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999999886554 599999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCce-eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 502 RNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 502 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.....+..
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~~~ 229 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRE 229 (277)
T ss_dssp ----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHC
T ss_pred cccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHHhc
Confidence 33221 223345689999999999753 678999999999999999999999964321 1112222222
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhhc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 626 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 626 (670)
.... .......++..+.+++.+||+.||++|| |++++++.|.++
T Consensus 230 ~~~~--~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCC--GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCC--CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1111 1111223456788999999999999999 899999888754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=374.96 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=199.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHhc-cccccccccccceeeeCCeeEEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIG-RIHHVNIIHLLGFCCDGSTRALIYE 424 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lv~e 424 (670)
|.+.+.||+|+||+||+|++. +++.||||++++. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346789999999999999986 6899999999753 344566777877765 6799999999999999999999999
Q ss_pred ecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCC
Q 005909 425 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 425 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~ 504 (670)
|+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999997654 589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCccc
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 584 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (670)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~- 220 (320)
T d1xjda_ 158 AK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------------EELFHSIRMDNP- 220 (320)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-
T ss_pred cc--ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCC-
Confidence 22 2345689999999999864 788999999999999999999999964322 122222221111
Q ss_pred cccchhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 005909 585 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 621 (670)
Q Consensus 585 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 621 (670)
.. +..++..+.+++.+||+.||++||++. |+++
T Consensus 221 ~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 112356788999999999999999995 6765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=376.43 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccc-cccccccccceeee----CCeeEEEEEecCC
Q 005909 355 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 428 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lv~e~~~~ 428 (670)
+.||+|+||+||+|++. +++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....++||||+++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 45999999999999974 789999999864 34677899987665 89999999999875 3568999999999
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC---CCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~---~~~~ki~DfGla~~~~~~~~ 505 (670)
|+|.++|.+... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++ ++.+||+|||+++.......
T Consensus 94 g~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 94 GELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp EEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc
Confidence 999999976432 3699999999999999999999998 9999999999999975 56799999999987765433
Q ss_pred eeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCCcccc
Q 005909 506 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 585 (670)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (670)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+...+.... ..
T Consensus 170 ---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--------~~~~~~~~i~~~~-~~ 235 (335)
T d2ozaa1 170 ---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGMKTRIRMGQ-YE 235 (335)
T ss_dssp ---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSCS-SS
T ss_pred ---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--------HHHHHHHHHhcCC-CC
Confidence 2345699999999999764 67889999999999999999999996533211 0011111111111 11
Q ss_pred ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 586 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 586 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
........++.++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2222334566789999999999999999999999885
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=368.62 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=195.4
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecC
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 427 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~ 427 (670)
.+.++||+|+||+||+|++. +|+.||||+++... ...+++.+|+++|++++|||||++++++.++...++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 34588999999999999984 68999999996543 235789999999999999999999999999999999999996
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCcee
Q 005909 428 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 507 (670)
Q Consensus 428 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~ 507 (670)
+ ++.+++.... ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++........
T Consensus 85 ~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~- 158 (298)
T d1gz8a_ 85 Q-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 158 (298)
T ss_dssp E-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred C-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence 5 4444443322 23599999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCCccccchHHHHHHhc
Q 005909 508 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDWIYDKLI 579 (670)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 579 (670)
.....||+.|+|||++... ...+.++|||||||++|||++|+.||........ ....+...+......-.
T Consensus 159 -~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2345689999999998764 3568899999999999999999999965321000 00000000000000000
Q ss_pred CCcccc----ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 580 QPEKED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 580 ~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
...... .........+..+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0001111234678889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-44 Score=363.42 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=196.7
Q ss_pred hhhccccccCceEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEecCC
Q 005909 352 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
.+.++||+|+||+||+|++++|+.||||++.... ...+.+.+|+.+|++++||||+++++++.+.+..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 4568899999999999999999999999997643 3357899999999999999999999999999999999999987
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCceee
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 508 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 508 (670)
+.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 85 DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 7666665433 2599999999999999999999998 9999999999999999999999999999876543321
Q ss_pred ecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC-------
Q 005909 509 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP------- 581 (670)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 581 (670)
.....+++.|+|||.+.+. ...+.++|||||||++|||++|+.||...... ..+ ..+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-------~~~-~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-------DQL-MRIFRILGTPNSKNWPN 227 (286)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH-HHHHHHHCCCCTTTSTT
T ss_pred cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-------HHH-HHHHHhhCCCChhhccc
Confidence 2334589999999999754 46789999999999999999999999653210 000 0000000000
Q ss_pred -------------ccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 -------------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 -------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.............+..+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111122235578899999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=367.21 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=192.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHhcccc--ccccccccceeeeCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~ 420 (670)
|.+.+.||+|+||+||+|++. +|+.||||+++... ....++.+|+.++++++ ||||+++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 456689999999999999985 78999999987532 11234678999999996 899999999999999999
Q ss_pred EEEEecCC-CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-CCCeEEeecCCcc
Q 005909 421 LIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK 498 (670)
Q Consensus 421 lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-~~~~ki~DfGla~ 498 (670)
+||||+.+ +++.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 86 lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 99999975 57777775543 599999999999999999999998 9999999999999985 5799999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 499 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
...... .....||+.|+|||++.+. ...+.++|||||||++|||++|+.||..... +....
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~ 220 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQ 220 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCC
T ss_pred eccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhcc
Confidence 754432 2345699999999999764 2346779999999999999999999964211 11100
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
. ... ..++.++.+++.+||+.||++|||++|++++
T Consensus 221 ~--~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V--FFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--CCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c--CCC-------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 001 1134568889999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=368.05 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=191.2
Q ss_pred hhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccccceeeeC------CeeEEEEEe
Q 005909 353 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIYEY 425 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lv~e~ 425 (670)
..++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||+++++++... ...++||||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 4578999999999999986 6999999999765532 23799999999999999999998543 246899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 504 (670)
++++.+..+.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 97665444443333444799999999999999999999998 999999999999999775 89999999998775544
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC----ccccchHHHHHHhcC
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWIYDKLIQ 580 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 580 (670)
.. ....|+..|+|||.+.+. ..++.++||||+||++|||++|+.||........... .......++......
T Consensus 178 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 178 PN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cc---ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 32 234689999999998754 4678999999999999999999999965322000000 000000111110000
Q ss_pred ---Cccc-----cccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 ---PEKE-----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 ---~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00011112345578899999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=361.89 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=190.6
Q ss_pred HhhhccccccCceEEEEEEeC-C-CcEEEEEEcccCC---cchHHHHHHHHHhccc---cccccccccceeee-----CC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GS 417 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~ 417 (670)
|++.++||+|+||+||+|++. + ++.||||+++... .....+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 445689999999999999974 3 6789999986432 2334567788777766 79999999998863 24
Q ss_pred eeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 418 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 418 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
..++++||+.++++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred eEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 678999999887665444332 23589999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHH
Q 005909 498 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 577 (670)
Q Consensus 498 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 577 (670)
+....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... . ....+...
T Consensus 164 ~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~ 230 (305)
T d1blxa_ 164 RIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------D-QLGKILDV 230 (305)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHHH
T ss_pred hhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHHh
Confidence 86543332 2345689999999999764 7889999999999999999999999753220 0 00001110
Q ss_pred hcC------------------CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 578 LIQ------------------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 578 ~~~------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
+.. ..............+..+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000001111122234567889999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=354.20 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=190.5
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee--------CCe
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--------GST 418 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~~ 418 (670)
|.+.++||+|+||+||+|++. +|+.||||++.... ...+++.+|+.+|++++||||+++++++.. ...
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 345689999999999999985 79999999986543 345778999999999999999999998755 345
Q ss_pred eEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 419 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 419 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.++||||+.++.+....... ..+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 78999999877666554332 2588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcee--eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHH
Q 005909 499 AHSRNRSVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 576 (670)
Q Consensus 499 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 576 (670)
......... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--------~~~~~~i~~ 236 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--------QHQLALISQ 236 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCH--------HHHHHHHHH
Confidence 765432211 12234689999999998754 3578899999999999999999999964321 000000111
Q ss_pred Hhc--------------------CCccccc-cch--hhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 005909 577 KLI--------------------QPEKEDF-VEE--EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 623 (670)
Q Consensus 577 ~~~--------------------~~~~~~~-~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 623 (670)
... ....... ... ........+.+++.+||+.||++|||++|++++=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 000 0000000 000 0111234677899999999999999999999763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=361.32 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=193.4
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHhccccccccccccceeeeCC----eeEEEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIY 423 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lv~ 423 (670)
|.+.++||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 445689999999999999874 79999999997654 23567899999999999999999999987543 335566
Q ss_pred EecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCC
Q 005909 424 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 424 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~ 503 (670)
+|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 777799999999653 489999999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccee-eecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------CC-----ccc
Q 005909 504 RSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NT-----TEA 568 (670)
Q Consensus 504 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~---------~~-----~~~ 568 (670)
.... ......||+.|+|||++... ..++.++||||+||++|||++|+.||......... .. ...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 2211 12345689999999998654 46688999999999999999999999654320000 00 000
Q ss_pred cchHHHHHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 569 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....+.......................++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000000001111234568899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=357.87 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=189.6
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCC------eeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 420 (670)
|.+.++||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+.+|++++|||||++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 345688999999999999975 69999999997543 23467899999999999999999999997654 468
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+||||+ +.+|..+++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 999999 56777766443 599999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCC---ccccchHHH---
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWI--- 574 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~--- 574 (670)
.... +...||+.|+|||++.+. ...+.++||||+||++|||++|+.||........... .....+...
T Consensus 172 ~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 172 DSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred CCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 5432 345689999999999754 3568899999999999999999999975422000000 000000000
Q ss_pred ---------HHHhcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 575 ---------YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 575 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... ...............+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcchhhhhhhccCCcc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0001000 0011111112234567889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-41 Score=346.34 Aligned_cols=259 Identities=17% Similarity=0.240 Sum_probs=200.8
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccc-cccccccceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.++||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.+..+.| +|++.+++++.++...++||||+ +
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 456789999999999999975 68999999986543 23457788999999965 89999999999999999999999 7
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECC-----CCCeEEeecCCccccCCC
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRN 503 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~-----~~~~ki~DfGla~~~~~~ 503 (670)
++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 85 ~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 85 PSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 899998865433 589999999999999999999998 9999999999999964 578999999999876533
Q ss_pred Cce-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHh
Q 005909 504 RSV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 578 (670)
Q Consensus 504 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (670)
... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .... ...++
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~-----~~~~i 228 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQ-----KYERI 228 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHH-----HHHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccch----hHHH-----HHHHH
Confidence 211 112345699999999999764 6899999999999999999999999754321 0000 11111
Q ss_pred cCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhcc
Q 005909 579 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 627 (670)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 627 (670)
..........+....+++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1100000111111223567888999999999999999999988887653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=348.76 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=200.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeeeCCeeEEEEEec
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 426 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lv~e~~ 426 (670)
|++.++||+|+||+||+|++. +++.||||+++... ...+++.+|+.+|++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 345689999999999999985 78999999986543 34578899999999999999999999999999999999999
Q ss_pred CCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccCCCCce
Q 005909 427 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 506 (670)
Q Consensus 427 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~~~~~~ 506 (670)
.+++|..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++........
T Consensus 84 ~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 84 DQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999888776543 588999999999999999999998 9999999999999999999999999999877544332
Q ss_pred eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC------
Q 005909 507 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ------ 580 (670)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 580 (670)
.....++..|+|||.+... ...+.++|||||||++|||++|+.||...... .. ....+......
T Consensus 158 --~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~------~~-~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV------DD-QLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH------HH-HHHHHHHHHCCCCTTTC
T ss_pred --ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCH------HH-HHHHHHhhcCCCChhhh
Confidence 2334578899999998754 35688999999999999999999997532210 00 00000000000
Q ss_pred --------Cc------cccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 581 --------PE------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 581 --------~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.. ...............+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0001111122335568889999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=349.66 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=194.1
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhccccccccccc-cceeeeCCeeEEEEEecCC
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHL-LGFCCDGSTRALIYEYMPN 428 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-~g~~~~~~~~~lv~e~~~~ 428 (670)
|.+.++||+|+||+||+|++. +|+.||||++..... .+++..|++++++++|+|++.. .++..+++..++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 456789999999999999975 689999999876443 3567899999999987765555 45556778889999999 5
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEEC---CCCCeEEeecCCccccCCCCc
Q 005909 429 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRS 505 (670)
Q Consensus 429 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~---~~~~~ki~DfGla~~~~~~~~ 505 (670)
++|.+.+..... .+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 87 ~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 677666644332 589999999999999999999998 999999999999985 456799999999997754332
Q ss_pred e-----eeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 506 V-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 506 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ...............
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~----~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEKKMST 235 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHHS
T ss_pred ccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHH----HHHHHHHhhcccCCC
Confidence 1 122345699999999999764 67899999999999999999999997543211 001111111111111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhhc
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 626 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 626 (670)
........++.++.+++.+||+.||++||++.++.+.|+..
T Consensus 236 -----~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 236 -----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111123456788999999999999999999999888754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=353.46 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=199.5
Q ss_pred HhhhccccccCceEEEEEEeC----CCcEEEEEEcccCC-----cchHHHHHHHHHhccccc-cccccccceeeeCCeeE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRA 420 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~ 420 (670)
|.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456789999999999999862 47899999986532 345678899999999976 89999999999999999
Q ss_pred EEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCcccc
Q 005909 421 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 500 (670)
Q Consensus 421 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~ 500 (670)
+++||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 106 ~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999997654 478899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcC
Q 005909 501 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 580 (670)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (670)
....... .....|++.|+|||.+.+....++.++|||||||+||||++|+.||...... .....+......
T Consensus 180 ~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--------~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------NSQAEISRRILK 250 (322)
T ss_dssp CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------CCHHHHHHHHHH
T ss_pred ccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhccc
Confidence 4332221 2335689999999999765456788999999999999999999999754321 111122222111
Q ss_pred CccccccchhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 005909 581 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 622 (670)
Q Consensus 581 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 622 (670)
... ..+...+.++.+++.+||+.||++|| +++|++++
T Consensus 251 ~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 01112456788999999999999999 48888864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=353.02 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=195.1
Q ss_pred HHhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-ccccccccceeeeC--CeeEEEEEe
Q 005909 350 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDG--STRALIYEY 425 (670)
Q Consensus 350 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lv~e~ 425 (670)
.+.+.++||+|+||+||+|++. +|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 3556789999999999999985 7899999998754 3577899999999995 99999999998744 468899999
Q ss_pred cCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCC-CeEEeecCCccccCCCC
Q 005909 426 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNR 504 (670)
Q Consensus 426 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~-~~ki~DfGla~~~~~~~ 504 (670)
+++++|..+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 114 ~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 114 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred cCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999977642 489999999999999999999998 999999999999998654 69999999998776543
Q ss_pred ceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCc------cccchHHHHHHh
Q 005909 505 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT------EAYFPDWIYDKL 578 (670)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~ 578 (670)
. .....+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||............ ......+.....
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred c---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 2345689999999998764 35688999999999999999999999654321000000 000000000000
Q ss_pred cCC-----------c---c-ccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 579 IQP-----------E---K-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 579 ~~~-----------~---~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
... . . ..........++.++.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0 001111223345678899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=343.13 Aligned_cols=257 Identities=23% Similarity=0.245 Sum_probs=185.3
Q ss_pred hhhccccccCceEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHhccccccccccccceeee------CCeeEE
Q 005909 352 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRAL 421 (670)
Q Consensus 352 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~l 421 (670)
++.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 45579999999999999986 69999999997643 234578899999999999999999999863 357899
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
||||+.++.+ +.+.. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 100 v~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 100 VMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 9999965544 44422 489999999999999999999998 99999999999999999999999999988765
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------C--Cccccc
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------N--TTEAYF 570 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~---------~--~~~~~~ 570 (670)
.... .....+|+.|+|||++.+. .++.++||||+||+++||++|+.||......... . ......
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 4332 2334589999999999764 6788999999999999999999999643210000 0 000000
Q ss_pred hHHHHHH--------------hcCCccccccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 571 PDWIYDK--------------LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 571 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
....... .................+..+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000001111222345567789999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=349.80 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=191.0
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHhccccccccccccceeeeC-----CeeEE
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRAL 421 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 421 (670)
|++.++||+|+||+||+|++. +|+.||||++..... ..+.+.+|+.+|++++||||+++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 445689999999999999975 799999999976542 345788999999999999999999998643 34567
Q ss_pred EEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEeecCCccccC
Q 005909 422 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 501 (670)
Q Consensus 422 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~DfGla~~~~ 501 (670)
+++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 78888899999998543 499999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccchHHHHHHhcCC
Q 005909 502 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 581 (670)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (670)
.. .....|++.|+|||.+.+. ...+.++|||||||++|||++|+.||...... .....+.......
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--------~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLILRLVGTP 238 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCC
T ss_pred cc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcCCC
Confidence 32 2335689999999987654 35688999999999999999999999653220 0000010000000
Q ss_pred ---------------------cccc-ccchhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 005909 582 ---------------------EKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 622 (670)
Q Consensus 582 ---------------------~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 622 (670)
.... ............+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 0000111234567899999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-37 Score=322.42 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=189.9
Q ss_pred HhhhccccccCceEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHhcccc-----------ccccccccceeeeC--
Q 005909 351 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----------HVNIIHLLGFCCDG-- 416 (670)
Q Consensus 351 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~-- 416 (670)
|.+.++||+|+||+||+|+.. +|+.||||+++......+.+.+|+.++++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 567799999999999999985 7999999999877656678889999988875 47899999887643
Q ss_pred CeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCC------eE
Q 005909 417 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT------PK 490 (670)
Q Consensus 417 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~------~k 490 (670)
...+++++++..+..............+++..+..++.|++.||+|||+. .+|+||||||+||||+.++. +|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceee
Confidence 45667777776555444443333444689999999999999999999973 28999999999999976653 99
Q ss_pred EeecCCccccCCCCceeeecCCCCCccccchhhcccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCCCCccccc
Q 005909 491 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF 570 (670)
Q Consensus 491 i~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDV~SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 570 (670)
++|||.+....... ....||+.|+|||++.. ..++.++||||+||+++||++|+.||.+......... ...+
T Consensus 173 l~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~-~~~~ 244 (362)
T d1q8ya_ 173 IADLGNACWYDEHY-----TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD-DDHI 244 (362)
T ss_dssp ECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------CH-HHHH
T ss_pred Eeeccccccccccc-----ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccccch-hHHH
Confidence 99999997654322 23458999999999875 3678899999999999999999999976433111110 0000
Q ss_pred h----------HHHHHH------hcC------Cccc----------cccchhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 005909 571 P----------DWIYDK------LIQ------PEKE----------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 618 (670)
Q Consensus 571 ~----------~~~~~~------~~~------~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 618 (670)
. ...... ... .... ..........+..+.+++.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 000000 000 0000 0011123456778999999999999999999999
Q ss_pred HHHH
Q 005909 619 VVEM 622 (670)
Q Consensus 619 vl~~ 622 (670)
++++
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9886
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.9e-23 Score=193.46 Aligned_cols=161 Identities=14% Similarity=0.119 Sum_probs=118.0
Q ss_pred hhccccccCceEEEEEEeCCCcEEEEEEcccCCc-------------------chHHHHHHHHHhcccccccccccccee
Q 005909 353 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------FSDNFINEVATIGRIHHVNIIHLLGFC 413 (670)
Q Consensus 353 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~H~nIv~l~g~~ 413 (670)
+.++||+|+||+||+|++.+|+.||||+++.... ....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4578999999999999998999999998753210 112345688899999999998877553
Q ss_pred eeCCeeEEEEEecCCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCcEEECCCCCeEEee
Q 005909 414 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 493 (670)
Q Consensus 414 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIll~~~~~~ki~D 493 (670)
..+++|||++++.+.+ ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2379999998765443 22333467899999999999998 99999999999999965 589999
Q ss_pred cCCccccCCCCceeeecCCCCCccccc------hhhcccccCCCCccchhHHHHHHH
Q 005909 494 FGLAKAHSRNRSVVTMTGPRGTIGYIA------PEIFMRNLGNPSGKSDVYSYGMLL 544 (670)
Q Consensus 494 fGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~sDV~SlGvvl 544 (670)
||+|+........ .|.. .|.+.+ .++.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITYFSR---TYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHHHcC---CCCCcccHHHHHHHH
Confidence 9999765433221 1211 122322 456789999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=3.9e-06 Score=81.13 Aligned_cols=130 Identities=15% Similarity=0.088 Sum_probs=89.5
Q ss_pred cCceEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHhcccc-ccccccccceeeeCCeeEEEEEecCCCCccccccc
Q 005909 360 GGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR 437 (670)
Q Consensus 360 G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 437 (670)
++.+.||+... +++.+++|+..... .....+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 34468999875 55556777765432 33445778888877773 43466778888888889999999998877654422
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------------
Q 005909 438 EKENLSLKPARLLEIALGVAHAIEYLHNGC-------------------------------------------------- 467 (670)
Q Consensus 438 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 467 (670)
. . ....++.++++.|+.||+..
T Consensus 104 ~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 E-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 1 12335566667777777421
Q ss_pred ------CCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 468 ------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 468 ------~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
...++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127899999999999987777899998663
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=1.1e-05 Score=77.33 Aligned_cols=130 Identities=19% Similarity=0.192 Sum_probs=87.3
Q ss_pred cccccCc-eEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhccccc--cccccccceeeeCCeeEEEEEecCCCCcc
Q 005909 356 KLGTGGY-GNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYMPNGSLG 432 (670)
Q Consensus 356 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lv~e~~~~gsL~ 432 (670)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++||+++++.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3455543 68999998888888999865443 3456778888877743 33566788888888889999999887664
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 005909 433 DLLSREKENLSLKPARLLEIALGVAHAIEYLHN----------------------------------------------- 465 (670)
Q Consensus 433 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 465 (670)
+.. .... ..+.++++.|+-||+
T Consensus 95 ~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 421 1111 122333444444442
Q ss_pred ----CC----CCCeEecCCCCCcEEECCCCCeEEeecCCcc
Q 005909 466 ----GC----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 498 (670)
Q Consensus 466 ----~~----~~~ivH~dlkp~NIll~~~~~~ki~DfGla~ 498 (670)
.. ...++|+|+.|.|||++++..+.|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 10 1237999999999999987777899998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.00029 Score=71.89 Aligned_cols=74 Identities=15% Similarity=0.100 Sum_probs=48.0
Q ss_pred ccccccCceEEEEEEeCC-CcEEEEEEcccC--------CcchHHHHHHHHHhcccc-c--cccccccceeeeCCeeEEE
Q 005909 355 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKT--------SNFSDNFINEVATIGRIH-H--VNIIHLLGFCCDGSTRALI 422 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~lv 422 (670)
+.||.|....||+....+ ++.++||.-... ....++...|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 568999999999998764 678889864321 112345567888877663 2 334555543 55567899
Q ss_pred EEecCCCC
Q 005909 423 YEYMPNGS 430 (670)
Q Consensus 423 ~e~~~~gs 430 (670)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00065 Score=67.29 Aligned_cols=70 Identities=13% Similarity=0.102 Sum_probs=50.1
Q ss_pred ceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccccc--c---cccc--eeeeCCeeEEEEEecCCCCc
Q 005909 362 YGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI--I---HLLG--FCCDGSTRALIYEYMPNGSL 431 (670)
Q Consensus 362 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI--v---~l~g--~~~~~~~~~lv~e~~~~gsL 431 (670)
--.||+++..+|+.+++|+.+......+++..|+..+..|....+ + ..-+ .....+..+.+++++++..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 358999999999999999988766667888899988888753222 1 2111 23445667889999976544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.63 E-value=0.0035 Score=63.58 Aligned_cols=73 Identities=14% Similarity=0.277 Sum_probs=50.5
Q ss_pred ccccccCceEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHhcccccccc-ccccceeeeCCeeEEEEEe
Q 005909 355 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEY 425 (670)
Q Consensus 355 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lv~e~ 425 (670)
+.|+.|-.-.+|+...++ .+.|++++..... ..-+..+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 568888889999998754 3567777766433 33456689999888853444 466766643 579999
Q ss_pred cCCCCcc
Q 005909 426 MPNGSLG 432 (670)
Q Consensus 426 ~~~gsL~ 432 (670)
+++.+|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9875553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.01 E-value=0.028 Score=54.56 Aligned_cols=140 Identities=13% Similarity=0.072 Sum_probs=73.4
Q ss_pred cccccCceEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHhcccccccc--cccc----c--eeeeCCeeEEEEEecC
Q 005909 356 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI--IHLL----G--FCCDGSTRALIYEYMP 427 (670)
Q Consensus 356 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~----g--~~~~~~~~~lv~e~~~ 427 (670)
.|..|.--+.|+.+..+|+ +++|+..... ..+++..|++++..+.+.++ ...+ | +.........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 4567777889999887765 7889876532 23455667777777743222 1111 1 1223445566677765
Q ss_pred CCCccccccc--------------c----c--CCCCCC------------------HHHHHHHHHHHHHHHHHHHcC-CC
Q 005909 428 NGSLGDLLSR--------------E----K--ENLSLK------------------PARLLEIALGVAHAIEYLHNG-CE 468 (670)
Q Consensus 428 ~gsL~~~l~~--------------~----~--~~~~l~------------------~~~~~~i~~~ia~gL~yLH~~-~~ 468 (670)
+......-.. . . ...... .......+......+.-.+.. ..
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 5433221100 0 0 000000 001112222233333333321 23
Q ss_pred CCeEecCCCCCcEEECCCCCeEEeecCCc
Q 005909 469 LRILHLDIKPQNVLLDPDFTPKVSDFGLA 497 (670)
Q Consensus 469 ~~ivH~dlkp~NIll~~~~~~ki~DfGla 497 (670)
.++||+|+.++||+++.+...-|.||+.+
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccccCCcchhhhhcccccceeEeccccc
Confidence 47999999999999998877789999976
|